International consensus statement on allergy and rhinology: Allergic rhinitis - 2023.

التفاصيل البيبلوغرافية
العنوان:	International consensus statement on allergy and rhinology: Allergic rhinitis - 2023.
المؤلفون:	Wise SK; Otolaryngology-HNS, Emory University, Atlanta, Georgia, USA., Damask C; Otolaryngology-HNS, Private Practice, University of Central Florida, Lake Mary, Florida, USA., Roland LT; Otolaryngology-HNS, Washington University, St. Louis, Missouri, USA., Ebert C; Otolaryngology-HNS, University of North Carolina, Chapel Hill, North Carolina, USA., Levy JM; Otolaryngology-HNS, Emory University, Atlanta, Georgia, USA., Lin S; Otolaryngology-HNS, University of Wisconsin, Madison, Wisconsin, USA., Luong A; Otolaryngology-HNS, McGovern Medical School of the University of Texas, Houston, Texas, USA., Rodriguez K; Otolaryngology-HNS, University Hospitals Cleveland Medical Center, Cleveland, Ohio, USA., Sedaghat AR; Otolaryngology-HNS, University of Cincinnati, Cincinnati, Ohio, USA., Toskala E; Otolaryngology-HNS, Thomas Jefferson University, Philadelphia, Pennsylvania, USA., Villwock J; Otolaryngology-HNS, University of Kansas, Kansas City, Kansas, USA., Abdullah B; Otolaryngology-HNS, Universiti Sains Malaysia, Kubang, Kerian, Kelantan, Malaysia., Akdis C; Immunology, Infectious Diseases, Swiss Institute of Allergy and Asthma Research, Davos, Switzerland., Alt JA; Otolaryngology-HNS, University of Utah, Salt Lake City, Utah, USA., Ansotegui IJ; Allergy/Immunology, Hospital Quironsalud Bizkala, Bilbao, Spain., Azar A; Allergy/Immunology, Johns Hopkins University, Baltimore, Maryland, USA., Baroody F; Otolaryngology-HNS, University of Chicago, Chicago, Illinois, USA., Benninger MS; Otolaryngology-HNS, Cleveland Clinic, Cleveland, Ohio, USA., Bernstein J; Allergy/Immunology, University of Cincinnati, Cincinnati, Ohio, USA., Brook C; Otolaryngology-HNS, Harvard University, Beth Israel Deaconess Medical Center, Boston, Massachusetts, USA., Campbell R; Otolaryngology-HNS, Macquarie University, Sydney, NSW, Australia., Casale T; Allergy/Immunology, University of South Florida College of Medicine, Tampa, Florida, USA., Chaaban MR; Otolaryngology-HNS, Cleveland Clinic, Case Western Reserve University, Cleveland, Ohio, USA., Chew FT; Allergy/Immunology, Genetics, National University of Singapore, Singapore, Singapore., Chambliss J; Allergy/Immunology, University of Texas Southwestern, Dallas, Texas, USA., Cianferoni A; Allergy/Immunology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA., Custovic A; Pediatric allergy, Imperial College London, London, UK., Davis EM; Otolaryngology-HNS, Boston University, Boston, Massachusetts, USA., DelGaudio JM; Otolaryngology-HNS, Emory University, Atlanta, Georgia, USA., Ellis AK; Allergy/Immunology, Queens University, Kingston, ON, Canada., Flanagan C; Otolaryngology-HNS, Emory University, Atlanta, Georgia, USA., Fokkens WJ; Otorhinolaryngology, Amsterdam University Medical Centres, Amsterdam, Netherlands., Franzese C; Otolaryngology-HNS, University of Missouri, Columbia, Missouri, USA., Greenhawt M; Allergy/Immunology, Pediatrics, University of Colorado, Children's Hospital Colorado, Aurora, Colorado, USA., Gill A; Otolaryngology-HNS, University of Michigan, Ann Arbor, Michigan, USA., Halderman A; Otolaryngology-HNS, University of Texas Southwestern, Dallas, Texas, USA., Hohlfeld JM; Respiratory Medicine, Fraunhofer Institute for Toxicology and Experimental Medicine ITEM, Hannover Medical School, German Center for Lung Research, Hannover, Germany., Incorvaia C; Allergy, Private Practice, Milan, Italy., Joe SA; Otolaryngology-HNS, University of Illinois Chicago, Chicago, Illinois, USA., Joshi S; Allergy/Immunology, Oregon Health and Science University, Portland, Oregon, USA., Kuruvilla ME; Allergy/Immunology, Emory University, Atlanta, Georgia, USA., Kim J; Otolaryngology-HNS, Johns Hopkins University, Baltimore, Maryland, USA., Klein AM; Otolaryngology-HNS, Emory University, Atlanta, Georgia, USA., Krouse HJ; Otorhinolaryngology Nursing, University of Texas Rio Grande Valley, Edinburg, Texas, USA., Kuan EC; Otolaryngology-HNS, University of California Irvine, Orange, California, USA., Lang D; Allergy/Immunology, Cleveland Clinic, Cleveland, Ohio, USA., Larenas-Linnemann D; Allergy/Immunology, Pediatric, Medica Sur Clinical Foundation and Hospital, Mexico City, Mexico., Laury AM; Otolaryngology-HNS, Bellevue ENT, Bellevue, Washington, USA., Lechner M; Otolaryngology-HNS, University College London, Barts Health NHS Trust, London, UK., Lee SE; Otolaryngology-HNS, Brigham and Women's Hospital, Boston, Massachusetts, USA., Lee VS; Otolaryngology-HNS, University of Illinois Chicago, Chicago, Illinois, USA., Loftus P; Otolaryngology-HNS, University of California San Francisco, San Francisco, California, USA., Marcus S; Otolaryngology-HNS, Stony Brook University, Stony Brook, New York, USA., Marzouk H; Otolaryngology-HNS, State University of New York Upstate, Syracuse, New York, USA., Mattos J; Otolaryngology-HNS, University of Virginia, Charlottesville, Virginia, USA., McCoul E; Otolaryngology-HNS, Ochsner Clinic, New Orleans, Louisiana, USA., Melen E; Pediatric Allergy, Karolinska Institutet, Stockholm, Sweden., Mims JW; Otolaryngology-HNS, Wake Forest University, Winston Salem, North Carolina, USA., Mullol J; Otorhinolaryngology, Hospital Clinic Barcelona, Barcelona, Spain., Nayak JV; Otolaryngology-HNS, Stanford University, Palo Alto, California, USA., Oppenheimer J; Allergy/Immunology, Rutgers, State University of New Jersey, Newark, New Jersey, USA., Orlandi RR; Otolaryngology-HNS, University of Utah, Salt Lake City, Utah, USA., Phillips K; Otolaryngology-HNS, University of Cincinnati, Cincinnati, Ohio, USA., Platt M; Otolaryngology-HNS, Boston University, Boston, Massachusetts, USA., Ramanathan M Jr; Otolaryngology-HNS, Johns Hopkins University, Baltimore, Maryland, USA., Raymond M; Otolaryngology-HNS, Mayo Clinic, Jacksonville, Florida, USA., Rhee CS; Rhinology/Allergy, Seoul National University Hospital and College of Medicine, Seoul, Korea., Reitsma S; Otolaryngology-HNS, University of Amsterdam, Amsterdam, Netherlands., Ryan M; Otolaryngology-HNS, University of Texas Southwestern, Dallas, Texas, USA., Sastre J; Allergy, Fundacion Jiminez Diaz, University Autonoma de Madrid, Madrid, Spain., Schlosser RJ; Otolaryngology-HNS, Medical University of South Carolina, Charleston, South Carolina, USA., Schuman TA; Otolaryngology-HNS, Virginia Commonwealth University, Richmond, Virginia, USA., Shaker MS; Allergy/Immunology, Dartmouth Geisel School of Medicine, Lebanon, New Hampshire, USA., Sheikh A; Primary Care, University of Edinburgh, Edinburgh, Scotland., Smith KA; Otolaryngology-HNS, University of Utah, Salt Lake City, Utah, USA., Soyka MB; Otolaryngology-HNS, University of Zurich, University Hospital of Zurich, Zurich, Switzerland., Takashima M; Otolaryngology-HNS, Houston Methodist Academic Institute, Houston, Texas, USA., Tang M; Allergy/Immunology, University of California San Francisco, San Francisco, California, USA., Tantilipikorn P; Rhinology/Allergy, Mahidol University, Siriraj Hospital, Bangkok, Thailand., Taw MB; Integrative East-West Medicine, University of California Los Angeles, Westlake Village, California, USA., Tversky J; Allergy/Immunology, Johns Hopkins University, Baltimore, Maryland, USA., Tyler MA; Otolaryngology-HNS, University of Minnesota, Minneapolis, Minnesota, USA., Veling MC; Otolaryngology-HNS, University of Texas Southwestern, Dallas, Texas, USA., Wallace D; Allergy/Immunology, Nova Southeastern University, Ft. Lauderdale, Florida, USA., Wang Y; Otolaryngology-HNS, National University of Singapore, Singapore, Singapore., White A; Allergy/Immunology, Scripps Clinic, San Diego, California, USA., Zhang L; Otolaryngology-HNS, Beijing Tongren Hospital, Beijing, China.
المصدر:	International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2023 Apr; Vol. 13 (4), pp. 293-859. Date of Electronic Publication: 2023 Mar 06.
نوع المنشور:	Journal Article; Review
اللغة:	English
بيانات الدورية:	Publisher: Published for ARS-AAOA by Wiley-Blackwell Country of Publication: United States NLM ID: 101550261 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-6984 (Electronic) Linking ISSN: 20426976 NLM ISO Abbreviation: Int Forum Allergy Rhinol Subsets: MEDLINE
أسماء مطبوعة:	Original Publication: Hoboken : Published for ARS-AAOA by Wiley-Blackwell
مواضيع طبية MeSH:	Iron-Dextran Complex* , Rhinitis, Allergic/diagnosis , Rhinitis, Allergic/therapy, Humans ; Allergens
مستخلص:	Background: In the 5 years that have passed since the publication of the 2018 International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR-Allergic Rhinitis 2018), the literature has expanded substantially. The ICAR-Allergic Rhinitis 2023 update presents 144 individual topics on allergic rhinitis (AR), expanded by over 40 topics from the 2018 document. Originally presented topics from 2018 have also been reviewed and updated. The executive summary highlights key evidence-based findings and recommendation from the full document. Methods: ICAR-Allergic Rhinitis 2023 employed established evidence-based review with recommendation (EBRR) methodology to individually evaluate each topic. Stepwise iterative peer review and consensus was performed for each topic. The final document was then collated and includes the results of this work. Results: ICAR-Allergic Rhinitis 2023 includes 10 major content areas and 144 individual topics related to AR. For a substantial proportion of topics included, an aggregate grade of evidence is presented, which is determined by collating the levels of evidence for each available study identified in the literature. For topics in which a diagnostic or therapeutic intervention is considered, a recommendation summary is presented, which considers the aggregate grade of evidence, benefit, harm, and cost. Conclusion: The ICAR-Allergic Rhinitis 2023 update provides a comprehensive evaluation of AR and the currently available evidence. It is this evidence that contributes to our current knowledge base and recommendations for patient evaluation and treatment. (© 2023 The Authors. International Forum of Allergy & Rhinology published by Wiley Periodicals LLC on behalf of American Academy of Otolaryngic Allergy and American Rhinologic Society.)
التعليقات:	Comment in: Int Forum Allergy Rhinol. 2023 Sep;13(9):1838-1840. (PMID: 37475593) Comment in: Int Forum Allergy Rhinol. 2023 Sep;13(9):1834-1835. (PMID: 37478135)
References:	Wise SK, Lin SY, Toskala E, et al. International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis. Int Forum Allergy Rhinol. 2018;8(2):108-352. https://doi.org/10.1002/alr.22073. Rudmik L, Smith TL. Development of an evidence-based review with recommendations using an online iterative process. Int Forum Allergy Rhinol. 2011;1(6):431-437. https://doi.org/10.1002/alr.20095. Moher D, Liberati A, Tetzlaff J, Altman DG, Group P. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Med. 2009;3(3):e123-e130. American Academy of Pediatrics Steering Committee on Quality I, Management. Classifying recommendations for clinical practice guidelines. Pediatrics. 2004;114(3):874-877. https://doi.org/10.1542/peds.2004-1260. Bousquet J, Van Cauwenberge P, Khaltaev N, Aria Workshop Group, World Health Organization. Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol. 2001;108(5 Suppl):S147-S334. https://doi.org/10.1067/mai.2001.118891. Orlandi RR, Kingdom TT, Hwang PH, et al. International Consensus Statement on Allergy and Rhinology: Rhinosinusitis. Int Forum Allergy Rhinol. 2016;6(suppl 1):S22-S209. https://doi.org/10.1002/alr.21695. Orlandi RR, Kingdom TT, Smith TL, et al. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol. 2021;11(3):213-739. https://doi.org/10.1002/alr.22741. Wang EW, Zanation AM, Gardner PA, et al. ICAR: endoscopic skull-base surgery. Int Forum Allergy Rhinol. 2019;9(S3):S145-S365. https://doi.org/10.1002/alr.22326. Patel ZM, Holbrook EH, Turner JH, et al. International consensus statement on allergy and rhinology: Olfaction. Int Forum Allergy Rhinol. 2022;12(4):327-680. https://doi.org/10.1002/alr.22929. Sackett DL, Rosenberg WM, Gray JA, Haynes RB, Richardson WS. Evidence based medicine: what it is and what it isn't. BMJ. 1996;312(7023):71-72. https://doi.org/10.1136/bmj.312.7023.71. OCEBM Levels of Evidence Working Group: The Oxford 2011 Levels of Evidence. Accessed April 4, 2019. http://www.cebm.net/index.aspx?o=5653. Handbook for grading the quality of evidence and the strength of recommendations using the GRADE approach, updated October 2013. Accessed April 2, 2019. https://gdt.gradepro.org/app/handbook/handbook.html. Bousquet J, Bachert C, Canonica GW, et al. Unmet needs in severe chronic upper airway disease (SCUAD). J Allergy Clin Immunol. 2009;124(3):428-433. https://doi.org/10.1016/j.jaci.2009.06.027. Bousquet JJ, Schunemann HJ, Togias A, et al. Next-generation ARIA care pathways for rhinitis and asthma: a model for multimorbid chronic diseases. Clin Transl Allergy. 2019;9:44. https://doi.org/10.1186/s13601-019-0279-2. Asher MI, Montefort S, Bjorksten B, et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006;368(9537):733-743. https://doi.org/10.1016/S0140-6736(06)69283-0. Vinke JG, KleinJan A, Severijnen LW, Hoeve LJ, Fokkens WJ. Differences in nasal cellular infiltrates between allergic children and age-matched controls. Eur Respir J. 1999;13(4):797-803. https://doi.org/10.1034/j.1399-3003.1999.13d17.x. Bauchau V, Durham SR. Prevalence and rate of diagnosis of allergic rhinitis in Europe. Eur Respir J. 2004;24(5):758-764. https://doi.org/10.1183/09031936.04.00013904. Bauchau V, Durham SR. Epidemiological characterization of the intermittent and persistent types of allergic rhinitis. Allergy. 2005;60(3):350-353. https://doi.org/10.1111/j.1398-9995.2005.00751.x. Ciprandi G, Buscaglia S, Pesce G, et al. Minimal persistent inflammation is present at mucosal level in patients with asymptomatic rhinitis and mite allergy. J Allergy Clin Immunol. 1995;96(6 pt 1):971-979. https://doi.org/10.1016/s0091-6749(95)70235-0. Platts-Mills TA, Hayden ML, Chapman MD, Wilkins SR. Seasonal variation in dust mite and grass-pollen allergens in dust from the houses of patients with asthma. J Allergy Clin Immunol. 1987;79(5):781-791. https://doi.org/10.1016/0091-6749(87)90211-9. Connell JT. Quantitative intranasal pollen challenges. 3. The priming effect in allergic rhinitis. J Allergy. 1969;43(1):33-44. https://doi.org/10.1016/0021-8707(69)90018-5. Wachs M, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Observations on the pathogenesis of nasal priming. J Allergy Clin Immunol. 1989;84(4 pt 1):492-501. https://doi.org/10.1016/0091-6749(89)90362-x. Juliusson S, Bende M. Priming effect of a birch pollen season studied with laser Doppler flowmetry in patients with allergic rhinitis. Clin Allergy. 1988;18(6):615-618. https://doi.org/10.1111/j.1365-2222.1988.tb02913.x. Naito K, Ishihara M, Senoh Y, Takeda N, Yokoyama N, Iwata S. Seasonal variations of nasal resistance in allergic rhinitis and environmental pollen counts. II: Efficacy of preseasonal therapy. Auris Nasus Larynx. 1993;20(1):31-38. https://doi.org/10.1016/s0385-8146(12)80208-2. Koh YY, Lim HS, Min KU, Min YG. Airways of allergic rhinitics are ‘primed’ to repeated allergen inhalation challenge. Clin Exp Allergy. 1994;24(4):337-346. https://doi.org/10.1111/j.1365-2222.1994.tb00244.x. Assing K, Bodtger U, Poulsen LK, Malling HJ. Grass pollen symptoms interfere with the recollection of birch pollen symptoms - a prospective study of suspected, asymptomatic skin sensitization. Allergy. 2007;62(4):373-377. https://doi.org/10.1111/j.1398-9995.2006.01280.x. Knani J, Campbell A, Enander I, Peterson CG, Michel FB, Bousquet J. Indirect evidence of nasal inflammation assessed by titration of inflammatory mediators and enumeration of cells in nasal secretions of patients with chronic rhinitis. J Allergy Clin Immunol. 1992;90(6 pt 1):880-889. https://doi.org/10.1016/0091-6749(92)90460-j. Ricca V, Landi M, Ferrero P, et al. Minimal persistent inflammation is also present in patients with seasonal allergic rhinitis. J Allergy Clin Immunol. 2000;105(1 pt 1):54-57. https://doi.org/10.1016/s0091-6749(00)90177-5. Riediker M, Monn C, Koller T, Stahel WA, Wuthrich B. Air pollutants enhance rhinoconjunctivitis symptoms in pollen-allergic individuals. Ann Allergy Asthma Immunol. 2001;87(4):311-318. https://doi.org/10.1016/S1081-1206(10)62246-6. Bousquet J, Annesi-Maesano I, Carat F, et al. Characteristics of intermittent and persistent allergic rhinitis: DREAMS study group. Clin Exp Allergy. 2005;35(6):728-732. https://doi.org/10.1111/j.1365-2222.2005.02274.x. Wallace DV, Dykewicz MS, Bernstein DI, et al. The diagnosis and management of rhinitis: an updated practice parameter. J Allergy Clin Immunol. 2008;122(2 suppl):S1-S84. https://doi.org/10.1016/j.jaci.2008.06.003. Van Hoecke H, Vastesaeger N, Dewulf L, Sys L, van Cauwenberge P. Classification and management of allergic rhinitis patients in general practice during pollen season. Allergy. 2006;61(6):705-711. https://doi.org/10.1111/j.1398-9995.2006.01057.x. Demoly P, Allaert FA, Lecasble M, Bousquet J, Pragma. Validation of the classification of ARIA (allergic rhinitis and its impact on asthma). Allergy. 2003;58(7):672-675. https://doi.org/10.1034/j.1398-9995.2003.t01-1-00202.x. Bachert C, van Cauwenberge P, Olbrecht J, van Schoor J. Prevalence, classification and perception of allergic and nonallergic rhinitis in Belgium. Allergy. 2006;61(6):693-698. https://doi.org/10.1111/j.1398-9995.2006.01054.x. Todo-Bom A, Loureiro C, Almeida MM, et al. Epidemiology of rhinitis in Portugal: evaluation of the intermittent and the persistent types. Allergy. 2007;62(9):1038-1043. https://doi.org/10.1111/j.1398-9995.2007.01448.x. Custovic A, Henderson J, Simpson A. Does understanding endotypes translate to better asthma management options for all? J Allergy Clin Immunol. 2019;144(1):25-33. https://doi.org/10.1016/j.jaci.2019.05.016. Akar-Ghibril N, Casale T, Custovic A, Phipatanakul W. Allergic Endotypes and Phenotypes of Asthma. J Allergy Clin Immunol Pract. 2020;8(2):429-440. https://doi.org/10.1016/j.jaip.2019.11.008. Saglani S, Wisnivesky JP, Charokopos A, Pascoe CD, Halayko AJ, Custovic A. Update in Asthma 2019. Am J Respir Crit Care Med. 2020;202(2):184-192. https://doi.org/10.1164/rccm.202003-0596UP. Thien F, Beggs PJ, Csutoros D, et al. The Melbourne epidemic thunderstorm asthma event 2016: an investigation of environmental triggers, effect on health services, and patient risk factors. Lancet Planet Health. 2018;2(6):e255-e263. https://doi.org/10.1016/S2542-5196(18)30120-7. Thien F. Melbourne epidemic thunderstorm asthma event 2016: lessons learnt from the perfect storm. Respirology. 2018;23(11):976-977. https://doi.org/10.1111/resp.13410. O'Hehir RE, Varese NP, Deckert K, et al. Epidemic Thunderstorm asthma protection with five-grass pollen tablet sublingual immunotherapy: a clinical trial. Am J Respir Crit Care Med. 2018;198(1):126-128. https://doi.org/10.1164/rccm.201711-2337LE. Custovic A, Custovic D, Kljaic Bukvic B, Fontanella S, Haider S. Atopic phenotypes and their implication in the atopic march. Expert Rev Clin Immunol. 2020;16(9):873-881. https://doi.org/10.1080/1744666X.2020.1816825. Oksel C, Custovic A. Development of allergic sensitization and its relevance to paediatric asthma. Curr Opin Allergy Clin Immunol. 2018;18(2):109-116. https://doi.org/10.1097/ACI.0000000000000430. Shtessel M, Tversky J. Reliability of allergy skin testing. Ann Allergy Asthma Immunol. 2018;120(1):80-83. https://doi.org/10.1016/j.anai.2017.10.015. Simpson A, Soderstrom L, Ahlstedt S, Murray CS, Woodcock A, Custovic A. IgE antibody quantification and the probability of wheeze in preschool children. J Allergy Clin Immunol. 2005;116(4):744-749. https://doi.org/10.1016/j.jaci.2005.06.032. Marinho S, Simpson A, Lowe L, Kissen P, Murray C, Custovic A. Rhinoconjunctivitis in 5-year-old children: a population-based birth cohort study. Allergy. 2007;62(4):385-393. https://doi.org/10.1111/j.1398-9995.2006.01294.x. Marinho S, Simpson A, Marsden P, Smith JA, Custovic A. Quantification of atopy, lung function and airway hypersensitivity in adults. Clin Transl Allergy. 2011;1(1):16. https://doi.org/10.1186/2045-7022-1-16. Roberts G, Ollert M, Aalberse R, et al. A new framework for the interpretation of IgE sensitization tests. Allergy. 2016;71(11):1540-1551. https://doi.org/10.1111/all.12939. Eguiluz-Gracia I, Testera-Montes A, Gonzalez M, et al. Safety and reproducibility of nasal allergen challenge. Allergy. 2019;74(6):1125-1134. https://doi.org/10.1111/all.13728. Ramchandani R, Linton S, Hossenbaccus L, Ellis AK. Comparing the nasal allergen challenge and environmental exposure unit models of allergic rhinitis. Ann Allergy Asthma Immunol. 2021;127(2):163-164. https://doi.org/10.1016/j.anai.2021.04.012. Custovic A, Sonntag HJ, Buchan IE, Belgrave D, Simpson A, Prosperi MCF. Evolution pathways of IgE responses to grass and mite allergens throughout childhood. J Allergy Clin Immunol. 2015;136(6):1645-1652.e8. https://doi.org/10.1016/j.jaci.2015.03.041. Howard R, Belgrave D, Papastamoulis P, Simpson A, Rattray M, Custovic A. Evolution of IgE responses to multiple allergen components throughout childhood. J Allergy Clin Immunol. 2018;142(4):1322-1330. https://doi.org/10.1016/j.jaci.2017.11.064. Simpson A, Lazic N, Belgrave DC, et al. Patterns of IgE responses to multiple allergen components and clinical symptoms at age 11 years. J Allergy Clin Immunol. 2015;136(5):1224-1231. https://doi.org/10.1016/j.jaci.2015.03.027. Prosperi MC, Marinho S, Simpson A, Custovic A, Buchan IE. Predicting phenotypes of asthma and eczema with machine learning. BMC Med Genomics. 2014;7(suppl 1):S7. https://doi.org/10.1186/1755-8794-7-S1-S7. Prosperi MC, Belgrave D, Buchan I, Simpson A, Custovic A. Challenges in interpreting allergen microarrays in relation to clinical symptoms: a machine learning approach. Pediatr Allergy Immunol. 2014;25(1):71-79. https://doi.org/10.1111/pai.12139. Fontanella S, Frainay C, Murray CS, Simpson A, Custovic A. Machine learning to identify pairwise interactions between specific IgE antibodies and their association with asthma: a cross-sectional analysis within a population-based birth cohort. PLoS Med. 2018;15(11):e1002691. https://doi.org/10.1371/journal.pmed.1002691. Roberts G, Fontanella S, Selby A, et al. Connectivity patterns between multiple allergen specific IgE antibodies and their association with severe asthma. J Allergy Clin Immunol. 2020;146(4):821-830. https://doi.org/10.1016/j.jaci.2020.02.031. Niespodziana K, Borochova K, Pazderova P, et al. Toward personalization of asthma treatment according to trigger factors. J Allergy Clin Immunol. 2020;145(6):1529-1534. https://doi.org/10.1016/j.jaci.2020.02.001. Varghese M, Glaum MC, Lockey RF. Drug-induced rhinitis. Clin Exp Allergy. 2010;40(3):381-384. https://doi.org/10.1111/j.1365-2222.2009.03450.x. Settipane RA, Kaliner MA. Chapter 14: nonallergic rhinitis. Am J Rhinol Allergy. 2013;27(suppl 1):S48-S51. https://doi.org/10.2500/ajra.2013.27.3927. Agnihotri NT, McGrath KG. Allergic and nonallergic rhinitis. Allergy Asthma Proc. 2019;40(6):376-379. https://doi.org/10.2500/aap.2019.40.4251. Walgama ES, Hwang PH. Aspirin-exacerbated respiratory disease. Otolaryngol Clin North Am. 2017;50(1):83-94. https://doi.org/10.1016/j.otc.2016.08.007. Laidlaw TM, Levy JM. NSAID-ERD syndrome: the new hope from prevention, early diagnosis, and new therapeutic targets. Curr Allergy Asthma Rep. 2020;20(4):10. https://doi.org/10.1007/s11882-020-00905-9. Kowalski ML, Agache I, Bavbek S, et al. Diagnosis and management of NSAID-Exacerbated Respiratory Disease (N-ERD) - a EAACI position paper. Allergy. 2019;74(1):28-39. https://doi.org/10.1111/all.13599. Sousa AR, Parikh A, Scadding G, Corrigan CJ, Lee TH. Leukotriene-receptor expression on nasal mucosal inflammatory cells in aspirin-sensitive rhinosinusitis. N Engl J Med. 2002;347(19):1493-1499. https://doi.org/10.1056/NEJMoa013508. Barnes PJ. Neurogenic inflammation in the airways. Respir Physiol. 2001;125(1-2):145-154. https://doi.org/10.1016/s0034-5687(00)00210-3. Kaliner MA, Baraniuk JN, Benninger M, et al. Consensus definition of nonallergic rhinopathy, previously referred to as vasomotor rhinitis, nonallergic rhinitis, and/or idiopathic rhinitis. World Allergy Organ J. 2009;2(6):119-120. https://doi.org/10.1097/WOX.0b013e3181a8e15a. Settipane RA, Charnock DR. Epidemiology of rhinitis: allergic and nonallergic. Clin Allergy Immunol. 2007;19:23-34. Mah GT, Tejani AM, Musini VM. Methyldopa for primary hypertension. Cochrane Database Syst Rev. 2009;(4):CD003893. https://doi.org/10.1002/14651858.CD003893.pub3. Boswell-Smith V, Spina D, Page CP. Phosphodiesterase inhibitors. Br J Pharmacol. 2006;147(suppl 1):S252-S257. https://doi.org/10.1038/sj.bjp.0706495. Andersson KE. PDE5 inhibitors - pharmacology and clinical applications 20 years after sildenafil discovery. Br J Pharmacol. 2018;175(13):2554-2565. https://doi.org/10.1111/bph.14205. Kiroglu AF, Bayrakli H, Yuca K, Cankaya H, Kiris M. Nasal obstruction as a common side-effect of sildenafil citrate. Tohoku J Exp Med. 2006;208(3):251-254. https://doi.org/10.1620/tjem.208.251. Motamed M, Sandhu D, Murty GE. Sildenafil and nasal obstruction. J Otolaryngol. 2003;32(4):259-261. https://doi.org/10.2310/7070.2003.41631. Cingi C, Ozdoganoglu T, Songu M. Nasal obstruction as a drug side effect. Ther Adv Respir Dis. 2011;5(3):175-182. https://doi.org/10.1177/1753465811403348. Ahmed WS, Geethakumari AM, Biswas KH. Phosphodiesterase 5 (PDE5): structure-function regulation and therapeutic applications of inhibitors. Biomed Pharmacother. 2021;134:111128. https://doi.org/10.1016/j.biopha.2020.111128. Togias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol. 2000;105(6 pt 2):S599-S604. https://doi.org/10.1067/mai.2000.106885. Pinargote P, Guillen D, Guarderas JC. ACE inhibitors: upper respiratory symptoms. BMJ Case Rep. 2014;2014. https://doi.org/10.1136/bcr-2014-205462. Riccio MM, Proud D. Evidence that enhanced nasal reactivity to bradykinin in patients with symptomatic allergy is mediated by neural reflexes. J Allergy Clin Immunol. 1996;97(6):1252-1263. https://doi.org/10.1016/s0091-6749(96)70193-8. Shirasaki H, Kanaizumi E, Himi T. Immunohistochemical localization of the bradykinin B1 and B2 receptors in human nasal mucosa. Mediators Inflamm. 2009;2009:102406. https://doi.org/10.1155/2009/102406. Trimarchi M, Miluzio A, Nicolai P, Morassi ML, Bussi M, Marchisio PC. Massive apoptosis erodes nasal mucosa of cocaine abusers. Am J Rhinol. 2006;20(2):160-164. Tan TH, Stevenson B, Yip D. Docetaxel-induced nasal septal perforation. Intern Med J. 2006;36(7):471-472. https://doi.org/10.1111/j.1445-5994.2006.01105.x. Lanier B, Kai G, Marple B, Wall GM. Pathophysiology and progression of nasal septal perforation. Ann Allergy Asthma Immunol. 2007;99(6):473-479; quiz 480-1, 521. https://doi.org/10.1016/S1081-1206(10)60373-0. Alexander D, Alexander K, Valentino J. Intranasal hydrocodone-acetaminophen abuse induced necrosis of the nasal cavity and pharynx. Laryngoscope. 2012;122(11):2378-2381. https://doi.org/10.1002/lary.23542. Wang SH, Wang HW, Wang JY. Effects of cocaine on human nasal mucosa. Eur Arch Otorhinolaryngol. 1993;250(4):245-248. https://doi.org/10.1007/BF00171534. Snyder RD, Snyder LB. Intranasal cocaine abuse in an allergists office. Ann Allergy. 1985;54(6):489-492. Hall LJ, Jackson RT. Effects of alpha and beta adrenergic agonists on nasal blood flow. Ann Otol Rhinol Laryngol. 1968;77(6):1120-1130. https://doi.org/10.1177/000348946807700610. Walker JS. Rhinitis medicamentosa. J Allergy. 1952;23(2):183-186. https://doi.org/10.1016/0021-8707(52)90093-2. Kim D, Steinhart B. Seizures induced by recreational abuse of bupropion tablets via nasal insufflation. CJEM. 2010;12(2):158-161. https://doi.org/10.1017/s1481803500012203. Sataloff RT, Gullane PJ, Goldstein DP. Sataloff's Comprehensive Textbook of Otolaryngology, Head and Neck Surgery. Jaypee Brothers Medical Publishing; 2016. Daws LC, Callaghan PD, Moron JA, et al. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem Biophys Res Commun. 2002;290(5):1545-1550. https://doi.org/10.1006/bbrc.2002.6384. Middleton LS, Nuzzo PA, Lofwall MR, Moody DE, Walsh SL. The pharmacodynamic and pharmacokinetic profile of intranasal crushed buprenorphine and buprenorphine/naloxone tablets in opioid abusers. Addiction. 2011;106(8):1460-1473. https://doi.org/10.1111/j.1360-0443.2011.03424.x. Zhang H, Prisinzano TE, Donovan MD. Permeation and metabolism of cocaine in the nasal mucosa. Eur J Drug Metab Pharmacokinet. 2012;37(4):255-262. https://doi.org/10.1007/s13318-012-0085-x. Lin RJ, Smith LJ. Laryngeal Manifestation of intranasal acetaminophen abuse and review of literature. Ear Nose Throat J. 2019;98(4):192-194. https://doi.org/10.1177/0145561319836807. Hardison SA, Marcum KK, Lintzenich CR. Severe necrosis of the palate and nasal septum resulting from intranasal abuse of acetaminophen. Ear Nose Throat J. 2015;94(10-11):E40-E42. Lin Y, Lu JY, Pinheiro-Neto CD, Jones DM, Gildener-Leapman N. Intranasal acetaminophen abuse and nasal, pharyngeal, and laryngotracheal damage. Cureus. 2019;11(8):e5432. https://doi.org/10.7759/cureus.5432. Morrison DA, Wise SK, DelGaudio JM, Chowdhury NI, Levy JM. Intranasal tissue necrosis associated with opioid abuse: case report and systematic review. Laryngoscope. 2018;128(8):1767-1771. https://doi.org/10.1002/lary.27069. Ramey JT, Bailen E, Lockey RF. Rhinitis medicamentosa. J Investig Allergol Clin Immunol. 2006;16(3):148-155. Graf PM. Rhinitis medicamentosa. Clin Allergy Immunol. 2007;19:295-304. Min YG, Kim HS, Suh SH, Jeon SY, Son YI, Yoon S. Paranasal sinusitis after long-term use of topical nasal decongestants. Acta Otolaryngol. 1996;116(3):465-471. https://doi.org/10.3109/00016489609137874. Mortuaire G, de Gabory L, Francois M, et al. Rebound congestion and rhinitis medicamentosa: nasal decongestants in clinical practice. Critical review of the literature by a medical panel. Eur Ann Otorhinolaryngol Head Neck Dis. 2013;130(3):137-144. https://doi.org/10.1016/j.anorl.2012.09.005. Zucker SM, Barton BM, McCoul ED. Management of rhinitis medicamentosa: a systematic review. Otolaryngol Head Neck Surg. 2019;160(3):429-438. https://doi.org/10.1177/0194599818807891. Graf P, Juto JE. Sustained use of xylometazoline nasal spray shortens the decongestive response and induces rebound swelling. Rhinology. 1995;33(1):14-17. Vicks Sinex. Thompson PDR; 2004. Fleece L, Mizes JS, Jolly PA, Baldwin RL. Rhinitis medicamentosa. Conceptualization, incidence, and treatment. Ala J Med Sci. 1984;21(2):205-208. Knipping S, Holzhausen HJ, Goetze G, Riederer A, Bloching MB. Rhinitis medicamentosa: electron microscopic changes of human nasal mucosa. Otolaryngol Head Neck Surg. 2007;136(1):57-61. https://doi.org/10.1016/j.otohns.2006.08.025. Marple B, Roland P, Benninger M. Safety review of benzalkonium chloride used as a preservative in intranasal solutions: an overview of conflicting data and opinions. Otolaryngol Head Neck Surg. 2004;130(1):131-141. https://doi.org/10.1016/j.otohns.2003.07.005. Graf P. Adverse effects of benzalkonium chloride on the nasal mucosa: allergic rhinitis and rhinitis medicamentosa. Clin Ther. 1999;21(10):1749-1755. https://doi.org/10.1016/S0149-2918(99)80053-8. Graf P. Rhinitis medicamentosa: a review of causes and treatment. Treat Respir Med. 2005;4(1):21-29. https://doi.org/10.2165/00151829-200504010-00003. Graf P. Benzalkonium chloride as a preservative in nasal solutions: re-examining the data. Respir Med. 2001;95(9):728-733. https://doi.org/10.1053/rmed.2001.1127. Kawabata M, Ohori J, Kurono Y. Effects of benzalkonium chloride on histamine H1 receptor mRNA expression in nasal epithelial cells. Auris Nasus Larynx. 2016;43(6):685-688. https://doi.org/10.1016/j.anl.2016.02.003. Morris S, Eccles R, Martez SJ, Riker DK, Witek TJ. An evaluation of nasal response following different treatment regimes of oxymetazoline with reference to rebound congestion. Am J Rhinol. 1997;11(2):109-115. https://doi.org/10.2500/105065897782537197. Chodirker WB. Rhinitis medicamentosa. Can Med Assoc J. 1981;124(4):370, 372. May M, West JW. The “stuffy” nose. Otolaryngol Clin North Am. 1973;6(3):655-674. Graf P, Hallen H, Juto JE. The pathophysiology and treatment of rhinitis medicamentosa. Clin Otolaryngol Allied Sci. 1995;20(3):224-229. https://doi.org/10.1111/j.1365-2273.1995.tb01853.x. Elwany S, Abdel-Salaam S. Treatment of rhinitis medicamentosa with fluticasone propionate - an experimental study. Eur Arch Otorhinolaryngol. 2001;258(3):116-119. https://doi.org/10.1007/s004050000309. Tas A, Yagiz R, Yalcin O, et al. Use of mometasone furoate aqueous nasal spray in the treatment of rhinitis medicamentosa: an experimental study. Otolaryngol Head Neck Surg. 2005;132(4):608-612. https://doi.org/10.1016/j.otohns.2005.01.010. Stephens AL, Jr., Boggs PB. Intranasal dexamethasone: an adjunct in the treatment of chemical rhinitis. Ann Allergy. 1968;26(11):612-613. Elwany SS, Stephanos WM. Rhinitis medicamentosa. An experimental histopathological and histochemical study. ORL J Otorhinolaryngol Relat Spec. 1983;45(4):187-194. https://doi.org/10.1159/000275642. Settipane RA. Other causes of rhinitis: mixed rhinitis, rhinitis medicamentosa, hormonal rhinitis, rhinitis of the elderly, and gustatory rhinitis. Immunol Allergy Clin North Am. 2011;31(3):457-467. https://doi.org/10.1016/j.iac.2011.05.011. Dykewicz MS, Fineman S, Skoner DP, et al. Diagnosis and management of rhinitis: complete guidelines of the Joint Task Force on Practice Parameters in Allergy, Asthma and Immunology. American Academy of Allergy, Asthma, and Immunology. Ann Allergy Asthma Immunol. 1998;81(5 pt 2):478-518. https://doi.org/10.1016/s1081-1206(10)63155-9. Akerlund A, Bende M. Sustained use of oxymetazoline nose drops aggrevates vasomotor rhinitis. Amer J Rhinol. 1991;5:157-160. Fowler J, Chin CJ, Massoud E. Rhinitis medicamentosa: a nationwide survey of Canadian otolaryngologists. J Otolaryngol Head Neck Surg. 2019;48(1):70. https://doi.org/10.1186/s40463-019-0392-1. Yoo JK, Seikaly H, Calhoun KH. Extended use of topical nasal decongestants. Laryngoscope. 1997;107(1):40-43. https://doi.org/10.1097/00005537-199701000-00010. Moscato G, Vandenplas O, Van Wijk RG, et al. EAACI position paper on occupational rhinitis. Respir Res. 2009;10:16. https://doi.org/10.1186/1465-9921-10-16. Kotz S, Pechtold L, Jorres RA, Nowak D, Chaker AM. Occupational rhinitis. Allergol Select. 2021;5:51-56. https://doi.org/10.5414/ALX02165E. Vandenplas O, Hox V, Bernstein D. Occupational rhinitis. J Allergy Clin Immunol Pract. 2020;8(10):3311-3321. https://doi.org/10.1016/j.jaip.2020.06.047. Tarlo SM, Lemiere C. Occupational asthma. N Engl J Med. 2014;370(7):640-649. https://doi.org/10.1056/NEJMra1301758. Ronsmans S, Steelant B, Backaert W, Nemery B, Van Gerven L. Diagnostic approach to occupational rhinitis: the role of nasal provocation tests. Curr Opin Allergy Clin Immunol. 2020;20(2):122-130. https://doi.org/10.1097/ACI.0000000000000608. Siracusa A, Desrosiers M, Marabini A. Epidemiology of occupational rhinitis: prevalence, aetiology and determinants. Clin Exp Allergy. 2000;30(11):1519-1534. https://doi.org/10.1046/j.1365-2222.2000.00946.x. Pala G, Pignatti P, Perfetti L, et al. Occupational rhinitis and asthma due to cabreuva wood dust. Ann Allergy Asthma Immunol. 2010;104(3):268-269. https://doi.org/10.1016/j.anai.2010.01.009. Lopata AL, Jeebhay MF. Airborne seafood allergens as a cause of occupational allergy and asthma. Curr Allergy Asthma Rep. 2013;13(3):288-297. https://doi.org/10.1007/s11882-013-0347-y. Siracusa A, De Blay F, Folletti I, et al. Asthma and exposure to cleaning products - a European Academy of Allergy and Clinical Immunology task force consensus statement. Allergy. 2013;68(12):1532-1545. https://doi.org/10.1111/all.12279. Siracusa A, Folletti I, Moscato G. Non-IgE-mediated and irritant-induced work-related rhinitis. Curr Opin Allergy Clin Immunol. 2013;13(2):159-166. https://doi.org/10.1097/ACI.0b013e32835e12e7. Folletti I, Zock JP, Moscato G, Siracusa A. Asthma and rhinitis in cleaning workers: a systematic review of epidemiological studies. J Asthma. 2014;51(1):18-28. https://doi.org/10.3109/02770903.2013.833217. Szeszenia-Dabrowska N, Swiatkowska B, Wilczynska U. Occupational diseases among farmers in Poland. Med Pr. 2016;67(2):163-171. Choroby zawodowe rolnikow w Polsce. https://doi.org/10.13075/mp.5893.00303. Rodier F, Gautrin D, Ghezzo H, Malo JL. Incidence of occupational rhinoconjunctivitis and risk factors in animal-health apprentices. J Allergy Clin Immunol. 2003;112(6):1105-1111. https://doi.org/10.1016/j.jaci.2003.08.011. Ruoppi P, Koistinen T, Susitaival P, Honkanen J, Soininen H. Frequency of allergic rhinitis to laboratory animals in university employees as confirmed by chamber challenges. Allergy. 2004;59(3):295-301. https://doi.org/10.1046/j.1398-9995.2003.00204.x. Schyllert C, Ronmark E, Andersson M, et al. Occupational exposure to chemicals drives the increased risk of asthma and rhinitis observed for exposure to vapours, gas, dust and fumes: a cross-sectional population-based study. Occup Environ Med. 2016;73(10):663-669. https://doi.org/10.1136/oemed-2016-103595. Krop EJ, Heederik DJ, Lutter R, et al. Associations between pre-employment immunologic and airway mucosal factors and the development of occupational allergy. J Allergy Clin Immunol. 2009;123(3):694-700, 700.e1-3. https://doi.org/10.1016/j.jaci.2008.12.021. Phipatanakul W, Matsui E, Portnoy J, et al. Environmental assessment and exposure reduction of rodents: a practice parameter. Ann Allergy Asthma Immunol. 2012;109(6):375-387. https://doi.org/10.1016/j.anai.2012.09.019. Pignatti P, Pala G, Pisati M, Perfetti L, Banchieri G, Moscato G. Nasal blown secretion evaluation in specific occupational nasal challenges. Int Arch Occup Environ Health. 2010;83(2):217-223. https://doi.org/10.1007/s00420-009-0459-9. Ottaviano G, Fokkens WJ. Measurements of nasal airflow and patency: a critical review with emphasis on the use of peak nasal inspiratory flow in daily practice. Allergy. 2016;71(2):162-174. https://doi.org/10.1111/all.12778. Wood RA, Phipatanakul W, Hamilton RG, Eggleston PA. A comparison of skin prick tests, intradermal skin tests, and RASTs in the diagnosis of cat allergy. J Allergy Clin Immunol. 1999;103(5 pt 1):773-779. https://doi.org/10.1016/s0091-6749(99)70419-7. Nam YH, Lee SK. Comparison between skin prick test and serum immunoglobulin E by CAP system to inhalant allergens. Ann Allergy Asthma Immunol. 2017;118(5):608-613. https://doi.org/10.1016/j.anai.2017.03.005. Raulf M, Quirce S, Vandenplas O. Addressing molecular diagnosis of occupational allergies. Curr Allergy Asthma Rep. 2018;18(1):6. https://doi.org/10.1007/s11882-018-0759-9. Amirneni A, Tversky J. High histamine control concentration leads to false negative allergy skin testing. Am J Rhinol Allergy. 2021;35(6):854-860. https://doi.org/10.1177/19458924211008685. Tversky JR, Chelladurai Y, McGready J, Hamilton RG. Performance and pain tolerability of current diagnostic allergy skin prick test devices. J Allergy Clin Immunol Pract. 2015;3(6):888-893. https://doi.org/10.1016/j.jaip.2015.07.022. Tversky J, MacGlashan D. Short-wave infrared camera as a novel solution to allergy skin testing. Allergy. 2020;75(4):965-968. https://doi.org/10.1111/all.14089. Kim YH, Jang TY. Nasal provocation test using allergen extract versus cold dry air provocation test: which and when? Am J Rhinol Allergy. 2013;27(2):113-117. https://doi.org/10.2500/ajra.2013.27.3870. Jang TY, Kim YH. Nasal provocation test is useful for discriminating allergic, nonallergic, and local allergic rhinitis. Am J Rhinol Allergy. 2015;29(4):e100-e104. https://doi.org/10.2500/ajra.2015.29.4214. Gomez F, Rondon C, Salas M, Campo P. Local allergic rhinitis: mechanisms, diagnosis and relevance for occupational rhinitis. Curr Opin Allergy Clin Immunol. 2015;15(2):111-116. https://doi.org/10.1097/ACI.0000000000000150. Bousquet J, Khaltaev N, Cruz AA, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) 2008 update (in collaboration with the World Health Organization, GA(2)LEN and AllerGen). Allergy. 2008;63(suppl 86):8-160. https://doi.org/10.1111/j.1398-9995.2007.01620.x. Moscato G, Pala G, Sastre J. Specific immunotherapy and biological treatments for occupational allergy. Curr Opin Allergy Clin Immunol. 2014;14(6):576-581. https://doi.org/10.1097/ACI.0000000000000105. Moscato G, Rolla G, Siracusa A. Occupational rhinitis: consensus on diagnosis and medicolegal implications. Curr Opin Otolaryngol Head Neck Surg. 2011;19(1):36-42. https://doi.org/10.1097/MOO.0b013e328341e228. Gerth van Wijk R, Patiwael JA, de Jong NW, de Groot H, Burdorf A. Occupational rhinitis in bell pepper greenhouse workers: determinants of leaving work and the effects of subsequent allergen avoidance on health-related quality of life. Allergy. 2011;66(7):903-908. https://doi.org/10.1111/j.1398-9995.2011.02556.x. Foss-Skiftesvik MH, Winther L, Johnsen CR, et al. High occurrence of rhinitis symptoms in hairdressing apprentices. Int Forum Allergy Rhinol. 2017;7(1):43-49. https://doi.org/10.1002/alr.21834. Rouadi PW, Idriss SA, Naclerio RM, et al. Immunopathological features of air pollution and its impact on inflammatory airway diseases (IAD). World Allergy Organ J. 2020;13(10):100467. https://doi.org/10.1016/j.waojou.2020.100467. Moscato G, Pala G, Folletti I, Siracusa A, Quirce S. Occupational rhinitis affects occupational asthma severity. J Occup Health. 2016;58(3):310-313. https://doi.org/10.1539/joh.15-0067-BR. Tai CF, Baraniuk JN. Upper airway neurogenic mechanisms. Curr Opin Allergy Clin Immunol. 2002;2(1):11-19. https://doi.org/10.1097/00130832-200202000-00003. Meggs WJ. RADS and RUDS-the toxic induction of asthma and rhinitis. J Toxicol Clin Toxicol. 1994;32(5):487-501. https://doi.org/10.3109/15563659409011053. Brooks SM, Weiss MA, Bernstein IL. Reactive airways dysfunction syndrome (RADS). Persistent asthma syndrome after high level irritant exposures. Chest. 1985;88(3):376-384. https://doi.org/10.1378/chest.88.3.376. Bello A, Quinn MM, Perry MJ, Milton DK. Characterization of occupational exposures to cleaning products used for common cleaning tasks - a pilot study of hospital cleaners. Environ Health. 2009;8:11. https://doi.org/10.1186/1476-069X-8-11. Chary A, Hennen J, Klein SG, Serchi T, Gutleb AC, Blomeke B. Respiratory sensitization: toxicological point of view on the available assays. Arch Toxicol. 2018;92(2):803-822. https://doi.org/10.1007/s00204-017-2088-5. Kimber I, Dearman RJ, Basketter DA. Diisocyanates, occupational asthma and IgE antibody: implications for hazard characterization. J Appl Toxicol. 2014;34(10):1073-1077. https://doi.org/10.1002/jat.3041. Kimber I, Dearman RJ. Chemical respiratory allergy: role of IgE antibody and relevance of route of exposure. Toxicology. 2002;181-182:311-315. https://doi.org/10.1016/s0300-483x(02)00299-8. Wisnewski AV. Developments in laboratory diagnostics for isocyanate asthma. Curr Opin Allergy Clin Immunol. 2007;7(2):138-145. https://doi.org/10.1097/ACI.0b013e3280895d22. Christensen DN, Franks ZG, McCrary HC, Saleh AA, Chang EH. A systematic review of the association between cigarette smoke exposure and chronic rhinosinusitis. Otolaryngol Head Neck Surg. 2018;158(5):801-816. https://doi.org/10.1177/0194599818757697. Eriksson J, Ekerljung L, Sundblad BM, et al. Cigarette smoking is associated with high prevalence of chronic rhinitis and low prevalence of allergic rhinitis in men. Allergy. 2013;68(3):347-354. https://doi.org/10.1111/all.12095. Yao TC, Chang SW, Chang WC, et al. Exposure to tobacco smoke and childhood rhinitis: a population-based study. Sci Rep. 2017;7:42836. https://doi.org/10.1038/srep42836. Lee A, Lee SY, Lee KS. The use of heated tobacco products is associated with asthma, allergic rhinitis, and atopic dermatitis in Korean adolescents. Sci Rep. 2019;9(1):17699. https://doi.org/10.1038/s41598-019-54102-4. Phulka JS, Howlett JW, Hu A. Cannabis related side effects in otolaryngology: a scoping review. J Otolaryngol Head Neck Surg. 2021;50(1):56. https://doi.org/10.1186/s40463-021-00538-6. Abramson MJ, Schindler C, Schikowski T, et al. Rhinitis in Swiss adults is associated with asthma and early life factors, but not second hand tobacco smoke or obesity. Allergol Int. 2016;65(2):192-198. https://doi.org/10.1016/j.alit.2015.11.004. Pallasaho P, Kainu A, Juusela M, Meren M, Sovijarvi A. High prevalence of rhinitis symptoms without allergic sensitization in Estonia and Finland. Eur Clin Respir J. 2015;2. https://doi.org/10.3402/ecrj.v2.25401. Shargorodsky J, Garcia-Esquinas E, Galan I, Navas-Acien A, Lin SY. Allergic sensitization, rhinitis and tobacco smoke exposure in US adults. PLoS One. 2015;10(7):e0131957. https://doi.org/10.1371/journal.pone.0131957. Hisinger-Molkanen H, Piirila P, Haahtela T, Sovijarvi A, Pallasaho P. Smoking, environmental tobacco smoke and occupational irritants increase the risk of chronic rhinitis. World Allergy Organ J. 2018;11(1):6. https://doi.org/10.1186/s40413-018-0184-5. Gleich GJ, Welsh PW, Yunginger JW, Hyatt RE, Catlett JB. Allergy to tobacco: an occupational hazard. N Engl J Med. 1980;302(11):617-619. https://doi.org/10.1056/NEJM198003133021107. Burrows B, Halonen M, Lebowitz MD, Knudson RJ, Barbee RA. The relationship of serum immunoglobulin E, allergy skin tests, and smoking to respiratory disorders. J Allergy Clin Immunol. 1982;70(3):199-204. https://doi.org/10.1016/0091-6749(82)90042-2. Bascom R, Kesavanathan J, Fitzgerald TK, Cheng KH, Swift DL. Sidestream tobacco smoke exposure acutely alters human nasal mucociliary clearance. Environ Health Perspect. 1995;103(11):1026-1030. https://doi.org/10.1289/ehp.951031026. Andre E, Campi B, Materazzi S, et al. Cigarette smoke-induced neurogenic inflammation is mediated by alpha, beta-unsaturated aldehydes and the TRPA1 receptor in rodents. J Clin Invest. 2008;118(7):2574-2582. https://doi.org/10.1172/JCI34886. Meggs WJ. Neurogenic inflammation and sensitivity to environmental chemicals. Environ Health Perspect. 1993;101(3):234-238. https://doi.org/10.1289/ehp.93101234. Bascom R, Kulle T, Kagey-Sobotka A, Proud D. Upper respiratory tract environmental tobacco smoke sensitivity. Am Rev Respir Dis. 1991;143(6):1304-1311. https://doi.org/10.1164/ajrccm/143.6.1304. Dykewicz MS, Wallace DV, Amrol DJ, et al. Rhinitis 2020: a practice parameter update. J Allergy Clin Immunol. 2020;146(4):721-767. https://doi.org/10.1016/j.jaci.2020.07.007. Fokkens WJ, Lund VJ, Hopkins C, et al. European Position Paper on rhinosinusitis and nasal polyps 2020. Rhinology. 2020;58(suppl S29):1-464. https://doi.org/10.4193/Rhin20.600. Meltzer EO, Hamilos DL, Hadley JA, et al. Rhinosinusitis: establishing definitions for clinical research and patient care. Otolaryngol Head Neck Surg. 2004;131(6 suppl):S1-S62. https://doi.org/10.1016/j.otohns.2004.09.067. Fokkens WJ, Lund VJ, Mullol J, et al. European Position Paper on rhinosinusitis and nasal polyps 2012. Rhinol Suppl. 2012;23:3 p preceding table of contents, 1-298. Aring AM, Chan MM. Current concepts in adult acute rhinosinusitis. Am Fam Physician. 2016;94(2):97-105. Canonica GW, Ciprandi G, Pesce GP, Buscaglia S, Paolieri F, Bagnasco M. ICAM-1 on epithelial cells in allergic subjects: a hallmark of allergic inflammation. Int Arch Allergy Immunol. 1995;107(1-3):99-102. https://doi.org/10.1159/000236943. Ciebiada M, Gorska-Ciebiada M, Gorski P. sICAM-1 and TNF-alpha in asthma and rhinitis: relationship with the presence of atopy. J Asthma. 2011;48(7):660-666. https://doi.org/10.3109/02770903.2011.604886. Tantilipikorn P. The relationship between allergic rhinitis and viral infections. Curr Opin Otolaryngol Head Neck Surg. 2014;22(3):249-252. https://doi.org/10.1097/MOO.0000000000000049. Gorska-Ciebiada M, Ciebiada M, Gorska MM, Gorski P, Grzelewska-Rzymowska I. Intercellular adhesion molecule 1 and tumor necrosis factor alpha in asthma and persistent allergic rhinitis: relationship with disease severity. Ann Allergy Asthma Immunol. 2006;97(1):66-72. https://doi.org/10.1016/S1081-1206(10)61372-5. Shiota Y, Wilson JG, Marukawa M, Ono T, Kaji M. Soluble intercellular adhesion molecule 1 (ICAM-1) antigen in sera of bronchial asthmatics. Chest. 1996;109(1):94-99. https://doi.org/10.1378/chest.109.1.94. Gosset P, Tillie-Leblond I, Janin A, et al. Expression of E-selectin, ICAM-1 and VCAM-1 on bronchial biopsies from allergic and non-allergic asthmatic patients. Int Arch Allergy Immunol. 1995;106(1):69-77. https://doi.org/10.1159/000236892. Kenealy T, Arroll B. Antibiotics for the common cold and acute purulent rhinitis. Cochrane Database Syst Rev. 2013;(6):CD000247. https://doi.org/10.1002/14651858.CD000247.pub3. Kaper NM, Breukel L, Venekamp RP, Grolman W, van der Heijden GJ. Absence of evidence for enhanced benefit of antibiotic therapy on recurrent acute rhinosinusitis episodes: a systematic review of the evidence base. Otolaryngol Head Neck Surg. 2013;149(5):664-667. https://doi.org/10.1177/0194599813505841. Lemiengre MB, van Driel ML, Merenstein D, Young J, De Sutter AI. Antibiotics for clinically diagnosed acute rhinosinusitis in adults. Cochrane Database Syst Rev. 2012;10:CD006089. https://doi.org/10.1002/14651858.CD006089.pub4. van den Broek MF, Gudden C, Kluijfhout WP, et al. No evidence for distinguishing bacterial from viral acute rhinosinusitis using symptom duration and purulent rhinorrhea: a systematic review of the evidence base. Otolaryngol Head Neck Surg. 2014;150(4):533-537. https://doi.org/10.1177/0194599814522595. Stjarne P, Odeback P, Stallberg B, Lundberg J, Olsson P. High costs and burden of illness in acute rhinosinusitis: real-life treatment patterns and outcomes in Swedish primary care. Prim Care Respir J. 2012;21(2):174-179; quiz 10p following 179. https://doi.org/10.4104/pcrj.2012.00011. Jaume F, Quinto L, Alobid I, Mullol J. Overuse of diagnostic tools and medications in acute rhinosinusitis in Spain: a population-based study (the PROSINUS study). BMJ Open. 2018;8(1):e018788. https://doi.org/10.1136/bmjopen-2017-018788. Seresirikachorn K, Snidvongs K, Chitsuthipakorn W, et al. EPOS2012 has better specificity compared to IDSA2012 for diagnosing acute bacterial rhinosinusitis. Rhinology. 2018;56(3):241-244. https://doi.org/10.4193/Rhin17.261. Chow AW, Benninger MS, Brook I, et al. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. Clin Infect Dis. 2012;54(8):e72-e112. https://doi.org/10.1093/cid/cir1043. Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg. 2015;152(2 suppl):S1-S39. https://doi.org/10.1177/0194599815572097. Lindbaek M, Hjortdahl P, Johnsen UL. Use of symptoms, signs, and blood tests to diagnose acute sinus infections in primary care: comparison with computed tomography. Fam Med. 1996;28(3):183-188. Ellegard EK. Pregnancy rhinitis. Immunol Allergy Clin North Am. 2006;26(1):119-135, vii. https://doi.org/10.1016/j.iac.2005.10.007. Ellegard EK. Clinical and pathogenetic characteristics of pregnancy rhinitis. Clin Rev Allergy Immunol. 2004;26(3):149-159. https://doi.org/10.1385/CRIAI:26:3:149. Ellegard E, Karlsson G. Nasal congestion during pregnancy. Clin Otolaryngol Allied Sci. 1999;24(4):307-311. https://doi.org/10.1046/j.1365-2273.1999.00264.x. Baudoin T, Simunjak T, Bacan N, Jelavic B, Kuna K, Kosec A. Redefining pregnancy-induced rhinitis. Am J Rhinol Allergy. 2021;35(3):315-322. https://doi.org/10.1177/1945892420957490. Ellegard E, Hellgren M, Toren K, Karlsson G. The incidence of pregnancy rhinitis. Gynecol Obstet Invest. 2000;49(2):98-101. https://doi.org/10.1159/000010223. Philpott CM, Conboy P, Al-Azzawi F, Murty G. Nasal physiological changes during pregnancy. Clin Otolaryngol Allied Sci. 2004;29(4):343-351. https://doi.org/10.1111/j.1365-2273.2004.00815.x. Toppozada H, Michaels L, Toppozada M, El-Ghazzawi I, Talaat M, Elwany S. The human respiratory nasal mucosa in pregnancy. An electron microscopic and histochemical study. J Laryngol Otol. 1982;96(7):613-626. https://doi.org/10.1017/s0022215100092902. Juniper EF, Guyatt GH, Andersson B, Ferrie PJ. Comparison of powder and aerosolized budesonide in perennial rhinitis: validation of rhinitis quality of life questionnaire. Ann Allergy. 1993;70(3):225-230. Kumar R, Hayhurst KL, Robson AK. Ear, nose, and throat manifestations during pregnancy. Otolaryngol Head Neck Surg. 2011;145(2):188-198. https://doi.org/10.1177/0194599811407572. Orban N, Maughan E, Bleach N. Pregnancy-induced rhinitis. Rhinology. 2013;51(2):111-119. https://doi.org/10.4193/Rhino12.045. Hamano N, Terada N, Maesako K, et al. Expression of histamine receptors in nasal epithelial cells and endothelial cells-the effects of sex hormones. Int Arch Allergy Immunol. 1998;115(3):220-227. https://doi.org/10.1159/000023904. Ellegard E, Oscarsson J, Bougoussa M, et al. Serum level of placental growth hormone is raised in pregnancy rhinitis. Arch Otolaryngol Head Neck Surg. 1998;124(4):439-443. https://doi.org/10.1001/archotol.124.4.439. Franklin KA, Holmgren PA, Jonsson F, Poromaa N, Stenlund H, Svanborg E. Snoring, pregnancy-induced hypertension, and growth retardation of the fetus. Chest. 2000;117(1):137-141. https://doi.org/10.1378/chest.117.1.137. Favilli A, Laurenti E, Stagni GM, Tassi L, Ricci G, Gerli S. Effects of sodium hyaluronate on symptoms and quality of life in women affected by pregnancy rhinitis: a pilot study. Gynecol Obstet Invest. 2019;84(2):159-165. https://doi.org/10.1159/000493137. Hellings PW, Klimek L, Cingi C, et al. Non-allergic rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2017;72(11):1657-1665. https://doi.org/10.1111/all.13200. Ellegard EK, Karlsson NG, Ellegard LH. Rhinitis in the menstrual cycle, pregnancy, and some endocrine disorders. Clin Allergy Immunol. 2007;19:305-321. Navarrete-Palacios E, Hudson R, Reyes-Guerrero G, Guevara-Guzman R. Correlation between cytological characteristics of the nasal epithelium and the menstrual cycle. Arch Otolaryngol Head Neck Surg. 2003;129(4):460-463. https://doi.org/10.1001/archotol.129.4.460. Proetz AW. Further observations of the effects of thyroid insufficiency on the nasal mucosa. Laryngoscope. 1950;60(7):627-633. https://doi.org/10.1288/00005537-195007000-00004. Kulekci Ozturk S, Sakci E, Kavvasoglu C. Rhinitis in patients with acquired hypothyroidism. Eur Arch Otorhinolaryngol. 2021;278(1):87-92. https://doi.org/10.1007/s00405-020-06254-7. Skinner DW, Richards SH. Acromegaly - the mucosal changes within the nose and paranasal sinuses. J Laryngol Otol. 1988;102(12):1107-1110. https://doi.org/10.1017/s0022215100107455. Sampson HA, Aceves S, Bock SA, et al. Food allergy: a practice parameter update-2014. J Allergy Clin Immunol. 2014;134(5):1016-1025.e43. https://doi.org/10.1016/j.jaci.2014.05.013. Jovancevic L, Georgalas C, Savovic S, Janjevic D. Gustatory rhinitis. Rhinology. 2010;48(1):7-10. https://doi.org/10.4193/Rhin07.153. Waibel KH, Chang C. Prevalence and food avoidance behaviors for gustatory rhinitis. Ann Allergy Asthma Immunol. 2008;100(3):200-205. https://doi.org/10.1016/S1081-1206(10)60443-7. Raphael G, Raphael MH, Kaliner M. Gustatory rhinitis: a syndrome of food-induced rhinorrhea. J Allergy Clin Immunol. 1989;83(1):110-115. https://doi.org/10.1016/0091-6749(89)90484-3. Georgalas C, Jovancevic L. Gustatory rhinitis. Curr Opin Otolaryngol Head Neck Surg. 2012;20(1):9-14. https://doi.org/10.1097/MOO.0b013e32834dfb52. Seki N, Shirasaki H, Kikuchi M, Sakamoto T, Watanabe N, Himi T. Expression and localization of TRPV1 in human nasal mucosa. Rhinology. 2006;44(2):128-134. Marshak T, Yun WK, Hazout C, Sacks R, Harvey RJ. A systematic review of the evidence base for vidian neurectomy in managing rhinitis. J Laryngol Otol. 2016;130(suppl 4):S7-S28. https://doi.org/10.1017/S0022215116008008. Nihlen U, Greiff LJ, Nyberg P, Persson CG, Andersson M. Alcohol-induced upper airway symptoms: prevalence and co-morbidity. Respir Med. 2005;99(6):762-769. https://doi.org/10.1016/j.rmed.2004.11.010. Glicksman JT, Parasher AK, Doghramji L, et al. Alcohol-induced respiratory symptoms improve after aspirin desensitization in patients with aspirin-exacerbated respiratory disease. Int Forum Allergy Rhinol. 2018;8(10):1093-1097. https://doi.org/10.1002/alr.22168. Cardet JC, White AA, Barrett NA, et al. Alcohol-induced respiratory symptoms are common in patients with aspirin exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2014;2(2):208-213. https://doi.org/10.1016/j.jaip.2013.12.003. De Schryver E, Derycke L, Campo P, et al. Alcohol hyper-responsiveness in chronic rhinosinusitis with nasal polyps. Clin Exp Allergy. 2017;47(2):245-253. https://doi.org/10.1111/cea.12836. Lomholt FK, Nielsen SF, Nordestgaard BG. High alcohol consumption causes high IgE levels but not high risk of allergic disease. J Allergy Clin Immunol. 2016;138(5):1404-1413.e13. https://doi.org/10.1016/j.jaci.2016.05.022. Ellis AK, Keith PK. Nonallergic rhinitis with eosinophilia syndrome. Curr Allergy Asthma Rep. 2006;6(3):215-220. https://doi.org/10.1007/s11882-006-0037-0. Jacobs RL, Freedman PM, Boswell RN. Nonallergic rhinitis with eosinophilia (NARES syndrome). Clinical and immunologic presentation. J Allergy Clin Immunol. 1981;67(4):253-262. https://doi.org/10.1016/0091-6749(81)90019-1. Simola M, Malmberg H. Sense of smell in allergic and nonallergic rhinitis. Allergy. 1998;53(2):190-194. https://doi.org/10.1111/j.1398-9995.1998.tb03869.x. Moneret-Vautrin DA, Jankowski R, Bene MC, et al. NARES: a model of inflammation caused by activated eosinophils? Rhinology. 1992;30(3):161-168. Powe DG, Huskisson RS, Carney AS, Jenkins D, Jones NS. Evidence for an inflammatory pathophysiology in idiopathic rhinitis. Clin Exp Allergy. 2001;31(6):864-872. https://doi.org/10.1046/j.1365-2222.2001.01106.x. Berger G, Goldberg A, Ophir D. The inferior turbinate mast cell population of patients with perennial allergic and nonallergic rhinitis. Am J Rhinol. 1997;11(1):63-66. https://doi.org/10.2500/105065897781446775. De Corso E, Baroni S, Battista M, et al. Nasal fluid release of eotaxin-3 and eotaxin-2 in persistent sinonasal eosinophilic inflammation. Int Forum Allergy Rhinol. 2014;4(8):617-624. https://doi.org/10.1002/alr.21348. De Corso E, Baroni S, Lucidi D, et al. Nasal lavage levels of granulocyte-macrophage colony-stimulating factor and chronic nasal hypereosinophilia. Int Forum Allergy Rhinol. 2015;5(6):557-562. https://doi.org/10.1002/alr.21519. Kramer MF, Burow G, Pfrogner E, Rasp G. In vitro diagnosis of chronic nasal inflammation. Clin Exp Allergy. 2004;34(7):1086-1092. https://doi.org/10.1111/j.1365-2222.2004.01989.x. Groger M, Klemens C, Wendt S, et al. Mediators and cytokines in persistent allergic rhinitis and nonallergic rhinitis with eosinophilia syndrome. Int Arch Allergy Immunol. 2012;159(2):171-178. https://doi.org/10.1159/000336169. Marcella R, Croce A, Moretti A, Barbacane RC, Di Giocchino M, Conti P. Transcription and translation of the chemokines RANTES and MCP-1 in nasal polyps and mucosa in allergic and non-allergic rhinopathies. Immunol Lett. 2003;90(2-3):71-75. https://doi.org/10.1016/s0165-2478(03)00163-9. Peric A, Sotirovic J, Spadijer-Mirkovic C, Matkovic-Jozin S, Peric AV, Vojvodic D. Nonselective chemokine levels in nasal secretions of patients with perennial nonallergic and allergic rhinitis. Int Forum Allergy Rhinol. 2016;6(4):392-397. https://doi.org/10.1002/alr.21684. Becker S, Rasp J, Eder K, Berghaus A, Kramer MF, Groger M. Non-allergic rhinitis with eosinophilia syndrome is not associated with local production of specific IgE in nasal mucosa. Eur Arch Otorhinolaryngol. 2016;273(6):1469-1475. https://doi.org/10.1007/s00405-015-3769-4. Eckrich J, Hinkel J, Fischl A, et al. Nasal IgE in subjects with allergic and non-allergic rhinitis. World Allergy Organ J. 2020;13(6):100129. https://doi.org/10.1016/j.waojou.2020.100129. Zhang M, Yan B, Wang Y, Wang C, Zhang L. Charcot-Leyden crystal protein in nasal secretions of patients with nonallergic rhinitis with eosinophilia syndrome. Int Arch Allergy Immunol. 2020;181(11):888-896. https://doi.org/10.1159/000509252. Meng Y, Yan B, Wang Y, Wu D, Zhang L, Wang C. Diagnosis and management of nonallergic rhinitis with eosinophilia syndrome using cystatin SN together with symptoms. World Allergy Organ J. 2020;13(7):100134. https://doi.org/10.1016/j.waojou.2020.100134. Numao T, Agrawal DK. Neuropeptides modulate human eosinophil chemotaxis. J Immunol. 1992;149(10):3309-3315. Kramer MF, de la Chaux R, Fintelmann R, Rasp G. NARES: a risk factor for obstructive sleep apnea? Am J Otolaryngol. 2004;25(3):173-177. https://doi.org/10.1016/j.amjoto.2003.12.004. Wang Q, Ji J, Xie Y, et al. Lower airway inflammation and hyperresponsiveness in non-asthmatic patients with non-allergic rhinitis. J Thorac Dis. 2015;7(10):1756-1764. https://doi.org/10.3978/j.issn.2072-1439.2015.10.26. Settipane RA, Lieberman P. Update on nonallergic rhinitis. Ann Allergy Asthma Immunol. 2001;86(5):494-507; quiz 507-8. https://doi.org/10.1016/S1081-1206(10)62896-7. Pipkorn U, Proud D, Lichtenstein LM, Kagey-Sobotka A, Norman PS, Naclerio RM. Inhibition of mediator release in allergic rhinitis by pretreatment with topical glucocorticosteroids. N Engl J Med. 1987;316(24):1506-1510. https://doi.org/10.1056/NEJM198706113162403. Webb DR, Meltzer EO, Finn AF, Jr., et al. Intranasal fluticasone propionate is effective for perennial nonallergic rhinitis with or without eosinophilia. Ann Allergy Asthma Immunol. 2002;88(4):385-390. https://doi.org/10.1016/S1081-1206(10)62369-1. Bachert C, van Cauwenberge P, Khaltaev N, World Health Organization. Allergic rhinitis and its impact on asthma. In collaboration with the World Health Organization. Executive summary of the workshop report. 7-10 December 1999, Geneva, Switzerland. Allergy. 2002;57(9):841-855. https://doi.org/10.1034/j.1398-9995.2002.23625.x. Banov CH, Lieberman P, Vasomotor Rhinitis Study Groups. Efficacy of azelastine nasal spray in the treatment of vasomotor (perennial nonallergic) rhinitis. Ann Allergy Asthma Immunol. 2001;86(1):28-35. https://doi.org/10.1016/S1081-1206(10)62352-6. De Corso E, Anzivino R, Galli J, et al. Antileukotrienes improve naso-ocular symptoms and biomarkers in patients with NARES and asthma. Laryngoscope. 2019;129(3):551-557. https://doi.org/10.1002/lary.27576. Settipane RA. Epidemiology of vasomotor rhinitis. World Allergy Organ J. 2009;2(6):115-118. https://doi.org/10.1097/WOX.0b013e3181ac91ae. Mullarkey MF, Hill JS, Webb DR. Allergic and nonallergic rhinitis: their characterization with attention to the meaning of nasal eosinophilia. J Allergy Clin Immunol. 1980;65(2):122-126. https://doi.org/10.1016/0091-6749(80)90196-7. Enberg RN. Perennial nonallergic rhinitis: a retrospective review. Ann Allergy. 1989;63(6 pt 1):513-516. Nozad CH, Michael LM, Betty Lew D, Michael CF. Non-allergic rhinitis: a case report and review. Clin Mol Allergy. 2010;8:1. https://doi.org/10.1186/1476-7961-8-1. Pattanaik D, Lieberman P. Vasomotor rhinitis. Curr Allergy Asthma Rep. 2010;10(2):84-91. https://doi.org/10.1007/s11882-010-0089-z. Campo P, Rondon C, Gould HJ, Barrionuevo E, Gevaert P, Blanca M. Local IgE in non-allergic rhinitis. Clin Exp Allergy. 2015;45(5):872-881. https://doi.org/10.1111/cea.12476. James LK, Durham SR. Rhinitis with negative skin tests and absent serum allergen-specific IgE: more evidence for local IgE? J Allergy Clin Immunol. 2009;124(5):1012-1013. https://doi.org/10.1016/j.jaci.2009.09.029. Hamizan AW, Rimmer J, Alvarado R, et al. Positive allergen reaction in allergic and nonallergic rhinitis: a systematic review. Int Forum Allergy Rhinol. 2017;7(9):868-877. https://doi.org/10.1002/alr.21988. Eifan AO, Durham SR. Pathogenesis of rhinitis. Clin Exp Allergy. 2016;46(9):1139-1151. https://doi.org/10.1111/cea.12780. Bernstein JA, Hastings L, Boespflug EL, Allendorfer JB, Lamy M, Eliassen JC. Alteration of brain activation patterns in nonallergic rhinitis patients using functional magnetic resonance imaging before and after treatment with intranasal azelastine. Ann Allergy Asthma Immunol. 2011;106(6):527-532. https://doi.org/10.1016/j.anai.2011.02.014. Segboer C, Gevorgyan A, Avdeeva K, et al. Intranasal corticosteroids for non-allergic rhinitis. Cochrane Database Syst Rev. 2019;2019(11):CD010592. https://doi.org/10.1002/14651858.CD010592.pub2. Lieberman P, Kaliner MA, Wheeler WJ. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis. Curr Med Res Opin. 2005;21(4):611-618. https://doi.org/10.1185/030079905X41408. Grossman J, Banov C, Boggs P, et al. Use of ipratropium bromide nasal spray in chronic treatment of nonallergic perennial rhinitis, alone and in combination with other perennial rhinitis medications. J Allergy Clin Immunol. 1995;95(5 pt 2):1123-1127. https://doi.org/10.1016/s0091-6749(95)70216-4. Yan CH, Hwang PH. Surgical management of nonallergic rhinitis. Otolaryngol Clin North Am. 2018;51(5):945-955. https://doi.org/10.1016/j.otc.2018.05.010. Ikeda K, Yokoi H, Saito T, Kawano K, Yao T, Furukawa M. Effect of resection of the posterior nasal nerve on functional and morphological changes in the inferior turbinate mucosa. Acta Otolaryngol. 2008;128(12):1337-1341. https://doi.org/10.1080/00016480801935525. Hwang PH, Lin B, Weiss R, Atkins J, Johnson J. Cryosurgical posterior nasal tissue ablation for the treatment of rhinitis. Int Forum Allergy Rhinol. 2017;7(10):952-956. https://doi.org/10.1002/alr.21991. Kompelli AR, Janz TA, Rowan NR, Nguyen SA, Soler ZM. Cryotherapy for the treatment of chronic rhinitis: a qualitative systematic review. Am J Rhinol Allergy. 2018;32(6):491-501. https://doi.org/10.1177/1945892418800879. Sahin-Yilmaz AA, Corey JP. Rhinitis in the elderly. Clin Allergy Immunol. 2007;19:209-219. Edelstein DR. Aging of the normal nose in adults. Laryngoscope. 1996;106(9 pt 2):1-25. https://doi.org/10.1097/00005537-199609001-00001. Lindemann J, Sannwald D, Wiesmiller K. Age-related changes in intranasal air conditioning in the elderly. Laryngoscope. 2008;118(8):1472-1475. https://doi.org/10.1097/MLG.0b013e3181758174. Pinto JM, Jeswani S. Rhinitis in the geriatric population. Allergy Asthma Clin Immunol. 2010;6(1):10. https://doi.org/10.1186/1710-1492-6-10. Rodriguez K, Rubinstein E, Ferguson BJ. Clear anterior rhinorrhea in the population. Int Forum Allergy Rhinol. 2015;5(11):1063-1067. https://doi.org/10.1002/alr.21583. Parashar R, Amir M, Pakhare A, Rathi P, Chaudhary L. Age related changes in autonomic functions. J Clin Diagn Res. 2016;10(3):CC11-CC15. https://doi.org/10.7860/JCDR/2016/16889.7497. Hotta H, Uchida S. Aging of the autonomic nervous system and possible improvements in autonomic activity using somatic afferent stimulation. Geriatr Gerontol Int. 2010;10(suppl 1):S127-S136. https://doi.org/10.1111/j.1447-0594.2010.00592.x. Lal D, Corey JP. Vasomotor rhinitis update. Curr Opin Otolaryngol Head Neck Surg. 2004;12(3):243-247. https://doi.org/10.1097/01.moo.0000122310.13359.79. Kimmelman CP, Ali GH. Vasomotor rhinitis. Otolaryngol Clin North Am. 1986;19(1):65-71. Georgitis JW. Prevalence and differential diagnosis of chronic rhinitis. Curr Allergy Asthma Rep. 2001;1(3):202-206. https://doi.org/10.1007/s11882-001-0006-6. Baptist AP, Nyenhuis S. Rhinitis in the elderly. Immunol Allergy Clin North Am. 2016;36(2):343-357. https://doi.org/10.1016/j.iac.2015.12.010. Janzen VD. Rhinological disorders in the elderly. J Otolaryngol. 1986;15(4):228-230. Ciftci Z, Catli T, Hanci D, Cingi C, Erdogan G. Rhinorrhoea in the elderly. Eur Arch Otorhinolaryngol. 2015;272(10):2587-2592. https://doi.org/10.1007/s00405-014-3182-4. Bozek A. Pharmacological management of allergic rhinitis in the elderly. Drugs Aging. 2017;34(1):21-28. https://doi.org/10.1007/s40266-016-0425-7. Ho JC, Chan KN, Hu WH, et al. The effect of aging on nasal mucociliary clearance, beat frequency, and ultrastructure of respiratory cilia. Am J Respir Crit Care Med. 2001;163(4):983-988. https://doi.org/10.1164/ajrccm.163.4.9909121. Mirza N, Kroger H, Doty RL. Influence of age on the ‘nasal cycle’. Laryngoscope. 1997;107(1):62-66. https://doi.org/10.1097/00005537-199701000-00014. Slavin RG. Treating rhinitis in the older population: special considerations. Allergy Asthma Clin Immunol. 2009;5(1):9. https://doi.org/10.1186/1710-1492-5-9. Schrodter S, Biermann E, Halata Z. Histological evaluation of age-related changes in human respiratory mucosa of the middle turbinate. Anat Embryol (Berl). 2003;207(1):19-27. https://doi.org/10.1007/s00429-003-0326-5. Milgrom H, Huang H. Allergic disorders at a venerable age: a mini-review. Gerontology. 2014;60(2):99-107. https://doi.org/10.1159/000355307. Wheatley LM, Togias A. Clinical practice. Allergic rhinitis. N Engl J Med. 2015;372(5):456-463. https://doi.org/10.1056/NEJMcp1412282. Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: allergic rhinitis executive summary. Otolaryngol Head Neck Surg. 2015;152(2):197-206. https://doi.org/10.1177/0194599814562166. Slavin RG. Special considerations in treatment of allergic rhinitis in the elderly: role of intranasal corticosteroids. Allergy Asthma Proc. 2010;31(3):179-184. https://doi.org/10.2500/aap.2010.31.3342. Bozek A, Cudak A, Walter Canonica G. Long-term efficacy of injected allergen immunotherapy for treatment of grass pollen allergy in elderly patients with allergic rhinitis. Allergy Asthma Proc. 2020;41(4):271-277. https://doi.org/10.2500/aap.2020.41.200035. Jain T, Sanju Kumar H, Guerrieri M, Ralli M, Di Mauro R. Primary atrophic rhinitis: ozeana and other infective forms. In: Di Girolamo S, ed. Atrophic Rhinitis. Springer; 2020:3-12. Wright J. Atrophic rhinitis in its historical, etiological and histological aspects. Laryngoscope. 1913;23:641-666. Ruskin S. A differential diagnosis and therapy of atrophic rhinitis and ozena. Arch Otolaryngol. 1932;15:222-257. Bunnag C, Jareoncharsri P, Tansuriyawong P, Bhothisuwan W, Chantarakul N. Characteristics of atrophic rhinitis in Thai patients at the Siriraj Hospital. Rhinology. 1999;37(3):125-130. Moore EJ, Kern EB. Atrophic rhinitis: a review of 242 cases. Am J Rhinol. 2001;15(6):355-361. Bist SS, Bisht M, Purohit JP, Saxena R. Study of histopathological changes in primary atrophic rhinitis. ISRN Otolaryngol. 2011;2011:269479. https://doi.org/10.5402/2011/269479. Bist SS, Bisht M, Purohit JP. Primary atrophic rhinitis: a clinical profile, microbiological and radiological study. ISRN Otolaryngol. 2012;2012:404075. https://doi.org/10.5402/2012/404075. Sinha SN, Sardana DS, Rajvanshi VS. A nine years' review of 273 cases of atrophic rhinitis and its management. J Laryngol Otol. 1977;91(7):591-600. https://doi.org/10.1017/s0022215100084097. Mishra A, Kawatra R, Gola M. Interventions for atrophic rhinitis. Cochrane Database Syst Rev. 2012;(2):CD008280. https://doi.org/10.1002/14651858.CD008280.pub2. Gigant L, Zoli A, Guiacomini PG, Zoli A. A secondary atrophis rhinitis: autoimmune and granulomatous forms. In: Di Girolamo S, ed. Atrophic Rhinitis. Springer; 2020:13-30. Ly TH, deShazo RD, Olivier J, Stringer SP, Daley W, Stodard CM. Diagnostic criteria for atrophic rhinosinusitis. Am J Med. 2009;122(8):747-753. https://doi.org/10.1016/j.amjmed.2008.12.025. Taylor M, Young A. Histopathological and histochemical studies on atrophic rhinitis. J Laryngol Otol. 1961;75:574-590. https://doi.org/10.1017/s0022215100058138. Zohar Y, Talmi YP, Strauss M, Finkelstein Y, Shvilli Y. Ozena revisited. J Otolaryngol. 1990;19(5):345-349. Chand MS, MacArthur CJ. Primary atrophic rhinitis: a summary of four cases and review of the literature. Otolaryngol Head Neck Surg. 1997;116(4):554-558. https://doi.org/10.1016/s0194-5998(97)70311-5. Sibert JR, Barton RP. Dominant inheritance in a family with primary atrophic rhinitis. J Med Genet. 1980;17(1):39-40. https://doi.org/10.1136/jmg.17.1.39. Scheithauer MO. Surgery of the turbinates and "empty nose" syndrome. GMS Curr Top Otorhinolaryngol Head Neck Surg. 2010;9:Doc03. https://doi.org/10.3205/cto000067. Coste A, Dessi P, Serrano E. Empty nose syndrome. Eur Ann Otorhinolaryngol Head Neck Dis. 2012;129(2):93-97. https://doi.org/10.1016/j.anorl.2012.02.001. Chhabra N, Houser SM. The diagnosis and management of empty nose syndrome. Otolaryngol Clin North Am. 2009;42(2):311-330, ix. https://doi.org/10.1016/j.otc.2009.02.001. Houser SM. Surgical treatment for empty nose syndrome. Arch Otolaryngol Head Neck Surg. 2007;133(9):858-863. https://doi.org/10.1001/archotol.133.9.858. Kuan EC, Suh JD, Wang MB. Empty nose syndrome. Curr Allergy Asthma Rep. 2015;15(1):493. https://doi.org/10.1007/s11882-014-0493-x. Velasquez N, Thamboo A, Habib AR, Huang Z, Nayak JV. The Empty Nose Syndrome 6-Item Questionnaire (ENS6Q): a validated 6-item questionnaire as a diagnostic aid for empty nose syndrome patients. Int Forum Allergy Rhinol. 2017;7(1):64-71. https://doi.org/10.1002/alr.21842. Payne SC. Empty nose syndrome: what are we really talking about? Otolaryngol Clin North Am. 2009;42(2):331-337, ix-x. https://doi.org/10.1016/j.otc.2009.02.002. Chang MT, Nayak JV. In Response to Inferior Meatus Augmentation Procedure (IMAP) for treatment of empty nose syndrome. Laryngoscope. 2022;132(6):E22. https://doi.org/10.1002/lary.30119. Thamboo A, Velasquez N, Ayoub N, Nayak JV. Distinguishing computed tomography findings in patients with empty nose syndrome. Int Forum Allergy Rhinol. 2016;6(10):1075-1082. https://doi.org/10.1002/alr.21774. Malik J, Li C, Maza G, et al. Computational fluid dynamic analysis of aggressive turbinate reductions: is it a culprit of empty nose syndrome? Int Forum Allergy Rhinol. 2019;9(8):891-899. https://doi.org/10.1002/alr.22350. Bautista DM, Siemens J, Glazer JM, et al. The menthol receptor TRPM8 is the principal detector of environmental cold. Nature. 2007;448(7150):204-208. https://doi.org/10.1038/nature05910. Zhao K, Blacker K, Luo Y, Bryant B, Jiang J. Perceiving nasal patency through mucosal cooling rather than air temperature or nasal resistance. PLoS One. 2011;6(10):e24618. https://doi.org/10.1371/journal.pone.0024618. Zhao K, Jiang J, Blacker K, et al. Regional peak mucosal cooling predicts the perception of nasal patency. Laryngoscope. 2014;124(3):589-595. https://doi.org/10.1002/lary.24265. Willatt DJ, Jones AS. The role of the temperature of the nasal lining in the sensation of nasal patency. Clin Otolaryngol Allied Sci. 1996;21(6):519-523. https://doi.org/10.1111/j.1365-2273.1996.tb01102.x. Kimbell JS, Frank DO, Laud P, Garcia GJ, Rhee JS. Changes in nasal airflow and heat transfer correlate with symptom improvement after surgery for nasal obstruction. J Biomech. 2013;46(15):2634-2643. https://doi.org/10.1016/j.jbiomech.2013.08.007. Lindemann J, Tsakiropoulou E, Scheithauer MO, Konstantinidis I, Wiesmiller KM. Impact of menthol inhalation on nasal mucosal temperature and nasal patency. Am J Rhinol. 2008;22(4):402-405. https://doi.org/10.2500/ajr.2008.22.3194. Sozansky J, Houser SM. Pathophysiology of empty nose syndrome. Laryngoscope. 2015;125(1):70-74. https://doi.org/10.1002/lary.24813. Li C, Farag AA, Leach J, et al. Computational fluid dynamics and trigeminal sensory examinations of empty nose syndrome patients. Laryngoscope. 2017;127(6):E176-E184. https://doi.org/10.1002/lary.26530. Li C, Farag AA, Maza G, et al. Investigation of the abnormal nasal aerodynamics and trigeminal functions among empty nose syndrome patients. Int Forum Allergy Rhinol. 2018;8(3):444-452. https://doi.org/10.1002/alr.22045. Malik J, Dholakia S, Spector BM, et al. Inferior meatus augmentation procedure (IMAP) normalizes nasal airflow patterns in empty nose syndrome patients via computational fluid dynamics (CFD) modeling. Int Forum Allergy Rhinol. 2021;11(5):902-909. https://doi.org/10.1002/alr.22720. Thamboo A, Velasquez N, Habib AR, Zarabanda D, Paknezhad H, Nayak JV. Defining surgical criteria for empty nose syndrome: validation of the office-based cotton test and clinical interpretability of the validated Empty Nose Syndrome 6-Item Questionnaire. Laryngoscope. 2017;127(8):1746-1752. https://doi.org/10.1002/lary.26549. Talmadge J, Nayak JV, Yao W, Citardi MJ. Management of postsurgical empty nose syndrome. Facial Plast Surg Clin North Am. 2019;27(4):465-475. https://doi.org/10.1016/j.fsc.2019.07.005. Kanjanawasee D, Campbell RG, Rimmer J, et al. Empty nose syndrome pathophysiology: a systematic review. Otolaryngol Head Neck Surg. 2021:1945998211052919. https://doi.org/10.1177/01945998211052919. Manji J, Nayak JV, Thamboo A. The functional and psychological burden of empty nose syndrome. Int Forum Allergy Rhinol. 2018;8(6):707-712. https://doi.org/10.1002/alr.22097. Huang CC, Wu PW, Fu CH, Huang CC, Chang PH, Lee TJ. Impact of psychologic burden on surgical outcome in empty nose syndrome. Laryngoscope. 2021;131(3):E694-E701. https://doi.org/10.1002/lary.28845. Huang CC, Wu PW, Lee CC, Chang PH, Huang CC, Lee TJ. Suicidal thoughts in patients with empty nose syndrome. Laryngoscope Investig Otolaryngol. 2022;7(1):22-28. https://doi.org/10.1002/lio2.730. Tian P, Hu J, Ma Y, et al. The clinical effect of psychosomatic interventions on empty nose syndrome secondary to turbinate-sparing techniques: a prospective self-controlled study. Int Forum Allergy Rhinol. 2021;11(6):984-992. https://doi.org/10.1002/alr.22726. Lemogne C, Consoli SM, Limosin F, Bonfils P. Treating empty nose syndrome as a somatic symptom disorder. Gen Hosp Psychiatry. 2015;37(3):273.e9-10. https://doi.org/10.1016/j.genhosppsych.2015.02.005. Borchard NA, Dholakia SS, Yan CH, Zarabanda D, Thamboo A, Nayak JV. Use of intranasal submucosal fillers as a transient implant to alter upper airway aerodynamics: implications for the assessment of empty nose syndrome. Int Forum Allergy Rhinol. 2019;9(6):681-687. https://doi.org/10.1002/alr.22299. Modrzynski M. Hyaluronic acid gel in the treatment of empty nose syndrome. Am J Rhinol Allergy. 2011;25(2):103-106. https://doi.org/10.2500/ajra.2011.25.3577. Saafan ME. Acellular dermal (alloderm) grafts versus silastic sheets implants for management of empty nose syndrome. Eur Arch Otorhinolaryngol. 2013;270(2):527-533. https://doi.org/10.1007/s00405-012-1955-1. Jiang C, Shi R, Sun Y. Study of inferior turbinate reconstruction with Medpor for the treatment of empty nose syndrome. Laryngoscope. 2013;123(5):1106-1111. https://doi.org/10.1002/lary.23908. Bastier PL, Bennani-Baiti AA, Stoll D, de Gabory L. beta-Tricalcium phosphate implant to repair empty nose syndrome: preliminary results. Otolaryngol Head Neck Surg. 2013;148(3):519-522. https://doi.org/10.1177/0194599812472436. Jung JH, Baguindali MA, Park JT, Jang YJ. Costal cartilage is a superior implant material than conchal cartilage in the treatment of empty nose syndrome. Otolaryngol Head Neck Surg. 2013;149(3):500-505. https://doi.org/10.1177/0194599813491223. Velasquez N, Huang Z, Humphreys IM, Nayak JV. Inferior turbinate reconstruction using porcine small intestine submucosal xenograft demonstrates improved quality of life outcomes in patients with empty nose syndrome. Int Forum Allergy Rhinol. 2015;5(11):1077-1081. https://doi.org/10.1002/alr.21633. Chang MT, Bartho M, Kim D, et al. Inferior Meatus Augmentation Procedure (IMAP) for treatment of empty nose syndrome. Laryngoscope. 2022;132(6):1285-1288. https://doi.org/10.1002/lary.30001. Thamboo A, Dholakia SS, Borchard NA, et al. Inferior Meatus Augmentation Procedure (IMAP) to treat empty nose syndrome: a pilot study. Otolaryngol Head Neck Surg. 2020;162(3):382-385. https://doi.org/10.1177/0194599819900263. Dholakia SS, Yang A, Kim D, et al. Long-term outcomes of inferior meatus augmentation procedure to treat empty nose syndrome. Laryngoscope. 2021;131(11):E2736-E2741. https://doi.org/10.1002/lary.29593. Malik J, Thamboo A, Dholakia S, et al. The cotton test redistributes nasal airflow in patients with empty nose syndrome. Int Forum Allergy Rhinol. 2020;10(4):539-545. https://doi.org/10.1002/alr.22489. Alobid I, Mullol J, Cid MC. Rhinitis of granulomatous and vasculitic diseases. Clin Allergy Immunol. 2007;19:221-239. Afiari A, Gabriel A, Gaiki MR. Concurrent use of mepolizumab and rituximab for eosinophilic granulomatosis with polyangiitis and multisystem involvement. Cureus. 2020;12(7):e9242. https://doi.org/10.7759/cureus.9242. Falk RJ, Gross WL, Guillevin L, et al. Granulomatosis with polyangiitis (Wegener's): an alternative name for Wegener's granulomatosis. Arthritis Rheum. 2011;63(4):863-864. https://doi.org/10.1002/art.30286. Sardana K, Goel K. Nasal septal ulceration. Clin Dermatol. 2014;32(6):817-826. https://doi.org/10.1016/j.clindermatol.2014.02.022. Erickson VR, Hwang PH. Wegener's granulomatosis: current trends in diagnosis and management. Curr Opin Otolaryngol Head Neck Surg. 2007;15(3):170-176. https://doi.org/10.1097/MOO.0b013e3281568b96. Nasser M, Cottin V. The respiratory system in autoimmune vascular diseases. Respiration. 2018;96(1):12-28. https://doi.org/10.1159/000486899. Holle JU, Gross WL. Neurological involvement in Wegener's granulomatosis. Curr Opin Rheumatol. 2011;23(1):7-11. https://doi.org/10.1097/BOR.0b013e32834115f9. Beltran Rodriguez-Cabo O, Reyes E, Rojas-Serrano J, Flores-Suarez LF. Increased histopathological yield for granulomatosis with polyangiitis based on nasal endoscopy of suspected active lesions. Eur Arch Otorhinolaryngol. 2018;275(2):425-429. https://doi.org/10.1007/s00405-017-4841-z. Al-Hussain T, Hussein MH, Conca W, Al Mana H, Akhtar M. Pathophysiology of ANCA-associated vasculitis. Adv Anat Pathol. 2017;24(4):226-234. https://doi.org/10.1097/PAP.0000000000000154. Lynch 3rd JP, Derhovanessian A, Tazelaar H, Belperio JA. Granulomatosis with polyangiitis (Wegener's granulomatosis): evolving concepts in treatment. Semin Respir Crit Care Med. 2018;39(4):434-458. https://doi.org/10.1055/s-0038-1660874. Noth I, Strek ME, Leff AR. Churg-Strauss syndrome. Lancet. 2003;361(9357):587-594. https://doi.org/10.1016/S0140-6736(03)12518-4. Groh M, Pagnoux C, Baldini C, et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss) (EGPA) Consensus Task Force recommendations for evaluation and management. Eur J Intern Med. 2015;26(7):545-553. https://doi.org/10.1016/j.ejim.2015.04.022. Chaigne B, Dion J, Guillevin L, Mouthon L, Terrier B. Physiopathologie de la granulomatose eosinophilique avec polyangeite (Churg-Strauss. Rev Med Interne. 2016;37:337-342. Wechsler ME, Akuthota P, Jayne D, et al. Mepolizumab or placebo for eosinophilic granulomatosis with polyangiitis. N Engl J Med. 2017;376(20):1921-1932. https://doi.org/10.1056/NEJMoa1702079. Crouser ED, Maier LA, Wilson KC, et al. Diagnosis and detection of sarcoidosis. An official American Thoracic Society Clinical Practice Guideline. Am J Respir Crit Care Med. 2020;201(8):e26-e51. https://doi.org/10.1164/rccm.202002-0251ST. Cereceda-Monteoliva N, Rouhani MJ, Maughan EF, et al. Sarcoidosis of the ear, nose and throat: A review of the literature. Clin Otolaryngol. 2021;46(5):935-940. https://doi.org/10.1111/coa.13814. Judson MA. The clinical features of sarcoidosis: a comprehensive review. Clin Rev Allergy Immunol. 2015;49(1):63-78. https://doi.org/10.1007/s12016-014-8450-y. Send T, Tuleta I, Koppen T, et al. Sarcoidosis of the paranasal sinuses. Eur Arch Otorhinolaryngol. 2019;276(7):1969-1974. https://doi.org/10.1007/s00405-019-05388-7. Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet. 2014;384(9957):1878-1888. https://doi.org/10.1016/S0140-6736(14)60128-8. Thong B, Olsen NJ. Systemic lupus erythematosus diagnosis and management. Rheumatology (Oxford). 2017;56(suppl_1):i3-i13. https://doi.org/10.1093/rheumatology/kew401. Samotij D, Reich A. Biologics in the treatment of lupus erythematosus: a critical literature review. Biomed Res Int. 2019;2019:8142368. https://doi.org/10.1155/2019/8142368. Tanaka Y, Tummala R. Anifrolumab, a monoclonal antibody to the type I interferon receptor subunit 1, for the treatment of systemic lupus erythematosus: an overview from clinical trials. Mod Rheumatol. 2021;31(1):1-12. https://doi.org/10.1080/14397595.2020.1812201. Helman SN, Barrow E, Edwards T, DelGaudio JM, Levy JM, Wise SK. The role of allergic rhinitis in chronic rhinosinusitis. Immunol Allergy Clin North Am. 2020;40(2):201-214. https://doi.org/10.1016/j.iac.2019.12.010. Min YG. The pathophysiology, diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol Res. 2010;2(2):65-76. https://doi.org/10.4168/aair.2010.2.2.65. Kakli HA, Riley TD. Allergic rhinitis. Prim Care. 2016;43(3):465-475. https://doi.org/10.1016/j.pop.2016.04.009. Benninger MS, Ferguson BJ, Hadley JA, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg. 2003;129(3 suppl):S1-S32. https://doi.org/10.1016/s0194-5998(03)01397-4. Shapiro DJ, Gonzales R, Cabana MD, Hersh AL. National trends in visit rates and antibiotic prescribing for children with acute sinusitis. Pediatrics. 2011;127(1):28-34. https://doi.org/10.1542/peds.2010-1340. Whyte A, Boeddinghaus R. Imaging of adult nasal obstruction. Clin Radiol. 2020;75(9):688-704. https://doi.org/10.1016/j.crad.2019.07.027. Hsu DW, Suh JD. Anatomy and Physiology of Nasal Obstruction. Otolaryngol Clin North Am. 2018;51(5):853-865. https://doi.org/10.1016/j.otc.2018.05.001. Cox DR, Wise SK. Medical Treatment of Nasal Airway Obstruction. Otolaryngol Clin North Am. 2018;51(5):897-908. https://doi.org/10.1016/j.otc.2018.05.004. Villwock JA, Kuppersmith RB. Diagnostic Algorithm for Evaluating Nasal Airway Obstruction. Otolaryngol Clin North Am. 2018;51(5):867-872. https://doi.org/10.1016/j.otc.2018.05.002. Samra S, Steitz JT, Hajnas N, Toriumi DM. Surgical Management of Nasal Valve Collapse. Otolaryngol Clin North Am. 2018;51(5):929-944. https://doi.org/10.1016/j.otc.2018.05.009. Alvo A, Villarroel G, Sedano C. Neonatal nasal obstruction. Eur Arch Otorhinolaryngol. 2021;278(10):3605-3611. https://doi.org/10.1007/s00405-020-06546-y. Harvey RJ, Sheahan PO, Schlosser RJ. Surgical management of benign sinonasal masses. Otolaryngol Clin North Am. 2009;42(2):353-375, x. https://doi.org/10.1016/j.otc.2009.01.006. Kuo MJ, Reid AP, Smith JE. Unilateral nasal obstruction: an unusual presentation of a complication of nasotracheal intubation. J Laryngol Otol. 1994;108(11):991-992. https://doi.org/10.1017/s0022215100128701. Tuluc M, Zhang X, Inniss S. Giant cell tumor of the nasal cavity: case report. Eur Arch Otorhinolaryngol. 2007;264(2):205-208. https://doi.org/10.1007/s00405-006-0143-6. Hongmei Y, Zhe W, Jing W, Daokui W, Peicheng C, Yongjie L. Delayed cerebrospinal fluid rhinorrhea after gamma knife surgery in a patient with a growth hormone-secreting adenoma. J Clin Neurosci. 2012;19(6):900-902. https://doi.org/10.1016/j.jocn.2011.09.016. Marchiano E, Carniol ET, Guzman DE, Raikundalia MD, Baredes S, Eloy JA. An Analysis of Patients Treated for Cerebrospinal Fluid Rhinorrhea in the United States from 2002 to 2010. J Neurol Surg B Skull Base. 2017;78(1):18-23. https://doi.org/10.1055/s-0036-1584297. Tufano RP, Thaler ER, Lanza DC, Goldberg AN, Kennedy DW. Endoscopic management of sinonasal inverted papilloma. Am J Rhinol. 1999;13(6):423-426. https://doi.org/10.2500/105065899781329665. Taylor MA, Saba NF. Cancer of the Paranasal Sinuses. Hematol Oncol Clin North Am. 2021;35(5):949-962. https://doi.org/10.1016/j.hoc.2021.05.006. Oakley GM, Alt JA, Schlosser RJ, Harvey RJ, Orlandi RR. Diagnosis of cerebrospinal fluid rhinorrhea: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2016;6(1):8-16. https://doi.org/10.1002/alr.21637. Kinoshita Y, Wasita B, Akatsuka K, Kambe A, Kurosaki M, Watanabe T. Choroid plexus papilloma presenting with cerebrospinal fluid rhinorrhea and otorrhea: case report. Neurol Med Chir (Tokyo). 2010;50(10):930-933. https://doi.org/10.2176/nmc.50.930. Kose OD, Kose TE, Erdem MA, Cankaya AB. Large rhinolith causing nasal obstruction. BMJ Case Rep. 2015;2015. https://doi.org/10.1136/bcr-2014-208260. Sumbullu MA, Tozoglu U, Yoruk O, Yilmaz AB, Ucuncu H. Rhinolithiasis: the importance of flat panel detector-based cone beam computed tomography in diagnosis and treatment. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2009;107(6):e65-e67. https://doi.org/10.1016/j.tripleo.2009.02.029. Okafor S, Kelly KM, Halderman AA. Management of sinusitis in the cystic fibrosis patient. Immunol Allergy Clin North Am. 2020;40(2):371-383. https://doi.org/10.1016/j.iac.2019.12.008. Shoemark A, Harman K. Primary ciliary dyskinesia. Semin Respir Crit Care Med. 2021;42(4):537-548. https://doi.org/10.1055/s-0041-1730919. Finocchio E, Locatelli F, Sanna F, et al. Gastritis and gastroesophageal reflux disease are strongly associated with non-allergic nasal disorders. BMC Pulm Med. 2021;21(1):53. https://doi.org/10.1186/s12890-020-01364-8. Dagli E, Yuksel A, Kaya M, Ugur KS, Turkay FC. Association of oral antireflux medication with laryngopharyngeal reflux and nasal resistance. JAMA Otolaryngol Head Neck Surg. 2017;143(5):478-483. https://doi.org/10.1001/jamaoto.2016.4127. Lou Z, Lou ZH. Laryngopharyngeal reflux is a potential cause of nasal congestion and obstructive sleep apnea syndrome. Eur Arch Otorhinolaryngol. 2018;275(9):2409-2411. https://doi.org/10.1007/s00405-017-4782-6. Kraft S, Kinet JP. New developments in FcepsilonRI regulation, function and inhibition. Nat Rev Immunol. 2007;7(5):365-378. https://doi.org/10.1038/nri2072. Acharya M, Borland G, Edkins AL, et al. CD23/FcepsilonRII: molecular multi-tasking. Clin Exp Immunol. 2010;162(1):12-23. https://doi.org/10.1111/j.1365-2249.2010.04210.x. Wu LC, Zarrin AA. The production and regulation of IgE by the immune system. Nat Rev Immunol. 2014;14(4):247-259. https://doi.org/10.1038/nri3632. Blank U, Huang H, Kawakami T. The high affinity IgE receptor: a signaling update. Curr Opin Immunol. 2021;72:51-58. https://doi.org/10.1016/j.coi.2021.03.015. Humbert M, Bousquet J, Bachert C, et al. IgE-mediated multimorbidities in allergic asthma and the potential for omalizumab therapy. J Allergy Clin Immunol Pract. 2019;7(5):1418-1429. https://doi.org/10.1016/j.jaip.2019.02.030. Paolini R, Jouvin MH, Kinet JP. Phosphorylation and dephosphorylation of the high-affinity receptor for immunoglobulin E immediately after receptor engagement and disengagement. Nature. 1991;353(6347):855-858. https://doi.org/10.1038/353855a0. Siraganian RP, de Castro RO, Barbu EA, Zhang J. Mast cell signaling: the role of protein tyrosine kinase Syk, its activation and screening methods for new pathway participants. FEBS Lett. 2010;584(24):4933-4940. https://doi.org/10.1016/j.febslet.2010.08.006. Costello PS, Turner M, Walters AE, et al. Critical role for the tyrosine kinase Syk in signalling through the high affinity IgE receptor of mast cells. Oncogene. 1996;13(12):2595-2605. Zhang J, Berenstein EH, Evans RL, Siraganian RP. Transfection of Syk protein tyrosine kinase reconstitutes high affinity IgE receptor-mediated degranulation in a Syk-negative variant of rat basophilic leukemia RBL-2H3 cells. J Exp Med. 1996;184(1):71-79. https://doi.org/10.1084/jem.184.1.71. Mukai K, Tsai M, Saito H, Galli SJ. Mast cells as sources of cytokines, chemokines, and growth factors. Immunol Rev. 2018;282(1):121-150. https://doi.org/10.1111/imr.12634. Draber P, Halova I, Polakovicova I, Kawakami T. Signal transduction and chemotaxis in mast cells. Eur J Pharmacol. 2016;778:11-23. https://doi.org/10.1016/j.ejphar.2015.02.057. Motakis E, Guhl S, Ishizu Y, et al. Redefinition of the human mast cell transcriptome by deep-CAGE sequencing. Blood. 2014;123(17):e58-e67. https://doi.org/10.1182/blood-2013-02-483792. Li Y, Gao J, Kamran M, et al. GATA2 regulates mast cell identity and responsiveness to antigenic stimulation by promoting chromatin remodeling at super-enhancers. Nat Commun. 2021;12(1):494. https://doi.org/10.1038/s41467-020-20766-0. Cildir G, Pant H, Lopez AF, Tergaonkar V. The transcriptional program, functional heterogeneity, and clinical targeting of mast cells. J Exp Med. 2017;214(9):2491-2506. https://doi.org/10.1084/jem.20170910. Jayapal M, Tay HK, Reghunathan R, et al. Genome-wide gene expression profiling of human mast cells stimulated by IgE or FcepsilonRI-aggregation reveals a complex network of genes involved in inflammatory responses. BMC Genomics. 2006;7:210. https://doi.org/10.1186/1471-2164-7-210. Anto JM, Bousquet J, Akdis M, et al. Mechanisms of the Development of Allergy (MeDALL): introducing novel concepts in allergy phenotypes. J Allergy Clin Immunol. 2017;139(2):388-399. https://doi.org/10.1016/j.jaci.2016.12.940. Oettgen HC, Geha RS. IgE in asthma and atopy: cellular and molecular connections. J Clin Invest. 1999;104(7):829-835. https://doi.org/10.1172/JCI8205. Galli SJ, Tsai M. IgE and mast cells in allergic disease. Nat Med. 2012;18(5):693-704. https://doi.org/10.1038/nm.2755. Berger A. Th1 and Th2 responses: what are they? BMJ. 2000;321(7258):424. https://doi.org/10.1136/bmj.321.7258.424. Chaplin DD. Overview of the immune response. J Allergy Clin Immunol. 2010;125(2 suppl 2):S3-S23. https://doi.org/10.1016/j.jaci.2009.12.980. Moro K, Yamada T, Tanabe M, et al. Innate production of T(H)2 cytokines by adipose tissue-associated c-Kit(+)Sca-1(+) lymphoid cells. Nature. 2010;463(7280):540-544. https://doi.org/10.1038/nature08636. Neill DR, Wong SH, Bellosi A, et al. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 2010;464(7293):1367-1370. https://doi.org/10.1038/nature08900. Halim TY, Steer CA, Matha L, et al. Group 2 innate lymphoid cells are critical for the initiation of adaptive T helper 2 cell-mediated allergic lung inflammation. Immunity. 2014;40(3):425-435. https://doi.org/10.1016/j.immuni.2014.01.011. Lambrecht BN, Hammad H. Allergens and the airway epithelium response: gateway to allergic sensitization. J Allergy Clin Immunol. 2014;134(3):499-507. https://doi.org/10.1016/j.jaci.2014.06.036. Cayrol C, Duval A, Schmitt P, et al. Environmental allergens induce allergic inflammation through proteolytic maturation of IL-33. Nat Immunol. 2018;19(4):375-385. https://doi.org/10.1038/s41590-018-0067-5. Roan F, Obata-Ninomiya K, Ziegler SF. Epithelial cell-derived cytokines: more than just signaling the alarm. J Clin Invest. 2019;129(4):1441-1451. https://doi.org/10.1172/JCI124606. Hammad H, Lambrecht BN. Barrier epithelial cells and the control of type 2 immunity. Immunity. 2015;43(1):29-40. https://doi.org/10.1016/j.immuni.2015.07.007. Osguthorpe JD. Pathophysiology of and potential new therapies for allergic rhinitis. Int Forum Allergy Rhinol. 2013;3(5):384-392. https://doi.org/10.1002/alr.21120. Sin B, Togias A. Pathophysiology of allergic and nonallergic rhinitis. Proc Am Thorac Soc. 2011;8(1):106-114. https://doi.org/10.1513/pats.201008-057RN. Pawankar R, Mori S, Ozu C, Kimura S. Overview on the pathomechanisms of allergic rhinitis. Asia Pac Allergy. 2011;1(3):157-167. https://doi.org/10.5415/apallergy.2011.1.3.157. Liu YJ. Thymic stromal lymphopoietin: master switch for allergic inflammation. J Exp Med. 2006;203(2):269-273. https://doi.org/10.1084/jem.20051745. Bousquet J, Anto JM, Bachert C, et al. Allergic rhinitis. Nat Rev Dis Primers. 2020;6(1):95. https://doi.org/10.1038/s41572-020-00227-0. Geha RS. Regulation of IgE synthesis in humans. J Allergy Clin Immunol. 1992;90(2):143-150. https://doi.org/10.1016/0091-6749(92)90064-9. Nurieva RI, Liu X, Dong C. Yin-Yang of costimulation: crucial controls of immune tolerance and function. Immunol Rev. 2009;229(1):88-100. https://doi.org/10.1111/j.1600-065X.2009.00769.x. Luna-Gomes T, Magalhaes KG, Mesquita-Santos FP, et al. Eosinophils as a novel cell source of prostaglandin D2: autocrine role in allergic inflammation. J Immunol. 2011;187(12):6518-6526. https://doi.org/10.4049/jimmunol.1101806. Xue L, Salimi M, Panse I, et al. Prostaglandin D2 activates group 2 innate lymphoid cells through chemoattractant receptor-homologous molecule expressed on TH2 cells. J Allergy Clin Immunol. 2014;133(4):1184-1194. https://doi.org/10.1016/j.jaci.2013.10.056. Togias A. Systemic effects of local allergic disease. J Allergy Clin Immunol. 2004;113(1 suppl):S8-S14. https://doi.org/10.1016/j.jaci.2003.09.051. Pinart M, Benet M, Annesi-Maesano I, et al. Comorbidity of eczema, rhinitis, and asthma in IgE-sensitised and non-IgE-sensitised children in MeDALL: a population-based cohort study. Lancet Respir Med. 2014;2(2):131-140. https://doi.org/10.1016/S2213-2600(13)70277-7. Togias AG. Systemic immunologic and inflammatory aspects of allergic rhinitis. J Allergy Clin Immunol. 2000;106(5 suppl):S247-S250. https://doi.org/10.1067/mai.2000.110157. Scadding G, Hellings P, Alobid I, et al. Diagnostic tools in Rhinology EAACI position paper. Clin Transl Allergy. 2011;1(1):2. https://doi.org/10.1186/2045-7022-1-2. Rondon C, Bogas G, Barrionuevo E, Blanca M, Torres MJ, Campo P. Nonallergic rhinitis and lower airway disease. Allergy. 2017;72(1):24-34. https://doi.org/10.1111/all.12988. Fuiano N, Fusilli S, Passalacqua G, Incorvaia C. Allergen-specific immunoglobulin E in the skin and nasal mucosa of symptomatic and asymptomatic children sensitized to aeroallergens. J Investig Allergol Clin Immunol. 2010;20(5):425-430. Rondon C, Campo P, Togias A, et al. Local allergic rhinitis: concept, pathophysiology, and management. J Allergy Clin Immunol. 2012;129(6):1460-1467. https://doi.org/10.1016/j.jaci.2012.02.032. Powe DG, Jagger C, Kleinjan A, Carney AS, Jenkins D, Jones NS. ‘Entopy’: localized mucosal allergic disease in the absence of systemic responses for atopy. Clin Exp Allergy. 2003;33(10):1374-1379. https://doi.org/10.1046/j.1365-2222.2003.01737.x. Rondon C, Campo P, Zambonino MA, et al. Follow-up study in local allergic rhinitis shows a consistent entity not evolving to systemic allergic rhinitis. J Allergy Clin Immunol. 2014;133(4):1026-1031. https://doi.org/10.1016/j.jaci.2013.10.034. Rondon C, Campo P, Eguiluz-Gracia I, et al. Local allergic rhinitis is an independent rhinitis phenotype: the results of a 10-year follow-up study. Allergy. 2018;73(2):470-478. https://doi.org/10.1111/all.13272. Sennekamp J, Joest I, Filipiak-Pittroff B, von Berg A, Berdel D. Local allergic nasal reactions convert to classic systemic allergic reactions: a long-term follow-up. Int Arch Allergy Immunol. 2015;166(2):154-160. https://doi.org/10.1159/000380852. Coker HA, Durham SR, Gould HJ. Local somatic hypermutation and class switch recombination in the nasal mucosa of allergic rhinitis patients. J Immunol. 2003;171(10):5602-5610. https://doi.org/10.4049/jimmunol.171.10.5602. Durham SR, Gould HJ, Thienes CP, et al. Expression of epsilon germ-line gene transcripts and mRNA for the epsilon heavy chain of IgE in nasal B cells and the effects of topical corticosteroid. Eur J Immunol. 1997;27(11):2899-2906. https://doi.org/10.1002/eji.1830271123. Platts-Mills TA. Local production of IgG, IgA and IgE antibodies in grass pollen hay fever. J Immunol. 1979;122(6):2218-2225. Takhar P, Smurthwaite L, Coker HA, et al. Allergen drives class switching to IgE in the nasal mucosa in allergic rhinitis. J Immunol. 2005;174(8):5024-5032. https://doi.org/10.4049/jimmunol.174.8.5024. Powe DG, Huskisson RS, Carney AS, et al. Mucosal T-cell phenotypes in persistent atopic and nonatopic rhinitis show an association with mast cells. Allergy. 2004;59(2):204-212. https://doi.org/10.1046/j.1398-9995.2003.00315.x. Rondon C, Dona I, Lopez S, et al. Seasonal idiopathic rhinitis with local inflammatory response and specific IgE in absence of systemic response. Allergy. 2008;63(10):1352-1358. https://doi.org/10.1111/j.1398-9995.2008.01695.x. Rondon C, Romero JJ, Lopez S, et al. Local IgE production and positive nasal provocation test in patients with persistent nonallergic rhinitis. J Allergy Clin Immunol. 2007;119(4):899-905. https://doi.org/10.1016/j.jaci.2007.01.006. Wedback A, Enbom H, Eriksson NE, Moverare R, Malcus I. Seasonal non-allergic rhinitis (SNAR) - a new disease entity? A clinical and immunological comparison between SNAR, seasonal allergic rhinitis and persistent non-allergic rhinitis. Rhinology. 2005;43(2):86-92. Huggins KG, Brostoff J. Local production of specific IgE antibodies in allergic-rhinitis patients with negative skin tests. Lancet. 1975;2(7926):148-150. https://doi.org/10.1016/s0140-6736(75)90056-2. Bozek A, Ignasiak B, Kasperska-Zajac A, Scierski W, Grzanka A, Jarzab J. Local allergic rhinitis in elderly patients. Ann Allergy Asthma Immunol. 2015;114(3):199-202. https://doi.org/10.1016/j.anai.2014.12.013. Klimek L, Bardenhewer C, Spielhaupter M, Harai C, Becker K, Pfaar O. Lokale allergische Rhinitis auf Alternaria alternata: Nachweis bei Patienten mit persistierender nasaler Symptomatik [Local allergic rhinitis to Alternaria alternata: Evidence for local IgE production exclusively in the nasal mucosa]. HNO. 2015 May;63(5):364-72. German. https://doi.org/10.1007/s00106-015-0005-x. Lopez S, Rondon C, Torres MJ, et al. Immediate and dual response to nasal challenge with Dermatophagoides pteronyssinus in local allergic rhinitis. Clin Exp Allergy. 2010;40(7):1007-1014. https://doi.org/10.1111/j.1365-2222.2010.03492.x. Samolinski B, Rapiejko P, Krzych-Falta E. Standards of nasal provocation tests. Postepy Dermatol Alergol. 2010;27:1669. Rondon C, Fernandez J, Lopez S, et al. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis. J Allergy Clin Immunol. 2009;124(5):1005-1011.e1. https://doi.org/10.1016/j.jaci.2009.07.018. Blanca-Lopez N, Campo P, Salas M, et al. Seasonal local allergic rhinitis in areas with high concentrations of grass pollen. J Investig Allergol Clin Immunol. 2016;26(2):83-91. https://doi.org/10.18176/jiaci.0018. Campo P, Eguiluz-Gracia I, Bogas G, et al. Local allergic rhinitis: implications for management. Clin Exp Allergy. 2019;49(1):6-16. https://doi.org/10.1111/cea.13192. Rondon C, Campo P, Galindo L, et al. Prevalence and clinical relevance of local allergic rhinitis. Allergy. 2012;67(10):1282-1288. https://doi.org/10.1111/all.12002. Campo P, Villalba M, Barrionuevo E, et al. Immunologic responses to the major allergen of Olea europaea in local and systemic allergic rhinitis subjects. Clin Exp Allergy. 2015;45(11):1703-1712. https://doi.org/10.1111/cea.12600. Gomez E, Campo P, Rondon C, et al. Role of the basophil activation test in the diagnosis of local allergic rhinitis. J Allergy Clin Immunol. 2013;132(4):975-676.e1-5. https://doi.org/10.1016/j.jaci.2013.07.016. Campo P, Salas M, Blanca-Lopez N, Rondon C. Local allergic rhinitis. Immunol Allergy Clin North Am. 2016;36(2):321-332. https://doi.org/10.1016/j.iac.2015.12.008. Reitsma S, Subramaniam S, Fokkens WWJ, Wang Y. Recent developments and highlights in rhinitis and allergen immunotherapy. Allergy. 2018;73(12):2306-2313. https://doi.org/10.1111/all.13617. Shin YS, Jung CG, Park HS. Prevalence and clinical characteristics of local allergic rhinitis to house dust mites. Curr Opin Allergy Clin Immunol. 2018;18(1):10-15. https://doi.org/10.1097/ACI.0000000000000413. Cheng KJ, Xu YY, Liu HY, Wang SQ. Serum eosinophil cationic protein level in Chinese subjects with nonallergic and local allergic rhinitis and its relation to the severity of disease. Am J Rhinol Allergy. 2013;27(1):8-12. https://doi.org/10.2500/ajra.2013.27.3845. Zicari AM, Occasi F, Di Fraia M, et al. Local allergic rhinitis in children: novel diagnostic features and potential biomarkers. Am J Rhinol Allergy. 2016;30(5):329-334. https://doi.org/10.2500/ajra.2016.30.4352. Duman H, Bostanci I, Ozmen S, Dogru M. The relevance of nasal provocation testing in children with nonallergic rhinitis. Int Arch Allergy Immunol. 2016;170(2):115-121. https://doi.org/10.1159/000447635. Altintoprak N, Kar M, Bayar Muluk N, et al. Update on local allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2016;87:105-109. https://doi.org/10.1016/j.ijporl.2016.06.008. Buntarickpornpan P, Veskitkul J, Pacharn P, et al. The proportion of local allergic rhinitis to Dermatophagoides pteronyssinus in children. Pediatr Allergy Immunol. 2016;27(6):574-579. https://doi.org/10.1111/pai.12606. Rondon C, Campo P, Blanca-Lopez N, Torres MJ, Blanca M. More research is needed for local allergic rhinitis. Int Arch Allergy Immunol. 2015;167(2):99-100. https://doi.org/10.1159/000436970. Papadopoulos NG, Bernstein JA, Demoly P, et al. Phenotypes and endotypes of rhinitis and their impact on management: a PRACTALL report. Allergy. 2015;70(5):474-494. https://doi.org/10.1111/all.12573. Toppila-Salmi S, van Drunen CM, Fokkens WJ, et al. Molecular mechanisms of nasal epithelium in rhinitis and rhinosinusitis. Curr Allergy Asthma Rep. 2015;15(2):495. https://doi.org/10.1007/s11882-014-0495-8. Scadding GK, Scadding GW. Innate and adaptive immunity in allergic airway disease. Curr Opin Allergy Clin Immunol. 2022;22(1):10-15. https://doi.org/10.1097/ACI.0000000000000800. Jacquet A, Robinson C. Proteolytic, lipidergic and polysaccharide molecular recognition shape innate responses to house dust mite allergens. Allergy. 2020;75(1):33-53. https://doi.org/10.1111/all.13940. Kortekaas Krohn I, Seys SF, Lund G, et al. Nasal epithelial barrier dysfunction increases sensitization and mast cell degranulation in the absence of allergic inflammation. Allergy. 2020;75(5):1155-1164. https://doi.org/10.1111/all.14132. Shim JS, Lee HS, Park DE, et al. Aggravation of asthmatic inflammation by chlorine exposure via innate lymphoid cells and CD11c(intermediate) macrophages. Allergy. 2020;75(2):381-391. https://doi.org/10.1111/all.14017. Kim J, Kim YC, Ham J, et al. The effect of air pollutants on airway innate immune cells in patients with asthma. Allergy. 2020;75(9):2372-2376. https://doi.org/10.1111/all.14323. Steelant B, Farre R, Wawrzyniak P, et al. Impaired barrier function in patients with house dust mite-induced allergic rhinitis is accompanied by decreased occludin and zonula occludens-1 expression. J Allergy Clin Immunol. 2016;137(4):1043-1053.e5. https://doi.org/10.1016/j.jaci.2015.10.050. Pat Y, Ogulur I. The epithelial barrier hypothesis: a 20-year journey. Allergy. 2021;76(11):3560-3562. https://doi.org/10.1111/all.14899. van Tongeren J, Golebski K, Van Egmond D, de Groot EJ, Fokkens WJ, van Drunen CM. Synergy between TLR-2 and TLR-3 signaling in primary human nasal epithelial cells. Immunobiology. 2015;220(4):445-451. https://doi.org/10.1016/j.imbio.2014.11.004. Radman M, Golshiri A, Shamsizadeh A, et al. Toll-like receptor 4 plays significant roles during allergic rhinitis. Allergol Immunopathol (Madr). 2015;43(4):416-420. https://doi.org/10.1016/j.aller.2014.04.006. Mjosberg JM, Trifari S, Crellin NK, et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol. 2011;12(11):1055-1062. https://doi.org/10.1038/ni.2104. Matsushita K, Kato Y, Akasaki S, Yoshimoto T. Proallergic cytokines and group 2 innate lymphoid cells in allergic nasal diseases. Allergol Int. 2015;64(3):235-240. https://doi.org/10.1016/j.alit.2014.12.008. Bartemes KR, Kephart GM, Fox SJ, Kita H. Enhanced innate type 2 immune response in peripheral blood from patients with asthma. J Allergy Clin Immunol. 2014;134(3):671-678.e4. https://doi.org/10.1016/j.jaci.2014.06.024. Hong H, Liao S, Chen F, Yang Q, Wang DY. Role of IL-25, IL-33, and TSLP in triggering united airway diseases toward type 2 inflammation. Allergy. 2020;75(11):2794-2804. https://doi.org/10.1111/all.14526. Doherty TA, Scott D, Walford HH, et al. Allergen challenge in allergic rhinitis rapidly induces increased peripheral blood type 2 innate lymphoid cells that express CD84. J Allergy Clin Immunol. 2014;133(4):1203-1205. https://doi.org/10.1016/j.jaci.2013.12.1086. Lao-Araya M, Steveling E, Scadding GW, Durham SR, Shamji MH. Seasonal increases in peripheral innate lymphoid type 2 cells are inhibited by subcutaneous grass pollen immunotherapy. J Allergy Clin Immunol. 2014;134(5):1193-1195.e4. https://doi.org/10.1016/j.jaci.2014.07.029. Dhariwal J, Cameron A, Trujillo-Torralbo MB, et al. Mucosal type 2 innate lymphoid cells are a key component of the allergic response to aeroallergens. Am J Respir Crit Care Med. 2017;195(12):1586-1596. https://doi.org/10.1164/rccm.201609-1846OC. Xie Y, Ju X, Beaudin S, et al. Effect of intranasal corticosteroid treatment on allergen-induced changes in group 2 innate lymphoid cells in allergic rhinitis with mild asthma. Allergy. 2021;76(9):2797-2808. https://doi.org/10.1111/all.14835. Sugita K, Steer CA, Martinez-Gonzalez I, et al. Type 2 innate lymphoid cells disrupt bronchial epithelial barrier integrity by targeting tight junctions through IL-13 in asthmatic patients. J Allergy Clin Immunol. 2018;141(1):300-310.e11. https://doi.org/10.1016/j.jaci.2017.02.038. Boguniewicz M, Beck LA, Sher L, et al. Dupilumab improves asthma and sinonasal outcomes in adults with moderate to severe atopic dermatitis. J Allergy Clin Immunol Pract. 2021;9(3):1212-1223.e6. https://doi.org/10.1016/j.jaip.2020.12.059. Orimo K, Tamari M, Saito H, Matsumoto K, Nakae S, Morita H. Characteristics of tissue-resident ILCs and their potential as therapeutic targets in mucosal and skin inflammatory diseases. Allergy. 2021;76(11):3332-3348. https://doi.org/10.1111/all.14863. Akdis M, Aab A, Altunbulakli C, et al. Interleukins (from IL-1 to IL-38), interferons, transforming growth factor beta, and TNF-alpha: Receptors, functions, and roles in diseases. J Allergy Clin Immunol. 2016;138(4):984-1010. https://doi.org/10.1016/j.jaci.2016.06.033. Zheng H, Zhang Y, Pan J, et al. The role of type 2 innate lymphoid cells in allergic diseases. Front Immunol. 2021;12:586078. https://doi.org/10.3389/fimmu.2021.586078. Schuijs MJ, Willart MA, Vergote K, et al. Farm dust and endotoxin protect against allergy through A20 induction in lung epithelial cells. Science. 2015;349(6252):1106-1110. https://doi.org/10.1126/science.aac6623. Lambrecht BN, Hammad H. The immunology of asthma. Nat Immunol. 2015;16(1):45-56. https://doi.org/10.1038/ni.3049. Muraro A, Lemanske Jr. RF, Hellings PW, et al. Precision medicine in patients with allergic diseases: airway diseases and atopic dermatitis-PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2016;137(5):1347-1358. https://doi.org/10.1016/j.jaci.2016.03.010. Nian JB, Zeng M, Zheng J, et al. Epithelial cells expressed IL-33 to promote degranulation of mast cells through inhibition on ST2/PI3K/mTOR-mediated autophagy in allergic rhinitis. Cell Cycle. 2020;19(10):1132-1142. https://doi.org/10.1080/15384101.2020.1749402. Cheng KJ, Zhou ML, Liu YC, Wang C, Xu YY. The role of CD40 in allergic rhinitis and airway remodelling. Mediators Inflamm. 2021;2021:6694109. https://doi.org/10.1155/2021/6694109. KleinJan A, Willart M, van Rijt LS, et al. An essential role for dendritic cells in human and experimental allergic rhinitis. J Allergy Clin Immunol. 2006;118(5):1117-1125. https://doi.org/10.1016/j.jaci.2006.05.030. Hammad H, Plantinga M, Deswarte K, et al. Inflammatory dendritic cells-not basophils-are necessary and sufficient for induction of Th2 immunity to inhaled house dust mite allergen. J Exp Med. 2010;207(10):2097-2111. https://doi.org/10.1084/jem.20101563. Meng Y, Wang C, Zhang L. Advances and novel developments in allergic rhinitis. Allergy. 2020;75(12):3069-3076. https://doi.org/10.1111/all.14586. Annunziato F, Romagnani C, Romagnani S. The 3 major types of innate and adaptive cell-mediated effector immunity. J Allergy Clin Immunol. 2015;135(3):626-635. https://doi.org/10.1016/j.jaci.2014.11.001. Durham SR, Ying S, Varney VA, et al. Cytokine messenger RNA expression for IL-3, IL-4, IL-5, and granulocyte/macrophage-colony-stimulating factor in the nasal mucosa after local allergen provocation: relationship to tissue eosinophilia. J Immunol. 1992;148(8):2390-2394. Sogut A, Yilmaz O, Kirmaz C, et al. Regulatory-T, T-helper 1, and T-helper 2 cell differentiation in nasal mucosa of allergic rhinitis with olive pollen sensitivity. Int Arch Allergy Immunol. 2012;157(4):349-353. https://doi.org/10.1159/000329159. Pawankar RU, Okuda M, Okubo K, Ra C. Lymphocyte subsets of the nasal mucosa in perennial allergic rhinitis. Am J Respir Crit Care Med. 1995;152(6 pt 1):2049-2058. https://doi.org/10.1164/ajrccm.152.6.8520775. Soyka MB, Wawrzyniak P, Eiwegger T, et al. Defective epithelial barrier in chronic rhinosinusitis: the regulation of tight junctions by IFN-gamma and IL-4. J Allergy Clin Immunol. 2012;130(5):1087-1096.e10. https://doi.org/10.1016/j.jaci.2012.05.052. Kubo T, Wawrzyniak P, Morita H, et al. CpG-DNA enhances the tight junction integrity of the bronchial epithelial cell barrier. J Allergy Clin Immunol. 2015;136(5):1413-1416.e1-8. https://doi.org/10.1016/j.jaci.2015.05.006. Georas SN, Rezaee F. Epithelial barrier function: at the front line of asthma immunology and allergic airway inflammation. J Allergy Clin Immunol. 2014;134(3):509-520. https://doi.org/10.1016/j.jaci.2014.05.049. Akdis M. Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol. 2006;18(6):738-744. https://doi.org/10.1016/j.coi.2006.06.003. Akdis M, Akdis CA. Therapeutic manipulation of immune tolerance in allergic disease. Nat Rev Drug Discov. 2009;8(8):645-660. https://doi.org/10.1038/nrd2653. Raedler D, Ballenberger N, Klucker E, et al. Identification of novel immune phenotypes for allergic and nonallergic childhood asthma. J Allergy Clin Immunol. 2015;135(1):81-91. https://doi.org/10.1016/j.jaci.2014.07.046. Akdis M, Verhagen J, Taylor A, et al. Immune responses in healthy and allergic individuals are characterized by a fine balance between allergen-specific T regulatory 1 and T helper 2 cells. J Exp Med. 2004;199(11):1567-1575. https://doi.org/10.1084/jem.20032058. Suarez-Fueyo A, Ramos T, Galan A, et al. Grass tablet sublingual immunotherapy downregulates the TH2 cytokine response followed by regulatory T-cell generation. J Allergy Clin Immunol. 2014;133(1):130-138.e1-2. https://doi.org/10.1016/j.jaci.2013.09.043. Fox EM, Torrero MN, Evans H, Mitre E. Immunologic characterization of 3 murine regimens of allergen-specific immunotherapy. J Allergy Clin Immunol. 2015;135(5):1341-1351.e1-7. https://doi.org/10.1016/j.jaci.2014.07.052. Akdis CA, Akdis M. Advances in allergen immunotherapy: aiming for complete tolerance to allergens. Sci Transl Med. 2015;7(280):280ps6. https://doi.org/10.1126/scitranslmed.aaa7390. Jansen K, Cevhertas L, Ma S, Satitsuksanoa P, Akdis M, van de Veen W. Regulatory B cells, A to Z. Allergy. 2021;76(9):2699-2715. https://doi.org/10.1111/all.14763. Hofmann MA, Fluhr JW, Ruwwe-Glosenkamp C, Stevanovic K, Bergmann KC, Zuberbier T. Role of IL-17 in atopy - a systematic review. Clin Transl Allergy. 2021;11(6):e12047. https://doi.org/10.1002/clt2.12047. Yu X, Wang M, Cao Z. Reduced CD4(+)T cell CXCR3 expression in patients with allergic rhinitis. Front Immunol. 2020;11:581180. https://doi.org/10.3389/fimmu.2020.581180. Morita H, Arae K, Unno H, et al. An interleukin-33-mast cell-interleukin-2 axis suppresses papain-induced allergic inflammation by promoting regulatory T cell numbers. Immunity. 2015;43(1):175-186. https://doi.org/10.1016/j.immuni.2015.06.021. Ganzer U, Bachert C. Localization of IgE synthesis in immediate-type allergy of the upper respiratory tract. ORL J Otorhinolaryngol Relat Spec. 1988;50(4):257-264. https://doi.org/10.1159/000276000. KleinJan A, Vinke JG, Severijnen LW, Fokkens WJ. Local production and detection of (specific) IgE in nasal B-cells and plasma cells of allergic rhinitis patients. Eur Respir J. 2000;15(3):491-497. https://doi.org/10.1034/j.1399-3003.2000.15.11.x. Yao Y, Wang N, Chen CL, et al. CD23 expression on switched memory B cells bridges T-B cell interaction in allergic rhinitis. Allergy. 2020;75(10):2599-2612. https://doi.org/10.1111/all.14288. Bentley AM, Jacobson MR, Cumberworth V, et al. Immunohistology of the nasal mucosa in seasonal allergic rhinitis: increases in activated eosinophils and epithelial mast cells. J Allergy Clin Immunol. 1992;89(4):877-883. https://doi.org/10.1016/0091-6749(92)90444-7. Gomez E, Corrado OJ, Baldwin DL, Swanston AR, Davies RJ. Direct in vivo evidence for mast cell degranulation during allergen-induced reactions in man. J Allergy Clin Immunol. 1986;78(4 pt 1):637-645. https://doi.org/10.1016/0091-6749(86)90082-5. Haenuki Y, Matsushita K, Futatsugi-Yumikura S, et al. A critical role of IL-33 in experimental allergic rhinitis. J Allergy Clin Immunol. 2012;130(1):184-194.e11. https://doi.org/10.1016/j.jaci.2012.02.013. KleinJan A, McEuen AR, Dijkstra MD, Buckley MG, Walls AF, Fokkens WJ. Basophil and eosinophil accumulation and mast cell degranulation in the nasal mucosa of patients with hay fever after local allergen provocation. J Allergy Clin Immunol. 2000;106(4):677-686. https://doi.org/10.1067/mai.2000.109621. Semik-Orzech A, Barczyk A, Wiaderkiewicz R, Pierzchala W. Eotaxin, but not IL-8, is increased in upper and lower airways of allergic rhinitis subjects after nasal allergen challenge. Allergy Asthma Proc. 2011;32(3):230-238. https://doi.org/10.2500/aap.2011.32.3435. Kim TH, Lee JY, Lee HM, et al. Remodelling of nasal mucosa in mild and severe persistent allergic rhinitis with special reference to the distribution of collagen, proteoglycans, and lymphatic vessels. Clin Exp Allergy. 2010;40(12):1742-1754. https://doi.org/10.1111/j.1365-2222.2010.03612.x. Pawankar R, Yamagishi S, Yagi T. Revisiting the roles of mast cells in allergic rhinitis and its relation to local IgE synthesis. Am J Rhinol. 2000;14(5):309-317. https://doi.org/10.2500/105065800781329582. Pawankar R. Mast cells in allergic airway disease and chronic rhinosinusitis. Chem Immunol Allergy. 2005;87:111-129. https://doi.org/10.1159/000087639. Powe DG, Hiskisson RS, Carney AS, Jenkins D, Jones NS. Idiopathic and allergic rhinitis show a similar inflammatory response. Clin Otolaryngol Allied Sci. 2000;25(6):570-576. https://doi.org/10.1046/j.1365-2273.2000.00422-2.x. Divekar R, Kita H. Recent advances in epithelium-derived cytokines (IL-33, IL-25, and thymic stromal lymphopoietin) and allergic inflammation. Curr Opin Allergy Clin Immunol. 2015;15(1):98-103. https://doi.org/10.1097/ACI.0000000000000133. Wang W, Li Y, Lv Z, et al. Bronchial allergen challenge of patients with atopic asthma triggers an alarmin (IL-33, TSLP, and IL-25) response in the airways epithelium and submucosa. J Immunol. 2018;201(8):2221-2231. https://doi.org/10.4049/jimmunol.1800709. Hussain M, Borcard L, Walsh KP, et al. Basophil-derived IL-4 promotes epicutaneous antigen sensitization concomitant with the development of food allergy. J Allergy Clin Immunol. 2018;141(1):223-234.e5. https://doi.org/10.1016/j.jaci.2017.02.035. Corren J, Ziegler SF. TSLP: from allergy to cancer. Nat Immunol. 2019;20(12):1603-1609. https://doi.org/10.1038/s41590-019-0524-9. London Jr. NR, Lane AP. Innate immunity and chronic rhinosinusitis: what we have learned from animal models. Laryngoscope Investig Otolaryngol. 2016;1(3):49-56. https://doi.org/10.1002/lio2.21. Pawankar R. Epithelial cells as immunoregulators in allergic airway diseases. Curr Opin Allergy Clin Immunol. 2002;2(1):1-5. https://doi.org/10.1097/00130832-200202000-00001. Peng YQ, Qin ZL, Fang SB, et al. Effects of myeloid and plasmacytoid dendritic cells on ILC2s in patients with allergic rhinitis. J Allergy Clin Immunol. 2020;145(3):855-867.e8. https://doi.org/10.1016/j.jaci.2019.11.029. Kabata H, Moro K, Koyasu S. The group 2 innate lymphoid cell (ILC2) regulatory network and its underlying mechanisms. Immunol Rev. 2018;286(1):37-52. https://doi.org/10.1111/imr.12706. Wilhelm C, Hirota K, Stieglitz B, et al. An IL-9 fate reporter demonstrates the induction of an innate IL-9 response in lung inflammation. Nat Immunol. 2011;12(11):1071-1077. https://doi.org/10.1038/ni.2133. Turner JE, Morrison PJ, Wilhelm C, et al. IL-9-mediated survival of type 2 innate lymphoid cells promotes damage control in helminth-induced lung inflammation. J Exp Med. 2013;210(13):2951-2965. https://doi.org/10.1084/jem.20130071. Wilson AM, Duong M, Crawford L, Denburg J. An evaluation of peripheral blood eosinophil/basophil progenitors following nasal allergen challenge in patients with allergic rhinitis. Clin Exp Allergy. 2005;35(1):39-44. https://doi.org/10.1111/j.1365-2222.2004.02072.x. Bradding P, Holgate ST. The mast cell as a source of cytokines in asthma. Ann N Y Acad Sci. 1996;796:272-281. https://doi.org/10.1111/j.1749-6632.1996.tb32589.x. Pawankar RU, Okuda M, Hasegawa S, et al. Interleukin-13 expression in the nasal mucosa of perennial allergic rhinitis. Am J Respir Crit Care Med. 1995;152(6 pt 1):2059-2067. https://doi.org/10.1164/ajrccm.152.6.8520776. Pawankar R, Okuda M, Yssel H, Okumura K, Ra C. Nasal mast cells in perennial allergic rhinitics exhibit increased expression of the Fc epsilonRI, CD40L, IL-4, and IL-13, and can induce IgE synthesis in B cells. J Clin Invest. 1997;99(7):1492-1499. https://doi.org/10.1172/JCI119311. Pawankar R. Inflammatory mechanisms in allergic rhinitis. Curr Opin Allergy Clin Immunol. 2007;7(1):1-4. https://doi.org/10.1097/ACI.0b013e3280145347. Nonaka M, Pawankar R, Fukumoto A, Ogihara N, Sakanushi A, Yagi T. Induction of eotaxin production by interleukin-4, interleukin-13 and lipopolysaccharide by nasal fibroblasts. Clin Exp Allergy. 2004;34(5):804-811. https://doi.org/10.1111/j.1365-2222.2004.1954.x. Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med. 2009;360(10):985-993. https://doi.org/10.1056/NEJMoa0805435. Nakamaru Y, Oridate N, Nishihira J, Takagi D, Furuta Y, Fukuda S. Macrophage migration inhibitory factor in allergic rhinitis: its identification in eosinophils at the site of inflammation. Ann Otol Rhinol Laryngol. 2004;113(3 pt 1):205-209. https://doi.org/10.1177/000348940411300306. Kobayashi H, Gleich GJ, Butterfield JH, Kita H. Human eosinophils produce neurotrophins and secrete nerve growth factor on immunologic stimuli. Blood. 2002;99(6):2214-2220. https://doi.org/10.1182/blood.v99.6.2214. Pappu R, Ramirez-Carrozzi V, Sambandam A. The interleukin-17 cytokine family: critical players in host defence and inflammatory diseases. Immunology. 2011;134(1):8-16. https://doi.org/10.1111/j.1365-2567.2011.03465.x. Mandhane SN, Shah JH, Thennati R. Allergic rhinitis: an update on disease, present treatments and future prospects. Int Immunopharmacol. 2011;11(11):1646-1662. https://doi.org/10.1016/j.intimp.2011.07.005. Kim D, Baraniuk JN. Neural aspects of allergic rhinitis. Curr Opin Otolaryngol Head Neck Surg. 2007;15(4):268-273. https://doi.org/10.1097/MOO.0b013e328259c372. Pfaar O, Raap U, Holz M, Hormann K, Klimek L. Pathophysiology of itching and sneezing in allergic rhinitis. Swiss Med Wkly. 2009;139(3-4):35-40. doi:smw-12468. Singh U, Bernstein JA, Haar L, Luther K, Jones WK. Azelastine desensitization of transient receptor potential vanilloid 1: a potential mechanism explaining its therapeutic effect in nonallergic rhinitis. Am J Rhinol Allergy. 2014;28(3):215-224. https://doi.org/10.2500/ajra.2014.28.4059. Singh U, Bernstein JA, Lorentz H, et al. A pilot study investigating clinical responses and biological pathways of azelastine/fluticasone in nonallergic vasomotor rhinitis before and after cold dry air provocation. Int Arch Allergy Immunol. 2017;173(3):153-164. https://doi.org/10.1159/000478698. Kuruvilla M, Kalangara J, Lee FEE. Neuropathic pain and itch mechanisms underlying allergic conjunctivitis. J Investig Allergol Clin Immunol. 2019;29(5):349-356. https://doi.org/10.18176/jiaci.0320. Gawlik R, Jawor B, Rogala B, Parzynski S, DuBuske L. Effect of intranasal azelastine on substance P release in perennial nonallergic rhinitis patients. Am J Rhinol Allergy. 2013;27(6):514-516. https://doi.org/10.2500/ajra.2013.27.3955. Baraniuk JN, Kaliner MA. Neuropeptides and nasal secretion. J Allergy Clin Immunol. 1990;86(4 pt 2):620-627. https://doi.org/10.1016/s0091-6749(05)80226-x. Bernstein JA, Davis BP, Picard JK, Cooper JP, Zheng S, Levin LS. A randomized, double-blind, parallel trial comparing capsaicin nasal spray with placebo in subjects with a significant component of nonallergic rhinitis. Ann Allergy Asthma Immunol. 2011;107(2):171-178. https://doi.org/10.1016/j.anai.2011.05.016. Golpanian RS, Smith P, Yosipovitch G. Itch in organs beyond the skin. Curr Allergy Asthma Rep. 2020;20(9):49. https://doi.org/10.1007/s11882-020-00947-z. Mosimann BL, White MV, Hohman RJ, Goldrich MS, Kaulbach HC, Kaliner MA. Substance P, calcitonin gene-related peptide, and vasoactive intestinal peptide increase in nasal secretions after allergen challenge in atopic patients. J Allergy Clin Immunol. 1993;92(1 pt 1):95-104. https://doi.org/10.1016/0091-6749(93)90043-f. Singh U, Bernstein JA. Intranasal capsaicin in management of nonallergic (vasomotor) rhinitis. Prog Drug Res. 2014;68:147-170. https://doi.org/10.1007/978-3-0348-0828-6_6. Sanico AM, Koliatsos VE, Stanisz AM, Bienenstock J, Togias A. Neural hyperresponsiveness and nerve growth factor in allergic rhinitis. Int Arch Allergy Immunol. 1999;118(2-4):154-158. https://doi.org/10.1159/000024054. Bresciani M, Laliberte F, Laliberte MF, Gramiccioni C, Bonini S. Nerve growth factor localization in the nasal mucosa of patients with persistent allergic rhinitis. Allergy. 2009;64(1):112-117. https://doi.org/10.1111/j.1398-9995.2008.01831.x. O'Hanlon S, Facer P, Simpson KD, Sandhu G, Saleh HA, Anand P. Neuronal markers in allergic rhinitis: expression and correlation with sensory testing. Laryngoscope. 2007;117(9):1519-1527. https://doi.org/10.1097/MLG.0b013e3180ca7846. Abbott-Banner K, Poll C, Verkuyl JM. Targeting TRP channels in airway disorders. Curr Top Med Chem. 2013;13(3):310-321. https://doi.org/10.2174/1568026611313030008. Ba G, Tang R, Sun X, Li Z, Lin H, Zhang W. Therapeutic effects of SKF-96365 on murine allergic rhinitis induced by OVA. Int J Immunopathol Pharmacol. 2021;35:20587384211015054. https://doi.org/10.1177/20587384211015054. Backaert W, Steelant B, Hellings PW, Talavera K, Van Gerven L. A TRiP through the roles of transient receptor potential cation channels in type 2 upper airway inflammation. Curr Allergy Asthma Rep. 2021;21(3):20. https://doi.org/10.1007/s11882-020-00981-x. Nam JH, Kim WK. The role of TRP channels in allergic inflammation and its clinical relevance. Curr Med Chem. 2020;27(9):1446-1468. https://doi.org/10.2174/0929867326666181126113015. Vareille M, Kieninger E, Edwards MR, Regamey N. The airway epithelium: soldier in the fight against respiratory viruses. Clin Microbiol Rev. 2011;24(1):210-229. https://doi.org/10.1128/CMR.00014-10. Wang DY, Li Y, Yan Y, Li C, Shi L. Upper airway stem cells: understanding the nose and role for future cell therapy. Curr Allergy Asthma Rep. 2015;15(1):490. https://doi.org/10.1007/s11882-014-0490-0. Akira S. Pathogen recognition by innate immunity and its signaling. Proc Jpn Acad Ser B Phys Biol Sci. 2009;85(4):143-156. https://doi.org/10.2183/pjab.85.143. Chen CR, Kachramanoglou C, Li D, Andrews P, Choi D. Anatomy and cellular constituents of the human olfactory mucosa: a review. J Neurol Surg B Skull Base. 2014;75(5):293-300. https://doi.org/10.1055/s-0033-1361837. Bustamante-Marin XM, Ostrowski LE. Cilia and mucociliary clearance. Cold Spring Harb Perspect Biol. 2017;9(4):a028241. https://doi.org/10.1101/cshperspect.a028241. Scherzad A, Hagen R, Hackenberg S. Current understanding of nasal epithelial cell mis-differentiation. J Inflamm Res. 2019;12:309-317. https://doi.org/10.2147/JIR.S180853. Hamelmann E. Development of allergic airway inflammation in early life - interaction of early viral infections and allergic sensitization. Allergol Select. 2018;2(1):132-137. https://doi.org/10.5414/ALX01635E. Shin SH, Ye MK, Lee DW, Chae MH, Han BD. Nasal epithelial cells activated with alternaria and house dust mite induce not only Th2 but also Th1 immune responses. Int J Mol Sci. 2020;21(8):2693. https://doi.org/10.3390/ijms21082693. Bergougnan C, Dittlein DC, Hummer E, et al. Physical and immunological barrier of human primary nasal epithelial cells from non-allergic and allergic donors. World Allergy Organ J. 2020;13(3):100109. https://doi.org/10.1016/j.waojou.2020.100109. Orban NT, Jacobson MR, Nouri-Aria KT, Durham SR, Eifan AO. Repetitive nasal allergen challenge in allergic rhinitis: priming and Th2-type inflammation but no evidence of remodelling. Clin Exp Allergy. 2021;51(2):329-338. https://doi.org/10.1111/cea.13775. Watts AM, West NP, Cripps AW, Smith PK, Cox AJ. Distinct gene expression patterns between nasal mucosal cells and blood collected from allergic rhinitis sufferers. Int Arch Allergy Immunol. 2018;177(1):29-34. https://doi.org/10.1159/000489609. Groneberg DA, Peiser C, Dinh QT, et al. Distribution of respiratory mucin proteins in human nasal mucosa. Laryngoscope. 2003;113(3):520-524. https://doi.org/10.1097/00005537-200303000-00023. Lee SN, Kim SJ, Yoon SA, et al. CD44v3-positive intermediate progenitor cells contribute to airway goblet cell hyperplasia. Am J Respir Cell Mol Biol. 2021;64(2):247-259. https://doi.org/10.1165/rcmb.2020-0350OC. Siti Sarah CO, Md Shukri N, Mohd Ashari NS, Wong KK. Zonula occludens and nasal epithelial barrier integrity in allergic rhinitis. PeerJ. 2020;8:e9834. https://doi.org/10.7717/peerj.9834. Steelant B, Wawrzyniak P, Martens K, et al. Blocking histone deacetylase activity as a novel target for epithelial barrier defects in patients with allergic rhinitis. J Allergy Clin Immunol. 2019;144(5):1242-1253.e7. https://doi.org/10.1016/j.jaci.2019.04.027. Zhou LB, Zheng YM, Liao WJ, et al. MUC1 deficiency promotes nasal epithelial barrier dysfunction in subjects with allergic rhinitis. J Allergy Clin Immunol. 2019;144(6):1716-1719.e5. https://doi.org/10.1016/j.jaci.2019.07.042. Buckle FG, Cohen AB. Nasal mucosal hyperpermeability to macromolecules in atopic rhinitis and extrinsic asthma. J Allergy Clin Immunol. 1975;55(4):213-221. https://doi.org/10.1016/0091-6749(75)90139-6. Zhang Y, Derycke L, Holtappels G, et al. Th2 cytokines orchestrate the secretion of MUC5AC and MUC5B in IL-5-positive chronic rhinosinusitis with nasal polyps. Allergy. 2019;74(1):131-140. https://doi.org/10.1111/all.13489. Wang J, Wen L, Wang Y, Chen F. Therapeutic effect of histone deacetylase inhibitor, sodium butyrate, on allergic rhinitis in vivo. DNA Cell Biol. 2016;35(4):203-208. https://doi.org/10.1089/dna.2015.3037. Runswick S, Mitchell T, Davies P, Robinson C, Garrod DR. Pollen proteolytic enzymes degrade tight junctions. Respirology. 2007;12(6):834-842. https://doi.org/10.1111/j.1440-1843.2007.01175.x. Henriquez OA, Den Beste K, Hoddeson EK, Parkos CA, Nusrat A, Wise SK. House dust mite allergen Der p 1 effects on sinonasal epithelial tight junctions. Int Forum Allergy Rhinol. 2013;3(8):630-635. https://doi.org/10.1002/alr.21168. Steelant B, Seys SF, Van Gerven L, et al. Histamine and T helper cytokine-driven epithelial barrier dysfunction in allergic rhinitis. J Allergy Clin Immunol. 2018;141(3):951-963.e8. https://doi.org/10.1016/j.jaci.2017.08.039. Ohwada K, Konno T, Kohno T, et al. Effects of HMGB1 on tricellular tight junctions via TGF-beta signaling in human nasal epithelial cells. Int J Mol Sci. 2021;22(16):8390. https://doi.org/10.3390/ijms22168390. Fukuoka A, Matsushita K, Morikawa T, Takano H, Yoshimoto T. Diesel exhaust particles exacerbate allergic rhinitis in mice by disrupting the nasal epithelial barrier. Clin Exp Allergy. 2016;46(1):142-152. https://doi.org/10.1111/cea.12597. Kamekura R, Kojima T, Koizumi J, et al. Thymic stromal lymphopoietin enhances tight-junction barrier function of human nasal epithelial cells. Cell Tissue Res. 2009;338(2):283-293. https://doi.org/10.1007/s00441-009-0855-1. Hupin C, Gohy S, Bouzin C, Lecocq M, Polette M, Pilette C. Features of mesenchymal transition in the airway epithelium from chronic rhinosinusitis. Allergy. 2014;69(11):1540-1549. https://doi.org/10.1111/all.12503. Akdis CA. Does the epithelial barrier hypothesis explain the increase in allergy, autoimmunity and other chronic conditions? Nat Rev Immunol. 2021;21(11):739-751. https://doi.org/10.1038/s41577-021-00538-7. Wawrzyniak P, Wawrzyniak M, Wanke K, et al. Regulation of bronchial epithelial barrier integrity by type 2 cytokines and histone deacetylases in asthmatic patients. J Allergy Clin Immunol. 2017;139(1):93-103. https://doi.org/10.1016/j.jaci.2016.03.050. Nur Husna SM, Siti Sarah CO, Tan HT, Md Shukri N, Mohd Ashari NS, Wong KK. Reduced occludin and claudin-7 expression is associated with urban locations and exposure to second-hand smoke in allergic rhinitis patients. Sci Rep. 2021;11(1):1245. https://doi.org/10.1038/s41598-020-79208-y. Baeke F, Takiishi T, Korf H, Gysemans C, Mathieu C. Vitamin D: modulator of the immune system. Curr Opin Pharmacol. 2010;10(4):482-496. https://doi.org/10.1016/j.coph.2010.04.001. Adams JS, Hewison M. Update in vitamin D. J Clin Endocrinol Metab. 2010;95(2):471-478. https://doi.org/10.1210/jc.2009-1773. Kongsbak M, Levring TB, Geisler C, von Essen MR. The vitamin d receptor and T cell function. Front Immunol. 2013;4:148. https://doi.org/10.3389/fimmu.2013.00148. Tian HQ, Cheng L. The role of vitamin D in allergic rhinitis. Asia Pac Allergy. 2017;7(2):65-73. https://doi.org/10.5415/apallergy.2017.7.2.65. Hamzaoui A, Berraies A, Hamdi B, Kaabachi W, Ammar J, Hamzaoui K. Vitamin D reduces the differentiation and expansion of Th17 cells in young asthmatic children. Immunobiology. 2014;219(11):873-879. https://doi.org/10.1016/j.imbio.2014.07.009. Zhang H, Shih DQ, Zhang X. Mechanisms underlying effects of 1,25-dihydroxyvitamin D3 on the Th17 cells. Eur J Microbiol Immunol (Bp). 2013;3(4):237-240. https://doi.org/10.1556/EuJMI.3.2013.4.1. Urry Z, Chambers ES, Xystrakis E, et al. The role of 1alpha,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells. Eur J Immunol. 2012;42(10):2697-2708. https://doi.org/10.1002/eji.201242370. Jolliffe DA, Greenberg L, Hooper RL, et al. Vitamin D supplementation to prevent asthma exacerbations: a systematic review and meta-analysis of individual participant data. Lancet Respir Med. 2017;5(11):881-890. https://doi.org/10.1016/S2213-2600(17)30306-5. Riverin BD, Maguire JL, Li P. Vitamin D supplementation for childhood asthma: a systematic review and meta-analysis. PLoS One. 2015;10(8):e0136841. https://doi.org/10.1371/journal.pone.0136841. Wee JH, Cho SW, Kim JW, Rhee CS. Non-association between low vitamin d levels and aeroallergen-positivity evaluated using multiple allergen simultaneous test in Korean adults. Allergy Asthma Clin Immunol. 2021;17(1):23. https://doi.org/10.1186/s13223-021-00525-6. Bener A, Ehlayel MS, Bener HZ, Hamid Q. The impact of Vitamin D deficiency on asthma, allergic rhinitis and wheezing in children: an emerging public health problem. J Family Community Med. 2014;21(3):154-161. https://doi.org/10.4103/2230-8229.142967. Kim YH, Kim KW, Kim MJ, et al. Vitamin D levels in allergic rhinitis: a systematic review and meta-analysis. Pediatr Allergy Immunol. 2016;27(6):580-590. https://doi.org/10.1111/pai.12599. Bakhshaee M, Sharifian M, Esmatinia F, Rasoulian B, Mohebbi M. Therapeutic effect of vitamin D supplementation on allergic rhinitis. Eur Arch Otorhinolaryngol. 2019;276(10):2797-2801. https://doi.org/10.1007/s00405-019-05546-x. Jerzynska J, Stelmach W, Rychlik B, et al. Clinical and immunological effects of vitamin D supplementation during the pollen season in children with allergic rhinitis. Arch Med Sci. 2018;14(1):122-131. https://doi.org/10.5114/aoms.2016.61978. Takeno S, Yoshimura H, Kubota K, Taruya T, Ishino T, Hirakawa K. Comparison of nasal nitric oxide levels between the inferior turbinate surface and the middle meatus in patients with symptomatic allergic rhinitis. Allergol Int. 2014;63(3):475-483. https://doi.org/10.2332/allergolint.14-OA-0689. Takeno S, Osada R, Furukido K, Chen JH, Yajin K. Increased nitric oxide production in nasal epithelial cells from allergic patients-RT-PCR analysis and direct imaging by a fluorescence indicator: DAF-2 DA. Clin Exp Allergy. 2001;31(6):881-888. https://doi.org/10.1046/j.1365-2222.2001.01093.x. Yuksel H, Kirmaz C, Yilmaz O, et al. Nasal mucosal expression of nitric oxide synthases in patients with allergic rhinitis and its relation to asthma. Ann Allergy Asthma Immunol. 2008;100(1):12-16. https://doi.org/10.1016/S1081-1206(10)60398-5. Hou J, Lou H, Wang Y, et al. Nasal ventilation is an important factor in evaluating the diagnostic value of nasal nitric oxide in allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(6):686-694. https://doi.org/10.1002/alr.22087. Ren L, Zhang W, Zhang Y, Zhang L. Nasal nitric oxide is correlated with nasal patency and nasal symptoms. Allergy Asthma Immunol Res. 2019;11(3):367-380. https://doi.org/10.4168/aair.2019.11.3.367. Liu C, Zheng K, Liu X, et al. Use of nasal nitric oxide in the diagnosis of allergic rhinitis and nonallergic rhinitis in patients with and without sinus inflammation. J Allergy Clin Immunol Pract. 2020;8(5):1574-1581.e4. https://doi.org/10.1016/j.jaip.2019.12.017. Maniscalco M, Sofia M, Pelaia G. Nitric oxide in upper airways inflammatory diseases. Inflamm Res. 2007;56(2):58-69. https://doi.org/10.1007/s00011-006-6111-1. Barnes PJ, Dweik RA, Gelb AF, et al. Exhaled nitric oxide in pulmonary diseases: a comprehensive review. Chest. 2010;138(3):682-692. https://doi.org/10.1378/chest.09-2090. Maniscalco M, Bianco A, Mazzarella G, Motta A. Recent advances on nitric oxide in the upper airways. Curr Med Chem. 2016;23(24):2736-2745. https://doi.org/10.2174/0929867323666160627115335. Alam MS, Akaike T, Okamoto S, et al. Role of nitric oxide in host defense in murine salmonellosis as a function of its antibacterial and antiapoptotic activities. Infect Immun. 2002;70(6):3130-3142. https://doi.org/10.1128/IAI.70.6.3130-3142.2002. Poljakovic M, Persson K. Urinary tract infection in iNOS-deficient mice with focus on bacterial sensitivity to nitric oxide. Am J Physiol Renal Physiol. 2003;284(1):F22-F31. https://doi.org/10.1152/ajprenal.00101.2002. Rajaram K, Nelson DE. Chlamydia muridarum infection of macrophages elicits bactericidal nitric oxide production via reactive oxygen species and cathepsin B. Infect Immun. 2015;83(8):3164-3175. https://doi.org/10.1128/IAI.00382-15. Yadav R, Samuni Y, Abramson A, et al. Pro-oxidative synergic bactericidal effect of NO: kinetics and inhibition by nitroxides. Free Radic Biol Med. 2014;67:248-254. https://doi.org/10.1016/j.freeradbiomed.2013.10.012. Workman AD, Carey RM, Kohanski MA, et al. Relative susceptibility of airway organisms to antimicrobial effects of nitric oxide. Int Forum Allergy Rhinol. 2017;7(8):770-776. https://doi.org/10.1002/alr.21966. Carey RM, Chen B, Adappa ND, et al. Human upper airway epithelium produces nitric oxide in response to Staphylococcus epidermidis. Int Forum Allergy Rhinol. 2016;6(12):1238-1244. https://doi.org/10.1002/alr.21837. Freund JR, Mansfield CJ, Doghramji LJ, et al. Activation of airway epithelial bitter taste receptors by Pseudomonas aeruginosa quinolones modulates calcium, cyclic-AMP, and nitric oxide signaling. J Biol Chem. 2018;293(25):9824-9840. https://doi.org/10.1074/jbc.RA117.001005. Antosova M, Bencova A, Mokra D, Plevkova J, Pepucha L, Buday T. Exhaled and nasal nitric oxide - impact for allergic rhinitis. Physiol Res. 2020;69(suppl 1):S123-S130. https://doi.org/10.33549/physiolres.934393. Rolim WR, Pieretti JC, Reno DLS, et al. Antimicrobial activity and cytotoxicity to tumor cells of nitric oxide donor and silver nanoparticles containing PVA/PEG films for topical applications. ACS Appl Mater Interfaces. 2019;11(6):6589-6604. https://doi.org/10.1021/acsami.8b19021. Akaberi D, Krambrich J, Ling J, et al. Mitigation of the replication of SARS-CoV-2 by nitric oxide in vitro. Redox Biol. 2020;37:101734. https://doi.org/10.1016/j.redox.2020.101734. Pieretti JC, Rubilar O, Weller RB, Tortella GR, Seabra AB. Nitric oxide (NO) and nanoparticles - potential small tools for the war against COVID-19 and other human coronavirus infections. Virus Res. 2021;291:198202. https://doi.org/10.1016/j.virusres.2020.198202. Li D, Shirakami G, Zhan X, Johns RA. Regulation of ciliary beat frequency by the nitric oxide-cyclic guanosine monophosphate signaling pathway in rat airway epithelial cells. Am J Respir Cell Mol Biol. 2000;23(2):175-181. https://doi.org/10.1165/ajrcmb.23.2.4022. Hariri BM, Payne SJ, Chen B, et al. In vitro effects of anthocyanidins on sinonasal epithelial nitric oxide production and bacterial physiology. Am J Rhinol Allergy. 2016;30(4):261-268. https://doi.org/10.2500/ajra.2016.30.4331. Fowler CJ, Olivier KN, Leung JM, et al. Abnormal nasal nitric oxide production, ciliary beat frequency, and Toll-like receptor response in pulmonary nontuberculous mycobacterial disease epithelium. Am J Respir Crit Care Med. 2013;187(12):1374-1381. https://doi.org/10.1164/rccm.201212-2197OC. Jiao J, Wang H, Lou W, et al. Regulation of ciliary beat frequency by the nitric oxide signaling pathway in mouse nasal and tracheal epithelial cells. Exp Cell Res. 2011;317(17):2548-2553. https://doi.org/10.1016/j.yexcr.2011.07.007. Serbina NV, Salazar-Mather TP, Biron CA, Kuziel WA, Pamer EG. TNF/iNOS-producing dendritic cells mediate innate immune defense against bacterial infection. Immunity. 2003;19(1):59-70. https://doi.org/10.1016/s1074-7613(03)00171-7. Cobb JP, Hotchkiss RS, Swanson PE, et al. Inducible nitric oxide synthase (iNOS) gene deficiency increases the mortality of sepsis in mice. Surgery. 1999;126(2):438-442. MacMicking JD, North RJ, LaCourse R, Mudgett JS, Shah SK, Nathan CF. Identification of nitric oxide synthase as a protective locus against tuberculosis. Proc Natl Acad Sci U S A. 1997;94(10):5243-5248. https://doi.org/10.1073/pnas.94.10.5243. Mishra BB, Lovewell RR, Olive AJ, et al. Nitric oxide prevents a pathogen-permissive granulocytic inflammation during tuberculosis. Nat Microbiol. 2017;2:17072. https://doi.org/10.1038/nmicrobiol.2017.72. Bajwa G, DeBerardinis RJ, Shao B, Hall B, Farrar JD, Gill MA. Cutting Edge: Critical Role of Glycolysis in Human Plasmacytoid Dendritic Cell Antiviral Responses. J Immunol. 2016;196(5):2004-2009. https://doi.org/10.4049/jimmunol.1501557. Kopincova J, Calkovska A. Meconium-induced inflammation and surfactant inactivation: specifics of molecular mechanisms. Pediatr Res. 2016;79(4):514-521. https://doi.org/10.1038/pr.2015.265. Heffler E, Carpagnano GE, Favero E, et al. Fractional Exhaled Nitric Oxide (FENO) in the management of asthma: a position paper of the Italian Respiratory Society (SIP/IRS) and Italian Society of Allergy, Asthma and Clinical Immunology (SIAAIC). Multidiscip Respir Med. 2020;15(1):36. https://doi.org/10.4081/mrm.2020.36. Soares MP, Teixeira L, Moita LF. Disease tolerance and immunity in host protection against infection. Nat Rev Immunol. 2017;17(2):83-96. https://doi.org/10.1038/nri.2016.136. Garcia-Ortiz A, Serrador JM. Nitric oxide signaling in T cell-mediated immunity. Trends Mol Med. 2018;24(4):412-427. https://doi.org/10.1016/j.molmed.2018.02.002. Akdis CA, Arkwright PD, Bruggen MC, et al. Type 2 immunity in the skin and lungs. Allergy. 2020;75(7):1582-1605. https://doi.org/10.1111/all.14318. Monga N, Sethi GS, Kondepudi KK, Naura AS. Lipid mediators and asthma: scope of therapeutics. Biochem Pharmacol. 2020;179:113925. https://doi.org/10.1016/j.bcp.2020.113925. Huang F, Yin JN, Wang HB, Liu SY, Li YN. Association of imbalance of effector T cells and regulatory cells with the severity of asthma and allergic rhinitis in children. Allergy Asthma Proc. 2017;38(6):70-77. https://doi.org/10.2500/aap.2017.38.4076. Amiel E, Everts B, Fritz D, et al. Mechanistic target of rapamycin inhibition extends cellular lifespan in dendritic cells by preserving mitochondrial function. J Immunol. 2014;193(6):2821-2830. https://doi.org/10.4049/jimmunol.1302498. Everts B, Amiel E, van der Windt GJ, et al. Commitment to glycolysis sustains survival of NO-producing inflammatory dendritic cells. Blood. 2012;120(7):1422-1431. https://doi.org/10.1182/blood-2012-03-419747. Lawless SJ, Kedia-Mehta N, Walls JF, et al. Glucose represses dendritic cell-induced T cell responses. Nat Commun. 2017;8:15620. https://doi.org/10.1038/ncomms15620. Linke M, Fritsch SD, Sukhbaatar N, Hengstschlager M, Weichhart T. mTORC1 and mTORC2 as regulators of cell metabolism in immunity. FEBS Lett. 2017;591(19):3089-3103. https://doi.org/10.1002/1873-3468.12711. Chen C, Pore N, Behrooz A, Ismail-Beigi F, Maity A. Regulation of glut1 mRNA by hypoxia-inducible factor-1. Interaction between H-ras and hypoxia. J Biol Chem. 2001;276(12):9519-9525. https://doi.org/10.1074/jbc.M010144200. Xu L, Huang Y, Yang J, et al. Dendritic cell-derived nitric oxide is involved in IL-4-induced suppression of experimental allergic encephalomyelitis (EAE) in Lewis rats. Clin Exp Immunol. 1999;118(1):115-121. https://doi.org/10.1046/j.1365-2249.1999.01029.x. Nathan C. Nitric oxide as a secretory product of mammalian cells. FASEB J. 1992;6(12):3051-3064. Bogdan C. Nitric oxide and the immune response. Nat Immunol. 2001;2(10):907-916. https://doi.org/10.1038/ni1001-907. Nathan C. Specificity of a third kind: reactive oxygen and nitrogen intermediates in cell signaling. J Clin Invest. 2003;111(6):769-778. https://doi.org/10.1172/JCI18174. Bogdan C. Regulation of lymphocytes by nitric oxide. Methods Mol Biol. 2011;677:375-393. https://doi.org/10.1007/978-1-60761-869-0_24. Wink DA, Hines HB, Cheng RY, et al. Nitric oxide and redox mechanisms in the immune response. J Leukoc Biol. 2011;89(6):873-891. https://doi.org/10.1189/jlb.1010550. Ibiza S, Serrador JM. The role of nitric oxide in the regulation of adaptive immune responses. Immunologia. 2008;27:103-117. Bogdan C. Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol. 2015;36(3):161-178. https://doi.org/10.1016/j.it.2015.01.003. Bailey JD, Diotallevi M, Nicol T, et al. Nitric oxide modulates metabolic remodeling in inflammatory macrophages through TCA cycle regulation and itaconate accumulation. Cell Rep. 2019;28(1):218-230.e7. https://doi.org/10.1016/j.celrep.2019.06.018. Lee M, Rey K, Besler K, Wang C, Choy J. Immunobiology of nitric oxide and regulation of inducible nitric oxide synthase. Results Probl Cell Differ. 2017;62:181-207. https://doi.org/10.1007/978-3-319-54090-0_8. Pavord ID, Afzalnia S, Menzies-Gow A, Heaney LG. The current and future role of biomarkers in type 2 cytokine-mediated asthma management. Clin Exp Allergy. 2017;47(2):148-160. https://doi.org/10.1111/cea.12881. Bachert C, Han JK, Desrosiers M, et al. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Lancet. 2019;394(10209):1638-1650. https://doi.org/10.1016/S0140-6736(19)31881-1. Nesi RT, Barroso MV, Souza Muniz V, et al. Pharmacological modulation of reactive oxygen species (ROS) improves the airway hyperresponsiveness by shifting the Th1 response in allergic inflammation induced by ovalbumin. Free Radic Res. 2017;51(7-8):708-722. https://doi.org/10.1080/10715762.2017.1364377. Bove PF, van der Vliet A. Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation. Free Radic Biol Med. 2006;41(4):515-527. https://doi.org/10.1016/j.freeradbiomed.2006.05.011. Sparkman L, Boggaram V. Nitric oxide increases IL-8 gene transcription and mRNA stability to enhance IL-8 gene expression in lung epithelial cells. Am J Physiol Lung Cell Mol Physiol. 2004;287(4):L764-L773. https://doi.org/10.1152/ajplung.00165.2004. Gottipati KR, Bandari SK, Nonnenmann MW, et al. Transcriptional mechanisms and protein kinase signaling mediate organic dust induction of IL-8 expression in lung epithelial and THP-1 cells. Am J Physiol Lung Cell Mol Physiol. 2015;308(1):L11-L21. https://doi.org/10.1152/ajplung.00215.2014. Vocca L, Di Sano C, Uasuf CG, et al. IL-33/ST2 axis controls Th2/IL-31 and Th17 immune response in allergic airway diseases. Immunobiology. 2015;220(8):954-963. https://doi.org/10.1016/j.imbio.2015.02.005. Uchida M, Anderson EL, Squillace DL, et al. Oxidative stress serves as a key checkpoint for IL-33 release by airway epithelium. Allergy. 2017;72(10):1521-1531. https://doi.org/10.1111/all.13158. Ursell LK, Metcalf JL, Parfrey LW, Knight R. Defining the human microbiome. Nutr Rev. 2012;70(suppl 1):S38-S44. https://doi.org/10.1111/j.1753-4887.2012.00493.x. Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature. 2010;464(7285):59-65. https://doi.org/10.1038/nature08821. International Human Genome Sequencing Consortium. Finishing the euchromatic sequence of the human genome. Nature. 2004;431(7011):931-945. https://doi.org/10.1038/nature03001. Fierer N, Hamady M, Lauber CL, Knight R. The influence of sex, handedness, and washing on the diversity of hand surface bacteria. Proc Natl Acad Sci U S A. 2008;105(46):17994-17999. https://doi.org/10.1073/pnas.0807920105. Turnbaugh PJ, Hamady M, Yatsunenko T, et al. A core gut microbiome in obese and lean twins. Nature. 2009;457(7228):480-484. https://doi.org/10.1038/nature07540. Abrahamsson TR, Jakobsson HE, Andersson AF, Bjorksten B, Engstrand L, Jenmalm MC. Low gut microbiota diversity in early infancy precedes asthma at school age. Clin Exp Allergy. 2014;44(6):842-850. https://doi.org/10.1111/cea.12253. Sjogren YM, Jenmalm MC, Bottcher MF, Bjorksten B, Sverremark-Ekstrom E. Altered early infant gut microbiota in children developing allergy up to 5 years of age. Clin Exp Allergy. 2009;39(4):518-526. https://doi.org/10.1111/j.1365-2222.2008.03156.x. Melli LC, do Carmo-Rodrigues MS, Araujo-Filho HB, Sole D, de Morais MB. Intestinal microbiota and allergic diseases: a systematic review. Allergol Immunopathol (Madr). 2016;44(2):177-188. https://doi.org/10.1016/j.aller.2015.01.013. Fujimura KE, Sitarik AR, Havstad S, et al. Neonatal gut microbiota associates with childhood multisensitized atopy and T cell differentiation. Nat Med. 2016;22(10):1187-1191. https://doi.org/10.1038/nm.4176. Ipci K, Altintoprak N, Muluk NB, Senturk M, Cingi C. The possible mechanisms of the human microbiome in allergic diseases. Eur Arch Otorhinolaryngol. 2017;274(2):617-626. https://doi.org/10.1007/s00405-016-4058-6. Bisgaard H, Li N, Bonnelykke K, et al. Reduced diversity of the intestinal microbiota during infancy is associated with increased risk of allergic disease at school age. J Allergy Clin Immunol. 2011;128(3):646-652.e1-5. https://doi.org/10.1016/j.jaci.2011.04.060. Watts AM, West NP, Zhang P, Smith PK, Cripps AW, Cox AJ. The gut microbiome of adults with allergic rhinitis is characterised by reduced diversity and an altered abundance of key microbial taxa compared to controls. Int Arch Allergy Immunol. 2021;182(2):94-105. https://doi.org/10.1159/000510536. Zhou MS, Zhang B, Gao ZL, et al. Altered diversity and composition of gut microbiota in patients with allergic rhinitis. Microb Pathog. 2021;161(pt A):105272. https://doi.org/10.1016/j.micpath.2021.105272. Hua X, Goedert JJ, Pu A, Yu G, Shi J. Allergy associations with the adult fecal microbiota: analysis of the American Gut Project. EBioMedicine. 2016;3:172-179. https://doi.org/10.1016/j.ebiom.2015.11.038. Choi CH, Poroyko V, Watanabe S, et al. Seasonal allergic rhinitis affects sinonasal microbiota. Am J Rhinol Allergy. 2014;28(4):281-286. https://doi.org/10.2500/ajra.2014.28.4050. Gan W, Yang F, Meng J, Liu F, Liu S, Xian J. Comparing the nasal bacterial microbiome diversity of allergic rhinitis, chronic rhinosinusitis and control subjects. Eur Arch Otorhinolaryngol. 2021;278(3):711-718. https://doi.org/10.1007/s00405-020-06311-1. Bender ME, Read TD, Edwards TS, et al. A Comparison of the Bacterial Nasal Microbiome in Allergic Rhinitis Patients Before and After Immunotherapy. Laryngoscope. 2020;130(12):E882-E888. https://doi.org/10.1002/lary.28599. Hu B, Kuang Y, Jing Y, Li Y, Zhao H, Ouyang H. Pediatric allergic rhinitis with functional gastrointestinal disease: Associations with the intestinal microbiota and gastrointestinal peptides and therapeutic effects of interventions. Hum Exp Toxicol. 2021;40(11):2012-2021. https://doi.org/10.1177/09603271211017325. Morin A, McKennan CG, Pedersen CT, et al. Epigenetic landscape links upper airway microbiota in infancy with allergic rhinitis at 6 years of age. J Allergy Clin Immunol. 2020;146(6):1358-1366. https://doi.org/10.1016/j.jaci.2020.07.005. Zhu L, Xu F, Wan W, et al. Gut microbial characteristics of adult patients with allergy rhinitis. Microb Cell Fact. 2020;19(1):171. https://doi.org/10.1186/s12934-020-01430-0. Giavina-Bianchi P, Aun MV, Takejima P, Kalil J, Agondi RC. United airway disease: current perspectives. J Asthma Allergy. 2016;9:93-100. https://doi.org/10.2147/JAA.S81541. Genuneit J, Seibold AM, Apfelbacher CJ, et al. Overview of systematic reviews in allergy epidemiology. Allergy. 2017;72(6):849-856. https://doi.org/10.1111/all.13123. Agache I, Beltran J, Akdis C, et al. Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma. Allergy. 2020;75(5):1023-1042. https://doi.org/10.1111/all.14221. Shamji MH, Palmer E, Layhadi JA, Moraes TJ, Eiwegger T. Biological treatment in allergic disease. Allergy. 2021;76(9):2934-2937. https://doi.org/10.1111/all.14954. Kanda A, Kobayashi Y, Asako M, Tomoda K, Kawauchi H, Iwai H. Regulation of interaction between the upper and lower airways in united airway disease. Med Sci (Basel). 2019;7(2):27. https://doi.org/10.3390/medsci7020027. Akdis CA, Bachert C, Cingi C, et al. Endotypes and phenotypes of chronic rhinosinusitis: a PRACTALL document of the European Academy of Allergy and Clinical Immunology and the American Academy of Allergy, Asthma & Immunology. J Allergy Clin Immunol. 2013;131(6):1479-1490. https://doi.org/10.1016/j.jaci.2013.02.036. Asano K, Ueki S, Tamari M, Imoto Y, Fujieda S, Taniguchi M. Adult-onset eosinophilic airway diseases. Allergy. 2020;75(12):3087-3099. https://doi.org/10.1111/all.14620. Backaert W, Steelant B, Jorissen M, et al. Self-reported nasal hyperreactivity is common in all chronic upper airway inflammatory phenotypes and not related to general well-being. Allergy. 2021;76(12):3806-3809. https://doi.org/10.1111/all.15060. Feijen J, Seys SF, Steelant B, et al. Prevalence and triggers of self-reported nasal hyperreactivity in adults with asthma. World Allergy Organ J. 2020;13(6):100132. https://doi.org/10.1016/j.waojou.2020.100132. Doulaptsi M, Steelant B, Prokopakis E, et al. Prevalence and impact of nasal hyperreactivity in chronic rhinosinusitis. Allergy. 2020;75(7):1768-1771. https://doi.org/10.1111/all.14199. Agache I, Sugita K, Morita H, Akdis M, Akdis CA. The Complex Type 2 Endotype in Allergy and Asthma: From Laboratory to Bedside. Curr Allergy Asthma Rep. 2015;15(6):29. https://doi.org/10.1007/s11882-015-0529-x. Avdeeva KS, Fokkens WJ, Reitsma S. Towards a new epidemiological definition of chronic rhinitis: prevalence of nasal complaints in the general population. Rhinology. 2021;59(3):258-266. https://doi.org/10.4193/Rhin20.637. Viiu B, Christer J, Fredrik S, et al. Asthma in combination with rhinitis and eczema is associated with a higher degree of type-2 inflammation and symptom burden than asthma alone. Allergy. 2021;76(12):3827-3829. https://doi.org/10.1111/all.15082. Camp J, Cane JL, Bafadhel M. Shall we focus on the eosinophil to guide treatment with systemic corticosteroids during acute exacerbations of COPD?: PRO. Med Sci (Basel). 2018;6(3):74. https://doi.org/10.3390/medsci6030074. Hox V, Lourijsen E, Jordens A, et al. Benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clin Transl Allergy. 2020;10:1. https://doi.org/10.1186/s13601-019-0303-6. Hox V, Lourijsen E, Jordens A, et al. Correction to: benefits and harm of systemic steroids for short- and long-term use in rhinitis and rhinosinusitis: an EAACI position paper. Clin Transl Allergy. 2020;10:38. https://doi.org/10.1186/s13601-020-00343-w. Agache I, Song Y, Alonso-Coello P, et al. Efficacy and safety of treatment with biologicals for severe chronic rhinosinusitis with nasal polyps: a systematic review for the EAACI guidelines. Allergy. 2021;76(8):2337-2353. https://doi.org/10.1111/all.14809. Hellings PW, Verhoeven E, Fokkens WJ. State-of-the-art overview on biological treatment for CRSwNP. Rhinology. 2021;59(2):151-163. https://doi.org/10.4193/Rhin20.570. Tomassen P, Vandeplas G, Van Zele T, et al. Inflammatory endotypes of chronic rhinosinusitis based on cluster analysis of biomarkers. J Allergy Clin Immunol. 2016;137(5):1449-1456.e4. https://doi.org/10.1016/j.jaci.2015.12.1324. Kato A, Peters AT, Stevens WW, Schleimer RP, Tan BK, Kern RC. Endotypes of chronic rhinosinusitis: relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches. Allergy. 2022;77(3):812-826. https://doi.org/10.1111/all.15074. Steelant B, Seys SF, Boeckxstaens G, Akdis CA, Ceuppens JL, Hellings PW. Restoring airway epithelial barrier dysfunction: a new therapeutic challenge in allergic airway disease. Rhinology. 2016;54(3):195-205. https://doi.org/10.4193/Rhino15.376. Scadding GK, Scadding GW. Innate and adaptive immunity: ILC2 and Th2 cells in upper and lower airway allergic diseases. J Allergy Clin Immunol Pract. 2021;9(5):1851-1857. https://doi.org/10.1016/j.jaip.2021.02.013. van der Ploeg EK, Golebski K, van Nimwegen M, et al. Steroid-resistant human inflammatory ILC2s are marked by CD45RO and elevated in type 2 respiratory diseases. Sci Immunol. 2021;6(55):eabd3489. https://doi.org/10.1126/sciimmunol.abd3489. Braunstahl GJ, Fokkens W. Nasal involvement in allergic asthma. Allergy. 2003;58(12):1235-1243. https://doi.org/10.1046/j.0105-4538.2003.00354.x. Izuhara Y, Matsumoto H, Nagasaki T, et al. Mouth breathing, another risk factor for asthma: the Nagahama study. Allergy. 2016;71(7):1031-1036. https://doi.org/10.1111/all.12885. Braunstahl GJ. United airways concept: what does it teach us about systemic inflammation in airways disease? Proc Am Thorac Soc. 2009;6(8):652-654. https://doi.org/10.1513/pats.200906-052DP. Corren J, Adinoff AD, Irvin CG. Changes in bronchial responsiveness following nasal provocation with allergen. J Allergy Clin Immunol. 1992;89(2):611-618. https://doi.org/10.1016/0091-6749(92)90329-z. Braunstahl GJ, Kleinjan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med. 2000;161(6):2051-2057. https://doi.org/10.1164/ajrccm.161.6.9906121. Braunstahl GJ, Overbeek SE, Fokkens WJ, et al. Segmental bronchoprovocation in allergic rhinitis patients affects mast cell and basophil numbers in nasal and bronchial mucosa. Am J Respir Crit Care Med. 2001;164(5):858-865. https://doi.org/10.1164/ajrccm.164.5.2006082. Braunstahl GJ, Overbeek SE, Kleinjan A, Prins JB, Hoogsteden HC, Fokkens WJ. Nasal allergen provocation induces adhesion molecule expression and tissue eosinophilia in upper and lower airways. J Allergy Clin Immunol. 2001;107(3):469-476. https://doi.org/10.1067/mai.2001.113046. Allakhverdi Z, Comeau MR, Smith DE, et al. CD34+ hemopoietic progenitor cells are potent effectors of allergic inflammation. J Allergy Clin Immunol. 2009;123(2):472-478. https://doi.org/10.1016/j.jaci.2008.10.022. Sergejeva S, Malmhall C, Lotvall J, Pullerits T. Increased number of CD34+ cells in nasal mucosa of allergic rhinitis patients: inhibition by a local corticosteroid. Clin Exp Allergy. 2005;35(1):34-38. https://doi.org/10.1111/j.1365-2222.2004.02038.x. Lans R, Fokkens WJ, Adriaensen G, Hoven DR, Drubbel JJ, Reitsma S. Real-life observational cohort verifies high efficacy of dupilumab for chronic rhinosinusitis with nasal polyps. Allergy. 2022;77(2):670-674. https://doi.org/10.1111/all.15134. ISAAC Steering Committee. ISAAC - The International Study of Asthma and Allergies in Childhood. Accessed November 1, 2021. http://isaac.auckland.ac.nz. World Health Organization. International Statistical Classigfication of Diseases and Related Health Problems (ICD). Accessed November 1, 2021. https://www.who.int/standards/classifications/classification-of-diseases. Alqahtani JM. Atopy and allergic diseases among Saudi young adults: a cross-sectional study. J Int Med Res. 2020;48(1):300060519899760. https://doi.org/10.1177/0300060519899760. Oliveira TB, Persigo ALK, Ferrazza CC, Ferreira ENN, Veiga ABG. Prevalence of asthma, allergic rhinitis and pollinosis in a city of Brazil: a monitoring study. Allergol Immunopathol (Madr). 2020;48(6):537-544. https://doi.org/10.1016/j.aller.2020.03.010. Nam JS, Hwang CS, Hong MP, Kim KS. Prevalence and clinical characteristics of allergic rhinitis in the elderly Korean population. Eur Arch Otorhinolaryngol. 2020;277(12):3367-3373. https://doi.org/10.1007/s00405-020-06256-5. Mortz CG, Andersen KE, Poulsen LK, Kjaer HF, Broesby-Olsen S, Bindslev-Jensen C. Atopic diseases and type I sensitization from adolescence to adulthood in an unselected population (TOACS) with focus on predictors for allergic rhinitis. Allergy. 2019;74(2):308-317. https://doi.org/10.1111/all.13630. Wang XY, Ma TT, Wang XY, et al. Prevalence of pollen-induced allergic rhinitis with high pollen exposure in grasslands of northern China. Allergy. 2018;73(6):1232-1243. https://doi.org/10.1111/all.13388. Schmitt J, Stadler E, Kuster D, Wustenberg EG. Medical care and treatment of allergic rhinitis: a population-based cohort study based on routine healthcare utilization data. Allergy. 2016;71(6):850-858. https://doi.org/10.1111/all.12838. Sorensen M, Wickman M, Sollid JU, Furberg AS, Klingenberg C. Allergic disease and Staphylococcus aureus carriage in adolescents in the Arctic region of Norway. Pediatr Allergy Immunol. 2016;27(7):728-735. https://doi.org/10.1111/pai.12595. Winther A, Dennison E, Ahmed LA, et al. The Tromso Study: Fit Futures: a study of Norwegian adolescents' lifestyle and bone health. Arch Osteoporos. 2014;9:185. https://doi.org/10.1007/s11657-014-0185-0. Jacobsen BK, Eggen AE, Mathiesen EB, Wilsgaard T, Njolstad I. Cohort profile: the Tromso study. Int J Epidemiol. 2012;41(4):961-967. https://doi.org/10.1093/ije/dyr049. Yang L, Fu J, Zhou Y. Research progress in Atopic March. Front Immunol. 2020;11:1907. https://doi.org/10.3389/fimmu.2020.01907. Park S, Jung PK, Choi M, et al. Association between occupational clusters and allergic rhinitis in the Korean population: analysis of the Korean National Health and Nutrition Examination Survey data. J Occup Health. 2018;60(4):312-319. https://doi.org/10.1539/joh.2017-0234-OA. Cardell LO, Olsson P, Andersson M, et al. TOTALL: high cost of allergic rhinitis-a national Swedish population-based questionnaire study. NPJ Prim Care Respir Med. 2016;26:15082. https://doi.org/10.1038/npjpcrm.2015.82. Idani E, Raji H, Madadizadeh F, Cheraghian B, Haddadzadeh Shoshtari M, Dastoorpoor M. Prevalence of asthma and other allergic conditions in adults in Khuzestan, southwest Iran, 2018. BMC Public Health. 2019;19(1):303. https://doi.org/10.1186/s12889-019-6491-0. Reijula J, Latvala J, Makela M, Siitonen S, Saario M, Haahtela T. Long-term trends of asthma, allergic rhinitis and atopic eczema in young Finnish men: a retrospective analysis, 1926-2017. Eur Respir J. 2020;56(6):1902144. https://doi.org/10.1183/13993003.02144-2019. Maio S, Baldacci S, Carrozzi L, et al. Respiratory symptoms/diseases prevalence is still increasing: a 25-yr population study. Respir Med. 2016;110:58-65. https://doi.org/10.1016/j.rmed.2015.11.006. Janson C, Johannessen A, Franklin K, et al. Change in the prevalence asthma, rhinitis and respiratory symptom over a 20 year period: associations to year of birth, life style and sleep related symptoms. BMC Pulm Med. 2018;18(1):152. https://doi.org/10.1186/s12890-018-0690-9. Sucharew H, Ryan PH, Bernstein D, et al. Exposure to traffic exhaust and night cough during early childhood: the CCAAPS birth cohort. Pediatr Allergy Immunol. 2010;21(2 pt 1):253-259. https://doi.org/10.1111/j.1399-3038.2009.00952.x. Herr M, Clarisse B, Nikasinovic L, et al. Does allergic rhinitis exist in infancy? Findings from the PARIS birth cohort. Allergy. 2011;66(2):214-221. https://doi.org/10.1111/j.1398-9995.2010.02467.x. Kulig M, Klettke U, Wahn V, Forster J, Bauer CP, Wahn U. Development of seasonal allergic rhinitis during the first 7 years of life. J Allergy Clin Immunol. 2000;106(5):832-839. https://doi.org/10.1067/mai.2000.110098. Westman M, Stjarne P, Asarnoj A, et al. Natural course and comorbidities of allergic and nonallergic rhinitis in children. J Allergy Clin Immunol. 2012;129(2):403-408. https://doi.org/10.1016/j.jaci.2011.09.036. Ait-Khaled N, Pearce N, Anderson HR, et al. Global map of the prevalence of symptoms of rhinoconjunctivitis in children: The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three. Allergy. 2009;64(1):123-148. https://doi.org/10.1111/j.1398-9995.2008.01884.x. Bjorksten B, Clayton T, Ellwood P, Stewart A, Strachan D, Group IPIS. Worldwide time trends for symptoms of rhinitis and conjunctivitis: Phase III of the International Study of Asthma and Allergies in Childhood. Pediatr Allergy Immunol. 2008;19(2):110-124. https://doi.org/10.1111/j.1399-3038.2007.00601.x. Mallol J, Crane J, von Mutius E, et al. The International Study of Asthma and Allergies in Childhood (ISAAC) Phase Three: a global synthesis. Allergol Immunopathol (Madr). 2013;41(2):73-85. https://doi.org/10.1016/j.aller.2012.03.001. Strachan D, Sibbald B, Weiland S, et al. Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: the International Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol. 1997;8(4):161-176. https://doi.org/10.1111/j.1399-3038.1997.tb00156.x. Soto-Martinez ME, Yock-Corrales A, Camacho-Badilla K, et al. The current prevalence of asthma, allergic rhinitis, and eczema related symptoms in school-aged children in Costa Rica. J Asthma. 2019;56(4):360-368. https://doi.org/10.1080/02770903.2018.1455860. Morikawa E, Sasaki M, Yoshida K, Adachi Y, Odajima H, Akasawa A. Nationwide survey of the prevalence of wheeze, rhino-conjunctivitis, and eczema among Japanese children in 2015. Allergol Int. 2020;69(1):98-103. https://doi.org/10.1016/j.alit.2019.08.010. Ibrahim NM, Almarzouqi FI, Al Melaih FA, Farouk H, Alsayed M, AlJassim FM. Prevalence of asthma and allergies among children in the United Arab Emirates: a cross-sectional study. World Allergy Organ J. 2021;14(10):100588. https://doi.org/10.1016/j.waojou.2021.100588. Ozoh OB, Aderibigbe SA, Ayuk AC, et al. The prevalence of asthma and allergic rhinitis in Nigeria: a nationwide survey among children, adolescents and adults. PLoS One. 2019;14(9):e0222281. https://doi.org/10.1371/journal.pone.0222281. de Oliveira TB, Moscon JG, Ferreira E, da Veiga ABG. Prevalence of symptoms of asthma and allergic rhinitis in children in Southern Brazil: a ten-year monitoring study. J Asthma. 2020;57(4):373-380. https://doi.org/10.1080/02770903.2019.1573253. Ochoa-Aviles C, Morillo D, Rodriguez A, et al. Prevalence and risk factors for asthma, rhinitis, eczema, and atopy among preschool children in an Andean city. PLoS One. 2020;15(7):e0234633. https://doi.org/10.1371/journal.pone.0234633. Tong H, Gao L, Deng Y, et al. Prevalence of allergic rhinitis and associated risk factors in 6 to 12 years schoolchildren from Wuhan in Central China: a cross-sectional study. Am J Rhinol Allergy. 2020;34(5):632-641. https://doi.org/10.1177/1945892420920499. Zhang HL, Wang BY, Luo Y, et al. Association of pet-keeping in home with self-reported asthma and asthma-related symptoms in 11611 school children from China. J Asthma. 2021;58(12):1555-1564. https://doi.org/10.1080/02770903.2020.1818772. Pols DH, Wartna JB, Moed H, van Alphen EI, Bohnen AM, Bindels PJ. Atopic dermatitis, asthma and allergic rhinitis in general practice and the open population: a systematic review. Scand J Prim Health Care. 2016;34(2):143-150. https://doi.org/10.3109/02813432.2016.1160629. Van Wonderen KE, Van Der Mark LB, Mohrs J, Bindels PJ, Van Aalderen WM, Ter Riet G. Different definitions in childhood asthma: how dependable is the dependent variable? Eur Respir J. 2010;36(1):48-56. https://doi.org/10.1183/09031936.00154409. Pols DHJ, Nielen MMJ, Korevaar JC, Bindels PJE, Bohnen AM. Reliably estimating prevalences of atopic children: an epidemiological study in an extensive and representative primary care database. NPJ Prim Care Respir Med. 2017;27(1):23. https://doi.org/10.1038/s41533-017-0025-y. Kurukulaaratchy RJ, Karmaus W, Raza A, Matthews S, Roberts G, Arshad SH. The influence of gender and atopy on the natural history of rhinitis in the first 18 years of life. Clin Exp Allergy. 2011;41(6):851-859. https://doi.org/10.1111/j.1365-2222.2011.03765.x. de Jong NW, Elbert NJ, Mensink-Bout SM, et al. Parental and child factors associated with inhalant and food allergy in a population-based prospective cohort study: the Generation R Study. Eur J Pediatr. 2019;178(10):1507-1517. https://doi.org/10.1007/s00431-019-03441-5. Strachan DP, Rutter CE, Asher MI, et al. Worldwide time trends in prevalence of symptoms of rhinoconjunctivitis in children: Global Asthma Network Phase I. Pediatr Allergy Immunol. 2022;33(1):e13656. https://doi.org/10.1111/pai.13656. Bousquet PJ, Leynaert B, Neukirch F, et al. Geographical distribution of atopic rhinitis in the European Community Respiratory Health Survey I. Allergy. 2008;63(10):1301-1309. https://doi.org/10.1111/j.1398-9995.2008.01824.x. Variations in the prevalence of respiratory symptoms, self-reported asthma attacks, and use of asthma medication in the European Community Respiratory Health Survey (ECRHS). Eur Respir J. 1996;9(4):687-695. https://doi.org/10.1183/09031936.96.09040687. Weinmayr G, Forastiere F, Weiland SK, et al. International variation in prevalence of rhinitis and its relationship with sensitisation to perennial and seasonal allergens. Eur Respir J. 2008;32(5):1250-1261. https://doi.org/10.1183/09031936.00157807. Wang XD, Zheng M, Lou HF, et al. An increased prevalence of self-reported allergic rhinitis in major Chinese cities from 2005 to 2011. Allergy. 2016;71(8):1170-1180. https://doi.org/10.1111/all.12874. Anderegg WRL, Abatzoglou JT, Anderegg LDL, Bielory L, Kinney PL, Ziska L. Anthropogenic climate change is worsening North American pollen seasons. Proc Natl Acad Sci U S A. 2021;118(7):e2013284118. https://doi.org/10.1073/pnas.2013284118. Lake IR, Jones NR, Agnew M, et al. Climate change and future pollen allergy in Europe. Environ Health Perspect. 2017;125(3):385-391. https://doi.org/10.1289/EHP173. Erbas B, Lowe AJ, Lodge CJ, et al. Persistent pollen exposure during infancy is associated with increased risk of subsequent childhood asthma and hayfever. Clin Exp Allergy. 2013;43(3):337-343. https://doi.org/10.1111/cea.12071. Toth I, Peternel R, Gajnik D, Vojnikovic B. Micro-regional hypersensitivity variations to inhalant allergens in the city of Zagreb and Zagreb County. Coll Antropol. 2011;35(suppl 2):31-37. Kim J, Han Y, Seo SC, et al. Association of carbon monoxide levels with allergic diseases in children. Allergy Asthma Proc. 2016;37(1):e1-e7. https://doi.org/10.2500/aap.2016.37.3918. Li CW, Chen DD, Zhong JT, et al. Epidemiological characterization and risk factors of allergic rhinitis in the general population in Guangzhou City in China. PLoS One. 2014;9(12):e114950. https://doi.org/10.1371/journal.pone.0114950. Ahn JC, Kim JW, Lee CH, Rhee CS. Prevalence and risk factors of chronic rhinosinusitus, allergic rhinitis, and nasal septal deviation: results of the Korean National Health and Nutrition Survey 2008-2012. JAMA Otolaryngol Head Neck Surg. 2016;142(2):162-167. https://doi.org/10.1001/jamaoto.2015.3142. Song WJ, Sohn KH, Kang MG, et al. Urban-rural differences in the prevalence of allergen sensitization and self-reported rhinitis in the elderly population. Ann Allergy Asthma Immunol. 2015;114(6):455-461. https://doi.org/10.1016/j.anai.2015.03.008. Zheng M, Wang X, Wang M, et al. Clinical characteristics of allergic rhinitis patients in 13 metropolitan cities of China. Allergy. 2021;76(2):577-581. https://doi.org/10.1111/all.14561. Beggs PJ, Katelaris CH, Medek D, et al. Differences in grass pollen allergen exposure across Australia. Aust N Z J Public Health. 2015;39(1):51-55. https://doi.org/10.1111/1753-6405.12325. Westman M, Kull I, Lind T, et al. The link between parental allergy and offspring allergic and nonallergic rhinitis. Allergy. 2013;68(12):1571-1578. https://doi.org/10.1111/all.12267. Thomsen SF, Ulrik CS, Kyvik KO, et al. Genetic and environmental contributions to hay fever among young adult twins. Respir Med. 2006;100(12):2177-2182. https://doi.org/10.1016/j.rmed.2006.03.013. Rasanen M, Laitinen T, Kaprio J, Koskenvuo M, Laitinen LA. Hay fever - a Finnish nationwide study of adolescent twins and their parents. Allergy. 1998;53(9):885-890. https://doi.org/10.1111/j.1398-9995.1998.tb03996.x. Ferreira MA, Matheson MC, Tang CS, et al. Genome-wide association analysis identifies 11 risk variants associated with the asthma with hay fever phenotype. J Allergy Clin Immunol. 2014;133(6):1564-1571. https://doi.org/10.1016/j.jaci.2013.10.030. Hinds DA, McMahon G, Kiefer AK, et al. A genome-wide association meta-analysis of self-reported allergy identifies shared and allergy-specific susceptibility loci. Nat Genet. 2013;45(8):907-911. https://doi.org/10.1038/ng.2686. Ramasamy A, Curjuric I, Coin LJ, et al. A genome-wide meta-analysis of genetic variants associated with allergic rhinitis and grass sensitization and their interaction with birth order. J Allergy Clin Immunol. 2011;128(5):996-1005. https://doi.org/10.1016/j.jaci.2011.08.030. Johansson A, Rask-Andersen M, Karlsson T, Ek WE. Genome-wide association analysis of 350 000 Caucasians from the UK Biobank identifies novel loci for asthma, hay fever and eczema. Hum Mol Genet. 2019;28(23):4022-4041. https://doi.org/10.1093/hmg/ddz175. Waage J, Standl M, Curtin JA, et al. Genome-wide association and HLA fine-mapping studies identify risk loci and genetic pathways underlying allergic rhinitis. Nat Genet. 2018;50(8):1072-1080. https://doi.org/10.1038/s41588-018-0157-1. Ferreira MA, Matheson MC, Duffy DL, et al. Identification of IL6R and chromosome 11q13.5 as risk loci for asthma. Lancet. 2011;378(9795):1006-1014. https://doi.org/10.1016/S0140-6736(11)60874-X. Weidinger S, Willis-Owen SA, Kamatani Y, et al. A genome-wide association study of atopic dermatitis identifies loci with overlapping effects on asthma and psoriasis. Hum Mol Genet. 2013;22(23):4841-4856. https://doi.org/10.1093/hmg/ddt317. Marenholz I, Esparza-Gordillo J, Ruschendorf F, et al. Meta-analysis identifies seven susceptibility loci involved in the atopic march. Nat Commun. 2015;6:8804. https://doi.org/10.1038/ncomms9804. Stockis J, Colau D, Coulie PG, Lucas S. Membrane protein GARP is a receptor for latent TGF-beta on the surface of activated human Treg. Eur J Immunol. 2009;39(12):3315-3322. https://doi.org/10.1002/eji.200939684. Bonnelykke K, Matheson MC, Pers TH, et al. Meta-analysis of genome-wide association studies identifies ten loci influencing allergic sensitization. Nat Genet. 2013;45(8):902-906. https://doi.org/10.1038/ng.2694. Ferreira MA, Vonk JM, Baurecht H, et al. Shared genetic origin of asthma, hay fever and eczema elucidates allergic disease biology. Nat Genet. 2017;49(12):1752-1757. https://doi.org/10.1038/ng.3985. Ferreira MAR, Vonk JM, Baurecht H, et al. Eleven loci with new reproducible genetic associations with allergic disease risk. J Allergy Clin Immunol. 2019;143(2):691-699. https://doi.org/10.1016/j.jaci.2018.03.012. Backman JD, Li AH, Marcketta A, et al. Exome sequencing and analysis of 454,787 UK Biobank participants. Nature. 2021;599(7886):628-634. https://doi.org/10.1038/s41586-021-04103-z. Davila I, Mullol J, Ferrer M, et al. Genetic aspects of allergic rhinitis. J Investig Allergol Clin Immunol. 2009;19(suppl 1):25-31. Andiappan AK, Nilsson D, Hallden C, et al. Investigating highly replicated asthma genes as candidate genes for allergic rhinitis. BMC Med Genet. 2013;14:51. https://doi.org/10.1186/1471-2350-14-51. Nilsson D, Andiappan AK, Hallden C, et al. Toll-like receptor gene polymorphisms are associated with allergic rhinitis: a case control study. BMC Med Genet. 2012;13:66. https://doi.org/10.1186/1471-2350-13-66. Kang I, Oh YK, Lee SH, Jung HM, Chae SC, Lee JH. Identification of polymorphisms in the Toll-like receptor gene and the association with allergic rhinitis. Eur Arch Otorhinolaryngol. 2010;267(3):385-389. https://doi.org/10.1007/s00405-009-1100-y. Kormann MS, Ferstl R, Depner M, et al. Rare TLR2 mutations reduce TLR2 receptor function and can increase atopy risk. Allergy. 2009;64(4):636-642. https://doi.org/10.1111/j.1398-9995.2008.01891.x. Moller-Larsen S, Nyegaard M, Haagerup A, Vestbo J, Kruse TA, Borglum AD. Association analysis identifies TLR7 and TLR8 as novel risk genes in asthma and related disorders. Thorax. 2008;63(12):1064-1069. https://doi.org/10.1136/thx.2007.094128. Sun Q, Liu Y, Zhang S, et al. Thymic stromal lymphopoietin polymorphisms and allergic rhinitis risk: a systematic review and meta-analysis with 6351 cases and 11472 controls. Int J Clin Exp Med. 2015;8(9):15752-15758. Nilsson D, Andiappan AK, Hallden C, et al. Poor reproducibility of allergic rhinitis SNP associations. PLoS One. 2013;8(1):e53975. https://doi.org/10.1371/journal.pone.0053975. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol. 2008;8(3):169-182. https://doi.org/10.1038/nri2257. London SJ, Melen E. Genomic interactions with exposure to inhaled pollutants. J Allergy Clin Immunol. 2019;143(6):2011-2013.e1. https://doi.org/10.1016/j.jaci.2019.04.008. Gruzieva O, Xu CJ, Breton CV, et al. Epigenome-wide meta-analysis of methylation in children related to prenatal NO2 air pollution exposure. Environ Health Perspect. 2017;125(1):104-110. https://doi.org/10.1289/EHP36. Merid SK, Novoloaca A, Sharp GC, et al. Epigenome-wide meta-analysis of blood DNA methylation in newborns and children identifies numerous loci related to gestational age. Genome Med. 2020;12(1):25. https://doi.org/10.1186/s13073-020-0716-9. Li JY, Zhang Y, Lin XP, et al. Association between DNA hypomethylation at IL13 gene and allergic rhinitis in house dust mite-sensitized subjects. Clin Exp Allergy. 2016;46(2):298-307. https://doi.org/10.1111/cea.12647. Nestor CE, Barrenas F, Wang H, et al. DNA methylation changes separate allergic patients from healthy controls and may reflect altered CD4+ T-cell population structure. PLoS Genet. 2014;10(1):e1004059. https://doi.org/10.1371/journal.pgen.1004059. Sarnowski C, Laprise C, Malerba G, et al. DNA methylation within melatonin receptor 1A (MTNR1A) mediates paternally transmitted genetic variant effect on asthma plus rhinitis. J Allergy Clin Immunol. 2016;138(3):748-753. https://doi.org/10.1016/j.jaci.2015.12.1341. Liang L, Willis-Owen SAG, Laprise C, et al. An epigenome-wide association study of total serum immunoglobulin E concentration. Nature. 2015;520(7549):670-674. https://doi.org/10.1038/nature14125. Everson TM, Lyons G, Zhang H, et al. DNA methylation loci associated with atopy and high serum IgE: a genome-wide application of recursive Random Forest feature selection. Genome Med. 2015;7:89. https://doi.org/10.1186/s13073-015-0213-8. Qi C, Jiang Y, Yang IV, et al. Nasal DNA methylation profiling of asthma and rhinitis. J Allergy Clin Immunol. 2020;145(6):1655-1663. https://doi.org/10.1016/j.jaci.2019.12.911. Xu CJ, Gruzieva O, Qi C, et al. Shared DNA methylation signatures in childhood allergy: the MeDALL study. J Allergy Clin Immunol. 2021;147(3):1031-1040. https://doi.org/10.1016/j.jaci.2020.11.044. Andiappan AK, de Wang Y, Anantharaman R, et al. Genome-wide association study for atopy and allergic rhinitis in a Singapore Chinese population. PLoS One. 2011;6(5):e19719. https://doi.org/10.1371/journal.pone.0019719. Bunyavanich S, Schadt EE, Himes BE, et al. Integrated genome-wide association, coexpression network, and expression single nucleotide polymorphism analysis identifies novel pathway in allergic rhinitis. BMC Med Genomics. 2014;7:48. https://doi.org/10.1186/1755-8794-7-48. Sakaue S, Kanai M, Tanigawa Y, et al. A cross-population atlas of genetic associations for 220 human phenotypes. Nat Genet. 2021;53(10):1415-1424. https://doi.org/10.1038/s41588-021-00931-x. Toelle BG, Ng KK, Crisafulli D, et al. Eight-year outcomes of the Childhood Asthma Prevention Study. J Allergy Clin Immunol. 2010;126(2):388-389. 389.e1-3. https://doi.org/10.1016/j.jaci.2010.04.031. Marks GB, Mihrshahi S, Kemp AS, et al. Prevention of asthma during the first 5 years of life: a randomized controlled trial. J Allergy Clin Immunol. 2006;118(1):53-61. https://doi.org/10.1016/j.jaci.2006.04.004. Gehring U, de Jongste JC, Kerkhof M, et al. The 8-year follow-up of the PIAMA intervention study assessing the effect of mite-impermeable mattress covers. Allergy. 2012;67(2):248-256. https://doi.org/10.1111/j.1398-9995.2011.02739.x. Gabet S, Ranciere F, Just J, et al. Asthma and allergic rhinitis risk depends on house dust mite specific IgE levels in PARIS birth cohort children. World Allergy Organ J. 2019;12(9):100057. https://doi.org/10.1016/j.waojou.2019.100057. Arshad SH, Bateman B, Sadeghnejad A, Gant C, Matthews SM. Prevention of allergic disease during childhood by allergen avoidance: the Isle of Wight prevention study. J Allergy Clin Immunol. 2007;119(2):307-313. https://doi.org/10.1016/j.jaci.2006.12.621. Chan-Yeung M, Ferguson A, Watson W, et al. The Canadian Childhood Asthma Primary Prevention Study: outcomes at 7 years of age. J Allergy Clin Immunol. 2005;116(1):49-55. https://doi.org/10.1016/j.jaci.2005.03.029. Calderon MA, Linneberg A, Kleine-Tebbe J, et al. Respiratory allergy caused by house dust mites: what do we really know? J Allergy Clin Immunol. 2015;136(1):38-48. https://doi.org/10.1016/j.jaci.2014.10.012. Wahn U, Lau S, Bergmann R, et al. Indoor allergen exposure is a risk factor for sensitization during the first three years of life. J Allergy Clin Immunol. 1997;99(6 pt 1):763-769. https://doi.org/10.1016/s0091-6749(97)80009-7. Tovey ER, Almqvist C, Li Q, Crisafulli D, Marks GB. Nonlinear relationship of mite allergen exposure to mite sensitization and asthma in a birth cohort. J Allergy Clin Immunol. 2008;122(1):114-118. 118.e1-5. https://doi.org/10.1016/j.jaci.2008.05.010. Schram-Bijkerk D, Doekes G, Boeve M, et al. Nonlinear relations between house dust mite allergen levels and mite sensitization in farm and nonfarm children. Allergy. 2006;61(5):640-647. https://doi.org/10.1111/j.1398-9995.2006.01079.x. Torrent M, Sunyer J, Munoz L, et al. Early-life domestic aeroallergen exposure and IgE sensitization at age 4 years. J Allergy Clin Immunol. 2006;118(3):742-748. https://doi.org/10.1016/j.jaci.2006.04.059. Cullinan P, MacNeill SJ, Harris JM, et al. Early allergen exposure, skin prick responses, and atopic wheeze at age 5 in English children: a cohort study. Thorax. 2004;59(10):855-861. https://doi.org/10.1136/thx.2003.019877. Lau S, Falkenhorst G, Weber A, et al. High mite-allergen exposure increases the risk of sensitization in atopic children and young adults. J Allergy Clin Immunol. 1989;84(5 pt 1):718-725. https://doi.org/10.1016/0091-6749(89)90300-x. Kuehr J, Frischer T, Meinert R, et al. Mite allergen exposure is a risk for the incidence of specific sensitization. J Allergy Clin Immunol. 1994;94(1):44-52. https://doi.org/10.1016/0091-6749(94)90070-1. Lodge CJ, Lowe AJ, Gurrin LC, et al. House dust mite sensitization in toddlers predicts current wheeze at age 12 years. J Allergy Clin Immunol. 2011;128(4):782-788.e9. https://doi.org/10.1016/j.jaci.2011.06.038. Schoos AM, Chawes BL, Jelding-Dannemand E, Elfman LB, Bisgaard H. Early indoor aeroallergen exposure is not associated with development of sensitization or allergic rhinitis in high-risk children. Allergy. 2016;71(5):684-691. https://doi.org/10.1111/all.12853. Illi S, Weber J, Zutavern A, et al. Perinatal influences on the development of asthma and atopy in childhood. Ann Allergy Asthma Immunol. 2014;112(2):132-139.e1. https://doi.org/10.1016/j.anai.2013.11.019. Kihlstrom A, Lilja G, Pershagen G, Hedlin G. Exposure to birch pollen in infancy and development of atopic disease in childhood. J Allergy Clin Immunol. 2002;110(1):78-84. https://doi.org/10.1067/mai.2002.125829. Scadding GK, Smith PK, Blaiss M, et al. Allergic Rhinitis in Childhood and the New EUFOREA Algorithm. Front Allergy. 2021;2:706589. https://doi.org/10.3389/falgy.2021.706589. Lipiec A, Sybilski A, Komorowski J, et al. Sensitisation to airborne allergens as a risk factor for allergic rhinitis and asthma in the Polish population. Postepy Dermatol Alergol. 2020;37(5):751-759. https://doi.org/10.5114/ada.2019.84231. Hatzler L, Panetta V, Lau S, et al. Molecular spreading and predictive value of preclinical IgE response to Phleum pratense in children with hay fever. J Allergy Clin Immunol. 2012;130(4):894-901.e5. https://doi.org/10.1016/j.jaci.2012.05.053. Gough H, Grabenhenrich L, Reich A, et al. Allergic multimorbidity of asthma, rhinitis and eczema over 20 years in the German birth cohort MAS. Pediatr Allergy Immunol. 2015;26(5):431-437. https://doi.org/10.1111/pai.12410. Grabenhenrich LB, Keil T, Reich A, et al. Prediction and prevention of allergic rhinitis: a birth cohort study of 20 years. J Allergy Clin Immunol. 2015;136(4):932-940.e12. https://doi.org/10.1016/j.jaci.2015.03.040. Lee KS, Kim K, Choi YJ, et al. Increased sensitization rates to tree pollens in allergic children and adolescents and a change in the pollen season in the metropolitan area of Seoul, Korea. Pediatr Allergy Immunol. 2021;32(5):872-879. https://doi.org/10.1111/pai.13472. Westman M, Aberg K, Apostolovic D, et al. Sensitization to grass pollen allergen molecules in a birth cohort-natural Phl p 4 as an early indicator of grass pollen allergy. J Allergy Clin Immunol. 2020;145(4):1174-1181.e6. https://doi.org/10.1016/j.jaci.2020.01.006. Westman M, Lupinek C, Bousquet J, et al. Early childhood IgE reactivity to pathogenesis-related class 10 proteins predicts allergic rhinitis in adolescence. J Allergy Clin Immunol. 2015;135(5):1199-1206.e1-11. https://doi.org/10.1016/j.jaci.2014.10.042. Gao X, Yin M, Yang P, et al. Effect of exposure to cats and dogs on the risk of asthma and allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2020;34(5):703-714. https://doi.org/10.1177/1945892420932487. Ojwang V, Nwaru BI, Takkinen HM, et al. Early exposure to cats, dogs and farm animals and the risk of childhood asthma and allergy. Pediatr Allergy Immunol. 2020;31(3):265-272. https://doi.org/10.1111/pai.13186. Al-Tamprouri C, Malin B, Bill H, Lennart B, Anna S. Cat and dog ownership during/after the first year of life and risk for sensitization and reported allergy symptoms at age 13. Immun Inflamm Dis. 2019;7(4):250-257. https://doi.org/10.1002/iid3.267. Sultesz M, Horvath A, Molnar D, et al. Prevalence of allergic rhinitis, related comorbidities and risk factors in schoolchildren. Allergy Asthma Clin Immunol. 2020;16(1):98. https://doi.org/10.1186/s13223-020-00495-1. Ho CL, Wu WF. Risk factor analysis of allergic rhinitis in 6-8 year-old children in Taipei. PLoS One. 2021;16(4):e0249572. Alm B, Goksor E, Thengilsdottir H, et al. Early protective and risk factors for allergic rhinitis at age 4(1/2) yr. Pediatr Allergy Immunol. 2011;22(4):398-404. https://doi.org/10.1111/j.1399-3038.2011.01153.x. Dunlop J, Matsui E, Sharma HP. Allergic rhinitis: environmental determinants. Immunol Allergy Clin North Am. 2016;36(2):367-377. https://doi.org/10.1016/j.iac.2015.12.012. Sandini U, Kukkonen AK, Poussa T, Sandini L, Savilahti E, Kuitunen M. Protective and risk factors for allergic diseases in high-risk children at the ages of two and five years. Int Arch Allergy Immunol. 2011;156(3):339-348. https://doi.org/10.1159/000323907. Fasce L, Tosca MA, Silvestri M, Olcese R, Pistorio A, Rossi GA. “Early” cat ownership and the risk of sensitization and allergic rhinitis in Ligurian children with respiratory symptoms. Ann Allergy Asthma Immunol. 2005;94(5):561-565. https://doi.org/10.1016/S1081-1206(10)61134-9. Dimich-Ward H, Chow Y, Chung J, Trask C. Contact with livestock-a protective effect against allergies and asthma? Clin Exp Allergy. 2006;36(9):1122-1129. https://doi.org/10.1111/j.1365-2222.2006.02556.x. Majkowska-Wojciechowska B, Pelka J, Korzon L, et al. Prevalence of allergy, patterns of allergic sensitization and allergy risk factors in rural and urban children. Allergy. 2007;62(9):1044-1050. https://doi.org/10.1111/j.1398-9995.2007.01457.x. Matheson MC, Dharmage SC, Abramson MJ, et al. Early-life risk factors and incidence of rhinitis: results from the European Community Respiratory Health Study - an international population-based cohort study. J Allergy Clin Immunol. 2011;128(4):816-823.e5. https://doi.org/10.1016/j.jaci.2011.05.039. Perkin MR, Bader T, Rudnicka AR, Strachan DP, Owen CG. Inter-relationship between rhinitis and conjunctivitis in allergic rhinoconjunctivitis and associated risk factors in rural UK children. PLoS One. 2015;10(11):e0143651. https://doi.org/10.1371/journal.pone.0143651. Vargas C, Bustos P, Diaz PV, Amigo H, Rona RJ. Childhood environment and atopic conditions, with emphasis on asthma in a Chilean agricultural area. J Asthma. 2008;45(1):73-78. https://doi.org/10.1080/02770900701752540. Lampi J, Canoy D, Jarvis D, et al. Farming environment and prevalence of atopy at age 31: prospective birth cohort study in Finland. Clin Exp Allergy. 2011;41(7):987-993. https://doi.org/10.1111/j.1365-2222.2011.03777.x. Perzanowski MS, Chew GL, Divjan A, et al. Cat ownership is a risk factor for the development of anti-cat IgE but not current wheeze at age 5 years in an inner-city cohort. J Allergy Clin Immunol. 2008;121(4):1047-1052. https://doi.org/10.1016/j.jaci.2008.02.005. Nafstad P, Magnus P, Gaarder PI, Jaakkola JJ. Exposure to pets and atopy-related diseases in the first 4 years of life. Allergy. 2001;56(4):307-312. https://doi.org/10.1034/j.1398-9995.2001.00881.x. Tamay Z, Akcay A, Ones U, Guler N, Kilic G, Zencir M. Prevalence and risk factors for allergic rhinitis in primary school children. Int J Pediatr Otorhinolaryngol. 2007;71(3):463-471. https://doi.org/10.1016/j.ijporl.2006.11.013. Batlles-Garrido J, Torres-Borrego J, Rubi-Ruiz T, et al. Prevalence and factors linked to allergic rhinitis in 10 and 11-year-old children in Almeria. Isaac Phase II, Spain. Allergol Immunopathol (Madr). 2010;38(3):135-141. https://doi.org/10.1016/j.aller.2009.09.005. Lombardi E, Simoni M, La Grutta S, et al. Effects of pet exposure in the first year of life on respiratory and allergic symptoms in 7-yr-old children. The SIDRIA-2 study. Pediatr Allergy Immunol. 2010;21(2 pt 1):268-276. https://doi.org/10.1111/j.1399-3038.2009.00910.x. Ibargoyen-Roteta N, Aguinaga-Ontoso I, Fernandez-Benitez M, et al. Role of the home environment in rhinoconjunctivitis and eczema in schoolchildren in Pamplona, Spain. J Investig Allergol Clin Immunol. 2007;17(3):137-144. Kurosaka F, Terada T, Tanaka A, et al. Risk factors for wheezing, eczema and rhinoconjunctivitis in the previous 12 months among six-year-old children in Himeji City, Japan: food allergy, older siblings, day-care attendance and parental allergy history. Allergol Int. 2011;60(3):317-330. https://doi.org/10.2332/allergolint.10-OA-0246. Brunekreef B, Von Mutius E, Wong G, et al. Exposure to cats and dogs, and symptoms of asthma, rhinoconjunctivitis, and eczema. Epidemiology. 2012;23(5):742-750. https://doi.org/10.1097/EDE.0b013e318261f040. Tamay Z, Akcay A, Ergin A, Guler N. Prevalence of allergic rhinitis and risk factors in 6- to 7-yearold children in Istanbul, Turkey. Turk J Pediatr. 2014;56(1):31-40. Yang SI, Lee E, Jung YH, et al. Effect of antibiotic use and mold exposure in infancy on allergic rhinitis in susceptible adolescents. Ann Allergy Asthma Immunol. 2014;113(2):160-165.e1. https://doi.org/10.1016/j.anai.2014.05.019. Hesselmar B, Aberg N, Aberg B, Eriksson B, Bjorksten B. Does early exposure to cat or dog protect against later allergy development? Clin Exp Allergy. 1999;29(5):611-617. https://doi.org/10.1046/j.1365-2222.1999.00534.x. Leynaert B, Neukirch C, Jarvis D, et al. Does living on a farm during childhood protect against asthma, allergic rhinitis, and atopy in adulthood? Am J Respir Crit Care Med. 2001;164(10 pt 1):1829-1834. https://doi.org/10.1164/ajrccm.164.10.2103137. Anyo G, Brunekreef B, de Meer G, Aarts F, Janssen NA, van Vliet P. Early, current and past pet ownership: associations with sensitization, bronchial responsiveness and allergic symptoms in school children. Clin Exp Allergy. 2002;32(3):361-366. https://doi.org/10.1046/j.1365-2222.2002.01254.x. Waser M, von Mutius E, Riedler J, et al. Exposure to pets, and the association with hay fever, asthma, and atopic sensitization in rural children. Allergy. 2005;60(2):177-184. https://doi.org/10.1111/j.1398-9995.2004.00645.x. Sultesz M, Katona G, Hirschberg A, Galffy G. Prevalence and risk factors for allergic rhinitis in primary schoolchildren in Budapest. Int J Pediatr Otorhinolaryngol. 2010;74(5):503-509. https://doi.org/10.1016/j.ijporl.2010.02.008. Kim WK, Kwon JW, Seo JH, et al. Interaction between IL13 genotype and environmental factors in the risk for allergic rhinitis in Korean children. J Allergy Clin Immunol. 2012;130(2):421-426.e5. https://doi.org/10.1016/j.jaci.2012.04.052. Lam A, Wong GW, Poon CM, Lee SS. A GIS-based assessment of environmental influences on allergy development in children. Asia Pac J Public Health. 2014;26(6):575-587. https://doi.org/10.1177/1010539511428488. Torfi Y, Bitarafan N, Rajabi M. Impact of socioeconomic and environmental factors on atopic eczema and allergic rhinitis: a cross sectional study. EXCLI J. 2015;14:1040-1048. https://doi.org/10.17179/excli2015-519. Kellberger J, Dressel H, Vogelberg C, et al. Prediction of the incidence and persistence allergic rhinitis in adolescence: a prospective cohort study. J Allergy Clin Immunol. 2012;129(2):397-402, 402.e1-3. https://doi.org/10.1016/j.jaci.2011.08.016. Lodrup Carlsen KC, Roll S, Carlsen KH, et al. Does pet ownership in infancy lead to asthma or allergy at school age? Pooled analysis of individual participant data from 11 European birth cohorts. PLoS One. 2012;7(8):e43214. https://doi.org/10.1371/journal.pone.0043214. Chen CM, Morgenstern V, Bischof W, et al. Dog ownership and contact during childhood and later allergy development. Eur Respir J. 2008;31(5):963-973. https://doi.org/10.1183/09031936.00092807. Chen CM, Rzehak P, Zutavern A, et al. Longitudinal study on cat allergen exposure and the development of allergy in young children. J Allergy Clin Immunol. 2007;119(5):1148-1155. https://doi.org/10.1016/j.jaci.2007.02.017. Tischer CG, Hohmann C, Thiering E, et al. Meta-analysis of mould and dampness exposure on asthma and allergy in eight European birth cohorts: an ENRIECO initiative. Allergy. 2011;66(12):1570-1579. https://doi.org/10.1111/j.1398-9995.2011.02712.x. Behbod B, Sordillo JE, Hoffman EB, et al. Asthma and allergy development: contrasting influences of yeasts and other fungal exposures. Clin Exp Allergy. 2015;45(1):154-163. https://doi.org/10.1111/cea.12401. Ellie AS, Sun Y, Hou J, Wang P, Zhang Q, Sundell J. Prevalence of childhood asthma and allergies and their associations with perinatal exposure to home environmental factors: a cross-sectional study in Tianjin, China. Int J Environ Res Public Health. 2021;18(8):4131. https://doi.org/10.3390/ijerph18084131. Caillaud D, Leynaert B, Keirsbulck M, Nadif R, Anses Working Group - mould. Indoor mould exposure, asthma and rhinitis: findings from systematic reviews and recent longitudinal studies. Eur Respir Rev. 2018;27(148):170137. https://doi.org/10.1183/16000617.0137-2017. Nevalainen A, Taubel M, Hyvarinen A. Indoor fungi: companions and contaminants. Indoor Air. 2015;25(2):125-156. https://doi.org/10.1111/ina.12182. Deng Q, Lu C, Ou C, Chen L, Yuan H. Preconceptional, prenatal and postnatal exposure to outdoor and indoor environmental factors on allergic diseases/symptoms in preschool children. Chemosphere. 2016;152:459-467. https://doi.org/10.1016/j.chemosphere.2016.03.032. Lin Z, Norback D, Wang T, et al. The first 2-year home environment in relation to the new onset and remission of asthmatic and allergic symptoms in 4246 preschool children. Sci Total Environ. 2016;553:204-210. https://doi.org/10.1016/j.scitotenv.2016.02.040. Kuyucu S, Saraclar Y, Tuncer A, et al. Epidemiologic characteristics of rhinitis in Turkish children: the International Study of Asthma and Allergies in Childhood (ISAAC) phase 2. Pediatr Allergy Immunol. 2006;17(4):269-277. https://doi.org/10.1111/j.1399-3038.2006.00407.x. Bornehag CG, Sundell J, Hagerhed-Engman L, et al. 'Dampness' at home and its association with airway, nose, and skin symptoms among 10,851 preschool children in Sweden: a cross-sectional study. Indoor Air. 2005;15(suppl 10):48-55. https://doi.org/10.1111/j.1600-0668.2005.00306.x. Thacher JD, Gruzieva O, Pershagen G, et al. Mold and dampness exposure and allergic outcomes from birth to adolescence: data from the BAMSE cohort. Allergy. 2017;72(6):967-974. https://doi.org/10.1111/all.13102. Biagini JM, LeMasters GK, Ryan PH, et al. Environmental risk factors of rhinitis in early infancy. Pediatr Allergy Immunol. 2006;17(4):278-84. https://doi.org/10.1111/j.1399-3038.2006.00386.x. Testa D, DI Bari M, Nunziata M, et al. Allergic rhinitis and asthma assessment of risk factors in pediatric patients: a systematic review. Int J Pediatr Otorhinolaryngol. 2020;129:109759. https://doi.org/10.1016/j.ijporl.2019.109759. Hardjojo A, Shek LP, van Bever HP, Lee BW. Rhinitis in children less than 6 years of age: current knowledge and challenges. Asia Pac Allergy. 2011;1(3):115-122. https://doi.org/10.5415/apallergy.2011.1.3.115. Ierodiakonou D, Garcia-Larsen V, Logan A, et al. Timing of allergenic food introduction to the infant diet and risk of allergic or autoimmune disease: a systematic review and meta-analysis. JAMA. 2016;316(11):1181-1192. https://doi.org/10.1001/jama.2016.12623. du Toit G, Sayre PH, Roberts G, et al. Allergen specificity of early peanut consumption and effect on development of allergic disease in the Learning Early About Peanut Allergy study cohort. J Allergy Clin Immunol. 2018;141(4):1343-1353. https://doi.org/10.1016/j.jaci.2017.09.034. Fong WCG, Chan A, Zhang H, et al. Childhood food allergy and food allergen sensitisation are associated with adult airways disease: a birth cohort study. Pediatr Allergy Immunol. 2021;32(8):1764-1772. https://doi.org/10.1111/pai.13592. Erkkola M, Kaila M, Nwaru BI, et al. Maternal vitamin D intake during pregnancy is inversely associated with asthma and allergic rhinitis in 5-year-old children. Clin Exp Allergy. 2009;39(6):875-82. https://doi.org/10.1111/j.1365-2222.2009.03234.x. Oien T, Schjelvaag A, Storro O, Johnsen R, Simpson MR. Fish Consumption at one year of age reduces the risk of eczema, asthma and wheeze at six years of age. Nutrients. 2019;11(9):1969. https://doi.org/10.3390/nu11091969. Markevych I, Standl M, Lehmann I, von Berg A, Heinrich J. Food diversity during the first year of life and allergic diseases until 15 years. J Allergy Clin Immunol. 2017;140(6):1751-1754.e4. https://doi.org/10.1016/j.jaci.2017.08.011. Maslova E, Granstrom C, Hansen S, et al. Peanut and tree nut consumption during pregnancy and allergic disease in children-should mothers decrease their intake? Longitudinal evidence from the Danish National Birth Cohort. J Allergy Clin Immunol. 2012;130(3):724-732. https://doi.org/10.1016/j.jaci.2012.05.014. Maslova E, Strom M, Oken E, et al. Fish intake during pregnancy and the risk of child asthma and allergic rhinitis - longitudinal evidence from the Danish National Birth Cohort. Br J Nutr. 2013;110(7):1313-1325. https://doi.org/10.1017/S000711451300038X. Willers SM, Wijga AH, Brunekreef B, et al. Maternal food consumption during pregnancy and the longitudinal development of childhood asthma. Am J Respir Crit Care Med. 2008;178(2):124-131. https://doi.org/10.1164/rccm.200710-1544OC. Nwaru BI, Takkinen HM, Kaila M, et al. Food diversity in infancy and the risk of childhood asthma and allergies. J Allergy Clin Immunol. 2014;133(4):1084-1091. https://doi.org/10.1016/j.jaci.2013.12.1069. Roduit C, Frei R, Depner M, et al. Increased food diversity in the first year of life is inversely associated with allergic diseases. J Allergy Clin Immunol. 2014;133(4):1056-1064. https://doi.org/10.1016/j.jaci.2013.12.1044. Nwaru BI, Takkinen HM, Niemela O, et al. Timing of infant feeding in relation to childhood asthma and allergic diseases. J Allergy Clin Immunol. 2013;131(1):78-86. https://doi.org/10.1016/j.jaci.2012.10.028. Virtanen SM, Kaila M, Pekkanen J, et al. Early introduction of oats associated with decreased risk of persistent asthma and early introduction of fish with decreased risk of allergic rhinitis. Br J Nutr. 2010;103(2):266-273. https://doi.org/10.1017/S0007114509991541. Zeiger RS, Heller S. The development and prediction of atopy in high-risk children: follow-up at age seven years in a prospective randomized study of combined maternal and infant food allergen avoidance. J Allergy Clin Immunol. 1995;95(6):1179-1190. https://doi.org/10.1016/s0091-6749(95)70074-9. Lilja G, Dannaeus A, Foucard T, Graff-Lonnevig V, Johansson SG, Oman H. Effects of maternal diet during late pregnancy and lactation on the development of atopic diseases in infants up to 18 months of age - in-vivo results. Clin Exp Allergy. 1989;19(4):473-479. https://doi.org/10.1111/j.1365-2222.1989.tb02416.x. Falth-Magnusson K, Kjellman NI. Development of atopic disease in babies whose mothers were receiving exclusion diet during pregnancy - a randomized study. J Allergy Clin Immunol. 1987;80(6):868-875. https://doi.org/10.1016/s0091-6749(87)80279-8. Willers SM, Devereux G, Craig LC, et al. Maternal food consumption during pregnancy and asthma, respiratory and atopic symptoms in 5-year-old children. Thorax. 2007;62(9):773-779. https://doi.org/10.1136/thx.2006.074187. Alduraywish SA, Lodge CJ, Campbell B, et al. The march from early life food sensitization to allergic disease: a systematic review and meta-analyses of birth cohort studies. Allergy. 2016;71(1):77-89. https://doi.org/10.1111/all.12784. Brockow I, Zutavern A, Hoffmann U, et al. Early allergic sensitizations and their relevance to atopic diseases in children aged 6 years: results of the GINI study. J Investig Allergol Clin Immunol. 2009;19(3):180-187. Garden FL, Simpson JM, Marks GB, Investigators C. Atopy phenotypes in the Childhood Asthma Prevention Study (CAPS) cohort and the relationship with allergic disease: clinical mechanisms in allergic disease. Clin Exp Allergy. 2013;43(6):633-641. https://doi.org/10.1111/cea.12095. Kulig M, Bergmann R, Tacke U, Wahn U, Guggenmoos-Holzmann I. Long-lasting sensitization to food during the first two years precedes allergic airway disease. The MAS Study Group, Germany. Pediatr Allergy Immunol. 1998;9(2):61-67. https://doi.org/10.1111/j.1399-3038.1998.tb00305.x. Chiu CY, Huang YL, Tsai MH, et al. Sensitization to food and inhalant allergens in relation to atopic diseases in early childhood: a birth cohort study. PLoS One. 2014;9(7):e102809. https://doi.org/10.1371/journal.pone.0102809. Kjaer HF, Eller E, Andersen KE, Host A, Bindslev-Jensen C. The association between early sensitization patterns and subsequent allergic disease. The DARC birth cohort study. Pediatr Allergy Immunol. 2009;20(8):726-734. https://doi.org/10.1111/j.1399-3038.2009.00862.x. Zutavern A, Brockow I, Schaaf B, et al. Timing of solid food introduction in relation to eczema, asthma, allergic rhinitis, and food and inhalant sensitization at the age of 6 years: results from the prospective birth cohort study LISA. Pediatrics. 2008;121(1):e44-e52. https://doi.org/10.1542/peds.2006-3553. Ekelund L, Gloppen I, Oien T, Simpson MR. Duration of breastfeeding, age at introduction of complementary foods and allergy-related diseases: a prospective cohort study. Int Breastfeed J. 2021;16(1):5. https://doi.org/10.1186/s13006-020-00352-2. Venter C, Agostoni C, Arshad SH, et al. Dietary factors during pregnancy and atopic outcomes in childhood: a systematic review from the European Academy of Allergy and Clinical Immunology. Pediatr Allergy Immunol. 2020;31(8):889-912. https://doi.org/10.1111/pai.13303. Fleischer DM, Spergel JM, Assa'ad AH, Pongracic JA. Primary prevention of allergic disease through nutritional interventions. J Allergy Clin Immunol Pract. 2013;1(1):29-36. https://doi.org/10.1016/j.jaip.2012.09.003. Greer FR, Sicherer SH, Burks AW, American Academy of Pediatrics Committee on Nutrition, American Academy of Pediatrics Section on Allergy and Immunology. Effects of early nutritional interventions on the development of atopic disease in infants and children: the role of maternal dietary restriction, breastfeeding, timing of introduction of complementary foods, and hydrolyzed formulas. Pediatrics. 2008;121(1):183-191. https://doi.org/10.1542/peds.2007-3022. Donovan S, Dewey K, Novotny R, et al. Maternal Diet during Pregnancy and Lactation and Risk of Child Food Allergies and Atopic Allergic Diseases: A Systematic Review [Internet]. Alexandria (VA): USDA Nutrition Evidence Systematic Review; 2020 Jul. https://doi.org/10.52570/NESR.DGAC2020.SR0207. Kramer MS, Kakuma R. Maternal dietary antigen avoidance during pregnancy or lactation, or both, for preventing or treating atopic disease in the child. Cochrane Database Syst Rev. 2012;(9):CD000133. https://doi.org/10.1002/14651858.CD000133.pub3. Air pollution. Accessed November 18, 2021. https://www.who.int/health-topics/air-pollution. Gorr MW, Falvo MJ, Wold LE. Air pollution and other environmental modulators of cardiac function. Compr Physiol. 2017;7(4):1479-1495. https://doi.org/10.1002/cphy.c170017. Li J, Sun S, Tang R, et al. Major air pollutants and risk of COPD exacerbations: a systematic review and meta-analysis. Int J Chron Obstruct Pulmon Dis. 2016;11:3079-3091. https://doi.org/10.2147/COPD.S122282. Carlsten C, Blomberg A, Pui M, et al. Diesel exhaust augments allergen-induced lower airway inflammation in allergic individuals: a controlled human exposure study. Thorax. 2016;71(1):35-44. https://doi.org/10.1136/thoraxjnl-2015-207399. Hernandez M, Brickey WJ, Alexis NE, et al. Airway cells from atopic asthmatic patients exposed to ozone display an enhanced innate immune gene profile. J Allergy Clin Immunol. 2012;129(1):259-261.e1-2. https://doi.org/10.1016/j.jaci.2011.11.007. Anderson HR, Ruggles R, Pandey KD, et al. Ambient particulate pollution and the world-wide prevalence of asthma, rhinoconjunctivitis and eczema in children: phase one of the International Study of Asthma and Allergies in Childhood (ISAAC). Occup Environ Med. 2010;67(5):293-300. https://doi.org/10.1136/oem.2009.048785. Chiang TY, Yuan TH, Shie RH, Chen CF, Chan CC. Increased incidence of allergic rhinitis, bronchitis and asthma, in children living near a petrochemical complex with SO2 pollution. Environ Int. 2016;96:1-7. https://doi.org/10.1016/j.envint.2016.08.009. Singh S, Sharma BB, Salvi S, et al. Allergic rhinitis, rhinoconjunctivitis, and eczema: prevalence and associated factors in children. Clin Respir J. 2018;12(2):547-556. https://doi.org/10.1111/crj.12561. Jung DY, Leem JH, Kim HC, et al. Effect of traffic-related air pollution on allergic disease: results of the children's health and environmental research. Allergy Asthma Immunol Res. 2015;7(4):359-366. https://doi.org/10.4168/aair.2015.7.4.359. Shirinde J, Wichmann J, Voyi K. Allergic rhinitis, rhinoconjunctivitis and hayfever symptoms among children are associated with frequency of truck traffic near residences: a cross sectional study. Environ Health. 2015;14:84. https://doi.org/10.1186/s12940-015-0072-1. Kim BJ, Kwon JW, Seo JH, et al. Association of ozone exposure with asthma, allergic rhinitis, and allergic sensitization. Ann Allergy Asthma Immunol. 2011;107(3):214-219.e1. https://doi.org/10.1016/j.anai.2011.05.025. Codispoti CD, LeMasters GK, Levin L, et al. Traffic pollution is associated with early childhood aeroallergen sensitization. Ann Allergy Asthma Immunol. 2015;114(2):126-133. https://doi.org/10.1016/j.anai.2014.10.020. Gehring U, Wijga AH, Hoek G, et al. Exposure to air pollution and development of asthma and rhinoconjunctivitis throughout childhood and adolescence: a population-based birth cohort study. Lancet Respir Med. 2015;3(12):933-942. https://doi.org/10.1016/S2213-2600(15)00426-9. Li S, Wu W, Wang G, et al. Association between exposure to air pollution and risk of allergic rhinitis: a systematic review and meta-analysis. Environ Res. 2022;205:112472. https://doi.org/10.1016/j.envres.2021.112472. Burte E, Leynaert B, Marcon A, et al. Long-term air pollution exposure is associated with increased severity of rhinitis in 2 European cohorts. J Allergy Clin Immunol. 2020;145(3):834-842.e6. https://doi.org/10.1016/j.jaci.2019.11.040. Teng B, Zhang X, Yi C, et al. The association between ambient air pollution and allergic rhinitis: further epidemiological evidence from Changchun, Northeastern China. Int J Environ Res Public Health. 2017;14(3):226. https://doi.org/10.3390/ijerph14030226. To T, Zhu J, Stieb D, et al. Early life exposure to air pollution and incidence of childhood asthma, allergic rhinitis and eczema. Eur Respir J. 2020;55(2):1900913. https://doi.org/10.1183/13993003.00913-2019. Zou QY, Shen Y, Ke X, Hong SL, Kang HY. Exposure to air pollution and risk of prevalence of childhood allergic rhinitis: a meta-analysis. Int J Pediatr Otorhinolaryngol. 2018;112:82-90. https://doi.org/10.1016/j.ijporl.2018.06.039. Lin L, Li T, Sun M, et al. Effect of particulate matter exposure on the prevalence of allergic rhinitis in children: a systematic review and meta-analysis. Chemosphere. 2021;268:128841. https://doi.org/10.1016/j.chemosphere.2020.128841. Hao S, Yuan F, Pang P, Yang B, Jiang X, Yan A. Early childhood traffic-related air pollution and risk of allergic rhinitis at 2-4 years of age modification by family stress and male gender: a case-control study in Shenyang, China. Environ Health Prev Med. 2021;26(1):48. https://doi.org/10.1186/s12199-021-00969-7. Mookherjee N, Piyadasa H, Ryu MH, et al. Inhaled diesel exhaust alters the allergen-induced bronchial secretome in humans. Eur Respir J. 2018;51(1):1701385. https://doi.org/10.1183/13993003.01385-2017. Clifford RL, Jones MJ, MacIsaac JL, et al. Inhalation of diesel exhaust and allergen alters human bronchial epithelium DNA methylation. J Allergy Clin Immunol. 2017;139(1):112-121. https://doi.org/10.1016/j.jaci.2016.03.046. Wooding DJ, Ryu MH, Huls A, et al. Particle depletion does not remediate acute effects of traffic-related air pollution and allergen. A randomized, double-blind crossover study. Am J Respir Crit Care Med. 2019;200(5):565-574. https://doi.org/10.1164/rccm.201809-1657OC. Ellis AK, Murrieta-Aguttes M, Furey S, Picard P, Carlsten C. Effect of fexofenadine hydrochloride on allergic rhinitis aggravated by air pollutants. ERJ Open Res. 2021;7(2):00806-2020. https://doi.org/10.1183/23120541.00806-2020. Bousquet J, Anto JM, Annesi-Maesano I, et al. POLLAR: Impact of air POLLution on Asthma and Rhinitis; a European Institute of Innovation and Technology Health (EIT Health) project. Clin Transl Allergy. 2018;8:36. https://doi.org/10.1186/s13601-018-0221-z. Naclerio R, Ansotegui IJ, Bousquet J, et al. International expert consensus on the management of allergic rhinitis (AR) aggravated by air pollutants: impact of air pollution on patients with AR: current knowledge and future strategies. World Allergy Organ J. 2020;13(3):100106. https://doi.org/10.1016/j.waojou.2020.100106. Chung HY, Hsieh CJ, Tseng CC, Yiin LM. Association between the first occurrence of allergic rhinitis in preschool children and air pollution in Taiwan. Int J Environ Res Public Health. 2016;13(3):268. https://doi.org/10.3390/ijerph13030268. Liu W, Huang C, Hu Y, et al. Associations of gestational and early life exposures to ambient air pollution with childhood respiratory diseases in Shanghai, China: a retrospective cohort study. Environ Int. 2016;92-93:284-293. https://doi.org/10.1016/j.envint.2016.04.019. Wang IJ, Tung TH, Tang CS, Zhao ZH. Allergens, air pollutants, and childhood allergic diseases. Int J Hyg Environ Health. 2016;219(1):66-71. https://doi.org/10.1016/j.ijheh.2015.09.001. Kim HH, Lee CS, Yu SD, et al. Near-road exposure and impact of air pollution on allergic diseases in elementary school children: a cross-sectional study. Yonsei Med J. 2016;57(3):698-713. https://doi.org/10.3349/ymj.2016.57.3.698. Hur K, Liang J, Lin SY. The role of secondhand smoke in sinusitis: a systematic review. Int Forum Allergy Rhinol. 2014;4(1):22-28. https://doi.org/10.1002/alr.21232. Saulyte J, Regueira C, Montes-Martinez A, Khudyakov P, Takkouche B. Active or passive exposure to tobacco smoking and allergic rhinitis, allergic dermatitis, and food allergy in adults and children: a systematic review and meta-analysis. PLoS Med. 2014;11(3):e1001611. https://doi.org/10.1371/journal.pmed.1001611. Keil T, Lau S, Roll S, et al. Maternal smoking increases risk of allergic sensitization and wheezing only in children with allergic predisposition: longitudinal analysis from birth to 10 years. Allergy. 2009;64(3):445-451. https://doi.org/10.1111/j.1398-9995.2008.01867.x. Lin SY, Reh DD, Clipp S, Irani L, Navas-Acien A. Allergic rhinitis and secondhand tobacco smoke: a population-based study. Am J Rhinol Allergy. 2011;25(2):e66-e71. https://doi.org/10.2500/ajra.2011.25.3580. Bendtsen P, Gronbaek M, Kjaer SK, Munk C, Linneberg A, Tolstrup JS. Alcohol consumption and the risk of self-reported perennial and seasonal allergic rhinitis in young adult women in a population-based cohort study. Clin Exp Allergy. 2008;38(7):1179-1185. https://doi.org/10.1111/j.1365-2222.2008.02945.x. Gangl K, Reininger R, Bernhard D, et al. Cigarette smoke facilitates allergen penetration across respiratory epithelium. Allergy. 2009;64(3):398-405. https://doi.org/10.1111/j.1398-9995.2008.01861.x. Ueha R, Ueha S, Kondo K, Nishijima H, Yamasoba T. Effects of cigarette smoke on the nasal respiratory and olfactory mucosa in allergic rhinitis mice. Front Neurosci. 2020;14:126. https://doi.org/10.3389/fnins.2020.00126. Mishra NC, Rir-Sima-Ah J, Langley RJ, et al. Nicotine primarily suppresses lung Th2 but not goblet cell and muscle cell responses to allergens. J Immunol. 2008;180(11):7655-7663. https://doi.org/10.4049/jimmunol.180.11.7655. Skaaby T, Taylor AE, Jacobsen RK, et al. Investigating the causal effect of smoking on hay fever and asthma: a Mendelian randomization meta-analysis in the CARTA consortium. Sci Rep. 2017;7(1):2224. https://doi.org/10.1038/s41598-017-01977-w. Zhou Y, Chen J, Dong Y, et al. Maternal tobacco exposure during pregnancy and allergic rhinitis in offspring: a systematic review and meta-analysis. Medicine (Baltimore). 2021;100(34):e26986. https://doi.org/10.1097/MD.0000000000026986. Thacher JD, Gehring U, Gruzieva O, et al. Maternal smoking during pregnancy and early childhood and development of asthma and rhinoconjunctivitis - a MeDALL Project. Environ Health Perspect. 2018;126(4):047005. https://doi.org/10.1289/EHP2738. Ciprandi G, Silvestri M, Pistorio A, Tosca MA, Cirillo I. Clustering analysis in outpatients with allergic rhinitis in clinical practice. Allergy. 2019;74(3):607-610. https://doi.org/10.1111/all.13645. Chung SJ, Kim BK, Oh JH, et al. Novel tobacco products including electronic cigarette and heated tobacco products increase risk of allergic rhinitis and asthma in adolescents: analysis of Korean youth survey. Allergy. 2020;75(7):1640-1648. https://doi.org/10.1111/all.14212. Waite KJ. Blackley and the development of hay fever as a disease of civilization in the nineteenth century. Med Hist. 1995;39(2):186-196. https://doi.org/10.1017/s0025727300059834. Strachan DP. Family size, infection and atopy: the first decade of the “hygiene hypothesis”. Thorax. 2000;55(suppl 1):S2-S10. https://doi.org/10.1136/thorax.55.suppl_1.s2. Wee JH, Park MW, Min C, Park IS, Park B, Choi HG. The association between high hygiene scores and allergic rhinitis in Korean adolescents. Int Forum Allergy Rhinol. 2020;10(8):1024-1030. https://doi.org/10.1002/alr.22569. Chen JT, Krieger N, Van Den Eeden SK, Quesenberry CP. Different slopes for different folks: socioeconomic and racial/ethnic disparities in asthma and hay fever among 173,859 U.S. men and women. Environ Health Perspect. 2002;110(Suppl 2):211-216. https://doi.org/10.1289/ehp.02110s2211. Li F, Zhou Y, Li S, et al. Prevalence and risk factors of childhood allergic diseases in eight metropolitan cities in China: a multicenter study. BMC Public Health. 2011;11:437. https://doi.org/10.1186/1471-2458-11-437. Hammer-Helmich L, Linneberg A, Thomsen SF, Glumer C. Association between parental socioeconomic position and prevalence of asthma, atopic eczema and hay fever in children. Scand J Public Health. 2014;42(2):120-127. https://doi.org/10.1177/1403494813505727. Mercer MJ, Joubert G, Ehrlich RI, et al. Socioeconomic status and prevalence of allergic rhinitis and atopic eczema symptoms in young adolescents. Pediatr Allergy Immunol. 2004;15(3):234-241. https://doi.org/10.1111/j.1399-3038.2004.00125.x. Talay F, Kurt B, Tug T, Kurt OK, Goksugur N, Yasar Z. The prevalence of asthma and allergic diseases among adults 30-49 years of age in Bolu, Western Black Sea Region of Turkey. Clin Ter. 2014;165(1):e59-e63. https://doi.org/10.7471/CT.2014.1673. Lewis SA, Weiss ST, Platts-Mills TA, Syring M, Gold DR. Association of specific allergen sensitization with socioeconomic factors and allergic disease in a population of Boston women. J Allergy Clin Immunol. 2001;107(4):615-622. https://doi.org/10.1067/mai.2001.113523. Almqvist C, Pershagen G, Wickman M. Low socioeconomic status as a risk factor for asthma, rhinitis and sensitization at 4 years in a birth cohort. Clin Exp Allergy. 2005;35(5):612-618. https://doi.org/10.1111/j.1365-2222.2005.02243.x. Lee KS, Rha YH, Oh IH, Choi YS, Choi SH. Socioeconomic and sociodemographic factors related to allergic diseases in Korean adolescents based on the Seventh Korea Youth Risk Behavior Web-based Survey: a cross-sectional study. BMC Pediatr. 2016;16:19. https://doi.org/10.1186/s12887-016-0549-2. Braback L, Hjern A, Rasmussen F. Social class in asthma and allergic rhinitis: a national cohort study over three decades. Eur Respir J. 2005;26(6):1064-1068. https://doi.org/10.1183/09031936.05.00022105. Penaranda A, Garcia E, Barragan AM, et al. Factors associated with allergic rhinitis in Colombian subpopulations aged 1 to 17 and 18 to 59. Rhinology. 2016;54(1):56-67. https://doi.org/10.4193/Rhino14.234. Bergmann RL, Edenharter G, Bergmann KE, Lau S, Wahn U. Socioeconomic status is a risk factor for allergy in parents but not in their children. Clin Exp Allergy. 2000;30(12):1740-1745. https://doi.org/10.1046/j.1365-2222.2000.00927.x. Lewis SA, Britton JR. Consistent effects of high socioeconomic status and low birth order, and the modifying effect of maternal smoking on the risk of allergic disease during childhood. Respir Med. 1998;92(10):1237-1244. https://doi.org/10.1016/s0954-6111(98)90427-9. Goh DY, Chew FT, Quek SC, Lee BW. Prevalence and severity of asthma, rhinitis, and eczema in Singapore schoolchildren. Arch Dis Child. 1996;74(2):131-135. https://doi.org/10.1136/adc.74.2.131. Bion V, Lockett GA, Soto-Ramirez N, et al. Evaluating the efficacy of breastfeeding guidelines on long-term outcomes for allergic disease. Allergy. 2016;71(5):661-670. https://doi.org/10.1111/all.12833. Muraro A, Halken S, Arshad SH, et al. EAACI food allergy and anaphylaxis guidelines. Primary prevention of food allergy. Allergy. 2014;69(5):590-601. https://doi.org/10.1111/all.12398. Hoppu U, Kalliomaki M, Laiho K, Isolauri E. Breast milk - immunomodulatory signals against allergic diseases. Allergy. 2001;56(suppl 67):23-26. https://doi.org/10.1034/j.1398-9995.2001.00908.x. Friedman NJ, Zeiger RS. The role of breast-feeding in the development of allergies and asthma. J Allergy Clin Immunol. 2005;115(6):1238-1248. https://doi.org/10.1016/j.jaci.2005.01.069. Hoang MP, Samuthpongtorn J, Seresirikachorn K, Snidvongs K. Prolonged breastfeeding and protective effects against the development of allergic rhinitis: a systematic review and meta-analysis. Rhinology. 2022;60(2):82-91. https://doi.org/10.4193/Rhin21.274. Gungor D, Nadaud P, LaPergola CC, et al. Infant milk-feeding practices and food allergies, allergic rhinitis, atopic dermatitis, and asthma throughout the life span: a systematic review. Am J Clin Nutr. 2019;109(suppl_7):772S-799S. https://doi.org/10.1093/ajcn/nqy283. Codispoti CD, Levin L, LeMasters GK, et al. Breast-feeding, aeroallergen sensitization, and environmental exposures during infancy are determinants of childhood allergic rhinitis. J Allergy Clin Immunol. 2010;125(5):1054-1060.e1. https://doi.org/10.1016/j.jaci.2010.02.004. Huang C, Liu W, Cai J, et al. Breastfeeding and timing of first dietary introduction in relation to childhood asthma, allergies, and airway diseases: a cross-sectional study. J Asthma. 2017;54(5):488-497. https://doi.org/10.1080/02770903.2016.1231203. Han DH, Shin JM, An S, et al. Long-term breastfeeding in the prevention of allergic rhinitis: Allergic Rhinitis Cohort Study for Kids (ARCO-Kids Study). Clin Exp Otorhinolaryngol. 2019;12(3):301-307. https://doi.org/10.21053/ceo.2018.01781. Ek WE, Karlsson T, Hernandes CA, Rask-Andersen M, Johansson A. Breast-feeding and risk of asthma, hay fever, and eczema. J Allergy Clin Immunol. 2018;141(3):1157-1159.e9. https://doi.org/10.1016/j.jaci.2017.10.022. Heinrich J. Modulation of allergy risk by breast feeding. Curr Opin Clin Nutr Metab Care. 2017;20(3):217-221. https://doi.org/10.1097/MCO.0000000000000366. Nuzzi G, Di Cicco ME, Peroni DG. Breastfeeding and allergic diseases: what's new? Children (Basel). 2021;8(5):330. https://doi.org/10.3390/children8050330. Lodge CJ, Tan DJ, Lau MX, et al. Breastfeeding and asthma and allergies: a systematic review and meta-analysis. Acta Paediatr. 2015;104(467):38-53. https://doi.org/10.1111/apa.13132. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol. 2010;126(3):466-476. https://doi.org/10.1016/j.jaci.2010.06.047. Seidman MD, Gurgel RK, Lin SY, et al. Clinical practice guideline: allergic rhinitis. Otolaryngol Head Neck Surg. 2015;152(1 suppl):S1-S43. https://doi.org/10.1177/0194599814561600. Lodge CJ, Lowe AJ, Gurrin LC, et al. Pets at birth do not increase allergic disease in at-risk children. Clin Exp Allergy. 2012;42(9):1377-1385. https://doi.org/10.1111/j.1365-2222.2012.04032.x. Takkouche B, Gonzalez-Barcala FJ, Etminan M, Fitzgerald M. Exposure to furry pets and the risk of asthma and allergic rhinitis: a meta-analysis. Allergy. 2008;63(7):857-864. https://doi.org/10.1111/j.1398-9995.2008.01732.x. Lodge CJ, Allen KJ, Lowe AJ, et al. Perinatal cat and dog exposure and the risk of asthma and allergy in the urban environment: a systematic review of longitudinal studies. Clin Dev Immunol. 2012;2012:176484. https://doi.org/10.1155/2012/176484. Luo S, Sun Y, Hou J, et al. Pet keeping in childhood and asthma and allergy among children in Tianjin area, China. PLoS One. 2018;13(5):e0197274. https://doi.org/10.1371/journal.pone.0197274. Chen CM, Heinrich J. Re: exposure to furry pets and the risk of asthma and allergic rhinitis: a meta-analysis. Allergy. 2009;64(3):494-495. https://doi.org/10.1111/j.1398-9995.2008.01930.x. Holt PG, Sly PD. Non-atopic intrinsic asthma and the ‘family tree’ of chronic respiratory disease syndromes. Clin Exp Allergy. 2009;39(6):807-811. https://doi.org/10.1111/j.1365-2222.2009.03258.x. Dharmage SC, Lodge CL, Matheson MC, Campbell B, Lowe AJ. Exposure to cats: update on risks for sensitization and allergic diseases. Curr Allergy Asthma Rep. 2012;12(5):413-423. https://doi.org/10.1007/s11882-012-0288-x. Strachan DP. Hay fever, hygiene, and household size. BMJ. 1989;299(6710):1259-1260. https://doi.org/10.1136/bmj.299.6710.1259. von Hertzen L, Hanski I, Haahtela T. Natural immunity. Biodiversity loss and inflammatory diseases are two global megatrends that might be related. EMBO Rep. 2011;12(11):1089-1093. https://doi.org/10.1038/embor.2011.195. Karmaus W, Botezan C. Does a higher number of siblings protect against the development of allergy and asthma? A review. J Epidemiol Community Health. 2002;56(3):209-217. https://doi.org/10.1136/jech.56.3.209. Strachan DP, Ait-Khaled N, Foliaki S, et al. Siblings, asthma, rhinoconjunctivitis and eczema: a worldwide perspective from the International Study of Asthma and Allergies in Childhood. Clin Exp Allergy. 2015;45(1):126-136. https://doi.org/10.1111/cea.12349. Campbell BE, Lodge CJ, Lowe AJ, Burgess JA, Matheson MC, Dharmage SC. Exposure to ‘farming’ and objective markers of atopy: a systematic review and meta-analysis. Clin Exp Allergy. 2015;45(4):744-757. https://doi.org/10.1111/cea.12429. House JS, Wyss AB, Hoppin JA, et al. Early-life farm exposures and adult asthma and atopy in the Agricultural Lung Health Study. J Allergy Clin Immunol. 2017;140(1):249-256.e14. https://doi.org/10.1016/j.jaci.2016.09.036. Riedler J, Eder W, Oberfeld G, Schreuer M. Austrian children living on a farm have less hay fever, asthma and allergic sensitization. Clin Exp Allergy. 2000;30(2):194-200. https://doi.org/10.1046/j.1365-2222.2000.00799.x. Von Ehrenstein OS, Von Mutius E, Illi S, Baumann L, Bohm O, von Kries R. Reduced risk of hay fever and asthma among children of farmers. Clin Exp Allergy. 2000;30(2):187-193. https://doi.org/10.1046/j.1365-2222.2000.00801.x. Riedler J, Braun-Fahrlander C, Eder W, et al. Exposure to farming in early life and development of asthma and allergy: a cross-sectional survey. Lancet. 2001;358(9288):1129-1133. https://doi.org/10.1016/S0140-6736(01)06252-3. Barnes M, Cullinan P, Athanasaki P, et al. Crete: does farming explain urban and rural differences in atopy? Clin Exp Allergy. 2001;31(12):1822-1828. https://doi.org/10.1046/j.1365-2222.2001.01240.x. Downs SH, Marks GB, Mitakakis TZ, Leuppi JD, Car NG, Peat JK. Having lived on a farm and protection against allergic diseases in Australia. Clin Exp Allergy. 2001;31(4):570-575. https://doi.org/10.1046/j.1365-2222.2001.01070.x. Wickens K, Lane JM, Fitzharris P, et al. Farm residence and exposures and the risk of allergic diseases in New Zealand children. Allergy. 2002;57(12):1171-1179. https://doi.org/10.1034/j.1398-9995.2002.t01-1-23644.x. Remes ST, Pekkanen J, Soininen L, Kajosaari M, Husman T, Koivikko A. Does heredity modify the association between farming and allergy in children? Acta Paediatr. 2002;91(11):1163-1169. https://doi.org/10.1111/j.1651-2227.2002.tb00122.x. Remes ST, Iivanainen K, Koskela H, Pekkanen J. Which factors explain the lower prevalence of atopy amongst farmers' children? Clin Exp Allergy. 2003;33(4):427-434. https://doi.org/10.1046/j.1365-2222.2003.01566.x. Martinez FD, Holt PG. Role of microbial burden in aetiology of allergy and asthma. Lancet. 1999;354(suppl 2):SII12-SII15. https://doi.org/10.1016/s0140-6736(99)90437-3. Simpson A, Martinez FD. The role of lipopolysaccharide in the development of atopy in humans. Clin Exp Allergy. 2010;40(2):209-223. https://doi.org/10.1111/j.1365-2222.2009.03391.x. Tischer C, Gehring U, Chen CM, et al. Respiratory health in children, and indoor exposure to (1,3)-beta-D-glucan, EPS mould components and endotoxin. Eur Respir J. 2011;37(5):1050-1059. https://doi.org/10.1183/09031936.00091210. Arrieta MC, Stiemsma LT, Dimitriu PA, et al. Early infancy microbial and metabolic alterations affect risk of childhood asthma. Sci Transl Med. 2015;7(307):307ra152. https://doi.org/10.1126/scitranslmed.aab2271. Hanski I, von Hertzen L, Fyhrquist N, et al. Environmental biodiversity, human microbiota, and allergy are interrelated. Proc Natl Acad Sci U S A. 2012;109(21):8334-8339. https://doi.org/10.1073/pnas.1205624109. Fyhrquist N, Ruokolainen L, Suomalainen A, et al. Acinetobacter species in the skin microbiota protect against allergic sensitization and inflammation. J Allergy Clin Immunol. 2014;134(6):1301-1309. e11. https://doi.org/10.1016/j.jaci.2014.07.059. Stsepetova J, Sepp E, Julge K, Vaughan E, Mikelsaar M, de Vos WM. Molecularly assessed shifts of Bifidobacterium ssp. and less diverse microbial communities are characteristic of 5-year-old allergic children. FEMS Immunol Med Microbiol. 2007;51(2):260-269. https://doi.org/10.1111/j.1574-695X.2007.00306.x. Cuello-Garcia CA, Brozek JL, Fiocchi A, et al. Probiotics for the prevention of allergy: a systematic review and meta-analysis of randomized controlled trials. J Allergy Clin Immunol. 2015;136(4):952-961. https://doi.org/10.1016/j.jaci.2015.04.031. Holster IL, Vila AM, Caudri D, et al. The impact of Helicobacter pylori on atopic disorders in childhood. Helicobacter. 2012;17(3):232-237. https://doi.org/10.1111/j.1523-5378.2012.00934.x. Akiner U, Yener HM, Gozen ED, Kuzu SB, Canakcioglu S. Helicobacter pylori in allergic and non-allergic rhinitis does play a protective or causative role? Eur Arch Otorhinolaryngol. 2020;277(1):141-145. https://doi.org/10.1007/s00405-019-05659-3. Lionetti E, Leonardi S, Lanzafame A, et al. Helicobacter pylori infection and atopic diseases: is there a relationship? A systematic review and meta-analysis. World J Gastroenterol. 2014;20(46):17635-17647. https://doi.org/10.3748/wjg.v20.i46.17635. Ruokolainen L, Paalanen L, Karkman A, et al. Significant disparities in allergy prevalence and microbiota between the young people in Finnish and Russian Karelia. Clin Exp Allergy. 2017;47(5):665-674. https://doi.org/10.1111/cea.12895. Valkonen M, Wouters IM, Taubel M, et al. Bacterial exposures and associations with atopy and asthma in children. PLoS One. 2015;10(6):e0131594. https://doi.org/10.1371/journal.pone.0131594. Ege MJ, Mayer M, Normand AC, et al. Exposure to environmental microorganisms and childhood asthma. N Engl J Med. 2011;364(8):701-709. https://doi.org/10.1056/NEJMoa1007302. von Hertzen L, Laatikainen T, Pitkanen T, et al. Microbial content of drinking water in Finnish and Russian Karelia - implications for atopy prevalence. Allergy. 2007;62(3):288-292. https://doi.org/10.1111/j.1398-9995.2006.01281.x. Chen R, Zheng D, Zhang Y, Sima G. Efficacy and safety of twice-daily olopatadine-mometasone combination nasal spray (GSP301) in the treatment of allergic rhinitis: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2022;279(4):1691-1699. https://doi.org/10.1007/s00405-021-07085-w. Zhang K, Li AR, Miglani A, Nguyen SA, Schlosser RJ. Effect of medical therapy in allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2022;36(2):269-280. https://doi.org/10.1177/19458924211041438. Li AR, Zhang K, Reddy PD, et al. Systematic review of measures of disease severity in rhinitis. Int Forum Allergy Rhinol. 2021;11(9):1367-1377. https://doi.org/10.1002/alr.22794. Calderon MA, Casale TB, Demoly P. Validation of Patient-reported outcomes for clinical trials in allergic rhinitis: a systematic review. J Allergy Clin Immunol Pract. 2019;7(5):1450-1461.e6. https://doi.org/10.1016/j.jaip.2019.01.015. Linneberg A, Dam Petersen K, Hahn-Pedersen J, Hammerby E, Serup-Hansen N, Boxall N. Burden of allergic respiratory disease: a systematic review. Clin Mol Allergy. 2016;14:12. https://doi.org/10.1186/s12948-016-0049-9. Hahn-Pedersen J, Boxall N, Maier W, Linneberg A, Serup-Hansen N. Systematic literature review assessing data on the burden of allergic rhinitis from a cost and quality of life perspective. Value Health. 2014;17(7):A602. https://doi.org/10.1016/j.jval.2014.08.2087. Juniper EF, Guyatt GH. Development and testing of a new measure of health status for clinical trials in rhinoconjunctivitis. Clin Exp Allergy. 1991;21(1):77-83. https://doi.org/10.1111/j.1365-2222.1991.tb00807.x. McHorney CA, Ware JE, Jr., Lu JF, Sherbourne CD. The MOS 36-item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups. Med Care. 1994;32(1):40-66. https://doi.org/10.1097/00005650-199401000-00004. Ware J, Jr., Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233. https://doi.org/10.1097/00005650-199603000-00003. Husain Q, Hoehle L, Phillips K, Caradonna DS, Gray ST, Sedaghat AR. The 22-Item Sinonasal Outcome Test as a tool for the assessment of quality of life and symptom control in allergic rhinitis. Am J Rhinol Allergy. 2020;34(2):209-216. https://doi.org/10.1177/1945892419884789. Passali FM, Passali GC, Passali D, Ciprandi G. Smell impairment in patients with allergic rhinitis. Int Forum Allergy Rhinol. 2021;11(6):1031-1032. https://doi.org/10.1002/alr.22786. Yamada T, Yamamoto H, Kubo S, et al. Efficacy of mometasone furoate nasal spray for nasal symptoms, quality of life, rhinitis-disturbed sleep, and nasal nitric oxide in patients with perennial allergic rhinitis. Allergy Asthma Proc. 2012;33(2):e9-e16. https://doi.org/10.2500/aap.2012.33.3509. Bousquet J, Zuberbier T, Canonica GW, Fokkens WJ, Gopalan G, Shekar T. Randomized controlled trial of desloratadine for persistent allergic rhinitis: correlations between symptom improvement and quality of life. Allergy Asthma Proc. 2013;34(3):274-282. https://doi.org/10.2500/aap.2013.34.3668. Holmberg K, Tonnel AB, Dreyfus I, et al. Desloratadine relieves nasal congestion and improves quality-of-life in persistent allergic rhinitis. Allergy. 2009;64(11):1663-1670. https://doi.org/10.1111/j.1398-9995.2009.02096.x. Walter Canonica G, Bousquet J, Van Hammee G, et al. Levocetirizine improves health-related quality of life and health status in persistent allergic rhinitis. Respir Med. 2006;100(10):1706-1715. https://doi.org/10.1016/j.rmed.2006.03.039. Bachert C, Bousquet J, Canonica GW, et al. Levocetirizine improves quality of life and reduces costs in long-term management of persistent allergic rhinitis. J Allergy Clin Immunol. 2004;114(4):838-844. https://doi.org/10.1016/j.jaci.2004.05.070. Pedregal-Mallo D, Pacheco E, Rodrigo JP, Llorente JL, Alvarez-Marcos C. Impact of immunotherapy on quality of life in patients with house dust mite allergic rhinitis. Allergy. 2020;75(7):1783-1785. https://doi.org/10.1111/all.14215. Hoiby AS, Strand V, Robinson DS, Sager A, Rak S. Efficacy, safety, and immunological effects of a 2-year immunotherapy with Depigoid birch pollen extract: a randomized, double-blind, placebo-controlled study. Clin Exp Allergy. 2010;40(7):1062-1070. https://doi.org/10.1111/j.1365-2222.2010.03521.x. Di Rienzo V, Pucci S, D'Alo S, et al. Effects of high-dose sublingual immunotherapy on quality of life in patients with cypress-induced rhinitis: a placebo-controlled study. Clin Exp Allergy Reviews. 2006;6(3):67-70. Colas C, Monzon S, Venturini M, Lezaun A. Double-blind, placebo-controlled study with a modified therapeutic vaccine of Salsola kali (Russian thistle) administered through use of a cluster schedule. J Allergy Clin Immunol. 2006;117(4):810-816. https://doi.org/10.1016/j.jaci.2005.11.039. Juel-Berg N, Darling P, Bolvig J, et al. Intranasal corticosteroids compared with oral antihistamines in allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2017;31(1):19-28. https://doi.org/10.2500/ajra.2016.30.4397. Tatar EC, Surenoglu UA, Ozdek A, Saylam G, Korkmaz H. The effect of combined medical treatment on quality of life in persistent allergic rhinitis. Indian J Otolaryngol Head Neck Surg. 2013;65(suppl 2):333-337. https://doi.org/10.1007/s12070-012-0486-9. Fasola S, Montalbano L, Ferrante G, et al. RAPP-children: a new tool for assessing quality of life in patients with asthma and rhinitis. Clin Exp Allergy. 2020;50(6):662-671. https://doi.org/10.1111/cea.13599. Bosnic-Anticevich S, Smith P, Abramson M, et al. Impact of allergic rhinitis on the day-to-day lives of children: insights from an Australian cross-sectional study. BMJ Open. 2020;10(11):e038870. https://doi.org/10.1136/bmjopen-2020-038870. Hwang TY, Kim SK, Kim SH, Kim M. A cross sectional survey on health-related quality of life among parents of children with allergic symptoms using the EQ-5D-5L. J Asthma. 2019;56(11):1239-1245. https://doi.org/10.1080/02770903.2019.1571086. Valls-Mateus M, Marino-Sanchez F, Ruiz-Echevarria K, et al. Nasal obstructive disorders impair health-related quality of life in adolescents with persistent allergic rhinitis: a real-life study. Pediatr Allergy Immunol. 2017;28(5):438-445. https://doi.org/10.1111/pai.12724. Sikorska-Szaflik H, Sozanska B. Quality of life in allergic rhinitis - children's and their parents' perspective in polish urban and rural population. Health Qual Life Outcomes. 2020;18(1):64. https://doi.org/10.1186/s12955-020-01315-1. Ravens-Sieberer U, Bullinger M. Assessing health-related quality of life in chronically ill children with the German KINDL: first psychometric and content analytical results. Qual Life Res. 1998;7(5):399-407. https://doi.org/10.1023/a:1008853819715. Juniper EF, Howland WC, Roberts NB, Thompson AK, King DR. Measuring quality of life in children with rhinoconjunctivitis. J Allergy Clin Immunol. 1998;101(2 pt 1):163-170. https://doi.org/10.1016/s0091-6749(98)70380-x. Segall N, Prenner B, Lumry W, Caracta CF, Tantry SK. Long-term safety and efficacy of olopatadine-mometasone combination nasal spray in patients with perennial allergic rhinitis. Allergy Asthma Proc. 2019;40(5):301-310. https://doi.org/10.2500/aap.2019.40.4233. Majani G, Baiardini I, Giardini A, et al. Health-related quality of life assessment in young adults with seasonal allergic rhinitis. Allergy. 2001;56(4):313-317. https://doi.org/10.1034/j.1398-9995.2001.00852.x. Aruthra R, Kumar M. To study the impact of allergic rhinitis on quality of life in a tertiary care hospital. Intern J Cur Res Rev. 2021;13(2):118-120. Zhu R, Wang J, Wu Y, et al. The Allergic Rhinitis Control Test Questionnaire is valuable in guiding step-down pharmacotherapy treatment of allergic rhinitis. J Allergy Clin Immunol Pract. 2019;7(1):272-278. https://doi.org/10.1016/j.jaip.2018.05.028. Bousquet J, Arnavielhe S, Bedbrook A, et al. The Allergic Rhinitis and its Impact on Asthma (ARIA) score of allergic rhinitis using mobile technology correlates with quality of life: The MASK study. Allergy. 2018;73(2):505-510. https://doi.org/10.1111/all.13307. Hoehle LP, Speth MM, Phillips KM, et al. Association between symptoms of allergic rhinitis with decreased general health-related quality of life. Am J Rhinol Allergy. 2017;31(4):235-239. https://doi.org/10.2500/ajra.2017.31.4444. Filanowicz M, Szynkiewicz E, Cegla B, Bartuzi Z. Analysis of the quality of life of patients with asthma and allergic rhinitis after immunotherapy. Postepy Dermatol Alergol. 2016;33(2):134-141. https://doi.org/10.5114/pdia.2015.48061. Jaruvongvanich V, Mongkolpathumrat P, Chantaphakul H, Klaewsongkram J. Extranasal symptoms of allergic rhinitis are difficult to treat and affect quality of life. Allergol Int. 2016;65(2):199-203. https://doi.org/10.1016/j.alit.2015.11.006. Song Y, Wang M, Xie J, et al. Prevalence of allergic rhinitis among elementary and middle school students in Changsha city and its impact on quality of life. J Laryngol Otol. 2015;129(11):1108-1114. https://doi.org/10.1017/S0022215115002492. Bousquet PJ, Demoly P, Devillier P, Mesbah K, Bousquet J. Impact of allergic rhinitis symptoms on quality of life in primary care. Int Arch Allergy Immunol. 2013;160(4):393-400. https://doi.org/10.1159/000342991. Katelaris CH, Sacks R, Theron PN. Allergic rhinoconjunctivitis in the Australian population: burden of disease and attitudes to intranasal corticosteroid treatment. Am J Rhinol Allergy. 2013;27(6):506-509. https://doi.org/10.2500/ajra.2013.27.3965. de la Hoz Caballer B, Rodriguez M, Fraj J, Cerecedo I, Antolin-Amerigo D, Colas C. Allergic rhinitis and its impact on work productivity in primary care practice and a comparison with other common diseases: the Cross-sectional study to evAluate work Productivity in allergic Rhinitis compared with other common dIseases (CAPRI) study. Am J Rhinol Allergy. 2012;26(5):390-394. https://doi.org/10.2500/ajra.2012.26.3799. Meltzer EO, Gross GN, Katial R, Storms WW. Allergic rhinitis substantially impacts patient quality of life: findings from the Nasal Allergy Survey Assessing Limitations. J Fam Pract. 2012;61(2 suppl):S5-S10. Stull DE, Schaefer M, Crespi S, Sandor DW. Relative strength of relationships of nasal congestion and ocular symptoms with sleep, mood and productivity. Curr Med Res Opin. 2009;25(7):1785-1792. https://doi.org/10.1185/03007990903021968. Witt CM, Reinhold T, Jena S, Brinkhaus B, Willich SN. Cost-effectiveness of acupuncture in women and men with allergic rhinitis: a randomized controlled study in usual care. Am J Epidemiol. 2009;169(5):562-571. https://doi.org/10.1093/aje/kwn370. Brinkhaus B, Witt CM, Jena S, Liecker B, Wegscheider K, Willich SN. Acupuncture in patients with allergic rhinitis: a pragmatic randomized trial. Ann Allergy Asthma Immunol. 2008;101(5):535-543. https://doi.org/10.1016/S1081-1206(10)60294-3. Petersen KD, Kronborg C, Gyrd-Hansen D, Dahl R, Larsen JN, Lowenstein H. Quality of life in rhinoconjunctivitis assessed with generic and disease-specific questionnaires. Allergy. 2008;63(3):284-291. https://doi.org/10.1111/j.1398-9995.2007.01583.x. Ciprandi G, Klersy C, Cirillo I, Marseglia GL. Quality of life in allergic rhinitis: relationship with clinical, immunological, and functional aspects. Clin Exp Allergy. 2007;37(10):1528-1535. https://doi.org/10.1111/j.1365-2222.2007.02809.x. Radcliffe MJ, Lewith GT, Turner RG, Prescott P, Church MK, Holgate ST. Enzyme potentiated desensitisation in treatment of seasonal allergic rhinitis: double blind randomised controlled study. BMJ. 2003;327(7409):251-254. https://doi.org/10.1136/bmj.327.7409.251. Gerth Van Wijk R, Terreehorst IT, Mulder PG, Garrelds IM, Blom HM, Popering S. Intranasal capsaicin is lacking therapeutic effect in perennial allergic rhinitis to house dust mite. A placebo-controlled study. Clin Exp Allergy. 2000;30(12):1792-1798. https://doi.org/10.1046/j.1365-2222.2000.00920.x. Leynaert B, Neukirch C, Liard R, Bousquet J, Neukirch F. Quality of life in allergic rhinitis and asthma. A population-based study of young adults. Am J Respir Crit Care Med. 2000;162(4 pt 1):1391-1396. https://doi.org/10.1164/ajrccm.162.4.9912033. Cuesta-Herranz J, Laguna JJ, Mielgo R, et al. Quality of life improvement with allergen immunotherapy treatment in patients with rhinoconjunctivitis in real life conditions. Results of an observational prospective study (ICARA). Eur Ann Allergy Clin Immunol. 2019;51(5). https://doi.org/10.23822/EurAnnACI.1764-1489.104. Gillman GS, Staltari GV, Chang YF, Mattos JL. A prospective study of outcomes of septoplasty with turbinate reductions in patients with allergic rhinitis. Otolaryngol Head Neck Surg. 2019;160(6):1118-1123. https://doi.org/10.1177/0194599819838761. Baiardini I, Fasola S, Montalbano L, et al. RHINASTHMA-Children: a new quality of life tool for patients with respiratory allergy. Pediatr Allergy Immunol. 2017;28(1):102-105. https://doi.org/10.1111/pai.12667. Novakova SM, Staevska MT, Novakova PI, et al. Quality of life improvement after a three-year course of sublingual immunotherapy in patients with house dust mite and grass pollen induced allergic rhinitis: results from real-life. Health Qual Life Outcomes. 2017;15(1):189. https://doi.org/10.1186/s12955-017-0764-z. Schwanke T, Carragee E, Bremberg M, Reisacher WR. Quality-of-life outcomes in patients who underwent subcutaneous immunotherapy and sublingual immunotherapy in a real-world clinical setting. Am J Rhinol Allergy. 2017;31(5):310-316. https://doi.org/10.2500/ajra.2017.31.4465. Bukstein D, Parikh R, Eid S, Ferro T, Morello JP. Beclomethasone Dipropionate Nasal Aerosol in Patients with Perennial Allergic Rhinitis (BALANCE) study: 6-month results. Allergy Asthma Proc. 2016;37(2):121-130. https://doi.org/10.2500/aap.2016.37.3939. Cingi C, Oghan F, Eskiizmir G, Yaz A, Ural A, Erdogmus N. Desloratadine-montelukast combination improves quality of life and decreases nasal obstruction in patients with perennial allergic rhinitis. Int Forum Allergy Rhinol. 2013;3(10):801-806. https://doi.org/10.1002/alr.21185. Demoly P, Bousquet PJ, Mesbah K, Bousquet J, Devillier P. Visual analogue scale in patients treated for allergic rhinitis: an observational prospective study in primary care: asthma and rhinitis. Clin Exp Allergy. 2013;43(8):881-888. https://doi.org/10.1111/cea.12121. Ciprandi G, Cadario G, Valle C, et al. Sublingual immunotherapy in polysensitized patients: effect on quality of life. J Investig Allergol Clin Immunol. 2010;20(4):274-279. Cadario G, Ciprandi G, Di Cara G, et al. Comparison between continuous or intermittent schedules of sublingual immunotherapy for house dust mites: effects on compliance, patients satisfaction, quality of life and safety. Int J Immunopathol Pharmacol. 2008;21(2):471-473. https://doi.org/10.1177/039463200802100229. Laforest L, Bousquet J, Neukirch F, et al. Influence of sociodemographic factors on quality of life during pollen season in seasonal allergic rhinitis patients. Ann Allergy Asthma Immunol. 2005;95(1):26-32. https://doi.org/10.1016/S1081-1206(10)61184-2. Zheng M, Wang X, Ge S, et al. Allergic and non-allergic rhinitis are common in obstructive sleep apnea but not associated with disease severity. J Clin Sleep Med. 2017;13(8):959-966. https://doi.org/10.5664/jcsm.6694. Liu J, Wu Y, Wu P, Xu Z, Ni X. Analysis of the impact of allergic rhinitis on the children with sleep disordered breathing. Int J Pediatr Otorhinolaryngol. 2020;138:110380. https://doi.org/10.1016/j.ijporl.2020.110380. Shanqun L, Shenyuan L, Zhou J, Bai C. The role of montelukast and intranasal budesonide on OSAHS and allergic rhinitis. Allergy. 2009;64:591. Gurevich F, Glass C, Davies M, et al. The effect of intranasal steroid budesonide on the congestion-related sleep disturbance and daytime somnolence in patients with perennial allergic rhinitis. Allergy Asthma Proc. 2005;26(4):268-274. Hughes K, Glass C, Ripchinski M, et al. Efficacy of the topical nasal steroid budesonide on improving sleep and daytime somnolence in patients with perennial allergic rhinitis. Allergy. 2003;58(5):380-385. https://doi.org/10.1034/j.1398-9995.2003.00093.x. Craig TJ, Teets S, Lehman EB, Chinchilli VM, Zwillich C. Nasal congestion secondary to allergic rhinitis as a cause of sleep disturbance and daytime fatigue and the response to topical nasal corticosteroids. J Allergy Clin Immunol. 1998;101(5):633-637. https://doi.org/10.1016/s0091-6749(98)70171-x. Mansfield LE, Posey CR. Daytime sleepiness and cognitive performance improve in seasonal allergic rhinitis treated with intranasal fluticasone propionate. Allergy Asthma Proc. 2007;28(2):226-229. https://doi.org/10.2500/aap.2007.28.2950. Bilgilisoy Filiz M, Filiz S, Baran RT, et al. Restless legs syndrome in children with allergic rhinitis: a comparative study on frequency, severity and sleep quality. Turk J Phys Med Rehabil. 2018;64(3):198-204. https://doi.org/10.5606/tftrd.2018.2265. Kim DK, Han DH. Impact of allergic rhinitis on quality of life after adenotonsillectomy for pediatric sleep-disordered breathing. Int Forum Allergy Rhinol. 2015;5(8):741-746. https://doi.org/10.1002/alr.21529. Lai PH, Yang PS, Lai WY, Lin CL, Hsu CY, Wei CC. Allergic rhinitis and the associated risk of nocturnal enuresis in children: a population-based cohort study. Int Forum Allergy Rhinol. 2018;8(11):1260-1266. https://doi.org/10.1002/alr.22219. Krouse HJ, Davis JE, Krouse JH. Immune mediators in allergic rhinitis and sleep. Otolaryngol Head Neck Surg. 2002;126(6):607-613. https://doi.org/10.1067/mhn.2002.125300. McNicholas WT, Tarlo S, Cole P, et al. Obstructive apneas during sleep in patients with seasonal allergic rhinitis. Am Rev Respir Dis. 1982;126(4):625-628. https://doi.org/10.1164/arrd.1982.126.4.625. Acar M, Cingi C, Sakallioglu O, San T, Fatih Yimenicioglu M, Bal C. The effects of mometasone furoate and desloratadine in obstructive sleep apnea syndrome patients with allergic rhinitis. Am J Rhinol Allergy. 2013;27(4):e113-e116. https://doi.org/10.2500/ajra.2013.27.3921. Young T, Finn L, Kim H. Nasal obstruction as a risk factor for sleep-disordered breathing. The University of Wisconsin Sleep and Respiratory Research Group. J Allergy Clin Immunol. 1997;99(2):S757-S762. https://doi.org/10.1016/s0091-6749(97)70124-6. Lavigne F, Petrof BJ, Johnson JR, et al. Effect of topical corticosteroids on allergic airway inflammation and disease severity in obstructive sleep apnoea. Clin Exp Allergy. 2013;43(10):1124-1133. https://doi.org/10.1111/cea.12158. Lavie P, Gertner R, Zomer J, Podoshin L. Breathing disorders in sleep associated with "microarousals' in patients with allergic rhinitis. Acta Otolaryngol. 1981;92(5-6):529-533. https://doi.org/10.3109/00016488109133292. Berson SR, Klimczak J, Prezio EA, Hu S, Abraham M. Clinical associations between allergies and rapid eye movement sleep disturbances. Int Forum Allergy Rhinol. 2018;8(7):817-824. https://doi.org/10.1002/alr.22099. Liu J, Zhang X, Zhao Y, Wang Y. The association between allergic rhinitis and sleep: a systematic review and meta-analysis of observational studies. PLoS One. 2020;15(2):e0228533. https://doi.org/10.1371/journal.pone.0228533. Berson SR, Klimczak JA, Prezio EA, Abraham MT. House dust mite related allergic rhinitis and REM sleep disturbances. Am J Otolaryngol. 2020;41(6):102709. https://doi.org/10.1016/j.amjoto.2020.102709. Pace A, Iannella G, Rossetti V, et al. Diagnosis of obstructive sleep apnea in patients with allergic and non-allergic rhinitis. Medicina (Kaunas). 2020;56(9):454. https://doi.org/10.3390/medicina56090454. Meng J, Xuan J, Qiao X, et al. Assessment of sleep impairment in persistent allergic rhinitis patients using polysomnography. Int Arch Allergy Immunol. 2011;155(1):57-62. https://doi.org/10.1159/000317244. Bozkurt B, Serife Ugur K, Karamanli H, Kucuker F, Ozol D. Polysomnographic findings in persistent allergic rhinitis. Sleep Breath. 2017;21(2):255-261. https://doi.org/10.1007/s11325-016-1390-4. Thompson A, Sardana N, Craig TJ. Sleep impairment and daytime sleepiness in patients with allergic rhinitis: the role of congestion and inflammation. Ann Allergy Asthma Immunol. 2013;111(6):446-451. https://doi.org/10.1016/j.anai.2013.05.020. Rimmer J, Downie S, Bartlett DJ, Gralton J, Salome C. Sleep disturbance in persistent allergic rhinitis measured using actigraphy. Ann Allergy Asthma Immunol. 2009;103(3):190-194. https://doi.org/10.1016/S1081-1206(10)60180-9. Camhi SL, Morgan WJ, Pernisco N, Quan SF. Factors affecting sleep disturbances in children and adolescents. Sleep Med. 2000;1(2):117-123. https://doi.org/10.1016/s1389-9457(99)00005-2. Parikh NG, Junaid I, Sheinkopf L, Randhawa I, Santiago SM, Klaustermeyer WB. Clinical control in the dual diagnosis of obstructive sleep apnea syndrome and rhinitis: a prospective analysis. Am J Rhinol Allergy. 2014;28(1):e52-e55. https://doi.org/10.2500/ajra.2014.28.3977. Fried J, Yuen E, Zhang K, et al. Impact of treatment for nasal cavity disorders on sleep quality: systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2022;166(4):633-642. https://doi.org/10.1177/01945998211029527. Munoz-Cano R, Ribo P, Araujo G, Giralt E, Sanchez-Lopez J, Valero A. Severity of allergic rhinitis impacts sleep and anxiety: results from a large Spanish cohort. Clin Transl Allergy. 2018;8:23. https://doi.org/10.1186/s13601-018-0212-0. Colas C, Galera H, Anibarro B, et al. Disease severity impairs sleep quality in allergic rhinitis (The SOMNIAAR study). Clin Exp Allergy. 2012;42(7):1080-1087. https://doi.org/10.1111/j.1365-2222.2011.03935.x. Romano M, James S, Farrington E, Perry R, Elliott L. The impact of perennial allergic rhinitis with/without allergic asthma on sleep, work and activity level. Allergy Asthma Clin Immunol. 2019;15:81. https://doi.org/10.1186/s13223-019-0391-9. Roxbury CR, Qiu M, Shargorodsky J, Lin SY. Association between allergic rhinitis and poor sleep parameters in U.S. adults. Int Forum Allergy Rhinol. 2018;8(10):1098-1106. https://doi.org/10.1002/alr.22174. Leger D, Bonnefoy B, Pigearias B, de La Giclais B, Chartier A. Poor sleep is highly associated with house dust mite allergic rhinitis in adults and children. Allergy Asthma Clin Immunol. 2017;13:36. https://doi.org/10.1186/s13223-017-0208-7. Gadi G, Wali S, Koshak E, et al. The prevalence of allergic rhinitis and atopic markers in obstructive sleep apnea. J Epidemiol Glob Health. 2017;7(1):37-44. https://doi.org/10.1016/j.jegh.2016.06.001. Park CE, Shin SY, Lee KH, Cho JS, Kim SW. The effect of allergic rhinitis on the degree of stress, fatigue and quality of life in OSA patients. Eur Arch Otorhinolaryngol. 2012;269(9):2061-2064. https://doi.org/10.1007/s00405-011-1888-0. Udaka T, Suzuki H, Fujimura T, et al. Chronic nasal obstruction causes daytime sleepiness and decreased quality of life even in the absence of snoring. Am J Rhinol. 2007;21(5):564-569. https://doi.org/10.2500/ajr.2007.21.3087. Leger D, Annesi-Maesano I, Carat F, et al. Allergic rhinitis and its consequences on quality of sleep: an unexplored area. Arch Intern Med. 2006;166(16):1744-1748. https://doi.org/10.1001/archinte.166.16.1744. Canova CR, Downs SH, Knoblauch A, Andersson M, Tamm M, Leuppi JD. Increased prevalence of perennial allergic rhinitis in patients with obstructive sleep apnea. Respiration. 2004;71(2):138-143. https://doi.org/10.1159/000076674. Mintz M, Garcia J, Diener P, Liao Y, Dupclay L, Georges G. Triamcinolone acetonide aqueous nasal spray improves nocturnal rhinitis-related quality of life in patients treated in a primary care setting: the Quality of Sleep in Allergic Rhinitis study. Ann Allergy Asthma Immunol. 2004;92(2):255-261. https://doi.org/10.1016/S1081-1206(10)61557-8. Stuck BA, Czajkowski J, Hagner AE, et al. Changes in daytime sleepiness, quality of life, and objective sleep patterns in seasonal allergic rhinitis: a controlled clinical trial. J Allergy Clin Immunol. 2004;113(4):663-638. https://doi.org/10.1016/j.jaci.2003.12.589. Janson C, De Backer W, Gislason T, et al. Increased prevalence of sleep disturbances and daytime sleepiness in subjects with bronchial asthma: a population study of young adults in three European countries. Eur Respir J. 1996;9(10):2132-2138. https://doi.org/10.1183/09031936.96.09102132. Lin SY, Melvin TA, Boss EF, Ishman SL. The association between allergic rhinitis and sleep-disordered breathing in children: a systematic review. Int Forum Allergy Rhinol. 2013;3(6):504-509. https://doi.org/10.1002/alr.21123. Lee K, Choi IH, Hong Y, Lee H, Lee SH, Kim TH. Association between allergic rhinitis-related factors and sleep duration in adolescents: Korea National Health and Nutrition Examination Survey V (2010-2012). Int J Pediatr Otorhinolaryngol. 2021;142:110613. https://doi.org/10.1016/j.ijporl.2021.110613. Giraldo-Cadavid LF, Perdomo-Sanchez K, Cordoba-Gravini JL, et al. Allergic rhinitis and OSA in children residing at a high altitude. Chest. 2020;157(2):384-393. https://doi.org/10.1016/j.chest.2019.09.018. Perikleous E, Steiropoulos P, Nena E, et al. Association of asthma and allergic rhinitis with sleep-disordered breathing in childhood. Front Pediatr. 2018;6:250. https://doi.org/10.3389/fped.2018.00250. Di Francesco RC, Alvarez J. Allergic rhinitis affects the duration of rapid eye movement sleep in children with sleep-disordered breathing without sleep apnea. Int Forum Allergy Rhinol. 2016;6(5):465-471. https://doi.org/10.1002/alr.21689. Chimenz R, Manti S, Fede C, et al. Primary nocturnal enuresis in children with allergic rhinitis and severe adenotonsillar hypertrophy: a single center pilot study. J Biol Regul Homeost Agents. 2015;29(2 suppl 1):73-79. Koinis-Mitchell D, Kopel SJ, Boergers J, et al. Asthma, allergic rhinitis, and sleep problems in urban children. J Clin Sleep Med. 2015;11(2):101-110. https://doi.org/10.5664/jcsm.4450. Poachanukoon O, Kitcharoensakkul M. Snoring and sleep problems in children with and without allergic rhinitis: a case control study. J Med Assoc Thai. 2015;98(suppl 2):S138-S144. Kwon JA, Lee M, Yoo KB, Park EC. Does the duration and time of sleep increase the risk of allergic rhinitis? Results of the 6-year nationwide Korea youth risk behavior web-based survey. PLoS One. 2013;8(8):e72507. https://doi.org/10.1371/journal.pone.0072507. Bhattacharjee R, Kheirandish-Gozal L, Spruyt K, et al. Adenotonsillectomy outcomes in treatment of obstructive sleep apnea in children: a multicenter retrospective study. Am J Respir Crit Care Med. 2010;182(5):676-683. https://doi.org/10.1164/rccm.200912-1930OC. Li AM, Au CT, So HK, Lau J, Ng PC, Wing YK. Prevalence and risk factors of habitual snoring in primary school children. Chest. 2010;138(3):519-527. https://doi.org/10.1378/chest.09-1926. Vichyanond P, Suratannon C, Lertbunnaphong P, Jirapongsananuruk O, Visitsunthorn N. Clinical characteristics of children with non-allergic rhinitis vs with allergic rhinitis. Asian Pac J Allergy Immunol. 2010;28(4):270-274. Barone JG, Hanson C, DaJusta DG, Gioia K, England SJ, Schneider D. Nocturnal enuresis and overweight are associated with obstructive sleep apnea. Pediatrics. 2009;124(1):e53-e59. https://doi.org/10.1542/peds.2008-2805. Sogut A, Yilmaz O, Dinc G, Yuksel H. Prevalence of habitual snoring and symptoms of sleep-disordered breathing in adolescents. Int J Pediatr Otorhinolaryngol. 2009;73(12):1769-1773. https://doi.org/10.1016/j.ijporl.2009.09.026. Liukkonen K, Virkkula P, Aronen ET, Kirjavainen T, Pitkaranta A. All snoring is not adenoids in young children. Int J Pediatr Otorhinolaryngol. 2008;72(6):879-884. https://doi.org/10.1016/j.ijporl.2008.02.018. Kalra M, Lemasters G, Bernstein D, et al. Atopy as a risk factor for habitual snoring at age 1 year. Chest. 2006;129(4):942-946. https://doi.org/10.1378/chest.129.4.942. Goldbart AD, Goldman JL, Veling MC, Gozal D. Leukotriene modifier therapy for mild sleep-disordered breathing in children. Am J Respir Crit Care Med. 2005;172(3):364-370. https://doi.org/10.1164/rccm.200408-1064OC. Ng DK, Kwok KL, Cheung JM, et al. Prevalence of sleep problems in Hong Kong primary school children: a community-based telephone survey. Chest. 2005;128(3):1315-1323. https://doi.org/10.1378/chest.128.3.1315. Sogut A, Altin R, Uzun L, et al. Prevalence of obstructive sleep apnea syndrome and associated symptoms in 3-11-year-old Turkish children. Pediatr Pulmonol. 2005;39(3):251-256. https://doi.org/10.1002/ppul.20179. Chng SY, Goh DY, Wang XS, Tan TN, Ong NB. Snoring and atopic disease: a strong association. Pediatr Pulmonol. 2004;38(3):210-216. https://doi.org/10.1002/ppul.20075. Kidon MI, See Y, Goh A, Chay OM, Balakrishnan A. Aeroallergen sensitization in pediatric allergic rhinitis in Singapore: is air-conditioning a factor in the tropics? Pediatr Allergy Immunol. 2004;15(4):340-343. https://doi.org/10.1111/j.1399-3038.2004.00152.x. Mansfield LE, Diaz G, Posey CR, Flores-Neder J. Sleep disordered breathing and daytime quality of life in children with allergic rhinitis during treatment with intranasal budesonide. Ann Allergy Asthma Immunol. 2004;92(2):240-244. https://doi.org/10.1016/S1081-1206(10)61554-2. Anuntaseree W, Rookkapan K, Kuasirikul S, Thongsuksai P. Snoring and obstructive sleep apnea in Thai school-age children: prevalence and predisposing factors. Pediatr Pulmonol. 2001;32(3):222-227. https://doi.org/10.1002/ppul.1112. McColley SA, Carroll JL, Curtis S, Loughlin GM, Sampson HA. High prevalence of allergic sensitization in children with habitual snoring and obstructive sleep apnea. Chest. 1997;111(1):170-173. https://doi.org/10.1378/chest.111.1.170. Brozek JL, Bousquet J, Agache I, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision. J Allergy Clin Immunol. 2017;140(4):950-958. https://doi.org/10.1016/j.jaci.2017.03.050. Katelaris CH, Lee BW, Potter PC, et al. Prevalence and diversity of allergic rhinitis in regions of the world beyond Europe and North America. Clin Exp Allergy. 2012;42(2):186-207. https://doi.org/10.1111/j.1365-2222.2011.03891.x. Dierick BJH, van der Molen T, Flokstra-de Blok BMJ, et al. Burden and socioeconomics of asthma, allergic rhinitis, atopic dermatitis and food allergy. Expert Rev Pharmacoecon Outcomes Res. 2020;20(5):437-453. https://doi.org/10.1080/14737167.2020.1819793. Kritikos V, Price D, Papi A, et al. The burden of self-reported rhinitis and associated risk for exacerbations with moderate-severe asthma in primary care patients. J Asthma Allergy. 2020;13:415-428. https://doi.org/10.2147/JAA.S266204. Strozek J, Samolinski BK, Klak A, et al. The indirect costs of allergic diseases. Int J Occup Med Environ Health. 2019;32(3):281-290. https://doi.org/10.13075/ijomeh.1896.01275. Al-Digheari A, Mahboub B, Tarraf H, et al. The clinical burden of allergic rhinitis in five Middle Eastern countries: results of the SNAPSHOT program. Allergy Asthma Clin Immunol. 2018;14:63. https://doi.org/10.1186/s13223-018-0298-x. Goetzel RZ, Long SR, Ozminkowski RJ, Hawkins K, Wang S, Lynch W. Health, absence, disability, and presenteeism cost estimates of certain physical and mental health conditions affecting U.S. employers. J Occup Environ Med. 2004;46(4):398-412. https://doi.org/10.1097/01.jom.0000121151.40413.bd. Workman AD, Dattilo L, Rathi VK, Bhattacharyya N. Contemporary incremental healthcare costs for allergic rhinitis in the United States. Laryngoscope. 2021;https://doi.org/10.1002/lary.29846. Roland LT, Wise SK, Wang H, Zhang P, Mehta C, Levy JM. The cost of rhinitis in the United States: a national insurance claims analysis. Int Forum Allergy Rhinol. 2021;11(5):946-948. https://doi.org/10.1002/alr.22748. Meltzer EO, Bukstein DA. The economic impact of allergic rhinitis and current guidelines for treatment. Ann Allergy Asthma Immunol. 2011;106(2 suppl):S12-S16. https://doi.org/10.1016/j.anai.2010.10.014. Law AW, Reed SD, Sundy JS, Schulman KA. Direct costs of allergic rhinitis in the United States: estimates from the 1996 Medical Expenditure Panel Survey. J Allergy Clin Immunol. 2003;111(2):296-300. https://doi.org/10.1067/mai.2003.68. Reed SD, Lee TA, McCrory DC. The economic burden of allergic rhinitis: a critical evaluation of the literature. Pharmacoeconomics. 2004;22(6):345-361. https://doi.org/10.2165/00019053-200422060-00002. Avdeeva KS, Reitsma S, Fokkens WJ. Direct and indirect costs of allergic and non-allergic rhinitis in the Netherlands. Allergy. 2020;75(11):2993-2996. https://doi.org/10.1111/all.14457. Bousquet J, Schroder-Bernhardi D, Bachert C, et al. Heterogeneity of the pharmacologic treatment of allergic rhinitis in Europe based on MIDAS and OTCims platforms. Clin Exp Allergy. 2021;51(8):1033-1045. https://doi.org/10.1111/cea.13884. Smith P, Price D, Harvey R, et al. Medication-related costs of rhinitis in Australia: a NostraData cross-sectional study of pharmacy purchases. J Asthma Allergy. 2017;10:153-161. https://doi.org/10.2147/JAA.S128431. Bousquet J, Schunemann HJ, Togias A, et al. Next-generation Allergic Rhinitis and Its Impact on Asthma (ARIA) guidelines for allergic rhinitis based on Grading of Recommendations Assessment, Development and Evaluation (GRADE) and real-world evidence. J Allergy Clin Immunol. 2020;145(1):70-80.e3. https://doi.org/10.1016/j.jaci.2019.06.049. Price D, Scadding G, Ryan D, et al. The hidden burden of adult allergic rhinitis: UK healthcare resource utilisation survey. Clin Transl Allergy. 2015;5:39. https://doi.org/10.1186/s13601-015-0083-6. Belhassen M, Demoly P, Bloch-Morot E, et al. Costs of perennial allergic rhinitis and allergic asthma increase with severity and poor disease control. Allergy. 2017;72(6):948-958. https://doi.org/10.1111/all.13098. Celik G, Mungan D, Abadoglu O, Pinar NM, Misirligil Z. Direct cost assessments in subjects with seasonal allergic rhinitis living in Ankara, Turkey. Allergy Asthma Proc. 2004;25(2):107-113. Yoo KH, Ahn HR, Park JK, et al. Burden of respiratory disease in Korea: an observational study on allergic rhinitis, asthma, COPD, and rhinosinusitis. Allergy Asthma Immunol Res. 2016;8(6):527-534. https://doi.org/10.4168/aair.2016.8.6.527. Kim SY, Yoon SJ, Jo MW, Kim EJ, Kim HJ, Oh IH. Economic burden of allergic rhinitis in Korea. Am J Rhinol Allergy. 2010;24(5):e110-e113. https://doi.org/10.2500/ajra.2010.24.3513. Ghoshal AG, Ravindran GD, Gangwal P, et al. The burden of segregated respiratory diseases in India and the quality of care in these patients: results from the Asia-Pacific Burden of Respiratory Diseases study. Lung India. 2016;33(6):611-619. https://doi.org/10.4103/0970-2113.192878. Nathan RA. The burden of allergic rhinitis. Allergy Asthma Proc. 2007;28(1):3-9. https://doi.org/10.2500/aap.2007.28.2934. Crystal-Peters J, Crown WH, Goetzel RZ, Schutt DC. The cost of productivity losses associated with allergic rhinitis. Am J Manag Care. 2000;6(3):373-378. Fineman SM. The burden of allergic rhinitis: beyond dollars and cents. Ann Allergy Asthma Immunol. 2002;88(4 suppl 1):2-7. https://doi.org/10.1016/s1081-1206(10)62022-4. Colas C, Brosa M, Anton E, et al. Estimate of the total costs of allergic rhinitis in specialized care based on real-world data: the FERIN Study. Allergy. 2017;72(6):959-966. https://doi.org/10.1111/all.13099. Canonica GW, Klimek L, Acaster S, et al. Burden of allergic rhinitis and impact of MP-AzeFlu from the patient perspective: pan European patient survey. Curr Med Res Opin. 2021;37(7):1259-1272. https://doi.org/10.1080/03007995.2021.1911973. Vandenplas O, Vinnikov D, Blanc PD, et al. Impact of rhinitis on work productivity: a systematic review. J Allergy Clin Immunol Pract. 2018;6(4):1274-1286.e9. https://doi.org/10.1016/j.jaip.2017.09.002. Lamb CE, Ratner PH, Johnson CE, et al. Economic impact of workplace productivity losses due to allergic rhinitis compared with select medical conditions in the United States from an employer perspective. Curr Med Res Opin. 2006;22(6):1203-1210. https://doi.org/10.1185/030079906X112552. Hellgren J, Cervin A, Nordling S, Bergman A, Cardell LO. Allergic rhinitis and the common cold-high cost to society. Allergy. 2010;65(6):776-783. https://doi.org/10.1111/j.1398-9995.2009.02269.x. Roger A, Arcala Campillo E, Torres MC, et al. Reduced work/academic performance and quality of life in patients with allergic rhinitis and impact of allergen immunotherapy. Allergy Asthma Clin Immunol. 2016;12:40. https://doi.org/10.1186/s13223-016-0146-9. Jauregui I, Mullol J, Davila I, et al. Allergic rhinitis and school performance. J Investig Allergol Clin Immunol. 2009;19(suppl 1):32-39. Schoenwetter WF, Dupclay Jr L, Appajosyula S, Botteman MF, Pashos CL. Economic impact and quality-of-life burden of allergic rhinitis. Curr Med Res Opin. 2004;20(3):305-317. https://doi.org/10.1185/030079903125003053. Mir E, Panjabi C, Shah A. Impact of allergic rhinitis in school going children. Asia Pac Allergy. 2012;2(2):93-100. https://doi.org/10.5415/apallergy.2012.2.2.93. Trikojat K, Buske-Kirschbaum A, Plessow F, Schmitt J, Fischer R. Memory and multitasking performance during acute allergic inflammation in seasonal allergic rhinitis. Clin Exp Allergy. 2017;47(4):479-487. https://doi.org/10.1111/cea.12893. Wang J, Xiao D, Chen H, Hu J. Cumulative evidence for association of rhinitis and depression. Allergy Asthma Clin Immunol. 2021;17(1):111. https://doi.org/10.1186/s13223-021-00615-5. Klimek L, Bachert C, Pfaar O, et al. ARIA guideline 2019: treatment of allergic rhinitis in the German health system. Allergol Select. 2019;3(1):22-50. https://doi.org/10.5414/ALX02120E. Cingi C, Bayar Muluk N, Scadding GK. Will every child have allergic rhinitis soon? Int J Pediatr Otorhinolaryngol. 2019;118:53-58. https://doi.org/10.1016/j.ijporl.2018.12.019. Small P, Frenkiel A, Becker A, Boisvert P, Bouchard J. The Canadian Rhinitis Working Group: rhinitis - a practical and comprehensive approach to assessment and therapt. J Otolaryngol. 2007;36(1):S5-S27. Scadding GK, Kariyawasam HH, Scadding G, et al. BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised 2017; First edition 2007). Clin Exp Allergy. 2017;47(7):856-889. https://doi.org/10.1111/cea.12953. Schatz M. A survey of the burden of allergic rhinitis in the USA. Allergy. 2007;62(suppl 85):9-16. https://doi.org/10.1111/j.1398-9995.2007.01548.x. Bousquet J, Devillier P, Anto JM, et al. Daily allergic multimorbidity in rhinitis using mobile technology: a novel concept of the MASK study. Allergy. 2018;73(8):1622-1631. https://doi.org/10.1111/all.13448. Ng ML, Warlow RS, Chrishanthan N, Ellis C, Walls R. Preliminary criteria for the definition of allergic rhinitis: a systematic evaluation of clinical parameters in a disease cohort (I). Clin Exp Allergy. 2000;30(9):1314-1331. https://doi.org/10.1046/j.1365-2222.2000.00853.x. Scadding GK, Hellings PW, Bachert C, et al. Allergic respiratory disease care in the COVID-19 era: A EUFOREA statement. World Allergy Organ J. 2020;13(5):100124. https://doi.org/10.1016/j.waojou.2020.100124. Costa DJ, Amouyal M, Lambert P, et al. How representative are clinical study patients with allergic rhinitis in primary care? J Allergy Clin Immunol. 2011;127(4):920-926.e1. https://doi.org/10.1016/j.jaci.2010.10.058. Raza SN, Yousuf K, Small P, Frenkiel S. Diagnosing allergic rhinitis: effectiveness of the physical examination in comparison to conventional skin testing. J Otolaryngol Head Neck Surg. 2011;40(5):407-412. Shaker MS, Oppenheimer J, Grayson M, et al. COVID-19: pandemic contingency planning for the allergy and immunology clinic. J Allergy Clin Immunol Pract. 2020;8(5):1477-1488.e5. https://doi.org/10.1016/j.jaip.2020.03.012. Ziade GK, Karami RA, Fakhri GB, et al. Reliability assessment of the endoscopic examination in patients with allergic rhinitis. Allergy Rhinol (Providence). 2016;7(3):135-138. https://doi.org/10.2500/ar.2016.7.0176. Jareoncharsri P, Thitadilok V, Bunnag C, Ungkanont K, Voraprayoon S, Tansuriyawong P. Nasal endoscopic findings in patients with perennial allergic rhinitis. Asian Pac J Allergy Immunol. 1999;17(4):261-267. Eren E, Aktas A, Arslanoglu S, et al. Diagnosis of allergic rhinitis: inter-rater reliability and predictive value of nasal endoscopic examination: a prospective observational study. Clin Otolaryngol. 2013;38(6):481-486. https://doi.org/10.1111/coa.12171. Ameli F, Tosca MA, Licari A, Gallo F, Ciprandi G. Can an otorhinolaryngological visit induce the suspect of allergic rhinitis in children? Eur Ann Allergy Clin Immunol. 2019;51(6):273-282. https://doi.org/10.23822/EurAnnACI.1764-1489.105. Ameli F, Brocchetti F, Tosca MA, Signori A, Ciprandi G. Nasal endoscopy in children with suspected allergic rhinitis. Laryngoscope. 2011;121(10):2055-2059. https://doi.org/10.1002/lary.22156. White LJ, Rotella MR, DelGaudio JM. Polypoid changes of the middle turbinate as an indicator of atopic disease. Int Forum Allergy Rhinol. 2014;4(5):376-380. https://doi.org/10.1002/alr.21290. Hamizan AW, Christensen JM, Ebenzer J, et al. Middle turbinate edema as a diagnostic marker of inhalant allergy. Int Forum Allergy Rhinol. 2017;7(1):37-42. https://doi.org/10.1002/alr.21835. Brunner JP, Jawad BA, McCoul ED. Polypoid change of the middle turbinate and paranasal sinus polyposis are distinct entities. Otolaryngol Head Neck Surg. 2017;157(3):519-523. https://doi.org/10.1177/0194599817711887. DelGaudio JM, Loftus PA, Hamizan AW, Harvey RJ, Wise SK. Central compartment atopic disease. Am J Rhinol Allergy. 2017;31(4):228-234. https://doi.org/10.2500/ajra.2017.31.4443. DelGaudio JM, Levy JM, Wise SK. Central compartment involvement in aspirin-exacerbated respiratory disease: the role of allergy and previous sinus surgery. Int Forum Allergy Rhinol. 2019;9(9):1017-1022. https://doi.org/10.1002/alr.22367. Hamizan AW, Loftus PA, Alvarado R, et al. Allergic phenotype of chronic rhinosinusitis based on radiologic pattern of disease. Laryngoscope. 2018;128(9):2015-2021. https://doi.org/10.1002/lary.27180. Marcus S, Schertzer J, Roland LT, Wise SK, Levy JM, DelGaudio JM. Central compartment atopic disease: prevalence of allergy and asthma compared with other subtypes of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2020;10(2):183-189. https://doi.org/10.1002/alr.22454. Roland LT, Marcus S, Schertzer JS, Wise SK, Levy JM, DelGaudio JM. Computed tomography findings can help identify different chronic rhinosinusitis with nasal polyp phenotypes. Am J Rhinol Allergy. 2020;34(5):679-685. https://doi.org/10.1177/1945892420923926. Lee K, Kim TH, Lee SH, Kang CH, Je BK, Oh S. Predictive value of radiologic central compartment atopic disease for identifying allergy and asthma in pediatric patients. Ear Nose Throat J. 2021:145561321997546. https://doi.org/10.1177/0145561321997546. Abdullah B, Vengathajalam S, Md Daud MK, Wan Mohammad Z, Hamizan A, Husain S. The clinical and radiological characterizations of the allergic phenotype of chronic rhinosinusitis with nasal polyps. J Asthma Allergy. 2020;13:523-531. https://doi.org/10.2147/JAA.S275536. Kaymakci M, Erel F, Bulbul E, Yazici H, Acar M, Yanik B. Maxillary sinus aeration in allergic rhinitis. J Craniofac Surg. 2015;26(4):e288-e290. https://doi.org/10.1097/SCS.0000000000001558. Hizli O, Kayabasi S, Ozkan D. Is Nasal Septal Body Size Associated With Inferior Turbinate Hypertrophy and Allergic Rhinitis? J Craniofac Surg. 2020;31(3):778-781. https://doi.org/10.1097/SCS.0000000000006107. Pearce MS, Salotti JA, Little MP, et al. Radiation exposure from CT scans in childhood and subsequent risk of leukaemia and brain tumours: a retrospective cohort study. Lancet. 2012;380(9840):499-505. https://doi.org/10.1016/S0140-6736(12)60815-0. Meulepas JM, Ronckers CM, Smets A, et al. Radiation exposure from pediatric CT scans and subsequent cancer risk in the Netherlands. J Natl Cancer Inst. 2019;111(3):256-263. https://doi.org/10.1093/jnci/djy104. Mathews JD, Forsythe AV, Brady Z, et al. Cancer risk in 680,000 people exposed to computed tomography scans in childhood or adolescence: data linkage study of 11 million Australians. BMJ. 2013;346:f2360. https://doi.org/10.1136/bmj.f2360. Sharhan SSA, Lee EJ, Hwang CS, et al. Radiological comparison of inferior turbinate hypertrophy between allergic and non-allergic rhinitis: does allergy really augment turbinate hypertrophy? Eur Arch Otorhinolaryngol. 2018;275(4):923-929. https://doi.org/10.1007/s00405-018-4893-8. Brown HM, Su S, Thantrey N. Prick testing for allergens standardized by using a precision needle. Clin Allergy. 1981;11(1):95-98. https://doi.org/10.1111/j.1365-2222.1981.tb01571.x. Ates A, Kinikli G, Turgay M, Aydogan N, Duman M. The results of skin prick testing in patients with allergic rhinitis: a comparison between a multiple lancet device and a single lancet. Asian Pac J Allergy Immunol. 2004;22(2-3):109-114. Phagoo SB, Wilson NM, Silverman M. Skin prick testing using allergen-coated lancets: a comparison between a multiple lancet device and a single lancet applied with varying pressures. Clin Exp Allergy. 1991;21(5):589-593. https://doi.org/10.1111/j.1365-2222.1991.tb00851.x. Rhodius R, Wickens K, Cheng S, Crane J. A comparison of two skin test methodologies and allergens from two different manufacturers. Ann Allergy Asthma Immunol. 2002;88(4):374-379. https://doi.org/10.1016/S1081-1206(10)62367-8. Anon JB. Introduction to in vivo allergy testing. Otolaryngol Head Neck Surg. 1993;109(3 pt 2):593-600. Kim BJ, Mun SK. Objective measurements using the skin prick test in allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2010;136(11):1104-1106. https://doi.org/10.1001/archoto.2010.185. Piette V, Bourret E, Bousquet J, Demoly P. Prick tests to aeroallergens: is it possible simply to wipe the device between tests? Allergy. 2002;57(10):940-942. https://doi.org/10.1034/j.1398-9995.2002.23536.x. Sander I, Fleischer C, Meurer U, Bruning T, Raulf-Heimsoth M. Allergen content of grass pollen preparations for skin prick testing and sublingual immunotherapy. Allergy. 2009;64(10):1486-1492. https://doi.org/10.1111/j.1398-9995.2009.02040.x. Curin M, Reininger R, Swoboda I, Focke M, Valenta R, Spitzauer S. Skin prick test extracts for dog allergy diagnosis show considerable variations regarding the content of major and minor dog allergens. Int Arch Allergy Immunol. 2011;154(3):258-263. https://doi.org/10.1159/000321113. Bousquet J, Heinzerling L, Bachert C, et al. Practical guide to skin prick tests in allergy to aeroallergens. Allergy. 2012;67(1):18-24. https://doi.org/10.1111/j.1398-9995.2011.02728.x. Canonica GW, Ansotegui IJ, Pawankar R, et al. A WAO - ARIA - GA(2)LEN consensus document on molecular-based allergy diagnostics. World Allergy Organ J. 2013;6(1):17. https://doi.org/10.1186/1939-4551-6-17. Bernstein IL, Li JT, Bernstein DI, et al. Allergy diagnostic testing: an updated practice parameter. Ann Allergy Asthma Immunol. 2008;100(3 suppl 3):S1-S148. https://doi.org/10.1016/s1081-1206(10)60305-5. Oppenheimer J, Nelson HS. Skin testing: a survey of allergists. Ann Allergy Asthma Immunol. 2006;96(1):19-23. https://doi.org/10.1016/S1081-1206(10)61034-4. Chafen JJ, Newberry SJ, Riedl MA, et al. Diagnosing and managing common food allergies: a systematic review. JAMA. 2010;303(18):1848-1856. https://doi.org/10.1001/jama.2010.582. Tschopp JM, Sistek D, Schindler C, et al. Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop). Results from 8329 randomized adults from the SAPALDIA Study. Swiss Study on Air Pollution and Lung Diseases in Adults. Allergy. 1998;53(6):608-613. https://doi.org/10.1111/j.1398-9995.1998.tb03937.x. Corren J, Shapiro G, Reimann J, et al. Allergen skin tests and free IgE levels during reduction and cessation of omalizumab therapy. J Allergy Clin Immunol. 2008;121(2):506-511. https://doi.org/10.1016/j.jaci.2007.11.026. Ansotegui IJ, Melioli G, Canonica GW, et al. IgE allergy diagnostics and other relevant tests in allergy, a World Allergy Organization position paper. World Allergy Organ J. 2020;13(2):100080. https://doi.org/10.1016/j.waojou.2019.100080. Nevis IF, Binkley K, Kabali C. Diagnostic accuracy of skin-prick testing for allergic rhinitis: a systematic review and meta-analysis. Allergy Asthma Clin Immunol. 2016;12:20. https://doi.org/10.1186/s13223-016-0126-0. Gungor A, Houser SM, Aquino BF, et al. A comparison of skin endpoint titration and skin-prick testing in the diagnosis of allergic rhinitis. Ear Nose Throat J. 2004;83(1):54-60. Krouse JH, Shah AG, Kerswill K. Skin testing in predicting response to nasal provocation with alternaria. Laryngoscope. 2004;114(8):1389-1393. https://doi.org/10.1097/00005537-200408000-00013. Krouse JH, Sadrazodi K, Kerswill K. Sensitivity and specificity of prick and intradermal testing in predicting response to nasal provocation with timothy grass antigen. Otolaryngol Head Neck Surg. 2004;131(3):215-219. https://doi.org/10.1016/j.otohns.2004.03.024. Zarei M, Remer CF, Kaplan MS, et al. Optimal skin prick wheal size for diagnosis of cat allergy. Ann Allergy Asthma Immunol. 2004;92(6):604-610. https://doi.org/10.1016/S1081-1206(10)61425-1. Pumhirun P, Jane-Trakoonroj S, Wasuwat P. Comparison of in vitro assay for specific IgE and skin prick test with intradermal test in patients with allergic rhinitis. Asian Pac J Allergy Immunol. 2000;18(3):157-160. Heinzerling L, Mari A, Bergmann KC, et al. The skin prick test - European standards. Clin Transl Allergy. 2013;3(1):3. https://doi.org/10.1186/2045-7022-3-3. Escudero AI, Sanchez-Guerrero IM, Mora AM, et al. Cost-effectiveness of various methods of diagnosing hypersensitivity to Alternaria. Allergol Immunopathol (Madr). 1993;21(4):153-157. Trevino RJ, Veling MC. The importance of quantifying skin reactivity in treating allergic rhinitis with immunotherapy. Ear Nose Throat J. 2000;79(5):362-364, 366. Peltier J, Ryan MW. Comparison of intradermal dilutional testing, skin prick testing, and modified quantitative testing for common allergens. Otolaryngol Head Neck Surg. 2007;137(2):246-249. https://doi.org/10.1016/j.otohns.2007.05.002. Calabria CW, Hagan L. The role of intradermal skin testing in inhalant allergy. Ann Allergy Asthma Immunol. 2008;101(4):337-347, quiz 347, 418. https://doi.org/10.1016/S1081-1206(10)60307-9. Niemeijer NR, Fluks AF, de Monchy JG. Optimization of skin testing. II. Evaluation of concentration and cutoff values, as compared with RAST and clinical history, in a multicenter study. Allergy. 1993;48(7):498-503. https://doi.org/10.1111/j.1398-9995.1993.tb01105.x. Health Quality Ontario. Skin testing for allergic rhinitis: a health technology assessment. Ont Health Technol Assess Ser. 2016;16(10):1-45. Larrabee YC, Reisacher W. Intradermal testing after negative skin prick testing for patients with high suspicion of allergy. Int Forum Allergy Rhinol. 2015;5(6):547-550. https://doi.org/10.1002/alr.21512. Nelson HS, Oppenheimer J, Buchmeier A, Kordash TR, Freshwater LL. An assessment of the role of intradermal skin testing in the diagnosis of clinically relevant allergy to timothy grass. J Allergy Clin Immunol. 1996;97(6):1193-1201. https://doi.org/10.1016/s0091-6749(96)70184-7. Schwindt CD, Hutcheson PS, Leu SY, Dykewicz MS. Role of intradermal skin tests in the evaluation of clinically relevant respiratory allergy assessed using patient history and nasal challenges. Ann Allergy Asthma Immunol. 2005;94(6):627-633. https://doi.org/10.1016/S1081-1206(10)61319-1. Lockey RF, Benedict LM, Turkeltaub PC, Bukantz SC. Fatalities from immunotherapy (IT) and skin testing (ST). J Allergy Clin Immunol. 1987;79(4):660-677. https://doi.org/10.1016/s0091-6749(87)80164-1. Sharma HP, Wood RA, Bravo AR, Matsui EC. A comparison of skin prick tests, intradermal skin tests, and specific IgE in the diagnosis of mouse allergy. J Allergy Clin Immunol. 2008;121(4):933-939. https://doi.org/10.1016/j.jaci.2008.01.023. Simons JP, Rubinstein EN, Kogut VJ, Melfi PJ, Ferguson BJ. Comparison of Multi-Test II skin prick testing to intradermal dilutional testing. Otolaryngol Head Neck Surg. 2004;130(5):536-544. https://doi.org/10.1016/j.otohns.2004.02.005. Niemeijer NR, Goedewaagen B, Kauffman HF, de Monchy JG. Optimization of skin testing. I. Choosing allergen concentrations and cutoff values by factorial design. Allergy. 1993;48(7):491-497. https://doi.org/10.1111/j.1398-9995.1993.tb01104.x. Hurst DS, McDaniel AB. Clinical relevance and advantages of intradermal test results in 371 patients with allergic rhinitis, asthma and/or otitis media with effusion. Cells. 2021;10(11):3224. https://doi.org/10.3390/cells10113224. Erel F, Sarioglu N, Kose M, et al. Intradermal skin testing in allergic rhinitis and asthma with negative skin prick tests. Iran J Allergy Asthma Immunol. 2017;16(3):193-197. Peltier J, Ryan MW. Comparison of intradermal dilutional testing with the Multi-Test II applicator in testing for mold allergy. Otolaryngol Head Neck Surg. 2006;134(2):240-244. https://doi.org/10.1016/j.otohns.2005.10.051. Seshul M, Pillsbury H, 3rd, Eby T. Use of intradermal dilutional testing and skin prick testing: clinical relevance and cost efficiency. Laryngoscope. 2006;116(9):1530-1538. https://doi.org/10.1097/01.mlg.0000234916.43285.f8. Purohit A, Laffer S, Metz-Favre C, et al. Poor association between allergen-specific serum immunoglobulin E levels, skin sensitivity and basophil degranulation: a study with recombinant birch pollen allergen Bet v 1 and an immunoglobulin E detection system measuring immunoglobulin E capable of binding to Fc epsilon RI. Clin Exp Allergy. 2005;35(2):186-192. https://doi.org/10.1111/j.1365-2222.2005.02156.x. Brown WG, Halonen MJ, Kaltenborn WT, Barbee RA. The relationship of respiratory allergy, skin test reactivity, and serum IgE in a community population sample. J Allergy Clin Immunol. 1979;63(5):328-335. https://doi.org/10.1016/0091-6749(79)90127-1. Reddy PM, Nagaya H, Pascual HC, et al. Reappraisal of intracutaneous tests in the diagnosis of reaginic allergy. J Allergy Clin Immunol. 1978;61(1):36-41. https://doi.org/10.1016/0091-6749(78)90471-2. Fornadley JA. Skin testing for inhalant allergy. Int Forum Allergy Rhinol. 2014;4(Suppl 2):S41-S45. https://doi.org/10.1002/alr.21393. Krouse JH, Krouse HJ. Modulation of immune mediators with MQT-based immunotherapy. Otolaryngol Head Neck Surg. 2006;134(5):746-750. https://doi.org/10.1016/j.otohns.2006.01.007. Tantilipikorn P, Danpornprasert P, Ngaotepprutaram P, Assanasen P, Bunnag C, Thinkhamrop B. The correlation between intradermal testing and serum specific IgE to house dust mite in negative skin prick test allergic rhinitis adult patients. Asian Pac J Allergy Immunol. 2015;33(4):308-311. https://doi.org/10.12932/AP0579.33.4.2015. Lewis AF, Franzese C, Stringer SP. Diagnostic evaluation of inhalant allergies: a cost-effectiveness analysis. Am J Rhinol. 2008;22(3):246-252. https://doi.org/10.2500/ajr.2008.22.3163. Long WF, Taylor RJ, Wagner CJ, Leavengood DC, Nelson HS. Skin test suppression by antihistamines and the development of subsensitivity. J Allergy Clin Immunol. 1985;76(1):113-117. https://doi.org/10.1016/0091-6749(85)90813-9. Phillips MJ, Meyrick Thomas RH, Moodley I, Davies RJ. A comparison of the in vivo effects of ketotifen, clemastine, chlorpheniramine and sodium cromoglycate on histamine and allergen induced weals in human skin. Br J Clin Pharmacol. 1983;15(3):277-286. https://doi.org/10.1111/j.1365-2125.1983.tb01500.x. Simons FE, Simons KJ. Clinical pharmacology of new histamine H1 receptor antagonists. Clin Pharmacokinet. 1999;36(5):329-352. https://doi.org/10.2165/00003088-199936050-00003. Cook TJ, MacQueen DM, Wittig HJ, Thornby JI, Lantos RL, Virtue CM. Degree and duration of skin test suppression and side effects with antihistamines. A double blind controlled study with five antihistamines. J Allergy Clin Immunol. 1973;51(2):71-77. https://doi.org/10.1016/s0091-6749(73)80002-8. Almind M, Dirksen A, Nielsen NH, Svendsen UG. Duration of the inhibitory activity on histamine-induced skin weals of sedative and non-sedative antihistamines. Allergy. 1988;43(8):593-596. https://doi.org/10.1111/j.1398-9995.1988.tb00932.x. Pearlman DS, Grossman J, Meltzer EO. Histamine skin test reactivity following single and multiple doses of azelastine nasal spray in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2003;91(3):258-262. https://doi.org/10.1016/S1081-1206(10)63527-2. Miller J, Nelson HS. Suppression of immediate skin tests by ranitidine. J Allergy Clin Immunol. 1989;84(6 pt 1):895-899. https://doi.org/10.1016/0091-6749(89)90386-2. Kupczyk M, Kuprys I, Bochenska-Marciniak M, Gorski P, Kuna P. Ranitidine (150 mg daily) inhibits wheal, flare, and itching reactions in skin-prick tests. Allergy Asthma Proc. 2007;28(6):711-715. https://doi.org/10.2500/aap.2007.28.3064. Harvey RP, Schocket AL. The effect of H1 and H2 blockade on cutaneous histamine response in man. J Allergy Clin Immunol. 1990;65(2):136-139. Rao KS, Menon PK, Hilman BC, Sebastian CS, Bairnsfather L. Duration of the suppressive effect of tricyclic antidepressants on histamine-induced wheal-and-flare reactions in human skin. J Allergy Clin Immunol. 1988;82(5 pt 1):752-757. https://doi.org/10.1016/0091-6749(88)90075-9. Isik SR, Celikel S, Karakaya G, Ulug B, Kalyoncu AF. The effects of antidepressants on the results of skin prick tests used in the diagnosis of allergic diseases. Int Arch Allergy Immunol. 2011;154(1):63-68. https://doi.org/10.1159/000319210. Noga O, Hanf G, Kunkel G. Immunological and clinical changes in allergic asthmatics following treatment with omalizumab. Int Arch Allergy Immunol. 2003;131(1):46-52. https://doi.org/10.1159/000070434. Hill 3rd SL, Krouse JH. The effects of montelukast on intradermal wheal and flare. Otolaryngol Head Neck Surg. 2003;129(3):199-203. https://doi.org/10.1016/S0194-5998(03)00607-7. Simons FE, Johnston L, Gu X, Simons KJ. Suppression of the early and late cutaneous allergic responses using fexofenadine and montelukast. Ann Allergy Asthma Immunol. 2001;86(1):44-50. https://doi.org/10.1016/S1081-1206(10)62354-X. Cuhadaroglu C, Erelel M, Kiyan E, Ece T, Erkan F. Role of Zafirlukast on skin prick test. Allergol Immunopathol (Madr). 2001;29(2):66-68. https://doi.org/10.1016/s0301-0546(01)79020-9. Des Roches A, Paradis L, Bougeard YH, Godard P, Bousquet J, Chanez P. Long-term oral corticosteroid therapy does not alter the results of immediate-type allergy skin prick tests. J Allergy Clin Immunol. 1996;98(3):522-527. https://doi.org/10.1016/s0091-6749(96)70085-4. Slott RI, Zweiman B. A controlled study of the effect of corticosteroids on immediate skin test reactivity. J Allergy Clin Immunol. 1974;54(4):229-234. https://doi.org/10.1016/0091-6749(74)90065-7. Olson R, Karpink MH, Shelanski S, Atkins PC, Zweiman B. Skin reactivity to codeine and histamine during prolonged corticosteroid therapy. J Allergy Clin Immunol. 1990;86(2):153-159. https://doi.org/10.1016/s0091-6749(05)80060-0. Geng B, Thakor A, Clayton E, Finkas L, Riedl MA. Factors associated with negative histamine control for penicillin allergy skin testing in the inpatient setting. Ann Allergy Asthma Immunol. 2015;115(1):33-38. https://doi.org/10.1016/j.anai.2015.04.012. Narasimha SK, Srinivas CR, Mathew AC. Effect of topical corticosteroid application frequency on histamine-induced wheals. Int J Dermatol. 2005;44(5):425-427. https://doi.org/10.1111/j.1365-4632.2005.02482.x. Andersson M, Pipkorn U. Inhibition of the dermal immediate allergic reaction through prolonged treatment with topical glucocorticosteroids. J Allergy Clin Immunol. 1987;79(2):345-349. https://doi.org/10.1016/0091-6749(87)90153-9. Pipkorn U, Hammarlund A, Enerback L. Prolonged treatment with topical glucocorticoids results in an inhibition of the allergen-induced weal-and-flare response and a reduction in skin mast cell numbers and histamine content. Clin Exp Allergy. 1989;19(1):19-25. https://doi.org/10.1111/j.1365-2222.1989.tb02338.x. Gradman J, Wolthers OD. Suppressive effects of topical mometasone furoate and tacrolimus on skin prick testing in children. Pediatr Dermatol. 2008;25(2):269-270. https://doi.org/10.1111/j.1525-1470.2008.00651.x. Shah KM, Rank MA, Dave SA, Oslie CL, Butterfield JH. Predicting which medication classes interfere with allergy skin testing. Allergy Asthma Proc. 2010;31(6):477-482. https://doi.org/10.2500/aap.2010.31.3382. Duenas-Laita A, Ruiz-Munoz P, Armentia A, Pinacho F, Martin-Armentia B. Successful treatment of chronic drug-resistant urticaria with alprazolam. J Allergy Clin Immunol. 2009;123(2):504-505. https://doi.org/10.1016/j.jaci.2008.12.005. Spergel JM, Nurse N, Taylor P, ParneixSpake A. Effect of topical pimecrolimus on epicutaneous skin testing. J Allergy Clin Immunol. 2004;114(3):695-697. https://doi.org/10.1016/j.jaci.2004.05.067. More DR, Napoli DC, Hagan LL. Herbal supplements and skin testing: the lack of effect of commonly used herbal supplements on histamine skin prick testing. Allergy. 2003;58(6):492-494. https://doi.org/10.1034/j.1398-9995.2003.00140.x. Simons FE, Simons KJ. Peripheral H1-blockade effect of fexofenadine. Ann Allergy Asthma Immunol. 1997;79(6):530-532. https://doi.org/10.1016/S1081-1206(10)63061-X. Komarow HD, Arceo S, Young M, Nelson C, Metcalfe DD. Dissociation between history and challenge in patients with physical urticaria. J Allergy Clin Immunol Pract. 2014;2(6):786-790. https://doi.org/10.1016/j.jaip.2014.07.008. Ando M, Shima M. Serum interleukins 12 and 18 and immunoglobulin E concentrations and allergic symptoms in Japanese schoolchildren. J Investig Allergol Clin Immunol. 2007;17(1):14-19. Marinho S, Simpson A, Soderstrom L, Woodcock A, Ahlstedt S, Custovic A. Quantification of atopy and the probability of rhinitis in preschool children: a population-based birth cohort study. Allergy. 2007;62(12):1379-1386. https://doi.org/10.1111/j.1398-9995.2007.01502.x. Salo PM, Calatroni A, Gergen PJ, et al. Allergy-related outcomes in relation to serum IgE: results from the National Health and Nutrition Examination Survey 2005-2006. J Allergy Clin Immunol. 2011;127(5):1226-1235.e7. https://doi.org/10.1016/j.jaci.2010.12.1106. Jacobs TS, Forno E, Brehm JM, et al. Underdiagnosis of allergic rhinitis in underserved children. J Allergy Clin Immunol. 2014;134(3):737-739.e6. https://doi.org/10.1016/j.jaci.2014.03.028. Tu YL, Chang SW, Tsai HJ, et al. Total serum IgE in a population-based study of Asian children in Taiwan: reference value and significance in the diagnosis of allergy. PLoS One. 2013;8(11):e80996. https://doi.org/10.1371/journal.pone.0080996. Park SC, Kim JH, Lee KH, Hong SC, Lee HS, Kang JW. Association of serum eosinophilia and total immunoglobulin E concentration with the risk of allergic symptoms and allergic sensitization, respectively: a 2-year follow-up study. Int J Pediatr Otorhinolaryngol. 2016;86:167-171. https://doi.org/10.1016/j.ijporl.2016.05.005. Kalpaklioglu AF, Kavut AB. Allergic and nonallergic rhinitis: can we find the differences/similarities between the two pictures? J Asthma. 2009;46(5):481-485. https://doi.org/10.1080/02770900902849897. Jung YG, Kim KH, Kim HY, Dhong HJ, Chung SK. Predictive capabilities of serum eosinophil cationic protein, percentage of eosinophils and total immunoglobulin E in allergic rhinitis without bronchial asthma. J Int Med Res. 2011;39(6):2209-2216. https://doi.org/10.1177/147323001103900617. Li Y, Wu R, Tian Y, Bao T, Tian Z. The correlation of serum eosinophil cationic protein level with eosinophil count, and total IgE level in Korean adult allergic rhinitis patients. Asian Pac J Allergy Immunol. 2016;34(1):33-37. https://doi.org/10.12932/AP0746. Sharma M, Khaitan T, Raman S, Jain R, Kabiraj A. Determination of Serum IgE and Eosinophils as a Diagnostic Indicator in Allergic Rhinitis. Indian J Otolaryngol Head Neck Surg. 2019;71(suppl 3):1957-1961. https://doi.org/10.1007/s12070-018-1383-7. Qamar S, Awan N, Cheema KM, Raza N, Ashraf S, Rehman A. Comparative analysis of nasal smear eosinophilia and serum IgE levels for the diagnosis of allergic rhinitis. J Coll Physicians Surg Pak. 2020;30(12):1297-1300. https://doi.org/10.29271/jcpsp.2020.12.1297. Karli R, Balbaloglu E, Uzun L, Cinar F, Ugur MB. Correlation of symptoms with total IgE and specific IgE levels in patients presenting with allergic rhinitis. Ther Adv Respir Dis. 2013;7(2):75-79. https://doi.org/10.1177/1753465812468500. Chung D, Park KT, Yarlagadda B, Davis EM, Platt M. The significance of serum total immunoglobulin E for in vitro diagnosis of allergic rhinitis. Int Forum Allergy Rhinol. 2014;4(1):56-60. https://doi.org/10.1002/alr.21240. Satwani H, Rehman A, Ashraf S, Hassan A. Is serum total IgE levels a good predictor of allergies in children? J Pak Med Assoc. 2009;59(10):698-702. Demirjian M, Rumbyrt JS, Gowda VC, Klaustermeyer WB. Serum IgE and eosinophil count in allergic rhinitis-analysis using a modified Bayes' theorem. Allergol Immunopathol (Madr). 2012;40(5):281-287. https://doi.org/10.1016/j.aller.2011.05.016. Shamji MH, Kappen JH, Akdis M, et al. Biomarkers for monitoring clinical efficacy of allergen immunotherapy for allergic rhinoconjunctivitis and allergic asthma: an EAACI Position Paper. Allergy. 2017;72(8):1156-1173. https://doi.org/10.1111/all.13138. Goodman RE, Chapman MD, Slater JE. The allergen: sources, extracts, and molecules for diagnosis of allergic disease. J Allergy Clin Immunol Pract. 2020;8(8):2506-2514. https://doi.org/10.1016/j.jaip.2020.06.043. Hamilton RG. Clinical laboratory assessment of immediate-type hypersensitivity. J Allergy Clin Immunol. 2010;125(2 suppl 2):S284-S296. https://doi.org/10.1016/j.jaci.2009.09.055. Steering Committee Authors, Review Panel Members. A WAO - ARIA - GA(2)LEN consensus document on molecular-based allergy diagnosis (PAMD@): update 2020. World Allergy Organ J. 2020;13(2):100091. https://doi.org/10.1016/j.waojou.2019.100091. Westwood M, Ramaekers B, Lang S, et al. ImmunoCAP(R) ISAC and Microtest for multiplex allergen testing in people with difficult to manage allergic disease: a systematic review and cost analysis. Health Technol Assess. 2016;20(67):1-178. https://doi.org/10.3310/hta20670. Cox L. Overview of serological-specific IgE antibody testing in children. Curr Allergy Asthma Rep. 2011;11(6):447-453. https://doi.org/10.1007/s11882-011-0226-3. Emanuel IA. In vitro testing for allergy diagnosis. Otolaryngol Clin North Am. 2003;36(5):879-893. https://doi.org/10.1016/s0030-6665(03)00051-3. Incorvaia C, Al-Ahmad M, Ansotegui IJ, et al. Personalized medicine for allergy treatment: allergen immunotherapy still a unique and unmatched model. Allergy. 2021;76(4):1041-1052. https://doi.org/10.1111/all.14575. Corsico AG, De Amici M, Ronzoni V, et al. Allergen-specific immunoglobulin E and allergic rhinitis severity. Allergy Rhinol (Providence). 2017;8(1):1-4. https://doi.org/10.2500/ar.2017.8.0187. Ciprandi G, De Amici M, Giunta V, Marseglia GL. Comparison of serum specific IgE and skin prick test in polysensitized patients. Int J Immunopathol Pharmacol. 2010;23(4):1293-1295. https://doi.org/10.1177/039463201002300438. Chen ST, Sun HL, Lu KH, Lue KH, Chou MC. Correlation of immunoglobulin E, eosinophil cationic protein, and eosinophil count with the severity of childhood perennial allergic rhinitis. J Microbiol Immunol Infect. 2006;39(3):212-218. Ciprandi G, Comite P, Ferrero F, Fontana V, Bruzzone M, Mussap M. Serum allergen-specific IgE, allergic rhinitis severity, and age. Rhinology. 2016;54(3):231-238. https://doi.org/10.4193/Rhino15.300. Ciprandi G, Comite P, Ferrero F, et al. Birch allergy and oral allergy syndrome: the practical relevance of serum immunoglobulin E to Bet v 1. Allergy Asthma Proc. 2016;37(1):43-49. https://doi.org/10.2500/aap.2016.37.3914. Howarth P, Malling HJ, Molimard M, Devillier P. Analysis of allergen immunotherapy studies shows increased clinical efficacy in highly symptomatic patients. Allergy. 2012;67(3):321-327. https://doi.org/10.1111/j.1398-9995.2011.02759.x. Kowalski ML, Ansotegui I, Aberer W, et al. Risk and safety requirements for diagnostic and therapeutic procedures in allergology: World Allergy Organization Statement. World Allergy Organ J. 2016;9(1):33. https://doi.org/10.1186/s40413-016-0122-3. Brown CE, Jones CJ, Stuttaford L, Robertson A, Rashid RS, Smith HE. A qualitative study of the allergy testing experiences, views and preferences of adult patients. Clin Transl Allergy. 2016;6(1):34. https://doi.org/10.1186/s13601-016-0125-8. Williams PB, Barnes JH, Szeinbach SL, Sullivan TJ. Analytic precision and accuracy of commercial immunoassays for specific IgE: establishing a standard. J Allergy Clin Immunol. 2000;105(6 pt 1):1221-1230. https://doi.org/10.1067/mai.2000.105219. Wood RA, Segall N, Ahlstedt S, Williams PB. Accuracy of IgE antibody laboratory results. Ann Allergy Asthma Immunol. 2007;99(1):34-41. https://doi.org/10.1016/S1081-1206(10)60618-7. Wang J, Godbold JH, Sampson HA. Correlation of serum allergy (IgE) tests performed by different assay systems. J Allergy Clin Immunol. 2008;121(5):1219-1224. https://doi.org/10.1016/j.jaci.2007.12.1150. Ownby DR, Bailey J. Comparison of MAST with radioallergosorbent and skin tests for diagnosis of allergy in children. Am J Dis Child. 1986;140(1):45-48. https://doi.org/10.1001/archpedi.1986.02140150047031. Ferguson AC, Murray AB. Predictive value of skin prick tests and radioallergosorbent tests for clinical allergy to dogs and cats. CMAJ. 1986;134(12):1365-1368. Wide L, Bennich H, Johansson SG. Diagnosis of allergy by an in-vitro test for allergen antibodies. Lancet. 1967;2(7526):1105-1107. https://doi.org/10.1016/s0140-6736(67)90615-0. Tian M, Zhou Y, Zhang W, Cui Y. Der p 1 and Der p 2 specific immunoglobulin E measurement for diagnosis of Dermatophagoides pteronyssinus allergy: a systematic review and meta-analysis. Allergy Asthma Proc. 2017;38(5):333-342. https://doi.org/10.2500/aap.2017.38.4073. Knight V, Wolf ML, Trikha A, Curran-Everett D, Hiserote M, Harbeck RJ. A comparison of specific IgE and skin prick test results to common environmental allergens using the HYTEC 288. J Immunol Methods. 2018;462:9-12. https://doi.org/10.1016/j.jim.2018.07.005. van Hage M, Schmid-Grendelmeier P, Skevaki C, et al. Performance evaluation of ImmunoCAP(R) ISAC 112: a multi-site study. Clin Chem Lab Med. 2017;55(4):571-577. https://doi.org/10.1515/cclm-2016-0586. Chinoy B, Yee E, Bahna SL. Skin testing versus radioallergosorbent testing for indoor allergens. Clin Mol Allergy. 2005;3(1):4. https://doi.org/10.1186/1476-7961-3-4. Bignardi D, Comite P, Mori I, et al. Allergen-specific IgE: comparison between skin prick test and serum assay in real life. Allergol Select. 2019;3(1):9-14. https://doi.org/10.5414/ALX01891E. KleinJan A, Godthelp T, van Toornenenbergen AW, Fokkens WJ. Allergen binding to specific IgE in the nasal mucosa of allergic patients. J Allergy Clin Immunol. 1997;99(4):515-521. https://doi.org/10.1016/s0091-6749(97)70079-4. Naclerio RM, Creticos PS, Norman PS, Lichtenstein LM. Mediator release after nasal airway challenge with allergen. Am Rev Respir Dis. 1986;134(5):1102. https://doi.org/10.1164/arrd.1986.134.5.1102. Ahn JY, Hong SJ, Choi BS. Clinical evaluation of techniques for measuring nasal-specific immunoglobulin E in pediatric patients. J Korean Med Sci. 2017;32(12):2005-2008. https://doi.org/10.3346/jkms.2017.32.12.2005. Campo P, Del Carmen Plaza-Seron M, Eguiluz-Gracia I, et al. Direct intranasal application of the solid phase of ImmunoCAP(R) increases nasal specific immunoglobulin E detection in local allergic rhinitis patients. Int Forum Allergy Rhinol. 2018;8(1):15-19. https://doi.org/10.1002/alr.22039. Ota Y, Ikemiyagi Y, Sato T, et al. Measuring local immunoglobulin E in the inferior turbinate nasal mucosa in patients with allergic rhinitis. Allergol Int. 2016;65(4):396-399. https://doi.org/10.1016/j.alit.2016.03.009. Hamizan A, Alvarado R, Rimmer J, et al. Nasal mucosal brushing as a diagnostic method for allergic rhinitis. Allergy Asthma Proc. 2019;40(3):167-172. https://doi.org/10.2500/aap.2019.40.4209. Reisacher WR. Mucosal brush biopsy testing of the inferior turbinate to detect local, antigen-specific immunoglobulin E. Int Forum Allergy Rhinol. 2012;2(1):69-74. https://doi.org/10.1002/alr.20103. Hamizan AW, Rimmer J, Alvarado R, et al. Turbinate-specific IgE in normal and rhinitic patients. Am J Rhinol Allergy. 2019;33(2):178-183. https://doi.org/10.1177/1945892418825224. Saricilar EC, Hamizan A, Alvarado R, et al. Optimizing protein harvest from nasal brushings for determining local allergy responses. Am J Rhinol Allergy. 2018;32(4):244-251. https://doi.org/10.1177/1945892418777668. Fuiano N, Fusilli S, Incorvaia C. A role for measurement of nasal IgE antibodies in diagnosis of Alternaria-induced rhinitis in children. Allergol Immunopathol (Madr). 2012;40(2):71-74. https://doi.org/10.1016/j.aller.2011.03.010. Krajewska-Wojtys A, Jarzab J, Gawlik R, Bozek A. Local allergic rhinitis to pollens is underdiagnosed in young patients. Am J Rhinol Allergy. 2016;30(6):198-201. https://doi.org/10.2500/ajra.2016.30.4369. Gelardi M, Guglielmi AV, Iannuzzi L, et al. Local allergic rhinitis: entopy or spontaneous response? World Allergy Organ J. 2016;9(1):39. https://doi.org/10.1186/s40413-016-0126-z. Santamaria L, Calle A, Tejada-Giraldo Biol M, Calvo V, Sanchez J, Cardona R. Nasal specific IgE to Der p is not an acceptable screening test to predict the outcome of the nasal challenge test in patients with non-allergic rhinitis. World Allergy Organ J. 2020;13(9):100461. https://doi.org/10.1016/j.waojou.2020.100461. Kim JH, Yoon MG, Seo DH, et al. Detection of allergen specific antibodies from nasal secretion of allergic rhinitis patients. Allergy Asthma Immunol Res. 2016;8(4):329-337. https://doi.org/10.4168/aair.2016.8.4.329. Hamizan AW, Rimmer J, Husain S, et al. Local specific immunoglobulin E among patients with nonallergic rhinitis: a systematic review. Rhinology. 2019;57(1):10-20. https://doi.org/10.4193/Rhin18.074. Eguiluz-Gracia I, Ariza A, Testera-Montes A, Rondon C, Campo P. Allergen Immunotherapy for local respiratory allergy. Curr Allergy Asthma Rep. 2020;20(7):23. https://doi.org/10.1007/s11882-020-00920-w. Schiavi L, Brindisi G, De Castro G, et al. Nasal reactivity evaluation in children with allergic rhinitis receiving grass pollen sublingual immunotherapy. Allergy Asthma Proc. 2020;41(5):357-362. https://doi.org/10.2500/aap.2020.41.200063. Lee KS, Yu J, Shim D, et al. Local immune responses in children and adults with allergic and nonallergic rhinitis. PLoS One. 2016;11(6):e0156979. https://doi.org/10.1371/journal.pone.0156979. Sakaida H, Masuda S, Takeuchi K. Measurement of Japanese cedar pollen-specific IgE in nasal secretions. Allergol Int. 2014;63(3):467-473. https://doi.org/10.2332/allergolint.13-OA-0668. Powe DG, Groot Kormelink T, Sisson M, et al. Evidence for the involvement of free light chain immunoglobulins in allergic and nonallergic rhinitis. J Allergy Clin Immunol. 2010;125(1):139-145.e1-3. https://doi.org/10.1016/j.jaci.2009.07.025. Ahn CN, Wise SK, Lathers DM, Mulligan RM, Harvey RJ, Schlosser RJ. Local production of antigen-specific IgE in different anatomic subsites of allergic fungal rhinosinusitis patients. Otolaryngol Head Neck Surg. 2009;141(1):97-103. https://doi.org/10.1016/j.otohns.2009.03.002. Castelli S, Arasi S, Tripodi S, et al. IgE antibody repertoire in nasal secretions of children and adults with seasonal allergic rhinitis: a molecular analysis. Pediatr Allergy Immunol. 2020;31(3):273-280. https://doi.org/10.1111/pai.13148. Sensi LG, Piacentini GL, Nobile E, et al. Changes in nasal specific IgE to mites after periods of allergen exposure-avoidance: a comparison with serum levels. Clin Exp Allergy. 1994;24(4):377-382. https://doi.org/10.1111/j.1365-2222.1994.tb00250.x. Nelson HS, Lahr J, Buchmeier A, McCormick D. Evaluation of devices for skin prick testing. J Allergy Clin Immunol. 1998;101(2 pt 1):153-156. https://doi.org/10.1016/S0091-6749(98)70409-9. Andersen HH, Lundgaard AC, Petersen AS, et al. The Lancet weight determines wheal diameter in response to skin prick testing with histamine. PLoS One. 2016;11(5):e0156211. https://doi.org/10.1371/journal.pone.0156211. Carr WW, Martin B, Howard RS, et al. Comparison of test devices for skin prick testing. J Allergy Clin Immunol. 2005;116(2):341-346. https://doi.org/10.1016/j.jaci.2005.03.035. Seibert SM, King TS, Kline D, Mende C, Craig T. Reliability of skin test results when read at different time points. Allergy Asthma Proc. 2011;32(3):203-205. https://doi.org/10.2500/aap.2011.32.3436. van der Veen MJ, Mulder M, Witteman AM, et al. False-positive skin prick test responses to commercially available dog dander extracts caused by contamination with house dust mite (Dermatophagoides pteronyssinus) allergens. J Allergy Clin Immunol. 1996;98(6 pt 1):1028-1034. https://doi.org/10.1016/s0091-6749(96)80187-4. McCann WA, Ownby DR. The reproducibility of the allergy skin test scoring and interpretation by board-certified/board-eligible allergists. Ann Allergy Asthma Immunol. 2002;89(4):368-371. https://doi.org/10.1016/S1081-1206(10)62037-6. Choi IS, Koh YI, Koh JS, Lee MG. Sensitivity of the skin prick test and specificity of the serum-specific IgE test for airway responsiveness to house dust mites in asthma. J Asthma. 2005;42(3):197-202. Jung YG, Cho HJ, Park GY, et al. Comparison of the skin-prick test and Phadia ImmunoCAP as tools to diagnose house-dust mite allergy. Am J Rhinol Allergy. 2010;24(3):226-229. https://doi.org/10.2500/ajra.2010.24.3459. Pastorello EA, Incorvaia C, Ortolani C, et al. Studies on the relationship between the level of specific IgE antibodies and the clinical expression of allergy: I. Definition of levels distinguishing patients with symptomatic from patients with asymptomatic allergy to common aeroallergens. J Allergy Clin Immunol. 1995;96(5 pt 1):580-587. https://doi.org/10.1016/s0091-6749(95)70255-5. Haxel BR, Huppertz T, Boessert P, Bast F, Fruth K. Correlation of skin test results and specific immunoglobulin E blood levels with nasal provocation testing for house-dust mite allergies. Am J Rhinol Allergy. 2016;30(1):60-64. https://doi.org/10.2500/ajra.2016.30.4262. Gendo K, Larson EB. Evidence-based diagnostic strategies for evaluating suspected allergic rhinitis. Ann Intern Med. 2004;140(4):278-289. https://doi.org/10.7326/0003-4819-140-4-200402170-00010. de Vos G, Nazari R, Ferastraoaru D, et al. Discordance between aeroallergen specific serum IgE and skin testing in children younger than 4 years. Ann Allergy Asthma Immunol. 2013;110(6):438-443. https://doi.org/10.1016/j.anai.2013.03.006. Hoffmann HJ, Santos AF, Mayorga C, et al. The clinical utility of basophil activation testing in diagnosis and monitoring of allergic disease. Allergy. 2015;70(11):1393-1405. https://doi.org/10.1111/all.12698. Gonzalez-Munoz M, Villota J, Moneo I. Analysis of basophil activation by flow cytometry in pediatric house dust mite allergy. Pediatr Allergy Immunol. 2008;19(4):342-347. https://doi.org/10.1111/j.1399-3038.2007.00656.x. Ozdemir SK, Guloglu D, Sin BA, Elhan AH, Ikinciogullari A, Misirligil Z. Reliability of basophil activation test using CD203c expression in diagnosis of pollen allergy. Am J Rhinol Allergy. 2011;25(6):e225-e231. https://doi.org/10.2500/ajra.2011.25.3723. Ogulur I, Kiykim A, Baris S, Ozen A, Yuce EG, Karakoc-Aydiner E. Basophil activation test for inhalant allergens in pediatric patients with allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2017;97:197-201. https://doi.org/10.1016/j.ijporl.2017.04.006. Zidarn M, Robic M, Krivec A, et al. Clinical and immunological differences between asymptomatic HDM-sensitized and HDM-allergic rhinitis patients. Clin Exp Allergy. 2019;49(6):808-818. https://doi.org/10.1111/cea.13361. Mahmood F, Hetland G, Nentwich I, Mirlashari MR, Ghiasvand R, Nissen-Meyer LSH. Agaricus blazei-based mushroom extract supplementation to birch allergic blood donors: a randomized clinical trial. Nutrients. 2019;11(10):2339. https://doi.org/10.3390/nu11102339. Saporta M, Kamei S, Persi L, Bousquet J, Arnoux B. Basophil activation during pollen season in patients monosensitized to grass pollens. Allergy. 2001;56(5):442-445. https://doi.org/10.1034/j.1398-9995.2001.056005442.x. Qiao Y, Chen J. Investigating the inflammatory cascade effect of basophil activation in children with allergic rhinitis or asthma, via the IgE-FcepsilonRI-NF-kappaB signaling pathway. Adv Clin Exp Med. 2021;30(7):673-679. https://doi.org/10.17219/acem/135756. Nagao M, Hiraguchi Y, Hosoki K, et al. Allergen-induced basophil CD203c expression as a biomarker for rush immunotherapy in patients with Japanese cedar pollinosis. Int Arch Allergy Immunol. 2008;146(suppl 1):47-53. https://doi.org/10.1159/000126061. Van Overtvelt L, Baron-Bodo V, Horiot S, et al. Changes in basophil activation during grass-pollen sublingual immunotherapy do not correlate with clinical efficacy. Allergy. 2011;66(12):1530-1537. https://doi.org/10.1111/j.1398-9995.2011.02696.x. Swamy RS, Reshamwala N, Hunter T, et al. Epigenetic modifications and improved regulatory T-cell function in subjects undergoing dual sublingual immunotherapy. J Allergy Clin Immunol. 2012;130(1):215-224.e7. https://doi.org/10.1016/j.jaci.2012.04.021. Caruso M, Cibella F, Emma R, et al. Basophil biomarkers as useful predictors for sublingual immunotherapy in allergic rhinitis. Int Immunopharmacol. 2018;60:50-58. https://doi.org/10.1016/j.intimp.2018.04.034. Kepil Ozdemir S, Sin BA, Guloglu D, Ikinciogullari A, Gencturk Z, Misirligil Z. Short-term preseasonal immunotherapy: is early clinical efficacy related to the basophil response? Int Arch Allergy Immunol. 2014;164(3):237-245. https://doi.org/10.1159/000365628. Zidarn M, Kosnik M, Silar M, Bajrovic N, Korosec P. Sustained effect of grass pollen subcutaneous immunotherapy on suppression of allergen-specific basophil response; a real-life, nonrandomized controlled study. Allergy. 2015;70(5):547-555. https://doi.org/10.1111/all.12581. Schmid JM, Wurtzen PA, Siddhuraj P, et al. Basophil sensitivity reflects long-term clinical outcome of subcutaneous immunotherapy in grass pollen-allergic patients. Allergy. 2021;76(5):1528-1538. https://doi.org/10.1111/all.14264. Kim SH, Kim SH, Chung SJ, et al. Changes in basophil activation during immunotherapy with house dust mite and mugwort in patients with allergic rhinitis. Asia Pac Allergy. 2018;8(1):e6. https://doi.org/10.5415/apallergy.2018.8.e6. Feng M, Zeng X, Su Q, et al. Allergen Immunotherapy-induced immunoglobulin G4 reduces basophil activation in house dust mite-allergic asthma patients. Front Cell Dev Biol. 2020;8:30. https://doi.org/10.3389/fcell.2020.00030. Soyyigit S, Guloglu D, Ikinciogullari A, et al. Immunologic alterations and efficacy of subcutaneous immunotherapy with Dermatophagoides pteronyssinus in monosensitized and polysensitized patients. Ann Allergy Asthma Immunol. 2016;116(3):244-251.e2. https://doi.org/10.1016/j.anai.2016.01.002. Aasbjerg K, Backer V, Lund G, et al. Immunological comparison of allergen immunotherapy tablet treatment and subcutaneous immunotherapy against grass allergy. Clin Exp Allergy. 2014;44(3):417-428. https://doi.org/10.1111/cea.12241. Ma S, Qiao Y. [Changes of basophil activation before and after treatment in children with allergic rhinitis and its clinical significance]. Revue Francaise D'Allergologie. 2021;61(6):393-397. Matricardi PM, Kleine-Tebbe J, Hoffmann HJ, et al. EAACI molecular allergology user's guide. Pediatr Allergy Immunol. 2016;27(suppl 23):1-250. https://doi.org/10.1111/pai.12563. Sastre-Ibanez M, Sastre J. Molecular allergy diagnosis for the clinical characterization of asthma. Expert Rev Mol Diagn. 2015;15(6):789-799. https://doi.org/10.1586/14737159.2015.1036745. Barber D, Diaz-Perales A, Escribese MM, et al. Molecular allergology and its impact in specific allergy diagnosis and therapy. Allergy. 2021;76(12):3642-3658. https://doi.org/10.1111/all.14969. Sastre J, Sastre-Ibanez M. Molecular diagnosis and immunotherapy. Curr Opin Allergy Clin Immunol. 2016;16(6):565-570. https://doi.org/10.1097/ACI.0000000000000318. Sastre J. Molecular diagnosis and immunotherapy. Curr Opin Allergy Clin Immunol. 2013;13(6):646-650. https://doi.org/10.1097/ACI.0b013e328364f4c6. Saltabayeva U, Garib V, Morenko M, et al. Greater real-life diagnostic efficacy of allergen molecule-based diagnosis for prescription of immunotherapy in an area with multiple pollen exposure. Int Arch Allergy Immunol. 2017;173(2):93-98. https://doi.org/10.1159/000477442. Scala E, Abeni D, Pomponi D, et al. Ole e 1, Ole e 7, and Ole e 9: identifying distinct clinical subsets of olive tree-allergic patients. J Allergy Clin Immunol. 2016;137(2):629-631.e3. https://doi.org/10.1016/j.jaci.2015.07.009. Sastre J, Rodriguez F, Campo P, Laffond E, Marin A, Alonso MD. Adverse reactions to immunotherapy are associated with different patterns of sensitization to grass allergens. Allergy. 2015;70(5):598-600. https://doi.org/10.1111/all.12575. Posa D, Perna S, Resch Y, et al. Evolution and predictive value of IgE responses toward a comprehensive panel of house dust mite allergens during the first 2 decades of life. J Allergy Clin Immunol. 2017;139(2):541-549.e8. https://doi.org/10.1016/j.jaci.2016.08.014. Bronnert M, Mancini J, Birnbaum J, et al. Component-resolved diagnosis with commercially available D. pteronyssinus Der p 1, Der p 2 and Der p 10: relevant markers for house dust mite allergy. Clin Exp Allergy. 2012;42(9):1406-1415. https://doi.org/10.1111/j.1365-2222.2012.04035.x. Celi G, Brusca I, Scala E, et al. House dust mite allergy in Italy-Diagnostic and clinical relevance of Der p 23 (and of minor allergens): a real-life, multicenter study. Allergy. 2019;74(9):1787-1789. https://doi.org/10.1111/all.13776. Barber D, Arias J, Boquete M, et al. Analysis of mite allergic patients in a diverse territory by improved diagnostic tools. Clin Exp Allergy. 2012;42(7):1129-1138. https://doi.org/10.1111/j.1365-2222.2012.03993.x. Carvalho Kdos A, de Melo-Neto OP, Magalhaes FB, et al. Blomia tropicalis Blo t 5 and Blo t 21 recombinant allergens might confer higher specificity to serodiagnostic assays than whole mite extract. BMC Immunol. 2013;14:11. https://doi.org/10.1186/1471-2172-14-11. Ayuso R, Reese G, Leong-Kee S, Plante M, Lehrer SB. Molecular basis of arthropod cross-reactivity: IgE-binding cross-reactive epitopes of shrimp, house dust mite and cockroach tropomyosins. Int Arch Allergy Immunol. 2002;129(1):38-48. https://doi.org/10.1159/000065172. Gamez C, Sanchez-Garcia S, Ibanez MD, et al. Tropomyosin IgE-positive results are a good predictor of shrimp allergy. Allergy. 2011;66(10):1375-1383. https://doi.org/10.1111/j.1398-9995.2011.02663.x. Rodriguez-Dominguez A, Berings M, Rohrbach A, et al. Molecular profiling of allergen-specific antibody responses may enhance success of specific immunotherapy. J Allergy Clin Immunol. 2020;146(5):1097-1108. https://doi.org/10.1016/j.jaci.2020.03.029. Saarelainen S, Taivainen A, Rytkonen-Nissinen M, et al. Assessment of recombinant dog allergens Can f 1 and Can f 2 for the diagnosis of dog allergy. Clin Exp Allergy. 2004;34(10):1576-1582. https://doi.org/10.1111/j.1365-2222.2004.02071.x. Mattsson L, Lundgren T, Everberg H, Larsson H, Lidholm J. Prostatic kallikrein: a new major dog allergen. J Allergy Clin Immunol. 2009;123(2):362-368. https://doi.org/10.1016/j.jaci.2008.11.021. Uriarte SA, Sastre J. Clinical relevance of molecular diagnosis in pet allergy. Allergy. 2016;71(7):1066-1068. https://doi.org/10.1111/all.12917. Schoos AM, Nwaru BI, Borres MP. Component-resolved diagnostics in pet allergy: current perspectives and future directions. J Allergy Clin Immunol. 2021;147(4):1164-1173. https://doi.org/10.1016/j.jaci.2020.12.640. Wintersand A, Asplund K, Binnmyr J, et al. Allergens in dog extracts: implication for diagnosis and treatment. Allergy. 2019;74(8):1472-1479. https://doi.org/10.1111/all.13785. Eder K, Becker S, San Nicolo M, Berghaus A, Groger M. Usefulness of component resolved analysis of cat allergy in routine clinical practice. Allergy Asthma Clin Immunol. 2016;12:58. https://doi.org/10.1186/s13223-016-0163-8. Smith W, Butler AJ, Hazell LA, et al. Fel d 4, a cat lipocalin allergen. Clin Exp Allergy. 2004;34(11):1732-1738. https://doi.org/10.1111/j.1365-2222.2004.02090.x. Saarelainen S, Rytkonen-Nissinen M, Rouvinen J, et al. Animal-derived lipocalin allergens exhibit immunoglobulin E cross-reactivity. Clin Exp Allergy. 2008;38(2):374-381. https://doi.org/10.1111/j.1365-2222.2007.02895.x. Arruda LK, Vailes LD, Ferriani VP, Santos AB, Pomes A, Chapman MD. Cockroach allergens and asthma. J Allergy Clin Immunol. 2001;107(3):419-428. https://doi.org/10.1067/mai.2001.112854. Postigo I, Gutierrez-Rodriguez A, Fernandez J, Guisantes JA, Sunen E, Martinez J. Diagnostic value of Alt a 1, fungal enolase and manganese-dependent superoxide dismutase in the component-resolved diagnosis of allergy to Pleosporaceae. Clin Exp Allergy. 2011;41(3):443-451. https://doi.org/10.1111/j.1365-2222.2010.03671.x. Kespohl S, Raulf M. Mould allergens: where do we stand with molecular allergy diagnostics?: Part 13 of the series Molecular Allergology. Allergo J Int. 2014;23(4):120-125. https://doi.org/10.1007/s40629-014-0014-4. Barber D, Moreno C, Ledesma A, et al. Degree of olive pollen exposure and sensitization patterns. Clinical implications. J Investig Allergol Clin Immunol. 2007;17(suppl 1):11-16. Sastre J. Molecular diagnosis in allergy. Clin Exp Allergy. 2010;40(10):1442-1460. https://doi.org/10.1111/j.1365-2222.2010.03585.x. Martinez-Canavate Burgos A, Torres-Borrego J, Molina Teran AB, et al. Molecular sensitization patterns and influence of molecular diagnosis in immunotherapy prescription in children sensitized to both grass and olive pollen. Pediatr Allergy Immunol. 2018;29(4):369-374. https://doi.org/10.1111/pai.12866. Moreno C, Justicia JL, Quiralte J, et al. Olive, grass or both? Molecular diagnosis for the allergen immunotherapy selection in polysensitized pollinic patients. Allergy. 2014;69(10):1357-1363. https://doi.org/10.1111/all.12474. Stringari G, Tripodi S, Caffarelli C, et al. The effect of component-resolved diagnosis on specific immunotherapy prescription in children with hay fever. J Allergy Clin Immunol. 2014;134(1):75-81. https://doi.org/10.1016/j.jaci.2014.01.042. Letran A, Espinazo M, Moreno F. Measurement of IgE to pollen allergen components is helpful in selecting patients for immunotherapy. Ann Allergy Asthma Immunol. 2013;111(4):295-297. https://doi.org/10.1016/j.anai.2013.07.005. Nolte M, Barber D, Maloney J, et al. Timothy specific IgE levels are associated with efficacy and safety of timothy grass sublingual immunotherapy tablet. Ann Allergy Asthma Immunol. 2015;115(6):509-515.e2. https://doi.org/10.1016/j.anai.2015.09.018. Rodinkova VV, Yuriev SD, Kryvopustova MV, Mokin VB, Kryzhanovskyi YM, Kurchenko AI. Molecular profile sensitization to house dust mites as an important aspect for predicting the efficiency of allergen immunotherapy. Front Immunol. 2022;13:848616. https://doi.org/10.3389/fimmu.2022.848616. Arroabarren E, Echechipia S, Galbete A, Lizaso MT, Olaguibel JM, Tabar AI. Association between component-resolved diagnosis of house dust mite allergy and efficacy and safety of specific immunotherapy. J Investig Allergol Clin Immunol. 2019;29(2):164-167. https://doi.org/10.18176/jiaci.0359. Chen KW, Zieglmayer P, Zieglmayer R, et al. Selection of house dust mite-allergic patients by molecular diagnosis may enhance success of specific immunotherapy. J Allergy Clin Immunol. 2019;143(3):1248-1252.e12. https://doi.org/10.1016/j.jaci.2018.10.048. di Coste A, Occasi F, De Castro G, et al. Predictivity of clinical efficacy of sublingual immunotherapy (SLIT) based on sensitisation pattern to molecular allergens in children with allergic rhinoconjunctivitis. Allergol Immunopathol (Madr). 2017;45(5):452-456. https://doi.org/10.1016/j.aller.2017.01.001. Darsow U, Brockow K, Pfab F, et al. Allergens. Heterogeneity of molecular sensitization profiles in grass pollen allergy-implications for immunotherapy? Clin Exp Allergy. 2014;44(5):778-786. https://doi.org/10.1111/cea.12303. Sastre J, Landivar ME, Ruiz-Garcia M, Andregnette-Rosigno MV, Mahillo I. How molecular diagnosis can change allergen-specific immunotherapy prescription in a complex pollen area. Allergy. 2012;67(5):709-711. https://doi.org/10.1111/j.1398-9995.2012.02808.x. Tripodi S, Frediani T, Lucarelli S, et al. Molecular profiles of IgE to Phleum pratense in children with grass pollen allergy: implications for specific immunotherapy. J Allergy Clin Immunol. 2012;129(3):834-839.e8. https://doi.org/10.1016/j.jaci.2011.10.045. Duffort O, Palomares O, Lombardero M, et al. Variability of Ole e 9 allergen in olive pollen extracts: relevance of minor allergens in immunotherapy treatments. Int Arch Allergy Immunol. 2006;140(2):131-138. https://doi.org/10.1159/000092532. Pfaar O, Calderon MA, Andrews CP, et al. Allergen exposure chambers: harmonizing current concepts and projecting the needs for the future - an EAACI Position Paper. Allergy. 2017;72(7):1035-1042. https://doi.org/10.1111/all.13133. Werfel T, Heratizadeh A, Niebuhr M, et al. Exacerbation of atopic dermatitis on grass pollen exposure in an environmental challenge chamber. J Allergy Clin Immunol. 2015;136(1):96-103.e9. https://doi.org/10.1016/j.jaci.2015.04.015. Badorrek P, Dick M, Emmert L, et al. Pollen starch granules in bronchial inflammation. Ann Allergy Asthma Immunol. 2012;109(3):208-214.e6. https://doi.org/10.1016/j.anai.2012.06.019. Ahuja SK, Manoharan MS, Harper NL, et al. Preservation of epithelial cell barrier function and muted inflammation in resistance to allergic rhinoconjunctivitis from house dust mite challenge. J Allergy Clin Immunol. 2017;139(3):844-854. https://doi.org/10.1016/j.jaci.2016.08.019. Smith AM, Ramirez RM, Harper N, et al. Large-scale provocation studies identify maladaptive responses to ubiquitous aeroallergens as a correlate of severe allergic rhinoconjunctivitis and asthma. Allergy. 2022;77(6):1797-1814. https://doi.org/10.1111/all.15124. Smith AM, Harper N, Meunier JA, et al. Repetitive aeroallergen challenges elucidate maladaptive epithelial and inflammatory traits that underpin allergic airway diseases. J Allergy Clin Immunol. 2021;148(2):533-549. https://doi.org/10.1016/j.jaci.2021.01.008. Ellis AK, Steacy LM, Hobsbawn B, Conway CE, Walker TJ. Clinical validation of controlled grass pollen challenge in the Environmental Exposure Unit (EEU). Allergy Asthma Clin Immunol. 2015;11(1):5. https://doi.org/10.1186/s13223-015-0071-3. Ellis AK, Soliman M, Steacy LM, Adams DE, Hobsbawn B, Walker TJ. Clinical validation of controlled exposure to birch pollen in the Environmental Exposure Unit (EEU). Allergy Asthma Clin Immunol. 2016;12:53. https://doi.org/10.1186/s13223-016-0156-7. Enomoto T, Ide T, Ogino S. Construction of an environmental exposure unit and investigation of the effects of cetirizine hydrochloride on symptoms of cedar pollinosis in Japan. J Investig Allergol Clin Immunol. 2007;17(3):173-81. Hashiguchi K, Tang H, Fujita T, et al. Validation study of the OHIO Chamber in patients with Japanese cedar pollinosis. Int Arch Allergy Immunol. 2009;149(2):141-149. https://doi.org/10.1159/000189197. Jacobs RL, Ramirez DA, Andrews CP. Validation of the biogenics research chamber for Juniperus ashei (mountain cedar) pollen. Ann Allergy Asthma Immunol. 2011;107(2):133-138. https://doi.org/10.1016/j.anai.2011.04.009. Krug N, Hohlfeld JM, Larbig M, et al. Validation of an environmental exposure unit for controlled human inhalation studies with grass pollen in patients with seasonal allergic rhinitis. Clin Exp Allergy. 2003;33(12):1667-1674. https://doi.org/10.1111/j.1365-2222.2003.01810.x. Lueer K, Biller H, Casper A, et al. Safety, efficacy and repeatability of a novel house dust mite allergen challenge technique in the Fraunhofer allergen challenge chamber. Allergy. 2016;71(12):1693-1700. https://doi.org/10.1111/all.12947. Ronborg SM, Mosbech H, Poulsen LK. Exposure chamber for allergen challenge. A placebo-controlled, double-blind trial in house-dust-mite asthma. Allergy. 1997;52(8):821-828. https://doi.org/10.1111/j.1398-9995.1997.tb02153.x. Zuberbier T, Abelson MB, Akdis CA, et al. Validation of the Global Allergy and Asthma European Network (GA(2)LEN) chamber for trials in allergy: innovation of a mobile allergen exposure chamber. J Allergy Clin Immunol. 2017;139(4):1158-1166. https://doi.org/10.1016/j.jaci.2016.08.025. Hohlfeld JM, Holland-Letz T, Larbig M, et al. Diagnostic value of outcome measures following allergen exposure in an environmental challenge chamber compared with natural conditions. Clin Exp Allergy. 2010;40(7):998-1006. https://doi.org/10.1111/j.1365-2222.2010.03498.x. Boelke G, Berger U, Bergmann KC, et al. Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA(2)LEN study. Clin Transl Allergy. 2017;7:33. https://doi.org/10.1186/s13601-017-0169-4. Gherasim A, Fauquert JL, Domis N, Siomboing X, de Blay F. Birch allergen challenges in allergic conjunctivitis using standard conjunctival allergen challenge and environmental exposure chamber. Clin Transl Allergy. 2021;11(6):e12053. https://doi.org/10.1002/clt2.12053. Jacobs RL, Ramirez DA, Rather CG, et al. Redness response phenotypes of allergic conjunctivitis in an allergen challenge chamber. Ann Allergy Asthma Immunol. 2017;118(1):86-93.e2. https://doi.org/10.1016/j.anai.2016.10.023. Badorrek P, Muller M, Koch W, Hohlfeld JM, Krug N. Specificity and reproducibility of nasal biomarkers in patients with allergic rhinitis after allergen challenge chamber exposure. Ann Allergy Asthma Immunol. 2017;118(3):290-297. https://doi.org/10.1016/j.anai.2017.01.018. North ML, Jones MJ, MacIsaac JL, et al. Blood and nasal epigenetics correlate with allergic rhinitis symptom development in the environmental exposure unit. Allergy. 2018;73(1):196-205. https://doi.org/10.1111/all.13263. Krug N, Gupta A, Badorrek P, et al. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis. J Allergy Clin Immunol. 2014;133(2):414-419. https://doi.org/10.1016/j.jaci.2013.10.013. Horak FF, Jager S, Nirnberger G, et al. Dose-related control of allergic rhinitis symptoms by a H1-receptor antagonist. Finding the proper doses [correction of dosis] of dimethindene maleate in patients with allergic rhinitis. Int Arch Allergy Immunol. 1994;103(3):298-302. https://doi.org/10.1159/000236643. Horak F, Jager S, Nirnberger G, et al. Pharmacodynamic dose finding of dimetindene in a sustained release formulation. Arzneimittelforschung. 1993;43(11):1193-1195. Day JH, Briscoe MP, Ratz JD, Ellis AK, Yao R, Danzig M. Onset of action of loratadine/montelukast in seasonal allergic rhinitis subjects exposed to ragweed pollen in the Environmental Exposure Unit. Allergy Asthma Proc. 2009;30(3):270-276. https://doi.org/10.2500/aap.2009.30.3234. Horak F, Zieglmayer P, Zieglmayer R, Lemell P. Onset of action of loratadine/montelukast in seasonal allergic rhinitis patients exposed to grass pollen. Arzneimittelforschung. 2010;60(5):249-255. https://doi.org/10.1055/s-0031-1296281. Berkowitz RB, Woodworth GG, Lutz C, et al. Onset of action, efficacy, and safety of fexofenadine 60 mg/pseudoephedrine 120 mg versus placebo in the Atlanta allergen exposure unit. Ann Allergy Asthma Immunol. 2002;89(1):38-45. https://doi.org/10.1016/S1081-1206(10)61909-6. Day JH, Briscoe MP, Rafeiro E, Ratz JD. Comparative clinical efficacy, onset and duration of action of levocetirizine and desloratadine for symptoms of seasonal allergic rhinitis in subjects evaluated in the Environmental Exposure Unit (EEU). Int J Clin Pract. 2004;58(2):109-118. https://doi.org/10.1111/j.1368-5031.2004.0117.x. Horak F, Zieglmayer UP, Zieglmayer R, et al. Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy. Curr Med Res Opin. 2006;22(1):151-157. https://doi.org/10.1185/030079906X80305. Bousquet J, Meltzer EO, Couroux P, et al. Onset of action of the fixed combination intranasal azelastine-fluticasone propionate in an allergen exposure chamber. J Allergy Clin Immunol Pract. 2018;6(5):1726-1732.e6. https://doi.org/10.1016/j.jaip.2018.01.031. Tenn MW, Steacy LM, Ng CC, Ellis AK. Onset of action for loratadine tablets for the symptomatic control of seasonal allergic rhinitis in adults challenged with ragweed pollen in the Environmental Exposure Unit: a post hoc analysis of total symptom score. Allergy Asthma Clin Immunol. 2018;14:5. https://doi.org/10.1186/s13223-017-0227-4. Day JH, Briscoe MP, Rafeiro E, Hewlett D, Jr., Chapman D, Kramer B. Randomized double-blind comparison of cetirizine and fexofenadine after pollen challenge in the Environmental Exposure Unit: duration of effect in subjects with seasonal allergic rhinitis. Allergy Asthma Proc. 2004;25(1):59-68. Murdoch RD, Bareille P, Ignar D, et al. Once-daily dosing of levocabastine has comparable efficacy to twice-daily dosing in the treatment of allergic rhinitis assessed in an allergen challenge chamber. Int J Clin Pharmacol Ther. 2015;53(10):811-818. https://doi.org/10.5414/CP202389. Horak F, Zieglmayer PU, Zieglmayer R, Kavina A, Lemell P. Levocetirizine has a longer duration of action on improving total nasal symptoms score than fexofenadine after single administration. Br J Clin Pharmacol. 2005;60(1):24-31. https://doi.org/10.1111/j.1365-2125.2005.02377.x. Krug N, Hohlfeld JM, Geldmacher H, et al. Effect of loteprednol etabonate nasal spray suspension on seasonal allergic rhinitis assessed by allergen challenge in an environmental exposure unit. Allergy. 2005;60(3):354-359. https://doi.org/10.1111/j.1398-9995.2005.00703.x. Salapatek AM, Patel P, Gopalan G, Varghese ST. Mometasone furoate nasal spray provides early, continuing relief of nasal congestion and improves nasal patency in allergic patients. Am J Rhinol Allergy. 2010;24(6):433-438. https://doi.org/10.2500/ajra.2010.24.3548. Zieglmayer P, Zieglmayer R, Bareille P, Rousell V, Salmon E, Horak F. Fluticasone furoate versus placebo in symptoms of grass-pollen allergic rhinitis induced by exposure in the Vienna Challenge Chamber. Curr Med Res Opin. 2008;24(6):1833-1840. https://doi.org/10.1185/03007990802155792. Ng CC, Romaikin D, Steacy LM, et al. Comparative nasal airflow with loratadine-pseudoephedrine and fluticasone nasal spray for allergic rhinitis. Ann Allergy Asthma Immunol. 2021;127(3):342-348.e2. https://doi.org/10.1016/j.anai.2021.05.001. Zieglmayer P, Schmutz R, Lemell P, et al. Fast effectiveness of a solubilized low-dose budesonide nasal spray in allergic rhinitis. Clin Exp Allergy. 2020;50(9):1065-1077. https://doi.org/10.1111/cea.13691. Badorrek P, Dick M, Schauerte A, et al. A combination of cetirizine and pseudoephedrine has therapeutic benefits when compared to single drug treatment in allergic rhinitis. Int J Clin Pharmacol Ther. 2009;47(2):71-77. https://doi.org/10.5414/cpp47071. Barchuk WT, Salapatek AM, Ge T, D'Angelo P, Liu X. A proof-of-concept study of the effect of a novel H3-receptor antagonist in allergen-induced nasal congestion. J Allergy Clin Immunol. 2013;132(4):838-846.e1-6. https://doi.org/10.1016/j.jaci.2013.05.001. Horak F, Toth J, Marks B, et al. Efficacy and safety relative to placebo of an oral formulation of cetirizine and sustained-release pseudoephedrine in the management of nasal congestion. Allergy. 1998;53(9):849-856. https://doi.org/10.1111/j.1398-9995.1998.tb03990.x. Yonekura S, Okamoto Y, Yamamoto H, et al. Randomized double-blind study of prophylactic treatment with an antihistamine for seasonal allergic rhinitis. Int Arch Allergy Immunol. 2013;162(1):71-78. https://doi.org/10.1159/000350926. Jordakieva G, Kundi M, Lemell P, et al. Cetirizine inhibits gender-specific blood cell dynamics upon allergen contact in allergic rhinitis. Clin Immunol. 2020;215:108422. https://doi.org/10.1016/j.clim.2020.108422. Yonekura S, Okamoto Y, Sakurai D, et al. Efficacy of Desloratadine and levocetirizine in patients with cedar pollen-induced allergic rhinitis: a randomized, double-blind study. Int Arch Allergy Immunol. 2019;180(4):274-283. https://doi.org/10.1159/000503065. Hashiguchi K, Wakabayashi KI, Togawa M, Saito A, Okubo K. Therapeutic effect of bilastine in Japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber). Allergol Int. 2017;66(1):123-131. https://doi.org/10.1016/j.alit.2016.06.009. Bareille P, Murdoch RD, Denyer J, et al. The effects of a TRPV1 antagonist, SB-705498, in the treatment of seasonal allergic rhinitis. Int J Clin Pharmacol Ther. 2013;51(7):576-584. https://doi.org/10.5414/CP201890. Corren J, Wood RA, Patel D, et al. Effects of omalizumab on changes in pulmonary function induced by controlled cat room challenge. J Allergy Clin Immunol. 2011;127(2):398-405. https://doi.org/10.1016/j.jaci.2010.09.043. Horak F. VTX-1463, a novel TLR8 agonist for the treatment of allergic rhinitis. Expert Opin Investig Drugs. 2011;20(7):981-986. https://doi.org/10.1517/13543784.2011.583237. Horak F, Zieglmayer P, Zieglmayer R, et al. The CRTH2 antagonist OC000459 reduces nasal and ocular symptoms in allergic subjects exposed to grass pollen, a randomised, placebo-controlled, double-blind trial. Allergy. 2012;67(12):1572-1579. https://doi.org/10.1111/all.12042. Gomes PJ, Abelson MB, Stein L, Viirre E, Villafranca JE, Lasser EC. Iodixanol nasal solution reduces allergic rhinoconjunctivitis signs and symptoms in Allergen BioCube((R)): a randomized clinical trial. J Asthma Allergy. 2019;12:71-81. https://doi.org/10.2147/JAA.S150251. Struss N, Badorrek P, Mattern C, Mattern U, Hohlfeld JM. The effect of a thixotropic nasal gel on nasal symptoms and inflammatory biomarkers in seasonal allergic rhinitis. Int Arch Allergy Immunol. 2020;181(5):385-394. https://doi.org/10.1159/000506129. Salapatek AM, Werkhauser N, Ismail B, Mosges R, Raskopf E, Bilstein A. Effects of ectoine containing nasal spray and eye drops on symptoms of seasonal allergic rhinoconjunctivitis. Clin Transl Allergy. 2021;11(1):e12006. https://doi.org/10.1002/clt2.12006. Xiao JZ, Kondo S, Yanagisawa N, et al. Clinical efficacy of probiotic Bifidobacterium longum for the treatment of symptoms of Japanese cedar pollen allergy in subjects evaluated in an environmental exposure unit. Allergol Int. 2007;56(1):67-75. https://doi.org/10.2332/allergolint.O-06-455. Bergmann KC, Krause L, Hiller J, et al. First evaluation of a symbiotic food supplement in an allergen exposure chamber in birch pollen allergic patients. World Allergy Organ J. 2021;14(1):100494. https://doi.org/10.1016/j.waojou.2020.100494. Ellis AK, Frankish CW, Armstrong K, et al. Persistence of the clinical effect of grass allergen peptide immunotherapy after the second and third grass pollen seasons. J Allergy Clin Immunol. 2020;145(2):610-618.e9. https://doi.org/10.1016/j.jaci.2019.09.010. Wagenmann M, Worm M, Akboga Y, Karjalainen M, Hohlfeld JM. Randomized immunotherapy trial in dual-allergic patients using "active allergen placebo" as control. Allergy. 2019;74(8):1480-1489. https://doi.org/10.1111/all.13842. Couroux P, Ipsen H, Stage BS, et al. A birch sublingual allergy immunotherapy tablet reduces rhinoconjunctivitis symptoms when exposed to birch and oak and induces IgG4 to allergens from all trees in the birch homologous group. Allergy. 2019;74(2):361-369. https://doi.org/10.1111/all.13606. Ellis AK, Tenn MW, Steacy LM, et al. Lack of effect of Timothy grass pollen sublingual immunotherapy tablet on birch pollen-induced allergic rhinoconjunctivitis in an environmental exposure unit. Ann Allergy Asthma Immunol. 2018;120(5):495-503. e2. https://doi.org/10.1016/j.anai.2018.02.003. Pfaar O, Hohlfeld JM, Al-Kadah B, et al. Dose-response relationship of a new Timothy grass pollen allergoid in comparison with a 6-grass pollen allergoid. Clin Exp Allergy. 2017;47(11):1445-1455. https://doi.org/10.1111/cea.12977. Ellis AK, Frankish CW, O'Hehir RE, et al. Treatment with grass allergen peptides improves symptoms of grass pollen-induced allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2017;140(2):486-496. https://doi.org/10.1016/j.jaci.2016.11.043. Zieglmayer P, Nolte H, Nelson HS, et al. Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial. Ann Allergy Asthma Immunol. 2016;117(6):690-696.e1. https://doi.org/10.1016/j.anai.2016.10.015. Horak F, Zieglmayer P, Zieglmayer R, et al. Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber. J Allergy Clin Immunol. 2009;124(3):471-477, 477.e1. https://doi.org/10.1016/j.jaci.2009.06.006. Meyer W, Narkus A, Salapatek AM, Hafner D. Double-blind, placebo-controlled, dose-ranging study of new recombinant hypoallergenic Bet v 1 in an environmental exposure chamber. Allergy. 2013;68(6):724-731. https://doi.org/10.1111/all.12148. Nolte H, Maloney J, Nelson HS, et al. Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber. J Allergy Clin Immunol. 2015;135(6):1494-1501.e6. https://doi.org/10.1016/j.jaci.2014.12.1911. Patel D, Couroux P, Hickey P, et al. Fel d 1-derived peptide antigen desensitization shows a persistent treatment effect 1 year after the start of dosing: a randomized, placebo-controlled study. J Allergy Clin Immunol. 2013;131(1):103-109.e1-7. https://doi.org/10.1016/j.jaci.2012.07.028. Patel P, Holdich T, Fischer von Weikersthal-Drachenberg KJ, Huber B. Efficacy of a short course of specific immunotherapy in patients with allergic rhinoconjunctivitis to ragweed pollen. J Allergy Clin Immunol. 2014;133(1):121-129.e1-2. https://doi.org/10.1016/j.jaci.2013.05.032. Gherasim A, de Blay F. Does air filtration work for cat allergen exposure? Curr Allergy Asthma Rep. 2020;20(6):18. https://doi.org/10.1007/s11882-020-00912-w. Gherasim A, Jacob A, Schoettel F, Domis N, de Blay F. Efficacy of air cleaners in asthmatics allergic to cat in ALYATEC((R)) environmental exposure chamber. Clin Exp Allergy. 2020;50(2):160-169. https://doi.org/10.1111/cea.13511. Rogol AD, Tkachenko N, Badorrek P, Hohlfeld JM, Bryson N. Phase 1 pharmacokinetics and phase 3 efficacy of testosterone nasal gel in subjects with seasonal allergies. Can Urol Assoc J. 2018;12(7):E349-E356. https://doi.org/10.5489/cuaj.4898. Khayath N, Doyen V, Gherasim A, et al. Validation of Strasbourg environmental exposure chamber (EEC) ALYATEC((R)) in mite allergic subjects with asthma. J Asthma. 2020;57(2):140-148. https://doi.org/10.1080/02770903.2018.1563902. Zieglmayer P, Lemell P, Chen KW, et al. Clinical validation of a house dust mite environmental challenge chamber model. J Allergy Clin Immunol. 2017;140(1):266-268.e5. https://doi.org/10.1016/j.jaci.2016.12.986. Koriyama M, Okamoto Y, Suzuki T, et al. Characteristics of Japanese cypress pollen-induced allergic rhinitis by environmental challenge chamber. Allergol Int. 2022;71(1):144-146. https://doi.org/10.1016/j.alit.2021.08.013. Gomes PJ, Lane KJ, Angjeli E, Stein L, Abelson MB. Technical and clinical validation of an environmental exposure unit for ragweed. J Asthma Allergy. 2016;9:215-221. https://doi.org/10.2147/JAA.S123547. Pfaar O, Zieglmayer P. Allergen exposure chambers: implementation in clinical trials in allergen immunotherapy. Clin Transl Allergy. 2020;10:33. https://doi.org/10.1186/s13601-020-00336-9. Pfaar O, Agache I, de Blay F, et al. Perspectives in allergen immunotherapy: 2019 and beyond. Allergy. 2019;74(suppl 108):3-25. https://doi.org/10.1111/all.14077. Pfaar O, Alvaro M, Cardona V, Hamelmann E, Mosges R, Kleine-Tebbe J. Clinical trials in allergen immunotherapy: current concepts and future needs. Allergy. 2018;73(9):1775-1783. https://doi.org/10.1111/all.13429. Pfaar O, Bergmann KC, Bonini S, et al. Technical standards in allergen exposure chambers worldwide - an EAACI Task Force Report. Allergy. 2021;76(12):3589-3612. https://doi.org/10.1111/all.14957. Ellis AK, DeVeaux M, Steacy L, et al. Environmental exposure unit simulates natural seasonal birch pollen exposures while maximizing change in allergic symptoms. Ann Allergy Asthma Immunol. 2021;127(4):488-495.e5. https://doi.org/10.1016/j.anai.2021.06.015. Agache I, Bilo M, Braunstahl GJ, et al. In vivo diagnosis of allergic diseases-allergen provocation tests. Allergy. 2015;70(4):355-365. https://doi.org/10.1111/all.12586. Riechelmann H, Epple B, Gropper G. Comparison of conjunctival and nasal provocation test in allergic rhinitis to house dust mite. Int Arch Allergy Immunol. 2003;130(1):51-59. https://doi.org/10.1159/000068369. Dordal MT, Lluch-Bernal M, Sanchez MC, et al. Allergen-specific nasal provocation testing: review by the rhinoconjunctivitis committee of the Spanish Society of Allergy and Clinical Immunology. J Investig Allergol Clin Immunol. 2011;21(1):1-12, quiz follow 12. Malm L, Gerth van Wijk R, Bachert C. Guidelines for nasal provocations with aspects on nasal patency, airflow, and airflow resistance. International Committee on Objective Assessment of the Nasal Airways, International Rhinologic Society. Rhinology. 2000;38(1):1-6. Gosepath J, Amedee RG, Mann WJ. Nasal provocation testing as an international standard for evaluation of allergic and nonallergic rhinitis. Laryngoscope. 2005;115(3):512-516. https://doi.org/10.1097/01.MLG.0000149682.56426.6B. Auge J, Vent J, Agache I, et al. EAACI Position paper on the standardization of nasal allergen challenges. Allergy. 2018;73(8):1597-1608. https://doi.org/10.1111/all.13416. Casset A, Khayath N, de Blay F. How in vitro assays contribute to allergy diagnosis. Curr Allergy Asthma Rep. 2016;16(11):82. https://doi.org/10.1007/s11882-016-0659-9. Santos AF, Alpan O, Hoffmann HJ. Basophil activation test: mechanisms and considerations for use in clinical trials and clinical practice. Allergy. 2021;76(8):2420-2432. https://doi.org/10.1111/all.14747. Larson D, Patel P, Salapatek AM, et al. Nasal allergen challenge and environmental exposure chamber challenge: a randomized trial comparing clinical and biological responses to cat allergen. J Allergy Clin Immunol. 2020;145(6):1585-1597. https://doi.org/10.1016/j.jaci.2020.02.024. Wanjun W, Qiurong H, Yanqing X, Mo X, Nili W, Jing L. Responsiveness of nasal provocation testing-but not skin test and specific immunoglobulin E blood level-correlates with severity of allergic rhinitis in dermatophagoides species-sensitized patients. Am J Rhinol Allergy. 2018;32(4):236-243. https://doi.org/10.1177/1945892418779435. Joo SH, Hyun KJ, Kim YH. Korean modification of the nasal provocation test with house dust mite antigen following the EAACI guidelines. Clin Exp Otorhinolaryngol. 2021;14(4):382-389. https://doi.org/10.21053/ceo.2020.00563. Xiao H, Jia Q, Zhang H, Zhang L, Liu G, Meng J. The importance of nasal provocation testing in the diagnosis of dermatophagoides pteronyssinus-induced allergic rhinitis. Am J Rhinol Allergy. 2022;36(2):191-197. https://doi.org/10.1177/19458924211037913. EAACI Task Force on Occupational Rhinitis, Moscato G, Vandenplas O, et al. Occupational rhinitis. Allergy. 2008;63(8):969-980. https://doi.org/10.1111/j.1398-9995.2008.01801.x. Rondon C, Campo P, Herrera R, et al. Nasal allergen provocation test with multiple aeroallergens detects polysensitization in local allergic rhinitis. J Allergy Clin Immunol. 2011;128(6):1192-1197. https://doi.org/10.1016/j.jaci.2011.06.012. Tantilipikorn P, Siriboonkoom P, Sookrung N, et al. Prevalence of local allergic rhinitis to Dermatophagoides pteronyssinus in chronic rhinitis with negative skin prick test. Asian Pac J Allergy Immunol. 2021;39(2):111-116. https://doi.org/10.12932/AP-170918-0408. Moller C, Bjorksten B, Nilsson G, Dreborg S. The precision of the conjunctival provocation test. Allergy. 1984;39(1):37-41. https://doi.org/10.1111/j.1398-9995.1984.tb01931.x. Bertel F, Mortemousque B, Sicard H, André C. Test de provocation conjonctival au Dermatophagoïdes pteronyssinus dans le diagnostic des conjonctivites allergiques aux acariens domestiques [Conjunctival provocation test with Dermatophagoides pteronyssinus in the diagnosis of allergic conjunctivitis from house mites]. J Fr Ophtalmol. 2001;24(6):581-589. Fauquert JL, Jedrzejczak-Czechowicz M, Rondon C, et al. Conjunctival allergen provocation test : guidelines for daily practice. Allergy. 2017;72(1):43-54. https://doi.org/10.1111/all.12986. Schoos AM, Chawes BL, Bloch J, et al. Children monosensitized to Can f 5 show different reactions to male and female dog allergen extract provocation: a randomized controlled trial. J Allergy Clin Immunol Pract. 2020;8(5):1592-1597.e2. https://doi.org/10.1016/j.jaip.2019.12.012. Gelis S, Rueda M, Pascal M, et al., Usefulness of the Nasal Allergen Provocation Test in the Diagnosis of Shellfish Allergy. J Investig Allergol Clin Immunol. 2022;32(6):460-470. doi: https://doi.org/10.18176/jiaci.0736. Krzych-Falta E, Furmanczyk K, Samolinski B. Specificity and sensitivity assessment of selected nasal provocation testing techniques. Postepy Dermatol Alergol. 2016;33(6):464-468. https://doi.org/10.5114/pdia.2016.61339. de Blay F, Doyen V, Lutz C, et al. A new, faster, and safe nasal provocation test method for diagnosing mite allergic rhinitis. Ann Allergy Asthma Immunol. 2015;115(5):385-390.e1. https://doi.org/10.1016/j.anai.2015.07.014. Agarwal G, Hernandez D, Citardi MJ, Fakhri S, Luong A. End-organ testing for allergic rhinitis with fungi is poorly correlated with fungal sensitivity. Otolaryngol Head Neck Surg. 2013;148(3):391-395. https://doi.org/10.1177/0194599812474224. Gelardi M, Iannuzzi L, Quaranta N, Landi M, Passalacqua G. NASAL cytology: practical aspects and clinical relevance. Clin Exp Allergy. 2016;46(6):785-792. https://doi.org/10.1111/cea.12730. Waecker NJ, Jr., Shope TR, Weber PA, Buck ML, Domingo RC, Hooper DG. The Rhino-Probe nasal curette for detecting respiratory syncytial virus in children. Pediatr Infect Dis J. 1993;12(4):326-329. https://doi.org/10.1097/00006454-199304000-00012. Gelardi M, Passalacqua G, Fiorella ML, Quaranta N. Assessment of biofilm by nasal cytology in different forms of rhinitis and its functional correlations. Eur Ann Allergy Clin Immunol. 2013;45(1):25-29. Canakcioglu S, Tahamiler R, Saritzali G, et al. Evaluation of nasal cytology in subjects with chronic rhinitis: a 7-year study. Am J Otolaryngol. 2009;30(5):312-317. https://doi.org/10.1016/j.amjoto.2008.06.015. Di Lorenzo G, Pacor ML, Amodio E, et al. Differences and similarities between allergic and nonallergic rhinitis in a large sample of adult patients with rhinitis symptoms. Int Arch Allergy Immunol. 2011;155(3):263-270. https://doi.org/10.1159/000320050. Gelardi M, Ciprandi G, Incorvaia C, et al. Allergic rhinitis phenotypes based on mono-allergy or poly-allergy. Inflamm Res. 2015;64(6):373-375. https://doi.org/10.1007/s00011-015-0826-9. Gelardi M, Incorvaia C, Passalacqua G, Quaranta N, Frati F. The classification of allergic rhinitis and its cytological correlate. Allergy. 2011;66(12):1624-1625. https://doi.org/10.1111/j.1398-9995.2011.02741.x. Gelardi M, Peroni DG, Incorvaia C, et al. Seasonal changes in nasal cytology in mite-allergic patients. J Inflamm Res. 2014;7:39-44. https://doi.org/10.2147/JIR.S54581. Ciofalo A, Cavaliere C, Incorvaia C, et al. Diagnostic performance of nasal cytology. Eur Arch Otorhinolaryngol. 2022;279(5):2451-2455. https://doi.org/10.1007/s00405-021-07044-5. Cavaliere C, Masieri S, Greco A, Lambiase A, Segatto M. Nasal expression of the vascular endothelial growth factor and its receptors is reduced by mepolizumab in chronic rhinosinusitis with nasal polyposis. Ann Allergy Asthma Immunol. 2021;126(4):442-443. https://doi.org/10.1016/j.anai.2021.01.010. Chen Y, Yang M, Deng J, Wang K, Shi J, Sun Y. Elevated levels of activated and pathogenic eosinophils characterize moderate-severe house dust mite allergic rhinitis. J Immunol Res. 2020;2020:8085615. https://doi.org/10.1155/2020/8085615. Spector SL, English G, Jones L. Clinical and nasal biopsy response to treatment of perennial rhinitis. J Allergy Clin Immunol. 1980;66(2):129-137. https://doi.org/10.1016/0091-6749(80)90060-3. Lim MC, Taylor RM, Naclerio RM. The histology of allergic rhinitis and its comparison to cellular changes in nasal lavage. Am J Respir Crit Care Med. 1995;151(1):136-144. https://doi.org/10.1164/ajrccm.151.1.7812543. Howarth PH, Persson CG, Meltzer EO, Jacobson MR, Durham SR, Silkoff PE. Objective monitoring of nasal airway inflammation in rhinitis. J Allergy Clin Immunol. 2005;115(3 suppl 1):S414-S441. https://doi.org/10.1016/j.jaci.2004.12.1134. De Corso E, Seccia V, Ottaviano G, et al. Clinical Evidence of Type 2 inflammation in non-allergic rhinitis with eosinophilia syndrome: a systematic review. Curr Allergy Asthma Rep. 2022;22(4):29-42. https://doi.org/10.1007/s11882-022-01027-0. Phothijindakul N, Chusakul S, Aeumjaturapat S, et al. Nasal cytology as a diagnostic tool for local allergic rhinitis. Am J Rhinol Allergy. 2019;33(5):540-544. https://doi.org/10.1177/1945892419850926. Gelardi M. "Overlapped" rhinitis: a real trap for rhinoallergologists. Eur Ann Allergy Clin Immunol. 2014;46(6):234-236. McHugh T, Levin M, Snidvongs K, Banglawala SM, Sommer DD. Comorbidities associated with eosinophilic chronic rhinosinusitis: a systematic review and meta-analysis. Clin Otolaryngol. 2020;45(4):574-583. https://doi.org/10.1111/coa.13536. Sivam A, Jeswani S, Reder L, et al. Olfactory cleft inflammation is present in seasonal allergic rhinitis and is reduced with intranasal steroids. Am J Rhinol Allergy. 2010;24(4):286-290. https://doi.org/10.2500/ajra.2010.24.3478. Uller L, Emanuelsson CA, Andersson M, Erjefalt JS, Greiff L, Persson CG. Early phase resolution of mucosal eosinophilic inflammation in allergic rhinitis. Respir Res. 2010;11:54. https://doi.org/10.1186/1465-9921-11-54. Asai K, Foley SC, Sumi Y, et al. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy increases CD4+CD25+ T cells in the nasal mucosa of subjects with allergic rhinitis. Allergol Int. 2008;57(4):377-381. https://doi.org/10.2332/allergolint.O-07-528. Rak S, Heinrich C, Scheynius A. Comparison of nasal immunohistology in patients with seasonal rhinoconjunctivitis treated with topical steroids or specific allergen immunotherapy. Allergy. 2005;60(5):643-649. https://doi.org/10.1111/j.1398-9995.2005.00763.x. Plewako H, Arvidsson M, Petruson K, et al. The effect of omalizumab on nasal allergic inflammation. J Allergy Clin Immunol. 2002;110(1):68-71. https://doi.org/10.1067/mai.2002.125488. Pullerits T, Linden A, Malmhall C, Lotvall J. Effect of seasonal allergen exposure on mucosal IL-16 and CD4+ cells in patients with allergic rhinitis. Allergy. 2001;56(9):871-877. Wilson DR, Nouri-Aria KT, Walker SM, et al. Grass pollen immunotherapy: symptomatic improvement correlates with reductions in eosinophils and IL-5 mRNA expression in the nasal mucosa during the pollen season. J Allergy Clin Immunol. 2001;107(6):971-976. https://doi.org/10.1067/mai.2001.115483. Radulovic S, Jacobson MR, Durham SR, Nouri-Aria KT. Grass pollen immunotherapy induces Foxp3-expressing CD4+ CD25+ cells in the nasal mucosa. J Allergy Clin Immunol. 2008;121(6):1467-1472, 1472.e1. https://doi.org/10.1016/j.jaci.2008.03.013. Till SJ, Jacobson MR, O'Brien F, et al. Recruitment of CD1a+ Langerhans cells to the nasal mucosa in seasonal allergic rhinitis and effects of topical corticosteroid therapy. Allergy. 2001;56(2):126-131. https://doi.org/10.1034/j.1398-9995.2001.056002126.x. Vogt K, Bachmann-Harildstad G, Lintermann A, Nechyporenko A, Peters F, Wernecke KD. The new agreement of the international RIGA consensus conference on nasal airway function tests. Rhinology. 2018;56(2):133-143. https://doi.org/10.4193/Rhin17.084. Vogt K, Wernecke KD, Behrbohm H, Gubisch W, Argale M. Four-phase rhinomanometry: a multicentric retrospective analysis of 36,563 clinical measurements. Eur Arch Otorhinolaryngol. 2016;273(5):1185-1198. https://doi.org/10.1007/s00405-015-3723-5. Rimmer J, Hellings P, Lund VJ, et al. European position paper on diagnostic tools in rhinology. Rhinology. 2019;57(suppl S28):1-41. https://doi.org/10.4193/Rhin19.410. Clement PA. Committee report on standardization of rhinomanometry. Rhinology. 1984;22(3):151-155. Ohki M, Naito K, Cole P. Dimensions and resistances of the human nose: racial differences. Laryngoscope. 1991;101(3):276-278. https://doi.org/10.1288/00005537-199103000-00009. Jones AS, Lancer JM, Stevens JC, Beckingham E. Nasal resistance to airflow (its measurement, reproducibility and normal parameters). J Laryngol Otol. 1987;101(8):800-808. https://doi.org/10.1017/s0022215100102762. Cole P. Stability of nasal airflow resistance. Clin Otolaryngol Allied Sci. 1989;14(2):177-1782. https://doi.org/10.1111/j.1365-2273.1989.tb00357.x. Shelton DM, Eiser NM. Evaluation of active anterior and posterior rhinomanometry in normal subjects. Clin Otolaryngol Allied Sci. 1992;17(2):178-182. https://doi.org/10.1111/j.1365-2273.1992.tb01068.x. Chen IC, Lin YT, Hsu JH, Liu YC, Wu JR, Dai ZK. Nasal airflow measured by rhinomanometry correlates with FeNO in children with asthma. PLoS One. 2016;11(10):e0165440. https://doi.org/10.1371/journal.pone.0165440. Merkle J, Kohlhas L, Zadoyan G, Mosges R, Hellmich M. Rhinomanometric reference intervals for normal total nasal airflow resistance. Rhinology. 2014;52(4):292-299. https://doi.org/10.4193/Rhino13.220. Suzina AH, Hamzah M, Samsudin AR. Active anterior rhinomanometry analysis in normal adult Malays. J Laryngol Otol. 2003;117(8):605-608. https://doi.org/10.1258/002221503768199924. Vogt K, Jalowayski AA, Althaus W, et al. 4-Phase-Rhinomanometry (4PR)-basics and practice 2010. Rhinol Suppl. 2010;21:1-50. Andre RF, Vuyk HD, Ahmed A, Graamans K, Nolst Trenite GJ. Correlation between subjective and objective evaluation of the nasal airway. A systematic review of the highest level of evidence. Clin Otolaryngol. 2009;34(6):518-525. https://doi.org/10.1111/j.1749-4486.2009.02042.x. Mohan S, Fuller JC, Ford SF, Lindsay RW. Diagnostic and therapeutic management of nasal airway obstruction: advances in diagnosis and treatment. JAMA Facial Plast Surg. 2018;20(5):409-418. https://doi.org/10.1001/jamafacial.2018.0279. Tarhan E, Coskun M, Cakmak O, Celik H, Cankurtaran M. Acoustic rhinometry in humans: accuracy of nasal passage area estimates, and ability to quantify paranasal sinus volume and ostium size. J Appl Physiol (1985). 2005;99(2):616-623. https://doi.org/10.1152/japplphysiol.00106.2005. Timperley D, Srubisky A, Stow N, Marcells GN, Harvey RJ. Minimal clinically important differences in nasal peak inspiratory flow. Rhinology. 2011;49(1):37-40. https://doi.org/10.4193/Rhino10.097. Chin D, Marcells G, Malek J, et al. Nasal peak inspiratory flow (NPIF) as a diagnostic tool for differentiating decongestable from structural nasal obstruction. Rhinology. 2014;52(2):116-121. https://doi.org/10.4193/Rhino13.126. Kirtsreesakul V, Leelapong J, Ruttanaphol S. Correlation between peak nasal flow reversibility and mucociliary clearance in allergic rhinitis. Laryngoscope. 2020;130(6):1372-1376. https://doi.org/10.1002/lary.28226. Mo S, Gupta SS, Stroud A, et al. Nasal peak inspiratory flow in healthy and obstructed patients: systematic review and meta-analysis. Laryngoscope. 2021;131(2):260-267. https://doi.org/10.1002/lary.28682. Krzych-Falta E, Samolinski BK. Objectification of the nasal patency assessment techniques used in nasal allergen provocation testing. Postepy Dermatol Alergol. 2020;37(5):635-640. https://doi.org/10.5114/ada.2019.81404. Ottaviano G, Ermolao A, Nardello E, et al. Breathing parameters associated to two different external nasal dilator strips in endurance athletes. Auris Nasus Larynx. 2017;44(6):713-718. https://doi.org/10.1016/j.anl.2017.01.006. Kirtsreesakul V, Leelapong J, Ruttanaphol S. Nasal peak inspiratory and expiratory flow measurements for assessing nasal obstruction in allergic rhinitis. Am J Rhinol Allergy. 2014;28(2):126-130. https://doi.org/10.2500/ajra.2014.28.4008. Wong DK, Saim L, Idrus RB, Saim A. Evaluating the incidence and severity of rhinitis using an peak nasal inspiratory flow meter and the SNOT-22 questionnaire. J Med Assoc Thai. 2021;104(5):701-708. Canakcioglu S, Tahamiler R, Saritzali G, Isildak H, Alimoglu Y. Nasal patency by rhinomanometry in patients with sensation of nasal obstruction. Am J Rhinol Allergy. 2009;23(3):300-302. https://doi.org/10.2500/ajra.2009.23.3312. Passali D, Mezzedimi C, Passali GC, Nuti D, Bellussi L. The role of rhinomanometry, acoustic rhinometry, and mucociliary transport time in the assessment of nasal patency. Ear Nose Throat J. 2000;79(5):397-400. Garcia GJM, Hariri BM, Patel RG, Rhee JS. The relationship between nasal resistance to airflow and the airspace minimal cross-sectional area. J Biomech. 2016;49(9):1670-1678. https://doi.org/10.1016/j.jbiomech.2016.03.051. Aksoy C, Elsurer C, Artac H, Bozkurt MK. Evaluation of olfactory function in children with seasonal allergic rhinitis and its correlation with acoustic rhinometry. Int J Pediatr Otorhinolaryngol. 2018;113:188-191. https://doi.org/10.1016/j.ijporl.2018.07.051. Barnes ML, Lipworth BJ. Removing nasal valve obstruction in peak nasal inspiratory flow measurement. Ann Allergy Asthma Immunol. 2007;99(1):59-60. https://doi.org/10.1016/S1081-1206(10)60622-9. Burrow A, Eccles R, Jones AS. The effects of camphor, eucalyptus and menthol vapour on nasal resistance to airflow and nasal sensation. Acta Otolaryngol. 1983;96(1-2):157-161. https://doi.org/10.3109/00016488309132886. Eccles R, Jones AS. The effect of menthol on nasal resistance to air flow. J Laryngol Otol. 1983;97(8):705-709. https://doi.org/10.1017/s002221510009486x. Jones AS, Lancer JM, Shone G, Stevens JC. The effect of lignocaine on nasal resistance and nasal sensation of airflow. Acta Otolaryngol. 1986;101(3-4):328-330. https://doi.org/10.3109/00016488609132846. Eccles R, Griffiths DH, Newton CG, Tolley NS. The effects of menthol isomers on nasal sensation of airflow. Clin Otolaryngol Allied Sci. 1988;13(1):25-29. https://doi.org/10.1111/j.1365-2273.1988.tb00277.x. Naito K, Ohoka E, Kato R, Kondo Y, Iwata S. The effect of L-menthol stimulation of the major palatine nerve on nasal patency. Auris Nasus Larynx. 1991;18(3):221-226. https://doi.org/10.1016/s0385-8146(12)80260-4. Naito K, Komori M, Kondo Y, Takeuchi M, Iwata S. The effect of L-menthol stimulation of the major palatine nerve on subjective and objective nasal patency. Auris Nasus Larynx. 1997;24(2):159-162. https://doi.org/10.1016/S0385-8146(96)00005-3. Jones AS, Crosher R, Wight RG, Lancer JM, Beckingham E. The effect of local anaesthesia of the nasal vestibule on nasal sensation of airflow and nasal resistance. Clin Otolaryngol Allied Sci. 1987;12(6):461-464. https://doi.org/10.1111/j.1365-2273.1987.tb00233.x. Barnes ML, White PS, Gardiner Q. Re: correlation between subjective and objective evaluation of the nasal airway. Clin Otolaryngol. 2010;35(2):152-153; author reply 153. https://doi.org/10.1111/j.1749-4486.2010.02110.x. van Spronsen E, Ingels KJ, Jansen AH, Graamans K, Fokkens WJ. Evidence-based recommendations regarding the differential diagnosis and assessment of nasal congestion: using the new GRADE system. Allergy. 2008;63(7):820-833. https://doi.org/10.1111/j.1398-9995.2008.01729.x. Ta NH, Gao J, Philpott C. A systematic review to examine the relationship between objective and patient-reported outcome measures in sinonasal disorders: recommendations for use in research and clinical practice. Int Forum Allergy Rhinol. 2021;11(5):910-923. https://doi.org/10.1002/alr.22744. Vogt K, Hasse W, Jalowayski AA. New resistance patterns in rhinomanometry: clinical evaluation of 5000 measurements. presented at: European Rhinologic Society; 2002. Iyer A, Athavale A. Nasal airway resistance and latent lower airway involvement in allergic rhinitis. J Assoc Physicians India. 2020;68(3):43-47. Pantin CT, Southworth T, Wetzel K, Singh D. Reproducibility of nasal allergen challenge responses in adults with allergic rhinitis. Clin Pharmacol. 2019;11:67-76. https://doi.org/10.2147/CPAA.S184404. Wong EH, Eccles R. Comparison of classic and 4-phase rhinomanometry methods, is there any difference? Rhinology. 2014;52(4):360-365. https://doi.org/10.4193/Rhino13.187. Brindisi G, De Vittori V, De Nola R, et al. The role of nasal nitric oxide and anterior active rhinomanometry in the diagnosis of allergic rhinitis and asthma: a message for pediatric clinical practice. J Asthma Allergy. 2021;14:265-274. https://doi.org/10.2147/JAA.S275692. Wandalsen GF, Mendes AI, Matsumoto F, Sole D. Acoustic rhinometry in nasal provocation tests in children and adolescents. J Investig Allergol Clin Immunol. 2016;26(3):156-160. https://doi.org/10.18176/jiaci.0036. Malizia V, Ferrante G, Cilluffo G, Fasola S, Montalbano L, La Grutta S. Rhinomanometry: point of care test (POCT) for allergic rhinitis in children? Allergol Immunopathol (Madr). 2021;49(5):28-31. https://doi.org/10.15586/aei.v49i5.429. Valero A, Navarro AM, Del Cuvillo A, et al. Position paper on nasal obstruction: evaluation and treatment. J Investig Allergol Clin Immunol. 2018;28(2):67-90. https://doi.org/10.18176/jiaci.0232. Takeno S, Okabayashi Y, Kohno T, Yumii K, Hirakawa K. The role of nasal fractional exhaled nitric oxide as an objective parameter independent of nasal airflow resistance in the diagnosis of allergic rhinitis. Auris Nasus Larynx. 2017;44(4):435-441. https://doi.org/10.1016/j.anl.2016.09.007. Demirbas D, Cingi C, Cakli H, Kaya E. Use of rhinomanometry in common rhinologic disorders. Expert Rev Med Devices. 2011;8(6):769-777. https://doi.org/10.1586/erd.11.45. Eguiluz-Gracia I, Testera-Montes A, Salas M, et al. Comparison of diagnostic accuracy of acoustic rhinometry and symptoms score for nasal allergen challenge monitoring. Allergy. 2021;76(1):371-375. https://doi.org/10.1111/all.14499. Isaac A, Major M, Witmans M, et al. Correlations between acoustic rhinometry, subjective symptoms, and endoscopic findings in symptomatic children with nasal obstruction. JAMA Otolaryngol Head Neck Surg. 2015;141(6):550-555. https://doi.org/10.1001/jamaoto.2015.0468. Wandalsen GF, Mendes AI, Sole D. Correlation between nasal resistance and different acoustic rhinometry parameters in children and adolescents with and without allergic rhinitis. Braz J Otorhinolaryngol. 2012;78(6):81-86. https://doi.org/10.5935/1808-8694.20120038. Ozturk F, Turktas I, Asal K, Ileri F, Munevver Pinar N. Effect of intranasal triamcinolone acetonide on bronchial hyper-responsiveness in children with seasonal allergic rhinitis and comparison of perceptional nasal obstruction with acoustic rhinometric assessment. Int J Pediatr Otorhinolaryngol. 2004;68(8):1007-1015. https://doi.org/10.1016/j.ijporl.2004.03.006. Sikorska-Szaflik H, Sozanska B. Peak nasal inspiratory flow in children with allergic rhinitis. Is it related to the quality of life? Allergol Immunopathol (Madr). 2020;48(2):187-193. https://doi.org/10.1016/j.aller.2019.08.002. Neighbour H, Soliman M, Steacy LM, et al. The Allergic Rhinitis Clinical Investigator Collaborative (AR-CIC): verification of nasal allergen challenge procedures in a study utilizing an investigational immunotherapy for cat allergy. Clin Transl Allergy. 2018;8:15. https://doi.org/10.1186/s13601-018-0198-7. Gupta N, Goel N, Kumar R. Correlation of exhaled nitric oxide, nasal nitric oxide and atopic status: a cross-sectional study in bronchial asthma and allergic rhinitis. Lung India. 2014;31(4):342-347. https://doi.org/10.4103/0970-2113.142107. Kimberly B, Nejadnik B, Giraud GD, Holden WE. Nasal contribution to exhaled nitric oxide at rest and during breathholding in humans. Am J Respir Crit Care Med. 1996;153(2):829-836. https://doi.org/10.1164/ajrccm.153.2.8564139. Lundberg JO, Farkas-Szallasi T, Weitzberg E, et al. High nitric oxide production in human paranasal sinuses. Nat Med. 1995;1(4):370-373. https://doi.org/10.1038/nm0495-370. Chatkin JM, Qian W, McClean PA, Zamel N, Haight J, Silkoff P. Nitric oxide accumulation in the nonventilated nasal cavity. Arch Otolaryngol Head Neck Surg. 1999;125(6):682-685. https://doi.org/10.1001/archotol.125.6.682. American Thoracic S, European Respiratory S. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med. 2005;171(8):912-930. https://doi.org/10.1164/rccm.200406-710ST. Malmberg LP, Petays T, Haahtela T, et al. Exhaled nitric oxide in healthy nonatopic school-age children: determinants and height-adjusted reference values. Pediatr Pulmonol. 2006;41(7):635-642. https://doi.org/10.1002/ppul.20417. Franklin PJ, Taplin R, Stick SM. A community study of exhaled nitric oxide in healthy children. Am J Respir Crit Care Med. 1999;159(1):69-73. https://doi.org/10.1164/ajrccm.159.1.9804134. Franklin PJ, Turner SW, Le Souef PN, Stick SM. Exhaled nitric oxide and asthma: complex interactions between atopy, airway responsiveness, and symptoms in a community population of children. Thorax. 2003;58(12):1048-1052. https://doi.org/10.1136/thorax.58.12.1048. Khatri SB, Iaccarino JM, Barochia A, et al. Use of fractional exhaled nitric oxide to guide the treatment of asthma: an official american thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2021;204(10):e97-e109. https://doi.org/10.1164/rccm.202109-2093ST. van Asch CJ, Balemans WA, Rovers MM, Schilder AG, van der Ent CK. Atopic disease and exhaled nitric oxide in an unselected population of young adults. Ann Allergy Asthma Immunol. 2008;100(1):59-65. https://doi.org/10.1016/S1081-1206(10)60406-1. Dweik RA, Sorkness RL, Wenzel S, et al. Use of exhaled nitric oxide measurement to identify a reactive, at-risk phenotype among patients with asthma. Am J Respir Crit Care Med. 2010;181(10):1033-1041. https://doi.org/10.1164/rccm.200905-0695OC. Moore WC, Meyers DA, Wenzel SE, et al. Identification of asthma phenotypes using cluster analysis in the Severe Asthma Research Program. Am J Respir Crit Care Med. 2010;181(4):315-323. https://doi.org/10.1164/rccm.200906-0896OC. Maniscalco M, Calabrese C, D'Amato M, et al. Association between exhaled nitric oxide and nasal polyposis in severe asthma. Respir Med. 2019;152:20-24. https://doi.org/10.1016/j.rmed.2019.04.017. Lipworth B, Kuo CR, Chan R. 2020 Updated Asthma Guidelines: clinical utility of fractional exhaled nitric oxide (Feno) in asthma management. J Allergy Clin Immunol. 2020;146(6):1281-1282. https://doi.org/10.1016/j.jaci.2020.03.006. Bencova A, Rozborilova E, Antosova M. Bidirectional link between upper and lower airways in patients with allergic rhinitis. Eur J Med Res. 2009;(14 suppl 4):18-20. https://doi.org/10.1186/2047-783x-14-s4-18. Hervas D, Rodriguez R, Garde J. Role of aeroallergen nasal challenge in asthmatic children. Allergol Immunopathol (Madr). 2011;39(1):17-22. https://doi.org/10.1016/j.aller.2010.03.003. Jang YY, Ahn JY. Evaluation of fractional exhaled nitric oxide in pediatric asthma and allergic rhinitis. Children (Basel). 2020;8(1):3. https://doi.org/10.3390/children8010003. Choi BS, Kim KW, Lee YJ, et al. Exhaled nitric oxide is associated with allergic inflammation in children. J Korean Med Sci. 2011;26(10):1265-1269. https://doi.org/10.3346/jkms.2011.26.10.1265. Lundberg JO, Nordvall SL, Weitzberg E, Kollberg H, Alving K. Exhaled nitric oxide in paediatric asthma and cystic fibrosis. Arch Dis Child. 1996;75(4):323-326. https://doi.org/10.1136/adc.75.4.323. Byrnes CA, Dinarevic S, Shinebourne EA, Barnes PJ, Bush A. Exhaled nitric oxide measurements in normal and asthmatic children. Pediatr Pulmonol. 1997;24(5):312-318. https://doi.org/10.1002/(sici)1099-0496(199711)24:5<312::aid-ppul2>3.0.co;2-k. Baraldi E, Azzolin NM, Carra S, Dario C, Marchesini L, Zacchello F. Effect of topical steroids on nasal nitric oxide production in children with perennial allergic rhinitis: a pilot study. Respir Med. 1998;92(3):558-561. https://doi.org/10.1016/s0954-6111(98)90308-0. Dweik RA, Boggs PB, Erzurum SC, et al. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med. 2011;184(5):602-615. https://doi.org/10.1164/rccm.9120-11ST. Shapiro AJ, Dell SD, Gaston B, et al. Nasal nitric oxide measurement in primary ciliary dyskinesia. A technical paper on standardized testing protocols. Ann Am Thorac Soc. 2020;17(2):e1-e12. https://doi.org/10.1513/AnnalsATS.201904-347OT. Lee KJ, Cho SH, Lee SH, et al. Nasal and exhaled nitric oxide in allergic rhinitis. Clin Exp Otorhinolaryngol. 2012;5(4):228-33. https://doi.org/10.3342/ceo.2012.5.4.228. Dotsch J, Demirakca S, Terbrack HG, Huls G, Rascher W, Kuhl PG. Airway nitric oxide in asthmatic children and patients with cystic fibrosis. Eur Respir J. 1996;9(12):2537-2540. https://doi.org/10.1183/09031936.96.09122537. Martin U, Bryden K, Devoy M, Howarth P. Increased levels of exhaled nitric oxide during nasal and oral breathing in subjects with seasonal rhinitis. J Allergy Clin Immunol. 1996;97(3):768-772. https://doi.org/10.1016/s0091-6749(96)80154-0. Kalpaklioglu AF, Baccioglu A, Yalim SA. Can nasal nitric oxide be a biomarker to differentiate allergic and non-allergic rhinitis? Egypt J Otolaryngol. 2021;37(1):91. Ambrosino P, Parrella P, Formisano R, et al. Clinical application of nasal nitric oxide measurement in allergic rhinitis: a systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2020;125(4):447-459.e5. https://doi.org/10.1016/j.anai.2020.07.003. Wang B, Wu Z, Wang F, Yin Z, Shi L, Liu Y. Nasal nitric oxide testing for allergic rhinitis patients: Systematic review and meta-analysis. Immun Inflamm Dis. 2021;9(3):635-648. https://doi.org/10.1002/iid3.439. Maniscalco M, Sofia M, Carratu L, Higenbottam T. Effect of nitric oxide inhibition on nasal airway resistance after nasal allergen challenge in allergic rhinitis. Eur J Clin Invest. 2001;31(5):462-466. https://doi.org/10.1046/j.1365-2362.2001.00825.x. Moody A, Fergusson W, Wells A, Bartley J, Kolbe J. Nasal levels of nitric oxide as an outcome variable in allergic upper respiratory tract disease: influence of atopy and hayfever on nNO. Am J Rhinol. 2006;20(5):425-429. https://doi.org/10.2500/ajr.2006.20.2921. Henriksen AH, Sue-Chu M, Holmen TL, Langhammer A, Bjermer L. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J. 1999;13(2):301-306. https://doi.org/10.1034/j.1399-3003.1999.13b14.x. Phillips PS, Sacks R, Marcells GN, Cohen NA, Harvey RJ. Nasal nitric oxide and sinonasal disease: a systematic review of published evidence. Otolaryngol Head Neck Surg. 2011;144(2):159-169. https://doi.org/10.1177/0194599810392667. Hervas D, Milan JM, Garde J. Differences in exhaled nitric oxide in atopic children. Allergol Immunopathol (Madr). 2008;36(6):331-335. https://doi.org/10.1016/s0301-0546(08)75865-8. Mucci T, Govindaraj S, Tversky J. Allergic rhinitis. Mt Sinai J Med. 2011;78(5):634-644. https://doi.org/10.1002/msj.20287. Tversky J, McGlashan D. Short wave infrared (SWIR) camera as a novel approach to allergy skin testing. J Allergy Clin Immunol. 2017;139(2):AB156. Deshpande PR, Rajan S, Sudeepthi BL, Abdul Nazir CP. Patient-reported outcomes: a new era in clinical research. Perspect Clin Res. 2011;2(4):137-144. https://doi.org/10.4103/2229-3485.86879. Scadding GW, Calderon MA, Shamji MH, et al. Effect of 2 years of treatment with sublingual grass pollen immunotherapy on nasal response to allergen challenge at 3 years among patients with moderate to severe seasonal allergic rhinitis: the GRASS randomized clinical trial. JAMA. 2017;317(6):615-625. https://doi.org/10.1001/jama.2016.21040. Zieglmayer P, Focke-Tejkl M, Schmutz R, et al. Mechanisms, safety and efficacy of a B cell epitope-based vaccine for immunotherapy of grass pollen allergy. EBioMedicine. 2016;11:43-57. https://doi.org/10.1016/j.ebiom.2016.08.022. Mosbech H, Canonica GW, Backer V, et al. SQ house dust mite sublingually administered immunotherapy tablet (ALK) improves allergic rhinitis in patients with house dust mite allergic asthma and rhinitis symptoms. Ann Allergy Asthma Immunol. 2015;114(2):134-140. https://doi.org/10.1016/j.anai.2014.11.015. Casale TB. Anti-immunoglobulin E (omalizumab) therapy in seasonal allergic rhinitis. Am J Respir Crit Care Med. 2001;164(8 pt 2):S18-S21. https://doi.org/10.1164/ajrccm.164.supplement_1.2103023. Calderon MA, Bernstein DI, Blaiss M, Andersen JS, Nolte H. A comparative analysis of symptom and medication scoring methods used in clinical trials of sublingual immunotherapy for seasonal allergic rhinitis. Clin Exp Allergy. 2014;44(10):1228-1239. https://doi.org/10.1111/cea.12331. Devillier P, Bousquet PJ, Grassin-Delyle S, et al. Comparison of outcome measures in allergic rhinitis in children, adolescents and adults. Pediatr Allergy Immunol. 2016;27(4):375-381. https://doi.org/10.1111/pai.12561. Bedard A, Basagana X, Anto JM, et al. Mobile technology offers novel insights into the control and treatment of allergic rhinitis: The MASK study. J Allergy Clin Immunol. 2019;144(1):135-143.e6. https://doi.org/10.1016/j.jaci.2019.01.053. Glattacker M, Boeker M, Anger R, et al. Evaluation of a Mobile Phone App for patients with pollen-related allergic rhinitis: prospective longitudinal field study. JMIR Mhealth Uhealth. 2020;8(4):e15514. https://doi.org/10.2196/15514. Bousquet J, Bewick M, Arnavielhe S, et al. Work productivity in rhinitis using cell phones: The MASK pilot study. Allergy. 2017;72(10):1475-1484. https://doi.org/10.1111/all.13177. Sousa-Pinto B, Eklund P, Pfaar O, et al. Validity, reliability, and responsiveness of daily monitoring visual analog scales in MASK-air(R). Clin Transl Allergy. 2021;11(7):e12062. https://doi.org/10.1002/clt2.12062. Zhou AH, Patel VR, Baredes S, Eloy JA, Hsueh WD. Mobile applications for allergic rhinitis. Ann Otol Rhinol Laryngol. 2018;127(11):836-840. https://doi.org/10.1177/0003489418798385. Jacome C, Pereira R, Almeida R, et al. Validation of App and Phone Versions of the Control of Allergic Rhinitis and Asthma Test (CARAT). J Investig Allergol Clin Immunol. 2021;31(3):270-273. https://doi.org/10.18176/jiaci.0640. Hafner D, Reich K, Matricardi PM, Meyer H, Kettner J, Narkus A. Prospective validation of 'Allergy-Control-SCORE(TM)': a novel symptom-medication score for clinical trials. Allergy. 2011;66(5):629-636. https://doi.org/10.1111/j.1398-9995.2010.02531.x. Demoly P, Jankowski R, Chassany O, Bessah Y, Allaert FA. Validation of a self-questionnaire for assessing the control of allergic rhinitis. Clin Exp Allergy. 2011;41(6):860-868. https://doi.org/10.1111/j.1365-2222.2011.03734.x. Demoly P, Calderon MA, Casale T, et al. Assessment of disease control in allergic rhinitis. Clin Transl Allergy. 2013;3(1):7. https://doi.org/10.1186/2045-7022-3-7. Meltzer EO, Schatz M, Nathan R, Garris C, Stanford RH, Kosinski M. Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis. J Allergy Clin Immunol. 2013;131(2):379-386. https://doi.org/10.1016/j.jaci.2012.10.022. Spector SL, Nicklas RA, Chapman JA, et al. Symptom severity assessment of allergic rhinitis: part 1. Ann Allergy Asthma Immunol. 2003;91(2):105-114. https://doi.org/10.1016/s1081-1206(10)62160-6. Annesi-Maesano I, Didier A, Klossek M, Chanal I, Moreau D, Bousquet J. The score for allergic rhinitis (SFAR): a simple and valid assessment method in population studies. Allergy. 2002;57(2):107-114. https://doi.org/10.1034/j.1398-9995.2002.1o3170.x. Bousquet PJ, Combescure C, Neukirch F, et al. Visual analog scales can assess the severity of rhinitis graded according to ARIA guidelines. Allergy. 2007;62(4):367-372. https://doi.org/10.1111/j.1398-9995.2006.01276.x. Devillier P, Chassany O, Vicaut E, et al. The minimally important difference in the Rhinoconjunctivitis Total Symptom Score in grass-pollen-induced allergic rhinoconjunctivitis. Allergy. 2014;69(12):1689-1695. https://doi.org/10.1111/all.12518. Fonseca JA, Nogueira-Silva L, Morais-Almeida M, et al. Validation of a questionnaire (CARAT10) to assess rhinitis and asthma in patients with asthma. Allergy. 2010;65(8):1042-1048. https://doi.org/10.1111/j.1398-9995.2009.02310.x. Baiardini I, Pasquali M, Giardini A, et al. Rhinasthma: a new specific QoL questionnaire for patients with rhinitis and asthma. Allergy. 2003;58(4):289-294. https://doi.org/10.1034/j.1398-9995.2003.00079.x. Tosca MA, Del Barba P, Licari A, Ciprandi G, Asthma and Rhinitis Control Study Group. The measurement of asthma and allergic rhinitis control in children and adolescents. Children (Basel). 2020;7(5):43. https://doi.org/10.3390/children7050043. Demoly P, Emminger W, Rehm D, Backer V, Tommerup L, Kleine-Tebbe J. Effective treatment of house dust mite-induced allergic rhinitis with 2 doses of the SQ HDM SLIT-tablet: results from a randomized, double-blind, placebo-controlled phase III trial. J Allergy Clin Immunol. 2016;137(2):444-451.e8. https://doi.org/10.1016/j.jaci.2015.06.036. Galimberti M, Passalacqua G, Incorvaia C, et al. Catching allergy by a simple questionnaire. World Allergy Organ J. 2015;8(1):16. https://doi.org/10.1186/s40413-015-0067-y. Klimek L, Bachert C, Lukat KF, Pfaar O, Meyer H, Narkus A. Allergy immunotherapy with a hypoallergenic recombinant birch pollen allergen rBet v 1-FV in a randomized controlled trial. Clin Transl Allergy. 2015;5:28. https://doi.org/10.1186/s13601-015-0071-x. Benninger MS, Senior BA. The development of the Rhinosinusitis Disability Index. Arch Otolaryngol Head Neck Surg. 1997;123(11):1175-1179. https://doi.org/10.1001/archotol.1997.01900110025004. Benninger MS, Benninger RM. The impact of allergic rhinitis on sexual activity, sleep, and fatigue. Allergy Asthma Proc. 2009;30(4):358-365. https://doi.org/10.2500/aap.2009.30.3244. Kupczyk M, Baiardini I, Molinengo G, et al. Cross-cultural adaptation and validation of the RhinAsthma Patient Perspective (RAPP) in the Polish population. Postepy Dermatol Alergol. 2020;37(1):97-102. https://doi.org/10.5114/ada.2020.93387. Werner CU, Koch L, Linde K, et al. Prospective observational study validating the German version of the Control of Allergic Rhinitis and Asthma Test (CARAT10). NPJ Prim Care Respir Med. 2018;28(1):45. https://doi.org/10.1038/s41533-018-0112-8. Emons JA, Flokstra BM, de Jong C, et al. Use of the Control of Allergic Rhinitis and Asthma Test (CARATkids) in children and adolescents: validation in Dutch. Pediatr Allergy Immunol. 2017;28(2):185-190. https://doi.org/10.1111/pai.12678. Nurmatov U, van Schayck CP, Hurwitz B, Sheikh A. House dust mite avoidance measures for perennial allergic rhinitis: an updated Cochrane systematic review. Allergy. 2012;67(2):158-165. https://doi.org/10.1111/j.1398-9995.2011.02752.x. International Consensus Report on the diagnosis and management of rhinitis. International Rhinitis Management Working Group. Allergy. 1994;49(19 suppl):1-34. Mackay IS, Durham SR. ABC of allergies. Perennial rhinitis. BMJ. 1998;316(7135):917-920. https://doi.org/10.1136/bmj.316.7135.917. Woodcock A, Custovic A. ABC of allergies. Avoiding exposure to indoor allergens. BMJ. 1998;316(7137):1075-1078. https://doi.org/10.1136/bmj.316.7137.1075. Krouse HJ. Environmental controls and avoidance measures. Int Forum Allergy Rhinol. 2014;4(suppl 2):S32-S34. https://doi.org/10.1002/alr.21383. Ghazala L, Schmid F, Helbling A, Pichler WJ, Pichler CE. Efficacy of house dust mite and allergen impermeable encasisgs in patients with house dust mite allergy [German]. Allergologie. 2004;27:26-34. Kniest FM, Wolfs BJ, Vos H, et al. Mechanisms and patient compliance of dust-mite avoidance regimens in dwellings of mite-allergic rhinitic patients. Clin Exp Allergy. 1992;22(7):681-689. https://doi.org/10.1111/j.1365-2222.1992.tb00191.x. Moon JS, Choi SO. Environmental controls in reducing house dust mites and nasal symptoms in patients with allergic rhinitis. Yonsei Med J. 1999;40(3):238-243. https://doi.org/10.3349/ymj.1999.40.3.238. Reisman RE, Mauriello PM, Davis GB, Georgitis JW, DeMasi JM. A double-blind study of the effectiveness of a high-efficiency particulate air (HEPA) filter in the treatment of patients with perennial allergic rhinitis and asthma. J Allergy Clin Immunol. 1990;85(6):1050-1057. https://doi.org/10.1016/0091-6749(90)90050-e. Terreehorst I, Hak E, Oosting AJ, et al. Evaluation of impermeable covers for bedding in patients with allergic rhinitis. N Engl J Med. 2003;349(3):237-246. https://doi.org/10.1056/NEJMoa023171. Berings M, Jult A, Vermeulen H, et al. Probiotics-impregnated bedding covers for house dust mite allergic rhinitis: a pilot randomized clinical trial. Clin Exp Allergy. 2017;47(8):1092-1096. https://doi.org/10.1111/cea.12937. Jeon YH, Lee YJ, Sohn MH, Lee HR. Effects of vacuuming mattresses on allergic rhinitis symptoms in children. Allergy Asthma Immunol Res. 2019;11(5):655-663. https://doi.org/10.4168/aair.2019.11.5.655. Antonicelli L, Bilo MB, Pucci S, Schou C, Bonifazi F. Efficacy of an air-cleaning device equipped with a high efficiency particulate air filter in house dust mite respiratory allergy. Allergy. 1991;46(8):594-600. https://doi.org/10.1111/j.1398-9995.1991.tb00629.x. Geller-Bernstein C, Pibourdin JM, Dornelas A, Fondarai J. Efficacy of the acaricide: acardust for the prevention of asthma and rhinitis due to dust mite allergy, in children. Allerg Immunol (Paris). 1995;27(5):147-154. Chen M, Wu Y, Yuan S, et al. Allergic rhinitis improvement in asthmatic children after using acaricidal bait: a randomized, double-blind, cross-placebo study. Front Pediatr. 2021;9:709139. https://doi.org/10.3389/fped.2021.709139. Sheikh A, Hurwitz B, Nurmatov U, van Schayck CP. House dust mite avoidance measures for perennial allergic rhinitis. Cochrane Database Syst Rev. 2010;4. Stillerman A, Nachtsheim C, Li W, Albrecht M, Waldman J. Efficacy of a novel air filtration pillow for avoidance of perennial allergens in symptomatic adults. Ann Allergy Asthma Immunol. 2010;104(5):440-449. https://doi.org/10.1016/j.anai.2010.03.006. Brehler R, Kniest F. Encasing study in mite-allergic patients: one-year, double-blind placebo and environment-controlled investigation. Allergy Clin Immunol Inter. 2006;18:15-19. Le Cann P, Paulus H, Glorennec P, Le Bot B, Frain S, Gangneux JP. Home environmental interventions for the prevention or control of allergic and respiratory diseases: what really works. J Allergy Clin Immunol Pract. 2017;5(1):66-79. https://doi.org/10.1016/j.jaip.2016.07.011. Rosenstreich DL, Eggleston P, Kattan M, et al. The role of cockroach allergy and exposure to cockroach allergen in causing morbidity among inner-city children with asthma. N Engl J Med. 1997;336(19):1356-1363. https://doi.org/10.1056/NEJM199705083361904. Chew GL. Assessment of environmental cockroach allergen exposure. Curr Allergy Asthma Rep. 2012;12(5):456-464. https://doi.org/10.1007/s11882-012-0287-y. Sever ML, Arbes SJ, Jr., Gore JC, et al. Cockroach allergen reduction by cockroach control alone in low-income urban homes: a randomized control trial. J Allergy Clin Immunol. 2007;120(4):849-855. https://doi.org/10.1016/j.jaci.2007.07.003. McConnell R, Milam J, Richardson J, et al. Educational intervention to control cockroach allergen exposure in the homes of hispanic children in Los Angeles: results of the La Casa study. Clin Exp Allergy. 2005;35(4):426-433. https://doi.org/10.1111/j.1365-2222.2005.02196.x. Arbes SJ, Jr., Sever M, Mehta J, et al. Abatement of cockroach allergens (Bla g 1 and Bla g 2) in low-income, urban housing: month 12 continuation results. J Allergy Clin Immunol. 2004;113(1):109-114. https://doi.org/10.1016/j.jaci.2003.10.042. McConnell R, Jones C, Milam J, et al. Cockroach counts and house dust allergen concentrations after professional cockroach control and cleaning. Ann Allergy Asthma Immunol. 2003;91(6):546-552. https://doi.org/10.1016/S1081-1206(10)61532-3. Wood RA, Eggleston PA, Rand C, Nixon WJ, Kanchanaraksa S. Cockroach allergen abatement with extermination and sodium hypochlorite cleaning in inner-city homes. Ann Allergy Asthma Immunol. 2001;87(1):60-64. https://doi.org/10.1016/S1081-1206(10)62324-1. Gergen PJ, Mortimer KM, Eggleston PA, et al. Results of the National Cooperative Inner-City Asthma Study (NCICAS) environmental intervention to reduce cockroach allergen exposure in inner-city homes. J Allergy Clin Immunol. 1999;103(3 pt 1):501-506. https://doi.org/10.1016/s0091-6749(99)70477-x. Eggleston PA, Wood RA, Rand C, Nixon WJ, Chen PH, Lukk P. Removal of cockroach allergen from inner-city homes. J Allergy Clin Immunol. 1999;104(4 pt 1):842-846. https://doi.org/10.1016/s0091-6749(99)70296-4. Williams LW, Reinfried P, Brenner RJ. Cockroach extermination does not rapidly reduce allergen in settled dust. J Allergy Clin Immunol. 1999;104(3 pt 1):702-703. https://doi.org/10.1016/s0091-6749(99)70346-5. Wang C, Eiden AL, Cooper R, Zha C, Wang D, Hamilton RG. Abatement of cockroach allergens by effective cockroach management in apartments. J Allergy Clin Immunol Pract. 2020;8(10):3608-3609. https://doi.org/10.1016/j.jaip.2020.06.040. Eggleston PA, Butz A, Rand C, et al. Home environmental intervention in inner-city asthma: a randomized controlled clinical trial. Ann Allergy Asthma Immunol. 2005;95(6):518-524. https://doi.org/10.1016/S1081-1206(10)61012-5. Morgan WJ, Crain EF, Gruchalla RS, et al. Results of a home-based environmental intervention among urban children with asthma. N Engl J Med. 2004;351(11):1068-1080. https://doi.org/10.1056/NEJMoa032097. Sever ML, Salo PM, Haynes AK, Zeldin DC. Inner-city environments and mitigation of cockroach allergen. Am J Prev Med. 2011;41(2 suppl 1):S55-S56. https://doi.org/10.1016/j.amepre.2011.05.007. Sanchez J, Diez S, Cardona R. Pet avoidance in allergy cases: is it possible to implement it? Biomedica. 2015;35(3):357-362. https://doi.org/10.7705/biomedica.v35i3.2634. Custovic A, Wijk RG. The effectiveness of measures to change the indoor environment in the treatment of allergic rhinitis and asthma: ARIA update (in collaboration with GA(2)LEN). Allergy. 2005;60(9):1112-1115. https://doi.org/10.1111/j.1398-9995.2005.00934.x. Portnoy J, Kennedy K, Sublett J, et al. Environmental assessment and exposure control: a practice parameter-furry animals. Ann Allergy Asthma Immunol. 2012;108(4):223. e1-15. https://doi.org/10.1016/j.anai.2012.02.015. Arshad SH. Environmental control for secondary prevention of asthma. Clin Exp Allergy. 2010;40(1):2-4. https://doi.org/10.1111/j.1365-2222.2009.03407.x. National Heart Lung and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 3 (EPR-3): Guidelines for the diagnosis and management of asthma. US Department of Health and Human Services, 2007. Matsui EC, Perzanowski M, Peng RD, et al. Effect of an integrated pest management intervention on asthma symptoms among mouse-sensitized children and adolescents with asthma: A randomized clinical trial. JAMA. 2017;317(10):1027-1036. https://doi.org/10.1001/jama.2016.21048. Wood RA, Johnson EF, Van Natta ML, Chen PH, Eggleston PA. A placebo-controlled trial of a HEPA air cleaner in the treatment of cat allergy. Am J Respir Crit Care Med. 1998;158(1):115-120. https://doi.org/10.1164/ajrccm.158.1.9712110. Avner DB, Perzanowski MS, Platts-Mills TA, Woodfolk JA. Evaluation of different techniques for washing cats: quantitation of allergen removed from the cat and the effect on airborne Fel d 1. J Allergy Clin Immunol. 1997;100(3):307-312. https://doi.org/10.1016/s0091-6749(97)70242-2. Hodson T, Custovic A, Simpson A, Chapman M, Woodcock A, Green R. Washing the dog reduces dog allergen levels, but the dog needs to be washed twice a week. J Allergy Clin Immunol. 1999;103(4):581-585. https://doi.org/10.1016/s0091-6749(99)70227-7. Matsui EC, Simons E, Rand C, et al. Airborne mouse allergen in the homes of inner-city children with asthma. J Allergy Clin Immunol. 2005;115(2):358-363. https://doi.org/10.1016/j.jaci.2004.11.007. Grant T, Phipatanakul W, Perzanowski M, et al. Reduction in mouse allergen exposure is associated with greater lung function growth. J Allergy Clin Immunol. 2020;145(2):646-653.e1. https://doi.org/10.1016/j.jaci.2019.08.043. Pongracic JA, Visness CM, Gruchalla RS, Evans R, 3rd, Mitchell HE. Effect of mouse allergen and rodent environmental intervention on asthma in inner-city children. Ann Allergy Asthma Immunol. 2008;101(1):35-41. https://doi.org/10.1016/S1081-1206(10)60832-0. Phipatanakul W, Cronin B, Wood RA, et al. Effect of environmental intervention on mouse allergen levels in homes of inner-city Boston children with asthma. Ann Allergy Asthma Immunol. 2004;92(4):420-425. https://doi.org/10.1016/S1081-1206(10)61777-2. DiMango E, Serebrisky D, Narula S, et al. Individualized household allergen intervention lowers allergen level but not asthma medication use: a randomized controlled trial. J Allergy Clin Immunol Pract. 2016;4(4):671-679.e4. https://doi.org/10.1016/j.jaip.2016.01.016. Jacobs TS, Forno E, Brehm JM, et al. Mouse allergen exposure and decreased risk of allergic rhinitis in school-aged children. Ann Allergy Asthma Immunol. 2014;113(6):614-618.e2. https://doi.org/10.1016/j.anai.2014.09.007. Sakaguchi M, Inouye S, Miyazawa H, Kamimura H, Kimura M, Yamazaki S. Evaluation of dust respirators for elimination of mouse aeroallergens. Lab Anim Sci. 1989;39(1):63-66. Bertelsen RJ, Carlsen KC, Granum B, et al. Do allergic families avoid keeping furry pets? Indoor Air. 2010;20(3):187-195. https://doi.org/10.1111/j.1600-0668.2009.00640.x. Curtin-Brosnan J, Saams J, Breysse P, Diette G, Bradley H, Matsui E. Relationship between cat and mouse allergen levels in the homes of inner city children with asthma. J Allergy Clin Immunol. 2009;123:64. Dykewicz MS, Wallace DV, Baroody F, et al. Treatment of seasonal allergic rhinitis: an evidence-based focused 2017 guideline update. Ann Allergy Asthma Immunol. 2017;119(6):489-511.e41. https://doi.org/10.1016/j.anai.2017.08.012. Reisacher WR. Allergy treatment: environmental control strategies. Otolaryngol Clin North Am. 2011;44(3):711-725, x. https://doi.org/10.1016/j.otc.2011.03.019. Ferguson BJ. Environmental controls of allergies. Otolaryngol Clin North Am. 2008;41(2):411-417, viii-ix. https://doi.org/10.1016/j.otc.2007.11.006. Bergmann KC, Berger M, Klimek L, et al. Nonpharmacological measures to prevent allergic symptoms in pollen allergy: a critical review. Allergol Select. 2021;5:349-360. https://doi.org/10.5414/ALX02294E. Li L, Zhang L, Mo JH, et al. Efficacy of indoor air purification in the treatment of Artemisia pollen-allergic rhinitis: a randomised, double-blind, clinical controlled trial. Clin Otolaryngol. 2020;45(3):394-401. https://doi.org/10.1111/coa.13514. Green BJ, Levetin E, Horner WE, Codina R, Barnes CS, Filley WV. Landscape plant selection criteria for the allergic patient. J Allergy Clin Immunol Pract. 2018;6(6):1869-1876. https://doi.org/10.1016/j.jaip.2018.05.020. van Cauwenberge P, Bachert C, Passalacqua G, et al. Consensus statement on the treatment of allergic rhinitis. European Academy of Allergology and Clinical Immunology. Allergy. 2000;55(2):116-134. https://doi.org/10.1034/j.1398-9995.2000.00526.x. Comert S, Karakaya G, Kalyoncu AF. Wraparound eyeglasses improve symptoms and quality of life in patients with seasonal allergic rhinoconjunctivitis. Int Forum Allergy Rhinol. 2016;6(7):722-730. https://doi.org/10.1002/alr.21737. Kenney P, Hilberg O, Laursen AC, Peel RG, Sigsgaard T. Preventive effect of nasal filters on allergic rhinitis: a randomized, double-blind, placebo-controlled crossover park study. J Allergy Clin Immunol. 2015;136(6):1566-1572.e5. https://doi.org/10.1016/j.jaci.2015.05.015. Chen X, Deng C, Mi J, et al. Barrier protection measures for the management of allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2020;34(4):564-572. https://doi.org/10.1177/1945892420912370. Chen QY, Li L, Zhang L, et al. Efficacy of indoor air purification in treating Artemisia (mugwort) pollen allergic rhinitis: study protocol for a randomised controlled trial. BMC Public Health. 2018;18(1):841. https://doi.org/10.1186/s12889-018-5678-0. Gautrin D, Desrosiers M, Castano R. Occupational rhinitis. Curr Opin Allergy Clin Immunol. 2006;6(2):77-84. https://doi.org/10.1097/01.all.0000216848.87699.38. Hox V, Steelant B, Fokkens W, Nemery B, Hellings PW. Occupational upper airway disease: how work affects the nose. Allergy. 2014;69(3):282-291. https://doi.org/10.1111/all.12347. Castano R, Trudeau C, Castellanos L, Malo JL. Prospective outcome assessment of occupational rhinitis after removal from exposure. J Occup Environ Med. 2013;55(5):579-585. https://doi.org/10.1097/JOM.0b013e318289ee17. Airaksinen LK, Luukkonen RA, Lindstrom I, Lauerma AI, Toskala EM. Long-term exposure and health-related quality of life among patients with occupational rhinitis. J Occup Environ Med. 2009;51(11):1288-1297. https://doi.org/10.1097/JOM.0b013e3181b9b242. Vandenplas O, Jamart J, Delwiche JP, Evrard G, Larbanois A. Occupational asthma caused by natural rubber latex: outcome according to cessation or reduction of exposure. J Allergy Clin Immunol. 2002;109(1):125-130. https://doi.org/10.1067/mai.2002.120760. Merget R, Schulte A, Gebler A, et al. Outcome of occupational asthma due to platinum salts after transferral to low-exposure areas. Int Arch Occup Environ Health. 1999;72(1):33-39. https://doi.org/10.1007/s004200050331. Taivainen AI, Tukiainen HO, Terho EO, Husman KR. Powered dust respirator helmets in the prevention of occupational asthma among farmers. Scand J Work Environ Health. 1998;24(6):503-507. https://doi.org/10.5271/sjweh.375. Golightly LK, Greos LS. Second-generation antihistamines: actions and efficacy in the management of allergic disorders. Drugs. 2005;65(3):341-384. https://doi.org/10.2165/00003495-200565030-00004. Lieberman P. The basics of histamine biology. Ann Allergy Asthma Immunol. 2011;106(2 suppl):S2-S5. https://doi.org/10.1016/j.anai.2010.08.005. Fein MN, Fischer DA, O'Keefe AW, Sussman GL. CSACI position statement: newer generation H1-antihistamines are safer than first-generation H1-antihistamines and should be the first-line antihistamines for the treatment of allergic rhinitis and urticaria. Allergy Asthma Clin Immunol. 2019;15:61. https://doi.org/10.1186/s13223-019-0375-9. Sanchez-Borges M, Ansotegui IJ. Second generation antihistamines: an update. Curr Opin Allergy Clin Immunol. 2019;19(4):358-364. https://doi.org/10.1097/ACI.0000000000000556. Bousquet J, Bindslev-Jensen C, Canonica GW, et al. The ARIA/EAACI criteria for antihistamines: an assessment of the efficacy, safety and pharmacology of desloratadine. Allergy. 2004;59(suppl 77):4-16. https://doi.org/10.1111/j.1398-9995.2004.00577.x. Kardas G, Panek M, Kuna P, Cieszynski J, Kardas P. Primary non-adherence to antihistamines-conclusions from e-prescription pilot data in Poland. Front Pharmacol. 2020;11:783. https://doi.org/10.3389/fphar.2020.00783. Blaiss MS. Cost-effectiveness of H1-antihistamines. Clin Allergy Immunol. 2002;17:319-336. Miligkos M, Dakoutrou M, Statha E, et al. Newer-generation antihistamines and the risk of adverse events in children: a systematic review. Pediatr Allergy Immunol. 2021;32(7):1533-1558. https://doi.org/10.1111/pai.13522. Sastre J. Ebastine in the treatment of allergic rhinitis and urticaria: 30 years of clinical studies and real-world experience. J Investig Allergol Clin Immunol. 2020;30(3):156-168. https://doi.org/10.18176/jiaci.0401. Mullol J, Bousquet J, Bachert C, et al. Update on rupatadine in the management of allergic disorders. Allergy. 2015;70(suppl 100):1-24. https://doi.org/10.1111/all.12531. Ridolo E, Montagni M, Bonzano L, Incorvaia C, Canonica GW. Bilastine: new insight into antihistamine treatment. Clin Mol Allergy. 2015;13(1):1. https://doi.org/10.1186/s12948-015-0008-x. Compalati E, Canonica GW. Efficacy and safety of rupatadine for allergic rhino-conjunctivitis: a systematic review of randomized, double-blind, placebo-controlled studies with meta-analysis. Curr Med Res Opin. 2013;29(11):1539-1551. https://doi.org/10.1185/03007995.2013.822855. Mosges R, Konig V, Koberlein J. The effectiveness of modern antihistamines for treatment of allergic rhinitis - an IPD meta-analysis of 140,853 patients. Allergol Int. 2013;62(2):215-222. https://doi.org/10.2332/allergolint.12-OA-0486. Compalati E, Baena-Cagnani R, Penagos M, et al. Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials. Int Arch Allergy Immunol. 2011;156(1):1-15. https://doi.org/10.1159/000321896. Ferrer M. Pharmacokinetic evaluation of levocetirizine. Expert Opin Drug Metab Toxicol. 2011;7(8):1035-1047. https://doi.org/10.1517/17425255.2011.590131. Mosges R, Konig V, Koberlein J. The effectiveness of levocetirizine in comparison with loratadine in treatment of allergic rhinitis - a meta-analysis. Allergol Int. 2011;60(4):541-546. https://doi.org/10.2332/allergolint.10-OA-0300. Bachert C. A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis. Clin Ther. 2009;31(5):921-944. https://doi.org/10.1016/j.clinthera.2009.05.017. Katiyar S, Prakash S. Pharmacological profile, efficacy and safety of rupatadine in allergic rhinitis. Prim Care Respir J. 2009;18(2):57-68. https://doi.org/10.3132/pcrj.2008.00043. Bachert C, van Cauwenberge P. Desloratadine treatment for intermittent and persistent allergic rhinitis: a review. Clin Ther. 2007;29(9):1795-1802. https://doi.org/10.1016/j.clinthera.2007.09.009. Canonica GW, Tarantini F, Compalati E, Penagos M. Efficacy of desloratadine in the treatment of allergic rhinitis: a meta-analysis of randomized, double-blind, controlled trials. Allergy. 2007;62(4):359-366. https://doi.org/10.1111/j.1398-9995.2006.01277.x. Patou J, De Smedt H, van Cauwenberge P, Bachert C. Pathophysiology of nasal obstruction and meta-analysis of early and late effects of levocetirizine. Clin Exp Allergy. 2006;36(8):972-981. https://doi.org/10.1111/j.1365-2222.2006.02544.x. Hore I, Georgalas C, Scadding G. Oral antihistamines for the symptom of nasal obstruction in persistent allergic rhinitis - a systematic review of randomized controlled trials. Clin Exp Allergy. 2005;35(2):207-212. https://doi.org/10.1111/j.1365-2222.2005.02159.x. Passalacqua G, Canonica GW. A review of the evidence from comparative studies of levocetirizine and desloratadine for the symptoms of allergic rhinitis. Clin Ther. 2005;27(7):979-992. https://doi.org/10.1016/j.clinthera.2005.07.011. Greisner WA, 3rd. Onset of action for the relief of allergic rhinitis symptoms with second-generation antihistamines. Allergy Asthma Proc. 2004;25(2):81-83. Limon L, Kockler DR. Desloratadine: a nonsedating antihistamine. Ann Pharmacother. 2003;37(2):237-246, quiz 313-6. https://doi.org/10.1177/106002800303700216. Scadding GK. Optimal management of allergic rhinitis. Arch Dis Child. 2015;100(6):576-582. https://doi.org/10.1136/archdischild-2014-306300. Penston J, Wormsley KG. Adverse reactions and interactions with H2-receptor antagonists. Med Toxicol. 1986;1(3):192-216. https://doi.org/10.1007/BF03259837. Wood-Baker R, Lau L, Howarth PH. Histamine and the nasal vasculature: the influence of H1 and H2-histamine receptor antagonism. Clin Otolaryngol Allied Sci. 1996;21(4):348-352. https://doi.org/10.1111/j.1365-2273.1996.tb01085.x. Taylor-Clark T, Sodha R, Warner B, Foreman J. Histamine receptors that influence blockage of the normal human nasal airway. Br J Pharmacol. 2005;144(6):867-874. https://doi.org/10.1038/sj.bjp.0706118. Wang D, Clement P, Smitz J. Effect of H1 and H2 antagonists on nasal symptoms and mediator release in atopic patients after nasal allergen challenge during the pollen season. Acta Otolaryngol. 1996;116(1):91-96. https://doi.org/10.3109/00016489609137720. Havas TE, Cole P, Parker L, Oprysk D, Ayiomamitis A. The effects of combined H1 and H2 histamine antagonists on alterations in nasal airflow resistance induced by topical histamine provocation. J Allergy Clin Immunol. 1986;78(5 pt 1):856-860. https://doi.org/10.1016/0091-6749(86)90230-7. Juliusson S, Bende M. Effect of systemically administered H1- and H2-receptor antagonists on nasal blood flow as measured with laser Doppler flowmetry in a provoked allergic reaction. Rhinology. 1996;34(1):24-27. Brooks CD, Butler D, Metzler C. Effect of H2 blockade in the challenged allergic nose. J Allergy Clin Immunol. 1982;70(5):373-376. https://doi.org/10.1016/0091-6749(82)90027-6. Carpenter GB, Bunker-Soler AL, Nelson HS. Evaluation of combined H1- and H2-receptor blocking agents in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 1983;71(4):412-417. https://doi.org/10.1016/0091-6749(83)90071-4. Carr WW, Ratner P, Munzel U, et al. Comparison of intranasal azelastine to intranasal fluticasone propionate for symptom control in moderate-to-severe seasonal allergic rhinitis. Allergy Asthma Proc. 2012;33(6):450-458. https://doi.org/10.2500/aap.2012.33.3626. Kalpaklioglu AF, Kavut AB. Comparison of azelastine versus triamcinolone nasal spray in allergic and nonallergic rhinitis. Am J Rhinol Allergy. 2010;24(1):29-33. https://doi.org/10.2500/ajra.2010.24.3423. Kaliner MA, Storms W, Tilles S, et al. Comparison of olopatadine 0.6% nasal spray versus fluticasone propionate 50 microg in the treatment of seasonal allergic rhinitis. Allergy Asthma Proc. 2009;30(3):255-262. https://doi.org/10.2500/aap.2009.30.3232. Patel P, D'Andrea C, Sacks HJ. Onset of action of azelastine nasal spray compared with mometasone nasal spray and placebo in subjects with seasonal allergic rhinitis evaluated in an environmental exposure chamber. Am J Rhinol. 2007;21(4):499-503. https://doi.org/10.2500/ajr.2007.21.3058. Patel D, Garadi R, Brubaker M, et al. Onset and duration of action of nasal sprays in seasonal allergic rhinitis patients: olopatadine hydrochloride versus mometasone furoate monohydrate. Allergy Asthma Proc. 2007;28(5):592-599. https://doi.org/10.2500/aap2007.28.3033. Berger W, Hampel Jr F, Bernstein J, Shah S, Sacks H, Meltzer EO. Impact of azelastine nasal spray on symptoms and quality of life compared with cetirizine oral tablets in patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2006;97(3):375-381. https://doi.org/10.1016/S1081-1206(10)60804-6. Corren J, Storms W, Bernstein J, et al. Effectiveness of azelastine nasal spray compared with oral cetirizine in patients with seasonal allergic rhinitis. Clin Ther. 2005;27(5):543-553. https://doi.org/10.1016/j.clinthera.2005.04.012. LaForce CF, Corren J, Wheeler WJ, Berger WE, Rhinitis Study Group. Efficacy of azelastine nasal spray in seasonal allergic rhinitis patients who remain symptomatic after treatment with fexofenadine. Ann Allergy Asthma Immunol. 2004;93(2):154-159. https://doi.org/10.1016/S1081-1206(10)61468-8. Berger WE, White MV, Rhinitis Study Group. Efficacy of azelastine nasal spray in patients with an unsatisfactory response to loratadine. Ann Allergy Asthma Immunol. 2003;91(2):205-211. https://doi.org/10.1016/S1081-1206(10)62179-5. Berlin JM, Golden SJ, Teets S, Lehman EB, Lucas T, Craig TJ. Efficacy of a steroid nasal spray compared with an antihistamine nasal spray in the treatment of perennial allergic rhinitis. J Am Osteopath Assoc. 2000;100(7 suppl):S8-S13. Berger WE, Fineman SM, Lieberman P, Miles RM. Double-blind trials of azelastine nasal spray monotherapy versus combination therapy with loratadine tablets and beclomethasone nasal spray in patients with seasonal allergic rhinitis. Rhinitis Study Groups. Ann Allergy Asthma Immunol. 1999;82(6):535-541. https://doi.org/10.1016/s1081-1206(10)63161-4. Stern MA, Wade AG, Ridout SM, Cambell LM. Nasal budesonide offers superior symptom relief in perennial allergic rhinitis in comparison to nasal azelastine. Ann Allergy Asthma Immunol. 1998;81(4):354-358. https://doi.org/10.1016/s1081-1206(10)63128-6. Jarvis D, Newson R, Lotvall J, et al. Asthma in adults and its association with chronic rhinosinusitis: the GA2LEN survey in Europe. Allergy. 2012;67(1):91-98. https://doi.org/10.1111/j.1398-9995.2011.02709.x. LaForce C, Dockhorn RJ, Prenner BM, et al. Safety and efficacy of azelastine nasal spray (Astelin NS) for seasonal allergic rhinitis: a 4-week comparative multicenter trial. Ann Allergy Asthma Immunol. 1996;76(2):181-188. https://doi.org/10.1016/S1081-1206(10)63420-5. Charpin D, Godard P, Garay RP, Baehre M, Herman D, Michel FB. A multicenter clinical study of the efficacy and tolerability of azelastine nasal spray in the treatment of seasonal allergic rhinitis: a comparison with oral cetirizine. Eur Arch Otorhinolaryngol. 1995;252(8):455-458. https://doi.org/10.1007/BF02114749. Pelucchi A, Chiapparino A, Mastropasqua B, Marazzini L, Hernandez A, Foresi A. Effect of intranasal azelastine and beclomethasone dipropionate on nasal symptoms, nasal cytology, and bronchial responsiveness to methacholine in allergic rhinitis in response to grass pollens. J Allergy Clin Immunol. 1995;95(2):515-523. https://doi.org/10.1016/s0091-6749(95)70313-6. Gastpar H, Nolte D, Aurich R, et al. Comparative efficacy of azelastine nasal spray and terfenadine in seasonal and perennial rhinitis. Allergy. 1994;49(3):152-158. https://doi.org/10.1111/j.1398-9995.1994.tb00818.x. Meltzer EO, Weiler JM, Dockhorn RJ, Widlitz MD, Freitag JJ. Azelastine nasal spray in the management of seasonal allergic rhinitis. Ann Allergy. 1994;72(4):354-359. Passali D, Piragine F. A comparison of azelastine nasal spray and cetirizine tablets in the treatment of allergic rhinitis. J Int Med Res. 1994;22(1):17-23. https://doi.org/10.1177/030006059402200102. Davies RJ, Lund VJ, Harten-Ash VJ. The effect of intranasal azelastine and beclomethasone on the symptoms and signs of nasal allergy in patients with perennial allergic rhinitis. Rhinology. 1993;31(4):159-164. Dorow P, Aurich R, Petzold U. Efficacy and tolerability of azelastine nasal spray in patients with allergic rhinitis compared to placebo and budesonide. Arzneimittelforschung. 1993;43(8):909-912. Gambardella R. A comparison of the efficacy of azelastine nasal spray and loratidine tablets in the treatment of seasonal allergic rhinitis. J Int Med Res. 1993;21(5):268-275. https://doi.org/10.1177/030006059302100505. Gastpar H, Aurich R, Petzold U, et al. Intranasal treatment of perennial allergic rhinitis. Comparison of azelastine nasal spray and budesonide nasal aerosol. Arzneimittelforschung. 1993;43(4):475-479. Howland WC, Amar NJ, Wheeler W, Sacks H. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in patients with allergy to Texas mountain cedar pollen. Int Forum Allergy Rhinol. 2011;1(4):275-279. https://doi.org/10.1002/alr.20065. Meltzer EO, Blaiss M, Fairchild CJ. Comprehensive report of olopatadine 0.6% nasal spray as treatment for children with seasonal allergic rhinitis. Allergy Asthma Proc. 2011;32(3):213-220. https://doi.org/10.2500/aap.2011.32.3448. Berger WE, Ratner PH, Casale TB, Meltzer EO, Wall GM. Safety and efficacy of olopatadine hydrochloride nasal spray 0.6% in pediatric subjects with allergic rhinitis. Allergy Asthma Proc. 2009;30(6):612-623. https://doi.org/10.2500/aap.2009.30.3298. Bernstein JA, Prenner B, Ferguson BJ, Portnoy J, Wheeler WJ, Sacks HJ. Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitis. Am J Rhinol Allergy. 2009;23(5):512-517. https://doi.org/10.2500/ajra.2009.23.3396. Shah S, Berger W, Lumry W, La Force C, Wheeler W, Sacks H. Efficacy and safety of azelastine 0.15% nasal spray and azelastine 0.10% nasal spray in patients with seasonal allergic rhinitis. Allergy Asthma Proc. 2009;30(6):628-633. https://doi.org/10.2500/aap.2009.30.3296. Shah SR, Nayak A, Ratner P, Roland P, Michael Wall G. Effects of olopatadine hydrochloride nasal spray 0.6% in the treatment of seasonal allergic rhinitis: a phase III, multicenter, randomized, double-blind, active- and placebo-controlled study in adolescents and adults. Clin Ther. 2009;31(1):99-107. https://doi.org/10.1016/j.clinthera.2009.01.016. van Bavel J, Howland WC, Amar NJ, Wheeler W, Sacks H. Efficacy and safety of azelastine 0.15% nasal spray administered once daily in subjects with seasonal allergic rhinitis. Allergy Asthma Proc. 2009;30(5):512-518. https://doi.org/10.2500/aap.2009.30.3284. Pipkorn P, Costantini C, Reynolds C, et al. The effects of the nasal antihistamines olopatadine and azelastine in nasal allergen provocation. Ann Allergy Asthma Immunol. 2008;101(1):82-89. https://doi.org/10.1016/S1081-1206(10)60839-3. Lumry W, Prenner B, Corren J, Wheeler W. Efficacy and safety of azelastine nasal spray at a dose of 1 spray per nostril twice daily. Ann Allergy Asthma Immunol. 2007;99(3):267-272. https://doi.org/10.1016/S1081-1206(10)60663-1. Hampel Jr FC, Ratner PH, Amar NJ, et al. Improved quality of life among seasonal allergic rhinitis patients treated with olopatadine HCl nasal spray 0.4% and olopatadine HCl nasal spray 0.6% compared with vehicle placebo. Allergy Asthma Proc. 2006;27(3):202-207. https://doi.org/10.2500/aap.2006.27.2862. Meltzer EO, Hampel FC, Ratner PH, et al. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2005;95(6):600-606. https://doi.org/10.1016/S1081-1206(10)61025-3. Ratner PH, Hampel FC, Amar NJ, et al. Safety and efficacy of olopatadine hydrochloride nasal spray for the treatment of seasonal allergic rhinitis to mountain cedar. Ann Allergy Asthma Immunol. 2005;95(5):474-479. https://doi.org/10.1016/S1081-1206(10)61174-X. Saengpanich S, Assanasen P, deTineo M, Haney L, Naclerio RM, Baroody FM. Effects of intranasal azelastine on the response to nasal allergen challenge. Laryngoscope. 2002;112(1):47-52. https://doi.org/10.1097/00005537-200201000-00009. Golden S, Teets SJ, Lehman EB, et al. Effect of topical nasal azelastine on the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2000;85(1):53-57. https://doi.org/10.1016/S1081-1206(10)62434-9. Herman D, Garay R, Le Gal M. A randomized double-blind placebo controlled study of azelastine nasal spray in children with perennial rhinitis. Int J Pediatr Otorhinolaryngol. 1997;39(1):1-8. https://doi.org/10.1016/S0165-5876(96)01457-7. Newson-Smith G, Powell M, Baehre M, Garnham SP, MacMahon MT. A placebo controlled study comparing the efficacy of intranasal azelastine and beclomethasone in the treatment of seasonal allergic rhinitis. Eur Arch Otorhinolaryngol. 1997;254(5):236-241. https://doi.org/10.1007/BF00874095. Weiler JM, Meltzer EO. Azelastine nasal spray as adjunctive therapy to azelastine tablets in the management of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 1997;79(4):327-332. https://doi.org/10.1016/S1081-1206(10)63023-2. Ratner PH, Findlay SR, Hampel Jr F, van Bavel J, Widlitz MD, Freitag JJ. A double-blind, controlled trial to assess the safety and efficacy of azelastine nasal spray in seasonal allergic rhinitis. J Allergy Clin Immunol. 1994;94(5):818-825. https://doi.org/10.1016/0091-6749(94)90148-1. Han D, Chen L, Cheng L, et al. A multicenter randomized double-blind 2-week comparison study of azelastine nasal spray 0.1% versus levocabastine nasal spray 0.05% in patients with moderate-to-severe allergic rhinitis. ORL J Otorhinolaryngol Relat Spec. 2011;73(5):260-265. https://doi.org/10.1159/000330269. Meltzer EO, Garadi R, Laforce C, et al. Comparative study of sensory attributes of two antihistamine nasal sprays: olopatadine 0.6% and azelastine 0.1%. Allergy Asthma Proc. 2008;29(6):659-668. https://doi.org/10.2500/aap.2008.29.3181. Falser N, Wober W, Rahlfs VW, Baehre M. Comparative efficacy and safety of azelastine and levocabastine nasal sprays in patients with seasonal allergic rhinitis. Arzneimittelforschung. 2001;51(5):387-393. https://doi.org/10.1055/s-0031-1300052. Pipkorn U, Proud D, Lichtenstein LM, et al. Effect of short-term systemic glucocorticoid treatment on human nasal mediator release after antigen challenge. J Clin Invest. 1987;80(4):957-961. https://doi.org/10.1172/JCI113188. Bascom R, Pipkorn U, Lichtenstein LM, Naclerio RM. The influx of inflammatory cells into nasal washings during the late response to antigen challenge. Effect of systemic steroid pretreatment. Am Rev Respir Dis. 1988;138(2):406-412. https://doi.org/10.1164/ajrccm/138.2.406. Bascom R, Pipkorn U, Proud D, et al. Major basic protein and eosinophil-derived neurotoxin concentrations in nasal-lavage fluid after antigen challenge: effect of systemic corticosteroids and relationship to eosinophil influx. J Allergy Clin Immunol. 1989;84(3):338-346. https://doi.org/10.1016/0091-6749(89)90418-1. Schwartz E, Levin L, Leibowitz H, et al. Oral cortisone therapy in ragweed hay fever. J Allergy. 1952;23(1):32-38. https://doi.org/10.1016/0021-8707(52)90071-3. Schiller IW, Lowell FC. Oral cortisone in the treatment of hay fever. J Allergy. 1953;24(4):297-301. https://doi.org/10.1016/0021-8707(53)90172-5. Schwartz E. Oral hydrocortisone therapy in bronchial asthma and bay fever. J Allergy. 1954;25(2):112-119. https://doi.org/10.1016/0021-8707(54)90149-5. Brooks CD, Karl KJ, Francom SF. Oral methylprednisolone acetate (Medrol Tablets) for seasonal rhinitis: examination of dose and symptom response. J Clin Pharmacol. 1993;33(9):816-822. https://doi.org/10.1002/j.1552-4604.1993.tb01957.x. Snyman JR, Potter PC, Groenewald M, Levin J, Claricort Study Group. Effect of betamethasone-loratadine combination therapy on severe exacerbations of allergic rhinitis: a randomised, controlled trial. Clin Drug Investig. 2004;24(5):265-274. https://doi.org/10.2165/00044011-200424050-00003. Kwaselow A, McLean J, Busse W, et al. A comparison of intranasal and oral flunisolide in the therapy of allergic rhinitis. Evidence for a topical effect. Allergy. 1985;40(5):363-367. https://doi.org/10.1111/j.1398-9995.1985.tb00248.x. Karaki M, Akiyama K, Mori N. Efficacy of intranasal steroid spray (mometasone furoate) on treatment of patients with seasonal allergic rhinitis: comparison with oral corticosteroids. Auris Nasus Larynx. 2013;40(3):277-281. https://doi.org/10.1016/j.anl.2012.09.004. Bascom R, Wachs M, Naclerio RM, Pipkorn U, Galli SJ, Lichtenstein LM. Basophil influx occurs after nasal antigen challenge: effects of topical corticosteroid pretreatment. J Allergy Clin Immunol. 1988;81(3):580-589. Erin EM, Leaker BR, Zacharasiewicz AS, et al. Single dose topical corticosteroid inhibits IL-5 and IL-13 in nasal lavage following grass pollen challenge. Allergy. 2005;60(12):1524-1529. https://doi.org/10.1111/j.1398-9995.2005.00928.x. Meltzer EO, Jalowayski AA, Orgel HA, Harris AG. Subjective and objective assessments in patients with seasonal allergic rhinitis: effects of therapy with mometasone furoate nasal spray. J Allergy Clin Immunol. 1998;102(1):39-49. https://doi.org/10.1016/s0091-6749(98)70053-3. Baroody FM, Cruz AA, Lichtenstein LM, Kagey-Sobotka A, Proud D, Naclerio RM. Intranasal beclomethasone inhibits antigen-induced nasal hyperresponsiveness to histamine. J Allergy Clin Immunol. 1992;90(3 pt 1):373-376. https://doi.org/10.1016/s0091-6749(05)80017-x. Meyer P, Andersson M, Persson CG, Greiff L. Steroid-sensitive indices of airway inflammation in children with seasonal allergic rhinitis. Pediatr Allergy Immunol. 2003;14(1):60-65. https://doi.org/10.1034/j.1399-3038.2003.02102.x. Penagos M, Compalati E, Tarantini F, Baena-Cagnani CE, Passalacqua G, Canonica GW. Efficacy of mometasone furoate nasal spray in the treatment of allergic rhinitis. Meta-analysis of randomized, double-blind, placebo-controlled, clinical trials. Allergy. 2008;63(10):1280-1291. https://doi.org/10.1111/j.1398-9995.2008.01808.x. Rodrigo GJ, Neffen H. Efficacy of fluticasone furoate nasal spray vs. placebo for the treatment of ocular and nasal symptoms of allergic rhinitis: a systematic review. Clin Exp Allergy. 2011;41(2):160-170. https://doi.org/10.1111/j.1365-2222.2010.03654.x. Urdaneta E, Tunceli K, Gates D. Effect of mometasone furoate nasal spray on moderate-to-severe nasal congestion in seasonal allergic rhinitis: a responder analysis. Allergy Asthma Proc. 2019;40(3):173-179. https://doi.org/10.2500/aap.2019.40.4214. Herman H. Once-daily administration of intranasal corticosteroids for allergic rhinitis: a comparative review of efficacy, safety, patient preference, and cost. Am J Rhinol. 2007;21(1):70-79. https://doi.org/10.2500/ajr.2007.21.2896. Rachelefsky G, Farrar JR. A control model to evaluate pharmacotherapy for allergic rhinitis in children. JAMA Pediatr. 2013;167(4):380-386. https://doi.org/10.1001/jamapediatrics.2013.623. Craig TJ, Mende C, Hughes K, Kakumanu S, Lehman EB, Chinchilli V. The effect of topical nasal fluticasone on objective sleep testing and the symptoms of rhinitis, sleep, and daytime somnolence in perennial allergic rhinitis. Allergy Asthma Proc. 2003;24(1):53-58. Meltzer EO, Munafo DA, Chung W, Gopalan G, Varghese ST. Intranasal mometasone furoate therapy for allergic rhinitis symptoms and rhinitis-disturbed sleep. Ann Allergy Asthma Immunol. 2010;105(1):65-74. https://doi.org/10.1016/j.anai.2010.04.020. Day JH, Briscoe MP, Rafeiro E, Ellis AK, Pettersson E, Akerlund A. Onset of action of intranasal budesonide (Rhinocort aqua) in seasonal allergic rhinitis studied in a controlled exposure model. J Allergy Clin Immunol. 2000;105(3):489-494. https://doi.org/10.1067/mai.2000.104550. Fokkens WJ, Cserhati E, dos Santos JM, et al. Budesonide aqueous nasal spray is an effective treatment in children with perennial allergic rhinitis, with an onset of action within 12 hours. Ann Allergy Asthma Immunol. 2002;89(3):279-284. https://doi.org/10.1016/s1081-1206(10)61955-2. Kaiser HB, Naclerio RM, Given J, Toler TN, Ellsworth A, Philpot EE. Fluticasone furoate nasal spray: a single treatment option for the symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2007;119(6):1430-1437. https://doi.org/10.1016/j.jaci.2007.02.022. Day J, Carrillo T. Comparison of the efficacy of budesonide and fluticasone propionate aqueous nasal spray for once daily treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 1998;102(6 pt 1):902-908. https://doi.org/10.1016/s0091-6749(98)70326-4. Juniper EF, Guyatt GH, O'Byrne PM, Viveiros M. Aqueous beclomethasone diproprionate nasal spray: regular versus "as required" use in the treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 1990;86(3 pt 1):380-386. https://doi.org/10.1016/s0091-6749(05)80101-0. Juniper EF, Guyatt GH, Archer B, Ferrie PJ. Aqueous beclomethasone dipropionate in the treatment of ragweed pollen-induced rhinitis: further exploration of "as needed" use. J Allergy Clin Immunol. 1993;92(1 pt 1):66-72. https://doi.org/10.1016/0091-6749(93)90039-i. Jen A, Baroody F, de Tineo M, Haney L, Blair C, Naclerio R. As-needed use of fluticasone propionate nasal spray reduces symptoms of seasonal allergic rhinitis. J Allergy Clin Immunol. 2000;105(4):732-738. https://doi.org/10.1067/mai.2000.105225. Dykewicz MS, Kaiser HB, Nathan RA, et al. Fluticasone propionate aqueous nasal spray improves nasal symptoms of seasonal allergic rhinitis when used as needed (prn). Ann Allergy Asthma Immunol. 2003;91(1):44-48. https://doi.org/10.1016/S1081-1206(10)62057-1. Thongngarm T, Wongsa C, Phinyo P, Assanasen P, Tantilipikorn P, Sompornrattanaphan M. As-needed versus regular use of fluticasone furoate nasal spray in patients with moderate to severe, persistent, perennial allergic rhinitis: a randomized controlled trial. J Allergy Clin Immunol Pract. 2021;9(3):1365-1373.e6. https://doi.org/10.1016/j.jaip.2020.09.057. DeWester J, Philpot EE, Westlund RE, Cook CK, Rickard KA. The efficacy of intranasal fluticasone propionate in the relief of ocular symptoms associated with seasonal allergic rhinitis. Allergy Asthma Proc. 2003;24(5):331-337. Bielory L, Chun Y, Bielory BP, Canonica GW. Impact of mometasone furoate nasal spray on individual ocular symptoms of allergic rhinitis: a meta-analysis. Allergy. 2011;66(5):686-693. https://doi.org/10.1111/j.1398-9995.2010.02543.x. Ratner P, Van Bavel J, Mohar D, et al. Efficacy of daily intranasal fluticasone propionate on ocular symptoms associated with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2015;114(2):141-147. https://doi.org/10.1016/j.anai.2014.11.012. Bielory L, Gross GN, Letierce A, Melas-Melt L, Lucio L. Ocular symptoms improvement from intranasal triamcinolone compared with placebo and intranasal fluticasone propionate: a meta-analysis. Ann Allergy Asthma Immunol. 2020;124(6):616-621.e3. https://doi.org/10.1016/j.anai.2020.01.012. Baroody FM, Shenaq D, DeTineo M, Wang J, Naclerio RM. Fluticasone furoate nasal spray reduces the nasal-ocular reflex: a mechanism for the efficacy of topical steroids in controlling allergic eye symptoms. J Allergy Clin Immunol. 2009;123(6):1342-1348. https://doi.org/10.1016/j.jaci.2009.03.015. Keith PK, Scadding GK. Are intranasal corticosteroids all equally consistent in managing ocular symptoms of seasonal allergic rhinitis? Curr Med Res Opin. 2009;25(8):2021-2041. https://doi.org/10.1185/03007990903094106. Taramarcaz P, Gibson PG. Intranasal corticosteroids for asthma control in people with coexisting asthma and rhinitis. Cochrane Database Syst Rev. 2003;(4):CD003570. https://doi.org/10.1002/14651858.CD003570. Lohia S, Schlosser RJ, Soler ZM. Impact of intranasal corticosteroids on asthma outcomes in allergic rhinitis: a meta-analysis. Allergy. 2013;68(5):569-579. https://doi.org/10.1111/all.12124. Yu CL, Huang WT, Wang CM. Treatment of allergic rhinitis reduces acute asthma exacerbation risk among asthmatic children aged 2-18 years. J Microbiol Immunol Infect. 2019;52(6):991-999. https://doi.org/10.1016/j.jmii.2018.10.003. Khattiyawittayakun L, Seresirikachorn K, Chitsuthipakorn W, Kanjanawasee D, Snidvongs K. Effects of double-dose intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2019;9(1):72-78. https://doi.org/10.1002/alr.22204. Weiner JM, Abramson MJ, Puy RM. Intranasal corticosteroids versus oral H1 receptor antagonists in allergic rhinitis: systematic review of randomised controlled trials. BMJ. 1998;317(7173):1624-1629. https://doi.org/10.1136/bmj.317.7173.1624. Yanez A, Rodrigo GJ. Intranasal corticosteroids versus topical H1 receptor antagonists for the treatment of allergic rhinitis: a systematic review with meta-analysis. Ann Allergy Asthma Immunol. 2002;89(5):479-484. https://doi.org/10.1016/S1081-1206(10)62085-6. Benninger M, Farrar JR, Blaiss M, et al. Evaluating approved medications to treat allergic rhinitis in the United States: an evidence-based review of efficacy for nasal symptoms by class. Ann Allergy Asthma Immunol. 2010;104(1):13-29. https://doi.org/10.1016/j.anai.2009.11.020. Wilson AM, O'Byrne PM, Parameswaran K. Leukotriene receptor antagonists for allergic rhinitis: a systematic review and meta-analysis. Am J Med. 2004;116(5):338-344. https://doi.org/10.1016/j.amjmed.2003.10.030. Bhattachan S, Neupane Y, Pradhan B, Thapa N. Comparison of outcomes between mometasone furoate intranasal spray and oral montelukast in patients with allergic rhinitis. J Nepal Health Res Counc. 2020;18(2):268-270. https://doi.org/10.33314/jnhrc.v18i2.2509. Meltzer EO. Formulation considerations of intranasal corticosteroids for the treatment of allergic rhinitis. Ann Allergy Asthma Immunol. 2007;98(1):12-21. https://doi.org/10.1016/S1081-1206(10)60854-X. May JR, Dolen WK. Evaluation of intranasal corticosteroid sensory attributes and patient preference for fluticasone furoate for the treatment of allergic rhinitis. Clin Ther. 2019;41(8):1589-1596. https://doi.org/10.1016/j.clinthera.2019.05.017. van Bavel JH, Ratner PH, Amar NJ, et al. Efficacy and safety of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with seasonal allergic rhinitis. Allergy Asthma Proc. 2012;33(5):386-396. https://doi.org/10.2500/aap.2012.33.3593. Meltzer EO, Jacobs RL, LaForce CF, Kelley CL, Dunbar SA, Tantry SK. Safety and efficacy of once-daily treatment with beclomethasone dipropionate nasal aerosol in subjects with perennial allergic rhinitis. Allergy Asthma Proc. 2012;33(3):249-257. https://doi.org/10.2500/aap.2012.33.3571. Ratner PH, Andrews C, Martin B, et al. A study of the efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol in patients with seasonal allergic rhinitis from mountain cedar pollen. Allergy Asthma Proc. 2012;33(1):27-35. https://doi.org/10.2500/aap.2012.33.3490. LaForce C, van Bavel J, Meltzer EO, Wingertzahn MA. Efficacy and safety of ciclesonide hydrofluoroalkane nasal aerosol once daily for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2009;103(2):166-173. https://doi.org/10.1016/S1081-1206(10)60171-8. Yang Q, Wang F, Li B, et al. The efficacy and safety of ciclesonide for the treatment of perennial allergic rhinitis: a systematic review and meta-analysis. Braz J Otorhinolaryngol. 2019;85(3):371-378. https://doi.org/10.1016/j.bjorl.2018.10.008. Maspero JF, Rosenblut A, Finn Jr A, Lim J, Wu W, Philpot E. Safety and efficacy of fluticasone furoate in pediatric patients with perennial allergic rhinitis. Otolaryngol Head Neck Surg. 2008;138(1):30-37. https://doi.org/10.1016/j.otohns.2007.10.023. Meltzer EO, Tripathy I, Maspero JF, Wu W, Philpot E. Safety and tolerability of fluticasone furoate nasal spray once daily in paediatric patients aged 6-11 years with allergic rhinitis: subanalysis of three randomized, double-blind, placebo-controlled, multicentre studies. Clin Drug Investig. 2009;29(2):79-86. https://doi.org/10.2165/0044011-200929020-00002. Rosenblut A, Bardin PG, Muller B, et al. Long-term safety of fluticasone furoate nasal spray in adults and adolescents with perennial allergic rhinitis. Allergy. 2007;62(9):1071-1077. https://doi.org/10.1111/j.1398-9995.2007.01521.x. Ratner PH, Meltzer EO, Teper A. Mometasone furoate nasal spray is safe and effective for 1-year treatment of children with perennial allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2009;73(5):651-657. https://doi.org/10.1016/j.ijporl.2008.12.025. Verkerk MM, Bhatia D, Rimmer J, Earls P, Sacks R, Harvey RJ. Intranasal steroids and the myth of mucosal atrophy: a systematic review of original histological assessments. Am J Rhinol Allergy. 2015;29(1):3-18. https://doi.org/10.2500/ajra.2015.29.4111. van As A, Bronsky EA, Dockhorn RJ, et al. Once daily fluticasone propionate is as effective for perennial allergic rhinitis as twice daily beclomethasone diproprionate. J Allergy Clin Immunol. 1993;91(6):1146-1154. https://doi.org/10.1016/0091-6749(93)90317-9. Brannan MD, Herron JM, Reidenberg P, Affrime MB. Lack of hypothalamic-pituitary-adrenal axis suppression with once-daily or twice-daily beclomethasone dipropionate aqueous nasal spray administered to patients with allergic rhinitis. Clin Ther. 1995;17(4):637-647. https://doi.org/10.1016/0149-2918(95)80040-9. Vargas R, Dockhorn RJ, Findlay SR, Korenblat PE, Field EA, Kral KM. Effect of fluticasone propionate aqueous nasal spray versus oral prednisone on the hypothalamic-pituitary-adrenal axis. J Allergy Clin Immunol. 1998;102(2):191-197. https://doi.org/10.1016/s0091-6749(98)70085-5. Howland 3rd WC, Dockhorn R, Gillman S, et al. A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocortical function in male patients with allergic rhinitis. J Allergy Clin Immunol. 1996;98(1):32-38. https://doi.org/10.1016/s0091-6749(96)70223-3. Nayak AS, Ellis MH, Gross GN, et al. The effects of triamcinolone acetonide aqueous nasal spray on adrenocortical function in children with allergic rhinitis. J Allergy Clin Immunol. 1998;101(2 pt 1):157-162. https://doi.org/10.1016/S0091-6749(98)70379-3. Galant SP, Melamed IR, Nayak AS, et al. Lack of effect of fluticasone propionate aqueous nasal spray on the hypothalamic-pituitary-adrenal axis in 2- and 3-year-old patients. Pediatrics. 2003;112(1 pt 1):96-100. https://doi.org/10.1542/peds.112.1.96. Kim K, Weiswasser M, Nave R, et al. Safety of once-daily ciclesonide nasal spray in cildren 2 to 5 years of age with perennial allergic rhinitis. Ped Asthma Allergy Immunol. 2007;20:229-242. Chervinsky P, Kunjibettu S, Miller DL, et al. Long-term safety and efficacy of intranasal ciclesonide in adult and adolescent patients with perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2007;99(1):69-76. https://doi.org/10.1016/S1081-1206(10)60624-2. Patel D, Ratner P, Clements D, Wu W, Faris M, Philpot E. Lack of effect on adult and adolescent hypothalamic-pituitary-adrenal axis function with use of fluticasone furoate nasal spray. Ann Allergy Asthma Immunol. 2008;100(5):490-496. https://doi.org/10.1016/S1081-1206(10)60476-0. Weinstein S, Qaqundah P, Georges G, Nayak A. Efficacy and safety of triamcinolone acetonide aqueous nasal spray in children aged 2 to 5 years with perennial allergic rhinitis: a randomized, double-blind, placebo-controlled study with an open-label extension. Ann Allergy Asthma Immunol. 2009;102(4):339-347. https://doi.org/10.1016/S1081-1206(10)60340-7. Tripathy I, Levy A, Ratner P, Clements D, Wu W, Philpot E. HPA axis safety of fluticasone furoate nasal spray once daily in children with perennial allergic rhinitis. Pediatr Allergy Immunol. 2009;20(3):287-294. https://doi.org/10.1111/j.1399-3038.2008.00775.x. Hampel Jr FC, Nayak NA, Segall N, Small CJ, Li J, Tantry SK. No hypothalamic-pituitary-adrenal function effect with beclomethasone dipropionate nasal aerosol, based on 24-hour serum cortisol in pediatric allergic rhinitis. Ann Allergy Asthma Immunol. 2015;115(2):137-142. https://doi.org/10.1016/j.anai.2015.05.019. Sampieri G, Namavarian A, Lee JJW, Hamour AF, Lee JM. Hypothalamic-pituitary-adrenal axis suppression and intranasal corticosteroid use: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2022;12(1):11-27. https://doi.org/10.1002/alr.22863. Liu A, Manche EE. Bilateral posterior subcapsular cataracts associated with long-term intranasal steroid use. J Cataract Refract Surg. 2011;37(8):1555-1558. https://doi.org/10.1016/j.jcrs.2011.05.020. Ahmadi N, Snidvongs K, Kalish L, et al. Intranasal corticosteroids do not affect intraocular pressure or lens opacity: a systematic review of controlled trials. Rhinology. 2015;53(4):290-302. https://doi.org/10.4193/Rhino15.020. Valenzuela CV, Liu JC, Vila PM, Simon L, Doering M, Lieu JEC. Intranasal corticosteroids do not lead to ocular changes: a systematic review and meta-analysis. Laryngoscope. 2019;129(1):6-12. https://doi.org/10.1002/lary.27209. Mener DJ, Shargorodsky J, Varadhan R, Lin SY. Topical intranasal corticosteroids and growth velocity in children: a meta-analysis. Int Forum Allergy Rhinol. 2015;5(2):95-103. https://doi.org/10.1002/alr.21430. Periasamy N, Pujary K, Bhandarkar AM, Bhandarkar ND, Ramaswamy B. Budesonide vs saline nasal irrigation in allergic rhinitis: a randomized placebo-controlled trial. Otolaryngol Head Neck Surg. 2020;162(6):979-984. https://doi.org/10.1177/0194599820919363. Brown K, Lane J, Silva MP, DeTineo M, Naclerio RM, Baroody FM. A pilot study of the effects of intranasal budesonide delivered by NasoNeb(R) on patients with perennial allergic rhinitis. Int Forum Allergy Rhinol. 2014;4(1):43-48. https://doi.org/10.1002/alr.21239. Profita M, Riccobono L, Bonanno A, et al. Effect of nebulized beclomethasone on airway inflammation and clinical status of children with allergic asthma and rhinitis: a randomized, double-blind, placebo-controlled study. Int Arch Allergy Immunol. 2013;161(1):53-64. https://doi.org/10.1159/000343137. Hehar SS, Mason JD, Stephen AB, et al. Twenty-four hour ambulatory nasal pH monitoring. Clin Otolaryngol Allied Sci. 1999;24(1):24-25. https://doi.org/10.1046/j.1365-2273.1999.00190.x. Camargos P, Ibiapina C, Lasmar L, Cruz AA. Obtaining concomitant control of allergic rhinitis and asthma with a nasally inhaled corticosteroid. Allergy. 2007;62(3):310-316. https://doi.org/10.1111/j.1398-9995.2007.01241.x. Shaikh WA. Exhaling a budesonide inhaler through the nose results in a significant reduction in dose requirement of budesonide nasal spray in patients having asthma with rhinitis. J Investig Allergol Clin Immunol. 1999;9(1):45-49. Daman Willems CE, Dinwiddie R, Grant DB, Rivers RP, Zahir M. Temporary inhibition of growth and adrenal suppression associated with the use of steroid nose drops. Eur J Pediatr. 1994;153(9):632-634. https://doi.org/10.1007/BF02190681. Kimmerle R, Rolla AR. Iatrogenic Cushing's syndrome due to dexamethasone nasal drops. Am J Med. 1985;79(4):535-537. https://doi.org/10.1016/0002-9343(85)90046-4. Daley-Yates PT, Baker RC. Systemic bioavailability of fluticasone propionate administered as nasal drops and aqueous nasal spray formulations. Br J Clin Pharmacol. 2001;51(1):103-105. https://doi.org/10.1046/j.1365-2125.2001.01325.x. Brown EB, Seidemen T, Siegelaub AB, Popovits C. Depo-methylprednisolone in the treatment of ragweed hay fever. Ann Allergy. 1960;18:1321-1330. Borum P, Gronborg H, Mygind N. Seasonal allergic rhinitis and depot injection of a corticosteroid. Evaluation of the efficacy of medication early and late in the season based on detailed symptom recording. Allergy. 1987;42(1):26-32. https://doi.org/10.1111/j.1398-9995.1987.tb02183.x. Axelsson A, Lindholm B. The effect of triamcinolone acetonide on allergic and vasomotor rhinitis. Acta Otolaryngol. 1972;73(1):64-67. https://doi.org/10.3109/00016487209138195. Laursen LC, Faurschou P, Munch EP. Intramuscular betamethasone dipropionate vs. topical beclomethasone dipropionate and placebo in hay fever. Allergy. 1988;43(6):420-424. https://doi.org/10.1111/j.1398-9995.1988.tb00912.x. Kronholm A. Injectable depot corticosteroid therapy in hay fever. J Int Med Res. 1979;7(4):314-317. https://doi.org/10.1177/030006057900700410. Ohlander BO, Hansson RE, Karlsson KE. A comparison of three injectable corticosteroids for the treatment of patients with seasonal hay fever. J Int Med Res. 1980;8(1):63-69. https://doi.org/10.1177/030006058000800111. Hermance WE, Gerardi A, Popovits CJ, Brown EB. Dexamethasone acetate suspension in the treatment of allergic rhinitis. Ann Allergy. 1969;27(12):617-621. Chervinsky P. Treatment of seasonal allergic rhinitis with long-acting steroid injections. A comparison of four preparations. Ann Allergy. 1968;26(4):190-193. Laursen LC, Faurschou P, Pals H, Svendsen UG, Weeke B. Intramuscular betamethasone dipropionate vs. oral prednisolone in hay fever patients. Allergy. 1987;42(3):168-172. https://doi.org/10.1111/j.1398-9995.1987.tb02194.x. Pichler WJ, Klint T, Blaser M, et al. Clinical comparison of systemic methylprednisolone acetate versus topical budesonide in patients with seasonal allergic rhinitis. Allergy. 1988;43(2):87-92. https://doi.org/10.1111/j.1398-9995.1988.tb00399.x. Bayoumy AB, van Schie F, Stegeman I, Blijleven EB, van der Veen EL, de Ru JA. Intramuscular corticosteroid injections in seasonal allergic rhinitis: a systematic review. Laryngoscope Investig Otolaryngol. 2021;6(5):911-923. https://doi.org/10.1002/lio2.645. Mygind N, Laursen LC, Dahl M. Systemic corticosteroid treatment for seasonal allergic rhinitis: a common but poorly documented therapy. Allergy. 2000;55(1):11-15. https://doi.org/10.1034/j.1398-9995.2000.00108.x. Aasbjerg K, Torp-Pedersen C, Vaag A, Backer V. Treating allergic rhinitis with depot-steroid injections increase risk of osteoporosis and diabetes. Respir Med. 2013;107(12):1852-1858. https://doi.org/10.1016/j.rmed.2013.09.007. Wall JW, Shure N. Intranasal cortisone; preliminary study. AMA Arch Otolaryngol. 1952;56(2):172-176. Sidi E, Tardif R. Traitement des rhinites allergiques accompagnées d'eczéma par des injections d'acétate d'hydrocortisone au niveau de la muqueuse nasale [Treatment of allergic rhinitis accompanied by eczema with hydrocortisone acetate injected into nasal mucous membrane]. Sem Hop. 1955;31(33):1922-1923. Simmons MW. Intranasal injection of corticosteroids. Calif Med. 1960;92:155-158. Baker Jr DC, Strauss RB. Intranasal injections of long acting corticosteroids. Ann Otol Rhinol Laryngol. 1962;71:525-531. https://doi.org/10.1177/000348946207100224. Mabry RL. Intraturbinal steroid injection: indications, results, and complications. South Med J. 1978;71(7):789-791, 794. https://doi.org/10.1097/00007611-197807000-00015. Yang TY, Jung YG, Kim YH, Jang TY. A comparison of the effects of botulinum toxin A and steroid injection on nasal allergy. Otolaryngol Head Neck Surg. 2008;139(3):367-371. https://doi.org/10.1016/j.otohns.2008.06.031. Rowe RJ, Dusler TW, Kinkella AM. Visual changes and triamcinolone. J Am Med Assoc. 1967;201:333. Byers B. Blindness secondary to steroid injections into the nasal turbinates. Arch Ophthalmol. 1979;97(1):79-80. https://doi.org/10.1001/archopht.1979.01020010019004. Martin PA, Church CA, Petti Jr GH, Hedayi R. Visual loss after intraturbinate steroid injection. Otolaryngol Head Neck Surg. 2003;128(2):280-281. https://doi.org/10.1067/mhn.2003.81. Nagasato D, Ikeda N, Masuda A, Kashimoto R, Ikeda T. Progression of glaucomatous optic neuropathy associated with chorioretinal microvascular embolism after intranasal injection of a corticosteroid suspension. Indian J Ophthalmol. 2020;68(8):1686-1687. https://doi.org/10.4103/ijo.IJO_2332_19. Moss WJ, Kjos KB, Karnezis TT, Lebovits MJ. Intranasal steroid injections and blindness: our personal experience and a review of the past 60 years. Laryngoscope. 2015;125(4):796-800. https://doi.org/10.1002/lary.25000. Eccles R. Substitution of phenylephrine for pseudoephedrine as a nasal decongeststant. An illogical way to control methamphetamine abuse. Br J Clin Pharmacol. 2007;63(1):10-14. https://doi.org/10.1111/j.1365-2125.2006.02833.x. Salerno SM, Jackson JL, Berbano EP. Effect of oral pseudoephedrine on blood pressure and heart rate: a meta-analysis. Arch Intern Med. 2005;165(15):1686-1694. https://doi.org/10.1001/archinte.165.15.1686. Bronsky E, Boggs P, Findlay S, et al. Comparative efficacy and safety of a once-daily loratadine-pseudoephedrine combination versus its components alone and placebo in the management of seasonal allergic rhinitis. J Allergy Clin Immunol. 1995;96(2):139-147. https://doi.org/10.1016/s0091-6749(95)70001-3. Grosclaude M, Mees K, Pinelli ME, Lucas M, Van de Venne H. Cetirizine and pseudoephedrine retard, given alone or in combination, in patients with seasonal allergic rhinitis. Rhinology. 1997;35(2):67-73. Dockhorn RJ, Williams BO, Sanders RL. Efficacy of acrivastine with pseudoephedrine in treatment of allergic rhinitis due to ragweed. Ann Allergy Asthma Immunol. 1996;76(2):204-208. https://doi.org/10.1016/S1081-1206(10)63423-0. Grubbe RE, Lumry WR, Anolik R. Efficacy and safety of desloratadine/pseudoephedrine combination vs its components in seasonal allergic rhinitis. J Investig Allergol Clin Immunol. 2009;19(2):117-124. Bertrand B, Jamart J, Marchal JL, Arendt C. Cetirizine and pseudoephedrine retard alone and in combination in the treatment of perennial allergic rhinitis: a double-blind multicentre study. Rhinology. 1996;34(2):91-96. Sussman GL, Mason J, Compton D, Stewart J, Ricard N. The efficacy and safety of fexofenadine HCl and pseudoephedrine, alone and in combination, in seasonal allergic rhinitis. J Allergy Clin Immunol. 1999;104(1):100-106. https://doi.org/10.1016/s0091-6749(99)70120-x. Mucha SM, deTineo M, Naclerio RM, Baroody FM. Comparison of montelukast and pseudoephedrine in the treatment of allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2006;132(2):164-172. https://doi.org/10.1001/archotol.132.2.164. Henauer S, Seppey M, Huguenot C, Pecoud A. Effects of terfenadine and pseudoephedrine, alone and in combination in a nasal provocation test and in perennial rhinitis. Eur J Clin Pharmacol. 1991;41(4):321-324. https://doi.org/10.1007/BF00314960. Empey DW, Frosolono MF, Hughes DT, Perkins JG. Comparison of pseudoephedrine and triprolidine, alone and in combination in preventing nasal congestion in subjects with allergic rhinitis using nasal histamine challenge. Br J Clin Pharmacol. 1984;18(1):86-89. https://doi.org/10.1111/j.1365-2125.1984.tb05026.x. Howarth PH, Harrison K, Smith S. The influence of terfenadine and pseudo-ephedrine alone and in combination on allergen-induced rhinitis. Int Arch Allergy Immunol. 1993;101(3):318-321. https://doi.org/10.1159/000236470. Meltzer EO, Ratner PH, McGraw T. Oral phenylephrine HCl for nasal congestion in seasonal allergic rhinitis: a randomized, open-label, placebo-controlled study. J Allergy Clin Immunol Pract. 2015;3(5):702-708. https://doi.org/10.1016/j.jaip.2015.05.007. Pleskow W, Grubbe R, Weiss S, Lutsky B. Efficacy and safety of an extended-release formulation of desloratadine and pseudoephedrine vs the individual components in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2005;94(3):348-354. https://doi.org/10.1016/S1081-1206(10)60986-6. Svensson C, Pipkorn U, Alkner U, Baumgarten CR, Persson CG. Topical vasoconstrictor (oxymetazoline) does not affect histamine-induced mucosal exudation of plasma in human nasal airways. Clin Exp Allergy. 1992;22(3):411-416. https://doi.org/10.1111/j.1365-2222.1992.tb03103.x. Bickford L, Shakib S, Taverner D. The nasal airways response in normal subjects to oxymetazoline spray: randomized double-blind placebo-controlled trial. Br J Clin Pharmacol. 1999;48(1):53-56. https://doi.org/10.1046/j.1365-2125.1999.00972.x. Gomez-Hervas J, Garcia-Valdecasas Bernal J, Fernandez-Prada M, Palomeque-Vera JM, Garcia-Ramos A, Fernandez-Castanys BF. Effects of oxymetazoline on nasal flow and maximum aerobic exercise performance in patients with inferior turbinate hypertrophy. Laryngoscope. 2015;125(6):1301-1306. https://doi.org/10.1002/lary.25107. Taverner D, Bickford L, Shakib S, Tonkin A. Evaluation of the dose-response relationship for intra-nasal oxymetazoline hydrochloride in normal adults. Eur J Clin Pharmacol. 1999;55(7):509-513. https://doi.org/10.1007/s002280050665. Barnes ML, Biallosterski BT, Gray RD, Fardon TC, Lipworth BJ. Decongestant effects of nasal xylometazoline and mometasone furoate in persistent allergic rhinitis. Rhinology. 2005;43(4):291-295. Pritchard S, Glover M, Guthrie G, et al. Effectiveness of 0.05% oxymetazoline (Vicks Sinex Micromist(R)) nasal spray in the treatment of objective nasal congestion demonstrated to 12 h post-administration by magnetic resonance imaging. Pulm Pharmacol Ther. 2014;27(1):121-126. https://doi.org/10.1016/j.pupt.2013.08.002. Druce HM, Ramsey DL, Karnati S, Carr AN. Topical nasal decongestant oxymetazoline (0.05%) provides relief of nasal symptoms for 12 hours. Rhinology. 2018;56(4):343-350. https://doi.org/10.4193/Rhin17.150. Watanabe H, Foo TH, Djazaeri B, Duncombe P, Mackay IS, Durham SR. Oxymetazoline nasal spray three times daily for four weeks in normal subjects is not associated with rebound congestion or tachyphylaxis. Rhinology. 2003;41(3):167-174. Graf P, Hallen H. Effect on the nasal mucosa of long-term treatment with oxymetazoline, benzalkonium chloride, and placebo nasal sprays. Laryngoscope. 1996;106(5 pt 1):605-609. https://doi.org/10.1097/00005537-199605000-00016. Petruson B. Treatment with xylometazoline (Otrivin) nosedrops over a six-week period. Rhinology. 1981;19(3):167-172. Song XH, Zhang L, Han DM, Wang KJ, Wang H, Zhang W. [Effects of oxymetazoline hydrochloride on ex vivo human nasal cilia movement measured with high-speed digital microscopy]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2008;43(4):268-271. Meltzer EO, Wallace D, Friedman HS, Navaratnam P, Scott EP, Nolte H. Meta-analyses of the efficacy of pharmacotherapies and sublingual allergy immunotherapy tablets for allergic rhinitis in adults and children. Rhinology. 2021;59(5):422-432. https://doi.org/10.4193/Rhin21.054. Krishnamoorthy M, Mohd Noor N, Mat Lazim N, Abdullah B. Efficacy of montelukast in allergic rhinitis treatment: a systematic review and meta-analysis. Drugs. 2020;80(17):1831-1851. https://doi.org/10.1007/s40265-020-01406-9. Okubo K, Hashiguchi K, Takeda T, et al. A randomized controlled phase II clinical trial comparing ONO-4053, a novel DP1 antagonist, with a leukotriene receptor antagonist pranlukast in patients with seasonal allergic rhinitis. Allergy. 2017;72(10):1565-1575. https://doi.org/10.1111/all.13174. Wei C. The efficacy and safety of H1-antihistamine versus Montelukast for allergic rhinitis: a systematic review and meta-analysis. Biomed Pharmacother. 2016;83:989-997. https://doi.org/10.1016/j.biopha.2016.08.003. Durham SR, Creticos PS, Nelson HS, et al. Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: pooled analyses. J Allergy Clin Immunol. 2016;138(4):1081-1088.e4. https://doi.org/10.1016/j.jaci.2016.04.061. Hashiguchi K, Okubo K, Inoue Y, et al. Evaluation of montelukast for the treatment of children with japanese cedar pollinosis using an artificial exposure chamber (OHIO Chamber). Allergy Rhinol (Providence). 2018;9:2152656718783599. https://doi.org/10.1177/2152656718783599. Yoshihara S, Kikuchi Y, Saitou M, et al. Efficacy of a leukotriene receptor antagonist for pediatric cedar pollen allergy complicated by asthma. Exp Ther Med. 2017;14(4):3233-3238. https://doi.org/10.3892/etm.2017.4893. Chen H, Lou H, Wang Y, Cao F, Zhang L, Wang C. Comparison of the efficacy and mechanisms of intranasal budesonide, montelukast, and their combination in treatment of patients with seasonal allergic rhinitis. Int Forum Allergy Rhinol. 2018;8(11):1242-1252. https://doi.org/10.1002/alr.22197. Jindal A, Suriyan S, Sagadevan S, et al. Comparison of oral montelukast and intranasal fluticasone in patients with asthma and allergic rhinitis. J Clin Diagn Res. 2016;10(8):OC06-OC10. https://doi.org/10.7860/JCDR/2016/20741.8268. Dalgic A, Dinc ME, Ulusoy S, Dizdar D, Is A, Topak M. Comparison of the effects of nasal steroids and montelukast on olfactory functions in patients with allergic rhinitis. Eur Ann Otorhinolaryngol Head Neck Dis. 2017;134(4):213-216. https://doi.org/10.1016/j.anorl.2016.05.012. Feng Y, Meng YP, Dong YY, Qiu CY, Cheng L. Management of allergic rhinitis with leukotriene receptor antagonists versus selective H1-antihistamines: a meta-analysis of current evidence. Allergy Asthma Clin Immunol. 2021;17(1):62. https://doi.org/10.1186/s13223-021-00564-z. Xiao J, Wu WX, Ye YY, Lin WJ, Wang L. A network meta-analysis of randomized controlled trials focusing on different allergic rhinitis medications. Am J Ther. 2016;23(6):e1568-e1578. https://doi.org/10.1097/MJT.0000000000000242. Xu Y, Zhang J, Wang J. The efficacy and safety of selective H1-antihistamine versus leukotriene receptor antagonist for seasonal allergic rhinitis: a meta-analysis. PLoS One. 2014;9(11):e112815. https://doi.org/10.1371/journal.pone.0112815. Devillier P, Dreyfus JF, Demoly P, Calderon MA. A meta-analysis of sublingual allergen immunotherapy and pharmacotherapy in pollen-induced seasonal allergic rhinoconjunctivitis. BMC Med. 2014;12:71. https://doi.org/10.1186/1741-7015-12-71. Li YJ, Zong M, Ding LF, Rui XQ, Ma BY, Qin LP. Efficacy of Chinese medicine acupoint application combined with montelukast on children with perennial allergic rhinitis: a randomized controlled trial. Chin J Integr Med. 2020;26(11):845-852. https://doi.org/10.1007/s11655-020-3099-2. U.S. Food and Drug Administration. FDA requires Boxed Warning about serious mental health side effects for asthma and allergy drug montelukast (Singulair); advises restricting use for allergic rhinitis. 2020. Accessed January 15, 2022. https://www.fda.gov/drugs/fda-requires-boxed-warning-about-serious-mental-health-side-effects-asthma-and-allergy-drug. American Academy of Family Physicians. Clinical practice guidelines: allergic rhinitis. Updated July 6, 2020. Accessed November 1, 2021. https://www.aafp.org/family-physician/patient-care/clinical-recommendations/all-clinical-recommendations/allergic-rhinitis.html. Goodman MJ, Jhaveri M, Saverno K, Meyer K, Nightengale B. Cost-effectiveness of second-generation antihistamines and montelukast in relieving allergic rhinitis nasal symptoms. Am Health Drug Benefits. 2008;1(8):26-34. Grainger J, Drake-Lee A. Montelukast in allergic rhinitis: a systematic review and meta-analysis. Clin Otolaryngol. 2006;31(5):360-367. https://doi.org/10.1111/j.1749-4486.2006.01276.x. Rodrigo GJ, Yanez A. The role of antileukotriene therapy in seasonal allergic rhinitis: a systematic review of randomized trials. Ann Allergy Asthma Immunol. 2006;96(6):779-786. https://doi.org/10.1016/S1081-1206(10)61339-7. Gonyeau MJ, Partisan AM. A clinical review of montelukast in the treatment of seasonal allergic rhinitis. Formulary. 2003;38:368-378. Endo S, Gotoh M, Okubo K, Hashiguchi K, Suzuki H, Masuyama K. Trial of pranlukast inhibitory effect for cedar exposure using an OHIO chamber. J Drug Assess. 2012;1(1):48-54. https://doi.org/10.3109/21556660.2012.703630. Wakabayashi K, Hashiguchi K, Kanzaki S, et al. Pranlukast dry syrup inhibits symptoms of Japanese cedar pollinosis in children using OHIO Chamber. Allergy Asthma Proc. 2012;33(1):102-109. https://doi.org/10.2500/aap.2012.33.3517. Day JH, Briscoe MP, Ratz JD. Efficacy of levocetirizine compared with montelukast in subjects with ragweed-induced seasonal allergic rhinitis in the Environmental Exposure Unit. Allergy Asthma Proc. 2008;29(3):304-312. https://doi.org/10.2500/aap.2008.29.3109. Jiang RS. Efficacy of a leukotriene receptor antagonist in the treatment of perennial allergic rhinitis. J Otolaryngol. 2006;35(2):117-121. https://doi.org/10.2310/7070.2005.5007. Patel P, Philip G, Yang W, et al. Randomized, double-blind, placebo-controlled study of montelukast for treating perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2005;95(6):551-557. https://doi.org/10.1016/S1081-1206(10)61018-6. Chervinsky P, Philip G, Malice MP, et al. Montelukast for treating fall allergic rhinitis: effect of pollen exposure in 3 studies. Ann Allergy Asthma Immunol. 2004;92(3):367-373. https://doi.org/10.1016/S1081-1206(10)61576-1. Philip G, Nayak AS, Berger WE, et al. The effect of montelukast on rhinitis symptoms in patients with asthma and seasonal allergic rhinitis. Curr Med Res Opin. 2004;20(10):1549-1558. https://doi.org/10.1185/030079904x3348. Ratner PH, Howland 3rd WC, Arastu R, et al. Fluticasone propionate aqueous nasal spray provided significantly greater improvement in daytime and nighttime nasal symptoms of seasonal allergic rhinitis compared with montelukast. Ann Allergy Asthma Immunol. 2003;90(5):536-542. https://doi.org/10.1016/S1081-1206(10)61847-9. van Adelsberg J, Philip G, Pedinoff AJ, et al. Montelukast improves symptoms of seasonal allergic rhinitis over a 4-week treatment period. Allergy. 2003;58(12):1268-1276. https://doi.org/10.1046/j.1398-9995.2003.00261.x. van Adelsberg J, Philip G, LaForce CF, et al. Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2003;90(2):214-222. https://doi.org/10.1016/S1081-1206(10)62144-8. Philip G, Malmstrom K, Hampel FC, et al. Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring. Clin Exp Allergy. 2002;32(7):1020-1028. https://doi.org/10.1046/j.1365-2222.2002.01422.x. Pullerits T, Praks L, Skoogh BE, Ani R, Lotvall J. Randomized placebo-controlled study comparing a leukotriene receptor antagonist and a nasal glucocorticoid in seasonal allergic rhinitis. Am J Respir Crit Care Med. 1999;159(6):1814-1818. https://doi.org/10.1164/ajrccm.159.6.9810016. Altounyan RE. Review of clinical activity and mode of action of sodium cromoglycate. Clin Allergy. 1980;(10 suppl):481-489. https://doi.org/10.1111/j.1365-2222.1980.tb02162.x. Kay AB, Walsh GM, Moqbel R, et al. Disodium cromoglycate inhibits activation of human inflammatory cells in vitro. J Allergy Clin Immunol. 1987;80(1):1-8. https://doi.org/10.1016/s0091-6749(87)80183-5. Taylor G, Shivalkar PR. Disodium cromoglycate: laboratory studies and clinical trial in allergic rhinitis. Clin Allergy. 1971;1(2):189-198. https://doi.org/10.1111/j.1365-2222.1971.tb03018.x. Pelikan Z. The diagnostic approach to immediate hypersensitivity in patients with allergic rhinitis; a comparison of nasal challenges and serum rast. Ann Allergy. 1983;51(3):395-400. Kolly M, Pecoud A. Comparison of levocabastine, a new selective H1-receptor antagonist, and disodium cromoglycate, in a nasal provocation test with allergen. Br J Clin Pharmacol. 1986;22(4):389-394. https://doi.org/10.1111/j.1365-2125.1986.tb02907.x. Davies HJ. Exposure of hay fever subjects to an indoor environmental grass pollen challenge system. Clin Allergy. 1985;15(5):419-427. https://doi.org/10.1111/j.1365-2222.1985.tb02291.x. Ibanez MD, Laso MT, Martinez-San Irineo M, Alonso E. Anaphylaxis to disodium cromoglycate. Ann Allergy Asthma Immunol. 1996;77(3):185-186. https://doi.org/10.1016/s1081-1206(10)63252-8. Wass U, Plaschke P, Bjorkander J, Belin L. Assay of specific IgE antibodies to disodium cromoglycate in serum from a patient with an immediate hypersensitivity reaction. J Allergy Clin Immunol. 1988;81(4):750-757. https://doi.org/10.1016/0091-6749(88)91049-4. Schatz M, Zeiger RS, Harden K, Hoffman CC, Chilingar L, Petitti D. The safety of asthma and allergy medications during pregnancy. J Allergy Clin Immunol. 1997;100(3):301-306. https://doi.org/10.1016/s0091-6749(97)70241-0. Mazzotta P, Loebstein R, Koren G. Treating allergic rhinitis in pregnancy. Safety considerations. Drug Saf. 1999;20(4):361-375. https://doi.org/10.2165/00002018-199920040-00005. Meltzer EO, NasalCrom Study Group. Efficacy and patient satisfaction with cromolyn sodium nasal solution in the treatment of seasonal allergic rhinitis: a placebo-controlled study. Clin Ther. 2002;24(6):942-952. https://doi.org/10.1016/s0149-2918(02)80009-1. Chandra RK, Heresi G, Woodford G. Double-blind controlled crossover trial of 4% intranasal sodium cromoglycate solution in patients with seasonal allergic rhinitis. Ann Allergy. 1982;49(3):131-134. Handelman NI, Friday GA, Schwartz HJ, et al. Cromolyn sodium nasal solution in the prophylactic treatment of pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol. 1977;59(3):237-242. https://doi.org/10.1016/0091-6749(77)90156-7. Nizami RM, Baboo MT. Efficacy double-blind, crossover study of sodium cromoglycate in patients with seasonal allergic rhinitis. Ann Allergy. 1977;38(1):42-45. Knight A, Underdown BJ, Demanuele F, Hargreave FE. Disodium cromoglycate in ragweed-allergic rhinitis. J Allergy Clin Immunol. 1976;58(2):278-283. https://doi.org/10.1016/0091-6749(76)90132-9. Lejeune M, Lefebvre PP, Delvenne P, El-Shazly AE. Nasal sodium cromoglycate (Lomusol) modulates the early phase reaction of mild to moderate persistent allergic rhinitis in patients mono-sensitized to house dust mite: a preliminary study. Int Immunopharmacol. 2015;26(1):272-276. https://doi.org/10.1016/j.intimp.2015.02.004. Tandon MK, Strahan EG. Double-blind crossover trial comparing beclomethasone dipropionate and sodium cromoglycate in perennial allergic rhinitis. Clin Allergy. 1980;10(4):459-462. https://doi.org/10.1111/j.1365-2222.1980.tb02129.x. McDowell MK, Spitz E. Treatment of chronic perennial allergic rhinitis: a double-blind trial of cromolyn sodium. Ann Allergy. 1977;39(3):169-174. Warland A, Kapstad B. The effect of disodium cromoglycate in perennial allergic rhinitis. A controlled clinical study. Acta Allergol. 1977;32(3):195-199. https://doi.org/10.1111/j.1398-9995.1977.tb01350.x. Cohan RH, Bloom FL, Rhoades RB, Wittig HJ, Haugh LD. Treatment of perennial allergic rhinitis with cromolyn sodium. Double-blind study on 34 adult patients. J Allergy Clin Immunol. 1976;58(1 pt. 2):121-128. https://doi.org/10.1016/0091-6749(76)90147-0. Orgel HA, Meltzer EO, Kemp JP, Ostrom NK, Welch MJ. Comparison of intranasal cromolyn sodium, 4%, and oral terfenadine for allergic rhinitis: symptoms, nasal cytology, nasal ciliary clearance, and rhinomanometry. Ann Allergy. 1991;66(3):237-244. Schata M, Jorde W, Richarz-Barthauer U. Levocabastine nasal spray better than sodium cromoglycate and placebo in the topical treatment of seasonal allergic rhinitis. J Allergy Clin Immunol. 1991;87(4):873-878. https://doi.org/10.1016/0091-6749(91)90136-c. Lange B, Lukat KF, Rettig K, Holtappels G, Bachert C. Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2005;95(3):272-282. https://doi.org/10.1016/S1081-1206(10)61225-2. Fisher WG. Comparison of budesonide and disodium cromoglycate for the treatment of seasonal allergic rhinitis in children. Ann Allergy. 1994;73(6):515-520. Bousquet J, Chanal I, Alquie MC, et al. Prevention of pollen rhinitis symptoms: comparison of fluticasone propionate aqueous nasal spray and disodium cromoglycate aqueous nasal spray. A multicenter, double-blind, double-dummy, parallel-group study. Allergy. 1993;48(5):327-333. https://doi.org/10.1111/j.1398-9995.1993.tb02401.x. Welsh PW, Stricker WE, Chu CP, et al. Efficacy of beclomethasone nasal solution, flunisolide, and cromolyn in relieving symptoms of ragweed allergy. Mayo Clin Proc. 1987;62(2):125-134. https://doi.org/10.1016/s0025-6196(12)61882-5. Bjerrum P, Illum P. Treatment of seasonal allergic rhinitis with budesonide and disodium cromoglycate. A double-blind clinical comparison between budesonide and disodium cromoglycate. Allergy. 1985;40(1):65-69. https://doi.org/10.1111/j.1398-9995.1985.tb04156.x. Morrow-Brown H, Jackson FA, Pover GM. A comparison of beclomethasone dipropionate aqueous nasal spray and sodium cromoglycate nasal spray in the management of seasonal allergic rhinitis. Allergol Immunopathol (Madr). 1984;12(5):355-361. Brown HM, Engler C, English JR. A comparative trial of flunisolide and sodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis. Clin Allergy. 1981;11(2):169-173. https://doi.org/10.1111/j.1365-2222.1981.tb01581.x. Wilson JA, Walker SR. A clinical study of the prophylactic use of betamethasone valerate and sodium cromoglycate in the treatment of seasonal allergic rhinitis. J Laryngol Otol. 1976;90(2):201-206. https://doi.org/10.1017/s0022215100081962. Frankland AW, Walker SR. A comparison of intranasal betamethasone valerate and sodium cromoglycate in seasonal allergic rhinitis. Clin Allergy. 1975;5(3):295-300. https://doi.org/10.1111/j.1365-2222.1975.tb01866.x. Pitsios C, Papadopoulos D, Kompoti E, et al. Efficacy and safety of mometasone furoate vs nedocromil sodium as prophylactic treatment for moderate/severe seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2006;96(5):673-678. https://doi.org/10.1016/S1081-1206(10)61064-2. Schuller DE, Selcow JE, Joos TH, et al. A multicenter trial of nedocromil sodium, 1% nasal solution, compared with cromolyn sodium and placebo in ragweed seasonal allergic rhinitis. J Allergy Clin Immunol. 1990;86(4 pt 1):554-561. https://doi.org/10.1016/s0091-6749(05)80212-x. Craig S, Rubinstein E, Reisman RE, Arbesman CE. Treatment of ragweed hay fever with intranasally administered disodium cromoglycate. Clin Allergy. 1977;7(6):569-576. https://doi.org/10.1111/j.1365-2222.1977.tb01487.x. Posey WC, Nelson HS. Controlled trials with four per cent cromolyn spray in seasonal allergic rhinitis. Clin Allergy. 1977;7(5):485-496. https://doi.org/10.1111/j.1365-2222.1977.tb01479.x. Becker B, Borum S, Nielsen K, Mygind N, Borum P. A time-dose study of the effect of topical ipratropium bromide on methacholine-induced rhinorrhoea in patients with perennial non-allergic rhinitis. Clin Otolaryngol Allied Sci. 1997;22(2):132-134. https://doi.org/10.1046/j.1365-2273.1997.00875.x. Sanwikarja S, Schmitz PI, Dieges PH. The effect of locally applied ipratropium aerosol on the nasal methacholine challenge in patients with allergic and non-allergic rhinitis. Ann Allergy. 1986;56(2):162-166. Ostberg B, Winther B, Mygind N. Cold air-induced rhinorrhea and high-dose ipratropium. Arch Otolaryngol Head Neck Surg. 1987;113(2):160-162. https://doi.org/10.1001/archotol.1987.01860020052011. Kirkegaard J, Mygind N, Molgaard F, et al. Ordinary and high-dose ipratropium in perennial nonallergic rhinitis. J Allergy Clin Immunol. 1987;79(4):585-590. https://doi.org/10.1016/s0091-6749(87)80153-7. Kirkegaard J, Mygind N, Molgaard F, et al. Ipratropium treatment of rhinorrhea in perennial nonallergic rhinitis. A Nordic multicenter study. Acta Otolaryngol Suppl. 1988;449:93-95. https://doi.org/10.3109/00016488809106386. Bonadonna P, Senna G, Zanon P, et al. Cold-induced rhinitis in skiers-clinical aspects and treatment with ipratropium bromide nasal spray: a randomized controlled trial. Am J Rhinol. 2001;15(5):297-301. Kaiser HB, Findlay SR, Georgitis JW, et al. The anticholinergic agent, ipratropium bromide, is useful in the treatment of rhinorrhea associated with perennial allergic rhinitis. Allergy Asthma Proc. 1998;19(1):23-29. https://doi.org/10.2500/108854198778557962. Kaiser HB, Findlay SR, Georgitis JW, et al. Long-term treatment of perennial allergic rhinitis with ipratropium bromide nasal spray 0.06%. J Allergy Clin Immunol. 1995;95(5 pt 2):1128-1132. https://doi.org/10.1016/s0091-6749(95)70217-2. Bronsky EA, Druce H, Findlay SR, et al. A clinical trial of ipratropium bromide nasal spray in patients with perennial nonallergic rhinitis. J Allergy Clin Immunol. 1995;95(5 pt 2):1117-1122. https://doi.org/10.1016/s0091-6749(95)70215-6. Kim KT, Kerwin E, Landwehr L, et al. Use of 0.06% ipratropium bromide nasal spray in children aged 2 to 5 years with rhinorrhea due to a common cold or allergies. Ann Allergy Asthma Immunol. 2005;94(1):73-79. https://doi.org/10.1016/s1081-1206(10)61289-6. Ensing K, de Zeeuw RA, Nossent GD, Koeter GH, Cornelissen PJ. Pharmacokinetics of ipratropium bromide after single dose inhalation and oral and intravenous administration. Eur J Clin Pharmacol. 1989;36(2):189-194. https://doi.org/10.1007/BF00609193. Meltzer EO, Orgel HA, Biondi R, et al. Ipratropium nasal spray in children with perennial rhinitis. Ann Allergy Asthma Immunol. 1997;78(5):485-491. https://doi.org/10.1016/S1081-1206(10)63236-X. Milgrom H, Biondi R, Georgitis JW, et al. Comparison of ipratropium bromide 0.03% with beclomethasone dipropionate in the treatment of perennial rhinitis in children. Ann Allergy Asthma Immunol. 1999;83(2):105-111. https://doi.org/10.1016/S1081-1206(10)62620-8. Dockhorn R, Aaronson D, Bronsky E, et al. Ipratropium bromide nasal spray 0.03% and beclomethasone nasal spray alone and in combination for the treatment of rhinorrhea in perennial rhinitis. Ann Allergy Asthma Immunol. 1999;82(4):349-359. https://doi.org/10.1016/S1081-1206(10)63284-X. Finn Jr AF, Aaronson D, Korenblat P, et al. Ipratropium bromide nasal spray 0.03% provides additional relief from rhinorrhea when combined with terfenadine in perennial rhinitis patients; a randomized, double-blind, active-controlled trial. Am J Rhinol. 1998;12(6):441-449. https://doi.org/10.2500/105065898780707919. Gorski P, Pazdrak K, Ruta U. Effect of ipratropium on nasal reactivity to histamine and eosinophil influx in perennial allergic rhinitis. Eur J Clin Pharmacol. 1993;44(6):545-547. https://doi.org/10.1007/BF02440856. Meltzer EO, Orgel HA, Bronsky EA, et al. Ipratropium bromide aqueous nasal spray for patients with perennial allergic rhinitis: a study of its effect on their symptoms, quality of life, and nasal cytology. J Allergy Clin Immunol. 1992;90(2):242-249. https://doi.org/10.1016/0091-6749(92)90078-g. Schultz Larsen F, Mygind N, Larsen FS. Ipratropium treatment for rhinorrhoea in patients with perennial rhinitis. An open follow-up study of efficacy and safety. Clin Otolaryngol Allied Sci. 1983;8(4):267-272. https://doi.org/10.1111/j.1365-2273.1983.tb01440.x. Borum P, Mygind N, Schultz Larsen F. Intranasal ipratropium: a new treatment for perennial rhinitis. Clin Otolaryngol Allied Sci. 1979;4(6):407-411. https://doi.org/10.1111/j.1365-2273.1979.tb01773.x. Cox L. Biologics and allergy immunotherapy in the treatment of allergic diseases. Immunol Allergy Clin North Am. 2020;40(4):687-700. https://doi.org/10.1016/j.iac.2020.06.008. Eschenbacher W, Straesser M, Knoeddler A, Li RC, Borish L. Biologics for the treatment of allergic rhinitis, chronic rhinosinusitis, and nasal polyposis. Immunol Allergy Clin North Am. 2020;40(4):539-547. https://doi.org/10.1016/j.iac.2020.06.001. Licari A, Marseglia G, Castagnoli R, Marseglia A, Ciprandi G. The discovery and development of omalizumab for the treatment of asthma. Expert Opin Drug Discov. 2015;10(9):1033-1042. https://doi.org/10.1517/17460441.2015.1048220. Tsabouri S, Tseretopoulou X, Priftis K, Ntzani EE. Omalizumab for the treatment of inadequately controlled allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials. J Allergy Clin Immunol Pract. 2014;2(3):332-340.e1. https://doi.org/10.1016/j.jaip.2014.02.001. Yu C, Wang K, Cui X, et al. Clinical efficacy and safety of omalizumab in the treatment of allergic rhinitis: a systematic review and meta-analysis of randomized clinical trials. Am J Rhinol Allergy. 2020;34(2):196-208. https://doi.org/10.1177/1945892419884774. Casale TB, Bernstein IL, Busse WW, et al. Use of an anti-IgE humanized monoclonal antibody in ragweed-induced allergic rhinitis. J Allergy Clin Immunol. 1997;100(1):110-121. https://doi.org/10.1016/s0091-6749(97)70202-1. Adelroth E, Rak S, Haahtela T, et al. Recombinant humanized mAb-E25, an anti-IgE mAb, in birch pollen-induced seasonal allergic rhinitis. J Allergy Clin Immunol. 2000;106(2):253-259. https://doi.org/10.1067/mai.2000.108310. Casale TB, Condemi J, LaForce C, et al. Effect of omalizumab on symptoms of seasonal allergic rhinitis: a randomized controlled trial. JAMA. 2001;286(23):2956-2967. https://doi.org/10.1001/jama.286.23.2956. Chervinsky P, Casale T, Townley R, et al. Omalizumab, an anti-IgE antibody, in the treatment of adults and adolescents with perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2003;91(2):160-167. https://doi.org/10.1016/S1081-1206(10)62171-0. Okubo K, Ogino S, Nagakura T, Ishikawa T. Omalizumab is effective and safe in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis. Allergol Int. 2006;55(4):379-386. https://doi.org/10.2332/allergolint.55.379. Corren J, Diaz-Sanchez D, Saxon A, et al. Effects of omalizumab, a humanized monoclonal anti-IgE antibody, on nasal reactivity to allergen and local IgE synthesis. Ann Allergy Asthma Immunol. 2004;93(3):243-248. https://doi.org/10.1016/S1081-1206(10)61495-0. Bez C, Schubert R, Kopp M, et al. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis. Clin Exp Allergy. 2004;34(7):1079-1085. https://doi.org/10.1111/j.1365-2222.2004.01998.x. Nagakura T, Ogino S, Okubo K, Sato N, Takahashi M, Ishikawa T. Omalizumab is more effective than suplatast tosilate in the treatment of Japanese cedar pollen-induced seasonal allergic rhinitis. Clin Exp Allergy. 2008;38(2):329-337. https://doi.org/10.1111/j.1365-2222.2007.02894.x. Davydov L. Omalizumab (Xolair) for treatment of asthma. Am Fam Physician. 2005;71(2):341-342. Bachert C, Hellings PW, Mullol J, et al. Dupilumab improves health-related quality of life in patients with chronic rhinosinusitis with nasal polyposis. Allergy. 2020;75(1):148-157. https://doi.org/10.1111/all.13984. Weinstein SF, Katial R, Jayawardena S, et al. Efficacy and safety of dupilumab in perennial allergic rhinitis and comorbid asthma. J Allergy Clin Immunol. 2018;142(1):171-177.e1. https://doi.org/10.1016/j.jaci.2017.11.051. Busse WW, Maspero JF, Lu Y, et al. Efficacy of dupilumab on clinical outcomes in patients with asthma and perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2020;125(5):565-576.e1. https://doi.org/10.1016/j.anai.2020.05.026. Corren J, Saini SS, Gagnon R, et al. Short-term subcutaneous allergy immunotherapy and dupilumab are well tolerated in allergic rhinitis: a randomized trial. J Asthma Allergy. 2021;14:1045-1063. https://doi.org/10.2147/JAA.S318892. Casale TB, Busse WW, Kline JN, et al. Omalizumab pretreatment decreases acute reactions after rush immunotherapy for ragweed-induced seasonal allergic rhinitis. J Allergy Clin Immunol. 2006;117(1):134-140. https://doi.org/10.1016/j.jaci.2005.09.036. Kuehr J, Brauburger J, Zielen S, et al. Efficacy of combination treatment with anti-IgE plus specific immunotherapy in polysensitized children and adolescents with seasonal allergic rhinitis. J Allergy Clin Immunol. 2002;109(2):274-280. https://doi.org/10.1067/mai.2002.121949. Cordray S, Harjo JB, Miner L. Comparison of intranasal hypertonic dead sea saline spray and intranasal aqueous triamcinolone spray in seasonal allergic rhinitis. Ear Nose Throat J. 2005;84(7):426-430. Rogkakou A, Guerra L, Massacane P, et al. Effects on symptoms and quality of life of hypertonic saline nasal spray added to antihistamine in persistent allergic rhinitis - a randomized controlled study. Eur Ann Allergy Clin Immunol. 2005;37(9):353-36. Ural A, Oktemer TK, Kizil Y, Ileri F, Uslu S. Impact of isotonic and hypertonic saline solutions on mucociliary activity in various nasal pathologies: clinical study. J Laryngol Otol. 2009;123(5):517-521. https://doi.org/10.1017/S0022215108003964. Garavello W, Somigliana E, Acaia B, Gaini L, Pignataro L, Gaini RM. Nasal lavage in pregnant women with seasonal allergic rhinitis: a randomized study. Int Arch Allergy Immunol. 2010;151(2):137-141. https://doi.org/10.1159/000236003. Chusakul S, Warathanasin S, Suksangpanya N, et al. Comparison of buffered and nonbuffered nasal saline irrigations in treating allergic rhinitis. Laryngoscope. 2013;123(1):53-56. https://doi.org/10.1002/lary.23617. Di Berardino F, Zanetti D, D'Amato G. Nasal rinsing with an atomized spray improves mucociliary clearance and clinical symptoms during peak grass pollen season. Am J Rhinol Allergy. 2017;31(1):40-43. https://doi.org/10.2500/ajra.2016.30.4383. Sansila K, Eiamprapai P, Sawangjit R. Effects of self-prepared hypertonic nasal saline irrigation in allergic rhinitis: a randomized controlled trial. Asian Pac J Allergy Immunol. 2020;38(3):200-207. https://doi.org/10.12932/AP-090618-0331. Lin L, Chen Z, Cao Y, Sun G. Normal saline solution nasal-pharyngeal irrigation improves chronic cough associated with allergic rhinitis. Am J Rhinol Allergy. 2017;31(2):96-104. https://doi.org/10.2500/ajra.2017.31.4418. Yata K, Srivanitchapoom C. The comparison of nasal irrigation outcome between 3% NaCl and 0.9% NaCl in adults majority with intermittent allergic rhinitis: a randomized double-blind study. Asian Pac J Allergy Immunol. 2021;39(1):9-14. https://doi.org/10.12932/AP-140520-0844. Li CL, Lin HC, Lin CY, Hsu TF. Effectiveness of hypertonic saline nasal irrigation for alleviating allergic rhinitis in children: a systematic review and meta-analysis. J Clin Med. 2019;8(1):64. https://doi.org/10.3390/jcm8010064. Li H, Sha Q, Zuo K, et al. Nasal saline irrigation facilitates control of allergic rhinitis by topical steroid in children. ORL J Otorhinolaryngol Relat Spec. 2009;71(1):50-55. https://doi.org/10.1159/000178165. Garavello W, Romagnoli M, Sordo L, Gaini RM, Di Berardino C, Angrisano A. Hypersaline nasal irrigation in children with symptomatic seasonal allergic rhinitis: a randomized study. Pediatr Allergy Immunol. 2003;14(2):140-143. https://doi.org/10.1034/j.1399-3038.2003.00021.x. Garavello W, Di Berardino F, Romagnoli M, Sambataro G, Gaini RM. Nasal rinsing with hypertonic solution: an adjunctive treatment for pediatric seasonal allergic rhinoconjunctivitis. Int Arch Allergy Immunol. 2005;137(4):310-314. https://doi.org/10.1159/000086462. Marchisio P, Varricchio A, Baggi E, et al. Hypertonic saline is more effective than normal saline in seasonal allergic rhinitis in children. Int J Immunopathol Pharmacol. 2012;25(3):721-730. https://doi.org/10.1177/039463201202500318. Satdhabudha A, Poachanukoon O. Efficacy of buffered hypertonic saline nasal irrigation in children with symptomatic allergic rhinitis: a randomized double-blind study. Int J Pediatr Otorhinolaryngol. 2012;76(4):583-588. https://doi.org/10.1016/j.ijporl.2012.01.022. Chen JR, Jin L, Li XY. The effectiveness of nasal saline irrigation (seawater) in treatment of allergic rhinitis in children. Int J Pediatr Otorhinolaryngol. 2014;78(7):1115-1118. https://doi.org/10.1016/j.ijporl.2014.04.026. Malizia V, Fasola S, Ferrante G, et al. Efficacy of buffered hypertonic saline nasal irrigation for nasal symptoms in children with seasonal allergic rhinitis: a randomized controlled trial. Int Arch Allergy Immunol. 2017;174(2):97-103. https://doi.org/10.1159/000481093. Jung M, Lee JY, Ryu G, et al. Beneficial effect of nasal saline irrigation in children with allergic rhinitis and asthma: a randomized clinical trial. Asian Pac J Allergy Immunol. 2020;38(4):251-257. https://doi.org/10.12932/AP-070918-0403. Hermelingmeier KE, Weber RK, Hellmich M, Heubach CP, Mosges R. Nasal irrigation as an adjunctive treatment in allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2012;26(5):e119-e125. https://doi.org/10.2500/ajra.2012.26.3787. Head K, Snidvongs K, Glew S, et al. Saline irrigation for allergic rhinitis. Cochrane Database Syst Rev. 2018;6:CD012597. https://doi.org/10.1002/14651858.CD012597.pub2. Wang Y, Jin L, Liu SX, Fan K, Qin ML, Yu SQ. Role of nasal saline irrigation in the treatment of allergic rhinitis in children and adults: a systematic analysis. Allergol Immunopathol (Madr). 2020;48(4):360-367. https://doi.org/10.1016/j.aller.2020.01.002. Ozdemir O. Various effects of different probiotic strains in allergic disorders: an update from laboratory and clinical data. Clin Exp Immunol. 2010;160(3):295-304. https://doi.org/10.1111/j.1365-2249.2010.04109.x. Guvenc IA, Muluk NB, Mutlu FS, et al. Do probiotics have a role in the treatment of allergic rhinitis? A comprehensive systematic review and meta-analysis. Am J Rhinol Allergy. 2016;30(5):157-175. https://doi.org/10.2500/ajra.2016.30.4354. Zajac AE, Adams AS, Turner JH. A systematic review and meta-analysis of probiotics for the treatment of allergic rhinitis. Int Forum Allergy Rhinol. 2015;5(6):524-532. https://doi.org/10.1002/alr.21492. Du X, Wang L, Wu S, et al. Efficacy of probiotic supplementary therapy for asthma, allergic rhinitis, and wheeze: a meta-analysis of randomized controlled trials. Allergy Asthma Proc. 2019;40(4):250-260. https://doi.org/10.2500/aap.2019.40.4227. Zuccotti G, Meneghin F, Aceti A, et al. Probiotics for prevention of atopic diseases in infants: systematic review and meta-analysis. Allergy. 2015;70(11):1356-1371. https://doi.org/10.1111/all.12700. Anania C, Di Marino VP, Olivero F, et al. Treatment with a probiotic mixture containing Bifidobacterium animalis Subsp. Lactis BB12 and Enterococcus faecium L3 for the prevention of allergic rhinitis symptoms in children: a randomized controlled trial. Nutrients. 2021;13(4):1315. https://doi.org/10.3390/nu13041315. Jalali MM, Soleimani R, Alavi Foumani A, Ganjeh Khosravi H. Add-on probiotics in patients with persistent allergic rhinitis: a randomized crossover clinical trial. Laryngoscope. 2019;129(8):1744-1750. https://doi.org/10.1002/lary.27858. Sumadiono S, Satria CD, Mardhiah N, Susanti GI. Immunotherapy and probiotic treatment for allergic rhinitis in children. Paediatr Indones. 2018;58(6):280-285. Dennis-Wall JC, Culpepper T, Nieves Jr C, et al. Probiotics (Lactobacillus gasseri KS-13, Bifidobacterium bifidum G9-1, and Bifidobacterium longum MM-2) improve rhinoconjunctivitis-specific quality of life in individuals with seasonal allergies: a double-blind, placebo-controlled, randomized trial. Am J Clin Nutr. 2017;105(3):758-767. https://doi.org/10.3945/ajcn.116.140012. Miraglia Del Giudice M, Indolfi C, Capasso M, Maiello N, Decimo F, Ciprandi G. Bifidobacterium mixture (B longum BB536, B infantis M-63, B breve M-16V) treatment in children with seasonal allergic rhinitis and intermittent asthma. Ital J Pediatr. 2017;43(1):25. https://doi.org/10.1186/s13052-017-0340-5. Beard S. Rhinitis. Prim Care. 2014;41(1):33-46. https://doi.org/10.1016/j.pop.2013.10.005. North ML, Walker TJ, Steacy LM, et al. Add-on histamine receptor-3 antagonist for allergic rhinitis: a double blind randomized crossover trial using the environmental exposure unit. Allergy Asthma Clin Immunol. 2014;10(1):33. https://doi.org/10.1186/1710-1492-10-33. Nathan RA, Finn Jr AF, LaForce C, et al. Comparison of cetirizine-pseudoephedrine and placebo in patients with seasonal allergic rhinitis and concomitant mild-to-moderate asthma: randomized, double-blind study. Ann Allergy Asthma Immunol. 2006;97(3):389-396. https://doi.org/10.1016/S1081-1206(10)60806-X. Chervinsky P, Nayak A, Rooklin A, Danzig M. Efficacy and safety of desloratadine/pseudoephedrine tablet, 2.5/120 mg two times a day, versus individual components in the treatment of patients with seasonal allergic rhinitis. Allergy Asthma Proc. 2005;26(5):391-396. Meltzer EO, Casale TB, Gold MS, et al. Efficacy and safety of clemastine-pseudoephedrine-acetaminophen versus pseudoephedrine-acetaminophen in the treatment of seasonal allergic rhinitis in a 1-day, placebo-controlled park study. Ann Allergy Asthma Immunol. 2003;90(1):79-86. https://doi.org/10.1016/S1081-1206(10)63618-6. McFadden EA, Gungor A, Ng B, Mamikoglu B, Moinuddin R, Corey J. Loratadine/pseudoephedrine for nasal symptoms in seasonal allergic rhinitis: a double-blind, placebo-controlled study. Ear Nose Throat J. 2000;79(4):254, 257-8, 260 passim. Serra HA, Alves O, Rizzo LF, Devoto FM, Ascierto H. Loratadine-pseudoephedrine in children with allergic rhinitis, a controlled double-blind trial. Br J Clin Pharmacol. 1998;45(2):147-150. https://doi.org/10.1046/j.1365-2125.1998.00657.x. Corren J, Harris AG, Aaronson D, et al. Efficacy and safety of loratadine plus pseudoephedrine in patients with seasonal allergic rhinitis and mild asthma. J Allergy Clin Immunol. 1997;100(6 pt 1):781-788. https://doi.org/10.1016/s0091-6749(97)70274-4. Williams BO, Hull H, McSorley P, Frosolono MF, Sanders RL. Efficacy of acrivastine plus pseudoephedrine for symptomatic relief of seasonal allergic rhinitis due to mountain cedar. Ann Allergy Asthma Immunol. 1996;76(5):432-438. https://doi.org/10.1016/S1081-1206(10)63460-6. Grossman J, Bronsky EA, Lanier BQ, et al. Loratadine-pseudoephedrine combination versus placebo in patients with seasonal allergic rhinitis. Ann Allergy. 1989;63(4):317-321. Storms WW, Bodman SF, Nathan RA, et al. SCH 434: a new antihistamine/decongestant for seasonal allergic rhinitis. J Allergy Clin Immunol. 1989;83(6):1083-1090. https://doi.org/10.1016/0091-6749(89)90450-8. Chen YA, Chang KP, Lin YS, Hao SP. A randomized, double-blind, parallel-group study to compare the efficacy and safety of a once-daily loratadine-pseudoephedrine combination with that of a twice-daily loratadine-pseudoephedrine combination in the treatment of allergic rhinitis. Eur Arch Otorhinolaryngol. 2007;264(9):1019-1025. https://doi.org/10.1007/s00405-007-0316-y. Chiang YC, Shyur SD, Chen TL, et al. A randomized controlled trial of cetirizine plus pseudoephedrine versus loratadine plus pseudoephedrine for perennial allergic rhinitis. Asian Pac J Allergy Immunol. 2006;24(2-3):97-103. Moinuddin R, deTineo M, Maleckar B, Naclerio RM, Baroody FM. Comparison of the combinations of fexofenadine-pseudoephedrine and loratadine-montelukast in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004;92(1):73-79. https://doi.org/10.1016/S1081-1206(10)61713-9. Simola M, Boss I, Holopainen E, et al. Astemizole in combination with pseudoephedrine in the treatment of seasonal allergic rhinitis. Rhinology. 1996;34(1):21-23. Prevost M, Turenne Y, Moote DW, et al. Comparative study of SCH 434 and CTM-D in the treatment of seasonal allergic rhinitis. Clin Ther. 1994;16(1):50-56. Segal AT, Falliers CJ, Grant JA, et al. Safety and efficacy of terfenadine/pseudoephedrine versus clemastine/phenylpropanolamine in the treatment of seasonal allergic rhinitis. Ann Allergy. 1993;70(5):389-394. Zieglmayer UP, Horak F, Toth J, Marks B, Berger UE, Burtin B. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus budesonide nasal spray in the management of nasal congestion in allergic rhinitis. Treat Respir Med. 2005;4(4):283-287. https://doi.org/10.2165/00151829-200504040-00006. Negrini AC, Troise C, Voltolini S, Horak F, Bachert C, Janssens M. Oral antihistamine/decongestant treatment compared with intranasal corticosteroids in seasonal allergic rhinitis. Clin Exp Allergy. 1995;25(1):60-65. https://doi.org/10.1111/j.1365-2222.1995.tb01003.x. Stubner UP, Toth J, Marks B, Berger UE, Burtin B, Horak F. Efficacy and safety of an oral formulation of cetirizine and prolonged-release pseudoephedrine versus xylometazoline nasal spray in nasal congestion. Arzneimittelforschung. 2001;51(11):904-910. https://doi.org/10.1055/s-0031-1300135. Kaiser HB, Banov CH, Berkowitz RR, et al. Comparative efficacy and safety of once-daily versus twice-daily loratadine-pseudoephedrine combinations versus placebo in seasonal allergic rhinitis. Am J Ther. 1998;5(4):245-251. https://doi.org/10.1097/00045391-199807000-00007. Pinar E, Eryigit O, Oncel S, Calli C, Yilmaz O, Yuksel H. Efficacy of nasal corticosteroids alone or combined with antihistamines or montelukast in treatment of allergic rhinitis. Auris Nasus Larynx. 2008;35(1):61-66. https://doi.org/10.1016/j.anl.2007.06.004. Anolik R, Mometasone Furoate Nasal Spray With Loratadine Study Group. Clinical benefits of combination treatment with mometasone furoate nasal spray and loratadine vs monotherapy with mometasone furoate in the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2008;100(3):264-271. https://doi.org/10.1016/S1081-1206(10)60452-8. Barnes ML, Ward JH, Fardon TC, Lipworth BJ. Effects of levocetirizine as add-on therapy to fluticasone in seasonal allergic rhinitis. Clin Exp Allergy. 2006;36(5):676-684. https://doi.org/10.1111/j.1365-2222.2006.02478.x. Di Lorenzo G, Pacor ML, Pellitteri ME, et al. Randomized placebo-controlled trial comparing fluticasone aqueous nasal spray in mono-therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis. Clin Exp Allergy. 2004;34(2):259-267. https://doi.org/10.1111/j.1365-2222.2004.01877.x. Ratner PH, van Bavel JH, Martin BG, et al. A comparison of the efficacy of fluticasone propionate aqueous nasal spray and loratadine, alone and in combination, for the treatment of seasonal allergic rhinitis. J Fam Pract. 1998;47(2):118-125. Seresirikachorn K, Chitsuthipakorn W, Kanjanawasee D, Khattiyawittayakun L, Snidvongs K. Effects of H1 antihistamine addition to intranasal corticosteroid for allergic rhinitis: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2018;8(10):1083-1092. https://doi.org/10.1002/alr.22166. Wang R, Zhang C. [Clinical evaluation of Montelukast plus Budesonide nasal spray and Desloratadine citrate disodium in treating moderate and severe persistent allergic rhinitis]. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2015;29(23):2041-2043. Modgill V, Badyal DK, Verghese A. Efficacy and safety of montelukast add-on therapy in allergic rhinitis. Methods Find Exp Clin Pharmacol. 2010;32(9):669-674. https://doi.org/10.1358/mf.2010.32.9.1533686. Benitez HH, Arvizu VM, Gutiérrez DJ, et al., Budesonida nasal más zafirlukast vs budesonida nasal más loratadina- pseudoefedrina en el control de los síntomas de la rinitis y el asma [Nasal budesonide plus zafirlukast vs nasal budesonide plus loratadine-pseudoephedrine for controlling the symptoms of rhinitis and asthma]. Rev Alerg Mex. 2005;52(2):90-95. Lanier BQ, Abelson MB, Berger WE, et al. Comparison of the efficacy of combined fluticasone propionate and olopatadine versus combined fluticasone propionate and fexofenadine for the treatment of allergic rhinoconjunctivitis induced by conjunctival allergen challenge. Clin Ther. 2002;24(7):1161-1174. https://doi.org/10.1016/s0149-2918(02)80027-3. Wilson A, Dempsey OJ, Sims EJ, Coutie WJ, Paterson MC, Lipworth BJ. Evaluation of treatment response in patients with seasonal allergic rhinitis using domiciliary nasal peak inspiratory flow. Clin Exp Allergy. 2000;30(6):833-838. https://doi.org/10.1046/j.1365-2222.2000.00749.x. Juniper EF, Kline PA, Hargreave FE, Dolovich J. Comparison of beclomethasone dipropionate aqueous nasal spray, astemizole, and the combination in the prophylactic treatment of ragweed pollen-induced rhinoconjunctivitis. J Allergy Clin Immunol. 1989;83(3):627-633. https://doi.org/10.1016/0091-6749(89)90075-4. Kim MK, Lee SY, Park HS, et al. A randomized, multicenter, double-blind, phase III study to evaluate the efficacy on allergic rhinitis and safety of a combination therapy of Montelukast and Levocetirizine in patients with asthma and allergic rhinitis. Clin Ther. 2018;40(7):1096-1107. e1. https://doi.org/10.1016/j.clinthera.2018.04.021. Liu G, Zhou X, Chen J, Liu F. Oral Antihistamines alone vs in combination with leukotriene receptor antagonists for allergic rhinitis: a meta-analysis. Otolaryngol Head Neck Surg. 2018;158(3):450-458. https://doi.org/10.1177/0194599817752624. Mahatme MS, Dakhale GN, Tadke K, Hiware SK, Dudhgaonkar SD, Wankhede S. Comparison of efficacy, safety, and cost-effectiveness of montelukast-levocetirizine and montelukast-fexofenadine in patients of allergic rhinitis: a randomized, double-blind clinical trial. Indian J Pharmacol. 2016;48(6):649-653. https://doi.org/10.4103/0253-7613.194854. Lu S, Malice MP, Dass SB, Reiss TF. Clinical studies of combination montelukast and loratadine in patients with seasonal allergic rhinitis. J Asthma. 2009;46(9):878-883. https://doi.org/10.3109/02770900903104540. Saengpanich S, deTineo M, Naclerio RM, Baroody FM. Fluticasone nasal spray and the combination of loratadine and montelukast in seasonal allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2003;129(5):557-562. https://doi.org/10.1001/archotol.129.5.557. Cingi C, Gunhan K, Gage-White L, Unlu H. Efficacy of leukotriene antagonists as concomitant therapy in allergic rhinitis. Laryngoscope. 2010;120(9):1718-1723. https://doi.org/10.1002/lary.20941. Li AM, Abdullah VJ, Tsen CS, et al. Leukotriene receptor antagonist in the treatment of childhood allergic rhinitis - a randomized placebo-controlled study. Pediatr Pulmonol. 2009;44(11):1085-1092. https://doi.org/10.1002/ppul.21102. Ciebiada M, Barylski M, Gorska Ciebiada M. Nasal eosinophilia and serum soluble intercellular adhesion molecule 1 in patients with allergic rhinitis treated with montelukast alone or in combination with desloratadine or levocetirizine. Am J Rhinol Allergy. 2013;27(2):e58-e62. https://doi.org/10.2500/ajra.2013.27.3881. Yamamoto H, Yamada T, Sakashita M, et al. Efficacy of prophylactic treatment with montelukast and montelukast plus add-on loratadine for seasonal allergic rhinitis. Allergy Asthma Proc. 2012;33(2):e17-e22. https://doi.org/10.2500/aap.2012.33.3514. Watanasomsiri A, Poachanukoon O, Vichyanond P. Efficacy of montelukast and loratadine as treatment for allergic rhinitis in children. Asian Pac J Allergy Immunol. 2008;26(2-3):89-95. Nayak AS, Philip G, Lu S, Malice MP, Reiss TF, Montelukast Fall Rhinitis Investigator Group. Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall. Ann Allergy Asthma Immunol. 2002;88(6):592-600. https://doi.org/10.1016/S1081-1206(10)61891-1. Meltzer EO, Malmstrom K, Lu S, et al. Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: a randomized, placebo-controlled clinical trial. J Allergy Clin Immunol. 2000;105(5):917-922. https://doi.org/10.1067/mai.2000.106040. Andrews CP, Mohar D, Salhi Y, Tantry SK. Efficacy and safety of twice-daily and once-daily olopatadine-mometasone combination nasal spray for seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2020;124(2):171-178.e2. https://doi.org/10.1016/j.anai.2019.11.007. Hampel FC, Pedinoff AJ, Jacobs RL, Caracta CF, Tantry SK. Olopatadine-mometasone combination nasal spray: evaluation of efficacy and safety in patients with seasonal allergic rhinitis. Allergy Asthma Proc. 2019;40(4):261-272. https://doi.org/10.2500/aap.2019.40.4223. Gross GN, Berman G, Amar NJ, Caracta CF, Tantry SK. Efficacy and safety of olopatadine-mometasone combination nasal spray for the treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2019;122(6):630-638.e3. https://doi.org/10.1016/j.anai.2019.03.017. Patel P, Salapatek AM, Tantry SK. Effect of olopatadine-mometasone combination nasal spray on seasonal allergic rhinitis symptoms in an environmental exposure chamber study. Ann Allergy Asthma Immunol. 2019;122(2):160-166.e1. https://doi.org/10.1016/j.anai.2018.10.011. Kortekaas Krohn I, Callebaut I, Alpizar YA, et al. MP29-02 reduces nasal hyperreactivity and nasal mediators in patients with house dust mite-allergic rhinitis. Allergy. 2018;73(5):1084-1093. https://doi.org/10.1111/all.13349. Berger W, Meltzer EO, Amar N, et al. Efficacy of MP-AzeFlu in children with seasonal allergic rhinitis: importance of paediatric symptom assessment. Pediatr Allergy Immunol. 2016;27(2):126-133. https://doi.org/10.1111/pai.12540. Meltzer E, Ratner P, Bachert C, et al. Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis. Int Arch Allergy Immunol. 2013;161(4):369-377. https://doi.org/10.1159/000351404. Price D, Shah S, Bhatia S, et al. A new therapy (MP29-02) is effective for the long-term treatment of chronic rhinitis. J Investig Allergol Clin Immunol. 2013;23(7):495-503. Carr W, Bernstein J, Lieberman P, et al. A novel intranasal therapy of azelastine with fluticasone for the treatment of allergic rhinitis. J Allergy Clin Immunol. 2012;129(5):1282-1289.e10. https://doi.org/10.1016/j.jaci.2012.01.077. Meltzer EO, LaForce C, Ratner P, Price D, Ginsberg D, Carr W. MP29-02 (a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate) in the treatment of seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial of efficacy and safety. Allergy Asthma Proc. 2012;33(4):324-332. https://doi.org/10.2500/aap.2012.33.3587. Salapatek AM, Lee J, Patel D, et al. Solubilized nasal steroid (CDX-947) when combined in the same solution nasal spray with an antihistamine (CDX-313) provides improved, fast-acting symptom relief in patients with allergic rhinitis. Allergy Asthma Proc. 2011;32(3):221-229. https://doi.org/10.2500/aap.2011.32.3444. Hampel FC, Ratner PH, Van Bavel J, et al. Double-blind, placebo-controlled study of azelastine and fluticasone in a single nasal spray delivery device. Ann Allergy Asthma Immunol. 2010;105(2):168-173. https://doi.org/10.1016/j.anai.2010.06.008. LaForce CF, Carr W, Tilles SA, et al. Evaluation of olopatadine hydrochloride nasal spray,.6%, used in combination with an intranasal corticosteroid in seasonal allergic rhinitis. Allergy Asthma Proc. 2010;31(2):132-140. https://doi.org/10.2500/aap.2010.31.3326. Ratner PH, Hampel F, Van Bavel J, et al. Combination therapy with azelastine hydrochloride nasal spray and fluticasone propionate nasal spray in the treatment of patients with seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2008;100(1):74-81. https://doi.org/10.1016/S1081-1206(10)60408-5. Ilyina NI, Edin AS, Astafieva NG, et al. Efficacy of a novel intranasal formulation of azelastine hydrochloride and fluticasone propionate, delivered in a single spray, for the treatment of seasonal allergic rhinitis: results from Russia. Int Arch Allergy Immunol. 2019;178(3):255-263. https://doi.org/10.1159/000494507. Berger W, Bousquet J, Fox AT, et al. MP-AzeFlu is more effective than fluticasone propionate for the treatment of allergic rhinitis in children. Allergy. 2016;71(8):1219-1222. https://doi.org/10.1111/all.12903. Klimek L, Bachert C, Stjarne P, et al. MP-AzeFlu provides rapid and effective allergic rhinitis control in real life: A pan-European study. Allergy Asthma Proc. 2016;37(5):376-386. https://doi.org/10.2500/aap.2016.37.3979. Klimek L, Bachert C, Mosges R, et al. Effectiveness of MP29-02 for the treatment of allergic rhinitis in real-life: results from a noninterventional study. Allergy Asthma Proc. 2015;36(1):40-47. https://doi.org/10.2500/aap.2015.36.3823. Klimek L, Poletti SC, Sperl A, et al. Olfaction in patients with allergic rhinitis: an indicator of successful MP-AzeFlu therapy. Int Forum Allergy Rhinol. 2017;7(3):287-292. https://doi.org/10.1002/alr.21877. Debbaneh PM, Bareiss AK, Wise SK, McCoul ED. Intranasal azelastine and fluticasone as combination therapy for allergic rhinitis: systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2019;161(3):412-418. https://doi.org/10.1177/0194599819841883. Du K, Qing H, Zheng M, Wang X, Zhang L. Intranasal antihistamine is superior to oral H1 antihistamine as an add-on therapy to intranasal corticosteroid for treating allergic rhinitis. Ann Allergy Asthma Immunol. 2020;125(5):589-596.e3. https://doi.org/10.1016/j.anai.2020.06.038. Seresirikachorn K, Mullol J, Limitlaohaphan K, Asvapoositkul V, Snidvongs K. Leukotriene receptor antagonist addition to intranasal steroid: systematic review and meta-analysis. Rhinology. 2021;59(1):2-9. https://doi.org/10.4193/Rhin20.126. Chen H, Zhang L, Lou H, Wang Y, Cao F, Wang C. A randomized trial of comparing a combination of montelukast and budesonide with budesonide in allergic rhinitis. Laryngoscope. 2021;131(4):E1054-E1061. https://doi.org/10.1002/lary.28433. Goh BS, Ismail MI, Husain S. Quality of life assessment in patients with moderate to severe allergic rhinitis treated with montelukast and/or intranasal steroids: a randomised, double-blind, placebo-controlled study. J Laryngol Otol. 2014;128(3):242-248. https://doi.org/10.1017/S002221511400036X. Esteitie R, deTineo M, Naclerio RM, Baroody FM. Effect of the addition of montelukast to fluticasone propionate for the treatment of perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2010;105(2):155-161. https://doi.org/10.1016/j.anai.2010.05.017. Florinescu-Gheorghe N-A, Popescu F, Alexandru DO. Treatment evaluation with mometasone furoate, alone or in combination with desloratadine/montelukast, in moderate severe allergic rhinitis. Acta Med Marisienis. 2014;60:106-108. Haenisch B, Walstab J, Herberhold S, et al. Alpha-adrenoceptor agonistic activity of oxymetazoline and xylometazoline. Fundam Clin Pharmacol. 2010;24(6):729-739. https://doi.org/10.1111/j.1472-8206.2009.00805.x. Kirtsreesakul V, Khanuengkitkong T, Ruttanaphol S. Does oxymetazoline increase the efficacy of nasal steroids in treating nasal polyposis? Am J Rhinol Allergy. 2016;30(3):195-200. https://doi.org/10.2500/ajra.2016.30.4294. Matreja PS, Gupta V, Kaur J, Singh S. Efficacy of fluticasona nd oxymetazoline as the treatment for allergic rhinitis. J Clin Diagnostic Res. 2012;6:4. Meltzer EO, Bernstein DI, Prenner BM, Berger WE, Shekar T, Teper AA. Mometasone furoate nasal spray plus oxymetazoline nasal spray: short-term efficacy and safety in seasonal allergic rhinitis. Am J Rhinol Allergy. 2013;27(2):102-108. https://doi.org/10.2500/ajra.2013.27.3864. Rael EL, Ramey J, Lockey RF. Oxymetazoline hydrochloride combined with mometasone nasal spray for persistent nasal congestion (pilot study). World Allergy Organ J. 2011;4(3):65-67. https://doi.org/10.1097/WOX.0b013e31820f8fae. Thongngarm T, Assanasen P, Pradubpongsa P, Tantilipikorn P. The effectiveness of oxymetazoline plus intranasal steroid in the treatment of chronic rhinitis: a randomised controlled trial. Asian Pac J Allergy Immunol. 2016;34(1):30-37. https://doi.org/10.12932/AP0649.34.1.2016. Baroody FM, Brown D, Gavanescu L, DeTineo M, Naclerio RM. Oxymetazoline adds to the effectiveness of fluticasone furoate in the treatment of perennial allergic rhinitis. J Allergy Clin Immunol. 2011;127(4):927-934. https://doi.org/10.1016/j.jaci.2011.01.037. Khattiyawittayakun L, Seresirikachorn K, Chitsuthipakorn W, Kanjanawasee D, Snidvongs K. Effects of decongestant addition to intranasal corticosteroid for chronic rhinitis: a systematic review and meta-analysis. Int Forum Allergy Rhinol. 2018;8(12):1445-1453. https://doi.org/10.1002/alr.22193. Kilic G. Treatment of allergic rhinitis in children. Antiinflamm Antiallergy Agents Med Chem. 2008;7:38-44. Scadding GK. Allergic rhinitis in children. Paediatrics Child Health. 2008;18:323-328. Yap L, Pothula VB, Warner J, Akhtar S, Yates E. The root and development of otorhinolaryngology in traditional Chinese medicine. Eur Arch Otorhinolaryngol. 2009;266(9):1353-1359. https://doi.org/10.1007/s00405-009-1041-5. Kaptchuk TJ. Acupuncture: theory, efficacy, and practice. Ann Intern Med. 2002;136(5):374-383. https://doi.org/10.7326/0003-4819-136-5-200203050-00010. Yang XY, Shi GX, Li QQ, Zhang ZH, Xu Q, Liu CZ. Characterization of deqi sensation and acupuncture effect. Evid Based Complement Alternat Med. 2013;2013:319734. https://doi.org/10.1155/2013/319734. Petti FB, Liguori A, Ippoliti F. Study on cytokines IL-2, IL-6, IL-10 in patients of chronic allergic rhinitis treated with acupuncture. J Tradit Chin Med. 2002;22(2):104-111. Feng S, Han M, Fan Y, et al. Acupuncture for the treatment of allergic rhinitis: a systematic review and meta-analysis. Am J Rhinol Allergy. 2015;29(1):57-62. https://doi.org/10.2500/ajra.2015.29.4116. Roberts J, Huissoon A, Dretzke J, Wang D, Hyde C. A systematic review of the clinical effectiveness of acupuncture for allergic rhinitis. BMC Complement Altern Med. 2008;8:13. https://doi.org/10.1186/1472-6882-8-13. Lee MS, Pittler MH, Shin BC, Kim JI, Ernst E. Acupuncture for allergic rhinitis: a systematic review. Ann Allergy Asthma Immunol. 2009;102(4):269-279; quiz 279-81, 307. https://doi.org/10.1016/S1081-1206(10)60330-4. Brinkhaus B, Ortiz M, Witt CM, et al. Acupuncture in patients with seasonal allergic rhinitis: a randomized trial. Ann Intern Med. 2013;158(4):225-234. https://doi.org/10.7326/0003-4819-158-4-201302190-00002. Wu AW, Gettelfinger JD, Ting JY, Mort C, Higgins TS. Alternative therapies for sinusitis and rhinitis: a systematic review utilizing a modified Delphi method. Int Forum Allergy Rhinol. 2020;10(4):496-504. https://doi.org/10.1002/alr.22488. Yin Z, Geng G, Xu G, Zhao L, Liang F. Acupuncture methods for allergic rhinitis: a systematic review and bayesian meta-analysis of randomized controlled trials. Chin Med. 2020;15:109. https://doi.org/10.1186/s13020-020-00389-9. Taw MB, Reddy WD, Omole FS, Seidman MD. Acupuncture and allergic rhinitis. Curr Opin Otolaryngol Head Neck Surg. 2015;23(3):216-220. https://doi.org/10.1097/MOO.0000000000000161. Zhang CS, Yang AW, Zhang AL, et al. Ear-acupressure for allergic rhinitis: a systematic review. Clin Otolaryngol. 2010;35(1):6-12. https://doi.org/10.1111/j.1749-4486.2009.02067.x. Li XR, Zhang QX, Liu M, et al. Catgut implantation at acupoints for allergic rhinitis: a systematic review. Chin J Integr Med. 2014;20(3):235-240. https://doi.org/10.1007/s11655-014-1748-z. Zhou F, Yan LJ, Yang GY, Liu JP. Acupoint herbal patching for allergic rhinitis: a systematic review and meta-analysis of randomised controlled trials. Clin Otolaryngol. 2015;40(6):551-568. https://doi.org/10.1111/coa.12410. Fu Q, Zhang L, Liu Y, et al. Effectiveness of acupuncturing at the sphenopalatine ganglion acupoint alone for treatment of allergic rhinitis: a systematic review and meta-analysis. Evid Based Complement Alternat Med. 2019;2019:6478102. https://doi.org/10.1155/2019/6478102. Li X. The mechanism analysis of treating nasal disease by sphenopalatine ganglion (acupoint “ZhiBi 3”) stimulation with acupuncture needle and an introduction to the relevant needling method. J Clin Otorhinolaryngol Head Neck Surg. 2011;5:193. Li XW, Tian ZP. A preliminary summary of the treatment on rhinitis puncturing sphenopalatine ganglion. Beijing J Chinese Med. 1990;9:36-38. Zhang J, Zhang Y, Huang X, et al. Different acupuncture therapies for allergic rhinitis: overview of systematic reviews and network meta-analysis. Evid Based Complement Alternat Med. 2020;2020:8363027. https://doi.org/10.1155/2020/8363027. Wang LL. [Characteristic of moxibustion and its warming-dredging effect]. Zhongguo Zhen Jiu. 2011;31(10):865-868. Yuan T, Xiong J, Yang J, et al. The effectiveness and safety of thunder fire moxibustion for treating allergic rhinitis: a PRISMA compliant systematic review and meta-analysis. Evid Based Complement Alternat Med. 2020;2020:6760436. https://doi.org/10.1155/2020/6760436. Kacaniova M, Pavlicova S, Hascik P, et al. Microbial communities in bees, pollen and honey from Slovakia. Acta Microbiol Immunol Hung. 2009;56(3):285-295. https://doi.org/10.1556/AMicr.56.2009.3.7. Duddukuri GR, Kumar PS, Kumar VB, Athota RR. Immunosuppressive effect of honey on the induction of allergen-specific humoral antibody response in mice. Int Arch Allergy Immunol. 1997;114(4):385-388. https://doi.org/10.1159/000237699. Ishikawa Y, Tokura T, Nakano N, et al. Inhibitory effect of honeybee-collected pollen on mast cell degranulation in vivo and in vitro. J Med Food. 2008;11(1):14-20. https://doi.org/10.1089/jmf.2006.163. Ishikawa Y, Tokura T, Ushio H, et al. Lipid-soluble components of honeybee-collected pollen exert antiallergic effect by inhibiting IgE-mediated mast cell activation in vivo. Phytother Res. 2009;23(11):1581-1586. https://doi.org/10.1002/ptr.2824. Subrahmanyam M. A prospective randomised clinical and histological study of superficial burn wound healing with honey and silver sulfadiazine. Burns. 1998;24(2):157-161. https://doi.org/10.1016/s0305-4179(97)00113-7. Al-Waili NS, Boni NS. Natural honey lowers plasma prostaglandin concentrations in normal individuals. J Med Food. 2003;6(2):129-133. https://doi.org/10.1089/109662003322233530. Asha'ari ZA, Ahmad MZ, Jihan WS, Che CM, Leman I. Ingestion of honey improves the symptoms of allergic rhinitis: evidence from a randomized placebo-controlled trial in the East coast of Peninsular Malaysia. Ann Saudi Med. 2013;33(5):469-475. https://doi.org/10.5144/0256-4947.2013.469. Saarinen K, Jantunen J, Haahtela T. Birch pollen honey for birch pollen allergy - a randomized controlled pilot study. Int Arch Allergy Immunol. 2011;155(2):160-166. https://doi.org/10.1159/000319821. Rajan TV, Tennen H, Lindquist RL, Cohen L, Clive J. Effect of ingestion of honey on symptoms of rhinoconjunctivitis. Ann Allergy Asthma Immunol. 2002;88(2):198-203. https://doi.org/10.1016/S1081-1206(10)61996-5. Bogdanov S, Jurendic T, Sieber R, Gallmann P. Honey for nutrition and health: a review. J Am Coll Nutr. 2008;27(6):677-689. https://doi.org/10.1080/07315724.2008.10719745. Passalacqua G, Bousquet PJ, Carlsen KH, et al. ARIA update: I - systematic review of complementary and alternative medicine for rhinitis and asthma. J Allergy Clin Immunol. 2006;117(5):1054-1062. https://doi.org/10.1016/j.jaci.2005.12.1308. Enomoto T, Nagasako-Akazome Y, Kanda T, Ikeda M, Dake Y. Clinical effects of apple polyphenols on persistent allergic rhinitis: a randomized double-blind placebo-controlled parallel arm study. J Investig Allergol Clin Immunol. 2006;16(5):283-289. Matkovic Z, Zivkovic V, Korica M, Plavec D, Pecanic S, Tudoric N. Efficacy and safety of Astragalus membranaceus in the treatment of patients with seasonal allergic rhinitis. Phytother Res. 2010;24(2):175-181. https://doi.org/10.1002/ptr.2877. D'Souza P, Amit A, Saxena VS, Bagchi D, Bagchi M, Stohs SJ. Antioxidant properties of Aller-7, a novel polyherbal formulation for allergic rhinitis. Drugs Exp Clin Res. 2004;30(3):99-109. Pratibha N, Saxena VS, Amit A, D'Souza P, Bagchi M, Bagchi D. Anti-inflammatory activities of Aller-7, a novel polyherbal formulation for allergic rhinitis. Int J Tissue React. 2004;26(1-2):43-51. Amit A, Saxena VS, Pratibha N, et al. Mast cell stabilization, lipoxygenase inhibition, hyaluronidase inhibition, antihistaminic and antispasmodic activities of Aller-7, a novel botanical formulation for allergic rhinitis. Drugs Exp Clin Res. 2003;29(3):107-115. Guo R, Pittler MH, Ernst E. Herbal medicines for the treatment of allergic rhinitis: a systematic review. Ann Allergy Asthma Immunol. 2007;99(6):483-495. https://doi.org/10.1016/S1081-1206(10)60375-4. Suzuki M, Yoshino K, Maeda-Yamamoto M, Miyase T, Sano M. Inhibitory effects of tea catechins and O-methylated derivatives of (-)-epigallocatechin-3-O-gallate on mouse type IV allergy. J Agric Food Chem. 2000;48(11):5649-5653. https://doi.org/10.1021/jf000313d. Maeda-Yamamoto M, Inagaki N, Kitaura J, et al. O-methylated catechins from tea leaves inhibit multiple protein kinases in mast cells. J Immunol. 2004;172(7):4486-4492. https://doi.org/10.4049/jimmunol.172.7.4486. Masuda S, Maeda-Yamamoto M, Usui S, Fujisawa T. 'Benifuuki' green tea containing o-methylated catechin reduces symptoms of Japanese cedar pollinosis: a randomized, double-blind, placebo-controlled trial. Allergol Int. 2014;63(2):211-217. https://doi.org/10.2332/allergolint.13-OA-0620. Hu G, Walls RS, Bass D, et al. The Chinese herbal formulation biminne in management of perennial allergic rhinitis: a randomized, double-blind, placebo-controlled, 12-week clinical trial. Ann Allergy Asthma Immunol. 2002;88(5):478-487. https://doi.org/10.1016/s1081-1206(10)62386-1. Shimoda H, Tanaka J, Yamada E, Morikawa T, Kasajima N, Yoshikawa M. Anti type I allergic property of Japanese butterbur extract and its mast cell degranulation inhibitory ingredients. J Agric Food Chem. 2006;54(8):2915-2920. https://doi.org/10.1021/jf052994o. Russell LC, Burchiel KJ. Neurophysiological effects of capsaicin. Brain Res. 1984;320(2-3):165-176. https://doi.org/10.1016/0165-0173(84)90005-5. Philip G, Baroody FM, Proud D, Naclerio RM, Togias AG. The human nasal response to capsaicin. J Allergy Clin Immunol. 1994;94(6 pt 1):1035-1045. https://doi.org/10.1016/0091-6749(94)90122-8. Cheng J, Yang XN, Liu X, Zhang SP. Capsaicin for allergic rhinitis in adults. Cochrane Database Syst Rev. 2006;(2):CD004460. https://doi.org/10.1002/14651858.CD004460.pub2. Fujiwara T, Nishida N, Nota J, et al. Efficacy of chlorophyll c2 for seasonal allergic rhinitis: single-center double-blind randomized control trial. Eur Arch Otorhinolaryngol. 2016;273(12):4289-4294. https://doi.org/10.1007/s00405-016-4133-z. Corren J, Lemay M, Lin Y, Rozga L, Randolph RK. Clinical and biochemical effects of a combination botanical product (ClearGuard) for allergy: a pilot randomized double-blind placebo-controlled trial. Nutr J. 2008;7:20. https://doi.org/10.1186/1475-2891-7-20. Turpeinen AM, Ylonen N, von Willebrand E, Basu S, Aro A. Immunological and metabolic effects of cis-9, trans-11-conjugated linoleic acid in subjects with birch pollen allergy. Br J Nutr. 2008;100(1):112-119. https://doi.org/10.1017/S0007114507886326. Bernstein DI, Bernstein CK, Deng C, et al. Evaluation of the clinical efficacy and safety of grapeseed extract in the treatment of fall seasonal allergic rhinitis: a pilot study. Ann Allergy Asthma Immunol. 2002;88(3):272-278. https://doi.org/10.1016/S1081-1206(10)62008-X. Hirano T, Kawai M, Arimitsu J, et al. Preventative effect of a flavonoid, enzymatically modified isoquercitrin on ocular symptoms of Japanese cedar pollinosis. Allergol Int. 2009;58(3):373-382. https://doi.org/10.2332/allergolint.08-OA-0070. Kawai M, Hirano T, Arimitsu J, et al. Effect of enzymatically modified isoquercitrin, a flavonoid, on symptoms of Japanese cedar pollinosis: a randomized double-blind placebo-controlled trial. Int Arch Allergy Immunol. 2009;149(4):359-368. https://doi.org/10.1159/000205582. Yamprasert R, Chanvimalueng W, Mukkasombut N, Itharat A. Ginger extract versus Loratadine in the treatment of allergic rhinitis: a randomized controlled trial. BMC Complement Med Ther. 2020;20(1):119. https://doi.org/10.1186/s12906-020-2875-z. Hewlings S, Kalman DS. Evaluating the impacts of methylsulfonylmethane on allergic rhinitis after a standard allergen challenge: randomized double-blind exploratory study. JMIR Res Protoc. 2018;7(11):e11139. https://doi.org/10.2196/11139. Chakravarty N. Inhibition of histamine release from mast cells by nigellone. Ann Allergy. 1993;70(3):237-242. El Gazzar M, El Mezayen R, Marecki JC, Nicolls MR, Canastar A, Dreskin SC. Anti-inflammatory effect of thymoquinone in a mouse model of allergic lung inflammation. Int Immunopharmacol. 2006;6(7):1135-1142. https://doi.org/10.1016/j.intimp.2006.02.004. Kalus U, Pruss A, Bystron J, et al. Effect of Nigella sativa (black seed) on subjective feeling in patients with allergic diseases. Phytother Res. 2003;17(10):1209-1214. https://doi.org/10.1002/ptr.1356. Nikakhlagh S, Rahim F, Aryani FH, Syahpoush A, Brougerdnya MG, Saki N. Herbal treatment of allergic rhinitis: the use of Nigella sativa. Am J Otolaryngol. 2011;32(5):402-407. https://doi.org/10.1016/j.amjoto.2010.07.019. Alsamarai AM, Abdulsatar M, Ahmed Alobaidi AH. Evaluation of topical black seed oil in the treatment of allergic rhinitis. Antiinflamm Antiallergy Agents Med Chem. 2014;13(1):75-82. https://doi.org/10.2174/18715230113129990014. Rotondo S, Rajtar G, Manarini S, et al. Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function. Br J Pharmacol. 1998;123(8):1691-1699. https://doi.org/10.1038/sj.bjp.0701784. Varilek GW, Yang F, Lee EY, et al. Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity. J Nutr. 2001;131(7):2034-2039. https://doi.org/10.1093/jn/131.7.2034. Yang F, de Villiers WJ, McClain CJ, Varilek GW. Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model. J Nutr. 1998;128(12):2334-2340. https://doi.org/10.1093/jn/128.12.2334. Makino T, Furuta Y, Wakushima H, Fujii H, Saito K, Kano Y. Anti-allergic effect of Perilla frutescens and its active constituents. Phytother Res. 2003;17(3):240-243. https://doi.org/10.1002/ptr.1115. Takano H, Osakabe N, Sanbongi C, et al. Extract of Perilla frutescens enriched for rosmarinic acid, a polyphenolic phytochemical, inhibits seasonal allergic rhinoconjunctivitis in humans. Exp Biol Med (Maywood). 2004;229(3):247-254. https://doi.org/10.1177/153537020422900305. Wassenberg J, Nutten S, Audran R, et al. Effect of Lactobacillus paracasei ST11 on a nasal provocation test with grass pollen in allergic rhinitis. Clin Exp Allergy. 2011;41(4):565-573. https://doi.org/10.1111/j.1365-2222.2011.03695.x. Perrin Y, Nutten S, Audran R, et al. Comparison of two oral probiotic preparations in a randomized crossover trial highlights a potentially beneficial effect of Lactobacillus paracasei NCC2461 in patients with allergic rhinitis. Clin Transl Allergy. 2014;4(1):1. https://doi.org/10.1186/2045-7022-4-1. Lenon GB, Xue CC, Story DF, Thien FC, McPhee S, Li CG. Inhibition of release of inflammatory mediators in primary and cultured cells by a Chinese herbal medicine formula for allergic rhinitis. Chin Med. 2007;2:2. https://doi.org/10.1186/1749-8546-2-2. Lenon GB, Li CG, Xue CC, Thien FC, Story DF. Inhibition of release of vasoactive and inflammatory mediators in airway and vascular tissues and macrophages by a chinese herbal medicine formula for allergic rhinitis. Evid Based Complement Alternat Med. 2007;4(2):209-217. https://doi.org/10.1093/ecam/nel083. Xue CC, Thien FC, Zhang JJ, Da Costa C, Li CG. Treatment for seasonal allergic rhinitis by Chinese herbal medicine: a randomized placebo controlled trial. Altern Ther Health Med. 2003;9(5):80-87. Mao TK, Van de Water J, Gershwin ME. Effects of a Spirulina-based dietary supplement on cytokine production from allergic rhinitis patients. J Med Food. 2005;8(1):27-30. https://doi.org/10.1089/jmf.2005.8.27. Karkos PD, Leong SC, Karkos CD, Sivaji N, Assimakopoulos DA. Spirulina in clinical practice: evidence-based human applications. Evid Based Complement Alternat Med. 2011;2011:531053. https://doi.org/10.1093/ecam/nen058. Cingi C, Conk-Dalay M, Cakli H, Bal C. The effects of spirulina on allergic rhinitis. Eur Arch Otorhinolaryngol. 2008;265(10):1219-1223. https://doi.org/10.1007/s00405-008-0642-8. Ishikura Y, Suwa Y, Okada T. Anti-allergic effects of Rubus suavissimus extract. Japanese J Inflamm. 1995;15:167-173. Yonekura S, Okamoto Y, Yamasaki K, et al. A randomized, double-blind, placebo-controlled study of ten-cha (Rubus suavissimus) on house dust mite allergic rhinitis. Auris Nasus Larynx. 2011;38(5):600-607. https://doi.org/10.1016/j.anl.2010.11.017. Das AK, Mizuguchi H, Kodama M, et al. Sho-seiryu-to suppresses histamine signaling at the transcriptional level in TDI-sensitized nasal allergy model rats. Allergol Int. 2009;58(1):81-88. https://doi.org/10.2332/allergolint.O-07-526. Baba S. Double-blind clinical trial of Sho-seiryu-to (TJ-19) for perennial allergic rhinitis. Pract Otol. 1995;88:389-405. Badar VA, Thawani VR, Wakode PT, et al. Efficacy of Tinospora cordifolia in allergic rhinitis. J Ethnopharmacol. 2005;96(3):445-449. https://doi.org/10.1016/j.jep.2004.09.034. Yoshimura M, Enomoto T, Dake Y, et al. An evaluation of the clinical efficacy of tomato extract for perennial allergic rhinitis. Allergol Int. 2007;56(3):225-230. https://doi.org/10.2332/allergolint.O-06-443. Roschek Jr B, Fink RC, McMichael M, Alberte RS. Nettle extract (Urtica dioica) affects key receptors and enzymes associated with allergic rhinitis. Phytother Res. 2009;23(7):920-926. https://doi.org/10.1002/ptr.2763. Mittman P. Randomized, double-blind study of freeze-dried Urtica dioica in the treatment of allergic rhinitis. Planta Med. 1990;56(1):44-47. https://doi.org/10.1055/s-2006-960881. Podoshin L, Gertner R, Fradis M. Treatment of perennial allergic rhinitis with ascorbic acid solution. Ear Nose Throat J. 1991;70(1):54-55. Shahar E, Hassoun G, Pollack S. Effect of vitamin E supplementation on the regular treatment of seasonal allergic rhinitis. Ann Allergy Asthma Immunol. 2004;92(6):654-658. https://doi.org/10.1016/S1081-1206(10)61432-9. Montano Velazquez BB, Jauregui-Renaud K, Banuelos Arias Adel C, et al. Vitamin E effects on nasal symptoms and serum specific IgE levels in patients with perennial allergic rhinitis. Ann Allergy Asthma Immunol. 2006;96(1):45-50. https://doi.org/10.1016/s1081-1206(10)61039-3. Cheng L, Chen J, Fu Q, et al. Chinese Society of Allergy Guidelines for diagnosis and treatment of allergic rhinitis. Allergy Asthma Immunol Res. 2018;10(4):300-353. https://doi.org/10.4168/aair.2018.10.4.300. Chen S, Guo SN, Marmori F, et al. Clinical Practice Guideline for allergic rhinitis treatment with acupuncture. Chin J Integr Med. 2021;27(2):83-90. https://doi.org/10.1007/s11655-020-3161-0. Fjermedal O, Saunte C, Pedersen S. Septoplasty and/or submucous resection? 5 years nasal septum operations. J Laryngol Otol. 1988;102(9):796-798. https://doi.org/10.1017/s0022215100106486. Karatzanis AD, Fragiadakis G, Moshandrea J, Zenk J, Iro H, Velegrakis GA. Septoplasty outcome in patients with and without allergic rhinitis. Rhinology. 2009;47(4):444-449. https://doi.org/10.4193/Rhin08.126. Mondina M, Marro M, Maurice S, Stoll D, de Gabory L. Assessment of nasal septoplasty using NOSE and RhinoQoL questionnaires. Eur Arch Otorhinolaryngol. 2012;269(10):2189-2195. https://doi.org/10.1007/s00405-011-1916-0. Stoksted P, Gutierrez C. The nasal passage following rhinoplastic surgery. J Laryngol Otol. 1983;97(1):49-54. https://doi.org/10.1017/s0022215100093798. Stewart MG, Smith TL, Weaver EM, et al. Outcomes after nasal septoplasty: results from the Nasal Obstruction Septoplasty Effectiveness (NOSE) study. Otolaryngol Head Neck Surg. 2004;130(3):283-290. https://doi.org/10.1016/j.otohns.2003.12.004. Bugten V, Nilsen AH, Thorstensen WM, Moxness MH, Amundsen MF, Nordgard S. Quality of life and symptoms before and after nasal septoplasty compared with healthy individuals. BMC Ear Nose Throat Disord. 2016;16:13. https://doi.org/10.1186/s12901-016-0031-7. Manteghi A, Din H, Bundogji N, Leuin SC. Pediatric septoplasty and functional septorhinoplasty: a quality of life outcome study. Int J Pediatr Otorhinolaryngol. 2018;111:16-20. https://doi.org/10.1016/j.ijporl.2018.05.016. Sokoya M, Gonzalez JR, Winkler AA. Effect of allergic rhinitis on nasal obstruction outcomes after functional open septorhinoplasty. Am J Otolaryngol. 2018;39(3):303-306. https://doi.org/10.1016/j.amjoto.2018.03.014. Kokubo LCP, Carvalho TBO, Fornazieri MA, Gomes EMC, Alves CMF, Sampaio ALL. Effects of septorhinoplasty on smell perception. Eur Arch Otorhinolaryngol. 2019;276(4):1247-1250. https://doi.org/10.1007/s00405-019-05356-1. Gerecci D, Casanueva FJ, Mace JC, et al. Nasal obstruction symptom evaluation (NOSE) score outcomes after septorhinoplasty. Laryngoscope. 2019;129(4):841-846. https://doi.org/10.1002/lary.27578. Kim SD, Jung DW, Lee JW, Park JH, Mun SJ, Cho KS. Relationship between allergic rhinitis and nasal surgery success in patients with obstructive sleep apnea. Am J Otolaryngol. 2021;42(6):103079. https://doi.org/10.1016/j.amjoto.2021.103079. Ghosh SK, Dutta M, Haldar D. Role of bilateral inferior turbinoplasty as an adjunct to septoplasty in improving nasal obstruction and subjective performance in patients with deviated nasal septum associated with allergic rhinitis: an interventional, prospective study. Ear Nose Throat J. 2021:1455613211015440. https://doi.org/10.1177/01455613211015440. Topal O, Celik SB, Erbek S, Erbek SS. Risk of nasal septal perforation following septoplasty in patients with allergic rhinitis. Eur Arch Otorhinolaryngol. 2011;268(2):231-233. https://doi.org/10.1007/s00405-010-1323-y. Eren E, Balci MK, Islek A. Analysis of patient- and procedure-related risk factors for nasal septal perforations following septoplasty. Eur Arch Otorhinolaryngol. 2022;279(3):1357-1361. https://doi.org/10.1007/s00405-021-06887-2. Kim YH, Kim BJ, Bang KH, Hwang Y, Jang TY. Septoplasty improves life quality related to allergy in patients with septal deviation and allergic rhinitis. Otolaryngol Head Neck Surg. 2011;145(6):910-914. https://doi.org/10.1177/0194599811424119. Chhabra N, Houser SM. The surgical management of allergic rhinitis. Otolaryngol Clin North Am. 2011;44(3):779-795, xi. https://doi.org/10.1016/j.otc.2011.03.007. Chhabra N, Houser SM. Surgery for allergic rhinitis. Int Forum Allergy Rhinol. 2014;4(suppl 2):S79-S83. https://doi.org/10.1002/alr.21387. Aksoy F, Yildirim YS, Veyseller B, Ozturan O, Demirhan H. Midterm outcomes of outfracture of the inferior turbinate. Otolaryngol Head Neck Surg. 2010;143(4):579-584. https://doi.org/10.1016/j.otohns.2010.06.915. Mori S, Fujieda S, Igarashi M, Fan GK, Saito H. Submucous turbinectomy decreases not only nasal stiffness but also sneezing and rhinorrhea in patients with perennial allergic rhinitis. Clin Exp Allergy. 1999;29(11):1542-1548. https://doi.org/10.1046/j.1365-2222.1999.00645.x. Kaymakci M, Gur OE, Ozdem C. Nasal obstruction: comparison of radiofrequency with lateral displacement of the inferior turbinate and radiofrequency alone. J Pak Med Assoc. 2014;64(1):33-37. Assanasen P, Banhiran W, Tantilipikorn P, Pinkaew B. Combined radiofrequency volumetric tissue reduction and lateral outfracture of hypertrophic inferior turbinate in the treatment of chronic rhinitis: short-term and long-term outcome. Int Forum Allergy Rhinol. 2014;4(4):339-344. https://doi.org/10.1002/alr.21278. Li KK, Powell NB, Riley RW, Troell RJ, Guilleminault C. Radiofrequency volumetric tissue reduction for treatment of turbinate hypertrophy: a pilot study. Otolaryngol Head Neck Surg. 1998;119(6):569-573. https://doi.org/10.1016/S0194-5998(98)70013-0. Passali D, Lauriello M, Anselmi M, Bellussi L. Treatment of hypertrophy of the inferior turbinate: long-term results in 382 patients randomly assigned to therapy. Ann Otol Rhinol Laryngol. 1999;108(6):569-575. https://doi.org/10.1177/000348949910800608. Zagólski O. Skuteczność mukotomii przy uzyciu pesety bipolarnej w leczeniu spływania do gardła u chorych z przewlekłym niezytem nosa-doniesienie wstepne [Effectiveness of bipolar coagulation in treatment of post-nasal drip in patients with chronic rhinitis-preliminary report]. Przegl Lek. 2007;64(1):9-11. Tani T, Seno S, Hanamitsu M, Shimizu T. [Clinical effectiveness of coblation-assisted inferior turbinoplasty]. Arerugi. 2008;57(8):1053-1060. Liu CM, Tan CD, Lee FP, Lin KN, Huang HM. Microdebrider-assisted versus radiofrequency-assisted inferior turbinoplasty. Laryngoscope. 2009;119(2):414-418. https://doi.org/10.1002/lary.20088. Hytonen ML, Back LJ, Malmivaara AV, Roine RP. Radiofrequency thermal ablation for patients with nasal symptoms: a systematic review of effectiveness and complications. Eur Arch Otorhinolaryngol. 2009;266(8):1257-1266. https://doi.org/10.1007/s00405-009-0914-y. Iwasaki A, Tokano H, Kamiyama R, Suzuki Y, Kitamura K. A 24-month-follow-up study of argon plasma coagulation of the inferior turbinate in patients with perennial nasal allergy. J Med Dent Sci. 2010;57(1):11-15. Zagolski O. Factors affecting outcome of inferior turbinate mucotomy in treatment of postnasal drip syndrome. Am J Rhinol Allergy. 2010;24(6):459-463. https://doi.org/10.2500/ajra.2010.24.3524. Lin HC, Lin PW, Friedman M, et al. Long-term results of radiofrequency turbinoplasty for allergic rhinitis refractory to medical therapy. Arch Otolaryngol Head Neck Surg. 2010;136(9):892-895. https://doi.org/10.1001/archoto.2010.135. Simeon R, Soufflet B, Souchal Delacour I. Coblation turbinate reduction in childhood allergic rhinitis. Eur Ann Otorhinolaryngol Head Neck Dis. 2010;127(2):77-82. https://doi.org/10.1016/j.anorl.2010.04.004. Gunhan K, Unlu H, Yuceturk AV, Songu M. Intranasal steroids or radiofrequency turbinoplasty in persistent allergic rhinitis: effects on quality of life and objective parameters. Eur Arch Otorhinolaryngol. 2011;268(6):845-850. https://doi.org/10.1007/s00405-010-1462-1. Di Rienzo Businco L, Di Rienzo Businco A, Ventura L, Laurino S, Lauriello M. Turbinoplasty with quantic molecular resonance in the treatment of persistent moderate-severe allergic rhinitis: Comparative analysis of efficacy. Am J Rhinol Allergy. 2014;28(2):164-168. https://doi.org/10.2500/ajra.2014.28.3990. Garzaro M, Pezzoli M, Pecorari G, Landolfo V, Defilippi S, Giordano C. Radiofrequency inferior turbinate reduction: an evaluation of olfactory and respiratory function. Otolaryngol Head Neck Surg. 2010;143(3):348-352. https://doi.org/10.1016/j.otohns.2010.06.908. Banhiran W, Tantilipikorn P, Metheetrairut C, Assanasen P, Bunnag C. Quality of life in patients with chronic rhinitis after radiofrequency inferior turbinate reduction. J Med Assoc Thai. 2010;93(8):950-960. Deenadayal DS, Kumar MN, Sudhakshin P, Hameed S. Radiofrequency reduction of inferior turbinates in allergic and non allergic rhinitis. Indian J Otolaryngol Head Neck Surg. 2014;66(suppl 1):231-236. https://doi.org/10.1007/s12070-011-0445-x. Ungkhara G, Purpermpulsiri P. Acoustic rhinometry evaluation in allergic rhinitis patients before and after turbinate radiofrequency ablation. J Med Assoc Thai. 2011;94(2):200-204. Parida PK, Santhosh K, Ganesan S, Surianarayanan G, Saxena SK. The efficacy of radiofrequency volumetric tissue reduction of hypertrophied inferior turbinate in allergic rhinitis. Indian J Med Sci. 2011;65(7):269-77. Lavinsky-Wolff M, Camargo Jr HL, Barone CR, et al. Effect of turbinate surgery in rhinoseptoplasty on quality-of-life and acoustic rhinometry outcomes: a randomized clinical trial. Laryngoscope. 2013;123(1):82-89. https://doi.org/10.1002/lary.23628. Garzaro M, Pezzoli M, Landolfo V, Defilippi S, Giordano C, Pecorari G. Radiofrequency inferior turbinate reduction: long-term olfactory and functional outcomes. Otolaryngol Head Neck Surg. 2012;146(1):146-150. https://doi.org/10.1177/0194599811423008. Incandela C, Calamusa G, Massenti MF, Incandela S, Speciale R, Amodio E. Long-term efficacy of radiofrequency treatment of turbinate hypertrophy: a patient based point of view. Indian J Otolaryngol Head Neck Surg. 2013;65(suppl 2):226-230. https://doi.org/10.1007/s12070-011-0337-0. Fradis M, Malatskey S, Magamsa I, Golz A. Effect of submucosal diathermy in chronic nasal obstruction due to turbinate enlargement. Am J Otolaryngol. 2002;23(6):332-336. https://doi.org/10.1053/ajot.2002.126857. Kojima Y, Tsuzuki K, Takebayashi H, Oka H, Sakagami M. Therapeutic evaluation of outpatient submucosal inferior turbinate surgery for patients with severe allergic rhinitis. Allergol Int. 2013;62(4):479-485. https://doi.org/10.2332/allergolint.12-OA-0533. Bitar MA, Kanaan AA, Sinno S. Efficacy and safety of inferior turbinates coblation in children. J Laryngol Otol. 2014;128(suppl 2):S48-S54. https://doi.org/10.1017/S0022215114000206. Akdag M, Dasdag S, Ozkurt FE, et al. Long-term effect of radiofrequency turbinoplasty in nasal obstruction. Biotechnol Biotechnol Equip. 2014;28(2):285-294. https://doi.org/10.1080/13102818.2014.909083. Assanasen P, Choochurn P, Banhiran W, Bunnag C. Radiofrequency inferior turbinate reduction improves smell ability of patients with chronic rhinitis and inferior turbinate hypertrophy. Allergy Rhinol (Providence). 2014;5(1):12-16. https://doi.org/10.2500/ar.2014.5.0077. Acevedo JL, Camacho M, Brietzke SE. Radiofrequency Ablation turbinoplasty versus microdebrider-assisted turbinoplasty: a systematic review and meta-analysis. Otolaryngol Head Neck Surg. 2015;153(6):951-956. https://doi.org/10.1177/0194599815607211. Arganbright JM, Jensen EL, Mattingly J, Gao D, Chan KH. Utility of inferior turbinoplasty for the treatment of nasal obstruction in children: a 10-year review. JAMA Otolaryngol Head Neck Surg. 2015;141(10):901-904. https://doi.org/10.1001/jamaoto.2015.1560. Shah AN, Brewster D, Mitzen K, Mullin D. Radiofrequency coblation versus intramural bipolar cautery for the treatment of inferior turbinate hypertrophy. Ann Otol Rhinol Laryngol. 2015;124(9):691-697. https://doi.org/10.1177/0003489415578709. Banhiran W, Assanasen P, Tantilipikorn P, Nujchanart N, Voraprayoon S, Bunnag C. A randomized study of temperature-controlled versus bipolar radiofrequency for inferior turbinate reduction. Eur Arch Otorhinolaryngol. 2015;272(10):2877-2884. https://doi.org/10.1007/s00405-014-3410-y. Sinno S, Mehta K, Lee ZH, Kidwai S, Saadeh PB, Lee MR. Inferior turbinate hypertrophy in rhinoplasty: systematic review of surgical techniques. Plast Reconstr Surg. 2016;138(3):419e-429e. https://doi.org/10.1097/PRS.0000000000002433. Ishida H, Yoshida T, Hasegawa T, Mohri M, Amatsu M. Submucous electrocautery following submucous resection of turbinate bone - a rationale of surgical treatment for allergic rhinitis. Auris Nasus Larynx. 2003;30(2):147-152. https://doi.org/10.1016/s0385-8146(03)00010-5. De Corso E, Bastanza G, Di Donfrancesco V, et al., Radiofrequency volumetric inferior turbinate reduction: long-term clinical results. Acta Otorhinolaryngol Ital. 2016;36(3):199-205. doi: https://doi.org/10.14639/0392-100X-964. Lukka VK, Jacob TM, Jeyaseelan V, Rupa V. Do turbinate reduction procedures restore epithelial integrity in patients with turbinate hypertrophy secondary to allergic rhinitis? A histopathological study. Eur Arch Otorhinolaryngol. 2018;275(6):1457-1467. https://doi.org/10.1007/s00405-018-4955-y. Turk B, Korkut AY, Kaya KS, et al. Results of radiofrequency ablation of inferior turbinate hypertrophy in patients with allergic and non-allergic rhinitis. Sisli Etfal Hastan Tip Bul. 2018;52(4):296-301. https://doi.org/10.14744/SEMB.2018.77992. Zhong B, Li LK, Deng D, et al. Effect of high-intensity focused ultrasound versus plasma radiofrequency ablation on recurrent allergic rhinitis. Med Sci Monit. 2019;25:6775-6781. https://doi.org/10.12659/MSM.916228. Kang T, Sung CM, Yang HC. Radiofrequency ablation of turbinates after septoplasty has no effect on allergic rhinitis symptoms other than nasal obstruction. Int Forum Allergy Rhinol. 2019;9(11):1257-1262. https://doi.org/10.1002/alr.22420. Mun IK, Yoo SH, Mo JH. Long-term outcome of concurrent coblator turbinoplasty with adenotonsillectomy in children with allergic rhinitis. Acta Otolaryngol. 2021;141(3):286-292. https://doi.org/10.1080/00016489.2020.1846782. Pecorari G, Riva G, Bartoli C, et al. Nasal cytology in radiofrequency turbinate volume reduction. ORL J Otorhinolaryngol Relat Spec. 2021;83(4):252-257. https://doi.org/10.1159/000513629. Whelan RL, Shaffer AD, Stapleton AL. Efficacy of inferior turbinate reduction in pediatric patients: a prospective analysis. Int Forum Allergy Rhinol. 2021;11(12):1654-1662. https://doi.org/10.1002/alr.22849. Ogino-Nishimura E, Okamura HO, Takiguchi Y. Argon plasma coagulation for intractable nasal obstruction occurring in patients with allergic rhinitis. Fukushima J Med Sci. 2003;49(1):15-22. https://doi.org/10.5387/fms.49.15. Lin HC, Lin PW, Su CY, Chang HW. Radiofrequency for the treatment of allergic rhinitis refractory to medical therapy. Laryngoscope. 2003;113(4):673-678. https://doi.org/10.1097/00005537-200304000-00017. Tokano H, Maehara H, Nakamura H, Makino N, Iwasaki A, Kitamura K. Short-term effect of argon plasma coagulation of the inferior turbinate in patients with perennial nasal allergy. Auris Nasus Larynx. 2005;32(2):145-50. https://doi.org/10.1016/j.anl.2005.01.002. Fang CX, Zhen SS. [Nasal endoscopy combined with multiple radiofrequency for perennial allergic rhinitis]. Di Yi Jun Yi Da Xue Xue Bao. 2005;25(7):876-877. Ding H, Liu J, Wang T, Xia G, Liu W. [Combination application of radiofrequency ablation in nasal operation]. Lin Chuang Er Bi Yan Hou Ke Za Zhi. 2005;19(20):918-919. 922. Quine SM, Aitken PM, Eccles R. Effect of submucosal diathermy to the inferior turbinates on unilateral and total nasal airflow in patients with rhinitis. Acta Otolaryngol. 1999;119(8):911-915. https://doi.org/10.1080/00016489950180270. Sroka R, Janda P, Killian T, Vaz F, Betz CS, Leunig A. Comparison of long term results after Ho:YAG and diode laser treatment of hyperplastic inferior nasal turbinates. Lasers Surg Med. 2007;39(4):324-331. https://doi.org/10.1002/lsm.20479. Chusakul S, Choktaweekarn T, Snidvongs K, Phannaso C, Aeumjaturapat S. Effect of the KTP laser in inferior turbinate surgery on eosinophil influx in allergic rhinitis. Otolaryngol Head Neck Surg. 2011;144(2):237-240. https://doi.org/10.1177/0194599810390448. Caffier PP, Scherer H, Neumann K, Luck S, Enzmann H, Haisch A. Diode laser treatment in therapy-resistant allergic rhinitis: impact on nasal obstruction and associated symptoms. Lasers Med Sci. 2011;26(1):57-67. https://doi.org/10.1007/s10103-010-0813-x. Gupta P, Kc T, Regmi D. Diode laser turbinate reduction in allergic rhinitis: a cross-sectional study. JNMA J Nepal Med Assoc. 2018;56(214):949-952. Sasaki K, Ohshiro T, Sakio R, et al. Efficacy of seasonal allergic rhinitis using an 810 nm diode laser system. Laser Ther. 2019;28(1):11-18. https://doi.org/10.5978/islsm.28_19-OR-01. Tanigawa T, Yashiki T, Hayashi K, Sato T. Carbon dioxide laser vaporization for turbinate: optimal conditions and indications. Auris Nasus Larynx. 2000;27(2):137-140. https://doi.org/10.1016/s0385-8146(99)00061-9. Kunachak S, Kulapaditharom B, Prakunhungsit S. Minimally invasive KTP laser treatment of perennial allergic rhinitis: a preliminary report. J Otolaryngol. 2000;29(3):139-143. Janda P, Sroka R, Betz CS, Grevers G, Leunig A. [Ho:YAG and diode laser treatment of hyperplastic inferior nasal turbinates]. Die Laserkonchotomie mit Ho:YAG- und Dioden-Laser zur Behandlung von hyperplastischen Nasenmuscheln. Laryngorhinootologie. 2002;81(7):484-490. https://doi.org/10.1055/s-2002-33288. Janda P, Sroka R, Tauber S, Baumgartner R, Grevers G, Leunig A. Diode laser treatment of hyperplastic inferior nasal turbinates. Lasers Surg Med. 2000;27(2):129-39. https://doi.org/10.1002/1096-9101(2000)27:2<129::aid-lsm4>3.0.co;2-r. Takeno S, Osada R, Ishino T, Yajin K. Laser surgery of the inferior turbinate for allergic rhinitis with seasonal exacerbation: an acoustic rhinometry study. Ann Otol Rhinol Laryngol. 2003;112(5):455-460. https://doi.org/10.1177/000348940311200513. Imamura S, Honda H. Carbon dioxide laser vaporization of the inferior turbinate for allergic rhinitis: short-term results. Ann Otol Rhinol Laryngol. 2003;112(12):1043-1049. https://doi.org/10.1177/000348940311201209. Sandhu AS, Temple RH, Timms MS. Partial laser turbinectomy: two year outcomes in patients with allergic and non-allergic rhinitis. Rhinology. 2004;42(2):81-84. Takeno S, Osada R, Furukido K, Yajin K. Analysis of local cytokine gene expression in patients with allergic rhinitis treated with CO2 laser surgery. Laryngoscope. 2000;110(11):1968-1974. https://doi.org/10.1097/00005537-200011000-00038. Lee JY. Efficacy of intra- and extraturbinal microdebrider turbinoplasty in perennial allergic rhinitis. Laryngoscope. 2013;123(12):2945-9. https://doi.org/10.1002/lary.24215. Parthasarathi K, Christensen JM, Alvarado R, Barham HP, Sacks R, Harvey RJ. Airflow and symptom outcomes between allergic and non-allergic rhinitis patients from turbinoplasty. Rhinology. 2017;55(4):332-338. https://doi.org/10.4193/Rhin16.210. Ikeda K, Oshima T, Suzuki M, Suzuki H, Shimomura A. Functional inferior turbinosurgery (FITS) for the treatment of resistant chronic rhinitis. Acta Otolaryngol. 2006;126(7):739-745. https://doi.org/10.1080/00016480500472853. Huang TW, Cheng PW. Changes in nasal resistance and quality of life after endoscopic microdebrider-assisted inferior turbinoplasty in patients with perennial allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2006;132(9):990-993. https://doi.org/10.1001/archotol.132.9.990. Wu CC, Lee SY, Hsu CJ, Yeh TH. Patients with positive allergen test have less favorable outcome after endoscopic microdebrider-assisted inferior turbinoplasty. Am J Rhinol. 2008;22(1):20-23. https://doi.org/10.2500/ajr.2008.22.3116. Chen YL, Tan CT, Huang HM. Long-term efficacy of microdebrider-assisted inferior turbinoplasty with lateralization for hypertrophic inferior turbinates in patients with perennial allergic rhinitis. Laryngoscope. 2008;118(7):1270-1274. https://doi.org/10.1097/MLG.0b013e31816d728e. Neri G, Mastronardi V, Traini T, D'Orazio F, Pugliese M, Cazzato F. Respecting nasal mucosa during turbinate surgery: end of the dogma? Rhinology. 2013;51(4):368-375. https://doi.org/10.4193/Rhino12.124. de Moura BH, Migliavacca RO, Lima RK, et al. Partial inferior turbinectomy in rhinoseptoplasty has no effect in quality-of-life outcomes: a randomized clinical trial. Laryngoscope. 2018;128(1):57-63. https://doi.org/10.1002/lary.26831. Suzuki M, Yokota M, Ozaki S, Murakami S. The effects of resection of the peripheral branches of the posterior nasal nerves in the inferior turbinate, with special focus on olfactory dysfunction. J Laryngol Otol. 2019;133(12):1046-1049. https://doi.org/10.1017/S0022215119002238. Mori S, Fujieda S, Yamada T, Kimura Y, Takahashi N, Saito H. Long-term effect of submucous turbinectomy in patients with perennial allergic rhinitis. Laryngoscope. 2002;112(5):865-869. https://doi.org/10.1097/00005537-200205000-00016. Ogawa T, Takeno S, Ishino T, Hirakawa K. Submucous turbinectomy combined with posterior nasal neurectomy in the management of severe allergic rhinitis: clinical outcomes and local cytokine changes. Auris Nasus Larynx. 2007;34(3):319-326. https://doi.org/10.1016/j.anl.2007.01.008. Tan G, Ma Y, Li H, Li W, Wang J. Long-term results of bilateral endoscopic vidian neurectomy in the management of moderate to severe persistent allergic rhinitis. Arch Otolaryngol Head Neck Surg. 2012;138(5):492-497. https://doi.org/10.1001/archoto.2012.284. Hamerschmidt R, Hamerschmidt R, Moreira AT, Tenorio SB, Timi JR. Comparison of turbinoplasty surgery efficacy in patients with and without allergic rhinitis. Braz J Otorhinolaryngol. 2016;82(2):131-139. https://doi.org/10.1016/j.bjorl.2015.10.010. Piromchai P, Pornumnouy W, Saeseow P, Chainansamit S. The minimum effective dose of abobotulinum toxin A injection for allergic rhinitis: a dose-escalation randomized controlled trial. Laryngoscope Investig Otolaryngol. 2021;6(1):6-12. https://doi.org/10.1002/lio2.499. Abtahi SM, Hashemi SM, Abtahi SH, Bastani B. Septal injection in comparison with inferior turbinates injection of botulinum toxin A in patients with allergic rhinitis. J Res Med Sci. 2013;18(5):400-404. Unal M, Sevim S, Dogu O, Vayisoglu Y, Kanik A. Effect of botulinum toxin type A on nasal symptoms in patients with allergic rhinitis: a double-blind, placebo-controlled clinical trial. Acta Otolaryngol. 2003;123(9):1060-1063. https://doi.org/10.1080/00016480310000755. Wei H, Zhang Y, Shi L, et al. Higher dosage of HIFU treatment may lead to higher and longer efficacy for moderate to severe perennial allergic rhinitis. Int J Med Sci. 2013;10(13):1914-1920. https://doi.org/10.7150/ijms.7117. Wei H, Shi L, Zhang J, et al. High-intensity focused ultrasound leads to histopathologic changes of the inferior turbinate mucosa with allergic inflammation. Ultrasound Med Biol. 2014;40(10):2425-2430. https://doi.org/10.1016/j.ultrasmedbio.2014.05.016. Ibrahim N, Tyler MA, Borchard NA, Rathor A, Nayak JV. Nasal vestibular body treatment for recalcitrant nasal obstruction. Int Forum Allergy Rhinol. 2020;10(3):388-394. https://doi.org/10.1002/alr.22463. Kim SJ, Kim HT, Park YH, Kim JY, Bae JH. Coblation nasal septal swell body reduction for treatment of nasal obstruction: a preliminary report. Eur Arch Otorhinolaryngol. 2016;273(9):2575-2578. https://doi.org/10.1007/s00405-016-3946-0. Karpishchenko S, Ulupov M, Gindryuk A , Kaplun D. Using thermal effect of 970 nm diode laser to reduce nasal swell body. Am J Otolaryngol. 2021;42(6):103165. https://doi.org/10.1016/j.amjoto.2021.103165. Catalano P, Ashmead MG, Carlson D. Radiofrequency ablation of septal swell body. Ann Otolaryngol Rhinol. 2015;2(11):1069. Yu MS, Kim JY, Kim BH, Kang SH, Lim DJ. Feasibility of septal body volume reduction for patients with nasal obstruction. Laryngoscope. 2015;125(7):1523-1528. https://doi.org/10.1002/lary.25154. Lai WS, Cheng SY, Lin YY, et al. Clinical assessment of diode laser-assisted endoscopic intrasphenoidal vidian neurectomy in the treatment of refractory rhinitis. Lasers Med Sci. 2017;32(9):2097-2104. https://doi.org/10.1007/s10103-017-2330-7. Su WF, Liu SC, Chiu FS, Lee CH. Antegrade transsphenoidal vidian neurectomy: short-term surgical outcome analysis. Am J Rhinol Allergy. 2011;25(6):e217-e220. https://doi.org/10.2500/ajra.2011.25.3704. Ai J, Xie Z, Qing X, et al. Clinical effect of endoscopic vidian neurectomy on bronchial asthma outcomes in patients with coexisting refractory allergic rhinitis and asthma. Am J Rhinol Allergy. 2018;32(3):139-146. https://doi.org/10.1177/1945892418764964. Shen L, Wang J, Kang X, et al. Clinical efficacy and possible mechanism of endoscopic vidian neurectomy for house dust mite-sensitive allergic rhinitis. ORL J Otorhinolaryngol Relat Spec. 2021;83(2):75-84. https://doi.org/10.1159/000511711. Maimaitiaili G, Kahaer K, Tang L, Zhang J. The effect of vidian neurectomy on pulmonary function in patients with allergic rhinitis and chronic rhinosinusitis with nasal polyps. Am J Med Sci. 2020;360(2):137-145. https://doi.org/10.1016/j.amjms.2020.04.024. Qi Y, Liu J, Peng S, Hou S, Zhang M, Wang Z. Efficacy of selective vidian neurectomy for allergic rhinitis combined with chronic rhinosinusitis. ORL J Otorhinolaryngol Relat Spec. 2021;83(5):327-334. https://doi.org/10.1159/000512083. Konno A. Historical, pathophysiological, and therapeutic aspects of vidian neurectomy. Curr Allergy Asthma Rep. 2010;10(2):105-112. https://doi.org/10.1007/s11882-010-0093-3. Bleier BS, Schlosser RJ. Endoscopic anatomy of the postganglionic pterygopalatine innervation of the posterolateral nasal mucosa. Int Forum Allergy Rhinol. 2011;1(2):113-117. https://doi.org/10.1002/alr.20011. Wang EW, Gardner PA, Fraser S, Stefko ST, Fernandez-Miranda JC, Snyderman CH. Reduced tearing with stable quality of life after vidian neurectomy: a prospective controlled trial. Laryngoscope. 2021;131(7):1487-1491. https://doi.org/10.1002/lary.29287. Makihara S, Okano M, Miyamoto S, et al. Underwater posterior nasal neurectomy compared to resection of peripheral branches of posterior nerve in severe allergic rhinitis. Acta Otolaryngol. 2021;141(8):780-785. https://doi.org/10.1080/00016489.2021.1925151. Hua H, Wang G, Zhao Y, Wang D, Qiu Z, Fang P. The long-term outcomes of posterior nasal neurectomy with or without pharyngeal neurectomy in patients with allergic rhinitis: a randomized controlled trial. Braz J Otorhinolaryngol. 2022;88(Suppl 1):S147-S155. https://doi.org/10.1016/j.bjorl.2021.05.006. Wang L, Chen M, Xu M. Effect of posterior nasal neurectomy on the suppression of allergic rhinitis. Am J Otolaryngol. 2020;41(3):102410. https://doi.org/10.1016/j.amjoto.2020.102410. Li S, Cheng J, Yang J, et al. Efficacy of posterior nasal neurectomy for allergic rhinitis combined with chronic rhinosinusitis with nasal polyps. Acta Otolaryngol. 2019;139(10):890-894. https://doi.org/10.1080/00016489.2019.1654132. Takahara D, Takeno S, Hamamoto T, Ishino T, Hirakawa K. Management of intractable nasal hyperreactivity by selective resection of posterior nasal nerve branches. Int J Otolaryngol. 2017;2017:1907862. https://doi.org/10.1155/2017/1907862. Ogi K, Manabe Y, Mori S, et al. Long-term effect of combined submucous turbinectomy and posterior nasal neurectomy in patients with allergic rhinitis. SN Comp Clin Med. 2019;1:540-546. Albu S, Trombitas V, Nagy A. Endoscopic microdebrider-assisted inferior turbinoplasty with and without posterior nasal neurectomy. Auris Nasus Larynx. 2014;41(3):273-277. https://doi.org/10.1016/j.anl.2013.10.018. Terao A, Meshitsuka K, Suzaki H, Fukuda S. Cryosurgery on postganglionic fibers (posterior nasal branches) of the pterygopalatine ganglion for vasomotor rhinitis. Acta Otolaryngol. 1983;96(1-2):139-148. https://doi.org/10.3109/00016488309132884. M Yen D, B Conley D, O'Malley EM, Byerly TA, Johnson J. Multiple site cryoablation treatment of the posterior nasal nerve for treatment of chronic rhinitis: an observational feasibility study. Allergy Rhinol (Providence). 2020;11:2152656720946996. https://doi.org/10.1177/2152656720946996. Del Signore AG, Greene JB, Russell JL, Yen DM, O'Malley EM, Schlosser RJ. Cryotherapy for treatment of chronic rhinitis: 3-month outcomes of a randomized, sham-controlled trial. Int Forum Allergy Rhinol. 2022;12(1):51-61. https://doi.org/10.1002/alr.22868. Ow RA, O'Malley EM, Han JK, Lam KK, Yen DM. Cryosurgical ablation for treatment of rhinitis: two-year results of a prospective multicenter study. Laryngoscope. 2021;131(9):1952-1957. https://doi.org/10.1002/lary.29453. Gerka Stuyt JA, Luk L, Keschner D, Garg R. Evaluation of in-office cryoablation of posterior nasal nerves for the treatment of rhinitis. Allergy Rhinol (Providence). 2021;12:2152656720988565. https://doi.org/10.1177/2152656720988565. Chang MT, Song S, Hwang PH. Cryosurgical ablation for treatment of rhinitis: a prospective multicenter study. Laryngoscope. 2020;130(8):1877-1884. https://doi.org/10.1002/lary.28301. Yoo F, Kuan EC, Batra PS, Chan CK, Tajudeen BA, Craig JR. Predictors of rhinorrhea response after posterior nasal nerve cryoablation for chronic rhinitis. Int Forum Allergy Rhinol. 2020;10(7):913-919. https://doi.org/10.1002/alr.22574. Ehmer D, McDuffie CM, Scurry Jr WC, et al. Temperature-controlled radiofrequency neurolysis for the treatment of rhinitis. Am J Rhinol Allergy. 2022;36(1):149-156. https://doi.org/10.1177/19458924211033400. Stolovitzky JP, Ow RA, Silvers SL, Bikhazi NB, Johnson CD, Takashima M. Effect of radiofrequency neurolysis on the symptoms of chronic rhinitis: a randomized controlled trial. OTO Open. 2021;5(3):2473974X211041124. https://doi.org/10.1177/2473974X211041124. Krespi YP, Wilson KA, Kizhner V. Laser ablation of posterior nasal nerves for rhinitis. Am J Otolaryngol. 2020;41(3):102396. https://doi.org/10.1016/j.amjoto.2020.102396. Singh AK, Kasle DA, Torabi SJ, Manes RP. Adverse events associated with ClariFix posterior nasal nerve cryoablation: a MAUDE database analysis. Otolaryngol Head Neck Surg. 2021;165(4):597-601. https://doi.org/10.1177/0194599820986581. Jose J, Coatesworth AP. Inferior turbinate surgery for nasal obstruction in allergic rhinitis after failed medical treatment. Cochrane Database Syst Rev. 2010;(12):CD005235. https://doi.org/10.1002/14651858.CD005235.pub2. Langille M, El-Hakim H. Pediatric inferior turbinoplasty with or without adenoidectomy: preliminary report on improvement of quality of life, symptom control, and safety. J Otolaryngol Head Neck Surg. 2011;40(5):420-426. Di Rienzo Businco L, Di Rienzo Businco A, Lauriello M. Comparative study on the effectiveness of Coblation-assisted turbinoplasty in allergic rhinitis. Rhinology. 2010;48(2):174-178. https://doi.org/10.4193/Rhin09.149. Kobayashi T, Hyodo M, Nakamura K, Komobuchi H, Honda N. Resection of peripheral branches of the posterior nasal nerve compared to conventional posterior neurectomy in severe allergic rhinitis. Auris Nasus Larynx. 2012;39(6):593-596. https://doi.org/10.1016/j.anl.2011.11.006. Roberts G, Pfaar O, Akdis CA, et al. EAACI Guidelines on allergen immunotherapy: allergic rhinoconjunctivitis. Allergy. 2018;73(4):765-798. https://doi.org/10.1111/all.13317. Cox L, Nelson H, Lockey R, et al. Allergen immunotherapy: a practice parameter third update. J Allergy Clin Immunol. 2011;127(1 suppl):S1-S55. https://doi.org/10.1016/j.jaci.2010.09.034. Matricardi PM, Kuna P, Panetta V, Wahn U, Narkus A. Subcutaneous immunotherapy and pharmacotherapy in seasonal allergic rhinitis: a comparison based on meta-analyses. J Allergy Clin Immunol. 2011;128(4):791-799.e6. https://doi.org/10.1016/j.jaci.2011.03.049. Radulovic S, Calderon MA, Wilson D, Durham S. Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev. 2010;(12):CD002893. https://doi.org/10.1002/14651858.CD002893.pub2. Tie K, Miller C, Zanation AM, Ebert Jr CS. Subcutaneous versus sublingual immunotherapy for adults with allergic rhinitis: a systematic review with meta-analyses. Laryngoscope. 2022;132(3):499-508. https://doi.org/10.1002/lary.29586. Durham SR, Walker SM, Varga EM, et al. Long-term clinical efficacy of grass-pollen immunotherapy. N Engl J Med. 1999;341(7):468-475. https://doi.org/10.1056/NEJM199908123410702. Ebner C, Kraft D, Ebner H. Booster immunotherapy (BIT). Allergy. 1994;49(1):38-42. https://doi.org/10.1111/j.1398-9995.1994.tb00771.x. Arroabarren E, Tabar AI, Echechipia S, Cambra K, Garcia BE, Alvarez-Puebla MJ. Optimal duration of allergen immunotherapy in children with dust mite respiratory allergy. Pediatr Allergy Immunol. 2015;26(1):34-41. https://doi.org/10.1111/pai.12296. Kristiansen M, Dhami S, Netuveli G, et al. Allergen immunotherapy for the prevention of allergy: a systematic review and meta-analysis. Pediatr Allergy Immunol. 2017;28(1):18-29. https://doi.org/10.1111/pai.12661. Schmitt J, Schwarz K, Stadler E, Wustenberg EG. Allergy immunotherapy for allergic rhinitis effectively prevents asthma: results from a large retrospective cohort study. J Allergy Clin Immunol. 2015;136(6):1511-1516. https://doi.org/10.1016/j.jaci.2015.07.038. Jacobsen L, Niggemann B, Dreborg S, et al. Specific immunotherapy has long-term preventive effect of seasonal and perennial asthma: 10-year follow-up on the PAT study. Allergy. 2007;62(8):943-948. https://doi.org/10.1111/j.1398-9995.2007.01451.x. Valovirta E, Petersen TH, Piotrowska T, et al. Results from the 5-year SQ grass sublingual immunotherapy tablet asthma prevention (GAP) trial in children with grass pollen allergy. J Allergy Clin Immunol. 2018;141(2):529-538.e13. https://doi.org/10.1016/j.jaci.2017.06.014. Fiocchi A, Pajno G, La Grutta S, et al. Safety of sublingual-swallow immunotherapy in children aged 3 to 7 years. Ann Allergy Asthma Immunol. 2005;95(3):254-258. https://doi.org/10.1016/S1081-1206(10)61222-7. Agostinis F, Tellarini L, Canonica GW, Falagiani P, Passalacqua G. Safety of sublingual immunotherapy with a monomeric allergoid in very young children. Allergy. 2005;60(1):133. https://doi.org/10.1111/j.1398-9995.2004.00616.x. Darsow U. Allergen-specific immunotherapy for atopic eczema: updated. Curr Opin Allergy Clin Immunol. 2012;12(6):665-669. https://doi.org/10.1097/ACI.0b013e3283588cf4. Passalacqua G, Canonica GW. Allergen immunotherapy: history and future developments. Immunol Allergy Clin North Am. 2016;36(1):1-12. https://doi.org/10.1016/j.iac.2015.08.001. Greenhawt M, Oppenheimer J, Nelson M, et al. Sublingual immunotherapy: a focused allergen immunotherapy practice parameter update. Ann Allergy Asthma Immunol. 2017;118(3):276-282.e2. https://doi.org/10.1016/j.anai.2016.12.009. Akdis M, Akdis CA. Mechanisms of allergen-specific immunotherapy: multiple suppressor factors at work in immune tolerance to allergens. J Allergy Clin Immunol. 2014;133(3):621-631. https://doi.org/10.1016/j.jaci.2013.12.1088. Nelson HS, Makatsori M, Calderon MA. Subcutaneous immunotherapy and sublingual immunotherapy: comparative efficacy, current and potential indications, and warnings - United States Versus Europe. Immunol Allergy Clin North Am. 2016;36(1):13-24. https://doi.org/10.1016/j.iac.2015.08.005. Lawrence MG, Steinke JW, Borish L. Basic science for the clinician: mechanisms of sublingual and subcutaneous immunotherapy. Ann Allergy Asthma Immunol. 2016;117(2):138-142. https://doi.org/10.1016/j.anai.2016.06.027. Dhami S, Nurmatov U, Arasi S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Allergy. 2017;72(11):1597-1631. https://doi.org/10.1111/all.13201. Nurmatov U, Dhami S, Arasi S, et al. Allergen immunotherapy for allergic rhinoconjunctivitis: a systematic overview of systematic reviews. Clin Transl Allergy. 2017;7:24. https://doi.org/10.1186/s13601-017-0159-6. Lin SY, Erekosima N, Suarez-Cuervo C, et al. Agency for Healthcare Research and Quality Comparative Effectiveness Reviews. Allergen-Specific Immunotherapy for the Treatment of Allergic Rhinoconjunctivitis and/or Asthma: Comparative Effectiveness Review. 2013. Epstein TG, Murphy-Berendts K, Liss GM, Bernstein DI. Risk factors for fatal and nonfatal reactions to immunotherapy (2008-2018): postinjection monitoring and severe asthma. Ann Allergy Asthma Immunol. 2021;127(1):64-69.e1. https://doi.org/10.1016/j.anai.2021.03.011. Bernstein DI, Wanner M, Borish L, Liss GM, Immunotherapy Committee, American Academy of Allergy, Asthma and Immunology. Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol. 2004;113(6):1129-1136. https://doi.org/10.1016/j.jaci.2004.02.006. Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI. AAAAI and ACAAI surveillance study of subcutaneous immunotherapy, Year 3: what practices modify the risk of systemic reactions? Ann Allergy Asthma Immunol. 2013;110(4):274-278, 278.e1. https://doi.org/10.1016/j.anai.2013.01.015. Lee S, Hess EP, Nestler DM, et al. Antihypertensive medication use is associated with increased organ system involvement and hospitalization in emergency department patients with anaphylaxis. J Allergy Clin Immunol. 2013;131(4):1103-1108. https://doi.org/10.1016/j.jaci.2013.01.011. Muller UR, Haeberli G. Use of beta-blockers during immunotherapy for Hymenoptera venom allergy. J Allergy Clin Immunol. 2005;115(3):606-610. https://doi.org/10.1016/j.jaci.2004.11.012. Pitsios C, Tsoumani M, Bilo MB, et al. Contraindications to immunotherapy: a global approach. Clin Transl Allergy. 2019;9:45. https://doi.org/10.1186/s13601-019-0285-4. Wohrl S, Kinaciyan T, Jalili A, Stingl G, Moritz KB. Malignancy and specific allergen immunotherapy: the results of a case series. Int Arch Allergy Immunol. 2011;156(3):313-319. https://doi.org/10.1159/000323519. Linneberg A, Jacobsen RK, Jespersen L, Abildstrom SZ. Association of subcutaneous allergen-specific immunotherapy with incidence of autoimmune disease, ischemic heart disease, and mortality. J Allergy Clin Immunol. 2012;129(2):413-419. https://doi.org/10.1016/j.jaci.2011.09.007. Bozek A, Kolodziejczyk K, Bednarski P. The relationship between autoimmunity and specific immunotherapy for allergic diseases. Hum Vaccin Immunother. 2015;11(12):2764-2768. https://doi.org/10.1080/21645515.2015.1087627. Shaikh WA. A retrospective study on the safety of immunotherapy in pregnancy. Clin Exp Allergy. 1993;23(10):857-860. https://doi.org/10.1111/j.1365-2222.1993.tb00264.x. Shaikh WA, Shaikh SW. A prospective study on the safety of sublingual immunotherapy in pregnancy. Allergy. 2012;67(6):741-743. https://doi.org/10.1111/j.1398-9995.2012.02815.x. Odactra House Dust Mite. (Dermatophagoides farinae and Dermatophagoides pteronyssinus) allergen extract tablet for sublingual use. Accessed October 8, 2021. fda.gov/media/103380/download. ORALAIR. (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract) tablet for sublingual use. Accessed July 3, 2022. https://www.fda.gov/media/87935/download. Grastek Timothy grass pollen extract tablet for sublingual use. Accessed July 3, 2022. https://www.fda.gov/media/88510/download. Ragwitek short ragweed pollen extract tablet for sublingual use. Accessed July 3, 2022. https://www.fda.gov/media/88712/download. Osguthorpe JD. The evolution of understanding inhalant allergy. Otolaryngol Clin North Am. 2011;44(3):519-535, vii. https://doi.org/10.1016/j.otc.2011.03.008. Noon L. Prophylactic inoculation against hayfever. Lancet. 1911;1:1572-1573. Mason WW, Ward WA. Standardized extracts. Otolaryngol Clin North Am. 1992;25(1):101-17. Zimmer J, Vieths S, Kaul S. Standardization and regulation of allergen products in the European Union. Curr Allergy Asthma Rep. 2016;16(3):21. https://doi.org/10.1007/s11882-016-0599-4. Carnes J, Iraola V, Gallego M, Leonor JR. Control process for manufacturing and standardization of allergenic molecules. Curr Allergy Asthma Rep. 2015;15(7):37. https://doi.org/10.1007/s11882-015-0541-1. Zimmer J, Bridgewater J, Ferreira F, van Ree R, Rabin RL, Vieths S. The history, present and future of allergen standardization in the United States and Europe. Front Immunol. 2021;12:725831. https://doi.org/10.3389/fimmu.2021.725831. Park KH, Son M, Choi SY, et al. In vitro evaluation of allergen potencies of commercial house dust mite sublingual immunotherapy reagents. Allergy Asthma Immunol Res. 2015;7(2):124-129. https://doi.org/10.4168/aair.2015.7.2.124. Thomsen GF, Schlunssen V, Skadhauge LR, et al. Are allergen batch differences and the use of double skin prick test important? BMC Pulm Med. 2015;15:33. https://doi.org/10.1186/s12890-015-0021-3. Slater JE. Standardized allergen extracts in the United States. Clin Allergy Immunol. 2004;18:421-432. Jutel M, Agache I, Bonini S, et al. International consensus on allergen immunotherapy II: mechanisms, standardization, and pharmacoeconomics. J Allergy Clin Immunol. 2016;137(2):358-368. https://doi.org/10.1016/j.jaci.2015.12.1300. Zakzuk J, Kilimajer J, Lockey R. World Allergy Organization Allergen Standardization and Characterization. Updated January 2019. Accessed June 3, 2022. https://www.worldallergy.org/education-and-programs/education/allergic-disease-resource-center/professionals/allergen-standardization-and-characterization. van Ree R, Chapman MD, Ferreira F, et al. The CREATE project: development of certified reference materials for allergenic products and validation of methods for their quantification. Allergy. 2008;63(3):310-326. https://doi.org/10.1111/j.1398-9995.2007.01612.x. Petrovsky N. Comparative Safety of vaccine adjuvants: a summary of current evidence and future needs. Drug Saf. 2015;38(11):1059-1074. https://doi.org/10.1007/s40264-015-0350-4. Gunawardana NC, Durham SR. New approaches to allergen immunotherapy. Ann Allergy Asthma Immunol. 2018;121(3):293-305. https://doi.org/10.1016/j.anai.2018.07.014. Leuthard DS, Duda A, Freiberger SN, et al. Microcrystalline tyrosine and aluminum as adjuvants in allergen-specific immunotherapy protect from IgE-mediated reactivity in mouse models and act independently of inflammasome and TLR signaling. J Immunol. 2018;200(9):3151-3159. https://doi.org/10.4049/jimmunol.1800035. Zubeldia JM, Ferrer M, Davila I, Justicia JL. adjuvants in allergen-specific immunotherapy: modulating and enhancing the immune response. J Investig Allergol Clin Immunol. 2019;29(2):103-111. https://doi.org/10.18176/jiaci.0349. Johnson L, Duschl A, Himly M. Nanotechnology-based vaccines for allergen-specific immunotherapy: potentials and challenges of conventional and novel adjuvants under research. Vaccines (Basel). 2020;8(2):237. https://doi.org/10.3390/vaccines8020237. Kirtland ME, Tsitoura DC, Durham SR, Shamji MH. Toll-like receptor agonists as adjuvants for allergen immunotherapy. Front Immunol. 2020;11:599083. https://doi.org/10.3389/fimmu.2020.599083. Feng Z, Yi X, Hajavi J. New and old adjuvants in allergen-specific immunotherapy: with a focus on nanoparticles. J Cell Physiol. 2021;236(2):863-876. https://doi.org/10.1002/jcp.29941. Norman PS, Lichtenstein LM. Comparisons of alum-precipitated and unprecipitated aqueous ragweed pollen extracts in the treatment of hay fever. J Allergy Clin Immunol. 1978;61(6):384-389. https://doi.org/10.1016/0091-6749(78)90118-5. Jensen-Jarolim E, Bachmann MF, Bonini S, et al. State-of-the-art in marketed adjuvants and formulations in allergen immunotherapy: a position paper of the European Academy of Allergy and Clinical Immunology (EAACI). Allergy. 2020;75(4):746-760. https://doi.org/10.1111/all.14134. Corrigan CJ, Kettner J, Doemer C, Cromwell O, Narkus A, Study G. Efficacy and safety of preseasonal-specific immunotherapy with an aluminium-adsorbed six-grass pollen allergoid. Allergy. 2005;60(6):801-807. https://doi.org/10.1111/j.1398-9995.2005.00790.x. Drachenberg KJ, Wheeler AW, Stuebner P, Horak F. A well-tolerated grass pollen-specific allergy vaccine containing a novel adjuvant, monophosphoryl lipid A, reduces allergic symptoms after only four preseasonal injections. Allergy. 2001;56(6):498-505. https://doi.org/10.1034/j.1398-9995.2001.056006498.x. Tulic MK, Fiset PO, Christodoulopoulos P, et al. Amb a 1-immunostimulatory oligodeoxynucleotide conjugate immunotherapy decreases the nasal inflammatory response. J Allergy Clin Immunol. 2004;113(2):235-241. https://doi.org/10.1016/j.jaci.2003.11.001. Torii Y, Ito T, Amakawa R, et al. Imidazoquinoline acts as immune adjuvant for functional alteration of thymic stromal lymphopoietin-mediated allergic T cell response. J Immunol. 2008;181(8):5340-5349. https://doi.org/10.4049/jimmunol.181.8.5340. Tversky JR, Bieneman AP, Chichester KL, Hamilton RG, Schroeder JT. Subcutaneous allergen immunotherapy restores human dendritic cell innate immune function. Clin Exp Allergy. 2010;40(1):94-102. https://doi.org/10.1111/j.1365-2222.2009.03388.x. Tversky JR, Le TV, Bieneman AP, Chichester KL, Hamilton RG, Schroeder JT. Human blood dendritic cells from allergic subjects have impaired capacity to produce interferon-alpha via Toll-like receptor 9. Clin Exp Allergy. 2008;38(5):781-788. https://doi.org/10.1111/j.1365-2222.2008.02954.x. Creticos PS, Schroeder JT, Hamilton RG, et al. Immunotherapy with a ragweed-toll-like receptor 9 agonist vaccine for allergic rhinitis. N Engl J Med. 2006;355(14):1445-1455. https://doi.org/10.1056/NEJMoa052916. Busse W, Korenblat P, Nayak A, et al. Phase 2/3 study of the novel vaccine Amb a 1 immunostimulatory oligodeoxyriboneucleotide conjugate AIC in ragweed allergic adults. J Allergy Clin Immunol. 2006;117:S88-S89. Leonard C, Montamat G, Davril C, et al. Comprehensive mapping of immune tolerance yields a regulatory TNF receptor 2 signature in a murine model of successful Fel d 1-specific immunotherapy using high-dose CpG adjuvant. Allergy. 2021;76(7):2153-2165. https://doi.org/10.1111/all.14716. Senti G, Johansen P, Haug S, et al. Use of A-type CpG oligodeoxynucleotides as an adjuvant in allergen-specific immunotherapy in humans: a phase I/IIa clinical trial. Clin Exp Allergy. 2009;39(4):562-570. https://doi.org/10.1111/j.1365-2222.2008.03191.x. Rosewich M, Lee D, Zielen S. Pollinex Quattro: an innovative four injections immunotherapy in allergic rhinitis. Hum Vaccin Immunother. 2013;9(7):1523-1531. https://doi.org/10.4161/hv.24631. DuBuske LM, Frew AJ, Horak F, et al. Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen. Allergy Asthma Proc. 2011;32(6):466. https://doi.org/10.2500/108854111798840203. Feynman R. Plenty of room at the bottom. 1959. Lecture to the American Physical Society. Marty JJ, Oppenheim RC, Speiser P. Nanoparticles-a new colloidal drug delivery system. Pharm Acta Helv. 1978;53(1):17-23. Toh ZQ, Anzela A, Tang ML, Licciardi PV. Probiotic therapy as a novel approach for allergic disease. Front Pharmacol. 2012;3:171. https://doi.org/10.3389/fphar.2012.00171. Ho HE, Bunyavanich S. Microbial adjuncts for food allergen immunotherapy. Curr Allergy Asthma Rep. 2019;19(5):25. https://doi.org/10.1007/s11882-019-0859-1. Liu PT, Stenger S, Li H, et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response. Science. 2006;311(5768):1770-1773. https://doi.org/10.1126/science.1123933. Hesse L, van Ieperen N, Petersen AH, Elberink J, van Oosterhout AJM, Nawijn MC. High dose vitamin D3 empowers effects of subcutaneous immunotherapy in a grass pollen-driven mouse model of asthma. Sci Rep. 2020;10(1):20876. https://doi.org/10.1038/s41598-020-77947-6. Heine G, Francuzik W, Doelle-Bierke S, et al. Immunomodulation of high-dose vitamin D supplementation during allergen-specific immunotherapy. Allergy. 2021;76(3):930-933. https://doi.org/10.1111/all.14541. Grundstrom J, Neimert-Andersson T, Kemi C, et al. Covalent coupling of vitamin D3 to the major cat allergen Fel d 1 improves the effects of allergen-specific immunotherapy in a mouse model for cat allergy. Int Arch Allergy Immunol. 2012;157(2):136-146. https://doi.org/10.1159/000327546. Liu C, Yang N, Song Y, et al. Ganoderic acid C1 isolated from the anti-asthma formula, ASHMI suppresses TNF-alpha production by mouse macrophages and peripheral blood mononuclear cells from asthma patients. Int Immunopharmacol. 2015;27(2):224-231. https://doi.org/10.1016/j.intimp.2015.05.018. Wen MC, Wei CH, Hu ZQ, et al. Efficacy and tolerability of anti-asthma herbal medicine intervention in adult patients with moderate-severe allergic asthma. J Allergy Clin Immunol. 2005;116(3):517-524. https://doi.org/10.1016/j.jaci.2005.05.029. Mahler V, Esch RE, Kleine-Tebbe J, et al. Understanding differences in allergen immunotherapy products and practices in North America and Europe. J Allergy Clin Immunol. 2019;143(3):813-828. https://doi.org/10.1016/j.jaci.2019.01.024. Valenta R, Niespodziana K, Focke-Tejkl M, et al. Recombinant allergens: what does the future hold? J Allergy Clin Immunol. 2011;127(4):860-864. https://doi.org/10.1016/j.jaci.2011.02.016. Zhernov Y, Curin M, Khaitov M, Karaulov A, Valenta R. Recombinant allergens for immunotherapy: state of the art. Curr Opin Allergy Clin Immunol. 2019;19(4):402-414. https://doi.org/10.1097/ACI.0000000000000536. Jutel M, Jaeger L, Suck R, Meyer H, Fiebig H, Cromwell O. Allergen-specific immunotherapy with recombinant grass pollen allergens. J Allergy Clin Immunol. 2005;116(3):608-613. https://doi.org/10.1016/j.jaci.2005.06.004. Klimek L, Schendzielorz P, Pinol R, Pfaar O. Specific subcutaneous immunotherapy with recombinant grass pollen allergens: first randomized dose-ranging safety study. Clin Exp Allergy. 2012;42(6):936-945. https://doi.org/10.1111/j.1365-2222.2012.03971.x. Pauli G, Larsen TH, Rak S, et al. Efficacy of recombinant birch pollen vaccine for the treatment of birch-allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2008;122(5):951-960. https://doi.org/10.1016/j.jaci.2008.09.017. Nony E, Bouley J, Le Mignon M, et al. Development and evaluation of a sublingual tablet based on recombinant Bet v 1 in birch pollen-allergic patients. Allergy. 2015;70(7):795-804. https://doi.org/10.1111/all.12622. Litwin A, Pesce AJ, Fischer T, Michael M, Michael JG. Regulation of the human immune response to ragweed pollen by immunotherapy. A controlled trial comparing the effect of immunosuppressive peptic fragments of short ragweed with standard treatment. Clin Exp Allergy. 1991;21(4):457-465. https://doi.org/10.1111/j.1365-2222.1991.tb01686.x. Purohit A, Niederberger V, Kronqvist M, et al. Clinical effects of immunotherapy with genetically modified recombinant birch pollen Bet v 1 derivatives. Clin Exp Allergy. 2008;38(9):1514-1525. https://doi.org/10.1111/j.1365-2222.2008.03042.x. Couroux P, Patel D, Armstrong K, Larche M, Hafner RP. Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects. Clin Exp Allergy. 2015;45(5):974-981. https://doi.org/10.1111/cea.12488. Maguire P, Nicodemus C, Robinson D, Aaronson D, Umetsu DT. The safety and efficacy of ALLERVAX CAT in cat allergic patients. Clin Immunol. 1999;93(3):222-231. https://doi.org/10.1006/clim.1999.4795. Norman PS, Ohman Jr JL, Long AA, et al. Treatment of cat allergy with T-cell reactive peptides. Am J Respir Crit Care Med. 1996;154(6 pt 1):1623-1628. https://doi.org/10.1164/ajrccm.154.6.8970345. Spertini F, Perrin Y, Audran R, et al. Safety and immunogenicity of immunotherapy with Bet v 1-derived contiguous overlapping peptides. J Allergy Clin Immunol. 2014;134(1):239-240.e13. https://doi.org/10.1016/j.jaci.2014.04.001. Spertini F, DellaCorte G, Kettner A, et al. Efficacy of 2 months of allergen-specific immunotherapy with Bet v 1-derived contiguous overlapping peptides in patients with allergic rhinoconjunctivitis: Results of a phase IIb study. J Allergy Clin Immunol. 2016;138(1):162-168. https://doi.org/10.1016/j.jaci.2016.02.044. Kettner A, DellaCorte G, de Blay F, et al. Benefit of Bet v 1 contiguous overlapping peptide immunotherapy persists during first follow-up season. J Allergy Clin Immunol. 2018;142(2):678-680.e7. https://doi.org/10.1016/j.jaci.2018.01.052. Jutel M, Kosowska A, Smolinska S. Allergen immunotherapy: past, present, and future. Allergy Asthma Immunol Res. 2016;8(3):191-197. https://doi.org/10.4168/aair.2016.8.3.191. Valenta R, Campana R, Focke-Tejkl M, Niederberger V. Vaccine development for allergen-specific immunotherapy based on recombinant allergens and synthetic allergen peptides: Lessons from the past and novel mechanisms of action for the future. J Allergy Clin Immunol. 2016;137(2):351-357. https://doi.org/10.1016/j.jaci.2015.12.1299. Norman PS, Lichtenstein LM, Marsh DG. Studies on allergoids from naturally occurring allergens. IV. Efficacy and safety of long-term allergoid treatment of ragweed hay fever. J Allergy Clin Immunol. 1981;68(6):460-470. https://doi.org/10.1016/0091-6749(81)90200-1. Grammer LC, Zeiss CR, Suszko IM, Shaughnessy MA, Patterson R. A double-blind, placebo-controlled trial of polymerized whole ragweed for immunotherapy of ragweed allergy. J Allergy Clin Immunol. 1982;69(6):494-499. https://doi.org/10.1016/0091-6749(82)90173-7. Bousquet J, Hejjaoui A, Soussana M, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. IV. Comparison of the safety and efficacy of two dosages of a high-molecular-weight allergoid. J Allergy Clin Immunol. 1990;85(2):490-497. https://doi.org/10.1016/0091-6749(90)90160-6. Bousquet J, Maasch HJ, Hejjaoui A, et al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. III. Efficacy and safety of unfractionated and high-molecular-weight preparations in rhinoconjunctivitis and asthma. J Allergy Clin Immunol. 1989;84(4 pt 1):546-556. https://doi.org/10.1016/0091-6749(89)90369-2. Riechelmann H, Schmutzhard J, van der Werf JF, Distler A, Kleinjans HA. Efficacy and safety of a glutaraldehyde-modified house dust mite extract in allergic rhinitis. Am J Rhinol Allergy. 2010;24(5):e104-e109. https://doi.org/10.2500/ajra.2010.24.3508. Passalacqua G, Albano M, Fregonese L, et al. Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet. 1998;351(9103):629-632. https://doi.org/10.1016/S0140-6736(97)07055-4. Rauber MM, Wu HK, Adams B, et al. Birch pollen allergen-specific immunotherapy with glutaraldehyde-modified allergoid induces IL-10 secretion and protective antibody responses. Allergy. 2019;74(8):1575-1579. https://doi.org/10.1111/all.13774. Ramesh M, Karagic M. New modalities of allergen immunotherapy. Hum Vaccin Immunother. 2018;14(12):2848-2863. https://doi.org/10.1080/21645515.2018.1502126. Pohlit H, Bellinghausen I, Frey H, Saloga J. Recent advances in the use of nanoparticles for allergen-specific immunotherapy. Allergy. 2017;72(10):1461-1474. https://doi.org/10.1111/all.13199. Basomba A, Tabar AI, de Rojas DH, et al. Allergen vaccination with a liposome-encapsulated extract of Dermatophagoides pteronyssinus: a randomized, double-blind, placebo-controlled trial in asthmatic patients. J Allergy Clin Immunol. 2002;109(6):943-948. https://doi.org/10.1067/mai.2002.124465. TePas EC, Hoyte EG, McIntire JJ, Umetsu DT. Clinical efficacy of microencapsulated timothy grass pollen extract in grass-allergic individuals. Ann Allergy Asthma Immunol. 2004;92(1):25-31. https://doi.org/10.1016/S1081-1206(10)61706-1. Frankland AW, Augustin R. Prophylaxis of summer hay-fever and asthma: a controlled trial comparing crude grass-pollen extracts with the isolated main protein component. Lancet. 1954;266(6821):1055-1057. https://doi.org/10.1016/s0140-6736(54)91620-7. Penagos M, Eifan AO, Durham SR, Scadding GW. Duration of allergen immunotherapy for long-term efficacy in allergic rhinoconjunctivitis. Curr Treat Options Allergy. 2018;5(3):275-290. https://doi.org/10.1007/s40521-018-0176-2. Bachert C, Larche M, Bonini S, et al. Allergen immunotherapy on the way to product-based evaluation - a WAO statement. World Allergy Organ J. 2015;8(1):29. https://doi.org/10.1186/s40413-015-0078-8. McEldowney SJ, Bush RK. Pollen immunotherapy: selection,prevention, and future directions. Curr Allergy Asthma Rep. 2006;6(5):420-426. https://doi.org/10.1007/s11882-996-0016-5. Coop CA. Immunotherapy for mold allergy. Clin Rev Allergy Immunol. 2014;47(3):289-298. https://doi.org/10.1007/s12016-013-8389-4. Nelson HS. Immunotherapy for house-dust mite allergy. Allergy Asthma Proc. 2018;39(4):264-272. https://doi.org/10.2500/aap.2018.39.4145. Dhami S, Agarwal A. Does evidence support the use of cat allergen immunotherapy? Curr Opin Allergy Clin Immunol. 2018;18(4):350-355. https://doi.org/10.1097/ACI.0000000000000457. Larenas-Linnemann D. Allergen immunotherapy: an update on protocols of administration. Curr Opin Allergy Clin Immunol. 2015;15(6):556-567. https://doi.org/10.1097/ACI.0000000000000220. Epstein TG, Liss GM, Murphy-Berendts K, Bernstein DI. AAAAI/ACAAI surveillance study of subcutaneous immunotherapy, years 2008-2012: an update on fatal and nonfatal systemic allergic reactions. J Allergy Clin Immunol Pract. 2014;2(2):161-167. https://doi.org/10.1016/j.jaip.2014.01.004. Epstein TG, Liss GM, Berendts KM, Bernstein DI. AAAAI/ACAAI Subcutaneous Immunotherapy Surveillance Study (2013-2017): fatalities, infections, delayed reactions, and use of epinephrine autoinjectors. J Allergy Clin Immunol Pract. 2019;7(6):1996-2003.e1. https://doi.org/10.1016/j.jaip.2019.01.058. DaVeiga SP, Liu X, Caruso K, Golubski S, Xu M, Lang DM. Systemic reactions associated with subcutaneous allergen immunotherapy: timing and risk assessment. Ann Allergy Asthma Immunol. 2011;106(6):533-537.e2. https://doi.org/10.1016/j.anai.2011.02.007. Hankin CS, Cox L, Lang D, et al. Allergy immunotherapy among Medicaid-enrolled children with allergic rhinitis: patterns of care, resource use, and costs. J Allergy Clin Immunol. 2008;121(1):227-232. https://doi.org/10.1016/j.jaci.2007.10.026. Hankin CS, Cox L, Lang D, et al. Allergen immunotherapy and health care cost benefits for children with allergic rhinitis: a large-scale, retrospective, matched cohort study. Ann Allergy Asthma Immunol. 2010;104(1):79-85. https://doi.org/10.1016/j.anai.2009.11.010. Sun D, Cafone J, Shaker M, Greenhawt M. The cost-effectiveness of requiring universal vs contextual self-injectable epinephrine autoinjector for allergen immunotherapy. Ann Allergy Asthma Immunol. 2019;123(6):582-589. https://doi.org/10.1016/j.anai.2019.09.009. Eng PA, Borer-Reinhold M, Heijnen IA, Gnehm HP. Twelve-year follow-up after discontinuation of preseasonal grass pollen immunotherapy in childhood. Allergy. 2006;61(2):198-201. https://doi.org/10.1111/j.1398-9995.2006.01011.x. Halken S, Larenas-Linnemann D, Roberts G, et al. EAACI guidelines on allergen immunotherapy: prevention of allergy. Pediatr Allergy Immunol. 2017;28(8):728-745. https://doi.org/10.1111/pai.12807. Des Roches A, Paradis L, Menardo JL, Bouges S, Daures JP, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol. 1997;99(4):450-453. https://doi.org/10.1016/s0091-6749(97)70069-1. Pajno GB, Barberio G, De Luca F, Morabito L, Parmiani S. Prevention of new sensitizations in asthmatic children monosensitized to house dust mite by specific immunotherapy. A six-year follow-up study. Clin Exp Allergy. 2001;31(9):1392-1397. https://doi.org/10.1046/j.1365-2222.2001.01161.x. Worm M, Rak S, Samolinski B, et al. Efficacy and safety of birch pollen allergoid subcutaneous immunotherapy: a 2-year double-blind, placebo-controlled, randomized trial plus 1-year open-label extension. Clin Exp Allergy. 2019;49(4):516-525. https://doi.org/10.1111/cea.13331. Xian M, Feng M, Dong Y, Wei N, Su Q, Li J. Changes in CD4+CD25+FoxP3+ regulatory T cells and serum cytokines in sublingual and subcutaneous immunotherapy in allergic rhinitis with or without asthma. Int Arch Allergy Immunol. 2020;181(1):71-80. https://doi.org/10.1159/000503143. Wang ZX, Shi H. Single-allergen sublingual immunotherapy versus multi-allergen subcutaneous immunotherapy for children with allergic rhinitis. J Huazhong Univ Sci Technolog Med Sci. 2017;37(3):407-411. https://doi.org/10.1007/s11596-017-1748-2. Bozek A, Kolodziejczyk K, Krajewska-Wojtys A, Jarzab J. Pre-seasonal, subcutaneous immunotherapy: a double-blinded, placebo-controlled study in elderly patients with an allergy to grass. Ann Allergy Asthma Immunol. 2016;116(2):156-161. https://doi.org/10.1016/j.anai.2015.12.013. Bozek A, Kolodziejczyk K, Kozlowska R, Canonica GW. Evidence of the efficacy and safety of house dust mite subcutaneous immunotherapy in elderly allergic rhinitis patients: a randomized, double-blind placebo-controlled trial. Clin Transl Allergy. 2017;7:43. https://doi.org/10.1186/s13601-017-0180-9. Kim JY, Jang MJ, Kim DY, Park SW, Han DH. Efficacy of subcutaneous and sublingual immunotherapy for house dust mite allergy: a network meta-analysis-based comparison. J Allergy Clin Immunol Pract. 2021;9(12):4450-4458.e6. https://doi.org/10.1016/j.jaip.2021.08.018. Jutel M, Agache I, Bonini S, et al. International consensus on allergy immunotherapy. J Allergy Clin Immunol. 2015;136(3):556-568. https://doi.org/10.1016/j.jaci.2015.04.047. Shamji MH, Larson D, Eifan A, et al. Differential induction of allergen-specific IgA responses following timothy grass subcutaneous and sublingual immunotherapy. J Allergy Clin Immunol. 2021;148(4):1061-1071.e11. https://doi.org/10.1016/j.jaci.2021.03.030. Rondon C, Campo P, Salas M, et al. Efficacy and safety of D. pteronyssinus immunotherapy in local allergic rhinitis: a double-blind placebo-controlled clinical trial. Allergy. 2016;71(7):1057-1061. https://doi.org/10.1111/all.12889. Kleine-Tebbe J, Walmar M, Bitsch-Jensen K, et al. Negative clinical results from a randomised, double-blind, placebo-controlled trial evaluating the efficacy of two doses of immunologically enhanced, grass subcutaneous immunotherapy despite dose-dependent immunological response. Clin Drug Investig. 2014;34(8):577-586. https://doi.org/10.1007/s40261-014-0216-z. Klimek L, Uhlig J, Mosges R, Rettig K, Pfaar O. A high polymerized grass pollen extract is efficacious and safe in a randomized double-blind, placebo-controlled study using a novel up-dosing cluster-protocol. Allergy. 2014;69(12):1629-1638. https://doi.org/10.1111/all.12513. Tworek D, Bochenska-Marciniak M, Kuprys-Lipinska I, Kupczyk M, Kuna P. Perennial is more effective than preseasonal subcutaneous immunotherapy in the treatment of seasonal allergic rhinoconjunctivitis. Am J Rhinol Allergy. 2013;27(4):304-308. https://doi.org/10.2500/ajra.2013.27.3935. James LK, Shamji MH, Walker SM, et al. Long-term tolerance after allergen immunotherapy is accompanied by selective persistence of blocking antibodies. J Allergy Clin Immunol. 2011;127(2):509-516.e1-5. https://doi.org/10.1016/j.jaci.2010.12.1080. Kuna P, Kaczmarek J, Kupczyk M. Efficacy and safety of immunotherapy for allergies to Alternaria alternata in children. J Allergy Clin Immunol. 2011;127(2):502-508.e1-6. https://doi.org/10.1016/j.jaci.2010.11.036. Pfaar O, Robinson DS, Sager A, Emuzyte R. Immunotherapy with depigmented-polymerized mixed tree pollen extract: a clinical trial and responder analysis. Allergy. 2010;65(12):1614-1621. https://doi.org/10.1111/j.1398-9995.2010.02413.x. Tabar AI, Lizaso MT, Garcia BE, et al. Double-blind, placebo-controlled study of Alternaria alternata immunotherapy: clinical efficacy and safety. Pediatr Allergy Immunol. 2008;19(1):67-75. https://doi.org/10.1111/j.1399-3038.2007.00589.x. Charpin D, Gouitaa M, Dron-Gonzalvez M, et al. Immunotherapy with an aluminum hydroxide-adsorbed Juniperus ashei foreign pollen extract in seasonal indigenous cypress pollen rhinoconjunctivitis. A double-blind, placebo-controlled study. Int Arch Allergy Immunol. 2007;143(2):83-91. https://doi.org/10.1159/000098656. Powell RJ, Frew AJ, Corrigan CJ, Durham SR. Effect of grass pollen immunotherapy with Alutard SQ on quality of life in seasonal allergic rhinoconjunctivitis. Allergy. 2007;62(11):1335-1338. https://doi.org/10.1111/j.1398-9995.2007.01455.x. Alvarez-Cuesta E, Aragoneses-Gilsanz E, Martin-Garcia C, Berges-Gimeno P, Gonzalez-Mancebo E, Cuesta-Herranz J. Immunotherapy with depigmented glutaraldehyde-polymerized extracts: changes in quality of life. Clin Exp Allergy. 2005;35(5):572-578. https://doi.org/10.1111/j.1365-2222.2005.02245.x. Dokic D, Schnitker J, Narkus A, Cromwell O, Frank E. Clinical effects of specific immunotherapy: a two-year double-blind, placebo-controlled study with a one year follow-up. Prilozi. 2005;26(2):113-129. Ferrer M, Burches E, Pelaez A, et al. Double-blind, placebo-controlled study of immunotherapy with Parietaria judaica: clinical efficacy and tolerance. J Investig Allergol Clin Immunol. 2005;15(4):283-292. Tabar AI, Echechipia S, Garcia BE, et al. Double-blind comparative study of cluster and conventional immunotherapy schedules with Dermatophagoides pteronyssinus. J Allergy Clin Immunol. 2005;116(1):109-118. https://doi.org/10.1016/j.jaci.2005.05.005. Crimi N, Li Gotti F, Mangano G, et al. A randomized, controlled study of specific immunotherapy in monosensitized subjects with seasonal rhinitis: effect on bronchial hyperresponsiveness, sputum inflammatory markers and development of asthma symptoms. Ann Ital Med Int. 2004;19(2):98-108. Mirone C, Albert F, Tosi A, et al. Efficacy and safety of subcutaneous immunotherapy with a biologically standardized extract of Ambrosia artemisiifolia pollen: a double-blind, placebo-controlled study. Clin Exp Allergy. 2004;34(9):1408-1414. https://doi.org/10.1111/j.1365-2222.2004.02056.x. Varney VA, Tabbah K, Mavroleon G, Frew AJ. Usefulness of specific immunotherapy in patients with severe perennial allergic rhinitis induced by house dust mite: a double-blind, randomized, placebo-controlled trial. Clin Exp Allergy. 2003;33(8):1076-1082. https://doi.org/10.1046/j.1365-2222.2003.01735.x. Arvidsson MB, Lowhagen O, Rak S. Effect of 2-year placebo-controlled immunotherapy on airway symptoms and medication in patients with birch pollen allergy. J Allergy Clin Immunol. 2002;109(5):777-783. https://doi.org/10.1067/mai.2002.123868. Bodtger U, Poulsen LK, Jacobi HH, Malling HJ. The safety and efficacy of subcutaneous birch pollen immunotherapy - a one-year, randomised, double-blind, placebo-controlled study. Allergy. 2002;57(4):297-305. https://doi.org/10.1034/j.1398-9995.2002.1o3532.x. Drachenberg K, Heinzkill M, Urban E. Short-term immunotherapy with tree pollen allergoids and the adjuvant monophosphoryl lipid-A - results from a multicentre, placebo-controlled, randomised, double-blind study. [Kurzzeit-Immuntherapie mit Baumpollen - Allergoiden und dem Adjuvans Monophosphoryl Lipid-A: Ergebnisse einer randomisierten, doppelblinden, plazebokontrollierten Multicenterstudie]. Allergologie. 2002;25:466-474. Leynadier F, Banoun L, Dollois B, et al. Immunotherapy with a calcium phosphate-adsorbed five-grass-pollen extract in seasonal rhinoconjunctivitis: a double-blind, placebo-controlled study. Clin Exp Allergy. 2001;31(7):988-996. https://doi.org/10.1046/j.1365-2222.2001.01145.x. Walker SM, Pajno GB, Lima MT, Wilson DR, Durham SR. Grass pollen immunotherapy for seasonal rhinitis and asthma: a randomized, controlled trial. J Allergy Clin Immunol. 2001;107(1):87-93. https://doi.org/10.1067/mai.2001.112027. Balda BR, Wolf H, Baumgarten C, et al. Tree-pollen allergy is efficiently treated by short-term immunotherapy (STI) with seven preseasonal injections of molecular standardized allergens. Allergy. 1998;53(8):740-748. https://doi.org/10.1111/j.1398-9995.1998.tb03969.x. Zenner HP, Baumgarten C, Rasp G, et al. Short-term immunotherapy: a prospective, randomized, double-blind, placebo-controlled multicenter study of molecular standardized grass and rye allergens in patients with grass pollen-induced allergic rhinitis. J Allergy Clin Immunol. 1997;100(1):23-29. https://doi.org/10.1016/s0091-6749(97)70190-8. Olsen OT, Frolund L, Heinig J, Jacobsen L, Svendsen UG. A double-blind, randomized study investigating the efficacy and specificity of immunotherapy with Artemisia vulgaris or Phleum pratense/betula verrucosa. Allergol Immunopathol (Madr). 1995;23(2):73-78. Ortolani C, Pastorello EA, Incorvaia C, et al. A double-blind, placebo-controlled study of immunotherapy with an alginate-conjugated extract of Parietaria judaica in patients with Parietaria hay fever. Allergy. 1994;49(1):13-21. https://doi.org/10.1111/j.1398-9995.1994.tb00767.x. Pastorello EA, Pravettoni V, Incorvaia C, et al. Clinical and immunological effects of immunotherapy with alum-absorbed grass allergoid in grass-pollen-induced hay fever. Allergy. 1992;47(4 pt 1):281-290. https://doi.org/10.1111/j.1398-9995.1992.tb02054.x. Varney VA, Gaga M, Frew AJ, Aber VR, Kay AB, Durham SR. Usefulness of immunotherapy in patients with severe summer hay fever uncontrolled by antiallergic drugs. BMJ. 1991;302(6771):265-269. https://doi.org/10.1136/bmj.302.6771.265. Grammer LC, Shaughnessy MA, Suszko IM, Shaughnessy JJ, Patterson R. A double-blind histamine placebo-controlled trial of polymerized whole grass for immunotherapy of grass allergy. J Allergy Clin Immunol. 1983;72(5 pt 1):448-453. https://doi.org/10.1016/0091-6749(83)90580-8. Weyer A, Donat N, L'Heritier C, et al. Grass pollen hyposensitization versus placebo therapy. I. Clinical effectiveness and methodological aspects of a pre-seasonal course of desensitization with a four-grass pollen extract. Allergy. 1981;36(5):309-317. https://doi.org/10.1111/j.1398-9995.1981.tb01582.x. Moreno V, Alvarino M, Rodriguez F, et al. Randomized dose-response study of subcutaneous immunotherapy with a Dermatophagoides pteronyssinus extract in patients with respiratory allergy. Immunotherapy. 2016;8(3):265-77. https://doi.org/10.2217/imt.15.124. Pfaar O, Urry Z, Robinson DS, et al. A randomized placebo-controlled trial of rush preseasonal depigmented polymerized grass pollen immunotherapy. Allergy. 2012;67(2):272-279. https://doi.org/10.1111/j.1398-9995.2011.02736.x. DuBuske LM, Frew AJ, Horak F, et al. Ultrashort-specific immunotherapy successfully treats seasonal allergic rhinoconjunctivitis to grass pollen. Allergy Asthma Proc. 2011;32(3):239-247. https://doi.org/10.2500/aap.2011.32.3453. Ceuppens JL, Bullens D, Kleinjans H, van der Werf J, Group PBES. Immunotherapy with a modified birch pollen extract in allergic rhinoconjunctivitis: clinical and immunological effects. Clin Exp Allergy. 2009;39(12):1903-1909. https://doi.org/10.1111/j.1365-2222.2009.03379.x. Chakraborty P, Roy I, Chatterjee S, Chanda S, Gupta-Bharracharya S. Phoenix sylvestris Roxb pollen allergy: a 2-year randomized controlled trial and follow-up study of immunotherapy in patients with seasonal allergy in an agricultural area of West Bengal, India. J Investig Allergol Clin Immunol. 2006;16(6):377-384. Frew AJ, Powell RJ, Corrigan CJ, Durham SR, Group UKIS. Efficacy and safety of specific immunotherapy with SQ allergen extract in treatment-resistant seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006;117(2):319-325. https://doi.org/10.1016/j.jaci.2005.11.014. Rak S, Heinrich C, Jacobsen L, Scheynius A, Venge P. A double-blinded, comparative study of the effects of short preseason specific immunotherapy and topical steroids in patients with allergic rhinoconjunctivitis and asthma. J Allergy Clin Immunol. 2001;108(6):921-928. https://doi.org/10.1067/mai.2001.119743. Ariano R, Kroon AM, Augeri G, Canonica GW, Passalacqua G. Long-term treatment with allergoid immunotherapy with Parietaria. Clinical and immunologic effects in a randomized, controlled trial. Allergy. 1999;54(4):313-319. https://doi.org/10.1034/j.1398-9995.1999.00900.x. Tari MG, Mancino M, Ghezzi E, Frank E, Cromwell O. Immunotherapy with an alum-adsorbed Parietaria-pollen allergoid: a 2-year, double-blind, placebo-controlled study. Allergy. 1997;52(1):65-74. https://doi.org/10.1111/j.1398-9995.1997.tb02547.x. Dolz I, Martinez-Cocera C, Bartolome JM, Cimarra M. A double-blind, placebo-controlled study of immunotherapy with grass-pollen extract Alutard SQ during a 3-year period with initial rush immunotherapy. Allergy. 1996;51(7):489-500. https://doi.org/10.1111/j.1398-9995.1996.tb04655.x. Brunet C, Bedard PM, Lavoie A, Jobin M, Hebert J. Allergic rhinitis to ragweed pollen. I. Reassessment of the effects of immunotherapy on cellular and humoral responses. J Allergy Clin Immunol. 1992;89(1 pt 1):76-86. https://doi.org/10.1016/s0091-6749(05)80043-0. Bousquet J, Becker WM, Hejjaoui A, et al. Differences in clinical and immunologic reactivity of patients allergic to grass pollens and to multiple-pollen species. II. Efficacy of a double-blind, placebo-controlled, specific immunotherapy with standardized extracts. J Allergy Clin Immunol. 1991;88(1):43-53. https://doi.org/10.1016/0091-6749(91)90299-4. Iliopoulos O, Proud D, Adkinson Jr NF, et al. Effects of immunotherapy on the early, late, and rechallenge nasal reaction to provocation with allergen: changes in inflammatory mediators and cells. J Allergy Clin Immunol. 1991;87(4):855-866. https://doi.org/10.1016/0091-6749(91)90134-a. Fell P, Brostoff J. A single dose desensitization for summer hay fever. Results of a double blind study-1988. Eur J Clin Pharmacol. 1990;38(1):77-79. https://doi.org/10.1007/BF00314808. Horst M, Hejjaoui A, Horst V, Michel FB, Bousquet J. Double-blind, placebo-controlled rush immunotherapy with a standardized Alternaria extract. J Allergy Clin Immunol. 1990;85(2):460-472. https://doi.org/10.1016/0091-6749(90)90156-x. Juniper EF, Kline PA, Ramsdale EH, Hargreave FE. Comparison of the efficacy and side effects of aqueous steroid nasal spray (budesonide) and allergen-injection therapy (Pollinex-R) in the treatment of seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 1990;85(3):606-611. https://doi.org/10.1016/0091-6749(90)90100-i. Ewan PW, Alexander MM, Snape C, Ind PW, Agrell B, Dreborg S. Effective hyposensitization in allergic rhinitis using a potent partially purified extract of house dust mite. Clin Allergy. 1988;18(5):501-508. https://doi.org/10.1111/j.1365-2222.1988.tb02900.x. Bousquet J, Hejjaoui A, Skassa-Brociek W, et al. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. I. Rush immunotherapy with allergoids and standardized orchard grass-pollen extract. J Allergy Clin Immunol. 1987;80(4):591-598. https://doi.org/10.1016/0091-6749(87)90013-3. Grammer LC, Shaughnessy MA, Bernhard MI, et al. The safety and activity of polymerized ragweed: a double-blind, placebo-controlled trial in 81 patients with ragweed rhinitis. J Allergy Clin Immunol. 1987;80(2):177-183. https://doi.org/10.1016/0091-6749(87)90127-8. Grammer LC, Shaughnessy MA, Suszko IM, Shaughnessy JJ, Patterson R. Persistence of efficacy after a brief course of polymerized ragweed allergen: a controlled study. J Allergy Clin Immunol. 1984;73(4):484-489. https://doi.org/10.1016/0091-6749(84)90359-2. Metzger WJ, Dorminey HC, Richerson HB, Weiler JM, Donnelly A, Moran D. Clinical and immunologic evaluation of glutaraldehyde-modified tyrosine-adsorbed short ragweed extract: a double-blind, placebo-controlled trial. J Allergy Clin Immunol. 1981;68(6):442-448. https://doi.org/10.1016/0091-6749(81)90198-6. Cox L. Accelerated immunotherapy schedules: review of efficacy and safety. Ann Allergy Asthma Immunol. 2006;97(2):126-137; quiz 137-140, 202. https://doi.org/10.1016/S1081-1206(10)60003-8. More DR, Hagan LL. Factors affecting compliance with allergen immunotherapy at a military medical center. Ann Allergy Asthma Immunol. 2002;88(4):391-394. https://doi.org/10.1016/S1081-1206(10)62370-8. Pfaar O, Biedermann T, Klimek L, Sager A, Robinson DS. Depigmented-polymerized mixed grass/birch pollen extract immunotherapy is effective in polysensitized patients. Allergy. 2013;68(10):1306-1313. https://doi.org/10.1111/all.12219. Klunker S, Saggar LR, Seyfert-Margolis V, et al. Combination treatment with omalizumab and rush immunotherapy for ragweed-induced allergic rhinitis: Inhibition of IgE-facilitated allergen binding. J Allergy Clin Immunol. 2007;120(3):688-695. https://doi.org/10.1016/j.jaci.2007.05.034. Morais-Almeida M, Arede C, Sampaio G, Borrego LM. Ultrarush schedule of subcutaneous immunotherapy with modified allergen extracts is safe in paediatric age. Asia Pac Allergy. 2016;6(1):35-42. https://doi.org/10.5415/apallergy.2016.6.1.35. Akmanlar N, Altintas DU, Guneser KS, Yilmaz M, Bingol G. Comparison of conventional and rush immunotherapy with der PI in childhood respiratory allergy. Allergol Immunopathol (Madr). 2000;28(4):213-218. Lilja G, Sundin B, Graff-Lonnevig V, et al. Immunotherapy with cat- and dog-dander extracts. IV. Effects of 2 years of treatment. J Allergy Clin Immunol. 1989;83(1):37-44. https://doi.org/10.1016/0091-6749(89)90475-2. Bousquet J, Hejjaoui A, Dhivert H, Clauzel AM, Michel FB. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. Systemic reactions during the rush protocol in patients suffering from asthma. J Allergy Clin Immunol. 1989;83(4):797-802. https://doi.org/10.1016/0091-6749(89)90017-1. Winslow AW, Turbyville JC, Sublett JW, Sublett JL, Pollard SJ. Comparison of systemic reactions in rush, cluster, and standard-build aeroallergen immunotherapy. Ann Allergy Asthma Immunol. 2016;117(5):542-545. https://doi.org/10.1016/j.anai.2016.09.005. Casanovas M, Martin R, Jimenez C, Caballero R, Fernandez-Caldas E. Safety of an ultra-rush immunotherapy build-up schedule with therapeutic vaccines containing depigmented and polymerized allergen extracts. Int Arch Allergy Immunol. 2006;139(2):153-158. https://doi.org/10.1159/000090392. Cook KA, Kelso JM, White AA. Increased risk of systemic reactions extends beyond completion of rush immunotherapy. J Allergy Clin Immunol Pract. 2017;5(6):1773-1775. https://doi.org/10.1016/j.jaip.2017.04.015. Portnoy J, Bagstad K, Kanarek H, Pacheco F, Hall B, Barnes C. Premedication reduces the incidence of systemic reactions during inhalant rush immunotherapy with mixtures of allergenic extracts. Ann Allergy. 1994;73(5):409-418. Hejjaoui A, Dhivert H, Michel FB, Bousquet J. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. IV. Systemic reactions according to the immunotherapy schedule. J Allergy Clin Immunol. 1990;85(2):473-479. https://doi.org/10.1016/0091-6749(90)90157-y. Feng S, Xu Y, Ma R, Sun Y, Luo X, Li H. Cluster subcutaneous allergen specific immunotherapy for the treatment of allergic rhinitis: a systematic review and meta-analysis. PLoS One. 2014;9(1):e86529. https://doi.org/10.1371/journal.pone.0086529. Jiang Z, Xiao H, Zhang H, Liu S, Meng J. Comparison of adverse events between cluster and conventional immunotherapy for allergic rhinitis patients with or without asthma: A systematic review and meta-analysis. Am J Otolaryngol. 2019;40(6):102269. https://doi.org/10.1016/j.amjoto.2019.07.013. Fan Q, Liu X, Gao J, Huang S, Ni L. Comparative analysis of cluster versus conventional immunotherapy in patients with allergic rhinitis. Exp Ther Med. 2017;13(2):717-722. https://doi.org/10.3892/etm.2017.4032. Nanda A, O'Connor M, Anand M, et al. Dose dependence and time course of the immunologic response to administration of standardized cat allergen extract. J Allergy Clin Immunol. 2004;114(6):1339-1344. https://doi.org/10.1016/j.jaci.2004.08.049. Subiza J, Feliu A, Subiza JL, Uhlig J, Fernandez-Caldas E. Cluster immunotherapy with a glutaraldehyde-modified mixture of grasses results in an improvement in specific nasal provocation tests in less than 2.5 months of treatment. Clin Exp Allergy. 2008;38(6):987-994. https://doi.org/10.1111/j.1365-2222.2008.02995.x. Yu J, Zhong N, Luo Q, et al. Early efficacy analysis of cluster and conventional immunotherapy in patients with allergic rhinitis. Ear Nose Throat J. 2021;100(5):378-385. https://doi.org/10.1177/0145561319863370. Zhang L, Wang C, Han D, Wang X, Zhao Y, Liu J. Comparative study of cluster and conventional immunotherapy schedules with dermatophagoides pteronyssinus in the treatment of persistent allergic rhinitis. Int Arch Allergy Immunol. 2009;148(2):161-169. https://doi.org/10.1159/000155747. Wang CS, Zhang W, Wang XD, et al. [Comparative study on cluster and conventional immunotherapy with Dermatophagoides pteronyssinus in patients with allergic rhinitis]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2011;46(12):981-985. Cook KA, Ford CM, Leyvas EA, Waalen J, White AA. Half of systemic reactions to allergen immunotherapy are delayed, majority require treatment with epinephrine. J Allergy Clin Immunol Pract. 2017;5(5):1415-1417. https://doi.org/10.1016/j.jaip.2017.03.025. Nielsen L, Johnsen CR, Mosbech H, Poulsen LK, Malling HJ. Antihistamine premedication in specific cluster immunotherapy: a double-blind, placebo-controlled study. J Allergy Clin Immunol. 1996;97(6):1207-1213. https://doi.org/10.1016/s0091-6749(96)70186-0. Larenas Linnemann DE. One hundred years of immunotherapy: review of the first landmark studies. Allergy Asthma Proc. 2012;33(2):122-128. https://doi.org/10.2500/aap.2012.33.3515. Scadding GK, Brostoff J. Low dose sublingual therapy in patients with allergic rhinitis due to house dust mite. Clin Allergy. 1986;16(5):483-491. https://doi.org/10.1111/j.1365-2222.1986.tb01983.x. Durham SR, Yang WH, Pedersen MR, Johansen N, Rak S. Sublingual immunotherapy with once-daily grass allergen tablets: a randomized controlled trial in seasonal allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2006;117(4):802-809. https://doi.org/10.1016/j.jaci.2005.12.1358. Didier A, Malling HJ, Worm M, et al. Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5-grass pollen tablet for seasonal allergic rhinitis. J Allergy Clin Immunol. 2007;120(6):1338-1345. https://doi.org/10.1016/j.jaci.2007.07.046. Calderon MA. Meta-analyses of specific immunotherapy trials. Drugs Today (Barc). 2008;44(suppl B):31-34. Cohen J. Statistical Power Analysis for the Behavioral Scienes. 2nd ed. Lawrence Erlbaum Associates; 1988. de Bot CM, Moed H, Berger MY, Roder E, van Wijk RG, van der Wouden JC. Sublingual immunotherapy in children with allergic rhinitis: quality of systematic reviews. Pediatr Allergy Immunol. 2011;22(6):548-558. https://doi.org/10.1111/j.1399-3038.2011.01165.x. Kim JM, Lin SY, Suarez-Cuervo C, et al. Allergen-specific immunotherapy for pediatric asthma and rhinoconjunctivitis: a systematic review. Pediatrics. 2013;131(6):1155-1167. https://doi.org/10.1542/peds.2013-0343. Larenas-Linnemann D, Blaiss M, Van Bever HP, Compalati E, Baena-Cagnani CE. Pediatric sublingual immunotherapy efficacy: evidence analysis, 2009-2012. Ann Allergy Asthma Immunol. 2013;110(6):402-415.e9. https://doi.org/10.1016/j.anai.2013.02.017. Chen L, Lei L, Cai Y, Li T. Specific sublingual immunotherapy in children with perennial rhinitis: a systemic review and meta-analysis. Int Forum Allergy Rhinol. 2020;10(11):1226-1235. https://doi.org/10.1002/alr.22589. Feng B, Wu J, Chen B, et al. Efficacy and safety of sublingual immunotherapy for allergic rhinitis in pediatric patients: a meta-analysis of randomized controlled trials. Am J Rhinol Allergy. 2017;31(1):27-35. https://doi.org/10.2500/ajra.2017.31.4382. Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Di Lorenzo G. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis-based comparison. J Allergy Clin Immunol. 2012;130(5):1097-1107.e2. https://doi.org/10.1016/j.jaci.2012.08.012. Nelson H, Cartier S, Allen-Ramey F, Lawton S, Calderon MA. Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy. J Allergy Clin Immunol Pract. 2015;3(2):256-266.e3. https://doi.org/10.1016/j.jaip.2014.09.018. Dranitsaris G, Ellis AK. Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost. J Eval Clin Pract. 2014;20(3):225-238. https://doi.org/10.1111/jep.12112. Chelladurai Y, Suarez-Cuervo C, Erekosima N, et al. Effectiveness of subcutaneous versus sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. J Allergy Clin Immunol Pract. 2013;1(4):361-369. https://doi.org/10.1016/j.jaip.2013.04.005. Aasbjerg K, Dalhoff KP, Backer V. Adverse events during immunotherapy against grass pollen-induced allergic rhinitis - differences between subcutaneous and sublingual treatment. Basic Clin Pharmacol Toxicol. 2015;117(2):73-84. https://doi.org/10.1111/bcpt.12416. Calderon MA, Casale TB, Nelson HS, Demoly P. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies. J Allergy Clin Immunol. 2013;132(6):1322-1336. https://doi.org/10.1016/j.jaci.2013.09.004. Ji DX, Tan JR, Yu HW. [Efficacy, safety and compliance of immunotherapy in the treatment of allergic rhinitis: a Meta-analysis]. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2019;54(12):894-901. https://doi.org/10.3760/cma.j.issn.1673-0860.2019.12.003. Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Macchia L, Di Lorenzo G. Efficacy of allergen immunotherapy in reducing the likelihood of developing new allergen sensitizations: a systematic review. Allergy. 2017;72(5):691-704. https://doi.org/10.1111/all.13104. Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Di Lorenzo G. Efficacy of grass pollen allergen sublingual immunotherapy tablets for seasonal allergic rhinoconjunctivitis: a systematic review and meta-analysis. JAMA Intern Med. 2015;175(8):1301-1309. https://doi.org/10.1001/jamainternmed.2015.2840. de Groot H, Bijl A. Anaphylactic reaction after the first dose of sublingual immunotherapy with grass pollen tablet. Allergy. 2009;64(6):963-964. https://doi.org/10.1111/j.1398-9995.2009.01998.x. Cochard MM, Eigenmann PA. Sublingual immunotherapy is not always a safe alternative to subcutaneous immunotherapy. J Allergy Clin Immunol. 2009;124(2):378-379. https://doi.org/10.1016/j.jaci.2009.04.040. Janssens NS, van Ouwerkerk L, Gerth van Wijk R, Karim F. Acute systemic reactions to sublingual immunotherapy for house dust mite. Allergy. 2020;75(11):2962-2963. https://doi.org/10.1111/all.14417. Creticos PS, Bernstein DI, Casale TB, Lockey RF, Maloney J, Nolte H. Coseasonal initiation of allergen immunotherapy: a systematic review. J Allergy Clin Immunol Pract. 2016;4(6):1194-1204.e4. https://doi.org/10.1016/j.jaip.2016.05.014. Maloney J, Durham S, Skoner D, et al. Safety of sublingual immunotherapy Timothy grass tablet in subjects with allergic rhinitis with or without conjunctivitis and history of asthma. Allergy. 2015;70(3):302-309. https://doi.org/10.1111/all.12560. Makatsori M, Scadding GW, Lombardo C, et al. Dropouts in sublingual allergen immunotherapy trials - a systematic review. Allergy. 2014;69(5):571-580. https://doi.org/10.1111/all.12385. Cafone J, Capucilli P, Hill DA, Spergel JM. Eosinophilic esophagitis during sublingual and oral allergen immunotherapy. Curr Opin Allergy Clin Immunol. 2019;19(4):350-357. https://doi.org/10.1097/ACI.0000000000000537. Oykhman P, Kim HL, Ellis AK. Allergen immunotherapy in pregnancy. Allergy Asthma Clin Immunol. 2015;11:31. https://doi.org/10.1186/s13223-015-0096-7. Larenas-Linnemann D. How does the efficacy and safety of Oralair((R)) compare to other products on the market? Ther Clin Risk Manag. 2016;12:831-850. https://doi.org/10.2147/TCRM.S70363. Larenas-Linnemann D. Direct comparison of efficacy of sublingual immunotherapy tablets for rhinoconjunctivitis. Ann Allergy Asthma Immunol. 2016;116(4):274-286. https://doi.org/10.1016/j.anai.2016.02.008. Meadows A, Kaambwa B, Novielli N, et al. A systematic review and economic evaluation of subcutaneous and sublingual allergen immunotherapy in adults and children with seasonal allergic rhinitis. Health Technol Assess. 2013;17(27):1-322, vi, xi-xiv, https://doi.org/10.3310/hta17270. Asaria M, Dhami S, van Ree R, et al. Health economic analysis of allergen immunotherapy for the management of allergic rhinitis, asthma, food allergy and venom allergy: a systematic overview. Allergy. 2018;73(2):269-283. https://doi.org/10.1111/all.13254. Yonekura S, Gotoh M, Kaneko S, Maekawa Y, Okubo K, Okamoto Y. Disease-modifying effect of Japanese cedar pollen sublingual immunotherapy tablets. J Allergy Clin Immunol Pract. 2021;9(11):4103-4116.e14. https://doi.org/10.1016/j.jaip.2021.06.060. Nolte H, Waserman S, Ellis AK, Biedermann T, Wurtzen PA. Treatment effect of the tree pollen SLIT-tablet on allergic rhinoconjunctivitis during oak pollen season. J Allergy Clin Immunol Pract. 2021;9(5):1871-1878. https://doi.org/10.1016/j.jaip.2021.01.035. Kim JY, Hwang D, Jang M, Rhee CS, Han DH. Clinical effectiveness of house dust mite immunotherapy in mono- versus poly-sensitised patients with allergic rhinitis: a systematic review and meta-analysis. Rhinology. 2021;59(4):352-359. https://doi.org/10.4193/Rhin20.588. Boldovjakova D, Cordoni S, Fraser CJ, et al. Sublingual immunotherapy vs placebo in the management of grass pollen-induced allergic rhinitis in adults: a systematic review and meta-analysis. Clin Otolaryngol. 2021;46(1):52-59. https://doi.org/10.1111/coa.13651. Blanco C, Bazire R, Argiz L, Hernandez-Pena J. Sublingual allergen immunotherapy for respiratory allergy: a systematic review. Drugs Context. 2018;7:212552. https://doi.org/10.7573/dic.212552. Radulovic S, Wilson D, Calderon M, Durham S. Systematic reviews of sublingual immunotherapy (SLIT). Allergy. 2011;66(6):740-752. https://doi.org/10.1111/j.1398-9995.2011.02583.x. Di Bona D, Plaia A, Scafidi V, Leto-Barone MS, Di Lorenzo G. Efficacy of sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a systematic review and meta-analysis. J Allergy Clin Immunol. 2010;126(3):558-566. https://doi.org/10.1016/j.jaci.2010.06.013. Lin SY, Erekosima N, Kim JM, et al. Sublingual immunotherapy for the treatment of allergic rhinoconjunctivitis and asthma: a systematic review. JAMA. 2013;309(12):1278-1288. https://doi.org/10.1001/jama.2013.2049. Ortiz AS, McMains KC, Laury AM. Single vs multiallergen sublingual immunotherapy in the polysensitized patient: a pilot study. Int Forum Allergy Rhinol. 2018;8(4):490-494. https://doi.org/10.1002/alr.22071. Li P, Li Q, Huang Z, Chen W, Lu Y, Tian M. Efficacy and safety of house dust mite sublingual immunotherapy in monosensitized and polysensitized children with respiratory allergic diseases. Int Forum Allergy Rhinol. 2014;4(10):796-801. https://doi.org/10.1002/alr.21397. Amar SM, Harbeck RJ, Sills M, Silveira LJ, O'Brien H, Nelson HS. Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract. J Allergy Clin Immunol. 2009;124(1):150-156.e1-5. https://doi.org/10.1016/j.jaci.2009.04.037. Moreno-Ancillo A, Moreno C, Ojeda P, et al. Efficacy and quality of life with once-daily sublingual immunotherapy with grasses plus olive pollen extract without updosing. J Investig Allergol Clin Immunol. 2007;17(6):399-405. Lee JE, Choi YS, Kim MS, et al. Efficacy of sublingual immunotherapy with house dust mite extract in polyallergen sensitized patients with allergic rhinitis. Ann Allergy Asthma Immunol. 2011;107(1):79-84. https://doi.org/10.1016/j.anai.2011.03.012. Li Y, Yu SY, Tang R, Zhao ZT, Sun JL. Sublingual immunotherapy tablets relieve symptoms in adults with allergic rhinitis: a meta-analysis of randomized clinical trials. Chin Med J (Engl). 2018;131(21):2583-2588. https://doi.org/10.4103/0366-6999.244108. Roder E, Berger MY, de Groot H, van Wijk RG. Immunotherapy in children and adolescents with allergic rhinoconjunctivitis: a systematic review. Pediatr Allergy Immunol. 2008;19(3):197-207. https://doi.org/10.1111/j.1399-3038.2007.00648.x. Dretzke J, Meadows A, Novielli N, Huissoon A, Fry-Smith A, Meads C. Subcutaneous and sublingual immunotherapy for seasonal allergic rhinitis: a systematic review and indirect comparison. J Allergy Clin Immunol. 2013;131(5):1361-1366. https://doi.org/10.1016/j.jaci.2013.02.013. Durham SR, Emminger W, Kapp A, et al. SQ-standardized sublingual grass immunotherapy: confirmation of disease modification 2 years after 3 years of treatment in a randomized trial. J Allergy Clin Immunol. 2012;129(3):717-725.e5. https://doi.org/10.1016/j.jaci.2011.12.973. Didier A, Malling HJ, Worm M, Horak F, Sussman GL. Prolonged efficacy of the 300IR 5-grass pollen tablet up to 2 years after treatment cessation, as measured by a recommended daily combined score. Clin Transl Allergy. 2015;5:12. https://doi.org/10.1186/s13601-015-0057-8. Valovirta E, Jacobsen L, Ljorring C, Koivikko A, Savolainen J. Clinical efficacy and safety of sublingual immunotherapy with tree pollen extract in children. Allergy. 2006;61(10):1177-1183. https://doi.org/10.1111/j.1398-9995.2006.01190.x. Nolte H, Hebert J, Berman G, et al. Randomized controlled trial of ragweed allergy immunotherapy tablet efficacy and safety in North American adults. Ann Allergy Asthma Immunol. 2013;110(6):450-456.e4. https://doi.org/10.1016/j.anai.2013.03.013. Creticos PS, Maloney J, Bernstein DI, et al. Randomized controlled trial of a ragweed allergy immunotherapy tablet in North American and European adults. J Allergy Clin Immunol. 2013;131(5):1342-1349.e6. https://doi.org/10.1016/j.jaci.2013.03.019. Skoner D, Gentile D, Bush R, Fasano MB, McLaughlin A, Esch RE. Sublingual immunotherapy in patients with allergic rhinoconjunctivitis caused by ragweed pollen. J Allergy Clin Immunol. 2010;125(3):660-666, 666.e1-666.e4. https://doi.org/10.1016/j.jaci.2009.12.931. Bergmann KC, Demoly P, Worm M, et al. Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis. J Allergy Clin Immunol. 2014;133(6):1608-1614.e6. https://doi.org/10.1016/j.jaci.2013.11.012. Cortellini G, Spadolini I, Patella V, et al. Sublingual immunotherapy for Alternaria-induced allergic rhinitis: a randomized placebo-controlled trial. Ann Allergy Asthma Immunol. 2010;105(5):382-386. https://doi.org/10.1016/j.anai.2010.08.007. Horak F, Jaeger S, Worm M, Melac M, Didier A. Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment. Clin Exp Allergy. 2009;39(3):394-400. https://doi.org/10.1111/j.1365-2222.2008.03153.x. Malling HJ, Montagut A, Melac M, et al. Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis. Clin Exp Allergy. 2009;39(3):387-393. https://doi.org/10.1111/j.1365-2222.2008.03152.x. Gotoh M, Okubo K, Yuta A, et al. Safety profile and immunological response of dual sublingual immunotherapy with house dust mite tablet and Japanese cedar pollen tablet. Allergol Int. 2020;69(1):104-110. https://doi.org/10.1016/j.alit.2019.07.007. Leatherman BD, Khalid A, Lee S, et al. Dosing of sublingual immunotherapy for allergic rhinitis: evidence-based review with recommendations. Int Forum Allergy Rhinol. 2015;5(9):773-783. https://doi.org/10.1002/alr.21561. Jin JJ, Li JT, Klimek L, Pfaar O. Sublingual immunotherapy dosing regimens: what is ideal? J Allergy Clin Immunol Pract. 2017;5(1):1-10. https://doi.org/10.1016/j.jaip.2016.09.027. Marogna M, Spadolini I, Massolo A, et al. Effects of sublingual immunotherapy for multiple or single allergens in polysensitized patients. Ann Allergy Asthma Immunol. 2007;98(3):274-280. https://doi.org/10.1016/S1081-1206(10)60718-1. Pfaar O, Nell MJ, Boot JD, et al. A randomized, 5-arm dose finding study with a mite allergoid SCIT in allergic rhinoconjunctivitis patients. Allergy. 2016;71(7):967-976. https://doi.org/10.1111/all.12860. Bozek A, Ignasiak B, Filipowska B, Jarzab J. House dust mite sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with allergic rhinitis. Clin Exp Allergy. 2013;43(2):242-248. https://doi.org/10.1111/cea.12039. Didier A, Melac M, Montagut A, Lheritier-Barrand M, Tabar A, Worm M. Agreement of efficacy assessments for five-grass pollen sublingual tablet immunotherapy. Allergy. 2009;64(1):166-171. https://doi.org/10.1111/j.1398-9995.2008.01767.x. Saporta D. Efficacy of sublingual immunotherapy versus subcutaneous injection immunotherapy in allergic patients. J Environ Public Health. 2012;2012:492405. https://doi.org/10.1155/2012/492405. Tsabouri S, Mavroudi A, Feketea G, Guibas GV. Subcutaneous and sublingual immunotherapy in allergic asthma in children. Front Pediatr. 2017;5:82. https://doi.org/10.3389/fped.2017.00082. Dhami S, Kakourou A, Asamoah F, et al. Allergen immunotherapy for allergic asthma: A systematic review and meta-analysis. Allergy. 2017;72(12):1825-1848. https://doi.org/10.1111/all.13208. Rice JL, Diette GB, Suarez-Cuervo C, et al. Allergen-specific immunotherapy in the treatment of pediatric asthma: a systematic review. Pediatrics. 2018;141(5):e20173833. https://doi.org/10.1542/peds.2017-3833. Epstein TG, Calabria C, Cox LS, Dreborg S. Current Evidence on safety and practical considerations for administration of sublingual allergen immunotherapy (SLIT) in the United States. J Allergy Clin Immunol Pract. 2017;5(1):34-40.e2. https://doi.org/10.1016/j.jaip.2016.09.017. Seiberling K, Hiebert J, Nyirady J, Lin S, Chang D. Cost of allergy immunotherapy: sublingual vs subcutaneous administration. Int Forum Allergy Rhinol. 2012;2(6):460-464. https://doi.org/10.1002/alr.21061. Reinhold T, Bruggenjurgen B. Cost-effectiveness of grass pollen SCIT compared with SLIT and symptomatic treatment. Allergo J Int. 2017;26(1):7-15. https://doi.org/10.1007/s40629-016-0002-y. Drazdauskaite G, Layhadi JA, Shamji MH. Mechanisms of allergen immunotherapy in allergic rhinitis. Curr Allergy Asthma Rep. 2020;21(1):2. https://doi.org/10.1007/s11882-020-00977-7. Pfaar O, Bachert C, Bufe A, et al. Guideline on allergen-specific immunotherapy in IgE-mediated allergic diseases: S2k Guideline of the German Society for Allergology and Clinical Immunology (DGAKI), the Society for Pediatric Allergy and Environmental Medicine (GPA), the Medical Association of German Allergologists (AeDA), the Austrian Society for Allergy and Immunology (OGAI), the Swiss Society for Allergy and Immunology (SGAI), the German Society of Dermatology (DDG), the German Society of Oto- Rhino-Laryngology, Head and Neck Surgery (DGHNO-KHC), the German Society of Pediatrics and Adolescent Medicine (DGKJ), the Society for Pediatric Pneumology (GPP), the German Respiratory Society (DGP), the German Association of ENT Surgeons (BV-HNO), the Professional Federation of Paediatricians and Youth Doctors (BVKJ), the Federal Association of Pulmonologists (BDP) and the German Dermatologists Association (BVDD). Allergo J Int. 2014;23(8):282-319. https://doi.org/10.1007/s40629-014-0032-2. Ott H, Sieber J, Brehler R, et al. Efficacy of grass pollen sublingual immunotherapy for three consecutive seasons and after cessation of treatment: the ECRIT study. Allergy. 2009;64(9):1394-1401. https://doi.org/10.1111/j.1398-9995.2009.02194.x. Naclerio RM, Proud D, Moylan B, et al. A double-blind study of the discontinuation of ragweed immunotherapy. J Allergy Clin Immunol. 1997;100(3):293-300. https://doi.org/10.1016/s0091-6749(97)70240-9. Cox LS, Hankin C, Lockey R. Allergy immunotherapy adherence and delivery route: location does not matter. J Allergy Clin Immunol Pract. 2014;2(2):156-160. https://doi.org/10.1016/j.jaip.2014.01.010. Vita D, Caminiti L, Ruggeri P, Pajno GB. Sublingual immunotherapy: adherence based on timing and monitoring control visits. Allergy. 2010;65(5):668-669. https://doi.org/10.1111/j.1398-9995.2009.02223.x. Hura N, Song S, Kamil RJ, Pierre G, Lin SY. Predictors of completion of sublingual immunotherapy. Laryngoscope. 2021;131(7):E2111-E2115. https://doi.org/10.1002/lary.29272. Chaaban MR, Mansi A, Tripple JW, Wise SK. SCIT versus SLIT: which one do you recommend, doc? Am J Med Sci. 2019;357(5):442-447. https://doi.org/10.1016/j.amjms.2019.02.004. Lin CH, Alandijani S, Lockey RF. Subcutaneous versus sublingual immunotherapy. Expert Rev Clin Immunol. 2016;12(8):801-803. https://doi.org/10.1080/1744666X.2016.1196137. Borg M, Lokke A, Hilberg O. Compliance in subcutaneous and sublingual allergen immunotherapy: a nationwide study. Respir Med. 2020;170:106039. https://doi.org/10.1016/j.rmed.2020.106039. Gotoh M, Kaminuma O. Sublingual immunotherapy: how sublingual allergen administration heals allergic diseases; current perspective about the mode of action. Pathogens. 2021;10(2):147. https://doi.org/10.3390/pathogens10020147. Allergenics. FDA. Accessed October 29, 2021. https://www.fda.gov/vaccines-blood-biologics/allergenics. Creticos PS. Sublingual immunotherapy for allergic rhinoconjunctivitis and asthma. Accessed October 26, 2021. https://www.uptodate.com/contents/sublingual-immunotherapy-for-allergic-rhinoconjunctivitis-and-asthma. Nolte H, Casale TB, Lockey RF, et al. Epinephrine use in clinical trials of sublingual immunotherapy tablets. J Allergy Clin Immunol Pract. 2017;5(1):84-89.e3. https://doi.org/10.1016/j.jaip.2016.08.017. Clark S, Wei W, Rudders SA, Camargo Jr CA. Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. J Allergy Clin Immunol. 2014;134(5):1125-1130. https://doi.org/10.1016/j.jaci.2014.05.018. Des Roches A, Paradis L, Knani J, et al. Immunotherapy with a standardized Dermatophagoides pteronyssinus extract. V. Duration of the efficacy of immunotherapy after its cessation. Allergy. 1996;51(6):430-433. https://doi.org/10.1111/j.1398-9995.1996.tb04643.x. Bousquet J, Maasch H, Martinot B, Hejjaoui A, Wahl R, Michel FB. Double-blind, placebo-controlled immunotherapy with mixed grass-pollen allergoids. II. Comparison between parameters assessing the efficacy of immunotherapy. J Allergy Clin Immunol. 1988;82(3 pt 1):439-446. https://doi.org/10.1016/0091-6749(88)90017-6. Pajno GB, Vita D, Caminiti L, et al. Children's compliance with allergen immunotherapy according to administration routes. J Allergy Clin Immunol. 2005;116(6):1380-1381. https://doi.org/10.1016/j.jaci.2005.07.034. Kiel MA, Roder E, Gerth van Wijk R, Al MJ, Hop WC, Rutten-van Molken MP. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy. J Allergy Clin Immunol. 2013;132(2):353-360.e2 https://doi.org/10.1016/j.jaci.2013.03.013. Sieber J, De Geest S, Shah-Hosseini K, Mosges R. Medication persistence with long-term, specific grass pollen immunotherapy measured by prescription renewal rates. Curr Med Res Opin. 2011;27(4):855-861. https://doi.org/10.1185/03007995.2011.559538. Senna G, Ridolo E, Calderon M, Lombardi C, Canonica GW, Passalacqua G. Evidence of adherence to allergen-specific immunotherapy. Curr Opin Allergy Clin Immunol. 2009;9(6):544-548. https://doi.org/10.1097/ACI.0b013e328332b8df. Leader BA, Rotella M, Stillman L, DelGaudio JM, Patel ZM, Wise SK. Immunotherapy compliance: comparison of subcutaneous versus sublingual immunotherapy. Int Forum Allergy Rhinol. 2016;6(5):460-464. https://doi.org/10.1002/alr.21699. Creticos PS. Subcutaneous immunotherapy (SCIT) for allergic disease: indications and efficacy. Accessed October 26, 2021. https://www.uptodate.com/contents/subcutaneous-immunotherapy-scit-for-allergic-disease-indications-and-efficacy. Nelson H. Preparation of allergen extracts fro therapeutic use. Accessed October 26, 2021. https://www.uptodate.com/contents/scit-preparation-of-allergen-extracts-for-therapeutic-use. Egan M, Atkins D. What is the relationship between eosinophilic esophagitis (EoE) and aeroallergens? Implications for allergen immunotherapy. Curr Allergy Asthma Rep. 2018;18(8):43. https://doi.org/10.1007/s11882-018-0798-2. Bos JD, Meinardi MM. The 500 Dalton rule for the skin penetration of chemical compounds and drugs. Exp Dermatol. 2000;9(3):165-169. https://doi.org/10.1034/j.1600-0625.2000.009003165.x. Senti G, Kundig TM. Novel delivery routes for allergy immunotherapy: intralymphatic, epicutaneous, and intradermal. Immunol Allergy Clin North Am. 2016;36(1):25-37. https://doi.org/10.1016/j.iac.2015.08.006. Wang Y, Kong Y, Wu MX. Innovative systems to deliver allergen powder for epicutaneous immunotherapy. Front Immunol. 2021;12:647954. https://doi.org/10.3389/fimmu.2021.647954. Esposito S, Isidori C, Pacitto A, et al. Epicutaneous immunotherapy in rhino-conjunctivitis and food allergies: a review of the literature. J Transl Med. 2018;16(1):329. https://doi.org/10.1186/s12967-018-1701-6. Senti G, Graf N, Haug S, et al. Epicutaneous allergen administration as a novel method of allergen-specific immunotherapy. J Allergy Clin Immunol. 2009;124(5):997-1002. https://doi.org/10.1016/j.jaci.2009.07.019. Agostinis F, Forti S, Di Berardino F. Grass transcutaneous immunotherapy in children with seasonal rhinoconjunctivitis. Allergy. 2010;65(3):410-411. https://doi.org/10.1111/j.1398-9995.2009.02189.x. Senti G, von Moos S, Tay F, et al. Epicutaneous allergen-specific immunotherapy ameliorates grass pollen-induced rhinoconjunctivitis: a double-blind, placebo-controlled dose escalation study. J Allergy Clin Immunol. 2012;129(1):128-135. https://doi.org/10.1016/j.jaci.2011.08.036. Senti G, von Moos S, Tay F, Graf N, Johansen P, Kundig TM. Determinants of efficacy and safety in epicutaneous allergen immunotherapy: summary of three clinical trials. Allergy. 2015;70(6):707-710. https://doi.org/10.1111/all.12600. Xiong L, Lin J, Luo Y, Chen W, Dai J. The efficacy and safety of epicutaneous immunotherapy for allergic diseases: a systematic review and meta-analysis. Int Arch Allergy Immunol. 2020;181(3):170-182. https://doi.org/10.1159/000504366. Senti G, Freiburghaus AU, Larenas-Linnemann D, et al. Intralymphatic immunotherapy: update and unmet needs. Int Arch Allergy Immunol. 2019;178(2):141-149. https://doi.org/10.1159/000493647. Hoang MP, Seresirikachorn K, Chitsuthipakorn W, Snidvongs K. Intralymphatic immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Rhinology. 2021;59(3):236-244. https://doi.org/10.4193/Rhin20.572. Aini NR, Mohd Noor N, Md Daud MK, Wise SK, Abdullah B. Efficacy and safety of intralymphatic immunotherapy in allergic rhinitis: a systematic review and meta-analysis. Clin Transl Allergy. 2021;11(6):e12055. https://doi.org/10.1002/clt2.12055. Hylander T, Latif L, Petersson-Westin U, Cardell LO. Intralymphatic allergen-specific immunotherapy: an effective and safe alternative treatment route for pollen-induced allergic rhinitis. J Allergy Clin Immunol. 2013;131(2):412-420. https://doi.org/10.1016/j.jaci.2012.10.056. Senti G, Prinz Vavricka BM, Erdmann I, et al. Intralymphatic allergen administration renders specific immunotherapy faster and safer: a randomized controlled trial. Proc Natl Acad Sci U S A. 2008;105(46):17908-17912. https://doi.org/10.1073/pnas.0803725105. Senti G, Crameri R, Kuster D, et al. Intralymphatic immunotherapy for cat allergy induces tolerance after only 3 injections. J Allergy Clin Immunol. 2012;129(5):1290-1296. https://doi.org/10.1016/j.jaci.2012.02.026. Witten M, Malling HJ, Blom L, Poulsen BC, Poulsen LK. Is intralymphatic immunotherapy ready for clinical use in patients with grass pollen allergy? J Allergy Clin Immunol. 2013;132(5):1248-1252.e5. https://doi.org/10.1016/j.jaci.2013.07.033. Patterson AM, Bonny AE, Shiels 2nd WE, Erwin EA. Three-injection intralymphatic immunotherapy in adolescents and young adults with grass pollen rhinoconjunctivitis. Ann Allergy Asthma Immunol. 2016;116(2):168-170. https://doi.org/10.1016/j.anai.2015.11.010. Hylander T, Larsson O, Petersson-Westin U, et al. Intralymphatic immunotherapy of pollen-induced rhinoconjunctivitis: a double-blind placebo-controlled trial. Respir Res. 2016;17:10. https://doi.org/10.1186/s12931-016-0324-9. Hellkvist L, Hjalmarsson E, Kumlien Georen S, et al. Intralymphatic immunotherapy with 2 concomitant allergens, birch and grass: a randomized, double-blind, placebo-controlled trial. J Allergy Clin Immunol. 2018;142(4):1338-1341.e9. https://doi.org/10.1016/j.jaci.2018.05.030. Konradsen JR, Grundstrom J, Hellkvist L, et al. Intralymphatic immunotherapy in pollen-allergic young adults with rhinoconjunctivitis and mild asthma: a randomized trial. J Allergy Clin Immunol. 2020;145(3):1005-1007.e7. https://doi.org/10.1016/j.jaci.2019.11.017. Skaarup SH, Schmid JM, Skjold T, Graumann O, Hoffmann HJ. Intralymphatic immunotherapy improves grass pollen allergic rhinoconjunctivitis: a 3-year randomized placebo-controlled trial. J Allergy Clin Immunol. 2021;147(3):1011-1019. https://doi.org/10.1016/j.jaci.2020.07.002. Thompson CP, Silvers S, Shapiro MA. Intralymphatic immunotherapy for mountain cedar pollinosis: a randomized, double-blind, placebo-controlled trial. Ann Allergy Asthma Immunol. 2020;125(3):311-318.e2. https://doi.org/10.1016/j.anai.2020.04.030. Terada T, Omura S, Kikuoka Y, et al. Sustained effects of intralymphatic pollen-specific immunotherapy on Japanese cedar pollinosis. Rhinology. 2020;58(3):241-247. https://doi.org/10.4193/Rhin19.301. Wang K, Zheng R, Chen Y, et al. Clinical efficacy and safety of cervical intralymphatic immunotherapy for house dust mite allergic rhinitis: a pilot study. Am J Otolaryngol. 2019;40(6):102280. https://doi.org/10.1016/j.amjoto.2019.102280. Lee SP, Choi SJ, Joe E, et al. A pilot study of intralymphatic immunotherapy for house dust mite, cat, and dog allergies. Allergy Asthma Immunol Res. 2017;9(3):272-277. https://doi.org/10.4168/aair.2017.9.3.272. Schmid JM, Nezam H, Madsen HH, Schmitz A, Hoffmann HJ. Intralymphatic immunotherapy induces allergen specific plasmablasts and increases tolerance to skin prick testing in a pilot study. Clin Transl Allergy. 2016;6:19. https://doi.org/10.1186/s13601-016-0107-x. Taudorf E, Laursen LC, Lanner A, et al. Oral immunotherapy in birch pollen hay fever. J Allergy Clin Immunol. 1987;80(2):153-161. https://doi.org/10.1016/0091-6749(87)90124-2. Oppenheimer J, Areson JG, Nelson HS. Safety and efficacy of oral immunotherapy with standardized cat extract. J Allergy Clin Immunol. 1994;93(1 pt 1):61-67. https://doi.org/10.1016/0091-6749(94)90233-x. Van Deusen MA, Angelini BL, Cordoro KM, Seiler BA, Wood L, Skoner DP. Efficacy and safety of oral immunotherapy with short ragweed extract. Ann Allergy Asthma Immunol. 1997;78(6):573-580. https://doi.org/10.1016/S1081-1206(10)63218-8. Vickery BP, Vereda A, Casale TB, et al. AR101 oral immunotherapy for peanut allergy. N Engl J Med. 2018;379(21):1991-2001. https://doi.org/10.1056/NEJMoa1812856. Allam JP, Stojanovski G, Friedrichs N, et al. Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy. 2008;63(6):720-7. https://doi.org/10.1111/j.1398-9995.2007.01611.x. Canonica GW, Cox L, Pawankar R, et al. Sublingual immunotherapy: World Allergy Organization position paper 2013 update. World Allergy Organ J. 2014;7(1):6. https://doi.org/10.1186/1939-4551-7-6. Reisacher WR, Suurna MV, Rochlin K, Bremberg MG, Tropper G. Oral mucosal immunotherapy for allergic rhinitis: a pilot study. Allergy Rhinol (Providence). 2016;7(1):21-28. https://doi.org/10.2500/ar.2016.7.0150. Passalacqua G, Albano M, Ruffoni S, et al. Nasal immunotherapy to Parietaria: evidence of reduction of local allergic inflammation. Am J Respir Crit Care Med. 1995;152(2):461-466. https://doi.org/10.1164/ajrccm.152.2.7633693. Andri L, Senna G, Betteli C, Givanni S, Andri G, Falagiani P. Local nasal immunotherapy for Dermatophagoides-induced rhinitis: efficacy of a powder extract. J Allergy Clin Immunol. 1993;91(5):987-996. https://doi.org/10.1016/0091-6749(93)90211-w. Tari MG, Mancino M, Monti G. Immunotherapy by inhalation of allergen in powder in house dust allergic asthma - a double-blind study. J Investig Allergol Clin Immunol. 1992;2(2):59-67. Saco T, Ugalde IC, Cardet JC, Casale TB. Strategies for choosing a biologic for your patient with allergy or asthma. Ann Allergy Asthma Immunol. 2021;127(6):627-637. https://doi.org/10.1016/j.anai.2021.09.009. Kamin W, Kopp MV, Erdnuess F, Schauer U, Zielen S, Wahn U. Safety of anti-IgE treatment with omalizumab in children with seasonal allergic rhinitis undergoing specific immunotherapy simultaneously. Pediatr Allergy Immunol. 2010;21(1 pt 2):e160-e165. https://doi.org/10.1111/j.1399-3038.2009.00900.x. Rolinck-Werninghaus C, Hamelmann E, Keil T, et al. The co-seasonal application of anti-IgE after preseasonal specific immunotherapy decreases ocular and nasal symptom scores and rescue medication use in grass pollen allergic children. Allergy. 2004;59(9):973-979. https://doi.org/10.1111/j.1398-9995.2004.00552.x. Lin H, Boesel KM, Griffith DT, et al. Omalizumab rapidly decreases nasal allergic response and FcepsilonRI on basophils. J Allergy Clin Immunol. 2004;113(2):297-302. https://doi.org/10.1016/j.jaci.2003.11.044. Prussin C, Griffith DT, Boesel KM, Lin H, Foster B, Casale TB. Omalizumab treatment downregulates dendritic cell FcepsilonRI expression. J Allergy Clin Immunol. 2003;112(6):1147-1154. https://doi.org/10.1016/j.jaci.2003.10.003. Kopp MV, Hamelmann E, Zielen S, et al. Combination of omalizumab and specific immunotherapy is superior to immunotherapy in patients with seasonal allergic rhinoconjunctivitis and co-morbid seasonal allergic asthma. Clin Exp Allergy. 2009;39(2):271-279. https://doi.org/10.1111/j.1365-2222.2008.03121.x. Kopp MV, Hamelmann E, Bendiks M, et al. Transient impact of omalizumab in pollen allergic patients undergoing specific immunotherapy. Pediatr Allergy Immunol. 2013;24(5):427-433. https://doi.org/10.1111/pai.12098. Massanari M, Nelson H, Casale T, et al. Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma. J Allergy Clin Immunol. 2010;125(2):383-389. https://doi.org/10.1016/j.jaci.2009.11.022. Slater JE. Preparation and standardization of allergen extracts. In: Adkinson NF, Burks AW, Busse WW, Holgate ST, Lemanske RFJ, eds. Allergy Principlses and Practice. 8 ed. Mosbe; 2014:470-481. Calderon MA, Cox L, Casale TB, Moingeon P, Demoly P. Multiple-allergen and single-allergen immunotherapy strategies in polysensitized patients: looking at the published evidence. J Allergy Clin Immunol. 2012;129(4):929-934. https://doi.org/10.1016/j.jaci.2011.11.019. Zuberbier T, Bachert C, Bousquet PJ, et al. GA(2) LEN/EAACI pocket guide for allergen-specific immunotherapy for allergic rhinitis and asthma. Allergy. 2010;65(12):1525-1530. https://doi.org/10.1111/j.1398-9995.2010.02474.x. Demoly P, Passalacqua G, Pfaar O, Sastre J, Wahn U. Management of the polyallergic patient with allergy immunotherapy: a practice-based approach. Allergy Asthma Clin Immunol. 2016;12:2. https://doi.org/10.1186/s13223-015-0109-6. Wahn U, Calderon MA, Demoly P. Real-life clinical practice and management of polysensitized patients with respiratory allergies: a large, global survey of clinicians prescribing allergen immunotherapy. Expert Rev Clin Immunol. 2017;13(3):283-289. https://doi.org/10.1080/1744666X.2017.1277142. Franklin W, Lowell FC. Comparison of two dosages of ragweed extract in the treatment of pollenosis. JAMA. 1967;201(12):915-917. Lowell FC, Franklin W. A double-blind study of the effectiveness and specificity of injecton therapy in ragweed hay fever. N Engl J Med. 1965;273(13):675-679. https://doi.org/10.1056/NEJM196509232731302. Johnstone DE, Dutton A. The value of hyposensitization therapy for bronchial asthma in children - a 14-year study. Pediatrics. 1968;42(5):793-802. Reid MJ, Moss RB, Hsu YP, Kwasnicki JM, Commerford TM, Nelson BL. Seasonal asthma in northern California: allergic causes and efficacy of immunotherapy. J Allergy Clin Immunol. 1986;78(4 pt 1):590-600. https://doi.org/10.1016/0091-6749(86)90076-x. El-Qutob D, Raducan I, Mencia G. A preliminary study to investigate effectiveness of a mixed extract of Dermatophagoides sp. house dust mites and Alternaria sp. mold. Eur Ann Allergy Clin Immunol. 2021;53(5):234-239. https://doi.org/10.23822/EurAnnACI.1764-1489.185. Nevot-Falco S, Mancebo EG, Martorell A, et al. Safety and effectiveness of a single multiallergen subcutaneous immunotherapy in polyallergic patients. Int Arch Allergy Immunol. 2021;182(12):1226-1230. https://doi.org/10.1159/000517473. Nelson HS. Multiallergen immunotherapy for allergic rhinitis and asthma. J Allergy Clin Immunol. 2009;123(4):763-769. https://doi.org/10.1016/j.jaci.2008.12.013. Blume SW, Yeomans K, Allen-Ramey F, et al. Administration and burden of subcutaneous immunotherapy for allergic rhinitis in U.S. and Canadian Clinical Practice. J Manag Care Spec Pharm. 2015;21(11):982-990. https://doi.org/10.18553/jmcp.2015.21.11.982. Kim JY, Han DH, Won TB, et al. Immunologic modification in mono- and poly-sensitized patients after sublingual immunotherapy. Laryngoscope. 2019;129(5):E170-E177. https://doi.org/10.1002/lary.27721. Song Y, Long J, Wang T, Xie J, Wang M, Tan G. Long-term efficacy of standardised specific subcutaneous immunotherapy in children with persistent allergic rhinitis due to multiple allergens including house dust mites. J Laryngol Otol. 2018;132(3):230-235. https://doi.org/10.1017/S0022215117002547. Search of: allergy immunotherapy \| Recruiting. Not yet recruiting, Active, not recruiting Studies \| Allergic Rhinitis - List Results. Accessed November 8, 2021. https://clinicaltrials.gov/ct2/results?term=allergy+immunotherapy&cond=Allergic+Rhinitis&Search=Apply&recrs=b&recrs=a&recrs=d&age_v=&gndr=&type=&rslt=. Nelson HS. Subcutaneous injection immunotherapy for optimal effectiveness. Immunol Allergy Clin North Am. 2011;31(2):211-226, viii. https://doi.org/10.1016/j.iac.2011.02.010. Esch RE. Allergen immunotherapy: what can and cannot be mixed? J Allergy Clin Immunol. 2008;122(3):659-660. https://doi.org/10.1016/j.jaci.2008.07.018. Grier TJ, LeFevre DM, Duncan EA, Esch RE, Coyne TC. Allergen stabilities and compatibilities in mixtures of high-protease fungal and insect extracts. Ann Allergy Asthma Immunol. 2012;108(6):439-447. https://doi.org/10.1016/j.anai.2012.04.012. Bozek A, Kolodziejczyk K, Warkocka-Szoltysek B, Jarzab J. Grass pollen sublingual immunotherapy: a double-blind, placebo-controlled study in elderly patients with seasonal allergic rhinitis. Am J Rhinol Allergy. 2014;28(5):423-427. https://doi.org/10.2500/ajra.2014.28.4091. Roberts G, Hurley C, Turcanu V, Lack G. Grass pollen immunotherapy as an effective therapy for childhood seasonal allergic asthma. J Allergy Clin Immunol. 2006;117(2):263-268. https://doi.org/10.1016/j.jaci.2005.09.054. Cools M, Van Bever HP, Weyler JJ, Stevens WJ. Long-term effects of specific immunotherapy, administered during childhood, in asthmatic patients allergic to either house-dust mite or to both house-dust mite and grass pollen. Allergy. 2000;55(1):69-73. https://doi.org/10.1034/j.1398-9995.2000.00191.x. Stelmach I, Sobocinska A, Majak P, Smejda K, Jerzynska J, Stelmach W. Comparison of the long-term efficacy of 3- and 5-year house dust mite allergen immunotherapy. Ann Allergy Asthma Immunol. 2012;109(4):274-278. https://doi.org/10.1016/j.anai.2012.07.015. Pfaar O, Sager A, Robinson DS. Safety and effect on reported symptoms of depigmented polymerized allergen immunotherapy: a retrospective study of 2927 paediatric patients. Pediatr Allergy Immunol. 2015;26(3):280-286. https://doi.org/10.1111/pai.12347. Wahn U, Bachert C, Heinrich J, Richter H, Zielen S. Real-world benefits of allergen immunotherapy for birch pollen-associated allergic rhinitis and asthma. Allergy. 2019;74(3):594-604. https://doi.org/10.1111/all.13598. Zielen S, Kardos P, Madonini E. Steroid-sparing effects with allergen-specific immunotherapy in children with asthma: a randomized controlled trial. J Allergy Clin Immunol. 2010;126(5):942-949. https://doi.org/10.1016/j.jaci.2010.06.002. Moller C, Dreborg S, Ferdousi HA, et al. Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol. 2002;109(2):251-256. https://doi.org/10.1067/mai.2002.121317. Niggemann B, Jacobsen L, Dreborg S, et al. Five-year follow-up on the PAT study: specific immunotherapy and long-term prevention of asthma in children. Allergy. 2006;61(7):855-859. https://doi.org/10.1111/j.1398-9995.2006.01068.x. Devillier P, Molimard M, Ansolabehere X, et al. Immunotherapy with grass pollen tablets reduces medication dispensing for allergic rhinitis and asthma: a retrospective database study in France. Allergy. 2019;74(7):1317-1326. https://doi.org/10.1111/all.13705. Lim CE, Sison CP, Ponda P. Comparison of pediatric and adult systemic reactions to subcutaneous immunotherapy. J Allergy Clin Immunol Pract. 2017;5(5):1241-1247.e2. https://doi.org/10.1016/j.jaip.2017.01.014. Liu JL, Ning WX, Li SX, et al. The safety profile of subcutaneous allergen immunotherapy in children with asthma in Hangzhou, East China. Allergol Immunopathol (Madr). 2017;45(6):541-548. https://doi.org/10.1016/j.aller.2017.04.002. Bousquet PJ, Castelli C, Daures JP, et al. Assessment of allergen sensitization in a general population-based survey (European Community Respiratory Health Survey I). Ann Epidemiol. 2010;20(11):797-803. https://doi.org/10.1016/j.annepidem.2010.05.012. Arbes Jr SJ, Gergen PJ, Elliott L, Zeldin DC. Prevalences of positive skin test responses to 10 common allergens in the US population: results from the third National Health and Nutrition Examination Survey. J Allergy Clin Immunol. 2005;116(2):377-383. https://doi.org/10.1016/j.jaci.2005.05.017. Ballardini N, Bergstrom A, Wahlgren CF, et al. IgE antibodies in relation to prevalence and multimorbidity of eczema, asthma, and rhinitis from birth to adolescence. Allergy. 2016;71(3):342-349. https://doi.org/10.1111/all.12798. Hauser M, Roulias A, Ferreira F, Egger M. Panallergens and their impact on the allergic patient. Allergy Asthma Clin Immunol. 2010;6(1):1. https://doi.org/10.1186/1710-1492-6-1. Aalberse RC, Aalberse JA. Molecular allergen-specific IgE assays as a complement to allergen extract-based sensitization assessment. J Allergy Clin Immunol Pract. 2015;3(6):863-869; quiz 870. https://doi.org/10.1016/j.jaip.2015.09.013. Senna G, Lombardi C, Canonica GW, Passalacqua G. How adherent to sublingual immunotherapy prescriptions are patients? The manufacturers' viewpoint. J Allergy Clin Immunol. 2010;126(3):668-669. https://doi.org/10.1016/j.jaci.2010.06.045. Kiotseridis H, Arvidsson P, Backer V, Braendholt V, Tunsater A. Adherence and quality of life in adults and children during 3-years of SLIT treatment with Grazax-a real life study. NPJ Prim Care Respir Med. 2018;28(1):4. https://doi.org/10.1038/s41533-018-0072-z. Chen H, Chen Y, Lin B, et al. Efficacy and adherence of sublingual immunotherapy in patients aged 60 to 75 years old with house dust mite-induced allergic rhinitis. Am J Otolaryngol. 2020;41(4):102538. https://doi.org/10.1016/j.amjoto.2020.102538. Vogelberg C, Bruggenjurgen B, Richter H, Jutel M. Real-world adherence and evidence of subcutaneous and sublingual immunotherapy in grass and tree pollen-induced allergic rhinitis and asthma. Patient Prefer Adherence. 2020;14:817-827. https://doi.org/10.2147/PPA.S242957. Lemberg ML, Berk T, Shah-Hosseini K, Kasche EM, Mosges R. Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center. Patient Prefer Adherence. 2017;11:63-70. https://doi.org/10.2147/PPA.S122948. Stone B, Rance K, Waddell D, Aagren M, Hammerby E, Tkacz JP. Real-world mapping of allergy immunotherapy in the United States: the argument for improving adherence. Allergy Asthma Proc. 2021;42(1):55-64. https://doi.org/10.2500/aap.2021.42.200114. Liu W, Zeng Q, He C, et al. Compliance, efficacy, and safety of subcutaneous and sublingual immunotherapy in children with allergic rhinitis. Pediatr Allergy Immunol. 2021;32(1):86-91. https://doi.org/10.1111/pai.13332. Hsu NM, Reisacher WR. A comparison of attrition rates in patients undergoing sublingual immunotherapy vs subcutaneous immunotherapy. Int Forum Allergy Rhinol. 2012;2(4):280-284. https://doi.org/10.1002/alr.21037. Allam JP, Andreasen JN, Mette J, Serup-Hansen N, Wustenberg EG. Comparison of allergy immunotherapy medication persistence with a sublingual immunotherapy tablet versus subcutaneous immunotherapy in Germany. J Allergy Clin Immunol. 2018;141(5):1898-1901.e5. https://doi.org/10.1016/j.jaci.2017.12.999. Sorri M, Hartikainen-Sorri AL, Karja J. Rhinitis during pregnancy. Rhinology. 1980;18(2):83-86. Incuado GA. Diagnosis and treatment of allergic rhinitis and sinusitis during pregnancy and lactation. Clin Rev Allergy Immunol. 2004;27(2):159-177. Murphy VE, Clifton VL, Gibson PG. Asthma exacerbations during pregnancy: incidence and association with adverse pregnancy outcomes. Thorax. 2006;61(2):169-176. https://doi.org/10.1136/thx.2005.049718. Metzger WJ, Turner E, Patterson R. The safety of immunotherapy during pregnancy. J Allergy Clin Immunol. 1978;61(4):268-272. https://doi.org/10.1016/0091-6749(78)90202-6. Dowdee A, Ossege J. Assessment of childhood allergy for the primary care practitioner. J Am Acad Nurse Pract. 2007;19(2):53-62. https://doi.org/10.1111/j.1745-7599.2006.00195.x. Berger WE. Allergic rhinitis in children: diagnosis and management strategies. Paediatr Drugs. 2004;6(4):233-250. https://doi.org/10.2165/00148581-200406040-00003. Doulaptsi M, Aoi N, Kawauchi H, Milioni A, Karatzanis A, Prokopakis E. Differentiating rhinitis in the paediatric population by giving focus on medical history and clinical examination. Med Sci (Basel). 2019;7(3):38. https://doi.org/10.3390/medsci7030038. Tharpe CA, Kemp SF. Pediatric allergic rhinitis. Immunol Allergy Clin North Am. 2015;35(1):185-198. https://doi.org/10.1016/j.iac.2014.09.003. Sanford T. Allergic rhinitis in children. Mo Med. 2008;105(3):230-234. Roberts G, Xatzipsalti M, Borrego LM, et al. Paediatric rhinitis: position paper of the European Academy of Allergy and Clinical Immunology. Allergy. 2013;68(9):1102-1116. https://doi.org/10.1111/all.12235. Izquierdo-Dominguez A, Valero AL, Mullol J. Comparative analysis of allergic rhinitis in children and adults. Curr Allergy Asthma Rep. 2013;13(2):142-151. https://doi.org/10.1007/s11882-012-0331-y. Reshma A, Baranwal AK. Child with allergies or allergic reactions. Indian J Pediatr. 2018;85(1):60-65. https://doi.org/10.1007/s12098-017-2436-8. Lee VS, Lin SY. Allergy and the pediatric otolaryngologist. Otolaryngol Clin North Am. 2019;52(5):863-873. https://doi.org/10.1016/j.otc.2019.05.005. Mims JW, Veling MC. Inhalant allergies in children. Otolaryngol Clin North Am. 2011;44(3):797-814, xi. https://doi.org/10.1016/j.otc.2011.03.013. Kwon C, Lee HY, Kim MG, Boo SH, Yeo SG. Allergic diseases in children with otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2013;77(2):158-161. https://doi.org/10.1016/j.ijporl.2012.09.039. Roditi RE, Veling M, Shin JJ. Age: an effect modifier of the association between allergic rhinitis and Otitis media with effusion. Laryngoscope. 2016;126(7):1687-1692. https://doi.org/10.1002/lary.25682. Olusesi AD, Undie NB, Amodu JE. Allergy history as a predictor of early onset adenoids/adenotonsillar hypertrophy among Nigerian children. Int J Pediatr Otorhinolaryngol. 2013;77(6):1032-1035. https://doi.org/10.1016/j.ijporl.2013.04.004. Evcimik MF, Dogru M, Cirik AA, Nepesov MI. Adenoid hypertrophy in children with allergic disease and influential factors. Int J Pediatr Otorhinolaryngol. 2015;79(5):694-697. https://doi.org/10.1016/j.ijporl.2015.02.017. Huang SW, Giannoni C. The risk of adenoid hypertrophy in children with allergic rhinitis. Ann Allergy Asthma Immunol. 2001;87(4):350-355. https://doi.org/10.1016/S1081-1206(10)62251-X. La Mantia I, Andaloro C. Demographics and clinical features predictive of allergic versus non-allergic rhinitis in children aged 6-18 years: a single-center experience of 1535 patients. Int J Pediatr Otorhinolaryngol. 2017;98:103-109. https://doi.org/10.1016/j.ijporl.2017.04.044. Brown T. Diagnosis and management of allergic rhinitis in children. Pediatr Ann. 2019;48(12):e485-e488. https://doi.org/10.3928/19382359-20191111-01. Eigenmann PA, Atanaskovic-Markovic M, O'B Hourihane J, et al. Testing children for allergies: why, how, who and when: an updated statement of the European Academy of Allergy and Clinical Immunology (EAACI) Section on Pediatrics and the EAACI-Clemens von Pirquet Foundation. Pediatr Allergy Immunol. 2013;24(2):195-209. https://doi.org/10.1111/pai.12066. Host A, Andrae S, Charkin S, et al. Allergy testing in children: why, who, when and how? Allergy. 2003;58(7):559-569. https://doi.org/10.1034/j.1398-9995.2003.00238.x. Chawes BLK, Kreiner-Moller E, Bisgaard H. Objective assessments of allergic and nonallergic rhinitis in young children. Allergy. 2009;64(10):1547-1553. https://doi.org/10.1111/j.1398-9995.2009.02085.x. Miller RE, Paradise JL, Friday GA, Fireman P, Voith D. The nasal smear for eosinophils. Its value in children with seasonal allergic rhinitis. Am J Dis Child. 1982;136(11):1009-1011. https://doi.org/10.1001/archpedi.1982.03970470053015. Mierzejewska A, Jung A, Kalicki B. Nasal cytology as a marker of atopy in children. Dis Markers. 2017;2017:4159251. https://doi.org/10.1155/2017/4159251. Jirapongsananuruk O, Vichyanond P. Nasal cytology in the diagnosis of allergic rhinitis in children. Ann Allergy Asthma Immunol. 1998;80(2):165-170. https://doi.org/10.1016/S1081-1206(10)62950-X. Kaliner MA, Berger WE, Ratner PH, Siegel CJ. The efficacy of intranasal antihistamines in the treatment of allergic rhinitis. Ann Allergy Asthma Immunol. 2011;106(2 suppl):S6-S11. https://doi.org/10.1016/j.anai.2010.08.010. Dibildox J. Safety and efficacy of mometasone furoate aqueous nasal spray in children with allergic rhinitis: results of recent clinical trials. J Allergy Clin Immunol. 2001;108(1 suppl):S54-S58. https://doi.org/10.1067/mai.2001.115567. Roberge RJ, Hirani KH, Rowland 3rd PL, Berkeley R, Krenzelok EP. Dextromethorphan- and pseudoephedrine-induced agitated psychosis and ataxia: case report. J Emerg Med. 1999;17(2):285-288. https://doi.org/10.1016/s0736-4679(98)00193-0. Sauder KL, Brady Jr WJ, Hennes H. Visual hallucinations in a toddler: accidental ingestion of a sympathomimetic over-the-counter nasal decongestant. Am J Emerg Med. 1997;15(5):521-526. https://doi.org/10.1016/s0735-6757(97)90200-x. Halken S, Lau S, Valovirta E. New visions in specific immunotherapy in children: an iPAC summary and future trends. Pediatr Allergy Immunol. 2008;19(suppl 19):60-70. https://doi.org/10.1111/j.1399-3038.2008.00768.x. Marogna M, Tomassetti D, Bernasconi A, et al. Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. Ann Allergy Asthma Immunol. 2008;101(2):206-11. https://doi.org/10.1016/s1081-1206(10)60211-6. Bousquet J, Pfaar O, Agache I, et al. ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy. Clin Transl Allergy. 2021;11(4):e12014. https://doi.org/10.1002/clt2.12014. Pitsios C, Demoly P, Bilo MB, et al. Clinical contraindications to allergen immunotherapy: an EAACI position paper. Allergy. 2015;70(8):897-909. https://doi.org/10.1111/all.12638. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012;18(5):716-725. https://doi.org/10.1038/nm.2678. von Mutius E, Drazen JM. A patient with asthma seeks medical advice in 1828, 1928, and 2012. N Engl J Med. 2012;366(9):827-834. https://doi.org/10.1056/NEJMra1102783. Global strategy for asthma management and prevention, 2021. Accessed November 6, 2021. www.ginasthma.org. Kavanagh J, Jackson DJ, Kent BD. Over- and under-diagnosis in asthma. Breathe (Sheff). 2019;15(1):e20-e27. https://doi.org/10.1183/20734735.0362-2018. Pavord ID, Beasley R, Agusti A, et al. After asthma: redefining airways diseases. Lancet. 2018;391(10118):350-400. https://doi.org/10.1016/S0140-6736(17)30879-6. Chung KF, Wenzel SE, Brozek JL, et al. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma. Eur Respir J. 2014;43(2):343-373. https://doi.org/10.1183/09031936.00202013. Pedersen CJ, Uddin MJ, Saha SK, Darmstadt GL. Prevalence of atopic dermatitis, asthma and rhinitis from infancy through adulthood in rural Bangladesh: a population-based, cross-sectional survey. BMJ Open. 2020;10(11):e042380. https://doi.org/10.1136/bmjopen-2020-042380. Tohidinik HR, Mallah N, Takkouche B. History of allergic rhinitis and risk of asthma; a systematic review and meta-analysis. World Allergy Organ J. 2019;12(10):100069. https://doi.org/10.1016/j.waojou.2019.100069. Machluf Y, Farkash R, Rotkopf R, Fink D, Chaiter Y. Asthma phenotypes and associated comorbidities in a large cohort of adolescents in Israel. J Asthma. 2020;57(7):722-735. https://doi.org/10.1080/02770903.2019.1604743. Heck S, Al-Shobash S, Rapp D, et al. High probability of comorbidities in bronchial asthma in Germany. NPJ Prim Care Respir Med. 2017;27(1):28. https://doi.org/10.1038/s41533-017-0026-x. Pols DHJ, Bohnen AM, Nielen MMJ, Korevaar JC, Bindels PJE. Risks for comorbidity in children with atopic disorders: an observational study in Dutch general practices. BMJ Open. 2017;7(11):e018091. https://doi.org/10.1136/bmjopen-2017-018091. Magnan A, Meunier JP, Saugnac C, Gasteau J, Neukirch F. Frequency and impact of allergic rhinitis in asthma patients in everyday general medical practice: a French observational cross-sectional study. Allergy. 2008;63(3):292-298. https://doi.org/10.1111/j.1398-9995.2007.01584.x. de Groot EP, Nijkamp A, Duiverman EJ, Brand PL. Allergic rhinitis is associated with poor asthma control in children with asthma. Thorax. 2012;67(7):582-587. https://doi.org/10.1136/thoraxjnl-2011-201168. Tay TR, Radhakrishna N, Hore-Lacy F, et al. Comorbidities in difficult asthma are independent risk factors for frequent exacerbations, poor control and diminished quality of life. Respirology. 2016;21(8):1384-1390. https://doi.org/10.1111/resp.12838. Deliu M, Belgrave D, Simpson A, Murray CS, Kerry G, Custovic A. Impact of rhinitis on asthma severity in school-age children. Allergy. 2014;69(11):1515-1521. https://doi.org/10.1111/all.12467. Holgate ST, Wenzel S, Postma DS, Weiss ST, Renz H, Sly PD. Asthma. Nat Rev Dis Primers. 2015;1:15025. https://doi.org/10.1038/nrdp.2015.25. Togias A, Gergen PJ, Hu JW, et al. Rhinitis in children and adolescents with asthma: ubiquitous, difficult to control, and associated with asthma outcomes. J Allergy Clin Immunol. 2019;143(3):1003-1011.e10. https://doi.org/10.1016/j.jaci.2018.07.041. Shaaban R, Zureik M, Soussan D, et al. Rhinitis and onset of asthma: a longitudinal population-based study. Lancet. 2008;372(9643):1049-1057. https://doi.org/10.1016/S0140-6736(08)61446-4. Fahy JV. Type 2 inflammation in asthma-present in most, absent in many. Nat Rev Immunol. 2015;15(1):57-65. https://doi.org/10.1038/nri3786. Kuruvilla ME, Lee FE, Lee GB. Understanding asthma phenotypes, endotypes, and mechanisms of disease. Clin Rev Allergy Immunol. 2019;56(2):219-233. https://doi.org/10.1007/s12016-018-8712-1. Todd S, Walsted ES, Grillo L, Livingston R, Menzies-Gow A, Hull JH. Novel assessment tool to detect breathing pattern disorder in patients with refractory asthma. Respirology. 2018;23(3):284-290. https://doi.org/10.1111/resp.13173. Barker N, Thevasagayam R, Ugonna K, Kirkby J. Pediatric dysfunctional breathing: proposed components, mechanisms, diagnosis, and management. Front Pediatr. 2020;8:379. https://doi.org/10.3389/fped.2020.00379. Seumois G, Zapardiel-Gonzalo J, White B, et al. Transcriptional profiling of Th2 cells identifies pathogenic features associated with asthma. J Immunol. 2016;197(2):655-664. https://doi.org/10.4049/jimmunol.1600397. Samitas K, Carter A, Kariyawasam HH, Xanthou G. Upper and lower airway remodelling mechanisms in asthma, allergic rhinitis and chronic rhinosinusitis: the one airway concept revisited. Allergy. 2018;73(5):993-1002. https://doi.org/10.1111/all.13373. Ullmann N, Mirra V, Di Marco A, et al. Asthma: differential diagnosis and comorbidities. Front Pediatr. 2018;6:276. https://doi.org/10.3389/fped.2018.00276. Shen Y, Zeng JH, Hong SL, Kang HY. Prevalence of allergic rhinitis comorbidity with asthma and asthma with allergic rhinitis in China: a meta-analysis. Asian Pac J Allergy Immunol. 2019;37(4):220-225. https://doi.org/10.12932/AP-120417-0072. Kou W, Li X, Yao H, Wei P. Meta-analysis of the comorbidity rate of allergic rhinitis and asthma in Chinese children. Int J Pediatr Otorhinolaryngol. 2018;107:131-134. https://doi.org/10.1016/j.ijporl.2018.02.001. Carr TF, Stern DA, Halonen M, Wright AL, Martinez FD. Non-atopic rhinitis at age 6 is associated with subsequent development of asthma. Clin Exp Allergy. 2019;49(1):35-43. https://doi.org/10.1111/cea.13276. Tosca MA, Duse M, Marseglia G, Ciprandi G, “ControL'Asma” Study Group. The practical clinical relevance of rhinitis classification in children with asthma: outcomes of the "ControL'Asma" study. Ann Allergy Asthma Immunol. 2019;123(5):516-519. https://doi.org/10.1016/j.anai.2019.08.003. Kisiel MA, Zhou X, Sundh J, et al. Data-driven questionnaire-based cluster analysis of asthma in Swedish adults. NPJ Prim Care Respir Med. 2020;30(1):14. https://doi.org/10.1038/s41533-020-0168-0. Heffler E, Blasi F, Latorre M, et al. The severe asthma network in italy: findings and perspectives. J Allergy Clin Immunol Pract. 2019;7(5):1462-1468. https://doi.org/10.1016/j.jaip.2018.10.016. Huang K, Yang T, Xu J, et al. Prevalence, risk factors, and management of asthma in China: a national cross-sectional study. Lancet. 2019;394(10196):407-418. https://doi.org/10.1016/S0140-6736(19)31147-X. Ji H, Hu Y, Zhang T, et al. Allergic comorbidity of asthma or wheezing, allergic rhinitis, and eczema: result from 333 029 allergic children in Shanghai, China. Am J Rhinol Allergy. 2020;34(2):189-195. https://doi.org/10.1177/1945892419883238. Sonia T, Meriem M, Yacine O, et al. Prevalence of asthma and rhinitis in a Tunisian population. Clin Respir J. 2018;12(2):608-615. https://doi.org/10.1111/crj.12570. Ziyab AH. Prevalence and risk factors of asthma, rhinitis, and eczema and their multimorbidity among young adults in Kuwait: a cross-sectional study. Biomed Res Int. 2017;2017:2184193. https://doi.org/10.1155/2017/2184193. Wright AL, Holberg CJ, Martinez FD, Halonen M, Morgan W, Taussig LM. Epidemiology of physician-diagnosed allergic rhinitis in childhood. Pediatrics. 1994;94(6 pt 1):895-901. Settipane RJ, Settipane GA. IgE and the allergy-asthma connection in the 23-year follow-up of Brown University students. Allergy Asthma Proc. 2000;21(4):221-225. https://doi.org/10.2500/108854100778248890. Guerra S, Sherrill DL, Baldacci S, et al. Rhinitis is an independent risk factor for developing cough apart from colds among adults. Allergy. 2005;60(3):343-349. https://doi.org/10.1111/j.1398-9995.2005.00717.x. Toren K, Olin AC, Hellgren J, Hermansson BA. Rhinitis increase the risk for adult-onset asthma-a Swedish population-based case-control study (MAP-study). Respir Med. 2002;96(8):635-641. https://doi.org/10.1053/rmed.2002.1319. Shaaban R, Zureik M, Soussan D, et al. Allergic rhinitis and onset of bronchial hyperresponsiveness: a population-based study. Am J Respir Crit Care Med. 2007;176(7):659-666. https://doi.org/10.1164/rccm.200703-427OC. Rochat MK, Illi S, Ege MJ, et al. Allergic rhinitis as a predictor for wheezing onset in school-aged children. J Allergy Clin Immunol. 2010;126(6):1170-1175.e2. https://doi.org/10.1016/j.jaci.2010.09.008. Hamouda S, Karila C, Connault T, Scheinmann P, de Blic J. Allergic rhinitis in children with asthma: a questionnaire-based study. Clin Exp Allergy. 2008;38(5):761-766. https://doi.org/10.1111/j.1365-2222.2008.02953.x. Antonicelli L, Micucci C, Voltolini S, et al. Allergic rhinitis and asthma comorbidity: ARIA classification of rhinitis does not correlate with the prevalence of asthma. Clin Exp Allergy. 2007;37(6):954-960. https://doi.org/10.1111/j.1365-2222.2007.02729.x. Jung S, Lee SY, Yoon J, et al. Risk factors and comorbidities associated with the allergic rhinitis phenotype in children according to the ARIA classification. Allergy Asthma Immunol Res. 2020;12(1):72-85. https://doi.org/10.4168/aair.2020.12.1.72. Sio YY, Pang SL, Say YH, et al. Sensitization to airborne fungal allergens associates with asthma and allergic rhinitis presentation and severity in the Singaporean/Malaysian population. Mycopathologia. 2021;186(5):583-588. https://doi.org/10.1007/s11046-021-00532-6. Arshad SH, Tariq SM, Matthews S, Hakim E. Sensitization to common allergens and its association with allergic disorders at age 4 years: a whole population birth cohort study. Pediatrics. 2001;108(2):E33. https://doi.org/10.1542/peds.108.2.e33. Bonay M, Neukirch C, Grandsaigne M, et al. Changes in airway inflammation following nasal allergic challenge in patients with seasonal rhinitis. Allergy. 2006;61(1):111-118. https://doi.org/10.1111/j.1398-9995.2006.00967.x. Panganiban RP, Wang Y, Howrylak J, et al. Circulating microRNAs as biomarkers in patients with allergic rhinitis and asthma. J Allergy Clin Immunol. 2016;137(5):1423-1432. https://doi.org/10.1016/j.jaci.2016.01.029. Deng Q, Lu C, Yu Y, Li Y, Sundell J, Norback D. Early life exposure to traffic-related air pollution and allergic rhinitis in preschool children. Respir Med. 2016;121:67-73. https://doi.org/10.1016/j.rmed.2016.10.016. Wang J, Zhang Y, Li B, et al. Asthma and allergic rhinitis among young parents in China in relation to outdoor air pollution, climate and home environment. Sci Total Environ. 2021;751:141734. https://doi.org/10.1016/j.scitotenv.2020.141734. Nordeide Kuiper I, Svanes C, Markevych I, et al. Lifelong exposure to air pollution and greenness in relation to asthma, rhinitis and lung function in adulthood. Environ Int. 2021;146:106219. https://doi.org/10.1016/j.envint.2020.106219. Polosa R, Knoke JD, Russo C, et al. Cigarette smoking is associated with a greater risk of incident asthma in allergic rhinitis. J Allergy Clin Immunol. 2008;121(6):1428-1434. https://doi.org/10.1016/j.jaci.2008.02.041. Ma T, Chen Y, Pang Y, et al. Prevalence and risk factors of allergic rhinitis and asthma in the southern edge of the plateau grassland region of northern China: a cross-sectional study. World Allergy Organ J. 2021;14(7):100537. https://doi.org/10.1016/j.waojou.2021.100537. Ibanez MD, Valero AL, Montoro J, et al. Analysis of comorbidities and therapeutic approach for allergic rhinitis in a pediatric population in Spain. Pediatr Allergy Immunol. 2013;24(7):678-684. https://doi.org/10.1111/pai.12126. Burgess JA, Walters EH, Byrnes GB, et al. Childhood allergic rhinitis predicts asthma incidence and persistence to middle age: a longitudinal study. J Allergy Clin Immunol. 2007;120(4):863-869. https://doi.org/10.1016/j.jaci.2007.07.020. Bodtger U, Poulsen LK, Linneberg A. Rhinitis symptoms and IgE sensitization as risk factors for development of later allergic rhinitis in adults. Allergy. 2006;61(6):712-716. https://doi.org/10.1111/j.1398-9995.2006.01140.x. Porsbjerg C, von Linstow ML, Ulrik CS, Nepper-Christensen S, Backer V. Risk factors for onset of asthma: a 12-year prospective follow-up study. Chest. 2006;129(2):309-316. https://doi.org/10.1378/chest.129.2.309. Plaschke PP, Janson C, Norrman E, Bjornsson E, Ellbjar S, Jarvholm B. Onset and remission of allergic rhinitis and asthma and the relationship with atopic sensitization and smoking. Am J Respir Crit Care Med. 2000;162(3 pt 1):920-924. https://doi.org/10.1164/ajrccm.162.3.9912030. Corren J. Allergic rhinitis and asthma: how important is the link? J Allergy Clin Immunol. 1997;99(2):S781-S786. https://doi.org/10.1016/s0091-6749(97)70127-1. Corren J. The impact of allergic rhinitis on bronchial asthma. J Allergy Clin Immunol. 1998;101(2 pt 2):S352-S356. https://doi.org/10.1016/s0091-6749(98)70218-0. Jeffery PK, Haahtela T. Allergic rhinitis and asthma: inflammation in a one-airway condition. BMC Pulm Med. 2006;6(suppl 1):S5. https://doi.org/10.1186/1471-2466-6-S1-S5. Bhimrao SK, Wilson SJ, Howarth PH. Airway inflammation in atopic patients: a comparison of the upper and lower airways. Otolaryngol Head Neck Surg. 2011;145(3):396-400. https://doi.org/10.1177/0194599811410531. Eriksson J, Bjerg A, Lotvall J, et al. Rhinitis phenotypes correlate with different symptom presentation and risk factor patterns of asthma. Respir Med. 2011;105(11):1611-1621. https://doi.org/10.1016/j.rmed.2011.06.004. Kersten ET, van Leeuwen JC, Brand PL, et al. Effect of an intranasal corticosteroid on exercise induced bronchoconstriction in asthmatic children. Pediatr Pulmonol. 2012;47(1):27-35. https://doi.org/10.1002/ppul.21511. Reed CE, Marcoux JP, Welsh PW. Effects of topical nasal treatment on asthma symptoms. J Allergy Clin Immunol. 1988;81(5 pt 2):1042-1047. https://doi.org/10.1016/0091-6749(88)90177-7. Corren J, Adinoff AD, Buchmeier AD, Irvin CG. Nasal beclomethasone prevents the seasonal increase in bronchial responsiveness in patients with allergic rhinitis and asthma. J Allergy Clin Immunol. 1992;90(2):250-256. https://doi.org/10.1016/0091-6749(92)90079-h. De Jong HJI, Voorham J, Scadding GK, et al. Evaluating the real-life effect of MP-AzeFlu on asthma outcomes in patients with allergic rhinitis and asthma in UK primary care. World Allergy Organ J. 2020;13(12):100490. https://doi.org/10.1016/j.waojou.2020.100490. Chyrek-Borowska S, Siergiejko Z, Michalska I. The effects of a new generation of H1 antihistamines (cetirizine and loratadine) on histamine release and the bronchial response to histamine in atopic patients. J Investig Allergol Clin Immunol. 1995;5(2):103-107. Wasserfallen JB, Leuenberger P, Pecoud A. Effect of cetirizine, a new H1 antihistamine, on the early and late allergic reactions in a bronchial provocation test with allergen. J Allergy Clin Immunol. 1993;91(6):1189-1197. https://doi.org/10.1016/0091-6749(93)90322-7. Nishimura M, Koga T, Kamimura T, et al. Comparison of leukotriene receptor antagonists and anti-histamines as an add-on therapy in patients with asthma complicated by allergic rhinitis. Kurume Med J. 2011;58(1):9-14. https://doi.org/10.2739/kurumemedj.58.9. Grembiale RD, Camporota L, Naty S, Tranfa CM, Djukanovic R, Marsico SA. Effects of specific immunotherapy in allergic rhinitic individuals with bronchial hyperresponsiveness. Am J Respir Crit Care Med. 2000;162(6):2048-2052. https://doi.org/10.1164/ajrccm.162.6.9909087. Rak S, Lowhagen O, Venge P. The effect of immunotherapy on bronchial hyperresponsiveness and eosinophil cationic protein in pollen-allergic patients. J Allergy Clin Immunol. 1988;82(3 pt 1):470-480. https://doi.org/10.1016/0091-6749(88)90021-8. Novembre E, Galli E, Landi F, et al. Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol. 2004;114(4):851-857. https://doi.org/10.1016/j.jaci.2004.07.012. Suissa S, Ernst P. Bias in observational study of the effectiveness of nasal corticosteroids in asthma. J Allergy Clin Immunol. 2005;115(4):714-719. https://doi.org/10.1016/j.jaci.2004.12.1118. D'Amato G, Ortega OPM, Annesi-Maesano I, D'Amato M. Prevention of allergic asthma with allergen avoidance measures and the role of exposome. Curr Allergy Asthma Rep. 2020;20(3):8. https://doi.org/10.1007/s11882-020-0901-3. Gotzsche PC, Johansen HK. House dust mite control measures for asthma. Cochrane Database Syst Rev. 2008;(2):CD001187. https://doi.org/10.1002/14651858.CD001187.pub3. Terreehorst I, Duivenvoorden HJ, Tempels-Pavlica Z, et al. The effect of encasings on quality of life in adult house dust mite allergic patients with rhinitis, asthma and/or atopic dermatitis. Allergy. 2005;60(7):888-93. https://doi.org/10.1111/j.1398-9995.2004.00677.x. Pasquali M, Baiardini I, Rogkakou A, et al. Levocetirizine in persistent allergic rhinitis and asthma: effects on symptoms, quality of life and inflammatory parameters. Clin Exp Allergy. 2006;36(9):1161-1167. https://doi.org/10.1111/j.1365-2222.2006.02548.x. Baena-Cagnani CE, Berger WE, DuBuske LM, et al. Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma. Int Arch Allergy Immunol. 2003;130(4):307-313. https://doi.org/10.1159/000070218. Berger WE, Schenkel EJ, Mansfield LE, Desloratadine Study Group. Safety and efficacy of desloratadine 5 mg in asthma patients with seasonal allergic rhinitis and nasal congestion. Ann Allergy Asthma Immunol. 2002;89(5):485-491. https://doi.org/10.1016/S1081-1206(10)62086-8. Grant JA, Nicodemus CF, Findlay SR, et al. Cetirizine in patients with seasonal rhinitis and concomitant asthma: prospective, randomized, placebo-controlled trial. J Allergy Clin Immunol. 1995;95(5 pt 1):923-932. https://doi.org/10.1016/s0091-6749(95)70090-0. Aubier M, Neukirch C, Peiffer C, Melac M. Effect of cetirizine on bronchial hyperresponsiveness in patients with seasonal allergic rhinitis and asthma. Allergy. 2001;56(1):35-42. https://doi.org/10.1034/j.1398-9995.2001.00629.x. Aaronson DW. Evaluation of cetirizine in patients with allergic rhinitis and perennial asthma. Ann Allergy Asthma Immunol. 1996;76(5):440-446. https://doi.org/10.1016/S1081-1206(10)63461-8. Simons FE. Is antihistamine (H1-receptor antagonist) therapy useful in clinical asthma? Clin Exp Allergy. 1999;29(suppl 3):98-104. https://doi.org/10.1046/j.1365-2222.1999.0290s3098.x. Bousquet J, Emonot A, Germouty J, et al. Double-blind multicenter study of cetirizine in grass-pollen-induced asthma. Ann Allergy. 1990;65(6):504-508. Van Ganse E, Kaufman L, Derde MP, Yernault JC, Delaunois L, Vincken W. Effects of antihistamines in adult asthma: a meta-analysis of clinical trials. Eur Respir J. 1997;10(10):2216-2224. https://doi.org/10.1183/09031936.97.10102216. Allergic factors associated with the development of asthma and the influence of cetirizine in a double-blind, randomised, placebo-controlled trial: first results of ETAC. Early Treatment of the Atopic Child. Pediatr Allergy Immunol. 1998;9(3):116-124. Bhargava S, Prakash A, Rehan HS, Gupta LK. Effect of systemic corticosteroids on serum apoptotic markers and quality of life in patients with asthma. Allergy Asthma Proc. 2015;36(4):275-282. https://doi.org/10.2500/aap.2015.36.3834. Sood V, Rogers L, Khurana S. Managing corticosteroid-related comorbidities in severe asthma. Chest. 2021;160(5):1614-1623. https://doi.org/10.1016/j.chest.2021.05.021. Henriksen JM, Wenzel A. Effect of an intranasally administered corticosteroid (budesonide) on nasal obstruction, mouth breathing, and asthma. Am Rev Respir Dis. 1984;130(6):1014-1048. https://doi.org/10.1164/arrd.1984.130.6.1014. Dahl R, Nielsen LP, Kips J, et al. Intranasal and inhaled fluticasone propionate for pollen-induced rhinitis and asthma. Allergy. 2005;60(7):875-881. https://doi.org/10.1111/j.1398-9995.2005.00819.x. Nathan RA, Yancey SW, Waitkus-Edwards K, et al. Fluticasone propionate nasal spray is superior to montelukast for allergic rhinitis while neither affects overall asthma control. Chest. 2005;128(4):1910-1920. https://doi.org/10.1378/chest.128.4.1910. Stelmach R, do Patrocinio TNM, Ribeiro M, Cukier A. Effect of treating allergic rhinitis with corticosteroids in patients with mild-to-moderate persistent asthma. Chest. 2005;128(5):3140-3147. https://doi.org/10.1378/chest.128.5.3140. Thio BJ, Slingerland GL, Fredriks AM, et al. Influence of intranasal steroids during the grass pollen season on bronchial responsiveness in children and young adults with asthma and hay fever. Thorax. 2000;55(10):826-832. https://doi.org/10.1136/thorax.55.10.826. Baiardini I, Villa E, Rogkakou A, et al. Effects of mometasone furoate on the quality of life: a randomized placebo-controlled trial in persistent allergic rhinitis and intermittent asthma using the Rhinasthma questionnaire. Clin Exp Allergy. 2011;41(3):417-423. https://doi.org/10.1111/j.1365-2222.2010.03660.x. Nair A, Vaidyanathan S, Clearie K, Williamson P, Meldrum K, Lipworth BJ. Steroid sparing effects of intranasal corticosteroids in asthma and allergic rhinitis. Allergy. 2010;65(3):359-367. https://doi.org/10.1111/j.1398-9995.2009.02187.x. Agondi RC, Machado ML, Kalil J, Giavina-Bianchi P. Intranasal corticosteroid administration reduces nonspecific bronchial hyperresponsiveness and improves asthma symptoms. J Asthma. 2008;45(9):754-757. https://doi.org/10.1080/02770900802249149. Pedroletti C, Lundahl J, Alving K, Hedlin G. Effect of nasal steroid treatment on airway inflammation determined by exhaled nitric oxide in allergic schoolchildren with perennial rhinitis and asthma. Pediatr Allergy Immunol. 2008;19(3):219-226. https://doi.org/10.1111/j.1399-3038.2007.00613.x. Watson WT, Becker AB, Simons FE. Treatment of allergic rhinitis with intranasal corticosteroids in patients with mild asthma: effect on lower airway responsiveness. J Allergy Clin Immunol. 1993;91(1 pt 1):97-101. https://doi.org/10.1016/0091-6749(93)90301-u. Gani F, Pozzi E, Crivellaro MA, et al. The role of patient training in the management of seasonal rhinitis and asthma: clinical implications. Allergy. 2001;56(1):65-68. https://doi.org/10.1034/j.1398-9995.2001.00794.x. Meltzer EO. Role for cysteinyl leukotriene receptor antagonist therapy in asthma and their potential role in allergic rhinitis based on the concept of "one linked airway disease". Ann Allergy Asthma Immunol. 2000;84(2):176-185; quiz 185-7. https://doi.org/10.1016/S1081-1206(10)62750-0. Egan M, Bunyavanich S. Allergic rhinitis: the "Ghost Diagnosis" in patients with asthma. Asthma Res Pract. 2015;1:8. https://doi.org/10.1186/s40733-015-0008-0. Nowak D. Management of asthma with anti-immunoglobulin E: a review of clinical trials of omalizumab. Respir Med. 2006;100(11):1907-1917. https://doi.org/10.1016/j.rmed.2005.10.004. Bousquet J, Cabrera P, Berkman N, et al. The effect of treatment with omalizumab, an anti-IgE antibody, on asthma exacerbations and emergency medical visits in patients with severe persistent asthma. Allergy. 2005;60(3):302-308. https://doi.org/10.1111/j.1398-9995.2004.00770.x. D'Amato G, Salzillo A, Piccolo A, D'Amato M, Liccardi G. A review of anti-IgE monoclonal antibody (omalizumab) as add on therapy for severe allergic (IgE-mediated) asthma. Ther Clin Risk Manag. 2007;3(4):613-619. Normansell R, Walker S, Milan SJ, Walters EH, Nair P. Omalizumab for asthma in adults and children. Cochrane Database Syst Rev. 2014;(1):CD003559. https://doi.org/10.1002/14651858.CD003559.pub4. Humbert M, Boulet LP, Niven RM, Panahloo Z, Blogg M, Ayre G. Omalizumab therapy: patients who achieve greatest benefit for their asthma experience greatest benefit for rhinitis. Allergy. 2009;64(1):81-84. https://doi.org/10.1111/j.1398-9995.2008.01846.x. Vignola AM, Humbert M, Bousquet J, et al. Efficacy and tolerability of anti-immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR. Allergy. 2004;59(7):709-717. https://doi.org/10.1111/j.1398-9995.2004.00550.x. Erekosima N, Suarez-Cuervo C, Ramanathan M, et al. Effectiveness of subcutaneous immunotherapy for allergic rhinoconjunctivitis and asthma: a systematic review. Laryngoscope. 2014;124(3):616-627. https://doi.org/10.1002/lary.24295. Sidenius K, Arvidsson P, Indbryn R, Emanuelsson CA. A real-life one-year non-interventional study assessing safety, tolerability, and treatment outcome of the SQ HDM SLIT-Tablet (Acarizax((R))) in house dust mite allergic rhinitis with or without asthma. Pulm Ther. 2021;7(1):221-236. https://doi.org/10.1007/s41030-021-00150-z. Inal A, Altintas DU, Yilmaz M, Karakoc GB, Kendirli SG, Sertdemir Y. Prevention of new sensitizations by specific immunotherapy in children with rhinitis and/or asthma monosensitized to house dust mite. J Investig Allergol Clin Immunol. 2007;17(2):85-91. Purello-D'Ambrosio F, Gangemi S, Merendino RA, et al. Prevention of new sensitizations in monosensitized subjects submitted to specific immunotherapy or not. A retrospective study. Clin Exp Allergy. 2001;31(8):1295-1302. https://doi.org/10.1046/j.1365-2222.2001.01027.x. Di Lorenzo G, Leto-Barone MS, La Piana S, Plaia A, Di Bona D. The effect of allergen immunotherapy in the onset of new sensitizations: a meta-analysis. Int Forum Allergy Rhinol. 2017;7(7):660-669. https://doi.org/10.1002/alr.21946. Fortescue R, Kew KM, Leung MST. Sublingual immunotherapy for asthma. Cochrane Database Syst Rev. 2020;9:CD011293. https://doi.org/10.1002/14651858.CD011293.pub3. Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention, 2019. Accessed July 4, 2022. www.ginasthma.org. 2020 Focused Update to the Asthma Management Guidelines: Clinician's Guide. Accessed July 4, 2022. https://www.nhlbi.nih.gov/sites/default/files/publications/AsthmaCliniciansGuideDesign-508.pdf. Katial RK, Oppenheimer JJ, Ostrom NK, et al. Adding montelukast to fluticasone propionate/salmeterol for control of asthma and seasonal allergic rhinitis. Allergy Asthma Proc. 2010;31(1):68-75. https://doi.org/10.2500/aap.2010.31.3306. Price DB, Swern A, Tozzi CA, Philip G, Polos P. Effect of montelukast on lung function in asthma patients with allergic rhinitis: analysis from the COMPACT trial. Allergy. 2006;61(6):737-742. https://doi.org/10.1111/j.1398-9995.2006.01007.x. Marcus S, Roland LT, DelGaudio JM, Wise SK. The relationship between allergy and chronic rhinosinusitis. Laryngoscope Investig Otolaryngol. 2019;4(1):13-17. https://doi.org/10.1002/lio2.236. Wilson KF, McMains KC, Orlandi RR. The association between allergy and chronic rhinosinusitis with and without nasal polyps: an evidence-based review with recommendations. Int Forum Allergy Rhinol. 2014;4(2):93-103. https://doi.org/10.1002/alr.21258. Baroody FM, Mucha SM, Detineo M, Naclerio RM. Nasal challenge with allergen leads to maxillary sinus inflammation. J Allergy Clin Immunol. 2008;121(5):1126-1132.e7. https://doi.org/10.1016/j.jaci.2008.02.010. Tan BK, Zirkle W, Chandra RK, et al. Atopic profile of patients failing medical therapy for chronic rhinosinusitis. Int Forum Allergy Rhinol. 2011;1(2):88-94. https://doi.org/10.1002/alr.20025. Pearlman AN, Chandra RK, Chang D, et al. Relationships between severity of chronic rhinosinusitis and nasal polyposis, asthma, and atopy. Am J Rhinol Allergy. 2009;23(2):145-148. https://doi.org/10.2500/ajra.2009.23.3284. Gelincik A, Buyukozturk S, Aslan I, et al. Allergic vs nonallergic rhinitis: which is more predisposing to chronic rhinosinusitis? Ann Allergy Asthma Immunol. 2008;101(1):18-22. https://doi.org/10.1016/S1081-1206(10)60829-0. Kirtsreesakul V, Ruttanaphol S. The relationship between allergy and rhinosinusitis. Rhinology. 2008;46(3):204-208. Robinson S, Douglas R, Wormald PJ. The relationship between atopy and chronic rhinosinusitis. Am J Rhinol. 2006;20(6):625-628. https://doi.org/10.2500/ajr.2006.20.2907. Alho OP, Karttunen R, Karttunen TJ. Nasal mucosa in natural colds: effects of allergic rhinitis and susceptibility to recurrent sinusitis. Clin Exp Immunol. 2004;137(2):366-372. https://doi.org/10.1111/j.1365-2249.2004.02530.x. Van Zele T, Gevaert P, Watelet JB, et al. Staphylococcus aureus colonization and IgE antibody formation to enterotoxins is increased in nasal polyposis. J Allergy Clin Immunol. 2004;114(4):981-983. https://doi.org/10.1016/j.jaci.2004.07.013. Berrettini S, Carabelli A, Sellari-Franceschini S, et al. Perennial allergic rhinitis and chronic sinusitis: correlation with rhinologic risk factors. Allergy. 1999;54(3):242-248. https://doi.org/10.1034/j.1398-9995.1999.00813.x. Al-Qudah M. Food sensitization in medically resistant chronic rhinosinusitis with or without nasal polyposis. Int Arch Allergy Immunol. 2016;169(1):40-44. https://doi.org/10.1159/000443737. Li QC, Cheng KJ, Wang F, Zhou SH. Role of atopy in chronic rhinosinusitis with nasal polyps: does an atopic condition affect the severity and recurrence of disease? J Laryngol Otol. 2016;130(7):640-644. https://doi.org/10.1017/S0022215116008112. Houser SM, Keen KJ. The role of allergy and smoking in chronic rhinosinusitis and polyposis. Laryngoscope. 2008;118(9):1521-1527. https://doi.org/10.1097/MLG.0b013e31817d01b8. Kirtsreesakul V. Role of allergy in the therapeutic response of nasal polyps. Asian Pac J Allergy Immunol. 2002;20(3):141-146. Gorgulu O, Ozdemir S, Canbolat EP, Sayar C, Olgun MK, Akbas Y. Analysis of the roles of smoking and allergy in nasal polyposis. Ann Otol Rhinol Laryngol. 2012;121(9):615-619. https://doi.org/10.1177/000348941212100909. Lill C, Loader B, Seemann R, et al. Milk allergy is frequent in patients with chronic sinusitis and nasal polyposis. Am J Rhinol Allergy. 2011;25(6):e221-e224. https://doi.org/10.2500/ajra.2011.25.3686. Munoz del Castillo F, Jurado-Ramos A, Fernandez-Conde BL, et al. Allergenic profile of nasal polyposis. J Investig Allergol Clin Immunol. 2009;19(2):110-116. Bonfils P, Malinvaud D. Influence of allergy in patients with nasal polyposis after endoscopic sinus surgery. Acta Otolaryngol. 2008;128(2):186-192. https://doi.org/10.1080/00016480701387165. Erbek SS, Erbek S, Topal O, Cakmak O. The role of allergy in the severity of nasal polyposis. Am J Rhinol. 2007;21(6):686-690. https://doi.org/10.2500/ajr.2007.21.3062. Bonfils P, Avan P, Malinvaud D. Influence of allergy on the symptoms and treatment of nasal polyposis. Acta Otolaryngol. 2006;126(8):839-844. https://doi.org/10.1080/00016480500504226. Collins MM, Loughran S, Davidson P, Wilson JA. Nasal polyposis: prevalence of positive food and inhalant skin tests. Otolaryngol Head Neck Surg. 2006;135(5):680-683. https://doi.org/10.1016/j.otohns.2006.07.005. Asero R, Bottazzi G. Nasal polyposis: a study of its association with airborne allergen hypersensitivity. Ann Allergy Asthma Immunol. 2001;86(3):283-285. https://doi.org/10.1016/S1081-1206(10)63299-1. Voegels RL, Santoro P, Butugan O, Formigoni LG. Nasal polyposis and allergy: is there a correlation? Am J Rhinol. 2001;15(1):9-14. https://doi.org/10.2500/105065801781329365. Asero R, Bottazzi G. Hypersensitivity to molds in patients with nasal polyposis: a clinical study. J Allergy Clin Immunol. 2000;105(1 pt 1):186-188. https://doi.org/10.1016/s0091-6749(00)90198-2. Pang YT, Eskici O, Wilson JA. Nasal polyposis: role of subclinical delayed food hypersensitivity. Otolaryngol Head Neck Surg. 2000;122(2):298-301. https://doi.org/10.1016/S0194-5998(00)70259-2. Pumhirun P, Limitlaohapanth C, Wasuwat P. Role of allergy in nasal polyps of Thai patients. Asian Pac J Allergy Immunol. 1999;17(1):13-15. Keith PK, Conway M, Evans S, et al. Nasal polyps: effects of seasonal allergen exposure. J Allergy Clin Immunol. 1994;93(3):567-574. https://doi.org/10.1016/s0091-6749(94)70068-0. Ence BK, Gourley DS, Jorgensen NL, et al. Allergic fungal sinusitis. Am J Rhinol. 1990;4:169-178. Schubert MS. Allergic fungal sinusitis. Otolaryngol Clin North Am. 2004;37(2):301-326. https://doi.org/10.1016/S0030-6665(03)00152-X. Bent 3rd JP, Kuhn FA. Diagnosis of allergic fungal sinusitis. Otolaryngol Head Neck Surg. 1994;111(5):580-588. https://doi.org/10.1177/019459989411100508. Saravanan K, Panda NK, Chakrabarti A, Das A, Bapuraj RJ. Allergic fungal rhinosinusitis: an attempt to resolve the diagnostic dilemma. Arch Otolaryngol Head Neck Surg. 2006;132(2):173-178. https://doi.org/10.1001/archotol.132.2.173. Hutcheson PS, Schubert MS, Slavin RG. Distinctions between allergic fungal rhinosinusitis and chronic rhinosinusitis. Am J Rhinol Allergy. 2010;24(6):405-408. https://doi.org/10.2500/ajra.2010.24.3533. Manning SC, Mabry RL, Schaefer SD, Close LG. Evidence of IgE-mediated hypersensitivity in allergic fungal sinusitis. Laryngoscope. 1993;103(7):717-721. https://doi.org/10.1288/00005537-199307000-00002. Stewart AE, Hunsaker DH. Fungus-specific IgG and IgE in allergic fungal rhinosinusitis. Otolaryngol Head Neck Surg. 2002;127(4):324-332. https://doi.org/10.1067/mhn.2002.126801. Ryan MW, Marple BF. Allergic fungal rhinosinusitis: diagnosis and management. Curr Opin Otolaryngol Head Neck Surg. 2007;15(1):18-22. https://doi.org/10.1097/MOO.0b013e328013dbd9. Collins M, Nair S, Smith W, Kette F, Gillis D, Wormald PJ. Role of local immunoglobulin E production in the pathophysiology of noninvasive fungal sinusitis. Laryngoscope. 2004;114(7):1242-1246. https://doi.org/10.1097/00005537-200407000-00019. Wise SK, Ahn CN, Lathers DM, Mulligan RM, Schlosser RJ. Antigen-specific IgE in sinus mucosa of allergic fungal rhinosinusitis patients. Am J Rhinol. 2008;22(5):451-456. https://doi.org/10.2500/ajr.2008.22.3227. Chang YT, Fang SY. Tissue-specific immunoglobulin E in maxillary sinus mucosa of allergic fungal sinusitis. Rhinology. 2008;46(3):226-230. Kuhn FA, Swain Jr R. Allergic fungal sinusitis: diagnosis and treatment. Curr Opin Otolaryngol Head Neck Surg. 2003;11(1):1-5. https://doi.org/10.1097/00020840-200302000-00001. Mabry RL, Marple BF, Folker RJ, Mabry CS. Immunotherapy for allergic fungal sinusitis: three years' experience. Otolaryngol Head Neck Surg. 1998;119(6):648-651. https://doi.org/10.1016/S0194-5998(98)70027-0. Folker RJ, Marple BF, Mabry RL, Mabry CS. Treatment of allergic fungal sinusitis: a comparison trial of postoperative immunotherapy with specific fungal antigens. Laryngoscope. 1998;108(11 pt 1):1623-1627. https://doi.org/10.1097/00005537-199811000-00007. Gan EC, Thamboo A, Rudmik L, Hwang PH, Ferguson BJ, Javer AR. Medical management of allergic fungal rhinosinusitis following endoscopic sinus surgery: an evidence-based review and recommendations. Int Forum Allergy Rhinol. 2014;4(9):702-715. https://doi.org/10.1002/alr.21352. Doellman MS, Dion GR, Weitzel EK, Reyes EG. Immunotherapy in allergic fungal sinusitis: the controversy continues. A recent review of literature. Allergy Rhinol (Providence). 2013;4(1):e32-e35. https://doi.org/10.2500/ar.2013.4.0045. Pant H, Kette FE, Smith WB, Wormald PJ, Macardle PJ. Fungal-specific humoral response in eosinophilic mucus chronic rhinosinusitis. Laryngoscope. 2005;115(4):601-606. https://doi.org/10.1097/01.mlg.0000161341.00258.54. Clark DW, Wenaas A, Luong A, Citardi MJ, Fakhri S. Staphylococcus aureus prevalence in allergic fungal rhinosinusitis vs other subsets of chronic rhinosinusitis with nasal polyps. Int Forum Allergy Rhinol. 2013;3(2):89-93. https://doi.org/10.1002/alr.21090. Ponikau JU, Sherris DA, Kern EB, et al. The diagnosis and incidence of allergic fungal sinusitis. Mayo Clin Proc. 1999;74(9):877-884. https://doi.org/10.4065/74.9.877. Cody 2nd DT, Neel 3rd HB, Ferreiro JA, Roberts GD. Allergic fungal sinusitis: the Mayo Clinic experience. Laryngoscope. 1994;104(9):1074-1079. https://doi.org/10.1288/00005537-199409000-00005. Dykewicz MS, Rodrigues JM, Slavin RG. Allergic fungal rhinosinusitis. J Allergy Clin Immunol. 2018;142(2):341-351. https://doi.org/10.1016/j.jaci.2018.06.023. Tyler MA, Luong AU. Current understanding of allergic fungal rhinosinusitis. World J Otorhinolaryngol Head Neck Surg. 2018;4(3):179-185. https://doi.org/10.1016/j.wjorl.2018.08.003. Lin YT, Lin CF, Liao CK, Chiang BL, Yeh TH. Clinical characteristics and cytokine profiles of central-compartment-type chronic rhinosinusitis. Int Forum Allergy Rhinol. 2021;11(7):1064-1073. https://doi.org/10.1002/alr.22759. Makary CA, Falco J, Sussman S, et al. Disease involvement in the central compartment in eosinophilic chronic rhinosinusitis. Int Forum Allergy Rhinol. 2021;11(10):1417-1423. https://doi.org/10.1002/alr.22803. Schertzer JS, Levy JM, Wise SK, Magliocca KR, DelGaudio JM. Is respiratory epithelial adenomatoid hamartoma related to central compartment atopic disease? Am J Rhinol Allergy. 2020;34(5):610-617. https://doi.org/10.1177/1945892420914212. Laidlaw TM, Boyce JA. Pathogenesis of aspirin-exacerbated respiratory disease and reactions. Immunol Allergy Clin North Am. 2013;33(2):195-210. https://doi.org/10.1016/j.iac.2012.11.006. Samter M, Beers Jr RF. Intolerance to aspirin. Clinical studies and consideration of its pathogenesis. Ann Intern Med. 1968;68(5):975-983. https://doi.org/10.7326/0003-4819-68-5-975. Bochenek G, Kuschill-Dziurda J, Szafraniec K, Plutecka H, Szczeklik A, Nizankowska-Mogilnicka E. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis. J Allergy Clin Immunol. 2014;133(1):98-103.e1-6. https://doi.org/10.1016/j.jaci.2013.07.004. Berges-Gimeno MP, Simon RA, Stevenson DD. The natural history and clinical characteristics of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol. 2002;89(5):474-478. https://doi.org/10.1016/S1081-1206(10)62084-4. Jakiela B, Soja J, Sladek K, et al. Heterogeneity of lower airway inflammation in patients with NSAID-exacerbated respiratory disease. J Allergy Clin Immunol. 2021;147(4):1269-1280. https://doi.org/10.1016/j.jaci.2020.08.007. Dona I, Barrionuevo E, Salas M, et al. NSAIDs-hypersensitivity often induces a blended reaction pattern involving multiple organs. Sci Rep. 2018;8(1):16710. https://doi.org/10.1038/s41598-018-34668-1. Bochenek G, Nizankowska E, Szczeklik A. The atopy trait in hypersensitivity to nonsteroidal anti-inflammatory drugs. Allergy. 1996;51(1):16-23. https://doi.org/10.1111/j.1398-9995.1996.tb04544.x. Stevens WW, Peters AT, Hirsch AG, et al. Clinical characteristics of patients with chronic rhinosinusitis with nasal polyps, asthma, and aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2017;5(4):1061-1070.e3. https://doi.org/10.1016/j.jaip.2016.12.027. Brown HJ, Tajudeen BA, Kuhar HN, Gattuso P, Batra PS, Mahdavinia M. Defining the allergic endotype of chronic rhinosinusitis by structured histopathology and clinical variables. J Allergy Clin Immunol Pract. 2021;9(10):3797-3804. https://doi.org/10.1016/j.jaip.2021.06.013. Buchheit KM, Dwyer DF, Ordovas-Montanes J, et al. IL-5 Ralpha marks nasal polyp IgG4- and IgE-expressing cells in aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2020;145(6):1574-1584. https://doi.org/10.1016/j.jaci.2020.02.035. Ta V, White AA. Survey-defined patient experiences with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol Pract. 2015;3(5):711-718. https://doi.org/10.1016/j.jaip.2015.03.001. Haque R, White AA, Jackson DJ, Hopkins C. Clinical evaluation and diagnosis of aspirin-exacerbated respiratory disease. J Allergy Clin Immunol. 2021;148(2):283-291. https://doi.org/10.1016/j.jaci.2021.06.018. Leonardi A, Castegnaro A, Valerio AL, Lazzarini D. Epidemiology of allergic conjunctivitis: clinical appearance and treatment patterns in a population-based study. Curr Opin Allergy Clin Immunol. 2015;15(5):482-488. https://doi.org/10.1097/ACI.0000000000000204. Miyazaki D, Fukagawa K, Okamoto S, et al. Epidemiological aspects of allergic conjunctivitis. Allergol Int. 2020;69(4):487-495. https://doi.org/10.1016/j.alit.2020.06.004. Singh K, Axelrod S, Bielory L. The epidemiology of ocular and nasal allergy in the United States, 1988-1994. J Allergy Clin Immunol. 2010;126(4):778-783.e6. https://doi.org/10.1016/j.jaci.2010.06.050. Navarro A, Colas C, Anton E, et al. Epidemiology of allergic rhinitis in allergy consultations in Spain: Alergologica-2005. J Investig Allergol Clin Immunol. 2009;19(suppl 2):7-13. Kosrirukvongs P, Visitsunthorn N, Vichyanond P, Bunnag C. Allergic conjunctivitis. Asian Pac J Allergy Immunol. 2001;19(4):237-244. Kim DH, Park YS, Jang HJ, Kim JH, Lim DH. Prevalence and allergen of allergic rhinitis in Korean children. Am J Rhinol Allergy. 2016;30(3):72-78. https://doi.org/10.2500/ajra.2013.27.4317. Han DH, Ahn JC, Mun SJ, Park SK, Oh SY, Rhee CS. Novel risk factors for allergic rhinitis in korean elementary school children: ARCO-kids Phase II in a Community. Allergy Asthma Immunol Res. 2015;7(3):234-240. https://doi.org/10.4168/aair.2015.7.3.234. Cibella F, Ferrante G, Cuttitta G, et al. The burden of rhinitis and rhinoconjunctivitis in adolescents. Allergy Asthma Immunol Res. 2015;7(1):44-50. https://doi.org/10.4168/aair.2015.7.1.44. Gradman J, Wolthers OD. Allergic conjunctivitis in children with asthma, rhinitis and eczema in a secondary outpatient clinic. Pediatr Allergy Immunol. 2006;17(7):524-526. https://doi.org/10.1111/j.1399-3038.2006.00429.x. Williams DC, Edney G, Maiden B, Smith PK. Recognition of allergic conjunctivitis in patients with allergic rhinitis. World Allergy Organ J. 2013;6(1):4. https://doi.org/10.1186/1939-4551-6-4. Wuthrich B, Brignoli R, Canevascini M, Gerber M. Epidemiological survey in hay fever patients: symptom prevalence and severity and influence on patient management. Schweiz Med Wochenschr. 1998;128(5):139-143. Sánchez-Hernández MC, Dordal MT, Navarro AM, et al., Severity and duration of allergic conjunctivitis: are they associated with severity and duration of allergic rhinitis and asthma? Eur Ann Allergy Clin Immunol. 2022;54(6):277-283. doi: https://doi.org/10.23822/EurAnnACI.1764-1489.231. Zhang SY, Li J, Liu R, et al. Association of allergic conjunctivitis with health-related quality of life in children and their parents. JAMA Ophthalmol. 2021;139(8):830-837. https://doi.org/10.1001/jamaophthalmol.2021.1708. Bielory L, Katelaris CH, Lightman S, Naclerio RM. Treating the ocular component of allergic rhinoconjunctivitis and related eye disorders. MedGenMed. 2007;9(3):35. Bielory L, Skoner DP, Blaiss MS, et al. Ocular and nasal allergy symptom burden in America: the Allergies, Immunotherapy, and RhinoconjunctivitiS (AIRS) surveys. Allergy Asthma Proc. 2014;35(3):211-218. https://doi.org/10.2500/aap.2014.35.3750. Frolund L, Durham SR, Calderon M, et al. Sustained effect of SQ-standardized grass allergy immunotherapy tablet on rhinoconjunctivitis quality of life. Allergy. 2010;65(6):753-757. https://doi.org/10.1111/j.1398-9995.2009.02238.x. Sayed KM, Kamel AG, Ali AH. One-year evaluation of clinical and immunological efficacy and safety of sublingual versus subcutaneous allergen immunotherapy in allergic conjunctivitis. Graefes Arch Clin Exp Ophthalmol. 2019;257(9):1989-1996. https://doi.org/10.1007/s00417-019-04389-w. Alexandropoulos T, Haidich AB, Pilalas D, Dardavessis T, Daniilidis M, Arvanitidou M. Characteristics of patients with allergic rhinitis in an outpatient clinic: a retrospective study. Allergol Immunopathol (Madr). 2013;41(3):194-200. https://doi.org/10.1016/j.aller.2011.12.008. Almaliotis D, Michailopoulos P, Gioulekas D, et al. Allergic conjunctivitis and the most common allergens in Northern Greece. World Allergy Organ J. 2013;6(1):12. https://doi.org/10.1186/1939-4551-6-12. Langan SM, Irvine AD, Weidinger S. Atopic dermatitis. Lancet. 2020;396(10247):345-360. https://doi.org/10.1016/S0140-6736(20)31286-1. Laughter MR, Maymone MBC, Mashayekhi S, et al. The global burden of atopic dermatitis: lessons from the Global Burden of Disease Study 1990-2017. Br J Dermatol. 2021;184(2):304-309. https://doi.org/10.1111/bjd.19580. Gabryszewski SJ, Chang X, Dudley JW, et al. Unsupervised modeling and genome-wide association identify novel features of allergic march trajectories. J Allergy Clin Immunol. 2021;147(2):677-685.e10. https://doi.org/10.1016/j.jaci.2020.06.026. Hill DA, Grundmeier RW, Ramos M, Spergel JM. Eosinophilic esophagitis is a late manifestation of the allergic march. J Allergy Clin Immunol Pract. 2018;6(5):1528-1533. https://doi.org/10.1016/j.jaip.2018.05.010. Tan R, Cvetkovski B, Kritikos V, et al. Identifying the hidden burden of allergic rhinitis (AR) in community pharmacy: a global phenomenon. Asthma Res Pract. 2017;3:8. https://doi.org/10.1186/s40733-017-0036-z. González-Mendoza T, Bedolla-Barajas M, Bedolla-Pulido TR, et al., La prevalencia de rinitis alérgica y dermatitis atópica en adolescentes tardíos difiere de acuerdo con el sexo [The prevalence of allergic rhinitis and atopic dermatitis in late adolescents differs according to their gender]. Rev Alerg Mex. 2019;66(2):147-153. doi: https://doi.org/10.29262/ram.v66i2.521. Bekic S, Martinek V, Talapko J, Majnaric L, Vasilj Mihaljevic M, Skrlec I. Atopic dermatitis and comorbidity. Healthcare (Basel). 2020;8(2):70. https://doi.org/10.3390/healthcare8020070. Huang YH, Huang LH, Kuo CF, Yu KH. Familial aggregation of atopic dermatitis and co-aggregation of allergic diseases in affected families in Taiwan. J Dermatol Sci. 2020;100(1):15-22. https://doi.org/10.1016/j.jdermsci.2020.07.007. Schoos AM, Chawes BL, Bønnelykke K, Stokholm J, Rasmussen MA, Bisgaard H. Increasing severity of early-onset atopic dermatitis, but not late-onset, associates with development of aeroallergen sensitization and allergic rhinitis in childhood. Allergy. 2022;77(4):1254-62. Wang LC, Chiang BL. Early-onset-early-resolving atopic dermatitis does not increase the risk of development of allergic diseases at 3 years old. J Formos Med Assoc. 2020;119(12):1854-1861. https://doi.org/10.1016/j.jfma.2020.02.014. Dharma C, Lefebvre DL, Tran MM, et al. Patterns of allergic sensitization and atopic dermatitis from 1 to 3 years: effects on allergic diseases. Clin Exp Allergy. 2018;48(1):48-59. https://doi.org/10.1111/cea.13063. Huang Y, Zhang Y, Zhang L. Prevalence of allergic and nonallergic rhinitis in a rural area of northern China based on sensitization to specific aeroallergens. Allergy Asthma Clin Immunol. 2018;14:77. https://doi.org/10.1186/s13223-018-0299-9. Biagini JM, Kroner JW, Baatyrbek Kyzy A, et al., Longitudinal atopic dermatitis endotypes: an atopic march paradigm that includes Black children. J Allergy Clin Immunol. 2022;149(5):1702-1710.e4. https://doi.org/10.1016/j.jaci.2021.09.036. Jeong JW, Lim KH, Lee WH, Won JY, Kwon JW. Heterogeneity of adult rhinitis for multimorbidity and age at onset among non-sensitized rhinitis and mono-/poly-sensitized rhinitis: a retrospective cross-sectional study. Int Arch Allergy Immunol. 2020;181(7):512-521. https://doi.org/10.1159/000507444. Raciborski F, Bousquet J, Bousqet J, et al. Dissociating polysensitization and multimorbidity in children and adults from a Polish general population cohort. Clin Transl Allergy. 2019;9:4. https://doi.org/10.1186/s13601-019-0246-y. Moreno-Lopez S, Perez-Herrera LC, Penaranda D, Hernandez DC, Garcia E, Penaranda A. Prevalence and associated factors of allergic diseases in school children and adolescents aged 6-7 and 13-14 years from two rural areas in Colombia. Allergol Immunopathol (Madr). 2021;49(3):153-161. https://doi.org/10.15586/aei.v49i3.183. Williams H, Robertson C, Stewart A, et al. Worldwide variations in the prevalence of symptoms of atopic eczema in the International Study of Asthma and Allergies in Childhood. J Allergy Clin Immunol. 1999;103(1 pt 1):125-138. https://doi.org/10.1016/s0091-6749(99)70536-1. Kim JP, Chao LX, Simpson EL, Silverberg JI. Persistence of atopic dermatitis (AD): a systematic review and meta-analysis. J Am Acad Dermatol. 2016;75(4):681-687.e11. https://doi.org/10.1016/j.jaad.2016.05.028. Rhodes HL, Thomas P, Sporik R, Holgate ST, Cogswell JJ. A birth cohort study of subjects at risk of atopy: twenty-two-year follow-up of wheeze and atopic status. Am J Respir Crit Care Med. 2002;165(2):176-180. https://doi.org/10.1164/ajrccm.165.2.2104032. Gustafsson D, Sjoberg O, Foucard T. Development of allergies and asthma in infants and young children with atopic dermatitis - a prospective follow-up to 7 years of age. Allergy. 2000;55(3):240-245. https://doi.org/10.1034/j.1398-9995.2000.00391.x. Schneider L, Hanifin J, Boguniewicz M, et al. Study of the atopic march: development of atopic comorbidities. Pediatr Dermatol. 2016;33(4):388-398. https://doi.org/10.1111/pde.12867. Mortz CG, Andersen KE, Dellgren C, Barington T, Bindslev-Jensen C. Atopic dermatitis from adolescence to adulthood in the TOACS cohort: prevalence, persistence and comorbidities. Allergy. 2015;70(7):836-845. https://doi.org/10.1111/all.12619. Sybilski AJ, Raciborski F, Lipiec A, et al. Atopic dermatitis is a serious health problem in Poland. Epidemiology studies based on the ECAP study. Postepy Dermatol Alergol. 2015;32(1):1-10. https://doi.org/10.5114/pdia.2014.40935. Bozek A, Jarzab J. Epidemiology of IgE-dependent allergic diseases in elderly patients in Poland. Am J Rhinol Allergy. 2013;27(5):e140-e145. https://doi.org/10.2500/ajra.2013.27.3920. Lowe AJ, Hosking CS, Bennett CM, et al. Skin prick test can identify eczematous infants at risk of asthma and allergic rhinitis. Clin Exp Allergy. 2007;37(11):1624-1631. https://doi.org/10.1111/j.1365-2222.2007.02822.x. Karaman O, Turgut CS, Uzuner N, et al. The determination of asthma, rhinitis, eczema, and atopy prevalence in 9- to 11-year-old children in the city of Izmir. Allergy Asthma Proc. 2006;27(4):319-324. https://doi.org/10.2500/aap.2006.27.2877. Yemaneberhan H, Flohr C, Lewis SA, et al. Prevalence and associated factors of atopic dermatitis symptoms in rural and urban Ethiopia. Clin Exp Allergy. 2004;34(5):779-785. https://doi.org/10.1111/j.1365-2222.2004.1946.x. Min YG, Choi BY, Kwon SK, et al. Multicenter study on the prevalence of perennial allergic rhinitis and allergy-associated disorders. J Korean Med Sci. 2001;16(6):697-701. https://doi.org/10.3346/jkms.2001.16.6.697. Leung R, Ho P. Asthma, allergy, and atopy in three south-east Asian populations. Thorax. 1994;49(12):1205-1210. https://doi.org/10.1136/thx.49.12.1205. Batlles Garrido J, Torres-Borrego J, Bonillo Perales A, et al. Prevalence and factors linked to atopic eczema in 10- and 11-year-old schoolchildren. Isaac 2 in Almeria, Spain. Allergol Immunopathol (Madr). 2010;38(4):174-180. https://doi.org/10.1016/j.aller.2009.10.008. Peroni DG, Piacentini GL, Bodini A, Rigotti E, Pigozzi R, Boner AL. Prevalence and risk factors for atopic dermatitis in preschool children. Br J Dermatol. 2008;158(3):539-543. https://doi.org/10.1111/j.1365-2133.2007.08344.x. Kidon MI, Chiang WC, Liew WK, et al. Sensitization to dust mites in children with allergic rhinitis in Singapore: does it matter if you scratch while you sneeze? Clin Exp Allergy. 2005;35(4):434-440. https://doi.org/10.1111/j.1365-2222.2005.02208.x. Kusel MM, Holt PG, de Klerk N, Sly PD. Support for 2 variants of eczema. J Allergy Clin Immunol. 2005;116(5):1067-1072. https://doi.org/10.1016/j.jaci.2005.06.038. Peroni DG, Piacentini GL, Alfonsi L, et al. Rhinitis in pre-school children: prevalence, association with allergic diseases and risk factors. Clin Exp Allergy. 2003;33(10):1349-1354. https://doi.org/10.1046/j.1365-2222.2003.01766.x. Ozdemir N, Ucgun I, Metintas S, Kolsuz M, Metintas M. The prevalence of asthma and allergy among university freshmen in Eskisehir, Turkey. Respir Med. 2000;94(6):536-541. https://doi.org/10.1053/rmed.1999.0728. Garcia-Gonzalez JJ, Vega-Chicote JM, Rico P, et al. Prevalence of atopy in students from Malaga, Spain. Ann Allergy Asthma Immunol. 1998;80(3):237-244. https://doi.org/10.1016/s1081-1206(10)62964-x. Cosme-Blanco W, Arroyo-Flores E, Ale H. Food allergies. Pediatr Rev. 2020;41(8):403-415. https://doi.org/10.1542/pir.2019-0037. Katelaris CH. Food allergy and oral allergy or pollen-food syndrome. Curr Opin Allergy Clin Immunol. 2010;10(3):246-251. https://doi.org/10.1097/ACI.0b013e32833973fb. Ebner C, Birkner T, Valenta R, et al. Common epitopes of birch pollen and apples-studies by western and northern blot. J Allergy Clin Immunol. 1991;88(4):588-594. https://doi.org/10.1016/0091-6749(91)90152-e. American Academy of Asthma Allergy & Immunology: Oral allergy syndrome - pollens and cross-reacting foods. Accessed March 19, 2022. https://www.aaaai.org/Aaaai/media/Media-Library-PDFs/Tools%20for%20the%20Public/Conditions%20Library/Library%20-%20Allergies/OAS-table_revised.pdf. Carlson G, Coop C. Pollen food allergy syndrome (PFAS): a review of current available literature. Ann Allergy Asthma Immunol. 2019;123(4):359-365. https://doi.org/10.1016/j.anai.2019.07.022. Dondi A, Tripodi S, Panetta V, et al. Pollen-induced allergic rhinitis in 1360 Italian children: comorbidities and determinants of severity. Pediatr Allergy Immunol. 2013;24(8):742-751. https://doi.org/10.1111/pai.12136. Sicherer SH, Warren CM, Dant C, Gupta RS, Nadeau KC. Food allergy from infancy through adulthood. J Allergy Clin Immunol Pract. 2020;8(6):1854-1864. https://doi.org/10.1016/j.jaip.2020.02.010. Ortolani C, Pastorello EA, Farioli L, et al. IgE-mediated allergy from vegetable allergens. Ann Allergy. 1993;71(5):470-476. Lieberman P, Nicklas RA, Randolph C, et al. Anaphylaxis - a practice parameter update 2015. Ann Allergy Asthma Immunol. 2015;115(5):341-384. https://doi.org/10.1016/j.anai.2015.07.019. Skamstrup Hansen K, Vestergaard H, Stahl Skov P, et al. Double-blind, placebo-controlled food challenge with apple. Allergy. 2001;56(2):109-117. https://doi.org/10.1034/j.1398-9995.2001.056002109.x. Rosen JP, Selcow JE, Mendelson LM, Grodofsky MP, Factor JM, Sampson HA. Skin testing with natural foods in patients suspected of having food allergies: is it a necessity? J Allergy Clin Immunol. 1994;93(6):1068-1070. https://doi.org/10.1016/s0091-6749(94)70056-7. de Jong NW, Terlouw S, van Boven FE, et al. Birch pollen related pear allergy: a single-blind oral challenge TRIAL with 2 pear cultivars. Nutrients. 2021;13(4):1355. https://doi.org/10.3390/nu13041355. Lee SC, Kim SR, Park KH, Lee JH, Park JW. Clinical features and culprit food allergens of Korean adult food allergy patients: a cross-sectional single-institute study. Allergy Asthma Immunol Res. 2019;11(5):723-735. https://doi.org/10.4168/aair.2019.11.5.723. Fuhrmann V, Huang HJ, Akarsu A, et al. From allergen molecules to molecular immunotherapy of nut allergy: a hard nut to crack. Front Immunol. 2021;12:742732. https://doi.org/10.3389/fimmu.2021.742732. Thompson JC, Kroker GF. The role of component-resolved testing in food allergy and oral allergy syndrome. Ann Allergy Asthma Immunol. 2010;104(6):543; author reply 543-4. https://doi.org/10.1016/j.anai.2010.03.011. Nicolaou N, Poorafshar M, Murray C, et al. Allergy or tolerance in children sensitized to peanut: prevalence and differentiation using component-resolved diagnostics. J Allergy Clin Immunol. 2010;125(1):191-197.e1-13. https://doi.org/10.1016/j.jaci.2009.10.008. Bolhaar ST, Tiemessen MM, Zuidmeer L, et al. Efficacy of birch-pollen immunotherapy on cross-reactive food allergy confirmed by skin tests and double-blind food challenges. Clin Exp Allergy. 2004;34(5):761-769. https://doi.org/10.1111/j.1365-2222.2004.1939.x. Inuo C, Kondo Y, Tanaka K, et al. Japanese cedar pollen-based subcutaneous immunotherapy decreases tomato fruit-specific basophil activation. Int Arch Allergy Immunol. 2015;167(2):137-145. https://doi.org/10.1159/000437325. Asero R. Effects of birch pollen-specific immunotherapy on apple allergy in birch pollen-hypersensitive patients. Clin Exp Allergy. 1998;28(11):1368-1373. https://doi.org/10.1046/j.1365-2222.1998.00399.x. Mauro M, Russello M, Incorvaia C, et al. Birch-apple syndrome treated with birch pollen immunotherapy. Int Arch Allergy Immunol. 2011;156(4):416-422. https://doi.org/10.1159/000323909. Krouse JH, Chadwick SJ, Gordon BR, Derebery J. Allergy and Immunology: An Otolaryngic Approach. Lippincott Williams & Wilkins; 2002. Cudowska B, Pawlowicz M, Lebensztejn DM. Pollen-related food allergy in children with seasonal allergic rhinitis. Postepy Dermatol Alergol. 2021;38(2):96-101. https://doi.org/10.5114/ada.2021.104284. Thong BY, Arulanandam S, Tan SC, et al. Shellfish/crustacean oral allergy syndrome among national service pre-enlistees in Singapore. Asia Pac Allergy. 2018;8(2):e18. https://doi.org/10.5415/apallergy.2018.8.e18. Diaz-Cabrera NM, Sanchez-Borges MA, Ledford DK. Atopy: a collection of comorbid conditions. J Allergy Clin Immunol Pract. 2021;9(11):3862-3866. https://doi.org/10.1016/j.jaip.2021.09.002. Matsumoto M, Takenaka M, Aoyagi K, et al. Factors associated with the development of oral allergy syndrome: a retrospective questionnaire survey of Japanese university students. Allergol Int. 2021;70(4):458-462. https://doi.org/10.1016/j.alit.2021.02.003. Ota M, Nishida Y, Yagi H, et al. Regional differences in the prevalence of oral allergy syndrome among Japanese children: a questionnaire-based survey. Asian Pacific Journal of Allergy and Immunology. 2020. doi: https://doi.org/10.12932/ap-130120-0739. Anvari S, Miller J, Yeh CY, Davis CM. IgE-mediated food allergy. Clin Rev Allergy Immunol. 2019;57(2):244-260. https://doi.org/10.1007/s12016-018-8710-3. Tong X, Tong H, Gao L, et al. A multicenter study of prevalence and risk factors for allergic rhinitis in primary school children in 5 cities of Hubei Province, China. Int Arch Allergy Immunol. 2022;183(1):34-44. https://doi.org/10.1159/000517948. Celakovska J, Bukac J. Analysis of food allergy in atopic dermatitis patients - association with concomitant allergic diseases. Indian J Dermatol. 2014;59(5):445-450. https://doi.org/10.4103/0019-5154.139867. Bilaver LA, Kanaley MK, Fierstein JL, Gupta RS. Prevalence and correlates of food allergy among medicaid-enrolled United States children. Acad Pediatr. 2021;21(1):84-92. https://doi.org/10.1016/j.acap.2020.03.005. Wang HT, Warren CM, Gupta RS, Davis CM. Prevalence and characteristics of shellfish allergy in the pediatric population of the United States. J Allergy Clin Immunol Pract. 2020;8(4):1359-1370.e2. https://doi.org/10.1016/j.jaip.2019.12.027. Ruffner MA, Wang KY, Dudley JW, et al. Elevated atopic comorbidity in patients with food protein-induced enterocolitis. J Allergy Clin Immunol Pract. 2020;8(3):1039-1046. https://doi.org/10.1016/j.jaip.2019.10.047. Bedolla-Pulido TR, Bedolla-Barajas M, Morales-Romero J, et al. Self-reported hypersensitivity and allergy to foods amongst Mexican adolescents: prevalence and associated factors. Allergol Immunopathol (Madr). 2019;47(3):246-253. https://doi.org/10.1016/j.aller.2018.09.004. Hill DA, Grundmeier RW, Ram G, Spergel JM. The epidemiologic characteristics of healthcare provider-diagnosed eczema, asthma, allergic rhinitis, and food allergy in children: a retrospective cohort study. BMC Pediatr. 2016;16:133. https://doi.org/10.1186/s12887-016-0673-z. Huang Y, Wang C, Zhang Y, Zhang L. Developing nomograms for identifying allergic rhinitis among chronic rhinitis: a real-world study. World Allergy Organ J. 2021;14(4):100534. https://doi.org/10.1016/j.waojou.2021.100534. Walter G, Kalicinsky C. Adult-onset IgE-mediated food allergy at a Winnipeg allergy clinic: a case series. Allergy Asthma Clin Immunol. 2020;16:85. https://doi.org/10.1186/s13223-020-00483-5. Lyons SA, Knulst AC, Burney PGJ, et al. Predicting food allergy: the value of patient history reinforced. Allergy. 2021;76(5):1454-1462. https://doi.org/10.1111/all.14583. Blaiss MS, Meadows JA, Yu S, et al. Economic burden of peanut allergy in pediatric patients with evidence of reactions to peanuts in the United States. J Manag Care Spec Pharm. 2021;27(4):516-527. https://doi.org/10.18553/jmcp.2021.20389. Blumchen K, DunnGalvin A, Timmermans F, et al. APPEAL-1: a pan-European survey of patient/caregiver perceptions of peanut allergy management. Allergy. 2020;75(11):2920-2935. https://doi.org/10.1111/all.14414. Scott LA, Jones BI, Berni TR, Berni ER, De Vries J, Currie CJ. Evaluation of the epidemiology of peanut allergy in the United Kingdom. Expert Rev Clin Immunol. 2019;15(12):1333-1339. https://doi.org/10.1080/1744666X.2020.1693264. Bedolla-Barajas M, Bedolla-Pulido TR, Macriz-Romero N, Morales-Romero J, Robles-Figueroa M. Prevalence of peanut, tree nut, sesame, and seafood allergy in Mexican adults. Rev Invest Clin. 2015;67(6):379-386. Taylor-Black S, Wang J. The prevalence and characteristics of food allergy in urban minority children. Ann Allergy Asthma Immunol. 2012;109(6):431-437. https://doi.org/10.1016/j.anai.2012.09.012. Diez S, Puerta L, Martinez D, Munoz M, Hernandez K, Sanchez J. Clinical relevance of shrimp sensitization in patients with allergic rhinitis: anti-Der p 10 IgE as predictor. Int Arch Allergy Immunol. 2021;182(10):971-979. https://doi.org/10.1159/000516005. Du Toit G, Roberts G, Sayre PH, et al. Identifying infants at high risk of peanut allergy: the Learning Early About Peanut Allergy (LEAP) screening study. J Allergy Clin Immunol. 2013;131(1):135-143.e1-12. https://doi.org/10.1016/j.jaci.2012.09.015. Fleischer DM, Sicherer S, Greenhawt M, et al. Consensus communication on early peanut introduction and the prevention of peanut allergy in high-risk infants. Pediatrics. 2015;136(3):600-604. https://doi.org/10.1542/peds.2015-2394. Logan K, Du Toit G, Giovannini M, Turcanu V, Lack G. Pediatric allergic diseases, food allergy, and oral tolerance. Annu Rev Cell Dev Biol. 2020;36:511-528. https://doi.org/10.1146/annurev-cellbio-100818-125346. Webber CM, England RW. Oral allergy syndrome: a clinical, diagnostic, and therapeutic challenge. Ann Allergy Asthma Immunol. 2010;104(2):101-108; quiz 109-10, 117. https://doi.org/10.1016/j.anai.2009.11.007. American College of Allergy, Asthma, & Immunology. Food allergy: a practice parameter. Ann Allergy Asthma Immunol. 2006;96(3 suppl 2):S1-S68. Lam HY, Tergaonkar V, Ahn KS. Mechanisms of allergen-specific immunotherapy for allergic rhinitis and food allergies. Biosci Rep. 2020;40(4):BSR20200256. https://doi.org/10.1042/BSR20200256. Schoos AM, Bullens D, Chawes BL, et al. Immunological outcomes of allergen-specific immunotherapy in food allergy. Front Immunol. 2020;11:568598. https://doi.org/10.3389/fimmu.2020.568598. Tordesillas L, Berin MC, Sampson HA. Immunology of food allergy. Immunity. 2017;47(1):32-50. https://doi.org/10.1016/j.immuni.2017.07.004. Marseglia GL, Poddighe D, Caimmi D, et al. Role of adenoids and adenoiditis in children with allergy and otitis media. Curr Allergy Asthma Rep. 2009;9(6):460-464. https://doi.org/10.1007/s11882-009-0068-4. Cassano P, Gelardi M, Cassano M, Fiorella ML, Fiorella R. Adenoid tissue rhinopharyngeal obstruction grading based on fiberendoscopic findings: a novel approach to therapeutic management. Int J Pediatr Otorhinolaryngol. 2003;67(12):1303-1309. https://doi.org/10.1016/j.ijporl.2003.07.018. Dogru M, Evcimik MF, Calim OF. Does adenoid hypertrophy affect disease severity in children with allergic rhinitis? Eur Arch Otorhinolaryngol. 2017;274(1):209-213. https://doi.org/10.1007/s00405-016-4196-x. Modrzynski M, Zawisza E. The influence of birch pollination on the adenoid size in children with intermittent allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2007;71(7):1017-1023. https://doi.org/10.1016/j.ijporl.2007.02.018. Atan Sahin O, Kececioglu N, Serdar M, Ozpinar A. The association of residential mold exposure and adenotonsillar hypertrophy in children living in damp environments. Int J Pediatr Otorhinolaryngol. 2016;88:233-238. https://doi.org/10.1016/j.ijporl.2016.07.018. Karaca CT, Toros SZ, Noseri H, et al. Role of allergy in children with adenotonsillar hypertrophy. J Craniofac Surg. 2012;23(6):e611-e613. https://doi.org/10.1097/SCS.0b013e31826cf562. Ameli F, Brocchetti F, Tosca MA, Signori A, Ciprandi G. Adenoidal hypertrophy and allergic rhinitis: is there an inverse relationship? Am J Rhinol Allergy. 2013;27(1):e5-e10. https://doi.org/10.2500/ajra.2013.27.3854. Sadeghi-Shabestari M, Jabbari Moghaddam Y, Ghaharri H. Is there any correlation between allergy and adenotonsillar tissue hypertrophy? Int J Pediatr Otorhinolaryngol. 2011;75(4):589-591. https://doi.org/10.1016/j.ijporl.2011.01.026. Eren E, Arslanoglu S, Erdem SB, et al. Chicken or the egg: the dilemma of allergic rhinitis versus adenoid hypertrophy. Rhinology. 2015;53(2):154-159. https://doi.org/10.4193/Rhino14.013. Karabulut B, Sahin-Onder S, Erkmen B, Cetemen A, Gergin O. Predictive fiberoptic endoscopic findings of upper airway in children with allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2019;124:143-146. https://doi.org/10.1016/j.ijporl.2019.06.004. Ni K, Zhao L, Wu J, Chen W, HongyaYang, Li X. Th17/Treg balance in children with obstructive sleep apnea syndrome and the relationship with allergic rhinitis. Int J Pediatr Otorhinolaryngol. 2015;79(9):1448-1454. https://doi.org/10.1016/j.ijporl.2015.06.026. Masieri S, Trabattoni D, Incorvaia C, et al. A role for Waldeyer's ring in immunological response to allergens. Curr Med Res Opin. 2014;30(2):203-205. https://doi.org/10.1185/03007995.2013.855185. Zhu F, Sun K, Yu L, Sun S, Wan Y, Shi L. Tissue cytokine adenoid experssion in hypertrophic adenoid gland in children with allergic rhinitis. J Coll Physicians Surg Pak. 2021;31(8):903-909. https://doi.org/10.29271/jcpsp.2021.08.903. Cho KS, Kim SH, Hong SL, et al. Local atopy in childhood adenotonsillar hypertrophy. Am J Rhinol Allergy. 2018;32(3):160-166. https://doi.org/10.1177/1945892418765003. Shin SY, Choi SJ, Hur GY, et al. Local production of total IgE and specific antibodies to the house dust mite in adenoid tissue. Pediatr Allergy Immunol. 2009;20(2):134-141. https://doi.org/10.1111/j.1399-3038.2008.00756.x. Shin SY, Ye YM, Eun YG, Kim SW, Cho JS, Park HS. Local IgE-mediated hypersensitivity to Alternaria in pediatric adenoid tissue. Int J Pediatr Otorhinolaryngol. 2012;76(10):1423-1428. https://doi.org/10.1016/j.ijporl.2012.06.015. Scadding G. Non-surgical treatment of adenoidal hypertrophy: the role of treating IgE-mediated inflammation. Pediatr Allergy Immunol. 2010;21(8):1095-1106. https://doi.org/10.1111/j.1399-3038.2010.01012.x. Zhang L, Mendoza-Sassi RA, Cesar JA, Chadha NK. Intranasal corticosteroids for nasal airway obstruction in children with moderate to severe adenoidal hypertrophy. Cochrane Database Syst Rev. 2008;(3):CD006286. https://doi.org/10.1002/14651858.CD006286.pub2. Chohan A, Lal A, Chohan K, Chakravarti A, Gomber S. Systematic review and meta-analysis of randomized controlled trials on the role of mometasone in adenoid hypertrophy in children. Int J Pediatr Otorhinolaryngol. 2015;79(10):1599-1608. https://doi.org/10.1016/j.ijporl.2015.07.009. Warman M, Granot E, Halperin D. Improvement in allergic and nonallergic rhinitis: a secondary benefit of adenoidectomy in children. Ear Nose Throat J. 2015;94(6):220;222;, 224-7. https://doi.org/10.1177/014556131509400607. Patel A, Brook CD, Levi JR. Factors associated with refractory nasal congestion following adenoidectomy. Ann Otol Rhinol Laryngol. 2021;130(2):148-152. https://doi.org/10.1177/0003489420940349. De Corso E, Galli J, Di Cesare T, et al. A systematic review of the clinical evidence and biomarkers linking allergy to adeno-tonsillar disease. Int J Pediatr Otorhinolaryngol. 2021;147:110799. https://doi.org/10.1016/j.ijporl.2021.110799. Pagella F, De Amici M, Pusateri A, et al. Adenoids and clinical symptoms: epidemiology of a cohort of 795 pediatric patients. Int J Pediatr Otorhinolaryngol. 2015;79(12):2137-2141. https://doi.org/10.1016/j.ijporl.2015.09.035. Schilder AG, Bhutta MF, Butler CC, et al. Eustachian tube dysfunction: consensus statement on definition, types, clinical presentation and diagnosis. Clin Otolaryngol. 2015;40(5):407-411. https://doi.org/10.1111/coa.12475. Yang B, Brook CD. The role of allergy in otologic disease. Otolaryngol Clin North Am. 2017;50(6):1091-1101. https://doi.org/10.1016/j.otc.2017.08.005. Fireman P. Otitis media and eustachian tube dysfunction: connection to allergic rhinitis. J Allergy Clin Immunol. 1997;99(2):S787-S797. https://doi.org/10.1016/s0091-6749(97)70130-1. Doyle WJ, Boehm S, Skoner DP. Physiologic responses to intranasal dose-response challenges with histamine, methacholine, bradykinin, and prostaglandin in adult volunteers with and without nasal allergy. J Allergy Clin Immunol. 1990;86(6 pt 1):924-935. https://doi.org/10.1016/s0091-6749(05)80156-3. Skoner DP, Doyle WJ, Boehm S, Fireman P. Priming of the nose and eustachian tube during nasal pollen exposure. Am J Rhinol Allergy. 1989;3(2):53-57. Friedman RA, Doyle WJ, Casselbrant ML, Bluestone C, Fireman P. Immunologic-mediated eustachian tube obstruction: a double-blind crossover study. J Allergy Clin Immunol. 1983;71(5):442-447. https://doi.org/10.1016/0091-6749(83)90459-1. Skoner DP, Doyle WJ, Chamovitz AH, Fireman P. Eustachian tube obstruction after intranasal challenge with house dust mite. Arch Otolaryngol Head Neck Surg. 1986;112(8):840-842. https://doi.org/10.1001/archotol.1986.03780080040008. Skoner DP, Doyle WJ, Fireman P. Eustachian tube obstruction (ETO) after histamine nasal provocation - a double-blind dose-response study. J Allergy Clin Immunol. 1987;79(1):27-31. https://doi.org/10.1016/s0091-6749(87)80012-x. O'Connor RD, Ort H, Leong AB, Cook DA, Street D, Hamburger RN. Tympanometric changes following nasal antigen challenge in children with allergic rhinitis. Ann Allergy. 1984;53(6):468-471. Downs BW, Butehorn 3rd HF, Prazma J, Rose AS, Stamat JC, Pillsbury 3rd HC. Action of histamine on eustachian tube function. Otolaryngol Head Neck Surg. 2001;124(4):414-420. https://doi.org/10.1067/mhn.2001.113943. Ebert Jr CS, Pollock HW, Dubin MG, et al. Effect of intranasal histamine challenge on Eustachian tube function. Int J Pediatr Otorhinolaryngol. 2002;63(3):189-198. https://doi.org/10.1016/s0165-5876(02)00007-1. Hardy SM, Heavner SB, White DR, McQueen CT, Prazma J, Pillsbury HC. Late-phase allergy and eustachian tube dysfunction. Otolaryngol Head Neck Surg. 2001;125(4):339-345. https://doi.org/10.1067/mhn.2001.119140. Osur SL, Volovitz B, Dickson S, Enck DC, Bernstein JM. Eustachian tube dysfunction in children with ragweed hayfever during natural pollen exposure. Allergy Proc. 1989;10(2):133-139. https://doi.org/10.2500/108854189778961071. Knight LC, Eccles R, Morris S. Seasonal allergic rhinitis and its effects on eustachian tube function and middle ear pressure. Clin Otolaryngol Allied Sci. 1992;17(4):308-312. https://doi.org/10.1111/j.1365-2273.1992.tb01002.x. Juszczak H, Aubin-Pouliot A, Sharon JD, Loftus PA. Sinonasal risk factors for eustachian tube dysfunction: cross-sectional findings from NHANES 2011-2012. Int Forum Allergy Rhinol. 2019;9(5):466-472. https://doi.org/10.1002/alr.22275. Lazo-Saenz JG, Galvan-Aguilera AA, Martinez-Ordaz VA, Velasco-Rodriguez VM, Nieves-Renteria A, Rincon-Castaneda C. Eustachian tube dysfunction in allergic rhinitis. Otolaryngol Head Neck Surg. 2005;132(4):626-629. https://doi.org/10.1016/j.otohns.2005.01.029. Gluth MB, McDonald DR, Weaver AL, Bauch CD, Beatty CW, Orvidas LJ. Management of eustachian tube dysfunction with nasal steroid spray: a prospective, randomized, placebo-controlled trial. Arch Otolaryngol Head Neck Surg. 2011;137(5):449-455. https://doi.org/10.1001/archoto.2011.56. Tucci DL, McCoul ED, Rosenfeld RM, et al. Clinical consensus statement: balloon dilation of the eustachian tube. Otolaryngol Head Neck Surg. 2019;161(1):6-17. https://doi.org/10.1177/0194599819848423. Pollock HW, Ebert CS, Dubin MG, White DR, Prazma J, Pillsbury 3rd HC. The role of soluble interleukin-4 receptor and interleukin-5 antibody in preventing late-phase allergy-induced eustachian tube dysfunction. Otolaryngol Head Neck Surg. 2002;127(3):169-176. https://doi.org/10.1067/mhn.2002.126901. Derebery MJ, Berliner KI. Allergic eustachian tube dysfunction: diagnosis and treatment. Am J Otol. 1997;18(2):160-165. Palmu A, Puhakka H, Rahko T, Takala AK. Diagnostic value of tympanometry in infants in clinical practice. Int J Pediatr Otorhinolaryngol. 1999;49(3):207-213. https://doi.org/10.1016/s0165-5876(99)00207-4. Rosenfeld RM, Shin JJ, Schwartz SR, et al. Clinical practice guideline: otitis media with effusion (update). Otolaryngol Head Neck Surg. 2016;154(1 suppl):S1-S41. https://doi.org/10.1177/0194599815623467. Caffarelli C, Savini E, Giordano S, Gianlupi G, Cavagni G. Atopy in children with otitis media with effusion. Clin Exp Allergy. 1998;28(5):591-596. https://doi.org/10.1046/j.1365-2222.1998.00284.x. Yeo SG, Park DC, Eun YG, Cha CI. The role of allergic rhinitis in the development of otitis media with effusion: effect on eustachian tube function. Am J Otolaryngol. 2007;28(3):148-152. https://doi.org/10.1016/j.amjoto.2006.07.011. Borge P. Atopy and secretory otitis media. Immunological studies and responses to topical corticosteroid therapy. J Laryngol Otol. 1983;97(2):117-129. https://doi.org/10.1017/s0022215100093890. Tomonaga K, Kurono Y, Mogi G. The role of nasal allergy in otitis media with effusion. A clinical study. Acta Otolaryngol Suppl. 1988;458:41-47. https://doi.org/10.3109/00016488809125100. Corey JP, Adham RE, Abbass AH, Seligman I. The role of IgE-mediated hypersensitivity in otitis media with effusion. Am J Otolaryngol. 1994;15(2):138-144. https://doi.org/10.1016/0196-0709(94)90063-9. Chantzi FM, Kafetzis DA, Bairamis T, et al. IgE sensitization, respiratory allergy symptoms, and heritability independently increase the risk of otitis media with effusion. Allergy. 2006;61(3):332-336. https://doi.org/10.1111/j.1398-9995.2006.00971.x. Gultekin E, Develioglu ON, Yener M, Ozdemir I, Kulekci M. Prevalence and risk factors for persistent otitis media with effusion in primary school children in Istanbul, Turkey. Auris Nasus Larynx. 2010;37(2):145-149. https://doi.org/10.1016/j.anl.2009.05.002. Sharifian MR, Mahmoudi M, Pourmomenarabi B, Keramati MR. Correlation between allergic rhinitis and otitis media with effusion. Iran J Otorhinolaryngol. 2019;31(105):209-215. Songu M, Islek A, Imre A, et al. Risk factors for otitis media with effusion in children with adenoid hypertrophy. Acta Otorhinolaryngol Ital. 2020;40(2):133-137. https://doi.org/10.14639/0392-100X-2456. McMahan JT, Calenoff E, Croft DJ, Barenholtz L, Weber LD. Chronic otitis media with effusion and allergy: modified RAST analysis of 119 cases. Otolaryngol Head Neck Surg. 1981;89(3 pt 1):427-431. https://doi.org/10.1177/019459988108900315. Hurst DS. Allergy management of refractory serous otitis media. Otolaryngol Head Neck Surg. 1990;102(6):664-669. https://doi.org/10.1177/019459989010200607. Hurst DS. Association of otitis media with effusion and allergy as demonstrated by intradermal skin testing and eosinophil cationic protein levels in both middle ear effusions and mucosal biopsies. Laryngoscope. 1996;106(9 pt 1):1128-1137. https://doi.org/10.1097/00005537-199609000-00017. Alles R, Parikh A, Hawk L, Darby Y, Romero JN, Scadding G. The prevalence of atopic disorders in children with chronic otitis media with effusion. Pediatr Allergy Immunol. 2001;12(2):102-106. https://doi.org/10.1046/j.0905-6157.2000.00008.x. Hurst DS. Efficacy of allergy immunotherapy as a treatment for patients with chronic otitis media with effusion. Int J Pediatr Otorhinolaryngol. 2008;72(8):1215-1223. https://doi.org/10.1016/j.ijporl.2008.04.013. Norhafizah S, Salina H, Goh BS. Prevalence of allergic rhinitis in children with otitis media with effusion. Eur Ann Allergy Clin Immunol. 2020;52(3):121-130. https://doi.org/10.23822/EurAnnACI.1764-1489.119. Kreiner-Moller E, Chawes BL, Caye-Thomasen P, Bonnelykke K, Bisgaard H. Allergic rhinitis is associated with otitis media with effusion: a birth cohort study. Clin Exp Allergy. 2012;42(11):1615-1620. https://doi.org/10.1111/j.1365-2222.2012.04038.x. Cheng X, Sheng H, Ma R, et al. Allergic rhinitis and allergy are risk factors for otitis media with effusion: a meta-analysis. Allergol Immunopathol (Madr). 2017;45(1):25-32. https://doi.org/10.1016/j.aller.2016.03.004. Byeon H. The association between allergic rhinitis and otitis media: a national representative sample of in South Korean children. Sci Rep. 2019;9(1):1610. https://doi.org/10.1038/s41598-018-38369-7. Torretta S, Pignataro L, Carioli D, et al. Phenotype profiling and allergy in otitis-prone children. Front Pediatr. 2018;6:383. https://doi.org/10.3389/fped.2018.00383. Bluestone CD. Current concepts in eustachian tube function as related to otitis media. Auris Nasus Larynx. 1985;12(suppl 1):S1-S4. https://doi.org/10.1016/s0385-8146(85)80083-3. Bluestone CD. Eustachian tube function: physiology, pathophysiology, and role of allergy in pathogenesis of otitis media. J Allergy Clin Immunol. 1983;72(3):242-251. https://doi.org/10.1016/0091-6749(83)90027-1. Bernstein JM, Ellis E, Li P. The role of IgE-mediated hypersensitivity in otitis media with effusion. Otolaryngol Head Neck Surg. 1981;89(5):874-878. https://doi.org/10.1177/019459988108900534. Bernstein JM, Lee J, Conboy K, Ellis E, Li P. The role of IgE-mediated hypersensitivity in recurrent otitis media with effusion. Am J Otol. 1983;5(1):66-69. Bernstein JM, Lee J, Conboy K, Ellis E, Li P. Further observations on the role of IgE-mediated hypersensitivity in recurrent otitis media with effusion. Otolaryngol Head Neck Surg. 1985;93(5):611-615. https://doi.org/10.1177/019459988509300508. Hurst DS, Weekley M, Ramanarayanan MP. Evidence of possible localized specific immunoglobulin E production in middle ear fluid as demonstrated by ELISA testing. Otolaryngol Head Neck Surg. 1999;121(3):224-230. https://doi.org/10.1016/S0194-5998(99)70176-2. Hurst DS, Venge P. Evidence of eosinophil, neutrophil, and mast-cell mediators in the effusion of OME patients with and without atopy. Allergy. 2000;55(5):435-441. https://doi.org/10.1034/j.1398-9995.2000.00289.x. Sobol SE, Taha R, Schloss MD, et al. T(H)2 cytokine expression in atopic children with otitis media with effusion. J Allergy Clin Immunol. 2002;110(1):125-130. https://doi.org/10.1067/mai.2002.125697. Tewfik TL, Mazer B. The links between allergy and otitis media with effusion. Curr Opin Otolaryngol Head Neck Surg. 2006;14(3):187-190. https://doi.org/10.1097/01.moo.0000193190.24849.f0. Wright ED, Hurst D, Miotto D, Giguere C, Hamid Q. Increased expression of major basic protein (MBP) and interleukin-5(IL-5) in middle ear biopsy specimens from atopic patients with persistent otitis media with effusion. Otolaryngol Head Neck Surg. 2000;123(5):533-538. https://doi.org/10.1067/mhn.2000.109472. Jang CH, Kim YH. Characterization of cytokines present in pediatric otitis media with effusion: comparison of allergy positive and negative. Int J Pediatr Otorhinolaryngol. 2002;66(1):37-40. https://doi.org/10.1016/s0165-5876(02)00185-4. Jang CH, Kim YH. Demonstration of RANTES and eosinophilic cataionic protein in otitis media with effusion with allergy. Int J Pediatr Otorhinolaryngol. 2003;67(5):531-533. https://doi.org/10.1016/s0165-5876(03)00015-6. Nguyen LH, Manoukian JJ, Tewfik TL, et al. Evidence of allergic inflammation in the middle ear and nasopharynx in atopic children with otitis media with effusion. J Otolaryngol. 2004;33(6):345-351. https://doi.org/10.2310/7070.2004.03073. Lildholdt T, Kortholm B. Beclomethasone nasal spray in the treatment of middle-ear effusion - a double-blind study. Int J Pediatr Otorhinolaryngol. 1982;4(2):133-137. https://doi.org/10.1016/0165-5876(82)90088-x. Williamson I, Benge S, Barton S, et al. Topical intranasal corticosteroids in 4-11 year old children with persistent bilateral otitis media with effusion in primary care: double blind randomised placebo controlled trial. BMJ. 2009;339:b4984. https://doi.org/10.1136/bmj.b4984. Griffin G, Flynn CA. Antihistamines and/or decongestants for otitis media with effusion (OME) in children. Cochrane Database Syst Rev. 2011;(9):CD003423. https://doi.org/10.1002/14651858.CD003423.pub3. Simpson SA, Lewis R, van der Voort J, Butler CC. Oral or topical nasal steroids for hearing loss associated with otitis media with effusion in children. Cochrane Database Syst Rev. 2011;(5):CD001935. https://doi.org/10.1002/14651858.CD001935.pub3. Schoem SR, Willard A, Combs JT. A prospective, randomized, placebo-controlled, double-blind study of montelukast's effect on persistent middle ear effusion. Ear Nose Throat J. 2010;89(9):434-437. Ertugay CK, Cingi C, Yaz A, et al. Effect of combination of montelukast and levocetirizine on otitis media with effusion: a prospective, placebo-controlled trial. Acta Otolaryngol. 2013;133(12):1266-1272. https://doi.org/10.3109/00016489.2013.824113. Sajjadi H, Paparella MM. Meniere's disease. Lancet. 2008;372(9636):406-414. https://doi.org/10.1016/S0140-6736(08)61161-7. Derebery MJ. Allergic and immunologic aspects of Meniere's disease. Otolaryngol Head Neck Surg. 1996;114(3):360-365. https://doi.org/10.1016/s0194-5998(96)70204-8. Derebery MJ, Berliner KI. Prevalence of allergy in Meniere's disease. Otolaryngol Head Neck Surg. 2000;123(1 pt 1):69-75. https://doi.org/10.1067/mhn.2000.105715. Tyrrell JS, Whinney DJ, Ukoumunne OC, Fleming LE, Osborne NJ. Prevalence, associated factors, and comorbid conditions for Meniere's disease. Ear Hear. 2014;35(4):e162-e169. https://doi.org/10.1097/AUD.0000000000000041. Sen P, Georgalas C, Papesch M. Co-morbidity of migraine and Meniere's disease - is allergy the link? J Laryngol Otol. 2005;119(6):455-460. https://doi.org/10.1258/0022215054273133. Keles E, Godekmerdan A, Kalidag T, et al. Meniere's disease and allergy: allergens and cytokines. J Laryngol Otol. 2004;118(9):688-693. https://doi.org/10.1258/0022215042244822. Roomiani M, Dehghani Firouzabadi F, Delbandi AA, et al. Evaluation of serum immunoreactivity to common indigenous iranian inhalation and food allergens in patients with Meniere's disease. Immunol Invest. 2021:1-10. https://doi.org/10.1080/08820139.2020.1869252. Ma Y, Sun Q, Zhang K, Bai L, Du L. High level of IgE in acute low-tone sensorineural hearing loss: a predictor for recurrence and Meniere disease transformation. Am J Otolaryngol. 2021;42(2):102856. https://doi.org/10.1016/j.amjoto.2020.102856. Hsu L, Zhu XN, Zhao YS. Immunoglobulin E and circulating immune complexes in endolymphatic hydrops. Ann Otol Rhinol Laryngol. 1990;99(7 pt 1):535-538. https://doi.org/10.1177/000348949009900707. Viscomi GJ, Bojrab DI. Use of electrocochleography to monitor antigenic challenge in Meniere's disease. Otolaryngol Head Neck Surg. 1992;107(6 pt 1):733-737. https://doi.org/10.1177/019459988910700604.1. Gibbs SR, Mabry RL, Roland PS, Shoup AG, Mabry CS. Electrocochleographic changes after intranasal allergen challenge: a possible diagnostic tool in patients with Meniere's disease. Otolaryngol Head Neck Surg. 1999;121(3):283-284. https://doi.org/10.1016/S0194-5998(99)70186-5. Derebery MJ, Valenzuela S. Meniere's syndrome and allergy. Otolaryngol Clin North Am. 1992;25(1):213-224. Derebery MJ. Allergic management of Meniere's disease: an outcome study. Otolaryngol Head Neck Surg. 2000;122(2):174-182. https://doi.org/10.1016/S0194-5998(00)70235-X. NCT04815187 - Repurposed use of allergic rhinitis and allergic asthma drug to reduce vertigo and hearing loss in Meniere's disease. Accessed March 6, 2021. https://clinicaltrials.gov/show/NCT04815187. Singh S, Nagarkar AN, Bansal S, Vir D, Gupta AK. Audiological manifestations of allergic rhinitis. J Laryngol Otol. 2011;125(9):906-910. https://doi.org/10.1017/S0022215111001137. Irwin RS, Baumann MH, Bolser DC, et al. Diagnosis and management of cough executive summary: ACCP evidence-based clinical practice guidelines. Chest. 2006;129(1 suppl):1S-23S. https://doi.org/10.1378/chest.129.1_suppl.1S. Passali D, de Benedetto F, de Benedetto M, et al. Rhino-bronchial syndrome. The SIO-AIMAR (Italian Society of Otorhinolaryngology, Head Neck Surgery-Interdisciplinary Scientific Association for the Study of the Respiratory Diseases) survey. Acta Otorhinolaryngol Ital. 2011;31(1):27-34. Krzych-Falta E, Piekarska B, Sybilski A, Wojas O, Samolinski B. The safety of nasal allergen challenge test assessed in lower airways. Iran J Allergy Asthma Immunol. 2015;14(6):581-588. Chakir J, Laviolette M, Turcotte H, Boutet M, Boulet LP. Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure. J Allergy Clin Immunol. 2000;106(5):904-910. https://doi.org/10.1067/mai.2000.110100. Chakir J, Laviolette M, Boutet M, Laliberte R, Dube J, Boulet LP. Lower airways remodeling in nonasthmatic subjects with allergic rhinitis. Lab Invest. 1996;75(5):735-44. Buday T, Gavliakova S, Mokry J, Medvedova I, Kavalcikova-Bogdanova N, Plevkova J. The guinea pig sensitized by house dust mite: a model of experimental cough studies. Adv Exp Med Biol. 2016;905:87-95. https://doi.org/10.1007/5584_2016_217. Lin HC, Cho SH, Ghoshal AG, et al. Respiratory diseases and the impact of cough in Taiwan: results from the APBORD observational study. Medicine (Baltimore). 2016;95(27):e3854. https://doi.org/10.1097/MD.0000000000003854. Cho SH, Lin HC, Ghoshal AG, et al. Respiratory disease in the Asia-Pacific region: cough as a key symptom. Allergy Asthma Proc. 2016;37(2):131-140. https://doi.org/10.2500/aap.2016.37.3925. He S, Li YJ, Chen J. Clinical features of allergic rhinitis in children of Shanghai, China. Genet Mol Res. 2016;15(2). https://doi.org/10.4238/gmr.15028118. Dicpinigiatis P, Birring S, McGarvey L, Schelfhout J, Tzontcheva A, Muccino D. Comorbid conditions and medical history among patients with refractory or unexplained chronic cough in two phase 3 clinical trials (COUGH-1 and COUGH-2). J Allergy Clin Immunol. 2021;147(2):AB61. Kim JH, Kim SA, Ku JY, Cho WK, Shin CH. Comparison of allergens and symptoms in patients with allergic rhinitis between 1990s and 2010s. Allergy Asthma Clin Immunol. 2020;16:58. https://doi.org/10.1186/s13223-020-00455-9. Tang W, Zhou J, Miao L, Shi G. Clinical features in patients of cough variant asthma with normal and high level of exhaled fractional nitric oxide. Clin Respir J. 2018;12(2):595-600. https://doi.org/10.1111/crj.12568. Nakajima T, Nagano T, Nishimura Y. Retrospective study of the effects of post-nasal drip symptoms on cough duration. In Vivo. 2021;35(3):1799-1803. https://doi.org/10.21873/invivo.12440. Chen LC, Zeng GS, Wu LL, et al. Diagnostic value of FeNO and MMEF for predicting cough variant asthma in chronic cough patients with or without allergic rhinitis. J Asthma. 2021;58(3):326-333. https://doi.org/10.1080/02770903.2019.1694035. Liu X, Wang X, Yao X, Wang Y, Sun Y, Zhang L. Value of exhaled nitric oxide and FEF25-75 in identifying factors associated with chronic cough in allergic rhinitis. Allergy Asthma Immunol Res. 2019;11(6):830-845. https://doi.org/10.4168/aair.2019.11.6.830. Deot N, Barr J, Mankowski N, Brunner J, McCoul ED. Effect of intranasal corticosteroids on secondary sinonasal symptoms: a systematic review of randomized trials. Am J Rhinol Allergy. 2019;33(5):601-607. https://doi.org/10.1177/1945892419844397. Reidy PM, Dworkin JP, Krouse JH. Laryngeal effects of antigen stimulation challenge with perennial allergen Dermatophagoides pteronyssinus. Otolaryngol Head Neck Surg. 2003;128(4):455-462. https://doi.org/10.1016/s0194-5998(03)00003-2. Lee K, Young Kang C, Lee H, Choi IH, Lee SH, Kim TH. Association of sinonasal factors with chronic laryngitis in Korean adults. JAMA Otolaryngol Head Neck Surg. 2019;145(10):919-925. https://doi.org/10.1001/jamaoto.2019.2134. Wang YT, Chang GH, Yang YH, et al. Allergic rhinitis and laryngeal pathology: real-world evidence. Healthcare (Basel). 2021;9(1):36. https://doi.org/10.3390/healthcare9010036. Millqvist E, Bende M, Brynnel M, Johansson I, Kappel S, Ohlsson AC. Voice change in seasonal allergic rhinitis. J Voice. 2008;22(4):512-515. https://doi.org/10.1016/j.jvoice.2006.12.003. Koc EA, Koc B, Erbek S. Comparison of acoustic and stroboscopic findings and voice handicap index between allergic rhinitis patients and controls. Balkan Med J. 2014;31(4):340-344. https://doi.org/10.5152/balkanmedj.2014.14511. Krouse JH, Dworkin JP, Carron MA, Stachler RJ. Baseline laryngeal effects among individuals with dust mite allergy. Otolaryngol Head Neck Surg. 2008;139(1):149-151. https://doi.org/10.1016/j.otohns.2008.04.001. Randhawa PS, Nouraei S, Mansuri S, Rubin JS. Allergic laryngitis as a cause of dysphonia: a preliminary report. Logoped Phoniatr Vocol. 2010;35(4):169-174. https://doi.org/10.3109/14015431003599012. Ohlsson AC, Drevsater A, Brynnel M, Johansson I. Allergic rhinitis and voice change. Logoped Phoniatr Vocol. 2016;41(4):143-148. https://doi.org/10.3109/14015439.2015.1049288. Velickovic V, Simovic S, Zovanovic S, Stojanovic J, Koravovic M, Mihailovic N. The factors asociated with allergic rhinitis in dysphonic professional voice users. Mediconski Casopis. 2017;51(3):73-78. Hamdan AL, Sibai A, Youssef M, Deeb R, Zaitoun F. The use of a screening questionnaire to determine the incidence of allergic rhinitis in singers with dysphonia. Arch Otolaryngol Head Neck Surg. 2006;132(5):547-549. https://doi.org/10.1001/archotol.132.5.547. Turley R, Cohen SM, Becker A, Ebert Jr CS. Role of rhinitis in laryngitis: another dimension of the unified airway. Ann Otol Rhinol Laryngol. 2011;120(8):505-510. https://doi.org/10.1177/000348941112000803. Simberg S, Sala E, Tuomainen J, Ronnemaa AM. Vocal symptoms and allergy - a pilot study. J Voice. 2009;23(1):136-139. https://doi.org/10.1016/j.jvoice.2007.03.010. Randhawa PS, Mansuri S, Rubin JS. Is dysphonia due to allergic laryngitis being misdiagnosed as laryngopharyngeal reflux? Logoped Phoniatr Vocol. 2010;35(1):1-5. https://doi.org/10.1080/14015430903002262. Alharethy S, Baqays A, Mesallam TA, et al. Correlation between allergic rhinitis and laryngopharyngeal reflux. Biomed Res Int. 2018;2018:2951928. https://doi.org/10.1155/2018/2951928. Roth DF, Ferguson BJ. Vocal allergy: recent advances in understanding the role of allergy in dysphonia. Curr Opin Otolaryngol Head Neck Surg. 2010;18(3):176-181. https://doi.org/10.1097/MOO.0b013e32833952af. Eren E, Arslanoglu S, Aktas A, et al. Factors confusing the diagnosis of laryngopharyngeal reflux: the role of allergic rhinitis and inter-rater variability of laryngeal findings. Eur Arch Otorhinolaryngol. 2014;271(4):743-747. https://doi.org/10.1007/s00405-013-2682-y. Jackson-Menaldi CA, Dzul AI, Holland RW. Allergies and vocal fold edema: a preliminary report. J Voice. 1999;13(1):113-122. https://doi.org/10.1016/s0892-1997(99)80065-4. Belafsky PC, Peake J, Smiley-Jewell SM, Verma SP, Dworkin-Valenti J, Pinkerton KE. Soot and house dust mite allergen cause eosinophilic laryngitis in an animal model. Laryngoscope. 2016;126(1):108-112. https://doi.org/10.1002/lary.25467. Mouadeb DA, Belafsky PC, Birchall M, Hood C, Konia T, Pinkerton KE. The effects of allergens and tobacco smoke on the laryngeal mucosa of guinea pigs. Otolaryngol Head Neck Surg. 2009;140(4):493-497. https://doi.org/10.1016/j.otohns.2008.12.034. Dworkin JP, Reidy PM, Stachler RJ, Krouse JH. Effects of sequential Dermatophagoides pteronyssinus antigen stimulation on anatomy and physiology of the larynx. Ear Nose Throat J. 2009;88(2):793-799. Roth DF, Abbott KV, Carroll TL, Ferguson BJ. Evidence for primary laryngeal inhalant allergy: a randomized, double-blinded crossover study. Int Forum Allergy Rhinol. 2013;3(1):10-18. https://doi.org/10.1002/alr.21051. Suzuki T, Okamoto Y, Yonekura S, Okuma Y, Sakurai T, Sakurai D. Characteristics of laryngeal symptoms induced in patients with allergic rhinitis in an environmental challenge chamber. Ann Allergy Asthma Immunol. 2016;116(6):491-496. https://doi.org/10.1016/j.anai.2016.03.011. Brook CD, Platt MP, Reese S, Noordzij JP. Utility of allergy testing in patients with chronic laryngopharyngeal symptoms: is it allergic laryngitis? Otolaryngol Head Neck Surg. 2016;154(1):41-45. https://doi.org/10.1177/0194599815607850. Brook C, Noordzij JP, Russell K, Aliphas A, Platt M. Predictive findings of allergic disease in fiberoptic nasolaryngoscopy. Laryngoscope. 2015;125(2):286-290. https://doi.org/10.1002/lary.24880. Leigh LY, Spergel JM. An in-depth characterization of a large cohort of adult patients with eosinophilic esophagitis. Ann Allergy Asthma Immunol. 2019;122(1):65-72.e1. https://doi.org/10.1016/j.anai.2018.09.452. Furuta GT, Liacouras CA, Collins MH, et al. Eosinophilic esophagitis in children and adults: a systematic review and consensus recommendations for diagnosis and treatment. Gastroenterology. 2007;133(4):1342-1363. https://doi.org/10.1053/j.gastro.2007.08.017. Benninger MS, Strohl M, Holy CE, Hanick AL, Bryson PC. Prevalence of atopic disease in patients with eosinophilic esophagitis. Int Forum Allergy Rhinol. 2017;7(8):757-762. https://doi.org/10.1002/alr.21968. Azzano P, Villard Truc F, Collardeau-Frachon S, Lachaux A. Children with eosinophilic esophagitis in real life: 10 years' experience with a focus on allergic management. Allergol Immunopathol (Madr). 2020;48(3):244-250. https://doi.org/10.1016/j.aller.2019.07.013. Ancellin M, Ricolfi-Waligova L, Clerc-Urmes I, et al. Management of eosinophilic esophagitis in children according to atopic status: a retrospective cohort in northeast of France. Arch Pediatr. 2020;27(3):122-127. https://doi.org/10.1016/j.arcped.2020.02.001. Mohammad AA, Wu SZ, Ibrahim O, et al. Prevalence of atopic comorbidities in eosinophilic esophagitis: a case-control study of 449 patients. J Am Acad Dermatol. 2017;76(3):559-560. https://doi.org/10.1016/j.jaad.2016.08.068. Alves Marcelino JL, Cardoso de Aguiar R, Cabral Duarte F, Celia Costa A, Pereira-Barbosa MA. Pediatric eosinophilic esophagitis in Portugal. Eur Ann Allergy Clin Immunol. 2017;49(2):66-74. Olson AA, Evans MD, Johansson MW, et al. Role of food and aeroallergen sensitization in eosinophilic esophagitis in adults. Ann Allergy Asthma Immunol. 2016;117(4):387-393.e2. https://doi.org/10.1016/j.anai.2016.08.008. Vernon N, Shah S, Lehman E, Ghaffari G. Comparison of atopic features between children and adults with eosinophilic esophagitis. Allergy Asthma Proc. 2014;35(5):409-414. https://doi.org/10.2500/aap.2014.35.3768. Chadha SN, Wang L, Correa H, Moulton D, Hummell DS. Pediatric eosinophilic esophagitis: the Vanderbilt experience. Ann Allergy Asthma Immunol. 2014;113(4):445-451. https://doi.org/10.1016/j.anai.2014.07.020. Castro Jimenez A, Gomez Torrijos E, Garcia Rodriguez R, et al. Demographic, clinical and allergological characteristics of Eosinophilic Esophagitis in a Spanish central region. Allergol Immunopathol (Madr). 2014;42(5):407-414. https://doi.org/10.1016/j.aller.2013.04.004. Spergel JM, Brown-Whitehorn TF, Beausoleil JL, et al. 14 years of eosinophilic esophagitis: clinical features and prognosis. J Pediatr Gastroenterol Nutr. 2009;48(1):30-36. https://doi.org/10.1097/MPG.0b013e3181788282. Roy-Ghanta S, Larosa DF, Katzka DA. Atopic characteristics of adult patients with eosinophilic esophagitis. Clin Gastroenterol Hepatol. 2008;6(5):531-535. https://doi.org/10.1016/j.cgh.2007.12.045. Assa'ad AH, Putnam PE, Collins MH, et al. Pediatric patients with eosinophilic esophagitis: an 8-year follow-up. J Allergy Clin Immunol. 2007;119(3):731-738. https://doi.org/10.1016/j.jaci.2006.10.044. Plaza-Martin AM, Jimenez-Feijoo R, Andaluz C, et al. Polysensitization to aeroallergens and food in eosinophilic esophagitis in a pediatric population. Allergol Immunopathol (Madr). 2007;35(1):35-37. https://doi.org/10.1016/s0301-0546(07)70227-6. Sugnanam KK, Collins JT, Smith PK, et al. Dichotomy of food and inhalant allergen sensitization in eosinophilic esophagitis. Allergy. 2007;62(11):1257-1260. https://doi.org/10.1111/j.1398-9995.2007.01454.x. Remedios M, Campbell C, Jones DM, Kerlin P. Eosinophilic esophagitis in adults: clinical, endoscopic, histologic findings, and response to treatment with fluticasone propionate. Gastrointest Endosc. 2006;63(1):3-12. https://doi.org/10.1016/j.gie.2005.07.049. Guajardo JR, Plotnick LM, Fende JM, Collins MH, Putnam PE, Rothenberg ME. Eosinophil-associated gastrointestinal disorders: a world-wide-web based registry. J Pediatr. 2002;141(4):576-581. https://doi.org/10.1067/mpd.2002.127663. Gonzalez-Cervera J, Arias A, Redondo-Gonzalez O, Cano-Mollinedo MM, Terreehorst I, Lucendo AJ. Association between atopic manifestations and eosinophilic esophagitis: a systematic review and meta-analysis. Ann Allergy Asthma Immunol. 2017;118(5):582-590.e2. https://doi.org/10.1016/j.anai.2017.02.006. Imamura K, Haruma K, Matsumoto H, et al. Clinical and endoscopic characteristics of eosinophilic esophagitis in Japan: a case-control study. Asia Pac Allergy. 2020;10(2):e16. https://doi.org/10.5415/apallergy.2020.10.e16. Armentia A, Martin-Armentia S, Alvarez-Nogal R, Armentia BM, Gayoso MJ, Fernandez-Gonzalez D. Germination of pollen grains in the oesophagus of individuals with eosinophilic oesophagitis. Clin Exp Allergy. 2019;49(4):471-473. https://doi.org/10.1111/cea.13312. Reed CC, Iglesia EGA, Commins SP, Dellon ES. Seasonal exacerbation of eosinophilic esophagitis histologic activity in adults and children implicates role of aeroallergens. Ann Allergy Asthma Immunol. 2019;122(3):296-301. https://doi.org/10.1016/j.anai.2018.12.013. Fahey L, Robinson G, Weinberger K, Giambrone AE, Solomon AB. Correlation between aeroallergen levels and new diagnosis of eosinophilic esophagitis in New York City. J Pediatr Gastroenterol Nutr. 2017;64(1):22-25. https://doi.org/10.1097/MPG.0000000000001245. Ram G, Lee J, Ott M, et al. Seasonal exacerbation of esophageal eosinophilia in children with eosinophilic esophagitis and allergic rhinitis. Ann Allergy Asthma Immunol. 2015;115(3):224-228.e1. https://doi.org/10.1016/j.anai.2015.07.004. Moawad FJ, Veerappan GR, Lake JM, et al. Correlation between eosinophilic oesophagitis and aeroallergens. Aliment Pharmacol Ther. 2010;31(4):509-515. https://doi.org/10.1111/j.1365-2036.2009.04199.x. Almansa C, Krishna M, Buchner AM, et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol. 2009;104(4):828-833. https://doi.org/10.1038/ajg.2008.169. Wang FY, Gupta SK, Fitzgerald JF. Is there a seasonal variation in the incidence or intensity of allergic eosinophilic esophagitis in newly diagnosed children? J Clin Gastroenterol. 2007;41(5):451-453. https://doi.org/10.1097/01.mcg.0000248019.16139.67. Fogg MI, Ruchelli E, Spergel JM. Pollen and eosinophilic esophagitis. J Allergy Clin Immunol. 2003;112(4):796-797. https://doi.org/10.1016/s0091-6749(03)01715-9. Armentia A, Martin-Armentia S, Martin-Armentia B, et al. Is eosinophilic esophagitis an equivalent of pollen allergic asthma? Analysis of biopsies and therapy guided by component resolved diagnosis. Allergol Immunopathol (Madr). 2018;46(2):181-189. https://doi.org/10.1016/j.aller.2017.11.001. Iglesia EGA, Commins SP, Dellon ES. Complete remission of eosinophilic esophagitis with multi-aeroallergen subcutaneous immunotherapy: a case report. J Allergy Clin Immunol Pract. 2021;9(6):2517-2519.e2. https://doi.org/10.1016/j.jaip.2021.01.045. Ramirez RM, Jacobs RL. Eosinophilic esophagitis treated with immunotherapy to dust mites. J Allergy Clin Immunol. 2013;132(2):503-504. https://doi.org/10.1016/j.jaci.2013.04.053. Lucendo AJ, Arias A, Redondo-Gonzalez O, Gonzalez-Cervera J. Seasonal distribution of initial diagnosis and clinical recrudescence of eosinophilic esophagitis: a systematic review and meta-analysis. Allergy. 2015;70(12):1640-1650. https://doi.org/10.1111/all.12767. Elias MK, Kopacova J, Arora AS, et al. The diagnosis of esophageal eosinophilia is not increased in the summer months. Dysphagia. 2015;30(1):67-73. https://doi.org/10.1007/s00455-014-9574-1. Frederickson NW, Bayman L, Valestin J, et al. Lack of seasonal variation in the incidence of eosinophilic oesophagitis in adolescent and adult non-PPI-responsive oesophageal eosinophilia midwestern US populations. United European Gastroenterol J. 2014;2(2):69-76. https://doi.org/10.1177/2050640614525152. Meltzer EO, Blaiss MS, Derebery MJ, et al. Burden of allergic rhinitis: results from the Pediatric Allergies in America survey. J Allergy Clin Immunol. 2009;124(3 suppl):S43-S70. https://doi.org/10.1016/j.jaci.2009.05.013. Meltzer EO, Nathan R, Derebery J, et al. Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey. Allergy Asthma Proc. 2009;30(3):244-254. https://doi.org/10.2500/aap.2009.30.3230. Young T, Finn L, Palta M. Chronic nasal congestion at night is a risk factor for snoring in a population-based cohort study. Arch Intern Med. 2001;161(12):1514-1519. https://doi.org/10.1001/archinte.161.12.1514. Staevska MT, Mandajieva MA, Dimitrov VD. Rhinitis and sleep apnea. Curr Allergy Asthma Rep. 2004;4(3):193-199. https://doi.org/10.1007/s11882-004-0026-0. Morris LG, Burschtin O, Lebowitz RA, Jacobs JB, Lee KC. Nasal obstruction and sleep-disordered breathing: a study using acoustic rhinometry. Am J Rhinol. 2005;19(1):33-39. Storms WW. Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. J Allergy Clin Immunol. 2004;114(5 suppl):S146-S153. https://doi.org/10.1016/j.jaci.2004.08.045. Shedden A. Impact of nasal congestion on quality of life and work productivity in allergic rhinitis: findings from a large online survey. Treat Respir Med. 2005;4(6):439-446. https://doi.org/10.2165/00151829-200504060-00007. Reinberg A, Gervais P, Levi F, Smolensky M, Del Cerro L, Ugolini C. Circadian and circannual rhythms of allergic rhinitis: an epidemiologic study involving chronobiologic methods. J Allergy Clin Immunol. 1988;81(1):51-62. https://doi.org/10.1016/0091-6749(88)90220-5. Tobaldini E, Costantino G, Solbiati M, et al. Sleep, sleep deprivation, autonomic nervous system and cardiovascular diseases. Neurosci Biobehav Rev. 2017;74(pt B):321-329. https://doi.org/10.1016/j.neubiorev.2016.07.004. Ferguson BJ. Influences of allergic rhinitis on sleep. Otolaryngol Head Neck Surg. 2004;130(5):617-629. https://doi.org/10.1016/j.otohns.2004.02.001. Tashiro M, Mochizuki H, Iwabuchi K, et al. Roles of histamine in regulation of arousal and cognition: functional neuroimaging of histamine H1 receptors in human brain. Life Sci. 2002;72(4-5):409-414. https://doi.org/10.1016/s0024-3205(02)02276-2. Sri Kantha S, Matsumura H, Kubo E, et al. Effects of prostaglandin D2, lipoxins and leukotrienes on sleep and brain temperature of rats. Prostaglandins Leukot Essent Fatty Acids. 1994;51(2):87-93. https://doi.org/10.1016/0952-3278(94)90083-3. Pasha S, Kumar S, Chatterjee AB, Krishnaswamy G. An obstructive sleep apnea primer: what the practicing allergist needs to know. Ann Allergy Asthma Immunol. 2017;118(3):259-268. https://doi.org/10.1016/j.anai.2016.07.033. Chirakalwasan N, Ruxrungtham K. The linkage of allergic rhinitis and obstructive sleep apnea. Asian Pac J Allergy Immunol. 2014;32(4):276-286. Mullington JM, Hinze-Selch D, Pollmacher T. Mediators of inflammation and their interaction with sleep: relevance for chronic fatigue syndrome and related conditions. Ann N Y Acad Sci. 2001;933:201-210. https://doi.org/10.1111/j.1749-6632.2001.tb05825.x. Tan SN, Abdullah B. The association between obstructive aleep apnea and allergic rhinitis: current literature review. Curr Respir Med Rev. 2021;17(1):13-19. Tankere F, Maisonobe T, Naccache L, et al. Further evidence for a central reorganisation of synaptic connectivity in patients with hypoglossal-facial anastomosis in man. Brain Res. 2000;864(1):87-94. https://doi.org/10.1016/s0006-8993(00)02177-6. Horner RL, Innes JA, Murphy K, Guz A. Evidence for reflex upper airway dilator muscle activation by sudden negative airway pressure in man. J Physiol. 1991;436:15-29. https://doi.org/10.1113/jphysiol.1991.sp018536. White DP, Edwards JK, Shea SA. Local reflex mechanisms: influence on basal genioglossal muscle activation in normal subjects. Sleep. 1998;21(7):719-728. https://doi.org/10.1093/sleep/21.7.719. Lo YL, Jordan AS, Malhotra A, et al. Influence of wakefulness on pharyngeal airway muscle activity. Thorax. 2007;62(9):799-805. https://doi.org/10.1136/thx.2006.072488. Baraniuk JN, Merck SJ. Nasal reflexes: implications for exercise, breathing, and sex. Curr Allergy Asthma Rep. 2008;8(2):147-153. https://doi.org/10.1007/s11882-008-0025-7. Basner RC, Simon PM, Schwartzstein RM, Weinberger SE, Weiss JW. Breathing route influences upper airway muscle activity in awake normal adults. J Appl Physiol (1985). 1989;66(4):1766-1771. https://doi.org/10.1152/jappl.1989.66.4.1766. Shintaro C, Park CS. Establishing a patent nasal passage in obstructive sleep apnea. Sleep Med Clin. 2019;14(1):41-50. https://doi.org/10.1016/j.jsmc.2018.10.005. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342(19):1378-1384. https://doi.org/10.1056/NEJM200005113421901. Kuniyoshi FH, Garcia-Touchard A, Gami AS, et al. Day-night variation of acute myocardial infarction in obstructive sleep apnea. J Am Coll Cardiol. 2008;52(5):343-346. https://doi.org/10.1016/j.jacc.2008.04.027. Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am J Respir Crit Care Med. 2005;172(11):1447-1451. https://doi.org/10.1164/rccm.200505-702OC. Kanagala R, Murali NS, Friedman PA, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107(20):2589-2594. https://doi.org/10.1161/01.CIR.0000068337.25994.21. Wang H, Parker JD, Newton GE, et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. J Am Coll Cardiol. 2007;49(15):1625-1631. https://doi.org/10.1016/j.jacc.2006.12.046. Marcus CL, Brooks LJ, Draper KA, et al. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012;130(3):576-584. https://doi.org/10.1542/peds.2012-1671. Ali NJ, Pitson D, Stradling JR. Natural history of snoring and related behaviour problems between the ages of 4 and 7 years. Arch Dis Child. 1994;71(1):74-76. https://doi.org/10.1136/adc.71.1.74. Isaiah A, Ernst T, Cloak CC, Clark DB, Chang L. Association between habitual snoring and cognitive performance among a large sample of preadolescent children. JAMA Otolaryngol Head Neck Surg. 2021;147(5):426-433. https://doi.org/10.1001/jamaoto.2020.5712. Jan JE, Reiter RJ, Bax MC, Ribary U, Freeman RD, Wasdell MB. Long-term sleep disturbances in children: a cause of neuronal loss. Eur J Paediatr Neurol. 2010;14(5):380-390. https://doi.org/10.1016/j.ejpn.2010.05.001. Morris LG, Burschtin O, Setlur J, et al. REM-associated nasal obstruction: a study with acoustic rhinometry during sleep. Otolaryngol Head Neck Surg. 2008;139(5):619-623. https://doi.org/10.1016/j.otohns.2008.08.017. Huseni S, Gutierrez MJ, Rodriguez-Martinez CE, et al. The link between rhinitis and rapid-eye-movement sleep breathing disturbances in children with obstructive sleep apnea. Am J Rhinol Allergy. 2014;28(1):56-61. https://doi.org/10.2500/ajra.2014.28.3994. Kimura A, Chiba S, Capasso R, et al. Phase of nasal cycle during sleep tends to be associated with sleep stage. Laryngoscope. 2013;123(8):2050-2055. https://doi.org/10.1002/lary.23986. Skirko JR, James KT, Shusterman DJ, Weaver EM. Association of allergic rhinitis with change in nasal congestion in new continuous positive airway pressure users. JAMA Otolaryngol Head Neck Surg. 2020;146(6):523-529. https://doi.org/10.1001/jamaoto.2020.0261. Inoue A, Chiba S, Matsuura K, Osafune H, Capasso R, Wada K. Nasal function and CPAP compliance. Auris Nasus Larynx. 2019;46(4):548-558. https://doi.org/10.1016/j.anl.2018.11.006. Iwata N, Nakata S, Inada H, Kimura A, Hirata M, Yasuma F. Clinical indication of nasal surgery for the CPAP intolerance in obstructive sleep apnea with nasal obstruction. Auris Nasus Larynx. 2020;47(6):1018-1022. https://doi.org/10.1016/j.anl.2020.06.005. Camacho M, Riaz M, Capasso R, et al. The effect of nasal surgery on continuous positive airway pressure device use and therapeutic treatment pressures: a systematic review and meta-analysis. Sleep. 2015;38(2):279-286. https://doi.org/10.5665/sleep.4414. Nakata S, Noda A, Yagi H, et al. Nasal resistance for determinant factor of nasal surgery in CPAP failure patients with obstructive sleep apnea syndrome. Rhinology. 2005;43(4):296-299. Poirier J, George C, Rotenberg B. The effect of nasal surgery on nasal continuous positive airway pressure compliance. Laryngoscope. 2014;124(1):317-319. https://doi.org/10.1002/lary.24131. Awad MI, Kacker A. Nasal obstruction considerations in sleep apnea. Otolaryngol Clin North Am. 2018;51(5):1003-1009. https://doi.org/10.1016/j.otc.2018.05.012. Craig TJ, Sherkat A, Safaee S. Congestion and sleep impairment in allergic rhinitis. Curr Allergy Asthma Rep. 2010;10(2):113-121. https://doi.org/10.1007/s11882-010-0091-5. Jalalia MM, Soleimanib R, Jalali SM, Mohisafata B. Evaluation of the effects of allergic rhinitis treatment on sexual functioning, sleep, and fatigue. Revue Francaise d-Allergologie. 2020;60(2):55-60. Kiely JL, Nolan P, McNicholas WT. Intranasal corticosteroid therapy for obstructive sleep apnoea in patients with co-existing rhinitis. Thorax. 2004;59(1):50-55. Jacobi H, Rehm D, Nolte H, Andersen KF, Demoly P. Effect of house dust mite SLIT-tablet treatment on quality of sleep in allergic rhinitis patients. J Allergy Clin Immunol. 2019;143:AB286. Mann RD, Pearce GL, Dunn N, Shakir S. Sedation with "non-sedating" antihistamines: four prescription-event monitoring studies in general practice. BMJ. 2000;320(7243):1184-1186. https://doi.org/10.1136/bmj.320.7243.1184. Hindmarch I, Shamsi Z. Antihistamines: models to assess sedative properties, assessment of sedation, safety and other side-effects. Clin Exp Allergy. 1999;29(suppl 3):133-142. https://doi.org/10.1046/j.1365-2222.1999.0290s3133.x. Chen ST, Lu KH, Sun HL, Chang WT, Lue KH, Chou MC. Randomized placebo-controlled trial comparing montelukast and cetirizine for treating perennial allergic rhinitis in children aged 2-6 yr. Pediatr Allergy Immunol. 2006;17(1):49-54. https://doi.org/10.1111/j.1399-3038.2005.00351.x. Clarenbach CF, Kohler M, Senn O, Thurnheer R, Bloch KE. Does nasal decongestion improve obstructive sleep apnea? J Sleep Res. 2008;17(4):444-449. https://doi.org/10.1111/j.1365-2869.2008.00667.x. Na HG, Sung CM, Yang HC. Effect of continuous positive airway pressure on symptoms of allergic rhinitis in patients with obstructive sleep apnea. World Allergy Organization J. 2020;13(8):100271. Chuang C, Tsai M, Tsai Y, Kuo C, Hsu C, Hung J. Increased risk of sleep apnea in patients of allergic rhinitis: a nationwide population-based study. presented at: American Thoracic Society; 2019; Dallas, TX. Wongvilairat S, Assanasen P, Banhiran W, Tantilipikorn P, Bunnag C. The prevalence of high risk of obstructive sleep apnea in patients with allergic rhinitis. Asian Pacific Journal of Allergy and Immunology. 2022;40(3):205-209. doi: https://doi.org/10.12932/ap-141218-0458. WHO Director-General's opening remarks at the media briefing on COVID-19 - 11 March 2020. Accessed November 13, 2021. https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-media-briefing-on-covid-19-11-march-2020. Mustafa SS, Shaker MS, Munblit D, Greenhawt M. Paediatric allergy practice in the era of coronavirus disease 2019. Curr Opin Allergy Clin Immunol. 2021;21(2):159-165. https://doi.org/10.1097/ACI.0000000000000727. Izquierdo-Dominguez A, Rojas-Lechuga MJ, Alobid I. Management of allergic diseases during COVID-19 outbreak. Curr Allergy Asthma Rep. 2021;21(2):8. https://doi.org/10.1007/s11882-021-00989-x. Searing DA, Dutmer CM, Fleischer DM, et al. A phased approach to resuming suspended allergy/immunology clinical services. J Allergy Clin Immunol Pract. 2020;8(7):2125-2134. https://doi.org/10.1016/j.jaip.2020.05.012. Pfaar O, Klimek L, Jutel M, et al. COVID-19 pandemic: practical considerations on the organization of an allergy clinic - an EAACI/ARIA Position Paper. Allergy. 2021;76(3):648-676. https://doi.org/10.1111/all.14453. Ozturk AB, Baccioglu A, Soyer O, Civelek E, Sekerel BE, Bavbek S. Change in allergy practice during the COVID-19 pandemic. Int Arch Allergy Immunol. 2021;182(1):49-52. https://doi.org/10.1159/000512079. Winders T, DuBuske L, Bukstein DA, Meltzer EO, Wallace D, Rance K. Shifts in allergy practice in a COVID-19 world: implications of pre-COVID-19 national health care provider and patient surveys of treatments for nasal allergies. Allergy Asthma Proc. 2021;42(4):301-309. https://doi.org/10.2500/aap.2021.42.210035. Tsao LR, Villanueva SA, Pines DA, et al. Impact of rapid transition to telemedicine-based delivery on allergy/immunology care during COVID-19. J Allergy Clin Immunol Pract. 2021;9(7):2672-2679.e2. https://doi.org/10.1016/j.jaip.2021.04.018. Ren J, Pang W, Luo Y, et al. Impact of allergic rhinitis and asthma on COVID-19 infection, hospitalization, and mortality. J Allergy Clin Immunol Pract. 2022;10(1):124-133. https://doi.org/10.1016/j.jaip.2021.10.049. Beken B, Ozturk GK, Aygun FD, Aydogmus C, Akar HH. Asthma and allergic diseases are not risk factors for hospitalization in children with coronavirus disease 2019. Ann Allergy Asthma Immunol. 2021;126(5):569-575. https://doi.org/10.1016/j.anai.2021.01.018. Yao Y, Wang H, Liu Z. Expression of ACE2 in airways: Implication for COVID-19 risk and disease management in patients with chronic inflammatory respiratory diseases. Clin Exp Allergy. 2020;50(12):1313-1324. https://doi.org/10.1111/cea.13746. Keswani A, Dhana K, Rosenthal JA, Moore D, Mahdavinia M. Atopy is predictive of a decreased need for hospitalization for coronavirus disease 2019. Ann Allergy Asthma Immunol. 2020;125(4):479-481. https://doi.org/10.1016/j.anai.2020.07.012. Du H, Dong X, Zhang JJ, et al. Clinical characteristics of 182 pediatric COVID-19 patients with different severities and allergic status. Allergy. 2021;76(2):510-532. https://doi.org/10.1111/all.14452. Darabi A, Dehghanfard M, Jozan S, et al. Investigating the association between allergic diseases and COVID-19 in 400 Iranian patients. Allergol Immunopathol (Madr). 2021;49(5):9-15. https://doi.org/10.15586/aei.v49i5.105. Ming W, Zuo J, Han J, Chen J. The impact of comorbid allergic airway disease on the severity and mortality of COVID-19: a systematic review and meta-analysis. Eur Arch Otorhinolaryngol. 2022;279(4):1675-1690. https://doi.org/10.1007/s00405-021-07072-1. Guvey A. How does allergic rhinitis impact the severity of COVID-19?: a case-control study. Eur Arch Otorhinolaryngol. 2021;278(11):4367-4371. https://doi.org/10.1007/s00405-021-06836-z. Hagemann J, Onorato GL, Jutel M, et al. Differentiation of COVID-19 signs and symptoms from allergic rhinitis and common cold: an ARIA-EAACI-GA(2) LEN consensus. Allergy. 2021;76(8):2354-2366. https://doi.org/10.1111/all.14815. Bruno C, Locatello LG, Cilona M, et al. Seasonal allergic rhinitis symptoms in relation to COVID-19. Allergy Rhinol (Providence). 2020;11:2152656720968804. https://doi.org/10.1177/2152656720968804. Ferreli F, Gaino F, Russo E, et al. Clinical presentation at the onset of COVID-19 and allergic rhinoconjunctivitis. J Allergy Clin Immunol Pract. 2020;8(10):3587-3589. https://doi.org/10.1016/j.jaip.2020.08.009. Jin L, Fan K, Tan S, Liu S, Wang Y, Yu S. Analysis of the characteristics of outpatient and emergency diseases in the department of otolaryngology during the "COVID-19" pandemic. Sci Prog. 2021;104(3):368504211036319. https://doi.org/10.1177/00368504211036319. Yoon D, Kim KE, Lee JE, Kim M, Kim JH. Impact of the coronavirus disease 2019 (COVID-19) pandemic on medical use of military hospitals in Korea. J Korean Med Sci. 2021;36(28):e204. https://doi.org/10.3346/jkms.2021.36.e204. Choi HG, Kong IG. Asthma, allergic rhinitis, and atopic dermatitis incidence in Korean adolescents before and after COVID-19. J Clin Med. 2021;10(15):3446. https://doi.org/10.3390/jcm10153446. Dayal AK, Sinha V. Trend of allergic rhinitis post COVID-19 pandemic: a retrospective observational study. Indian J Otolaryngol Head Neck Surg. 2020:1-3. https://doi.org/10.1007/s12070-020-02223-y. Gelardi M, Trecca E, Fortunato F, et al. COVID-19 lockdown and seasonal allergic rhinitis: our experience in 40 patients. Acta Biomed. 2021;92(2):e2021215. https://doi.org/10.23750/abm.v92i2.10953. Sozener ZC, Ozturk BO, Aydin O, et al. Coincidence of pollen season and coronavirus disease 2019 pandemic: less time outdoors - lesser allergy symptoms in 2020. Asia Pac Allergy. 2021;11(2):e16. https://doi.org/10.5415/apallergy.2021.11.e16. Zhang Y, Lan F, Zhang L. Advances and highlights in allergic rhinitis. Allergy. 2021;76(11):3383-3389. https://doi.org/10.1111/all.15044. Yucel E, Suleyman A, Hizli Demirkale Z, Guler N, Tamay ZU, Ozdemir C. ‘Stay at home’: is it good or not for house dust mite sensitized children with respiratory allergies? Pediatr Allergy Immunol. 2021;32(5):963-970. https://doi.org/10.1111/pai.13477. Gallo O, Bruno C, Orlando P, Locatello LG. The impact of lockdown on allergic rhinitis: what is good and what is bad? Laryngoscope Investig Otolaryngol. 2020;5(5):807-808. https://doi.org/10.1002/lio2.459. Dror AA, Eisenbach N, Marshak T, et al. Reduction of allergic rhinitis symptoms with face mask usage during the COVID-19 pandemic. J Allergy Clin Immunol Pract. 2020;8(10):3590-3593. https://doi.org/10.1016/j.jaip.2020.08.035. Mengi E, Kara CO, Alpturk U, Topuz B. The effect of face mask usage on the allergic rhinitis symptoms in patients with pollen allergy during the covid-19 pandemic. Am J Otolaryngol. 2022;43(1):103206. https://doi.org/10.1016/j.amjoto.2021.103206. Patella V, Delfino G, Florio G, et al. Management of the patient with allergic and immunological disorders in the pandemic COVID-19 era. Clin Mol Allergy. 2020;18:18. https://doi.org/10.1186/s12948-020-00134-5. Wang Y, Shi C, Yang Y, et al. Anxiety and depression in allergic rhinitis patients during COVID-19 pandemic in Wuhan, China. Asian Pac J Allergy Immunol. 2021. https://doi.org/10.12932/AP-140820-0941. Gonzalez-Diaz SN, Martin B, Villarreal-Gonzalez RV, et al. Psychological impact of the COVID-19 pandemic on patients with allergic diseases. World Allergy Organ J. 2021;14(3):100510. https://doi.org/10.1016/j.waojou.2021.100510. Radulesco T, Verillaud B, Bequignon E, et al. COVID-19 and rhinology, from the consultation room to the operating theatre. Eur Ann Otorhinolaryngol Head Neck Dis. 2020;137(4):309-314. https://doi.org/10.1016/j.anorl.2020.04.013. De Luca P, Scarpa A, Ralli M, et al. Nasal, pharyngeal and laryngeal endoscopy procedures during COVID-19 pandemic: available recommendations from national and international societies. Eur Arch Otorhinolaryngol. 2020;277(7):2151-2153. https://doi.org/10.1007/s00405-020-06028-1. Klimek L, Jutel M, Bousquet J, et al. Management of patients with chronic rhinosinusitis during the COVID-19 pandemic - an EAACI position paper. Allergy. 2021;76(3):677-688. https://doi.org/10.1111/all.14629. Zhang Y, Zhang L. Management practice of allergic rhinitis in china during the COVID-19 pandemic. Allergy Asthma Immunol Res. 2020;12(4):738-742. https://doi.org/10.4168/aair.2020.12.4.738. McCarty EB, Soldatova L, Brant JA, Newman JG. Innovations in otorhinolaryngology in the age of COVID-19: a systematic literature review. World J Otorhinolaryngol Head Neck Surg. 2022;8(3):224-238. https://doi.org/10.1016/j.wjorl.2021.01.001. Lee JH, Lee Y, Lee SY, et al. Management of allergic patients during the COVID-19 pandemic in Asia. Allergy Asthma Immunol Res. 2020;12(5):783-791. https://doi.org/10.4168/aair.2020.12.5.783. CDC - COVID-19 and Your Health - Centers for Disease Control and Prevention. Accessed November 13, 2021. https://www.cdc.gov/coronavirus/2019-ncov/prevent-getting-sick/prevention.html. Cianferoni A, Votto M. COVID-19 and allergy: how to take care of allergic patients during a pandemic? Pediatr Allergy Immunol. 2020;31(suppl 26):96-101. https://doi.org/10.1111/pai.13367. Klimek L, Pfaar O, Worm M, et al. Allergen immunotherapy in the current COVID-19 pandemic: a position paper of AeDA, ARIA, EAACI, DGAKI and GPA: position paper of the German ARIA Group(A) in cooperation with the Austrian ARIA Group(B), the Swiss ARIA Group(C), German Society for Applied Allergology (AEDA)(D), German Society for Allergology and Clinical Immunology (DGAKI)(E), Society for Pediatric Allergology (GPA)(F) in cooperation with AG Clinical Immunology, Allergology and Environmental Medicine of the DGHNO-KHC(G) and the European Academy of Allergy and Clinical Immunology (EAACI)(H). Allergol Select. 2020;4:44-52. https://doi.org/10.5414/ALX02147E. Matos S, Sharma A, Crosby D. Objective assessment of aerosolization during transnasal endoscopy: a systematic review. Otolaryngol Head Neck Surg. 2021:1945998211050632. https://doi.org/10.1177/01945998211050632. Thamboo A, Lea J, Sommer DD, et al. Clinical evidence based review and recommendations of aerosol generating medical procedures in otolaryngology - head and neck surgery during the COVID-19 pandemic. J Otolaryngol Head Neck Surg. 2020;49(1):28. https://doi.org/10.1186/s40463-020-00425-6. Workman AD, Welling DB, Carter BS, et al. Endonasal instrumentation and aerosolization risk in the era of COVID-19: simulation, literature review, and proposed mitigation strategies. Int Forum Allergy Rhinol. 2020;10(7):798-805. https://doi.org/10.1002/alr.22577. Sharma D, Rubel KE, Ye MJ, et al. Cadaveric simulation of endoscopic endonasal procedures: analysis of droplet splatter patterns during the COVID-19 pandemic. Otolaryngol Head Neck Surg. 2020;163(1):145-150. https://doi.org/10.1177/0194599820929274. Workman AD, Jafari A, Welling DB, et al. Airborne aerosol generation during endonasal procedures in the era of COVID-19: risks and recommendations. Otolaryngol Head Neck Surg. 2020;163(3):465-470. https://doi.org/10.1177/0194599820931805. Sharma D, Campiti VJ, Ye MJ, et al. Aerosol generation during routine rhinologic surgeries and in-office procedures. Laryngoscope Investig Otolaryngol. 2021;6(1):49-57. https://doi.org/10.1002/lio2.520. Murr AT, Lenze NR, Gelpi MW, et al. Quantification of aerosol concentrations during endonasal instrumentation in the clinic setting. Laryngoscope. 2021;131(5):E1415-E1421. https://doi.org/10.1002/lary.29122. Tan VYJ, Zhang EZY, Daniel D, et al. Respiratory droplet generation and dispersal during nasoendoscopy and upper respiratory swab testing. Head Neck. 2020;42(10):2779-2781. https://doi.org/10.1002/hed.26347. Di Maio P, Traverso D, Iocca O, De Virgilio A, Spriano G, Giudice M. Endoscopic nasopharyngoscopy and ENT specialist safety in the COVID 19 era: the back endoscopy approach to the patient. Eur Arch Otorhinolaryngol. 2020;277(9):2647-2648. https://doi.org/10.1007/s00405-020-06093-6. Olaguibel JM, Alobid I, Alvarez Puebla M, et al. Functional examination of the upper and lower airways in asthma and respiratory allergic diseases: considerations in the post-SARS-CoV-2 era. J Investig Allergol Clin Immunol. 2021;31(1):17-35. https://doi.org/10.18176/jiaci.0625. Suzaki I, Kobayashi H. Coronavirus disease 2019 and nasal conditions: a review of current evidence. In Vivo. 2021;35(3):1409-1417. https://doi.org/10.21873/invivo.12393. Liu DT, Phillips KM, Speth MM, Besser G, Mueller CA, Sedaghat AR. Portable HEPA purifiers to eliminate airborne SARS-CoV-2: a systematic review. Otolaryngol Head Neck Surg. 2022;166(4):615-622. https://doi.org/10.1177/01945998211022636. Christopherson DA, Yao WC, Lu M, Vijayakumar R, Sedaghat AR. High-efficiency particulate air filters in the era of COVID-19: function and efficacy. Otolaryngol Head Neck Surg. 2020;163(6):1153-1155. https://doi.org/10.1177/0194599820941838. Bousquet J, Akdis CA, Jutel M, et al. Intranasal corticosteroids in allergic rhinitis in COVID-19 infected patients: an ARIA-EAACI statement. Allergy. 2020;75(10):2440-2444. https://doi.org/10.1111/all.14302. Klimek L, Pfaar O, Hamelmann E, et al. COVID-19 vaccination and allergen immunotherapy (AIT) - a position paper of the German Society for Applied Allergology (AeDA) and the German Society for Allergology and Clinical Immunology (DGAKI). Allergol Select. 2021;5:251-259. https://doi.org/10.5414/ALX02245E. Nittner-Marszalska M, Rosiek-Biegus M, Kopec A, et al. Pfizer-BioNTech COVID-19 vaccine tolerance in allergic versus non-allergic individuals. Vaccines (Basel). 2021;9(6):553. https://doi.org/10.3390/vaccines9060553. Ding M, Dong X, Sun YL, et al. Recent advances and developments in COVID-19 in the context of allergic diseases. Clin Transl Allergy. 2021;11(7):e12065. https://doi.org/10.1002/clt2.12065. Gani F, Cottini M, Landi M, et al., Allergic rhinitis and COVID-19: friends or foes? Eur Ann Allergy Clin Immunol. 2022;54(2):53-59. doi: https://doi.org/10.23822/EurAnnACI.1764-1489.234. Adir Y, Humbert M, Saliba W. COVID-19 risk and outcomes in adult asthmatic patients treated with biologics or systemic corticosteroids: nationwide real-world evidence. J Allergy Clin Immunol. 2021;148(2):361-367.e13. https://doi.org/10.1016/j.jaci.2021.06.006. Strauss R, Jawhari N, Attaway AH, et al. Intranasal corticosteroids are associated with better outcomes in coronavirus disease 2019. J Allergy Clin Immunol Pract. 2021;9(11):3934-3940.e9. https://doi.org/10.1016/j.jaip.2021.08.007. Bozek A, Winterstein J. Montelukast's ability to fight COVID-19 infection. J Asthma. 2021;58(10):1348-1349. https://doi.org/10.1080/02770903.2020.1786112. Larenas-Linnemann DE, Ortega-Martell JA, Blandon-Vijil MV, et al. Coronavirus disease 2019, allergic diseases, and allergen immunotherapy: possible favorable mechanisms of interaction. Allergy Asthma Proc. 2021;42(3):187-197. https://doi.org/10.2500/aap.2021.42.210013. Pfaar O, Agache I, Bonini M, et al. COVID-19 pandemic and allergen immunotherapy-an EAACI survey. Allergy. 2021;76(11):3504-3516. https://doi.org/10.1111/all.14793. Koca Kalkan I, Ates H, Aksu K, et al. Real-life adherence to subcutaneous immunotherapy: what has changed in the era of the COVID-19 pandemic. World Allergy Organ J. 2021;14(7):100558. https://doi.org/10.1016/j.waojou.2021.100558. Aytekin ES, Soyer O, Sekerel BE, Sahiner UM. Subcutaneous allergen immunotherapy in children: real life compliance and effect of COVID-19 pandemic on compliance. Int Arch Allergy Immunol. 2021;182(7):631-636. https://doi.org/10.1159/000514587. Yegit OO, Demir S, Unal D, et al. Adherence to subcutaneous immunotherapy with aeroallergens in real-life practice during the COVID-19 pandemic. Allergy. 2022;77(1):197-206. https://doi.org/10.1111/all.14876. Shaker MS, Mosnaim G, Oppenheimer J, Stukus D, Abrams EM, Greenhawt M. Health and economic outcomes of home maintenance allergen immunotherapy in select patients with high health literacy during the COVID-19 pandemic: a cost-effectiveness analysis during exceptional times. J Allergy Clin Immunol Pract. 2020;8(7):2310-2321.e4. https://doi.org/10.1016/j.jaip.2020.05.007. Busse WW, Morgan WJ, Gergen PJ, et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med. 2011;364(11):1005-1015. https://doi.org/10.1056/NEJMoa1009705. Teach SJ, Gill MA, Togias A, et al. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. J Allergy Clin Immunol. 2015;136(6):1476-1485. https://doi.org/10.1016/j.jaci.2015.09.008. Esquivel A, Busse WW, Calatroni A, et al. Effects of omalizumab on rhinovirus infections, illnesses, and exacerbations of asthma. Am J Respir Crit Care Med. 2017;196(8):985-992. https://doi.org/10.1164/rccm.201701-0120OC. Hammad H, Lambrecht BN. The basic immunology of asthma. Cell. 2021;184(6):1469-1485. https://doi.org/10.1016/j.cell.2021.02.016. Denlinger LC, Phillips BR, Ramratnam S, et al. Inflammatory and comorbid features of patients with severe asthma and frequent exacerbations. Am J Respir Crit Care Med. 2017;195(3):302-313. https://doi.org/10.1164/rccm.201602-0419OC. Schroeder JT, Bieneman AP, Xiao H, et al. TLR9- and FcepsilonRI-mediated responses oppose one another in plasmacytoid dendritic cells by down-regulating receptor expression. J Immunol. 2005;175(9):5724-5731. https://doi.org/10.4049/jimmunol.175.9.5724. Liang C, Yang Z, Zou Q, Zhou M, Liu H, Fan J. Construction of an irreversible allergic rhinitis-induced olfactory loss mouse model. Biochem Biophys Res Commun. 2019;513(3):635-641. https://doi.org/10.1016/j.bbrc.2019.03.110. Gupta N, Harit A, Taneja HC, Kumar R, Tripathi AK. Olfaction and its correlates in allergic rhinitis: a case control study. Indian J Otolaryngol Head Neck Surg. 2019;71(suppl 3):1782-1786. https://doi.org/10.1007/s12070-017-1149-7. Bahri R, Custovic A, Korosec P, et al. Mast cell activation test in the diagnosis of allergic disease and anaphylaxis. J Allergy Clin Immunol. 2018;142(2):485-496, e16. https://doi.org/10.1016/j.jaci.2018.01.043. Bahri R, Bulfone-Paus S. Mast cell activation test (MAT). Methods Mol Biol. 2020;2163:227-238. https://doi.org/10.1007/978-1-0716-0696-4_19.
معلومات مُعتمدة:	MR/K002449/1 United Kingdom MRC_ Medical Research Council; MR/S002359/1 United Kingdom MRC_ Medical Research Council; MR/T031565/1 United Kingdom MRC_ Medical Research Council; MR/K002449/2 United Kingdom MRC_ Medical Research Council; MR/S025340/1 United Kingdom MRC_ Medical Research Council; MR/W028352/1 United Kingdom MRC_ Medical Research Council
فهرسة مساهمة:	Keywords: IgE; allergen extract; allergen immunotherapy; allergic rhinitis; allergy; antihistamine; asthma; atopic dermatitis; avoidance; biologic; cockroach; conjunctivitis; consensus; corticosteroid; cough; cromolyn; decongestant; environment; eosinophilic esophagitis; epicutaneous; epidemiology; evidence-based medicine; food allergy; house dust mite; immunoglobulin E; immunotherapy; inhalant allergy; leukotriene; microbiome; occupational rhinitis; omalizumab; pediatric; perennial; pet dander; pollen; probiotic; rhinitis; rhinosinusitis; saline; seasonal; sensitization; sinusitis; socioeconomic; specific IgE; subcutaneous immunotherapy; sublingual immunotherapy; systematic review; total IgE; transcutaneous immunotherapy; validated survey
المشرفين على المادة:	9004-66-4 (Iron-Dextran Complex) 0 (Allergens)
تواريخ الأحداث:	Date Created: 20230306 Date Completed: 20230320 Latest Revision: 20240228
رمز التحديث:	20240228
DOI:	10.1002/alr.23090
PMID:	36878860
قاعدة البيانات:	MEDLINE

View record at Wiley

Full Text Finder

الوصف
تدمد:	2042-6984
DOI:	10.1002/alr.23090